data_2m26_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m26 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.05 -1.463 . . . . 75.25 107.05 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.18 6.15 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.095 2.53 . . . . 72.15 114.528 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.62 -171.77 16.78 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.595 -1.802 . . . . 72.31 108.595 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.33 163.34 34.68 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.871 1.668 . . . . 64.21 109.609 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.15 152.12 81.3 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.651 1.568 . . . . 75.35 111.287 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.9 m -133.61 -173.93 3.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.854 2.462 . . . . 72.32 108.627 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.91 27.32 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.898 2.879 . . . . 65.31 114.868 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.73 137.71 23.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.036 -0.727 . . . . 72.32 109.036 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -134.04 159.23 41.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.797 0.839 . . . . 73.14 111.227 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -144.18 138.95 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.864 -1.902 . . . . 72.31 105.864 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -135.47 159.99 39.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.675 1.99 . . . . 74.42 108.404 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -83.69 170.92 13.73 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.987 -1.071 . . . . 73.44 108.4 171.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 161.6 29.15 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 123.888 0.875 . . . . 61.13 110.26 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.72 -27.77 52.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.57 1.513 . . . . 73.45 110.968 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.55 23.37 13.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.114 1.366 . . . . 75.42 110.854 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.24 -149.1 21.03 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.652 -1.28 . . . . 73.14 111.791 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 144.32 40.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.507 2.153 . . . . 73.25 107.5 152.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -80.13 141.67 35.52 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.947 1.299 . . . . 62.52 108.084 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.97 174.65 10.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.003 0.819 . . . . 75.35 110.015 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -175.31 155.91 1.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.013 2.525 . . . . 74.23 108.059 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -158.57 167.08 30.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.323 1.449 . . . . 75.44 109.316 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -138.65 162.99 49.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 125.866 1.666 . . . . 64.44 111.682 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.91 174.79 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.186 3.258 . . . . 73.34 113.808 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.92 179.01 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.88 3.054 . . . . 71.24 113.646 168.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.0 t -138.36 73.27 1.43 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 105.069 -2.197 . . . . 73.44 105.069 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 m -141.48 -66.34 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 107.736 -1.209 . . . . 72.43 107.736 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 173.64 6.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.814 2.045 . . . . 65.31 109.441 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 m -49.35 -57.77 6.29 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.267 1.427 . . . . 74.21 110.289 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.84 118.0 0.12 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.777 0.703 . . . . 65.15 111.379 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -102.4 73.81 1.36 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.617 -0.883 . . . . 75.13 108.617 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.26 149.91 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.384 -1.71 . . . . 73.43 106.384 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.81 -23.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.279 1.431 . . . . 64.23 112.639 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 -170.91 3.5 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 105.41 -2.07 . . . . 64.21 105.41 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.33 -178.56 5.54 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.211 -2.181 . . . . 72.23 111.599 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.98 162.47 40.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.648 0.779 . . . . 63.21 111.558 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 p -148.35 115.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.728 2.011 . . . . 74.11 112.154 172.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -99.69 88.37 3.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 74.44 108.664 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.58 135.52 54.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.496 -1.298 . . . . 64.21 107.496 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 150.81 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.121 1.368 . . . . 63.51 111.002 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 pt -152.03 168.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.997 1.719 . . . . 74.13 110.394 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.411 0 N-CA-C 107.016 -1.475 . . . . 75.51 107.016 160.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 108.305 -0.998 . . . . 75.35 108.305 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.32 5.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.43 -0.581 . . . . 73.23 109.43 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -127.92 176.58 7.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.159 0.984 . . . . 74.25 110.473 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.5 ptm -126.74 -7.5 6.17 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.533 1.133 . . . . 72.53 112.655 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 53.63 78.13 0.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.883 0.873 . . . . 74.41 111.324 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.5 m -77.69 -38.65 25.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-O 117.831 -1.08 . . . . 72.12 111.777 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -65.39 131.19 45.83 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 116.722 -1.991 . . . . 64.55 112.165 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 51.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.966 2.506 . . . . 64.14 108.262 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.82 166.06 13.46 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.77 -1.206 . . . . 74.11 110.29 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.52 -50.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.906 2.404 . . . . 75.32 109.783 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -90.71 154.94 45.92 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 125.845 1.658 . . . . 72.53 108.665 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.79 -173.22 1.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.471 2.114 . . . . 71.32 110.798 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p 57.34 60.57 2.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.454 1.502 . . . . 63.33 112.56 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.09 176.35 5.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.224 1.41 . . . . 61.51 110.014 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.61 -172.88 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.251 1.021 . . . . 62.23 110.906 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.19 139.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 125.612 1.565 . . . . 73.14 109.308 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.79 139.51 58.78 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.23 0.923 . . . . 75.34 110.088 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 t -63.15 -26.8 68.98 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.523 -0.736 . . . . 74.32 112.379 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -66.32 -21.26 66.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.855 0.862 . . . . 74.13 111.227 173.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -82.81 -33.04 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.626 -1.296 . . . . 65.34 110.533 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.98 -37.32 47.62 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.764 0.826 . . . . 72.33 112.206 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -60.93 -37.89 83.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.59 -0.522 . . . . 63.23 109.59 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -86.46 11.19 13.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.811 2.044 . . . . 75.14 111.645 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.53 155.69 16.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.008 1.323 . . . . 74.21 111.192 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 140.76 29.8 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.733 0.813 . . . . 74.43 110.064 173.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.57 155.01 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.89 0.852 . . . . 73.11 110.273 168.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.64 130.4 35.33 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 126.377 1.871 . . . . 72.32 108.534 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.59 3.59 4.58 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.473 1.109 . . . . 74.33 110.79 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 p -90.27 -19.11 24.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.705 2.002 . . . . 73.44 111.633 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -135.78 -62.03 0.7 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.59 1.086 . . . . 72.41 112.739 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -153.24 155.35 31.75 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 119.567 1.076 . . . . 71.24 109.902 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.58 112.94 3.19 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.96 1.773 . . . . 71.33 108.313 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.02 165.98 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.257 2.623 . . . . 75.33 109.886 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -90.11 135.19 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.955 -1.128 . . . . 74.43 107.955 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.6 mm -83.49 147.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.261 0.937 . . . . 62.41 110.637 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -137.25 115.76 11.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 71.12 110.122 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.77 87.38 6.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.646 1.578 . . . . 72.14 108.654 170.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mt -86.08 151.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.321 -1.363 . . . . 73.12 107.321 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.63 146.24 24.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.835 0.743 . . . . 44.15 110.337 164.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.69 129.55 34.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.123 0.969 . . . . 71.14 110.011 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 92.13 8.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 105.909 -1.886 . . . . 75.34 105.909 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.95 173.14 6.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.412 1.485 . . . . 75.54 109.636 175.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.57 -16.53 10.42 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.858 1.429 . . . . 74.44 114.858 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -18.72 34.02 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.576 -1.328 . . . . 72.14 112.126 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.62 50.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.807 1.67 . . . . 35.1 111.047 -166.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.41 133.67 49.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.71 -1.589 . . . . 73.43 106.71 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -148.23 -86.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.303 0.954 . . . . 64.32 111.151 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.67 82.66 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.954 2.436 . . . . 71.41 107.596 166.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.09 160.82 9.47 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.381 -0.825 . . . . 62.11 109.539 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -115.34 140.5 49.07 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.424 1.09 . . . . 74.21 108.321 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.77 103.75 14.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 105.604 -1.999 . . . . 73.52 105.604 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.98 152.3 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 75.54 107.098 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.34 121.19 17.56 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.704 -0.68 . . . . 74.33 109.57 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -76.28 84.49 3.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.756 -1.201 . . . . 71.33 107.756 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.92 150.72 48.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.5 -1.296 . . . . 75.11 107.5 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 69.6 27.84 4.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.789 1.235 . . . . 61.42 111.288 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 129.174 2.99 . . . . 64.41 113.648 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.017 -0.364 . . . . 72.44 110.017 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.2 134.49 21.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.963 2.442 . . . . 74.1 108.653 169.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.12 168.07 28.08 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.872 1.701 . . . . 64.42 109.328 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.05 165.76 2.11 Favored Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 125.861 1.664 . . . . 74.34 109.257 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -70.82 142.01 42.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.379 2.052 . . . . 74.2 109.541 149.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.82 175.48 9.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.123 1.369 . . . . 71.54 109.774 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.61 25.69 0.27 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.124 2.969 . . . . 75.44 114.966 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -55.44 143.41 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.829 1.652 . . . . 73.22 109.691 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -139.48 147.95 42.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.539 1.536 . . . . 75.43 108.132 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.87 144.21 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.874 -1.899 . . . . 75.43 105.874 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.1 m -144.79 155.79 43.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.635 1.574 . . . . 72.54 109.083 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.89 168.07 20.19 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.376 -0.827 . . . . 72.32 110.376 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.0 m -150.69 165.2 17.92 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.629 1.972 . . . . 54.23 106.915 170.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 -26.05 24.13 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.578 2.186 . . . . 62.42 110.702 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.73 -64.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.552 1.141 . . . . 63.03 109.183 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.73 -145.82 4.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.559 2.028 . . . . 74.12 108.669 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.04 133.9 55.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.155 0.977 . . . . 42.21 108.723 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.82 135.57 48.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.709 -1.219 . . . . 72.21 107.709 166.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mp -142.01 138.01 31.54 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 119.037 0.835 . . . . 75.2 110.503 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -144.0 153.45 42.25 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.297 -1.001 . . . . 73.4 108.297 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.32 21.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 74.04 108.357 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.11 165.8 16.65 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.124 0.97 . . . . 73.1 110.631 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.25 168.42 17.73 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.715 3.61 . . . . 75.43 113.625 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.27 175.25 11.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.382 2.721 . . . . 75.11 111.629 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.6 24.53 4.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.866 1.266 . . . . 75.41 111.731 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.17 -22.12 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.167 -0.958 . . . . 72.43 111.528 -158.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 t -166.16 162.39 17.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.162 2.185 . . . . 72.33 106.239 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -71.35 -68.93 0.41 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.373 1.069 . . . . 72.11 109.375 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.06 -173.05 10.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.623 -1.391 . . . . 71.04 109.623 -157.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -132.16 83.94 2.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.378 -1.341 . . . . 72.1 107.378 163.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.03 150.72 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.123 -1.066 . . . . 71.44 108.123 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.95 -25.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.788 1.635 . . . . 74.32 111.192 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 -175.86 3.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.35 1.46 . . . . 75.23 108.403 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -140.81 169.6 17.32 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.96 1.704 . . . . 72.4 108.878 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.4 m -152.68 161.16 42.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.439 0.696 . . . . 61.1 111.337 167.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.59 142.61 39.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.82 1.248 . . . . 63.43 108.672 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -127.0 115.83 19.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.929 2.092 . . . . 75.0 105.833 -171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -101.03 122.18 43.09 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.673 -1.602 . . . . 75.44 106.673 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.62 76.81 4.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.088 0.955 . . . . 74.11 109.801 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.25 175.77 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.135 0.974 . . . . 71.43 111.462 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.243 0 N-CA-C 106.061 -1.829 . . . . 71.15 106.061 169.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.311 0.577 . . . . 75.51 109.883 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.11 119.52 5.99 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.265 1.426 . . . . 61.42 108.847 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -137.69 169.93 16.93 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.751 0.82 . . . . 75.11 109.307 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -12.46 25.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 74.0 113.453 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 43.97 75.36 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.523 1.929 . . . . 73.3 111.531 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.9 m -65.19 -16.01 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.405 1.082 . . . . 63.4 113.343 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -121.24 117.43 27.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.538 0.735 . . . . 75.11 109.975 -169.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.3 m -130.82 137.89 49.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.764 -2.31 . . . . 64.23 104.764 154.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.26 7.94 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.645 1.111 . . . . 72.12 112.496 170.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.97 -14.86 10.8 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.977 3.118 . . . . 75.0 113.385 -170.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.1 m -111.29 85.83 5.91 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.525 1.13 . . . . 75.04 109.489 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.6 67.78 3.7 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.541 2.827 . . . . 75.34 110.646 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -157.13 11.8 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.785 1.234 . . . . 75.11 111.618 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -89.9 161.76 15.77 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.321 1.049 . . . . 74.03 113.27 -165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.05 164.46 17.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.538 1.935 . . . . 75.41 110.393 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.41 125.52 69.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.694 1.598 . . . . 64.43 107.15 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -66.98 160.79 25.69 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.322 1.049 . . . . 71.34 111.561 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -55.05 -33.66 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 71.44 110.391 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -61.06 -12.23 11.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.541 1.536 . . . . 61.43 113.768 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -118.58 7.85 11.86 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.121 1.368 . . . . 74.0 112.053 171.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.51 -12.91 10.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.366 1.466 . . . . 73.54 111.733 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.48 -60.95 2.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.873 1.269 . . . . 74.21 111.5 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -73.29 13.26 0.46 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 118.161 -0.923 . . . . 74.34 112.085 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.76 165.95 2.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.243 1.383 . . . . 63.45 110.122 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.5 108.38 12.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.972 -1.492 . . . . 74.13 106.972 166.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 mm -68.82 140.78 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.075 -1.454 . . . . 75.14 107.075 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -56.85 118.13 4.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.19 0.996 . . . . 75.41 109.085 169.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.41 31.37 6.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.98 1.312 . . . . 71.45 109.076 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -6.36 5.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.667 1.187 . . . . 75.12 110.363 -164.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -159.06 -66.25 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.762 2.825 . . . . 72.43 107.681 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -149.58 151.86 33.97 Favored Pre-proline 0 N--CA 1.463 0.2 0 C-N-CA 125.857 1.663 . . . . 74.34 109.413 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.21 100.78 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.967 2.445 . . . . 75.14 109.89 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.34 152.32 39.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.349 1.459 . . . . 73.5 110.453 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.3 mt -79.98 124.19 37.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.388 -1.708 . . . . 75.55 106.388 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 mm -101.52 101.39 12.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.759 -1.2 . . . . 73.52 107.759 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -79.21 152.62 30.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.156 0.982 . . . . 75.12 109.292 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.17 124.76 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 104.739 -2.319 . . . . 75.42 104.739 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.69 141.98 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 120.674 1.579 . . . . 75.5 108.149 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.42 155.52 45.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.745 0.702 . . . . 62.13 111.231 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 125.0 28.75 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.46 1.504 . . . . 51.2 109.883 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -74.49 101.33 4.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 104.729 -2.323 . . . . 75.43 104.729 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -115.84 174.62 5.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.431 0.634 . . . . 74.23 110.751 168.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.08 -23.94 67.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.274 0.842 . . . . 72.0 113.274 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -57.91 6.4 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.205 1.002 . . . . 74.42 110.653 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 165.5 12.33 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.333 1.921 . . . . 62.41 109.05 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -64.75 137.78 58.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.168 -1.419 . . . . 73.33 107.168 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.61 -64.15 0.01 OUTLIER Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.377 0.989 . . . . 52.1 111.907 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.07 71.65 6.18 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.554 2.836 . . . . 75.42 110.774 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.17 6.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.139 0.576 . . . . 74.4 109.857 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.5 m -81.04 113.12 19.02 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.527 -1.657 . . . . 64.3 106.527 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.8 151.02 27.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.987 -1.116 . . . . 75.54 107.987 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 76.2 t -143.72 143.58 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.018 -1.475 . . . . 75.3 107.018 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.84 154.19 39.98 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.827 0.739 . . . . 74.2 112.31 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -142.71 112.12 6.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.469 1.108 . . . . 72.51 109.774 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.428 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -88.53 3.05 51.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 128.702 2.801 . . . . 75.21 112.286 -172.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.27 18.4 16.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.954 1.702 . . . . 71.34 110.293 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 124.19 0.996 . . . . 64.33 113.493 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 108.995 -0.743 . . . . 75.31 108.995 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.18 134.95 32.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.221 1.947 . . . . 60.13 113.373 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.39 -179.81 53.33 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.367 1.461 . . . . 61.43 112.301 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 174.49 165.12 0.34 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.272 3.029 . . . . 72.14 110.138 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.34 150.81 81.2 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.624 2.216 . . . . 74.21 109.666 163.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -137.31 174.89 10.12 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.431 1.092 . . . . 72.44 110.606 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.99 10.14 4.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.942 2.497 . . . . 71.21 115.515 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -51.49 111.66 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 125.259 1.424 . . . . 74.43 113.051 -158.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -86.3 136.46 33.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.534 -1.284 . . . . 73.13 107.534 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.23 126.33 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.4 -2.074 . . . . 64.41 105.4 160.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -150.33 173.02 14.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 128.924 2.889 . . . . 62.13 106.227 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -90.05 159.68 16.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.985 -1.117 . . . . 74.25 107.985 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -129.56 160.61 63.66 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.559 -1.645 . . . . 75.31 106.559 157.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -52.65 -45.0 43.29 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 120.91 1.073 . . . . 73.24 109.37 150.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -79.33 26.31 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.59 2.356 . . . . 72.34 113.604 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.74 -113.32 2.35 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.283 0.944 . . . . 73.32 111.119 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.59 -160.95 1.09 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.233 1.813 . . . . 64.11 108.757 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -130.34 33.62 4.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.212 1.405 . . . . 74.03 112.766 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.69 103.42 1.09 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 127.029 2.132 . . . . 75.31 113.038 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -138.97 150.59 46.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.431 1.469 . . . . 72.04 110.424 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.419 ' CE3' HD13 ' A' ' 99' ' ' ILE . 1.1 p90 -139.27 162.62 34.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.382 1.073 . . . . 73.32 110.426 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.75 154.81 87.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.377 -0.374 . . . . 73.42 111.347 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.49 168.16 25.46 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.067 3.178 . . . . 64.02 110.9 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.59 116.13 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.141 2.561 . . . . 73.15 110.341 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.36 60.31 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.685 2.394 . . . . 74.21 106.266 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.48 -62.31 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 124.267 1.027 . . . . 73.24 111.329 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 p -133.38 167.02 21.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.304 -0.872 . . . . 74.21 110.583 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.7 10.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.316 2.246 . . . . 64.43 114.022 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.25 149.01 50.26 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.568 -1.413 . . . . 74.04 109.568 172.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -121.39 92.11 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.473 1.909 . . . . 73.35 106.517 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -73.73 144.49 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 72.25 106.589 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 pt -131.08 -13.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.924 1.69 . . . . 71.51 112.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -168.38 -175.4 2.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.724 2.41 . . . . 74.41 107.345 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.22 170.36 15.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.061 -1.025 . . . . 73.12 109.294 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.4 p -146.62 155.18 42.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.852 0.861 . . . . 71.21 112.898 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.8 t -141.68 137.98 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.466 1.906 . . . . 71.54 106.706 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -128.49 126.75 41.08 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.907 1.683 . . . . 73.43 107.052 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.4 tp -119.79 131.58 55.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.821 1.648 . . . . 75.53 109.911 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.55 135.85 54.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.914 1.234 . . . . 65.32 110.834 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.1 pt -141.11 -173.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.987 1.315 . . . . 73.1 111.003 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 72.44 112.503 -168.735 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 106.741 -1.577 . . . . 74.42 106.741 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.14 108.4 7.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.703 -1.221 . . . . 70.2 107.703 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -118.2 -174.69 2.71 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.826 1.65 . . . . 74.51 108.849 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.4 ttp -121.82 121.72 37.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.892 2.477 . . . . 75.2 107.275 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 107.177 -1.416 . . . . 74.1 107.177 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.2 -28.96 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.804 -0.56 . . . . 73.31 110.67 168.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -99.93 93.86 5.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.562 -0.711 . . . . 75.31 109.117 -159.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.3 71.92 0.85 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.991 1.317 . . . . 75.21 107.657 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.55 168.95 41.58 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.849 -0.9 . . . . 72.42 110.849 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.41 -55.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.565 2.844 . . . . 75.12 112.451 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 m -151.29 73.24 8.39 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.368 1.467 . . . . 73.23 109.763 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.72 -47.87 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-O 116.237 -1.651 . . . . 75.43 110.129 155.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.83 76.6 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.395 1.452 . . . . 71.34 109.451 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.5 t 77.52 83.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 130.051 3.341 . . . . 75.15 111.586 -166.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 97.1 2.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.777 -1.564 . . . . 71.21 106.777 145.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 t -133.35 106.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 120.739 -1.226 . . . . 73.24 108.349 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -61.77 142.3 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.885 1.674 . . . . 72.35 109.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 p -57.78 -26.31 61.74 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.46 0.704 . . . . 72.35 110.815 171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -53.6 -15.83 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.484 1.914 . . . . 61.11 114.115 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -99.23 -49.75 4.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.532 1.06 . . . . 74.34 109.824 171.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.6 -39.46 94.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.563 1.074 . . . . 72.53 112.261 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.8 t -56.25 -44.59 79.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.985 1.314 . . . . 75.52 109.521 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.19 1.43 44.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 75.12 112.376 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.19 145.96 47.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.779 0.799 . . . . 64.21 109.534 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -69.47 107.4 3.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.096 -1.816 . . . . 74.41 106.096 158.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.01 130.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 106.439 -1.689 . . . . 74.41 106.439 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.49 132.22 53.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.898 1.332 . . . . 71.21 109.246 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.81 32.2 5.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.675 -1.148 . . . . 73.31 108.263 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.66 -84.35 0.64 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.638 -1.986 . . . . 73.44 105.638 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -62.47 -64.34 0.95 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.75 0.82 . . . . 71.12 110.421 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -155.86 155.65 29.64 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 117.747 -1.121 . . . . 74.03 110.766 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.44 97.38 0.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.315 2.01 . . . . 54.5 107.949 169.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.71 169.99 23.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.704 2.002 . . . . 75.31 108.594 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.92 115.45 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.197 -1.779 . . . . 64.43 106.197 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.14 139.61 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.597 -1.26 . . . . 75.31 107.597 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.08 131.31 50.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.055 1.742 . . . . 74.24 107.811 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -103.32 137.72 41.06 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.193 -1.78 . . . . 75.03 106.193 155.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.419 HD13 ' CE3' ' A' ' 26' ' ' TRP . 67.0 mt -130.74 137.75 55.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 104.557 -2.386 . . . . 73.03 104.557 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.4 142.77 23.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.87 0.692 . . . . 75.43 112.87 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.59 128.35 36.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.433 1.893 . . . . 74.41 109.573 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.49 95.71 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.343 -1.725 . . . . 72.12 106.343 173.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.84 166.06 14.29 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.079 1.352 . . . . 75.15 108.297 169.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.24 -35.54 65.08 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.852 0.861 . . . . 74.51 112.438 -171.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -55.37 -21.08 13.9 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.204 1.187 . . . . 75.4 114.204 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.49 176.26 32.72 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.498 -1.441 . . . . 62.53 109.498 -168.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -79.73 55.87 2.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.548 1.166 . . . . 75.35 109.584 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.32 -64.73 3.65 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.632 1.587 . . . . 75.01 109.289 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.58 142.1 25.76 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 CA-C-N 118.942 1.371 . . . . 63.13 109.255 172.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.83 147.79 27.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.075 -1.083 . . . . 74.1 108.075 165.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -78.01 169.73 17.79 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.343 -0.614 . . . . 74.03 109.343 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.58 2.91 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.409 -1.7 . . . . 73.33 106.409 169.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.87 161.08 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.008 -1.479 . . . . 72.05 107.008 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 131.16 22.82 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.034 -1.839 . . . . 75.31 106.034 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -82.76 82.41 8.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.195 -1.039 . . . . 74.03 108.195 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.67 -16.69 63.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.763 0.71 . . . . 74.24 112.519 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.2 -17.66 64.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.284 -0.885 . . . . 72.42 111.269 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.444 -0.735 0 C-N-CA 126.012 1.725 . . . . 75.33 106.547 -174.226 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 107.3 -1.37 . . . . 74.33 107.3 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.39 6.92 1.01 Allowed 'Trans proline' 0 CA--C 1.545 1.035 1 C-N-CA 126.734 4.956 . . . . 61.13 114.464 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.87 -114.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.525 0 O-C-N 120.802 -1.186 . . . . 32.44 111.694 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.27 164.79 0.14 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.121 2.968 . . . . 74.15 111.404 -163.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.36 159.75 11.12 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 124.06 3.173 . . . . 73.32 110.804 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -136.45 -173.93 3.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.378 1.071 . . . . 70.24 110.233 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 33.43 3.49 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.929 2.492 . . . . 74.03 115.151 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.03 139.36 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.385 0.674 . . . . 65.13 109.924 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -124.04 140.13 53.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 125.545 1.538 . . . . 73.33 107.79 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.6 mt -147.3 134.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.83 -1.915 . . . . 74.41 105.83 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.04 163.29 40.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 74.33 108.237 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -81.97 164.1 21.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.144 0.884 . . . . 72.41 109.074 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -138.92 165.54 31.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.774 2.029 . . . . 73.32 106.897 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -64.25 -28.57 64.06 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.695 1.597 . . . . 72.31 111.631 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.52 17.92 11.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.64 1.576 . . . . 73.11 111.268 -163.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.38 -141.94 9.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.47 -1.452 . . . . 53.45 109.47 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.75 163.07 30.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.801 1.301 . . . . 54.54 111.416 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.02 134.76 34.24 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.253 1.821 . . . . 73.11 108.219 168.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 114.86 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.435 1.494 . . . . 73.12 110.152 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.1 p -135.33 168.81 18.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.654 0.661 . . . . 74.41 110.953 166.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -148.21 169.47 20.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 130.171 3.388 . . . . 74.21 107.048 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.04 151.72 42.65 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 123.999 0.92 . . . . 71.41 109.097 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.74 164.61 33.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.802 2.335 . . . . 64.21 111.245 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.88 139.83 90.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.888 3.059 . . . . 62.42 112.679 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.6 t -135.26 16.14 3.46 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.925 . . . . 61.32 113.173 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.91 -45.04 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.236 1.014 . . . . 71.15 110.345 -171.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 p -144.89 174.16 11.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.963 0.905 . . . . 65.41 109.689 168.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -50.4 -56.24 12.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.396 1.878 . . . . 70.32 114.019 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.97 176.76 5.53 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.298 1.904 . . . . 63.23 112.828 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -139.05 93.43 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.606 0.762 . . . . 73.32 109.222 158.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.46 150.95 3.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.264 -1.013 . . . . 74.15 108.264 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.7 -34.64 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.75 1.22 . . . . 65.23 111.644 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -160.43 -179.27 7.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.725 -1.213 . . . . 64.42 107.725 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -136.32 165.48 25.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.306 0.957 . . . . 71.54 110.413 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 t -145.75 153.57 41.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.041 0.936 . . . . 71.42 109.368 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.54 147.9 31.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.767 1.627 . . . . 71.13 107.305 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -133.0 145.53 50.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.275 -1.379 . . . . 72.32 107.275 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.28 134.58 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.713 -1.218 . . . . 72.34 107.713 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.09 131.24 49.91 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.75 -1.119 . . . . 63.24 109.71 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 pt -144.31 -174.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.751 -1.203 . . . . 73.14 107.751 168.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 126.256 1.823 . . . . 73.31 115.535 -176.9 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 112.399 0.518 . . . . 72.44 112.399 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.34 77.53 1.79 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.61 0.764 . . . . 70.31 111.488 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -139.59 129.97 25.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.998 0.919 . . . . 74.31 109.134 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.8 ttp -76.76 151.08 36.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.844 1.258 . . . . 54.42 109.523 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -79.62 71.39 6.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 73.54 112.784 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.56 -32.03 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 118.763 -0.636 . . . . 72.25 112.63 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -58.92 122.64 14.16 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.34 0.973 . . . . 74.54 110.545 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.9 t -157.18 40.7 0.31 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.676 0.79 . . . . 73.42 110.142 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.33 168.6 32.61 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 119.268 0.94 . . . . 54.14 112.029 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.75 -21.39 6.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.734 2.956 . . . . 71.33 115.438 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 m -82.9 143.47 46.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.315 -0.994 . . . . 73.43 108.315 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.55 -41.52 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.431 1.42 . . . . 72.32 109.563 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.9 m -74.7 79.65 2.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.564 -1.272 . . . . 52.51 107.564 161.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.08 171.76 11.33 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.671 -0.643 . . . . 73.12 110.011 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.13 178.45 6.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.767 0.827 . . . . 74.43 110.583 167.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.5 t -138.83 146.7 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.952 1.701 . . . . 74.33 108.247 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.41 165.41 14.95 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 129.088 2.955 . . . . 74.34 112.93 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -44.98 -47.38 11.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.093 1.357 . . . . 73.53 111.966 162.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.1 m -56.5 -50.67 71.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.144 0.884 . . . . 72.22 112.255 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -71.89 -33.88 68.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.539 0.736 . . . . 71.44 110.561 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.68 -39.8 92.7 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.02 0.928 . . . . 64.22 111.743 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 m -71.66 3.69 3.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 0.817 . . . . 74.24 113.114 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -117.76 -1.93 11.47 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.975 1.31 . . . . 73.25 111.288 166.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.63 118.57 13.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.205 0.911 . . . . 70.45 108.735 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.12 140.65 56.2 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.542 -0.54 . . . . 74.1 109.542 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.05 138.78 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.859 -0.793 . . . . 70.05 108.859 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.0 133.11 49.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.588 0.755 . . . . 72.33 109.185 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.51 3.48 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.282 1.033 . . . . 72.24 112.0 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.2 m -65.46 -31.44 72.53 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.496 1.043 . . . . 71.23 109.589 167.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.86 -69.31 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.825 -0.547 . . . . 71.22 111.38 -162.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.95 145.89 38.21 Favored Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 118.054 -0.974 . . . . 65.31 109.109 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.49 97.47 0.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.343 2.029 . . . . 73.13 108.437 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.22 162.87 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.24 2.616 . . . . 74.14 107.766 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.7 mt -105.02 136.11 40.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.861 -1.163 . . . . 74.01 107.861 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.13 125.75 53.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.147 0.979 . . . . 74.02 110.665 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -109.42 159.95 16.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.672 1.189 . . . . 72.45 109.775 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.0 126.95 44.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.188 -2.152 . . . . 74.35 105.188 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.9 mt -120.54 142.53 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.69 -1.596 . . . . 73.32 106.69 171.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 153.31 38.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.435 0.561 . . . . 74.03 111.56 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.47 131.8 40.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.898 1.279 . . . . 71.21 108.869 163.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -77.83 111.53 13.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.995 -1.854 . . . . 71.44 105.995 157.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -119.48 175.43 5.84 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.427 0.691 . . . . 74.23 111.027 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.27 -45.99 92.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.428 0.691 . . . . 74.41 112.295 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -61.84 -27.64 68.92 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.362 0.983 . . . . 74.42 110.627 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.63 -167.9 29.22 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.375 -1.49 . . . . 72.53 109.375 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.51 12.03 0.11 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.194 1.924 . . . . 74.13 116.194 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.4 -160.82 0.57 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.817 2.151 . . . . 63.31 112.11 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -75.2 178.55 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.542 2.161 . . . . 73.44 109.074 163.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.42 128.63 48.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.334 -0.987 . . . . 64.05 108.334 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.2 m -76.08 105.47 7.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.773 -1.195 . . . . 74.34 107.773 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.56 118.21 9.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.344 -1.724 . . . . 74.01 106.344 161.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.54 160.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 O-C-N 121.167 -0.958 . . . . 74.45 109.165 166.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.77 129.81 52.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.961 0.905 . . . . 74.31 109.215 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -85.37 85.45 7.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.396 -0.964 . . . . 73.11 108.396 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.1 mt -66.06 165.66 13.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.036 -0.727 . . . . 74.21 109.036 168.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 75.81 10.92 3.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.278 2.231 . . . . 62.14 113.497 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.246 0.877 0 N-CA-C 113.431 0.9 . . . . 64.13 113.431 161.172 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 109.212 -0.662 . . . . 75.31 109.212 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.13 168.12 22.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.84 2.36 . . . . 62.34 110.313 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.52 -132.64 11.27 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.703 -1.759 . . . . 71.0 108.703 -170.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.11 156.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.321 2.648 . . . . 74.11 111.841 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -68.97 159.23 54.77 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.894 1.729 . . . . 72.13 108.955 167.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.98 174.21 10.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.57 0.7 . . . . 64.11 109.853 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.3 27.28 2.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.094 2.157 . . . . 71.11 114.899 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -56.96 137.97 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.28 . . . . 72.4 108.699 -171.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -135.85 141.4 44.64 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.492 -1.299 . . . . 75.22 107.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 115' ' ' TRP . 5.5 mt -142.92 110.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.111 -1.07 . . . . 75.04 108.111 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -106.93 145.3 32.39 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.812 0.845 . . . . 74.22 109.831 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -82.53 158.86 22.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.38 0.672 . . . . 74.32 109.925 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -143.45 163.42 36.89 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.449 2.299 . . . . 74.4 109.545 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.97 -13.9 42.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.763 2.975 . . . . 73.31 113.684 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 2.47 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.411 2.284 . . . . 75.32 111.36 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.86 -127.29 2.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.223 0.92 . . . . 64.03 112.889 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.09 127.67 17.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.721 1.208 . . . . 72.44 108.418 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -70.17 98.62 1.37 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.52 1.528 . . . . 75.0 108.643 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.99 116.47 23.4 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.457 -1.312 . . . . 75.24 107.457 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 p -136.95 160.24 39.48 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.716 -0.615 . . . . 73.44 109.813 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 -178.41 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.192 0.597 . . . . 75.33 110.137 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -133.69 158.65 75.02 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 108.917 -0.771 . . . . 75.21 108.917 165.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.59 160.64 42.22 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.508 1.472 . . . . 71.43 109.525 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.58 170.93 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.308 1.339 . . . . 74.13 111.427 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 t -141.67 70.57 1.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 105.091 -2.189 . . . . 71.04 105.091 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.84 -65.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.124 0.97 . . . . 75.31 110.251 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -135.09 -173.11 3.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.564 1.074 . . . . 63.21 110.302 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -26.06 67.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.833 1.79 . . . . 63.01 115.833 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.36 94.67 0.01 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.721 2.105 . . . . 43.33 115.991 167.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -82.23 64.93 7.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.685 1.194 . . . . 71.1 111.621 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.57 147.43 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.58 -0.896 . . . . 75.33 108.58 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.33 -15.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.312 2.245 . . . . 75.42 112.1 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.19 178.06 10.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.764 1.626 . . . . 72.4 107.019 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.05 168.12 19.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.63 -1.248 . . . . 74.22 107.63 165.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.0 m -134.43 141.45 46.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.568 -0.901 . . . . 73.0 108.568 164.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.5 t -136.61 116.98 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.363 -2.458 . . . . 75.2 104.363 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -120.63 127.38 52.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.267 -1.012 . . . . 64.11 108.267 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -115.28 129.37 56.6 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 105.555 -2.017 . . . . 74.34 105.555 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.32 145.63 33.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 124.021 0.825 . . . . 74.22 109.367 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -145.23 -179.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.169 1.788 . . . . 72.12 107.903 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 123.063 0.545 . . . . 73.11 111.958 171.267 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 122.584 1.183 . . . . 74.41 111.336 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.63 148.3 30.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.759 -1.941 . . . . 62.14 105.759 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -143.32 151.14 40.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.691 0.678 . . . . 72.43 110.67 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -112.22 4.95 18.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.6 1.16 . . . . 74.32 113.506 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 49.93 78.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.842 1.657 . . . . 73.0 111.317 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.0 m -77.28 -5.82 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 75.13 112.751 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -56.24 112.69 1.3 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.974 1.31 . . . . 74.42 110.103 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.78 31.41 0.22 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.345 1.458 . . . . 75.42 110.164 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -125.75 75.01 0.41 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.765 1.174 . . . . 75.44 111.29 -170.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -67.33 -17.5 49.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.144 1.896 . . . . 61.44 111.721 165.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -56.58 144.35 64.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.87 1.268 . . . . 61.31 109.515 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.79 -21.02 38.92 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.976 1.784 . . . . 62.03 111.85 -174.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.63 145.85 33.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 128.461 2.704 . . . . 64.04 104.183 163.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -137.7 154.07 49.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.626 1.103 . . . . 72.2 110.242 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.07 163.91 27.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.513 1.149 . . . . 74.44 109.585 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.6 t -139.33 128.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 104.383 -2.451 . . . . 74.3 104.383 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.77 139.2 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.944 0.778 . . . . 64.03 109.502 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -30.27 63.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.843 1.657 . . . . 75.34 111.779 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.4 p -59.18 -14.61 11.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 55.4 113.595 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 t -88.07 -48.14 7.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.026 0.83 . . . . 64.14 108.947 168.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.38 -31.71 72.97 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.009 0.822 . . . . 63.12 112.151 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -44.89 -59.96 2.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.117 2.167 . . . . 74.43 108.386 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.35 0.29 37.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 75.01 111.929 -165.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 153.07 44.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.768 0.827 . . . . 72.43 110.884 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 132.5 36.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.093 -1.077 . . . . 75.0 108.093 165.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -84.06 145.44 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.431 1.092 . . . . 75.12 108.055 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -70.54 132.28 45.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.829 0.852 . . . . 73.34 109.181 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.55 23.72 11.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 75.34 109.995 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.53 -38.06 2.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.553 1.541 . . . . 74.33 111.892 -162.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -136.82 -52.89 0.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.447 1.099 . . . . 72.34 112.462 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -148.02 150.51 35.67 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 120.452 1.478 . . . . 73.11 110.84 158.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.51 95.93 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.816 3.01 . . . . 73.11 109.795 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.48 166.39 33.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.054 1.742 . . . . 64.22 110.6 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.1 mt -86.25 118.98 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.841 1.257 . . . . 63.33 107.735 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.56 145.76 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.52 -0.918 . . . . 73.04 108.52 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -131.92 125.45 31.7 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.682 -1.599 . . . . 71.01 106.682 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.85 126.36 32.88 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.901 -1.888 . . . . 73.2 105.901 164.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 mt -133.22 136.02 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.557 -1.646 . . . . 64.3 106.557 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 158.58 44.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.681 1.192 . . . . 75.32 108.709 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.82 101.38 9.23 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.814 1.246 . . . . 74.11 107.818 -171.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.23 111.03 1.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.958 1.703 . . . . 71.43 107.925 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -136.19 179.11 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.809 1.643 . . . . 44.14 111.378 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.89 -33.11 10.08 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.833 1.653 . . . . 75.04 114.002 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -60.75 -55.31 34.69 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.379 0.991 . . . . 73.32 111.247 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.68 174.55 19.32 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.131 -0.788 . . . . 64.4 111.131 -162.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -73.26 81.84 1.35 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.882 1.273 . . . . 75.24 109.639 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.08 -63.94 0.87 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.263 -1.299 . . . . 42.54 111.522 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.39 155.96 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.158 2.572 . . . . 71.22 109.131 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.58 103.19 1.21 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.96 -0.756 . . . . 73.23 108.96 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -71.82 146.81 47.77 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.459 -0.571 . . . . 73.41 109.459 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.86 83.67 1.8 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.234 1.013 . . . . 74.24 108.351 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.14 152.52 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.004 -1.48 . . . . 60.23 107.004 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.74 50.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.44 1.496 . . . . 75.32 108.284 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.403 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 16.2 t90 -136.61 111.58 8.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 75.04 110.113 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -86.29 -177.55 6.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.711 2.004 . . . . 72.33 110.687 -166.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 76.46 -2.67 2.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.025 2.53 . . . . 73.11 113.572 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 C--O 1.238 0.483 0 C-N-CA 124.111 0.964 . . . . 75.42 110.063 -179.745 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 108.408 -0.96 . . . . 73.34 108.408 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.68 7.39 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.073 1 C-N-CA 126.309 4.673 . . . . 72.43 115.463 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.37 -147.06 13.15 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.241 -1.537 . . . . 70.1 111.294 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.54 80.85 0.27 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.697 1.999 . . . . 74.3 112.881 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.88 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.165 . . . . 74.22 110.181 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.0 m -132.25 -177.45 4.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.189 1.396 . . . . 73.32 109.678 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.34 11.74 2.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.716 2.006 . . . . 72.01 114.688 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -56.95 131.98 20.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.665 1.586 . . . . 70.1 110.846 -166.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.73 163.74 22.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.352 1.061 . . . . 71.33 110.408 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.13 158.1 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.851 2.06 . . . . 72.22 106.459 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -144.44 133.91 23.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.236 2.214 . . . . 74.33 107.353 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -64.81 151.65 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.622 -0.881 . . . . 74.02 108.622 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.56 157.51 44.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 126.518 1.927 . . . . 52.44 106.001 176.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.24 -20.12 32.97 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.422 2.081 . . . . 70.31 111.639 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -114.93 13.47 17.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.0 2.92 . . . . 74.22 111.317 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.66 -163.54 30.02 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 118.878 0.763 . . . . 63.24 112.164 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.91 121.18 40.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 120.017 1.909 . . . . 71.33 106.562 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -58.62 124.47 19.77 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.385 -1.339 . . . . 72.33 107.385 165.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 mt -120.56 160.79 22.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.321 0.964 . . . . 74.23 109.08 172.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -155.47 165.2 37.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.85 0.75 . . . . 74.1 110.078 166.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.43 172.35 16.1 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 129.138 2.975 . . . . 72.42 108.236 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -129.3 161.74 56.77 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 124.454 1.102 . . . . 73.32 111.347 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.19 161.91 38.18 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.605 2.87 . . . . 74.2 113.392 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.39 143.11 51.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.35 2.033 . . . . 72.43 110.225 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -133.5 61.81 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.252 -1.758 . . . . 61.2 106.252 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.29 -68.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.678 -1.23 . . . . 73.44 107.678 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.6 p -130.22 170.92 13.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.605 1.562 . . . . 71.04 107.622 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -65.01 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.433 1.093 . . . . 71.42 110.414 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 144.48 2.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.665 -1.272 . . . . 71.4 112.18 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -100.47 83.17 2.57 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.776 -0.838 . . . . 74.32 108.747 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.85 143.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.635 -1.246 . . . . 73.31 107.635 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.87 -23.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.331 1.452 . . . . 74.23 111.367 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.66 -170.16 3.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.547 1.067 . . . . 65.03 109.95 171.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.23 175.28 9.25 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.051 1.34 . . . . 74.21 109.383 163.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -152.36 156.61 39.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.11 1.364 . . . . 64.23 109.434 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.4 t -148.0 121.61 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.949 -1.871 . . . . 52.52 105.949 -167.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -131.03 140.6 50.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.003 1.321 . . . . 74.4 109.273 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 125.98 46.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.424 -1.324 . . . . 74.13 107.424 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 116.82 15.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.581 1.552 . . . . 74.24 110.175 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.05 -176.61 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.819 2.048 . . . . 73.14 108.88 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 CA--C 1.537 0.46 0 O-C-N 121.87 -0.519 . . . . 72.21 112.145 171.626 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 107.48 -1.304 . . . . 73.04 107.48 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.1 112.63 13.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.52 -0.919 . . . . 73.42 108.52 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.19 150.08 40.56 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.595 1.158 . . . . 70.21 108.391 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.51 4.9 6.64 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.109 1.522 . . . . 73.03 115.109 -167.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 43.96 55.39 5.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.464 1.906 . . . . 64.24 113.172 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.76 -20.9 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.862 1.265 . . . . 74.43 112.671 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -58.76 120.17 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.022 0.828 . . . . 73.23 110.596 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -152.24 83.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.385 1.874 . . . . 72.13 105.969 161.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.91 159.85 28.26 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.252 -0.749 . . . . 73.01 111.474 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.11 -55.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 73.1 111.227 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.54 166.59 14.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.159 2.184 . . . . 70.23 110.509 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.46 169.05 23.23 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.807 1.671 . . . . 70.44 110.848 168.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 39.11 9.23 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.633 1.573 . . . . 72.43 112.145 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.2 m -85.5 175.71 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.337 1.065 . . . . 70.1 110.95 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 168.09 16.91 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.625 1.57 . . . . 74.31 109.333 165.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.1 p -130.64 144.2 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.236 1.414 . . . . 62.31 107.628 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -66.42 147.79 52.8 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.165 0.586 . . . . 52.24 112.285 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -48.47 81.09 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.962 1.705 . . . . 65.32 110.06 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.0 p -44.91 -48.58 11.25 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.573 1.949 . . . . 70.1 111.573 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.4 m -67.62 -42.16 82.81 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.343 -0.844 . . . . 73.01 111.214 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.49 -31.46 72.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.168 0.987 . . . . 73.31 111.407 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -64.39 -0.73 1.39 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.597 1.559 . . . . 72.12 114.283 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -120.62 -6.23 9.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.274 1.397 . . . . 70.42 111.679 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.47 137.75 57.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.788 1.235 . . . . 71.34 111.59 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 161.1 30.39 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.647 -0.872 . . . . 74.22 108.647 168.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.56 143.52 35.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.238 1.015 . . . . 74.04 108.447 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.98 82.45 0.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.768 1.627 . . . . 73.21 111.365 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.68 -18.35 61.56 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.637 -1.29 . . . . 73.43 111.21 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -17.81 64.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.224 1.41 . . . . 72.04 113.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.68 -75.02 0.17 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.433 1.015 . . . . 73.5 110.56 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.25 144.3 27.84 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 117.81 -1.091 . . . . 65.42 108.395 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 100.35 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.907 1.738 . . . . 74.21 109.8 -170.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 157.71 44.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.349 1.86 . . . . 74.33 109.085 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.1 mt -88.38 132.07 34.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.5 1.12 . . . . 73.0 109.168 169.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.6 136.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.777 1.275 . . . . 73.13 110.388 165.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -119.28 116.71 26.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 112.715 -2.039 . . . . 71.2 107.568 165.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -81.21 128.79 34.17 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 106.368 -1.716 . . . . 74.22 106.368 162.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.4 mt -133.62 151.7 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.684 -1.969 . . . . 73.32 105.684 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.49 151.91 25.0 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.522 0.729 . . . . 62.31 109.721 165.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.44 117.26 13.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.602 1.161 . . . . 74.11 109.97 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.95 99.8 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.643 -1.614 . . . . 74.4 106.643 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.99 172.98 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.688 1.595 . . . . 73.42 109.595 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -25.99 63.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.474 1.287 . . . . 73.04 114.474 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.55 25.45 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.541 -0.911 . . . . 74.04 108.541 174.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.36 167.04 12.89 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.913 -0.875 . . . . 72.43 110.913 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -61.6 117.94 6.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 74.23 106.477 160.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.21 -95.88 2.4 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.455 -1.858 . . . . 74.33 108.455 173.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.91 147.75 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.271 1.981 . . . . 70.4 110.673 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.05 110.48 10.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.601 1.56 . . . . 72.1 108.635 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 m -65.03 123.79 20.39 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.358 -0.978 . . . . 74.14 108.358 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -97.45 89.44 4.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.985 -1.487 . . . . 65.34 106.985 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.87 171.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 120.633 -0.427 . . . . 72.43 110.168 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.39 123.86 19.52 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.504 1.121 . . . . 71.32 108.161 172.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -82.48 87.91 6.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.847 1.259 . . . . 74.31 109.106 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.2 mt -73.93 0.87 12.1 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.319 1.229 . . . . 72.44 114.319 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -115.12 38.4 3.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.423 1.01 . . . . 71.54 108.765 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 106.612 -1.625 . . . . 74.1 106.612 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 N--CA 1.466 0.358 0 N-CA-C 106.998 -1.482 . . . . 74.34 106.998 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.66 67.34 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 126.079 4.519 . . . . 75.31 111.865 -168.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 166.35 35.86 Favored Glycine 0 C--N 1.332 0.36 0 O-C-N 121.097 -1.002 . . . . 74.22 111.96 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.29 161.45 7.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.977 2.511 . . . . 75.13 106.873 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.79 159.49 52.48 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.702 2.268 . . . . 62.25 112.139 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -127.27 -178.5 4.47 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 121.45 -0.781 . . . . 54.31 110.664 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.11 23.16 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.916 2.487 . . . . 64.44 114.652 171.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.79 126.83 21.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 118.721 0.691 . . . . 75.54 110.734 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -120.3 143.88 48.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.01 1.324 . . . . 75.34 107.81 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -144.26 126.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.49 -2.041 . . . . 75.41 105.49 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.7 m -143.61 149.77 37.81 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.023 1.329 . . . . 61.22 110.291 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -84.52 153.71 23.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 75.21 110.602 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 166.07 15.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 128.745 2.818 . . . . 61.13 107.119 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.59 -27.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.404 2.069 . . . . 63.12 113.693 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.66 -11.52 51.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.373 1.069 . . . . 75.12 112.164 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.67 -163.31 29.02 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.952 -1.259 . . . . 73.41 109.952 -161.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.62 30.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.061 0.945 . . . . 73.13 111.092 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -78.84 134.6 36.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.846 -1.168 . . . . 75.33 107.846 157.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.72 137.49 45.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.159 1.384 . . . . 75.32 107.761 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -142.92 167.25 22.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.445 1.02 . . . . 73.12 109.856 167.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -160.51 178.4 9.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.822 2.049 . . . . 72.21 109.825 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.6 158.25 66.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.925 -1.036 . . . . 74.03 111.998 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 170.82 18.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.04 3.16 . . . . 75.33 113.85 -168.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.68 166.49 17.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.754 2.303 . . . . 75.2 111.82 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 t -140.46 21.49 2.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.469 1.508 . . . . 74.4 110.128 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.72 -55.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.638 1.175 . . . . 75.2 108.461 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 p -124.46 103.46 8.19 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.511 1.124 . . . . 75.23 109.368 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -64.22 -73.41 0.12 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.995 0.918 . . . . 75.41 110.899 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 1.84 75.57 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 117.587 -1.674 . . . . 43.54 115.14 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt 65.26 83.58 0.17 Allowed 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 132.479 4.311 . . . . 74.01 111.113 -172.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.62 136.5 22.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 107.205 -1.406 . . . . 72.33 107.205 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.7 -17.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.071 1.748 . . . . 72.41 111.142 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 3.2 tp10 -164.58 -164.91 0.87 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.048 1.339 . . . . 75.23 109.237 172.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 1.1 m-85 -142.25 172.84 12.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.975 1.71 . . . . 73.31 110.527 171.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 p -138.41 167.49 21.77 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.526 1.131 . . . . 75.23 110.744 168.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 t -146.62 124.74 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 103.537 -2.764 . . . . 73.44 103.537 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.03 136.12 50.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.501 -1.296 . . . . 75.04 107.501 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -123.74 120.84 33.85 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.278 1.831 . . . . 74.13 107.278 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.55 145.94 55.46 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.886 -0.783 . . . . 72.11 108.886 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.97 -178.33 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.647 1.979 . . . . 74.31 107.845 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--O 1.235 0.305 0 O-C-N 121.427 -0.796 . . . . 71.12 109.709 170.339 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.408 0 N-CA-C 106.317 -1.734 . . . . 71.44 106.317 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.3 109.06 5.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.341 -1.355 . . . . 73.13 107.341 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -133.49 154.43 50.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.186 1.395 . . . . 74.11 107.286 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.6 ttp -72.44 117.31 13.95 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.282 -1.377 . . . . 74.21 107.282 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -70.26 80.2 0.53 Allowed 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 107.407 -1.331 . . . . 70.14 107.407 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.6 -18.83 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.816 0.847 . . . . 73.35 111.717 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.47 105.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.471 1.108 . . . . 75.34 110.65 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.3 m -140.24 99.21 3.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.776 -1.935 . . . . 75.25 105.776 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.12 28.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.404 -1.078 . . . . 63.34 110.404 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 -15.3 17.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.388 2.725 . . . . 75.35 113.09 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 m -136.46 165.98 31.26 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.702 1.601 . . . . 75.45 110.439 -169.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.48 175.35 0.56 Allowed 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.603 2.869 . . . . 75.42 112.932 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m 56.3 43.21 26.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.995 1.718 . . . . 74.32 112.303 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 99.5 m -65.89 123.3 19.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 74.33 109.522 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 171.73 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.99 0.916 . . . . 75.15 111.465 167.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.7 141.17 39.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.467 -1.309 . . . . 75.25 107.467 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -78.02 162.66 26.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.482 1.113 . . . . 75.42 112.483 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -31.71 71.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.738 1.615 . . . . 71.53 113.489 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.99 -45.16 86.79 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 120.902 -1.123 . . . . 71.31 112.307 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -63.69 -38.19 90.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.859 -0.591 . . . . 64.53 109.536 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.383 0.673 . . . . 60.53 112.086 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -67.42 -44.97 77.46 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.104 1.32 . . . . 55.02 109.666 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -73.87 -18.76 60.88 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 118.601 -0.714 . . . . 62.25 112.863 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.83 133.98 31.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.7 1.6 . . . . 60.35 112.165 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -70.81 127.14 31.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.156 -1.424 . . . . 74.34 107.156 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.61 125.33 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.546 -2.02 . . . . 75.44 105.546 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.63 127.17 30.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.84 -0.8 . . . . 75.15 108.84 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.83 9.84 16.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.918 0.487 . . . . 75.53 110.842 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -89.79 -24.04 21.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 74.21 111.114 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -142.6 -74.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.328 1.051 . . . . 74.35 109.828 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.29 60.81 Favored Pre-proline 0 CA--C 1.513 -0.45 0 C-N-CA 126.541 1.937 . . . . 75.41 109.134 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.23 84.01 1.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 123.166 2.577 . . . . 74.41 106.581 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.86 162.3 35.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.254 2.621 . . . . 63.11 110.678 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.4 mt -81.03 148.42 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 108.471 -0.937 . . . . 75.53 108.471 168.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.07 139.61 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 124.785 1.234 . . . . 71.21 108.919 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.02 138.28 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.671 -1.233 . . . . 75.55 107.671 168.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -94.83 134.47 37.42 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.22 -1.4 . . . . 75.15 107.22 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.3 134.95 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.458 -2.053 . . . . 75.34 105.458 163.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.46 153.45 46.27 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.961 0.904 . . . . 72.35 109.098 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.04 135.22 44.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.348 0.659 . . . . 74.12 109.687 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.89 79.92 9.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 104.607 -2.368 . . . . 73.33 104.607 167.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.04 161.88 13.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.114 0.966 . . . . 73.41 109.387 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.31 -22.46 66.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.814 1.245 . . . . 75.13 112.133 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -65.38 -14.42 60.82 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.338 1.236 . . . . 72.12 114.338 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.75 177.34 28.27 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.696 1.617 . . . . 54.43 110.81 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.93 30.58 1.05 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.56 1.544 . . . . 64.11 114.421 -165.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.97 -77.05 0.16 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.497 1.046 . . . . 71.12 114.27 -159.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -89.17 156.1 5.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.578 2.185 . . . . 75.31 110.629 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.87 156.72 46.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.2 1.0 . . . . 71.04 109.188 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.4 m -82.11 123.64 29.14 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.738 -1.949 . . . . 73.14 105.738 157.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -83.98 119.34 24.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.359 -2.089 . . . . 72.32 105.359 154.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.51 173.98 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 123.674 0.79 . . . . 74.14 109.413 165.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.4 156.41 45.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.85 1.66 . . . . 74.55 109.3 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -139.44 109.64 6.48 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 125.77 1.628 . . . . 75.21 111.366 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -96.54 160.57 14.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.328 2.251 . . . . 74.22 107.872 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 63.06 14.78 7.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.97 1.308 . . . . 73.15 111.493 -168.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.893 2.077 . . . . 73.55 112.391 162.676 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 117.289 -1.339 . . . . 64.21 112.541 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -60.3 165.33 11.11 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 CA-C-N 121.333 1.512 . . . . 71.11 111.411 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.45 -126.59 7.0 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.698 1.618 . . . . 75.11 109.657 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.81 151.81 0.11 Allowed Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 129.215 3.006 . . . . 64.53 114.376 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.66 155.28 69.38 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 123.652 2.902 . . . . 71.14 111.036 -177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -134.69 -179.47 5.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.699 1.6 . . . . 70.54 110.208 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.4 36.9 17.7 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.087 1.355 . . . . 73.51 112.07 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.63 134.17 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.286 -1.005 . . . . 53.03 108.286 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -131.05 155.53 46.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.452 1.101 . . . . 74.4 109.553 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.06 139.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.499 -2.038 . . . . 73.44 105.499 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -139.74 147.6 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.723 1.609 . . . . 73.33 109.559 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -79.24 143.31 35.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.37 -1.345 . . . . 73.41 107.37 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p -139.03 166.75 22.59 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.701 2.0 . . . . 72.02 108.022 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -56.53 -25.1 56.88 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.619 2.213 . . . . 74.2 113.355 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -87.58 -20.76 25.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.574 1.079 . . . . 73.23 111.558 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.11 -163.78 24.25 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.477 -1.049 . . . . 50.34 110.477 -159.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.65 135.54 36.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.884 0.874 . . . . 74.5 112.093 -166.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -84.58 86.58 7.29 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.941 2.096 . . . . 71.52 110.047 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.85 131.78 35.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.611 0.764 . . . . 74.33 110.247 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -145.85 152.75 39.99 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.269 . . . . 63.42 109.294 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -151.25 179.41 8.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.581 1.553 . . . . 74.44 110.885 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -65.35 160.8 55.83 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.618 0.599 . . . . 73.1 112.618 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.61 156.21 66.31 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.211 1.941 . . . . 63.4 109.13 156.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.95 95.58 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.024 2.483 . . . . 73.1 110.53 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -140.24 22.28 2.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.63 0.604 . . . . 71.14 112.63 -165.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.9 t -99.2 -50.96 10.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 O-C-N 121.742 -0.599 . . . . 74.1 110.158 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.5 p -131.24 164.31 25.86 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.44 1.096 . . . . 74.24 110.118 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -77.64 40.4 0.3 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.237 1.415 . . . . 71.4 111.996 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.12 132.63 15.37 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.516 -2.234 . . . . 74.11 107.516 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -76.86 79.85 3.44 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.681 -1.229 . . . . 74.51 107.681 171.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.65 146.18 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.485 -1.302 . . . . 64.51 107.485 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 pt -141.72 -17.49 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.119 2.168 . . . . 74.21 111.088 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -160.47 -168.79 2.24 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.59 1.086 . . . . 73.3 111.325 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -133.14 162.73 30.98 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.511 1.524 . . . . 75.43 109.805 164.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -142.33 160.17 40.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.784 1.634 . . . . 75.25 108.923 159.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.7 117.39 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.477 -1.675 . . . . 73.34 106.477 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -93.22 144.17 25.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.906 -1.146 . . . . 74.32 107.906 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.2 tp -129.75 132.08 46.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.768 2.027 . . . . 74.55 107.342 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.69 134.12 44.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.147 1.34 . . . . 61.14 109.127 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.34 172.5 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.833 1.253 . . . . 72.53 108.741 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 118.27 0.486 . . . . 75.34 110.522 166.008 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 122.066 0.936 . . . . 75.34 113.197 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.38 94.95 4.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.746 -1.946 . . . . 54.43 105.746 167.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.43 145.94 48.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.564 -1.643 . . . . 75.24 106.564 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.5 ttp -96.42 138.15 34.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.405 1.082 . . . . 73.44 109.731 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -79.49 65.51 4.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.774 1.23 . . . . 74.22 110.682 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.59 -32.87 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.882 1.273 . . . . 73.32 112.332 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -80.38 97.08 6.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.095 0.558 . . . . 74.51 112.238 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.31 117.77 25.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.183 -1.414 . . . . 64.32 107.183 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.53 160.98 12.05 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.651 -1.38 . . . . 73.54 109.651 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.29 -55.03 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.955 2.437 . . . . 72.34 112.011 -169.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -84.32 164.85 41.48 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 121.188 -0.945 . . . . 72.12 111.257 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.97 179.22 3.41 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.814 3.009 . . . . 72.14 111.297 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 m 58.47 28.13 16.51 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.627 1.343 . . . . 74.32 114.627 165.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.91 158.36 34.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.334 1.053 . . . . 71.32 111.936 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 169.41 18.28 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.116 0.966 . . . . 73.13 111.821 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.14 111.86 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 125.194 1.398 . . . . 75.43 109.041 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.5 144.53 16.85 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.27 1.428 . . . . 74.11 113.459 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.83 -26.71 68.88 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.281 1.432 . . . . 74.21 113.187 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.7 t -54.34 -54.49 39.66 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.38 -0.825 . . . . 71.02 109.847 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.19 -37.55 87.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.796 0.438 . . . . 75.03 111.075 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.16 -27.81 67.41 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.247 0.476 . . . . 75.34 111.278 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -74.0 -34.78 64.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.479 0.581 . . . . 63.22 111.506 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -76.7 -11.29 59.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.622 0.601 . . . . 55.35 112.622 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 134.74 48.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.837 0.827 . . . . 71.52 109.456 -174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -72.79 112.34 8.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.942 -1.026 . . . . 73.25 109.054 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.4 125.17 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 64.42 106.844 162.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.02 135.06 50.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.999 0.812 . . . . 53.12 109.94 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -130.84 56.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.823 1.249 . . . . 64.43 108.143 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 p -123.41 -21.47 5.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.328 -0.851 . . . . 75.35 112.964 163.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -131.86 -69.88 0.59 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.642 0.777 . . . . 74.23 112.245 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -144.27 158.42 54.78 Favored Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 120.421 -1.424 . . . . 74.24 109.073 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.77 96.99 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.685 2.257 . . . . 75.44 108.46 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.31 37.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.738 1.615 . . . . 73.11 107.753 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.52 120.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.381 -1.711 . . . . 71.22 106.381 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.93 152.7 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.239 -1.022 . . . . 75.21 108.239 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -131.74 152.73 50.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.989 0.915 . . . . 73.51 108.74 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -127.36 87.56 2.65 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 70.7 mt -90.64 133.37 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.27 -2.122 . . . . 63.12 105.27 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.64 131.63 19.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.283 0.563 . . . . 74.51 111.868 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.17 122.45 22.79 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.459 -0.941 . . . . 72.31 108.459 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -77.8 109.8 12.12 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 106.931 -1.507 . . . . 75.22 106.931 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.63 -178.63 5.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.175 0.99 . . . . 74.23 109.55 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.94 1.93 56.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.401 -0.818 . . . . 73.53 112.724 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -66.68 -68.39 0.38 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.384 -1.339 . . . . 73.54 107.384 154.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.34 37.59 0.27 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 119.34 -1.41 . . . . 75.22 115.725 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 59.59 -163.65 0.23 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.609 1.963 . . . . 75.23 109.792 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 161.97 -90.64 0.11 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 105.336 -3.106 . . . . 74.32 105.336 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -62.37 150.79 85.96 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.499 2.133 . . . . 72.52 110.296 172.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.95 112.25 5.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.499 -2.038 . . . . 60.22 105.499 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.8 m -58.83 124.54 20.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.84 0.856 . . . . 64.25 108.992 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -79.42 79.28 5.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.607 1.194 . . . . 75.53 108.379 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.78 146.77 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.243 -1.762 . . . . 75.11 106.243 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.66 128.44 39.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.094 -1.076 . . . . 75.51 108.094 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -92.64 104.82 17.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.211 0.604 . . . . 75.14 110.337 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.15 175.36 10.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.377 1.471 . . . . 72.33 109.427 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.22 14.69 3.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.117 2.167 . . . . 74.12 112.543 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 64.41 110.832 164.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 109.987 -0.375 . . . . 71.02 109.987 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 163.16 36.82 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.014 2.476 . . . . 70.34 110.547 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.31 -117.97 5.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.305 -1.118 . . . . 44.32 110.305 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 160.57 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 128.464 2.706 . . . . 64.13 112.361 -168.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.1 152.36 56.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.696 2.264 . . . . 72.35 109.217 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.17 177.0 8.53 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.861 1.664 . . . . 73.54 108.535 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.71 42.09 5.56 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.44 2.296 . . . . 70.44 111.633 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.95 120.73 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.168 0.987 . . . . 73.44 109.021 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -112.55 133.98 54.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.365 -0.976 . . . . 74.1 108.365 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.7 mt -144.4 124.84 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.728 1.211 . . . . 73.33 108.076 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.0 m -145.41 161.79 38.85 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.611 1.164 . . . . 64.33 112.281 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -83.89 146.01 28.3 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.325 1.05 . . . . 75.43 109.206 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 m -152.08 165.3 17.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.917 1.687 . . . . 73.34 108.204 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.86 -11.18 25.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.209 1.94 . . . . 75.34 113.544 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.72 7.5 8.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.011 0.924 . . . . 75.33 111.523 -164.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 174.0 13.6 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.82 2.153 . . . . 75.1 107.93 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.4 129.46 36.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.566 -1.272 . . . . 74.22 107.566 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -65.89 109.39 2.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.634 -1.247 . . . . 72.4 107.634 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.06 126.82 44.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.317 1.047 . . . . 62.5 108.693 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -139.43 154.18 47.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.331 0.652 . . . . 75.11 109.63 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -142.94 -178.91 6.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.132 1.373 . . . . 75.31 107.675 175.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.19 160.37 52.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.199 0.909 . . . . 74.32 111.22 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.57 156.05 64.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.734 3.623 . . . . 74.44 113.101 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.57 -176.67 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.113 3.209 . . . . 75.35 111.488 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 14.03 3.57 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.647 1.721 . . . . 65.04 115.647 -163.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.8 -54.55 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.774 -0.579 . . . . 72.45 111.468 -160.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -132.9 172.65 12.31 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.967 1.307 . . . . 73.14 107.908 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 m -51.74 -41.86 61.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.606 1.094 . . . . 72.34 112.394 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.71 163.87 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.087 0.851 . . . . 73.33 111.198 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -131.31 74.26 1.58 Allowed 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.512 -0.993 . . . . 74.12 108.641 164.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.22 152.44 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 75.22 106.439 167.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.24 -28.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.121 1.368 . . . . 72.25 110.403 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.39 -169.94 3.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.353 -1.351 . . . . 73.44 107.353 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -128.11 166.27 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.629 -1.248 . . . . 71.32 107.629 159.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -130.72 153.42 49.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.284 -1.376 . . . . 62.33 107.284 164.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 p -153.02 124.64 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 O-C-N 121.942 -0.474 . . . . 75.3 110.475 -171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -99.15 133.98 42.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.943 -1.132 . . . . 75.02 107.943 -171.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -117.63 130.23 56.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.639 2.375 . . . . 72.21 107.564 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.0 136.25 57.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 121.417 1.917 . . . . 71.34 112.992 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pt -145.11 175.5 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.194 1.398 . . . . 60.21 110.289 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 126.317 1.847 . . . . 74.41 112.754 164.328 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.24 0.562 0 N-CA-C 107.724 -1.213 . . . . 74.52 107.724 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.19 -154.24 0.06 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.724 -0.671 . . . . 74.25 111.92 162.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 76.69 160.54 0.22 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 131.23 3.812 . . . . 61.33 113.77 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -126.95 147.65 50.09 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.655 1.182 . . . . 74.3 110.068 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.62 93.72 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.203 2.201 . . . . 75.41 112.529 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -94.86 -26.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 116.456 -1.735 . . . . 75.1 110.162 -165.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.0 132.68 54.17 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 120.332 1.424 . . . . 72.13 109.409 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.0 p -155.01 27.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.548 1.139 . . . . 73.31 112.227 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.27 152.67 18.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.978 -0.901 . . . . 74.41 111.195 -168.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.33 -55.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.046 1.831 . . . . 72.14 109.053 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.87 144.95 97.99 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.29 -0.633 . . . . 72.43 109.29 169.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.56 -3.54 13.26 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.613 2.875 . . . . 62.22 112.604 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 p -98.58 44.99 1.02 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.461 1.482 . . . . 73.53 110.419 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.6 t -51.3 111.82 0.64 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.953 1.301 . . . . 71.31 110.706 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.3 130.24 37.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.288 -0.634 . . . . 64.52 109.288 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -76.35 95.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.846 -1.539 . . . . 75.4 106.846 162.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -75.75 163.71 26.99 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.294 -0.866 . . . . 74.43 109.694 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -53.09 -38.35 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.072 1.349 . . . . 73.42 112.115 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -40.09 63.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.784 2.034 . . . . 63.21 111.592 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.3 m -79.21 -36.09 40.65 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.105 -0.372 . . . . 75.23 111.873 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -25.53 68.23 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.85 0.46 . . . . 72.23 111.25 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.1 m -60.84 -10.86 6.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.345 1.239 . . . . 72.54 114.345 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -115.51 -6.66 12.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.644 1.111 . . . . 74.14 111.139 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.1 151.28 45.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.212 1.005 . . . . 73.52 109.997 -171.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -137.24 153.09 50.45 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.721 0.808 . . . . 74.2 112.117 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.419 ' CG2' ' HA ' ' A' ' 93' ' ' PRO . 1.9 mp -88.28 144.54 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.554 1.542 . . . . 73.41 109.593 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 90' ' ' THR . 7.5 t70 -79.16 71.42 5.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.417 1.887 . . . . 72.13 109.656 -172.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -62.33 4.45 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.258 1.023 . . . . 74.24 111.876 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.437 ' H ' ' C ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -84.57 -20.51 31.38 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.367 0.985 . . . . 74.13 110.258 169.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.8 p -141.66 -85.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.765 1.226 . . . . 73.34 111.286 161.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HE3' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -117.17 153.93 49.91 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 126.421 1.889 . . . . 74.21 112.093 -162.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HA ' ' CG2' ' A' ' 87' ' ' ILE . 83.2 Cg_endo -77.64 78.76 3.41 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.511 1.474 . . . . 74.24 112.765 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.69 157.24 44.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.54 2.736 . . . . 72.33 107.912 175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.3 mt -73.32 -21.3 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.572 0.582 . . . . 73.2 112.572 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.4 mm 60.68 142.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 130.187 3.395 . . . . 72.4 110.04 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -135.98 135.75 39.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.235 -1.394 . . . . 71.44 107.235 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -133.95 90.7 2.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.084 0.865 . . . . 74.53 109.627 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.1 mt -87.41 153.47 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.249 -1.389 . . . . 74.32 107.249 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.76 154.74 37.9 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.967 0.803 . . . . 72.31 111.769 159.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.47 116.22 13.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.217 1.807 . . . . 63.04 108.57 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -79.34 89.26 4.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.074 -2.195 . . . . 75.04 105.074 170.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -115.74 178.92 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.298 1.439 . . . . 64.25 109.972 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.94 -3.12 20.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.629 0.974 . . . . 75.35 113.629 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -91.19 -27.96 18.16 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 120.256 -1.527 . . . . 72.44 109.675 173.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.16 -179.25 20.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.631 1.11 . . . . 52.25 110.98 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -70.7 69.52 0.44 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.068 1.747 . . . . 75.22 109.271 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 -81.99 1.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.114 -1.594 . . . . 70.44 109.114 -169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.61 160.33 25.16 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.091 1.861 . . . . 64.45 109.05 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.71 36.92 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.973 0.909 . . . . 71.11 109.321 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -95.76 154.0 17.45 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.504 -1.295 . . . . 73.13 107.504 156.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -129.72 101.58 5.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.791 -2.3 . . . . 73.23 104.791 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.98 164.31 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.542 -1.281 . . . . 72.31 107.542 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 121.1 24.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.452 1.101 . . . . 74.54 108.095 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -91.74 79.7 5.36 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.316 -1.735 . . . . 74.3 106.316 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.424 HD23 ' HE3' ' A' ' 92' ' ' LYS . 44.5 mt -76.4 170.73 15.82 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.608 -0.886 . . . . 72.43 108.608 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 75.58 -6.14 2.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.895 2.478 . . . . 65.12 113.003 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--O 1.241 0.608 0 C-N-CA 125.428 1.491 . . . . 74.4 113.391 171.413 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 108.276 -1.009 . . . . 72.41 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.4 145.81 83.95 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.084 1.856 . . . . 71.24 109.061 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.9 -133.66 5.07 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.631 -1.387 . . . . 64.34 109.631 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.02 165.06 0.14 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 128.624 2.77 . . . . 75.2 111.249 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.51 156.33 64.17 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.458 2.105 . . . . 72.12 110.201 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.06 -178.97 5.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.837 0.827 . . . . 74.32 112.05 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.28 1.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.838 2.855 . . . . 60.33 115.744 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -44.47 129.67 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.87 2.468 . . . . 74.4 112.626 -154.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -115.01 131.03 57.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.439 1.095 . . . . 75.23 108.913 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.57 93.45 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.964 -1.495 . . . . 72.22 106.964 -175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -96.12 140.35 30.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.581 -1.19 . . . . 62.11 108.991 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -60.68 154.03 22.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.99 -0.744 . . . . 75.13 108.99 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.6 m -144.38 165.28 24.12 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 127.612 2.365 . . . . 74.03 107.963 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.98 -39.31 41.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.098 1.865 . . . . 75.51 112.06 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -106.48 9.79 31.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.732 0.813 . . . . 75.21 111.574 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.02 -137.37 4.76 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 120.414 -1.429 . . . . 62.14 112.185 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.12 144.85 32.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.797 0.839 . . . . 72.44 109.655 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -75.69 155.1 36.04 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 109.24 -0.652 . . . . 73.52 109.24 163.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 107.82 3.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.914 1.686 . . . . 55.33 108.711 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.3 p -123.41 158.6 30.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.034 0.833 . . . . 75.12 110.251 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -146.78 141.86 27.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.964 0.905 . . . . 72.21 111.556 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -76.36 150.9 83.01 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.348 1.059 . . . . 74.12 109.206 165.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.23 168.01 25.3 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.625 3.55 . . . . 74.03 111.126 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 153.11 77.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.198 1.265 . . . . 55.35 110.721 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 t -151.86 73.0 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.738 -1.949 . . . . 74.24 105.738 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -57.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.066 0.946 . . . . 71.12 110.201 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 p -134.86 167.53 20.72 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.448 -0.945 . . . . 73.23 108.448 162.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -47.01 -57.07 5.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.203 1.801 . . . . 73.35 113.132 -168.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.31 176.72 5.96 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.228 1.394 . . . . 64.3 111.103 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -141.27 92.06 2.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.379 -1.711 . . . . 71.25 106.379 157.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.76 145.28 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.632 -1.618 . . . . 75.33 106.632 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.45 -28.26 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.471 1.109 . . . . 71.53 110.932 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.36 -176.26 5.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.663 1.119 . . . . 74.21 110.283 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -139.64 166.11 25.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.355 1.062 . . . . 75.21 110.273 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.48 171.93 19.42 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.287 -0.634 . . . . 73.22 109.287 163.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.02 124.48 26.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.19 -1.781 . . . . 71.34 106.19 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -118.22 119.07 33.57 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.794 -1.928 . . . . 75.43 105.794 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.21 116.03 30.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.285 -1.746 . . . . 73.2 106.285 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.34 136.4 51.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.003 -1.11 . . . . 75.24 108.003 173.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 pt -130.37 -177.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.288 -1.745 . . . . 75.52 106.288 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.491 1.916 . . . . 71.5 110.858 178.191 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.412 0 N-CA-C 107.296 -1.372 . . . . 75.14 107.296 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.13 84.06 1.7 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.417 -0.811 . . . . 54.24 110.287 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.29 158.64 43.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.555 1.142 . . . . 71.21 109.81 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -102.83 7.03 39.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.501 0.926 . . . . 75.13 113.501 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 45.91 61.12 2.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.707 2.003 . . . . 74.5 114.398 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.65 -37.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.666 1.186 . . . . 73.23 113.545 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -64.68 118.81 9.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.969 0.804 . . . . 75.53 109.807 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.7 m -135.58 27.58 3.36 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.537 1.535 . . . . 75.21 109.656 164.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.19 161.05 37.25 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.973 -0.851 . . . . 75.2 110.973 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.83 -55.17 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.578 2.186 . . . . 74.45 110.013 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.86 158.75 31.15 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.864 1.266 . . . . 75.33 110.389 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.82 173.63 10.73 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.883 2.388 . . . . 75.42 110.863 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p 47.87 63.68 1.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.93 1.292 . . . . 71.52 109.782 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.3 p -70.98 -164.82 0.1 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.856 2.062 . . . . 74.5 110.21 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 pp -130.09 -176.49 3.96 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.227 -1.546 . . . . 72.55 108.799 164.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.402 HG13 ' CD2' ' A' ' 82' ' ' LEU . 31.0 t -135.98 148.23 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.632 1.105 . . . . 75.4 109.051 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -89.41 145.12 25.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.004 2.122 . . . . 73.53 111.084 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -62.48 -27.4 69.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.982 2.113 . . . . 73.54 112.83 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.5 p -57.53 -30.03 64.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.116 0.966 . . . . 74.32 111.28 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -78.44 -45.43 22.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.015 1.326 . . . . 72.4 109.298 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.402 ' CD2' HG13 ' A' ' 77' ' ' VAL . 3.5 mm? -58.35 -37.3 74.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.995 1.318 . . . . 75.22 111.87 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -50.08 -48.86 52.95 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.144 0.497 . . . . 62.53 110.531 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -84.32 -5.35 59.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.168 0.987 . . . . 75.41 112.076 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.81 138.07 55.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.083 0.944 . . . . 72.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -71.85 153.5 41.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.074 -1.421 . . . . 73.34 110.446 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -123.25 136.8 58.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.914 1.286 . . . . 71.43 109.261 -166.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.76 68.14 1.68 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 128.128 2.571 . . . . 74.33 112.197 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.71 73.07 0.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.827 1.299 . . . . 61.34 108.443 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.5 p -133.92 -28.5 1.37 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.234 2.213 . . . . 72.11 108.357 165.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.74 -50.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.084 0.954 . . . . 75.31 111.887 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.41 160.1 69.75 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 120.893 1.679 . . . . 73.24 112.541 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.53 74.1 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.579 2.186 . . . . 75.23 109.291 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.96 148.8 45.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.609 0.966 . . . . 63.2 113.609 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -83.98 133.9 28.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.917 1.287 . . . . 62.2 109.251 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -84.29 147.84 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.932 0.893 . . . . 64.21 110.601 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -126.57 145.56 50.49 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 125.331 1.452 . . . . 72.12 109.373 171.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -119.27 98.58 6.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.938 -1.875 . . . . 75.2 105.938 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 mt -113.17 133.14 59.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.456 -2.053 . . . . 74.04 105.456 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 149.86 47.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.85 -1.167 . . . . 75.43 107.85 167.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.03 28.49 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.113 -1.439 . . . . 74.44 107.113 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.87 99.96 3.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.003 -2.221 . . . . 75.41 105.003 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -121.92 163.7 18.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.067 1.347 . . . . 54.02 110.335 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.66 -21.15 62.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.707 -1.133 . . . . 72.23 112.436 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.78 -16.85 44.92 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.36 1.064 . . . . 75.32 112.888 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.58 36.77 4.72 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 118.55 0.614 . . . . 75.33 111.756 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.29 24.83 13.4 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.458 1.903 . . . . 75.22 111.865 165.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.87 -77.98 0.31 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.137 1.351 . . . . 73.0 112.098 -157.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.46 134.69 24.97 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.457 1.438 . . . . 75.33 109.403 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.99 164.07 26.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.074 1.75 . . . . 72.33 107.46 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 m -114.63 135.26 54.34 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.593 -1.632 . . . . 75.03 106.593 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.92 114.9 27.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.371 -2.085 . . . . 75.0 105.371 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 m -113.17 162.67 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 119.16 0.891 . . . . 75.13 108.913 167.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 135.85 52.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.364 -1.347 . . . . 75.32 107.364 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -120.89 102.08 8.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.274 1.035 . . . . 72.03 111.396 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.514 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.58 -10.95 28.18 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.741 2.417 . . . . 75.32 111.885 -169.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 2.21 2.92 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.076 1.75 . . . . 75.32 111.652 170.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.651 0 CA-C-N 120.654 1.57 . . . . 75.12 114.408 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.657 0 N-CA-C 107.57 -1.271 . . . . 73.52 107.57 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.78 136.51 58.06 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.136 1.224 . . . . 74.33 109.546 164.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.01 112.97 3.66 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 125.13 1.348 . . . . 73.11 114.356 165.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.96 31.01 Favored Pre-proline 0 C--N 1.314 -0.967 0 C-N-CA 127.025 2.13 . . . . 74.23 105.272 158.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.41 159.59 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.065 2.51 . . . . 73.53 111.268 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.1 m -134.41 176.52 8.54 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.662 1.185 . . . . 74.54 109.882 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 18.4 5.9 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.593 2.757 . . . . 65.11 113.758 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.58 120.98 7.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.369 0.668 . . . . 70.31 109.728 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.67 146.38 27.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.247 -1.39 . . . . 74.5 107.247 167.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.8 mt -135.71 133.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.383 -2.08 . . . . 74.13 105.383 161.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 t -146.82 144.51 29.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.434 1.494 . . . . 74.23 109.312 -173.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -80.45 158.26 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.124 0.57 . . . . 64.42 110.261 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.45 165.34 18.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.038 1.335 . . . . 61.0 107.935 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 -15.64 35.46 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.105 2.536 . . . . 70.31 113.464 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -107.74 -26.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.399 1.08 . . . . 70.23 111.66 -168.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.14 -165.61 37.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.582 -1.807 . . . . 63.43 108.582 -167.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.31 133.92 42.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.046 -1.465 . . . . 74.1 107.046 165.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -60.31 115.36 3.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.012 -1.477 . . . . 74.2 107.012 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.42 140.35 38.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.4 -1.704 . . . . 72.1 106.4 168.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 p -150.23 156.56 41.8 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.886 1.221 . . . . 74.14 109.953 164.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -139.91 158.37 44.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.487 1.515 . . . . 71.33 108.921 166.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -87.89 161.67 43.57 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.052 0.541 . . . . 64.23 110.523 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.8 168.08 19.56 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.904 . . . . 74.51 111.341 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.55 156.5 21.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.005 1.803 . . . . 74.51 112.973 -166.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.5 52.86 1.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.028 -1.471 . . . . 74.2 107.028 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.2 t -137.57 -87.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.149 -1.056 . . . . 74.32 108.149 160.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 t -168.68 40.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.968 -1.083 . . . . 71.34 110.037 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.4 p -68.23 -6.82 25.74 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.103 -1.623 . . . . 72.3 113.787 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.09 -124.99 6.71 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 120.248 -1.533 . . . . 72.42 111.49 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -109.11 88.43 2.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.351 1.86 . . . . 73.43 110.612 -167.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.04 125.58 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.867 1.667 . . . . 71.42 107.177 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.46 -27.93 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.398 1.079 . . . . 74.24 111.406 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -151.3 -171.44 3.93 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.692 1.597 . . . . 72.3 107.434 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 169.49 17.51 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.472 -1.393 . . . . 74.5 108.749 172.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.9 173.24 16.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.587 0.63 . . . . 72.22 112.6 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.65 99.28 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 128.733 2.813 . . . . 73.31 105.282 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.406 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 42.7 m-85 -82.99 153.34 25.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.957 -1.127 . . . . 73.34 107.957 163.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.3 tp -143.26 128.19 18.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.956 2.102 . . . . 74.24 106.105 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 112.78 13.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.829 0.852 . . . . 63.52 109.143 169.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 pt -86.75 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.155 -1.054 . . . . 72.11 108.155 160.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 124.231 1.012 . . . . 64.13 111.139 174.009 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--O 1.241 0.649 0 N-CA-C 109.586 -0.524 . . . . 72.45 109.586 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.36 120.93 25.06 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.448 0.536 . . . . 72.22 112.448 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.406 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 37.9 m-85 -148.97 170.91 17.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.268 1.827 . . . . 65.13 110.33 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 ttp -106.45 5.89 29.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.438 1.495 . . . . 73.34 113.225 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 44.44 44.35 6.91 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.772 1.629 . . . . 71.33 115.34 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.6 m -56.4 -9.75 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.446 1.647 . . . . 72.2 115.446 -171.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -53.67 98.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.292 1.044 . . . . 71.32 110.783 165.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.6 t -147.32 24.66 1.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.713 . . . . 72.2 109.145 162.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.79 159.0 53.34 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.123 -0.791 . . . . 52.54 111.123 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -83.49 -7.05 10.82 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.947 3.098 . . . . 73.02 112.372 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -131.86 156.61 79.9 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.431 1.892 . . . . 74.3 109.842 -166.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -4.01 11.96 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.389 3.393 . . . . 72.13 113.551 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 p -120.46 22.47 11.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.666 2.387 . . . . 65.24 110.212 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.25 -174.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.654 2.782 . . . . 74.21 115.34 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.32 102.4 3.06 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 104.881 -2.266 . . . . 71.01 104.881 167.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.55 108.3 20.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.222 -1.029 . . . . 73.03 108.222 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -77.0 165.48 24.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.629 0.728 . . . . 73.11 111.554 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.75 82.08 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.47 1.108 . . . . 72.12 111.956 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -64.42 -20.29 66.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.924 -1.036 . . . . 64.31 112.754 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -75.02 -35.84 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.877 1.217 . . . . 50.53 109.862 172.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.0 -30.58 63.88 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.098 1.359 . . . . 63.35 110.53 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.4 m -47.09 -44.13 20.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.927 1.291 . . . . 74.21 113.033 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -84.55 1.73 44.55 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.167 0.802 . . . . 73.22 113.167 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.0 143.58 55.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.823 0.82 . . . . 72.14 110.376 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -68.74 140.69 55.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.529 -1.214 . . . . 75.24 107.808 162.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.6 mm -101.5 123.51 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.91 -1.515 . . . . 73.41 106.91 172.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.74 145.45 52.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.693 0.621 . . . . 72.25 110.056 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.7 18.66 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.658 0.783 . . . . 75.25 111.307 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 t -110.11 -13.58 14.35 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.658 -0.651 . . . . 72.45 110.908 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -129.02 -63.17 0.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.407 1.483 . . . . 74.44 111.982 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -154.74 155.55 30.57 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 127.062 2.145 . . . . 75.31 108.352 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -60.57 101.82 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.433 2.756 . . . . 70.13 109.516 171.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.94 156.58 41.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 70.12 110.078 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.44 140.71 16.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.824 -1.917 . . . . 73.45 105.824 161.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.8 mm -109.26 115.12 48.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.366 1.466 . . . . 71.41 107.555 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -100.72 148.49 24.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.957 0.903 . . . . 64.23 109.338 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -132.06 94.09 3.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.542 -1.651 . . . . 74.34 106.542 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.1 mt -108.55 136.66 43.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.014 -2.217 . . . . 65.52 105.014 -172.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.52 41.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.909 0.777 . . . . 72.4 110.115 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 114.56 7.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.473 1.509 . . . . 73.34 108.066 172.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 81.55 4.72 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 105.475 -2.046 . . . . 73.13 105.475 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.06 166.02 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.9 1.68 . . . . 74.12 108.347 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mt-10 -74.48 -36.41 63.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.685 -1.143 . . . . 63.34 108.836 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -17.04 64.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 115.718 1.748 . . . . 54.3 115.718 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.82 -97.89 0.13 Allowed Glycine 0 CA--C 1.512 -0.134 0 CA-C-N 120.643 1.565 . . . . 62.11 112.882 -161.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 3.6 t80 55.52 21.86 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.833 2.853 . . . . 72.51 111.561 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.8 1.28 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.532 2.015 . . . . 52.42 108.35 -163.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.0 143.91 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.447 2.098 . . . . 73.12 109.904 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.18 117.65 16.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.386 -2.079 . . . . 72.32 105.386 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 m -53.14 120.99 6.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.924 -1.139 . . . . 71.41 107.924 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -82.64 88.9 6.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.041 -1.837 . . . . 74.52 106.041 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.21 156.58 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.462 -1.681 . . . . 73.13 106.462 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 164.13 28.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.87 -1.159 . . . . 74.5 107.87 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -137.6 114.31 10.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.62 0.724 . . . . 74.23 111.3 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 25.05 5.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.801 1.64 . . . . 74.5 112.19 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -108.97 7.75 26.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.507 1.523 . . . . 74.41 111.508 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 122.101 0.953 . . . . 63.54 109.021 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 112.772 0.656 . . . . 74.41 112.772 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.31 4.64 3.22 Favored 'Trans proline' 0 CA--C 1.536 0.611 1 C-N-CA 125.596 4.197 . . . . 62.4 114.304 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 140.84 8.3 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 108.089 -2.004 . . . . 75.14 108.089 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.98 161.97 28.27 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.547 2.339 . . . . 73.22 108.321 171.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -63.76 142.15 81.75 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.169 1.913 . . . . 73.44 109.258 160.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.2 m -127.23 170.9 11.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.223 1.409 . . . . 74.21 110.185 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.75 31.78 0.7 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.801 2.441 . . . . 75.42 114.951 169.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.442 HD11 ' H ' ' A' ' 13' ' ' ILE . 3.6 mp -54.96 143.61 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 126.597 1.959 . . . . 74.14 109.004 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -119.15 147.25 44.4 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.573 0.749 . . . . 75.31 109.362 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.4 mt -146.36 126.72 6.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.979 -1.489 . . . . 71.32 106.979 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -141.69 173.83 11.14 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 126.924 2.09 . . . . 75.43 107.752 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -130.64 159.86 35.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.197 0.999 . . . . 71.23 108.946 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 m -152.91 165.54 17.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 125.855 1.662 . . . . 54.21 107.987 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.54 -29.22 84.23 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.093 1.862 . . . . 72.43 112.761 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 -38.22 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.205 0.602 . . . . 73.25 110.702 -169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.34 -165.2 26.34 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.181 1.372 . . . . 71.04 112.965 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.48 140.1 50.05 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.968 1.884 . . . . 73.22 110.258 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -85.5 96.07 9.49 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.645 1.578 . . . . 72.42 109.546 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -98.25 125.26 43.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.26 1.024 . . . . 72.43 108.745 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -137.48 160.81 38.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.765 0.711 . . . . 73.3 109.262 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.11 166.97 31.9 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.896 . . . . 74.04 109.703 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -101.43 159.91 28.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.884 -0.579 . . . . 73.24 111.395 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.35 175.49 9.28 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.697 3.598 . . . . 72.0 113.138 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.57 117.02 4.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.044 1.829 . . . . 74.11 108.707 167.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 m -151.32 19.31 0.75 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.033 1.333 . . . . 75.34 112.816 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -104.5 -62.16 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.44 -1.319 . . . . 71.32 107.44 168.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -116.81 161.57 19.07 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.996 -1.113 . . . . 52.12 107.996 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 m -68.69 -66.66 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.408 0.683 . . . . 72.21 110.367 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 171.86 2.47 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 122.159 0.866 . . . . 43.51 111.793 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -110.85 76.56 0.98 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.671 -1.974 . . . . 75.33 105.671 163.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -64.83 147.42 12.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.117 -1.068 . . . . 75.32 108.117 170.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.5 pt -130.9 -26.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.656 1.982 . . . . 75.12 110.106 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -168.07 -175.33 2.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.871 1.669 . . . . 73.3 107.451 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -127.14 167.89 15.4 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.118 -1.614 . . . . 73.24 109.128 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t -143.67 168.69 19.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.999 -1.063 . . . . 64.12 111.507 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.45 128.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.282 -1.377 . . . . 64.21 107.282 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.62 144.58 43.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.253 1.021 . . . . 74.01 108.594 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -120.73 136.15 54.95 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.342 2.657 . . . . 75.21 107.662 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.13 130.59 41.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.52 1.963 . . . . 73.33 109.249 172.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.7 171.59 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.826 1.25 . . . . 75.01 109.217 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.11 0.964 . . . . 74.45 108.822 161.047 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 103.726 -2.694 . . . . 75.42 103.726 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.23 114.06 24.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.859 -0.793 . . . . 63.32 108.859 171.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -133.82 161.15 35.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.339 1.455 . . . . 74.43 108.812 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.4 ttp -105.5 130.39 53.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.957 1.303 . . . . 65.11 107.629 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -71.95 85.95 0.99 Allowed 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.987 -1.116 . . . . 75.43 107.987 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -65.39 -48.5 82.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.377 0.608 . . . . 75.21 109.857 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.84 104.77 4.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.846 1.258 . . . . 71.02 109.882 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.5 t -160.2 75.93 0.6 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.656 -0.868 . . . . 74.14 108.656 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.24 46.8 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.001 -1.095 . . . . 54.33 114.445 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.66 -7.09 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.935 3.757 . . . . 73.1 112.449 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 m -48.32 144.34 6.37 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.356 1.862 . . . . 71.31 112.362 -169.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.89 109.79 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.339 2.026 . . . . 74.41 109.121 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.57 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.818 1.647 . . . . 71.41 108.943 -170.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.2 t -171.49 159.89 5.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.608 2.004 . . . . 75.24 109.248 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -130.82 97.74 4.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.045 1.738 . . . . 75.01 106.351 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.83 117.03 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 106.855 -1.535 . . . . 75.03 106.855 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -60.66 148.07 39.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.492 0.587 . . . . 73.24 109.951 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -55.23 -32.15 62.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.186 0.994 . . . . 64.41 112.833 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -61.41 -28.32 69.17 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.643 1.111 . . . . 72.14 113.216 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -70.31 -38.16 74.9 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.593 -1.317 . . . . 74.03 109.708 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.04 -40.63 96.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.872 0.869 . . . . 75.45 108.912 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -59.46 -14.24 11.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.584 1.554 . . . . 73.23 115.072 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.82 -3.92 12.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.335 0.97 . . . . 65.45 111.401 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.12 153.12 22.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.016 0.926 . . . . 74.44 110.189 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -137.51 158.14 45.02 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.883 1.273 . . . . 75.25 109.654 -167.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.77 137.35 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.173 0.511 . . . . 72.41 110.92 -149.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.5 48.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.848 1.659 . . . . 74.42 110.8 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -57.85 -12.74 3.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.575 1.15 . . . . 73.53 113.364 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -17.91 60.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.646 1.178 . . . . 64.13 112.107 170.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -130.07 -58.19 1.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.813 1.645 . . . . 72.23 110.134 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -150.79 162.08 28.18 Favored Pre-proline 0 C--N 1.341 0.23 0 C-N-CA 124.753 1.221 . . . . 75.13 110.268 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.71 87.85 0.43 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.477 1.451 . . . . 54.12 108.805 155.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.481 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -151.61 155.45 38.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.74 2.016 . . . . 71.12 110.428 166.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mt -80.67 -25.22 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 116.295 1.961 . . . . 73.04 116.295 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mm 61.19 151.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 130.754 3.622 . . . . 74.25 111.625 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -127.77 145.23 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.65 -1.241 . . . . 75.41 107.65 166.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.53 99.76 8.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.555 -1.646 . . . . 72.34 106.555 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.29 127.46 66.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.811 -2.292 . . . . 64.42 104.811 -170.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.25 163.76 37.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.382 1.087 . . . . 72.2 113.334 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.75 123.63 30.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.777 1.631 . . . . 63.01 107.516 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -76.33 104.97 7.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.489 -1.671 . . . . 72.2 106.489 164.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -123.82 -179.47 4.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.912 1.285 . . . . 74.31 110.155 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.74 -28.62 60.85 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.011 0.745 . . . . 75.12 113.011 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.71 -13.41 59.22 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.933 0.893 . . . . 64.43 111.997 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.38 169.19 45.67 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 124.847 1.213 . . . . 63.2 111.018 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.83 73.9 0.18 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.727 2.011 . . . . 75.04 111.159 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 -64.77 2.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.039 1.78 . . . . 64.21 110.044 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.28 163.64 35.49 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 120.04 1.92 . . . . 73.0 111.493 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.68 100.67 1.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.231 -1.766 . . . . 61.1 106.231 168.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -79.18 93.87 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.104 -1.443 . . . . 75.11 107.104 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.76 84.55 3.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.642 1.577 . . . . 74.12 108.177 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -82.78 167.63 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.942 -1.133 . . . . 74.01 107.942 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 152.01 51.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.702 -0.851 . . . . 73.35 108.702 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.481 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 1.7 t90 -120.7 102.42 8.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.981 1.372 . . . . 75.22 113.297 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.408 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -91.93 14.06 16.78 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.435 -0.802 . . . . 74.14 111.201 -169.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -72.13 -2.0 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.195 -0.907 . . . . 75.24 110.913 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 120.84 1.655 . . . . 75.44 112.193 -177.343 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.251 -0.277 . . . . 74.22 110.251 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.88 172.03 17.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.287 2.658 . . . . 72.33 111.781 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.01 -113.7 3.72 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.808 -1.717 . . . . 74.2 108.808 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.14 155.18 0.15 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 129.936 3.294 . . . . 73.54 111.0 -162.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.84 141.63 59.85 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.43 1.42 . . . . 65.13 108.924 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -137.5 -169.54 2.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.057 2.143 . . . . 74.24 107.938 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.3 34.8 3.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.108 1.763 . . . . 72.34 112.194 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.06 131.12 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.436 -0.95 . . . . 74.12 108.436 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -133.06 151.31 52.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.848 1.659 . . . . 74.52 108.393 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.8 mt -142.73 91.79 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 105.041 -2.207 . . . . 72.44 105.041 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -88.19 108.32 19.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.251 -1.018 . . . . 71.24 108.251 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 139.71 45.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.315 0.646 . . . . 73.03 109.9 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -148.67 166.52 15.25 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 123.564 0.746 . . . . 74.32 111.056 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -51.42 -46.67 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.9 1.733 . . . . 73.4 111.281 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -28.61 65.11 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.297 1.039 . . . . 72.4 111.424 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -104.31 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.569 -1.413 . . . . 74.3 109.569 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.76 120.97 6.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.793 -1.188 . . . . 73.01 107.793 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.53 134.47 51.34 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.597 1.159 . . . . 71.02 108.903 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.9 mt -116.35 144.23 44.53 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.555 -0.535 . . . . 74.21 109.555 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 p -140.21 160.66 39.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 117.83 -1.081 . . . . 71.01 108.174 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -159.97 173.75 15.41 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.842 1.657 . . . . 71.44 108.875 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.47 162.8 20.06 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.419 1.088 . . . . 72.23 110.263 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.78 155.73 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.748 2.298 . . . . 65.03 111.154 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.62 149.39 23.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.067 2.512 . . . . 74.33 111.573 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 t 76.48 135.6 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.885 2.474 . . . . 72.32 109.466 -160.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.96 -27.53 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 113.821 -1.536 . . . . 73.5 108.48 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.2 p -87.65 175.27 7.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.756 -1.215 . . . . 74.13 110.233 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 p -45.79 -48.98 15.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.692 1.597 . . . . 70.11 114.094 -169.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.94 -169.99 41.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.426 -1.469 . . . . 70.54 109.426 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -142.19 52.31 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.307 1.443 . . . . 74.34 109.493 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.39 142.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.74 -0.837 . . . . 71.24 108.74 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 pt -136.09 -15.59 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.684 1.993 . . . . 74.2 111.651 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -169.42 -168.06 0.77 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.048 2.139 . . . . 74.2 107.602 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.23 -178.6 5.93 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.331 -1.481 . . . . 74.2 110.077 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -145.78 155.33 42.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.258 1.023 . . . . 54.42 111.24 167.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -146.75 93.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.408 2.683 . . . . 74.24 105.15 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -95.98 130.11 43.06 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.825 -1.176 . . . . 73.42 107.825 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.69 124.07 34.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.663 1.119 . . . . 73.04 107.993 -168.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.46 129.49 40.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.733 0.697 . . . . 73.03 110.99 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.2 pt -132.31 171.09 18.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.15 -1.796 . . . . 73.02 106.15 166.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 75.35 108.599 172.336 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.293 0 N-CA-C 106.668 -1.605 . . . . 74.31 106.668 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.68 113.37 7.07 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.143 -0.688 . . . . 72.14 109.143 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -134.0 -179.51 5.6 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.861 1.665 . . . . 72.35 110.506 -165.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.9 ptm -80.94 165.92 21.33 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.895 -1.15 . . . . 72.35 107.895 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -125.42 83.02 2.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.109 -1.441 . . . . 74.33 107.109 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.75 -38.44 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.966 -0.459 . . . . 73.13 110.282 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -54.59 110.57 0.65 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.361 . . . . 74.03 112.533 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.9 p -147.81 24.55 1.07 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.379 0.672 . . . . 74.32 111.883 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.83 163.78 29.72 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.298 -0.723 . . . . 73.13 112.456 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.06 -54.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.376 2.717 . . . . 54.31 110.524 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.18 143.86 96.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.06 -1.089 . . . . 64.4 108.06 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.9 -46.42 1.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.514 2.143 . . . . 65.21 109.935 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -66.04 77.0 0.09 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.399 2.68 . . . . 74.02 108.778 168.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.6 t -96.17 -173.17 2.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.39 2.276 . . . . 63.0 109.54 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.09 159.97 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.786 -1.196 . . . . 74.41 109.656 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.48 115.03 47.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.557 -2.016 . . . . 73.2 105.557 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 151.11 45.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.587 1.155 . . . . 71.2 111.159 -168.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 p -51.82 -43.58 63.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.757 1.623 . . . . 71.34 111.96 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.5 t -51.43 -63.43 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.495 1.518 . . . . 51.25 110.235 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -60.77 -33.93 73.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.051 0.54 . . . . 73.23 110.932 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.2 mt -66.85 -23.11 65.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 117.974 -1.012 . . . . 74.22 111.778 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -56.42 -24.4 44.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.495 1.043 . . . . 72.44 111.884 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -102.83 1.41 34.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.944 0.898 . . . . 73.04 111.687 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.7 120.87 13.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.627 0.649 . . . . 75.41 109.621 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -83.26 148.05 27.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.485 -0.931 . . . . 72.23 108.485 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -110.69 147.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.108 -0.701 . . . . 75.42 109.108 -163.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.65 71.0 0.7 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.854 1.662 . . . . 74.43 111.769 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -76.26 53.0 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.154 1.782 . . . . 74.21 108.238 170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -55.23 0.34 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.067 -1.02 . . . . 73.31 108.734 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -94.08 -68.63 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.808 -0.558 . . . . 75.33 110.121 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -148.14 144.31 18.69 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 125.587 1.555 . . . . 71.44 106.975 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -67.42 108.01 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.959 1.773 . . . . 73.44 111.238 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.264 . . -147.57 165.54 30.05 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 131.318 3.847 . . . . 75.22 107.369 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.23 137.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.606 -1.627 . . . . 74.04 106.606 160.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.9 mm -100.93 152.51 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.373 1.469 . . . . 73.11 109.29 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.73 129.2 34.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.032 1.333 . . . . 74.34 109.162 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -96.14 89.89 5.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.791 -1.559 . . . . 73.4 106.791 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.2 mt -94.33 134.88 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.705 -1.591 . . . . 74.03 106.705 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.7 144.09 25.88 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.528 0.731 . . . . 74.03 109.748 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.61 152.21 37.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.298 0.639 . . . . 73.13 110.448 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.1 98.33 8.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.482 -2.044 . . . . 73.33 105.482 171.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -129.6 -171.02 2.41 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.272 1.429 . . . . 73.44 108.519 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -61.05 -35.36 76.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.485 0.55 . . . . 74.22 112.485 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -60.98 -26.06 67.3 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.882 1.673 . . . . 74.24 112.843 -166.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.37 36.64 3.77 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 117.076 1.59 . . . . 72.32 117.076 156.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 55.47 92.39 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 129.832 3.253 . . . . 74.13 113.187 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -126.36 -70.45 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 126.728 2.108 . . . . 62.14 108.958 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.6 143.05 37.3 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 119.31 1.555 . . . . 73.34 109.479 -171.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.72 142.92 20.34 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.583 -1.266 . . . . 61.4 107.583 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 m -108.05 109.73 21.25 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.861 -0.792 . . . . 75.04 108.861 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -72.4 95.18 1.72 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.226 -1.027 . . . . 73.4 108.226 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.95 151.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.107 -1.072 . . . . 75.33 108.107 166.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.74 139.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.418 1.887 . . . . 74.32 106.751 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -124.18 100.14 6.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.503 0.721 . . . . 75.41 109.943 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 mp -90.18 42.64 1.11 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 122.611 1.196 . . . . 74.21 110.285 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.01 7.83 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.007 2.123 . . . . 71.33 109.38 176.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 118.719 0.691 . . . . 73.13 112.649 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 109.585 -0.524 . . . . 71.41 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.44 -20.61 13.96 Favored 'Trans proline' 0 C--N 1.347 0.472 1 C-N-CA 125.827 4.352 . . . . 73.31 113.048 -166.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.53 156.86 48.29 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.022 -1.231 . . . . 64.12 110.022 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.79 165.57 9.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 126.728 2.011 . . . . 52.23 107.176 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -61.47 146.17 97.32 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.466 1.444 . . . . 74.43 109.723 161.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.7 176.5 7.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.337 1.455 . . . . 71.33 109.422 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.29 31.75 0.61 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 128.815 2.846 . . . . 74.15 113.82 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.97 133.28 27.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.158 -1.053 . . . . 73.45 108.158 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -129.49 142.44 50.78 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 123.546 0.738 . . . . 74.1 109.244 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.53 128.98 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 103.251 -2.87 . . . . 71.43 103.251 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -147.14 137.08 23.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.562 1.145 . . . . 65.21 108.257 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -64.18 144.89 56.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.379 -0.971 . . . . 74.04 108.379 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.0 162.16 53.71 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 126.888 2.075 . . . . 74.03 106.424 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 -10.89 27.65 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.028 1.152 . . . . 71.1 112.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.141 0.882 . . . . 64.43 111.702 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -118.37 0.83 Allowed Glycine 0 C--N 1.342 0.886 0 O-C-N 120.494 -1.379 . . . . 72.4 110.763 -172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.47 132.45 26.08 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.537 1.169 . . . . 44.5 110.963 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.24 149.59 50.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.128 1.371 . . . . 64.11 109.44 162.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 2.9 mp -142.22 123.26 14.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.646 1.578 . . . . 72.23 108.702 166.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -133.35 156.96 46.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.092 -0.707 . . . . 72.31 109.092 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.403 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -148.68 178.57 8.53 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.816 0.446 . . . . 73.43 110.577 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -139.39 159.52 65.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.114 1.766 . . . . 74.14 110.363 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.22 167.35 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.156 2.57 . . . . 73.03 111.05 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.45 -55.58 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.649 2.233 . . . . 73.24 110.71 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.46 39.92 8.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.474 -1.306 . . . . 64.24 107.474 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.07 -49.96 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.99 1.316 . . . . 73.34 113.75 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -64.68 154.66 35.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.099 1.318 . . . . 70.42 109.864 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -95.41 55.43 1.72 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.681 0.792 . . . . 70.14 109.572 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.53 134.18 11.64 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 108.561 -1.815 . . . . 70.23 108.561 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -81.66 82.12 7.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.162 -1.051 . . . . 74.45 108.162 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.72 131.85 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.739 -1.578 . . . . 74.35 106.739 168.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -126.86 -24.24 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.869 1.267 . . . . 73.01 111.36 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -163.3 -170.53 2.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.209 1.404 . . . . 74.41 107.606 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.37 177.54 8.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.665 1.186 . . . . 74.14 110.302 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.453 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -135.43 154.56 51.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.15 1.38 . . . . 70.15 108.601 163.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -143.72 112.24 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.432 -2.062 . . . . 73.12 105.432 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 40' ' ' SER . 87.3 m-85 -110.93 150.95 28.48 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.337 1.055 . . . . 64.25 109.742 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.78 121.31 25.15 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.342 1.857 . . . . 74.41 106.045 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.33 121.81 15.2 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.227 1.011 . . . . 71.02 110.771 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 pt -136.79 -177.11 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.325 1.45 . . . . 72.32 109.084 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . 0.277 3.5 pp0? . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 123.292 1.52 . . . . 74.31 112.767 171.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.164 0.507 . . . . 72.11 110.589 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.78 102.85 4.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.856 1.262 . . . . 72.33 109.655 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -132.37 152.36 51.48 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.881 1.272 . . . . 52.44 109.58 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.1 ttp -78.34 5.0 11.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.457 1.28 . . . . 74.34 114.457 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.39 58.65 3.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.403 1.481 . . . . 65.03 112.155 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.79 -13.34 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.542 0.737 . . . . 64.34 112.9 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.21 -177.05 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.009 1.323 . . . . 64.33 112.063 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 44.7 m 62.57 42.69 8.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.455 1.902 . . . . 73.41 109.7 -168.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 155.88 42.04 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.111 -1.196 . . . . 72.0 110.111 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.74 -20.41 52.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.546 2.831 . . . . 74.44 112.692 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -135.05 149.37 70.11 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.95 1.3 . . . . 72.04 110.573 167.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.7 176.82 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 124.484 3.456 . . . . 42.51 111.86 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.6 p 46.63 40.71 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.45 1.5 . . . . 72.11 110.707 -170.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.66 123.88 23.5 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.22 1.808 . . . . 71.32 112.139 -167.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.39 147.37 26.29 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.933 1.293 . . . . 72.11 108.403 159.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.45 115.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.08 2.152 . . . . 72.24 105.711 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -65.53 154.38 38.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.801 0.84 . . . . 74.43 110.776 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -63.63 -19.25 64.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.633 1.173 . . . . 74.3 112.145 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -37.67 69.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.108 1.763 . . . . 73.4 111.204 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 m -71.64 -41.9 68.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.775 0.83 . . . . 73.12 111.267 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -26.19 67.23 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.4 1.08 . . . . 74.44 111.931 -175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.49 -33.33 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.233 1.413 . . . . 64.33 110.602 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.31 -18.82 23.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.113 1.365 . . . . 71.32 112.267 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.71 9.94 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.16 1.384 . . . . 74.01 109.665 -170.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 147.49 23.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.675 0.79 . . . . 73.0 109.207 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -103.13 140.73 20.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.443 0.64 . . . . 74.21 109.305 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -59.2 110.45 1.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.576 1.95 . . . . 74.34 109.643 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -112.93 14.29 19.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.205 1.002 . . . . 72.44 110.512 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 82.6 p -102.53 -18.85 15.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.947 1.299 . . . . 73.02 112.696 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.91 -81.03 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 74.43 108.67 172.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -142.86 149.13 48.58 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 117.044 -1.455 . . . . 72.21 109.352 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.67 98.56 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 73.31 110.869 -171.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.97 164.74 35.67 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.475 1.91 . . . . 65.04 108.969 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.1 mt -83.83 128.21 39.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.381 -1.711 . . . . 72.42 106.381 167.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.8 mm -76.88 132.07 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.683 -1.228 . . . . 73.43 107.683 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -118.2 143.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.5 -1.296 . . . . 74.34 107.5 168.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.16 119.83 35.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 106.365 -1.717 . . . . 71.44 106.365 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.44 137.06 58.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.302 -1.74 . . . . 72.35 106.302 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 144.89 27.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.415 0.686 . . . . 71.25 110.493 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.42 121.38 20.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.626 1.17 . . . . 72.44 109.915 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.64 81.3 6.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 104.946 -2.242 . . . . 71.11 104.946 166.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.12 165.62 11.81 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.273 -0.639 . . . . 74.12 109.273 164.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.9 -18.82 5.42 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.527 1.677 . . . . 74.45 115.527 -167.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -86.88 -13.05 45.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.778 -1.106 . . . . 74.05 113.316 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.26 172.91 16.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.566 1.075 . . . . 71.14 112.761 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -73.17 57.3 0.48 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.997 1.319 . . . . 74.03 109.977 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.05 3.9 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.031 -0.871 . . . . 73.11 111.116 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.29 158.47 57.44 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.64 1.56 . . . . 71.45 109.532 171.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.33 122.14 10.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.463 -1.68 . . . . 65.01 106.463 169.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.6 m -92.86 108.98 20.41 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.556 -1.646 . . . . 73.02 106.556 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -67.51 128.55 36.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.156 -1.794 . . . . 72.43 106.156 163.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.2 154.19 31.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.082 -1.821 . . . . 74.33 106.082 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.11 157.33 39.96 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.225 -1.028 . . . . 72.44 108.225 163.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -108.35 91.28 3.58 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 74.2 106.669 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.9 175.15 9.06 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.685 -0.857 . . . . 72.31 108.685 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 76.24 13.16 2.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.177 2.191 . . . . 74.22 112.637 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 122.698 1.237 . . . . 70.2 111.572 165.623 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.87 0 N-CA-C 109.722 -0.473 . . . . 72.11 109.722 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.84 84.18 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.096 2.531 . . . . 64.5 111.826 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.08 123.92 0.83 Allowed Glycine 0 C--N 1.338 0.668 0 O-C-N 121.005 -1.059 . . . . 75.11 115.73 171.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.71 157.83 40.54 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.294 1.438 . . . . 74.11 109.646 166.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.27 164.25 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.702 3.601 . . . . 74.43 112.419 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.5 m -137.58 -174.48 3.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 61.51 110.005 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.42 14.68 3.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.931 2.492 . . . . 75.55 116.986 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.453 HD11 ' H ' ' A' ' 13' ' ' ILE . 3.7 mp -56.48 141.28 13.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 126.558 1.943 . . . . 75.53 112.031 -168.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -139.82 116.52 10.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.331 1.452 . . . . 73.21 110.609 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -115.96 131.48 68.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.842 -2.651 . . . . 72.23 103.842 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 m -143.28 149.12 37.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.625 0.726 . . . . 63.53 110.346 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -74.06 159.24 32.94 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.506 -0.924 . . . . 74.55 108.506 162.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.533 ' HG ' ' CD2' ' A' ' 23' ' ' HIS . 74.2 m -143.77 166.32 20.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 130.208 3.403 . . . . 73.15 105.607 170.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -54.42 -44.08 52.81 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.678 1.585 . . . . 63.12 111.781 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -12.18 59.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.9 1.68 . . . . 72.15 113.501 -170.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.89 -160.72 29.88 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.123 -1.191 . . . . 53.14 110.123 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.69 116.15 30.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.228 1.011 . . . . 64.44 109.216 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.533 ' CD2' ' HG ' ' A' ' 18' ' ' SER . 10.5 m170 -69.25 140.23 54.46 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 129.603 3.161 . . . . 71.44 111.454 173.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.27 128.86 42.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.927 -1.138 . . . . 73.51 107.927 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -133.03 150.25 52.15 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.637 -0.875 . . . . 71.32 108.637 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.99 173.89 11.5 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.286 0.366 . . . . 74.33 110.272 173.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -66.85 154.62 91.66 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 119.806 -0.758 . . . . 74.33 112.277 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.36 160.84 44.01 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.752 2.302 . . . . 75.2 111.586 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.27 89.58 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.905 3.07 . . . . 73.11 112.182 -172.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -152.76 23.7 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.042 0.756 . . . . 61.3 113.042 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.4 t -126.23 -86.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.011 -0.995 . . . . 74.44 110.894 -171.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -131.75 -4.11 3.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.344 1.429 . . . . 75.4 110.978 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 p -55.66 -19.32 10.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.356 3.062 . . . . 73.43 116.179 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.4 -159.66 31.05 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 121.962 2.165 . . . . 61.11 111.675 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -79.52 93.64 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.822 1.649 . . . . 73.34 109.677 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.4 142.23 15.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.579 -1.267 . . . . 72.42 107.579 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.9 pt -135.49 -17.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.783 1.633 . . . . 74.41 111.464 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -159.93 -171.71 3.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.326 1.851 . . . . 72.5 107.434 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 16.9 m-85 -134.38 174.33 10.65 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.354 -1.467 . . . . 75.14 108.937 162.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 m -144.01 155.4 44.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.334 -0.854 . . . . 74.24 108.799 159.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -140.06 119.35 12.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 104.747 -2.316 . . . . 73.13 104.747 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -116.47 87.4 2.68 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.122 0.963 . . . . 73.41 109.814 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 tp -62.63 135.31 57.32 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.1 -1.444 . . . . 74.22 107.1 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.23 148.04 25.3 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.854 -0.795 . . . . 74.21 108.854 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.74 -165.9 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.223 1.809 . . . . 74.24 107.306 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 74.51 112.509 169.837 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 109.768 -0.456 . . . . 73.55 109.768 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.32 123.39 22.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.112 -0.699 . . . . 65.22 109.112 172.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -141.11 155.66 46.09 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.188 0.595 . . . . 74.51 112.22 -176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ttp -89.25 -39.36 13.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.81 0.844 . . . . 52.12 112.493 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 58.01 86.19 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.282 1.433 . . . . 73.31 109.085 -159.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.77 -5.91 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.904 -0.589 . . . . 73.11 112.067 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.3 103.07 7.74 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.584 0.629 . . . . 71.12 110.798 -163.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -137.17 53.67 1.88 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.03 1.332 . . . . 71.43 109.026 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.34 160.5 29.55 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.311 -0.868 . . . . 74.23 111.228 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -4.68 12.0 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.745 3.63 . . . . 72.22 112.591 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.0 m -43.46 89.31 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 130.047 3.339 . . . . 72.32 113.263 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -60.62 148.98 89.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.186 1.257 . . . . 73.14 111.139 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 p 46.21 47.36 13.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.838 1.255 . . . . 75.44 111.987 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.37 152.37 43.24 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.625 -1.297 . . . . 61.55 110.462 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.08 170.35 14.91 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.656 0.782 . . . . 64.35 110.883 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.55 122.57 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.033 1.733 . . . . 73.45 106.539 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.44 145.9 52.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.059 0.944 . . . . 73.13 109.657 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.8 p -54.28 -37.89 65.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.621 1.169 . . . . 45.03 111.649 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.77 -47.97 41.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.458 1.503 . . . . 74.42 111.268 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -78.99 -9.71 59.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.509 1.124 . . . . 53.04 112.899 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.5 mt -82.03 -34.55 29.46 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.579 1.081 . . . . 74.22 110.658 171.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -66.91 1.53 1.85 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 117.276 2.324 . . . . 73.44 117.276 -163.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -123.38 12.28 9.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.95 1.25 . . . . 72.14 111.505 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.01 156.72 37.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 122.478 1.132 . . . . 74.25 113.53 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 101.72 3.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.808 -1.182 . . . . 74.22 107.808 162.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.07 120.82 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.254 -1.758 . . . . 75.32 106.254 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.21 131.8 51.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 112.799 -2.0 . . . . 75.51 108.987 166.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.61 9.76 13.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.52 1.128 . . . . 75.54 111.162 171.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -6.5 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.799 -1.188 . . . . 71.14 113.942 -162.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.045 2.138 . . . . 73.33 111.026 173.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -151.8 156.18 34.21 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.604 1.561 . . . . 75.22 108.009 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.41 122.35 9.57 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.7 2.267 . . . . 72.41 108.748 164.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.47 -170.44 2.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.669 2.387 . . . . 73.31 108.645 161.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.9 mt -129.48 129.2 66.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 75.54 108.53 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.5 mm -72.49 142.19 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.507 1.523 . . . . 71.54 110.088 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -128.21 162.25 27.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.26 1.024 . . . . 75.51 108.934 167.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -134.98 84.72 2.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.327 1.851 . . . . 74.43 106.472 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.28 133.44 42.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.032 -1.469 . . . . 75.21 107.032 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.41 156.98 44.09 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.575 0.547 . . . . 54.01 110.497 161.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . . . -92.35 109.44 20.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.458 1.103 . . . . 64.14 109.758 -171.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HA ' ' CG ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -69.09 97.98 0.94 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.811 0.844 . . . . 74.31 109.142 -170.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -122.54 177.17 5.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.706 2.002 . . . . 61.22 110.824 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.63 -30.97 63.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.927 1.691 . . . . 74.12 113.821 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -8.96 58.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.207 1.188 . . . . 74.21 114.207 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.42 2.26 87.51 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.834 -1.166 . . . . 70.5 113.263 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 102' ' ' ARG . 19.4 p90 45.59 36.16 2.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.064 1.746 . . . . 74.33 115.448 156.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.75 -66.5 2.8 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.519 2.009 . . . . 73.21 113.455 -165.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.84 152.07 81.16 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.158 1.906 . . . . 73.11 110.241 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.35 169.86 14.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.584 1.154 . . . . 64.53 108.865 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.1 m -97.26 113.99 25.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.303 0.641 . . . . 75.14 110.045 -176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.49 75.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.505 1.522 . . . . 75.14 110.04 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.9 155.14 7.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.858 -1.164 . . . . 75.43 107.858 164.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -121.74 124.59 44.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.705 -1.591 . . . . 73.21 106.705 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.405 ' C ' ' H ' ' A' ' 117' ' ' GLN . 14.3 t90 -75.17 82.73 2.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.132 0.424 . . . . 74.33 109.859 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.7 mt -71.47 15.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.773 1.027 . . . . 74.14 113.773 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 115' ' ' TRP . 1.9 tt0 -95.74 -1.83 49.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.097 1.359 . . . . 72.14 111.637 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 C--O 1.234 0.274 0 CA-C-N 119.835 1.198 . . . . 72.22 110.449 -179.627 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.634 -0.135 . . . . 75.35 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.03 6.53 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.735 3.624 . . . . 64.13 114.581 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.2 143.77 15.32 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 107.958 -2.057 . . . . 71.24 107.958 170.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.3 154.7 36.42 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.053 1.341 . . . . 74.34 108.278 162.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.59 158.85 30.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.296 1.998 . . . . 71.52 111.934 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -133.09 -178.09 4.81 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.527 1.531 . . . . 75.33 109.414 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.21 12.98 4.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.54 1.536 . . . . 53.33 114.823 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.22 132.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.948 1.299 . . . . 71.43 110.049 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.8 152.76 45.45 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.534 1.133 . . . . 61.34 110.934 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -142.17 115.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.541 -1.651 . . . . 72.43 106.541 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -111.35 -167.7 1.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.442 2.297 . . . . 72.14 110.629 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -143.22 146.51 33.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.903 -1.147 . . . . 75.15 107.903 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -146.45 160.15 42.75 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 126.234 1.814 . . . . 75.33 106.95 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.99 73.44 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.777 1.652 . . . . 74.24 111.594 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.79 -59.73 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 128.807 2.843 . . . . 75.4 105.692 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.15 -166.15 38.56 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.683 -1.367 . . . . 62.03 109.683 -163.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.14 113.72 26.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.731 1.612 . . . . 53.32 110.583 -165.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 78.42 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.772 3.229 . . . . 73.02 112.187 164.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.87 110.29 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.873 -1.142 . . . . 75.04 108.41 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -130.27 158.22 40.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.595 0.634 . . . . 63.32 111.621 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 25.6 p90 -173.64 175.7 2.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.23 2.612 . . . . 63.11 110.377 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -115.46 165.21 14.9 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.964 0.906 . . . . 71.13 111.932 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.14 156.97 51.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.685 2.923 . . . . 72.13 111.226 167.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.64 139.64 70.71 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.9 1.733 . . . . 64.41 109.596 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 t -127.67 58.95 1.47 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.77 -2.308 . . . . 64.34 104.77 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.39 -85.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.164 -1.791 . . . . 75.43 106.164 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.1 p -112.86 166.11 11.69 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.344 0.52 . . . . 74.33 110.425 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 m -56.67 -72.92 0.07 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.568 1.547 . . . . 72.52 111.546 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.43 -173.8 11.1 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.474 -1.45 . . . . 74.11 109.474 -164.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -137.23 68.54 1.41 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.649 1.58 . . . . 74.53 107.881 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.8 140.52 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.702 -0.851 . . . . 73.4 108.702 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 pt -135.89 -21.65 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.514 1.526 . . . . 72.14 111.34 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -158.02 174.8 14.68 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.117 1.767 . . . . 72.4 106.929 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.75 163.63 32.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.084 0.954 . . . . 74.1 108.973 174.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -150.61 153.05 34.99 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.119 -0.988 . . . . 74.14 112.496 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.47 142.56 43.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 126.095 1.758 . . . . 63.03 107.533 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.7 120.22 40.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.562 -2.014 . . . . 71.31 105.562 170.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.36 132.93 53.67 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.257 1.423 . . . . 74.25 107.198 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.44 131.19 40.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 118.17 -0.919 . . . . 73.23 109.178 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.91 179.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.725 1.21 . . . . 74.11 110.79 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 C-N-CA 126.253 1.821 . . . . 73.25 109.614 167.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 118.815 -0.612 . . . . 73.14 109.842 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 174.64 104.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.098 2.159 . . . . 73.23 107.039 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -127.1 146.56 50.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.939 1.296 . . . . 75.23 110.106 -166.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttp -77.67 130.25 36.58 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.591 -1.263 . . . . 74.21 107.591 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -79.13 60.17 2.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.57 1.148 . . . . 75.03 109.551 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -53.19 -27.21 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 126.501 1.92 . . . . 71.32 113.903 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.0 121.71 27.03 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.45 -2.426 . . . . 73.24 104.45 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.5 t -152.03 79.59 1.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.733 -1.951 . . . . 74.24 105.733 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.93 176.56 45.0 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.717 -0.614 . . . . 75.43 112.358 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.26 -8.98 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.367 3.378 . . . . 73.33 112.64 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.38 158.14 8.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.59 1.556 . . . . 54.11 112.358 -172.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.16 -171.18 1.01 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.819 3.013 . . . . 71.04 110.653 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.83 110.76 0.25 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.806 2.442 . . . . 53.33 110.486 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.6 m -104.81 135.42 46.22 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.841 0.746 . . . . 72.12 110.261 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.48 119.96 10.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.335 1.054 . . . . 75.21 109.515 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.56 114.41 9.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.109 -1.812 . . . . 75.45 106.109 167.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.42 158.23 27.27 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.804 0.842 . . . . 72.34 110.744 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -50.06 -49.49 51.03 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.931 0.892 . . . . 64.41 112.318 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 p -59.99 -25.52 65.33 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.508 1.049 . . . . 61.33 113.697 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -40.01 32.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.845 1.202 . . . . 75.33 110.431 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.39 -45.31 94.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.319 1.047 . . . . 75.14 110.711 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -62.72 -24.18 67.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.513 1.525 . . . . 64.13 112.75 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -92.38 -9.52 41.44 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.211 1.004 . . . . 72.13 112.033 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.43 147.27 49.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.547 1.067 . . . . 75.23 111.232 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -93.62 129.3 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.382 1.073 . . . . 73.11 111.226 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -68.68 133.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 126.216 1.806 . . . . 75.52 109.331 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.47 111.29 3.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.856 -0.794 . . . . 61.51 108.856 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -103.62 64.1 0.8 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.144 0.973 . . . . 75.44 108.761 165.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 -26.77 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.029 -0.987 . . . . 74.44 113.616 171.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -146.52 -55.36 0.26 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.23 0.923 . . . . 73.34 111.266 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -149.53 144.53 17.94 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 117.161 -1.399 . . . . 75.12 108.19 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.63 97.37 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.144 2.563 . . . . 42.01 109.883 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.98 152.43 39.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.312 2.245 . . . . 75.13 109.2 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.5 mt -72.16 133.76 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.964 -1.495 . . . . 74.45 106.964 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.7 mm -81.61 136.07 23.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.068 0.947 . . . . 63.15 108.992 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -122.15 150.4 42.27 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.104 1.761 . . . . 75.12 107.785 165.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -133.26 132.96 42.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.169 -1.789 . . . . 75.53 106.169 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.8 mt -131.6 140.46 48.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.41 -0.959 . . . . 75.21 108.41 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.08 153.79 34.66 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.612 1.165 . . . . 74.33 110.497 170.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.14 141.38 41.93 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.734 0.813 . . . . 62.2 109.812 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.4 tpt85 -86.04 108.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 105.967 -1.864 . . . . 75.14 105.967 164.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -114.57 -176.15 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.398 -0.964 . . . . 71.41 108.398 165.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -52.51 -39.38 61.24 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.726 2.01 . . . . 72.0 112.048 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -47.7 53.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.28 -0.637 . . . . 73.43 109.28 -166.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.29 174.75 21.05 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.46 -0.656 . . . . 72.52 111.46 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -75.45 102.88 5.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.646 -1.612 . . . . 74.32 106.646 163.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.36 -64.71 0.86 Allowed Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.324 -1.265 . . . . 72.45 112.126 -171.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.73 179.02 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.21 2.607 . . . . 73.54 110.002 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.74 107.01 1.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.749 0.82 . . . . 73.41 109.159 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 m -71.53 110.13 5.92 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.386 -0.968 . . . . 74.14 108.386 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -82.08 103.12 11.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.451 1.5 . . . . 75.55 109.205 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.3 159.51 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.282 1.433 . . . . 55.14 107.747 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.43 155.45 45.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.724 -0.61 . . . . 72.21 110.325 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -138.32 109.56 6.88 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.107 0.963 . . . . 74.13 112.078 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.32 -177.93 5.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 128.732 2.813 . . . . 74.42 109.299 -177.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 73.72 9.84 4.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.14 1.776 . . . . 71.14 112.193 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.543 0.692 0 C-N-CA 127.185 2.194 . . . . 74.42 114.417 178.327 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 . . . . . 0 C--O 1.223 -0.325 0 CA-C-O 118.654 -0.688 . . . . 72.44 110.694 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.55 96.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.376 2.717 . . . . 71.35 110.927 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.48 113.78 0.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 124.117 0.865 . . . . 65.24 111.457 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.36 153.46 8.81 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.09 1.756 . . . . 72.11 109.14 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.33 166.9 19.95 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 124.976 3.784 . . . . 74.22 114.396 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -136.59 -179.12 5.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.383 2.273 . . . . 51.31 110.447 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.82 14.93 5.51 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 128.627 2.771 . . . . 74.22 115.386 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 131.65 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.219 0.608 . . . . 73.32 111.197 -162.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -125.17 148.5 48.57 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.715 1.206 . . . . 73.43 108.728 173.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -148.02 141.57 19.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.31 -1.737 . . . . 72.34 106.31 168.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -150.17 23.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.218 1.407 . . . . 74.24 112.962 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 tttm 48.68 -173.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.611 3.164 . . . . 73.21 112.944 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.87 165.13 19.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.192 1.397 . . . . 74.34 107.57 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.91 -24.41 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.82 2.347 . . . . 70.42 112.345 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.06 -9.92 16.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.984 2.114 . . . . 71.43 111.182 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.03 -123.08 1.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.686 -1.366 . . . . 50.24 109.686 -174.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.36 124.54 24.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.636 -0.697 . . . . 74.21 110.457 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -67.12 90.69 0.2 Allowed 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.448 0.699 . . . . 74.31 109.427 168.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.84 164.11 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.0 0.92 . . . . 73.22 108.558 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.96 157.87 16.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.017 1.727 . . . . 71.51 109.668 168.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -171.65 -179.73 2.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.74 2.016 . . . . 74.25 109.527 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -127.59 165.21 31.3 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 127.159 2.184 . . . . 73.33 109.432 169.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -66.21 168.49 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.668 2.912 . . . . 74.24 110.735 165.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.02 152.86 80.23 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.098 1.198 . . . . 72.15 109.861 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 p -118.68 17.61 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.542 1.137 . . . . 71.15 111.821 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.02 -45.25 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.825 1.25 . . . . 70.54 110.533 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.4 p -148.37 167.09 26.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.633 1.573 . . . . 71.45 107.926 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -46.23 -61.18 1.89 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.307 1.843 . . . . 71.12 111.945 -174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.06 113.12 0.06 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.899 1.238 . . . . 72.51 112.943 174.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -89.35 66.38 7.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.006 0.922 . . . . 70.15 109.419 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -71.03 151.64 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.15 -1.426 . . . . 64.13 107.15 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.3 pt -135.42 -21.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.376 1.87 . . . . 74.12 111.836 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.72 -167.36 1.52 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.813 0.845 . . . . 71.15 109.486 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -152.04 172.91 15.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.658 1.983 . . . . 72.33 108.365 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -150.29 175.68 11.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.812 0.733 . . . . 53.34 111.212 163.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -144.24 129.74 14.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.605 1.962 . . . . 73.11 107.222 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.405 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -119.71 119.37 33.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.558 -1.645 . . . . 73.04 106.558 165.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 tp -87.22 126.83 35.06 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.634 -1.987 . . . . 74.31 105.634 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.11 138.82 50.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.397 0.544 . . . . 74.21 110.524 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 pt -126.72 -178.84 2.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 125.925 1.69 . . . . 73.25 109.786 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 125.68 1.592 . . . . 75.14 109.2 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 65.13 112.921 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.19 135.05 15.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.42 -0.809 . . . . 63.25 109.865 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.405 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 78.5 m-85 -149.23 -164.16 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.234 2.613 . . . . 75.41 107.846 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.9 ttp -112.48 -6.69 13.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.592 1.157 . . . . 75.33 113.153 166.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 44.23 66.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.373 2.269 . . . . 64.32 111.614 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.34 -13.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 113.554 0.946 . . . . 74.32 113.554 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -57.13 135.72 56.37 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.087 -1.008 . . . . 73.34 112.027 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -142.37 97.68 3.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.761 2.024 . . . . 74.15 107.73 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 166.94 5.9 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.215 0.912 . . . . 72.15 113.376 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 -57.4 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.791 1.661 . . . . 74.05 113.716 -166.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.0 m 57.33 167.66 0.06 OUTLIER Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.208 0.913 . . . . 73.42 112.872 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.99 -24.23 45.77 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.465 1.443 . . . . 73.42 112.293 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 p -167.35 41.56 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.913 0.885 . . . . 64.14 109.33 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 16.2 p 45.11 -166.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.44 1.896 . . . . 53.4 112.432 -161.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.09 115.05 5.71 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.268 -0.895 . . . . 74.31 109.326 149.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.53 124.28 45.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 126.116 1.766 . . . . 70.41 107.502 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.19 49.04 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.212 1.805 . . . . 74.33 110.938 169.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t -70.46 -16.91 62.98 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.019 1.728 . . . . 70.03 112.311 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t -46.13 -53.83 9.7 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.008 0.822 . . . . 75.02 109.489 165.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -72.43 -19.96 61.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.192 0.812 . . . . 74.23 113.192 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.25 -34.02 65.62 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.547 0.612 . . . . 71.33 110.868 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -54.18 -47.46 72.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.849 0.459 . . . . 73.24 109.768 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.46 -7.48 38.32 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.771 1.628 . . . . 65.05 113.216 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.64 164.82 7.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.347 1.07 . . . . 74.44 110.713 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -128.12 160.23 32.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.842 -0.799 . . . . 72.13 108.842 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.56 123.38 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 106.964 -1.495 . . . . 70.15 106.964 -165.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.92 127.81 33.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.894 -1.151 . . . . 71.15 107.894 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.32 31.98 5.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.804 -1.184 . . . . 73.25 107.804 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.61 -11.87 7.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.967 1.307 . . . . 71.34 110.344 -171.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 p -142.25 -66.08 0.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.395 1.478 . . . . 74.11 109.861 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -150.48 152.92 33.71 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 127.802 2.441 . . . . 72.32 107.576 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.12 104.63 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.689 2.926 . . . . 73.25 109.556 173.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.74 153.1 38.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.17 1.388 . . . . 65.55 109.839 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 130.12 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.105 -1.813 . . . . 74.31 106.105 158.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.12 136.57 22.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.954 -1.499 . . . . 74.44 106.954 166.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.32 159.33 20.34 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.025 0.917 . . . . 74.01 110.25 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -131.19 100.73 5.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.859 1.664 . . . . 74.33 106.879 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.36 129.59 75.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 104.316 -2.475 . . . . 72.21 104.316 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.67 163.94 31.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.625 0.726 . . . . 74.21 109.863 171.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.99 132.7 34.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.821 -1.081 . . . . 73.41 108.286 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -84.5 105.49 15.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.334 -1.728 . . . . 74.21 106.334 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -115.18 -179.19 3.56 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.009 0.924 . . . . 73.14 110.484 173.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.34 -35.07 71.36 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.031 1.733 . . . . 73.11 114.526 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.11 -54.95 6.26 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 125.61 1.564 . . . . 73.51 108.957 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 159.34 164.39 14.59 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.414 -1.074 . . . . 70.52 110.414 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -87.49 45.54 1.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.616 1.566 . . . . 74.14 110.136 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.28 -87.14 0.07 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.295 1.902 . . . . 74.12 111.671 -156.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.46 163.48 38.89 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.151 1.901 . . . . 54.02 109.773 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.75 148.66 35.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.415 -0.957 . . . . 70.45 108.415 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.8 m -75.88 132.84 40.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.261 -1.755 . . . . 61.44 106.261 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -113.83 86.61 2.44 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 105.799 -1.926 . . . . 71.34 105.799 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.75 156.73 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 73.42 108.618 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.79 116.4 28.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.921 -1.511 . . . . 71.24 106.921 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -72.99 75.66 1.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.76 -1.2 . . . . 73.44 107.76 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.4 mt -70.99 150.79 45.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.5 -1.667 . . . . 72.24 106.5 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 66.29 24.29 10.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 63.51 111.146 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 O-C-N 121.792 -0.567 . . . . 65.51 111.76 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 110.124 -0.325 . . . . 70.52 110.124 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.97 5.66 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 125.149 3.9 . . . . 71.15 116.55 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.4 173.12 49.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.675 1.131 . . . . 74.44 112.394 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.3 161.02 24.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.225 1.41 . . . . 64.44 111.25 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.37 153.86 65.81 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.02 2.48 . . . . 74.15 110.989 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.4 m -137.38 -174.67 3.82 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.272 1.429 . . . . 74.15 110.605 -171.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.02 25.62 12.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.205 2.202 . . . . 71.41 114.205 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.25 141.12 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.681 1.192 . . . . 73.34 110.81 -172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -125.17 149.53 47.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.297 1.439 . . . . 75.22 109.007 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.0 mt -152.01 95.84 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.268 -1.753 . . . . 74.22 106.268 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 p -74.7 163.01 28.19 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.517 -0.92 . . . . 71.33 108.517 164.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -91.38 157.75 16.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.28 -1.378 . . . . 74.33 107.28 156.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 m -146.97 165.2 19.9 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.393 -1.336 . . . . 65.11 107.393 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.31 -37.43 61.28 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.324 1.35 . . . . 72.31 112.696 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.99 -47.99 14.06 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.331 -0.855 . . . . 74.52 110.682 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.74 -146.38 4.33 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.585 -0.606 . . . . 61.24 111.585 -156.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.03 133.8 32.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.321 1.448 . . . . 74.41 107.743 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -78.11 79.81 4.56 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.318 -0.623 . . . . 65.13 109.318 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.43 132.17 52.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.357 -1.349 . . . . 72.41 107.357 164.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -144.64 152.14 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.391 1.451 . . . . 72.35 109.255 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -137.56 167.57 21.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.206 1.403 . . . . 74.44 110.565 172.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.77 163.28 69.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.04 0.936 . . . . 74.34 112.328 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.11 164.83 26.2 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.391 2.727 . . . . 73.24 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.67 77.39 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.432 2.755 . . . . 65.21 110.359 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 t -133.02 24.73 4.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.293 2.237 . . . . 73.24 109.422 -171.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.53 -40.93 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.926 1.291 . . . . 74.14 107.95 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.0 p -149.45 174.08 12.87 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.017 1.727 . . . . 71.52 110.419 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -64.24 19.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.572 3.149 . . . . 72.42 114.88 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.59 -168.15 35.84 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 120.597 -1.314 . . . . 73.45 114.037 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -135.65 113.4 10.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.193 -1.004 . . . . 74.42 109.505 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -109.67 133.63 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.084 1.754 . . . . 64.13 108.144 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -131.62 -11.42 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 72.12 112.33 -163.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -160.45 -169.51 2.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.222 2.209 . . . . 65.22 106.685 163.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -128.4 169.27 14.47 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.22 -1.55 . . . . 74.35 108.879 165.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.0 m -145.03 156.93 44.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.171 -0.956 . . . . 72.41 110.526 166.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.66 125.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 105.618 -1.993 . . . . 74.11 105.618 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.23 127.33 55.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.735 -1.58 . . . . 74.11 106.735 171.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -121.85 130.54 53.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.983 1.713 . . . . 74.42 107.574 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.21 126.03 28.28 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.907 0.883 . . . . 71.42 113.068 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.53 -170.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.769 2.428 . . . . 74.53 109.236 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 126.046 1.738 . . . . 73.51 110.695 161.586 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 113.512 0.93 . . . . 74.55 113.512 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.27 82.72 1.97 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.333 0.587 . . . . 64.12 111.17 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -130.74 150.41 51.93 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.308 1.043 . . . . 73.31 108.911 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ttp -113.99 133.84 55.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.107 1.763 . . . . 72.44 108.233 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -82.19 56.73 3.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.606 1.562 . . . . 74.25 112.331 -167.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.66 -19.61 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 115.924 1.824 . . . . 73.34 115.924 -167.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.08 118.63 7.03 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.842 1.201 . . . . 73.51 110.032 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.6 m -152.13 73.69 1.06 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 127.172 2.189 . . . . 63.21 107.625 164.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.44 166.06 25.91 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 121.562 -0.711 . . . . 70.25 111.799 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 -55.64 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.614 2.21 . . . . 72.51 109.836 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -76.57 144.51 73.82 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.247 0.619 . . . . 74.35 109.785 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 -26.15 16.68 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.235 1.957 . . . . 73.53 112.882 -168.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p -80.88 68.9 7.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.232 0.924 . . . . 74.24 110.216 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.2 m -69.3 115.45 8.59 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.391 -0.818 . . . . 74.24 110.675 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.8 -178.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.977 2.111 . . . . 71.54 112.528 159.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.74 146.69 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.521 1.528 . . . . 71.21 108.222 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -96.26 161.81 13.78 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.601 2.36 . . . . 61.22 112.778 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -45.87 67.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.961 1.304 . . . . 63.24 111.72 169.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -62.37 -28.16 69.58 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.615 0.643 . . . . 64.12 111.623 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -80.36 -46.56 15.86 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.327 -0.858 . . . . 54.22 109.046 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.1 mt -52.83 -26.7 15.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.193 1.797 . . . . 71.55 112.926 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.4 m -45.36 -33.88 2.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.12 1.368 . . . . 70.12 113.232 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -95.0 -10.87 29.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.323 0.649 . . . . 72.21 111.263 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.66 24.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.061 0.846 . . . . 71.45 110.123 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.68 120.39 27.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.101 0.96 . . . . 73.35 109.819 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.08 138.24 21.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.992 1.717 . . . . 73.12 109.287 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.95 111.33 4.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.816 0.846 . . . . 74.33 111.006 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -100.65 20.09 15.78 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.461 -0.774 . . . . 73.03 110.993 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -4.01 6.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.456 0.909 . . . . 75.03 113.456 -163.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 -63.31 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.275 1.43 . . . . 75.23 108.492 161.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -153.68 154.19 29.95 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 106.536 -1.653 . . . . 72.45 106.536 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.29 110.16 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.389 2.059 . . . . 74.41 109.544 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.92 168.56 21.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.72 2.008 . . . . 73.32 109.301 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.7 mt -101.74 140.05 21.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.274 -1.75 . . . . 73.01 106.274 166.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.42 124.52 73.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.273 1.029 . . . . 72.03 110.085 -163.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.47 137.55 54.77 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.848 0.859 . . . . 63.52 112.488 -167.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -112.78 99.29 7.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.773 1.629 . . . . 72.14 108.057 167.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -98.34 144.75 10.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.396 -1.705 . . . . 72.54 106.396 174.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.23 142.28 29.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.284 1.034 . . . . 74.25 109.65 168.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.94 122.51 23.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.338 1.055 . . . . 74.41 108.87 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -72.89 117.83 15.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.856 -1.535 . . . . 74.23 106.856 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -131.59 -176.92 4.19 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 127.582 2.353 . . . . 74.54 109.502 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.78 -27.94 69.53 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.503 0.557 . . . . 74.11 112.503 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -74.48 -32.13 62.45 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.158 -0.964 . . . . 73.41 113.05 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.73 166.8 38.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.597 -1.001 . . . . 63.31 110.597 -166.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.08 64.14 3.2 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.563 1.545 . . . . 74.51 111.689 -170.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.43 -75.44 0.35 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.291 -1.124 . . . . 74.44 110.291 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.99 167.65 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.06 3.173 . . . . 73.51 110.21 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 162.86 39.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.025 2.13 . . . . 71.24 107.192 165.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.2 t -79.95 179.32 7.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.161 -0.681 . . . . 71.23 109.161 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -150.54 73.01 1.11 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.143 0.577 . . . . 75.23 110.031 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.3 m -93.24 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.473 -0.767 . . . . 72.45 110.424 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 112.24 13.46 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.888 1.275 . . . . 75.35 110.232 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -71.65 82.68 0.85 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.73 0.812 . . . . 73.23 110.704 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.83 53.9 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.796 1.638 . . . . 74.24 108.68 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 17.67 2.99 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.874 1.27 . . . . 75.14 109.609 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.034 0.445 . . . . 72.24 110.271 164.165 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 . . . . . 0 N--CA 1.44 -0.954 0 N-CA-C 108.273 -1.01 . . . . 74.33 108.273 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -55.48 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.76 2.307 . . . . 71.43 112.868 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.73 41.58 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.733 -1.747 . . . . 62.24 108.733 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.27 159.42 32.11 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.755 1.622 . . . . 72.32 109.353 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.06 154.27 75.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.232 1.288 . . . . 65.44 111.719 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.3 m -142.41 -174.65 4.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.614 1.566 . . . . 74.34 109.488 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.84 37.79 10.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.034 2.534 . . . . 74.3 113.193 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.52 126.45 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.506 -1.294 . . . . 75.34 107.506 -171.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -137.56 150.76 47.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.669 -0.863 . . . . 73.51 108.669 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.86 149.74 30.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.459 -2.052 . . . . 74.33 105.459 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.81 135.84 36.65 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.309 -1.367 . . . . 70.31 107.309 174.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -72.01 143.85 49.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.398 -1.334 . . . . 73.12 107.398 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -126.34 165.64 26.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 125.877 1.671 . . . . 72.32 108.023 169.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.65 -15.2 40.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.359 2.04 . . . . 64.42 112.353 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.24 -29.22 13.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.753 1.221 . . . . 74.43 110.787 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.14 -152.37 16.94 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 116.377 -2.346 . . . . 63.14 110.539 -164.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.2 127.95 54.23 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 121.147 2.474 . . . . 71.14 108.731 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.49 126.14 26.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.214 -1.032 . . . . 74.13 108.214 164.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -113.12 145.33 41.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.031 -1.099 . . . . 72.4 108.031 170.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 t -150.28 171.82 16.35 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.415 0.552 . . . . 65.5 111.234 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.434 ' CE3' HD11 ' A' ' 99' ' ' ILE . 15.3 p90 -173.45 -171.57 0.7 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.765 2.026 . . . . 74.3 111.189 -172.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -111.57 165.49 12.72 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 127.948 2.499 . . . . 73.41 110.639 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -66.64 166.68 21.33 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.956 3.104 . . . . 53.3 112.598 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.46 -4.64 14.35 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 124.018 3.145 . . . . 72.41 111.773 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -148.25 138.43 22.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.916 -1.513 . . . . 54.11 106.916 -174.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.48 -49.53 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.498 0.666 . . . . 75.52 110.621 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 t -65.22 158.97 24.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.39 1.076 . . . . 63.13 109.907 163.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.8 m -54.86 -45.0 74.49 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.409 1.263 . . . . 73.31 114.409 -163.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.5 -171.48 46.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.965 0.802 . . . . 64.14 111.566 -171.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -116.42 56.19 0.79 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.571 1.549 . . . . 74.44 109.187 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.47 140.08 20.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 72.3 106.245 168.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.96 -23.03 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.573 1.149 . . . . 72.33 110.609 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -161.24 -175.53 4.9 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.285 1.434 . . . . 74.23 108.515 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -171.0 2.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.784 1.234 . . . . 74.13 109.469 170.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . 12.4 p -138.15 155.92 48.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.753 1.621 . . . . 71.01 107.917 157.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.64 112.43 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.197 -2.519 . . . . 73.42 104.197 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -111.51 160.24 17.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.758 0.823 . . . . 74.41 108.983 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 tp -149.96 139.47 21.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.79 2.036 . . . . 72.53 106.004 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.33 137.58 42.93 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.389 1.076 . . . . 74.32 110.34 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -141.76 -165.59 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.528 1.531 . . . . 72.43 110.343 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 127.083 2.153 . . . . 73.55 110.305 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 108.524 -0.917 . . . . 73.33 108.524 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.98 123.93 3.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 65.14 109.558 170.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -146.06 162.26 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.008 0.923 . . . . 74.53 111.333 -173.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.6 ttt -69.35 -29.83 67.72 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.042 1.337 . . . . 71.33 113.899 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 65.79 80.57 0.22 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.639 1.576 . . . . 74.01 110.516 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.72 -14.62 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.961 0.904 . . . . 74.41 112.488 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -54.34 116.13 2.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.406 1.482 . . . . 73.12 110.266 166.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -157.9 23.94 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.36 0.504 . . . . 72.41 112.36 157.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 154.54 29.69 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.918 -1.273 . . . . 73.3 109.918 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.06 -26.28 21.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.342 2.028 . . . . 65.34 111.845 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -122.81 163.53 32.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.472 1.509 . . . . 74.02 109.307 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.93 173.46 12.75 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.983 1.789 . . . . 74.34 111.027 170.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 t 50.46 59.91 4.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.03 1.332 . . . . 73.21 110.624 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.63 171.53 7.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.88 0.872 . . . . 73.11 110.673 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -76.29 171.65 14.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.624 1.342 . . . . 72.11 114.624 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 82' ' ' LEU . 2.9 p -130.25 109.43 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 C-N-CA 126.973 2.109 . . . . 73.11 111.266 171.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -57.43 146.75 28.4 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.246 2.219 . . . . 73.23 111.472 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 p -66.47 -23.68 66.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.737 1.014 . . . . 71.51 113.737 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 5.5 0.91 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.614 1.566 . . . . 73.43 113.599 167.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -108.64 -36.69 6.11 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.063 -1.023 . . . . 74.21 110.055 164.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' CD2' HG22 ' A' ' 77' ' ' VAL . 1.9 mm? -69.27 -37.39 77.86 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.421 1.088 . . . . 72.31 111.232 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -61.79 -0.86 0.51 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.693 1.597 . . . . 73.35 113.109 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -129.98 2.15 4.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.954 2.102 . . . . 70.24 110.255 -167.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.21 132.8 55.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.982 2.113 . . . . 72.51 109.125 -169.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -87.39 158.17 19.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.978 0.418 . . . . 65.53 110.875 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -84.43 146.94 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.898 1.279 . . . . 73.45 108.365 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.45 118.49 20.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.875 -1.157 . . . . 73.32 107.875 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 24.32 11.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.256 1.023 . . . . 73.43 109.789 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -100.65 -53.95 2.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.719 -1.215 . . . . 71.23 107.719 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.8 m -111.08 -54.26 2.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.178 1.791 . . . . 73.35 109.488 -166.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -160.47 150.08 14.32 Favored Pre-proline 0 C--N 1.343 0.298 0 C-N-CA 127.528 2.331 . . . . 63.14 109.87 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.86 101.56 0.23 Allowed 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 124.494 3.463 . . . . 71.21 109.89 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.0 172.9 15.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.95 1.7 . . . . 74.51 111.199 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.51 132.35 42.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.759 -1.571 . . . . 72.51 106.759 167.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.97 118.85 49.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 124.103 0.961 . . . . 73.51 109.488 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -93.08 178.34 5.78 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.771 1.228 . . . . 73.32 111.679 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.19 128.5 14.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 126.453 1.901 . . . . 65.2 106.638 167.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.434 HD11 ' CE3' ' A' ' 26' ' ' TRP . 34.1 mt -132.14 153.93 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 119.528 1.058 . . . . 73.23 109.512 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -167.78 136.6 2.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.536 2.334 . . . . 74.3 110.374 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.2 133.3 55.01 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.605 1.562 . . . . 65.34 112.849 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 92.11 9.02 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.747 -1.946 . . . . 73.23 105.747 161.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -101.34 -179.23 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.333 -0.988 . . . . 73.31 108.333 153.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -57.95 -21.77 45.7 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.105 1.15 . . . . 74.24 114.105 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -37.26 38.88 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.402 -0.811 . . . . 71.34 110.181 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.17 -171.8 13.97 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.162 1.363 . . . . 74.14 112.999 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 14.3 m-85 -81.7 66.1 7.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.969 1.708 . . . . 72.22 111.285 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.28 -74.22 1.08 Allowed Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.002 -1.061 . . . . 64.42 111.563 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.81 167.23 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.381 2.72 . . . . 72.14 110.118 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.46 152.17 44.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.725 0.774 . . . . 73.12 110.049 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.3 m -142.01 109.44 5.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.159 -1.793 . . . . 74.43 106.159 167.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -94.38 139.44 31.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.111 -1.44 . . . . 73.32 107.111 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -125.24 171.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.081 0.952 . . . . 73.42 110.43 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 113.46 14.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.525 1.53 . . . . 74.23 108.21 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -79.03 93.4 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.48 -1.304 . . . . 72.41 107.48 172.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.39 165.25 24.65 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.326 -1.361 . . . . 73.24 107.326 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.06 29.51 19.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.667 0.787 . . . . 75.43 109.892 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 O-C-N 120.246 -1.534 . . . . 74.32 114.503 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 108.922 -0.77 . . . . 73.33 108.922 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.75 114.28 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.105 2.537 . . . . 74.24 109.751 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.01 -161.83 35.12 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.147 -1.181 . . . . 72.53 110.147 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.06 82.86 0.21 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 127.092 2.157 . . . . 64.51 111.891 -163.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.31 165.59 24.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.165 2.577 . . . . 73.34 110.891 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.8 m -135.57 -175.59 4.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.265 1.426 . . . . 71.54 112.106 -173.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.8 25.95 2.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.673 2.789 . . . . 63.23 115.202 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.64 132.69 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.417 -0.802 . . . . 71.24 110.87 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -117.22 149.37 40.53 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.219 1.008 . . . . 75.01 109.073 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.6 mt -145.65 141.73 22.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 105.673 -1.973 . . . . 72.02 105.673 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.8 p -152.29 170.98 18.7 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.087 1.755 . . . . 73.32 108.861 168.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -95.37 160.02 14.73 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.804 0.729 . . . . 72.53 109.441 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.41 ' HG ' ' CD2' ' A' ' 23' ' ' HIS . 3.4 m -145.56 165.75 20.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.472 2.309 . . . . 73.23 109.391 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -70.66 -4.37 14.5 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.1 2.533 . . . . 73.43 112.349 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -131.85 29.13 4.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.45 1.5 . . . . 71.44 110.655 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.48 -158.36 21.18 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.377 -0.827 . . . . 63.51 112.739 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 153.03 23.77 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.484 1.142 . . . . 71.24 108.294 162.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.41 ' CD2' ' HG ' ' A' ' 18' ' ' SER . 0.9 OUTLIER -101.19 96.9 7.51 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.747 2.419 . . . . 73.44 109.167 -169.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.96 125.47 53.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.226 2.211 . . . . 73.51 110.061 -159.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -157.97 152.42 24.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.662 1.574 . . . . 51.21 114.427 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -149.28 -179.62 7.2 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 127.226 2.21 . . . . 72.21 113.151 -171.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -115.56 160.36 34.96 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 126.703 2.001 . . . . 70.25 112.756 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.52 176.24 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 126.647 4.898 . . . . 74.21 112.171 -176.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.75 113.52 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 108.083 -1.545 . . . . 71.54 108.083 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -103.47 13.95 32.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.952 0.901 . . . . 74.41 110.387 168.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 32' ' ' THR . 2.4 m -100.44 -84.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 127.536 2.334 . . . . 74.32 109.702 -174.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 31' ' ' VAL . 50.8 p -122.25 166.3 14.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.893 0.769 . . . . 75.3 109.364 170.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -60.0 -56.79 17.35 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.493 1.117 . . . . 73.1 110.205 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.13 -171.54 23.38 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.109 -0.796 . . . . 61.32 111.109 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -133.06 80.31 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.388 -0.967 . . . . 72.31 108.388 166.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -76.95 145.42 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.46 -1.311 . . . . 73.3 107.46 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -133.04 -24.49 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.342 1.457 . . . . 73.44 111.434 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 1.5 tp10 -168.1 -175.09 2.52 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 105.762 -1.94 . . . . 71.5 105.762 -174.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.472 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 75.2 m-85 -136.97 -166.15 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.546 -1.346 . . . . 72.22 109.913 175.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.96 159.71 41.73 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.35 2.26 . . . . 70.22 109.549 165.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.47 119.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 103.84 -2.652 . . . . 62.54 103.84 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -114.41 151.9 32.39 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.709 -0.849 . . . . 74.15 108.709 173.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 tp -136.25 117.86 14.93 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.627 1.971 . . . . 74.33 107.338 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.43 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.6 151.4 28.99 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.229 0.611 . . . . 63.51 111.623 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.38 172.49 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.571 1.148 . . . . 74.45 111.953 -169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.757 1.223 . . . . 70.33 109.955 156.831 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.676 -0.202 . . . . 73.22 110.549 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 87.93 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.479 0.581 . . . . 71.52 110.788 172.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 44' ' ' ALA . 13.5 m-30 -117.87 155.13 30.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.337 1.055 . . . . 74.13 110.052 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.7 ttp -87.03 146.9 25.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.632 0.773 . . . . 74.41 109.405 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.59 93.39 8.36 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.636 1.208 . . . . 62.35 110.961 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -71.61 1.16 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 124.599 1.16 . . . . 73.31 112.74 168.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -91.22 -163.92 1.1 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.992 1.717 . . . . 74.33 110.38 174.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.3 m 57.91 35.31 25.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.729 1.612 . . . . 74.24 110.829 -158.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.29 -177.48 9.89 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 110.167 -1.173 . . . . 71.21 110.167 163.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -26.08 28.71 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.432 1.421 . . . . 74.51 111.182 173.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.74 17.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.094 1.358 . . . . 73.12 109.541 -170.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.25 165.45 28.61 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.414 2.076 . . . . 74.44 109.745 160.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m 49.35 36.35 9.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.992 1.317 . . . . 62.51 113.034 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -88.9 162.28 16.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.653 1.216 . . . . 71.54 111.224 170.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.25 175.04 1.8 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.06 2.944 . . . . 74.15 113.705 172.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -135.8 119.68 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.236 1.014 . . . . 63.35 111.953 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -54.82 140.33 36.87 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.735 0.814 . . . . 73.32 111.599 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 p -56.14 -34.09 65.79 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.104 0.962 . . . . 72.55 112.799 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -55.17 -39.24 69.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.072 0.949 . . . . 72.55 111.583 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 t -74.55 -34.65 62.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.165 -0.959 . . . . 73.34 110.641 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.3 -33.77 76.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.633 0.651 . . . . 72.41 110.0 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -58.51 -37.21 75.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.633 1.573 . . . . 71.33 111.406 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.57 -5.58 59.26 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.068 -1.02 . . . . 72.52 112.711 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 149.82 21.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.607 -0.683 . . . . 72.44 111.166 -159.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 108.84 20.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.528 1.531 . . . . 74.43 109.693 -175.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -69.78 157.71 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.466 -0.938 . . . . 70.31 108.466 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -132.54 82.85 2.03 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.989 1.316 . . . . 63.13 108.656 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.96 121.61 5.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.438 1.273 . . . . 75.31 114.438 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 -22.62 43.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.63 -2.077 . . . . 75.44 112.894 159.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 p -143.67 -62.37 0.4 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.314 1.416 . . . . 74.31 112.797 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -104.49 141.86 23.41 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 116.811 -1.566 . . . . 75.43 109.218 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.48 120.58 7.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.229 1.953 . . . . 55.12 109.311 -176.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.95 147.71 50.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.604 -0.887 . . . . 64.23 108.604 160.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.3 mt -91.76 130.43 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 126.945 2.098 . . . . 74.33 105.768 168.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.4 mm -82.81 138.13 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.768 -1.197 . . . . 72.53 107.768 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.5 133.56 55.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.634 -1.247 . . . . 74.52 107.634 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -98.64 133.01 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 106.56 -1.645 . . . . 63.52 106.56 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 53.6 mt -135.87 140.27 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 105.686 -1.968 . . . . 62.24 105.686 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.27 164.48 35.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.511 0.724 . . . . 64.1 110.243 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.48 125.19 40.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.472 1.509 . . . . 70.53 111.15 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.473 ' HD3' ' CZ ' ' A' ' 107' ' ' TYR . 6.1 tpt180 -76.56 112.77 13.45 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.062 -1.459 . . . . 74.2 107.062 171.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 167.45 16.93 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.037 0.535 . . . . 71.41 111.346 162.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.66 -27.3 66.26 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.075 -0.391 . . . . 74.42 111.895 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -53.99 -40.02 66.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.336 1.454 . . . . 70.22 111.925 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.72 -173.37 27.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.632 2.063 . . . . 65.5 108.189 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.473 ' CZ ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -76.14 -5.05 44.91 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.126 1.528 . . . . 74.43 115.126 178.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.22 178.52 8.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.952 0.786 . . . . 42.44 111.958 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.95 148.13 63.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.584 1.523 . . . . 73.5 108.911 162.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 150.46 20.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.699 0.799 . . . . 71.32 109.485 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -68.27 166.26 16.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.071 0.948 . . . . 71.43 110.5 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -120.55 86.45 2.57 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.712 -1.958 . . . . 74.44 105.712 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.7 t -89.44 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 106.945 -1.502 . . . . 74.52 106.945 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.66 160.97 30.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.734 1.214 . . . . 74.04 107.945 165.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -119.27 80.13 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.637 1.575 . . . . 75.23 107.985 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.9 mt -64.73 -21.74 66.82 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.896 0.702 . . . . 72.32 112.896 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.27 28.19 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.103 1.361 . . . . 73.04 111.622 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.496 -1.298 . . . . 60.03 107.496 164.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.457 0 CA-C-O 118.595 -1.114 . . . . 72.22 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 71.4 m -116.97 -41.79 2.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.018 1.409 . . . . 53.25 111.27 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 149.49 94.57 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 120.089 -0.645 . . . . 73.22 110.366 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.68 -18.12 29.04 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.691 2.928 . . . . 71.21 113.498 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.84 -165.01 10.91 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.158 -1.177 . . . . 75.45 110.158 -167.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -88.43 165.3 28.96 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.05 -1.463 . . . . 75.25 107.05 169.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.18 6.15 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.095 2.53 . . . . 72.15 114.528 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.62 -171.77 16.78 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.595 -1.802 . . . . 72.31 108.595 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.33 163.34 34.68 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.871 1.668 . . . . 64.21 109.609 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.15 152.12 81.3 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.651 1.568 . . . . 75.35 111.287 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.9 m -133.61 -173.93 3.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.854 2.462 . . . . 72.32 108.627 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.91 27.32 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.898 2.879 . . . . 65.31 114.868 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.73 137.71 23.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.036 -0.727 . . . . 72.32 109.036 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -134.04 159.23 41.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.797 0.839 . . . . 73.14 111.227 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -144.18 138.95 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.864 -1.902 . . . . 72.31 105.864 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -135.47 159.99 39.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.675 1.99 . . . . 74.42 108.404 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -83.69 170.92 13.73 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.987 -1.071 . . . . 73.44 108.4 171.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 161.6 29.15 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 123.888 0.875 . . . . 61.13 110.26 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.72 -27.77 52.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.57 1.513 . . . . 73.45 110.968 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.55 23.37 13.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.114 1.366 . . . . 75.42 110.854 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.24 -149.1 21.03 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.652 -1.28 . . . . 73.14 111.791 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 144.32 40.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.507 2.153 . . . . 73.25 107.5 152.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -80.13 141.67 35.52 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.947 1.299 . . . . 62.52 108.084 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.97 174.65 10.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.003 0.819 . . . . 75.35 110.015 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -175.31 155.91 1.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.013 2.525 . . . . 74.23 108.059 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -158.57 167.08 30.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.323 1.449 . . . . 75.44 109.316 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -138.65 162.99 49.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 125.866 1.666 . . . . 64.44 111.682 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.91 174.79 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.186 3.258 . . . . 73.34 113.808 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.92 179.01 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.88 3.054 . . . . 71.24 113.646 168.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.0 t -138.36 73.27 1.43 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 105.069 -2.197 . . . . 73.44 105.069 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 m -141.48 -66.34 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 107.736 -1.209 . . . . 72.43 107.736 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 173.64 6.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.814 2.045 . . . . 65.31 109.441 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 m -49.35 -57.77 6.29 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.267 1.427 . . . . 74.21 110.289 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.84 118.0 0.12 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.777 0.703 . . . . 65.15 111.379 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -102.4 73.81 1.36 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.617 -0.883 . . . . 75.13 108.617 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.26 149.91 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.384 -1.71 . . . . 73.43 106.384 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.81 -23.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.279 1.431 . . . . 64.23 112.639 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 -170.91 3.5 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 105.41 -2.07 . . . . 64.21 105.41 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.33 -178.56 5.54 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.211 -2.181 . . . . 72.23 111.599 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.98 162.47 40.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.648 0.779 . . . . 63.21 111.558 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 p -148.35 115.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.728 2.011 . . . . 74.11 112.154 172.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -99.69 88.37 3.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 74.44 108.664 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.58 135.52 54.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.496 -1.298 . . . . 64.21 107.496 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 150.81 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.121 1.368 . . . . 63.51 111.002 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 pt -152.03 168.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.997 1.719 . . . . 74.13 110.394 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 92.23 7.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.016 -1.475 . . . . 75.51 107.016 160.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 t -162.97 172.77 14.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.781 -0.822 . . . . 74.14 108.781 149.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.3 m -73.0 150.22 42.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.9 -0.5 . . . . 74.54 109.796 159.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.81 178.47 9.86 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.309 -0.997 . . . . 73.43 108.309 169.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.91 166.41 11.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.843 0.857 . . . . 74.24 110.913 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 p -159.92 116.24 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.274 1.83 . . . . 72.23 106.202 -169.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.82 110.44 0.36 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.654 -0.978 . . . . 65.24 110.654 -169.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.31 152.88 68.54 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 117.666 0.733 . . . . 72.15 111.293 -163.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.33 122.9 11.52 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.474 2.116 . . . . 64.14 110.298 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 tptt 70.99 -3.43 2.03 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.437 2.295 . . . . 74.32 114.892 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m 52.19 86.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 123.001 1.382 . . . . 71.12 107.606 -150.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -133.13 36.87 3.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.374 -0.83 . . . . 73.31 109.593 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.96 68.9 0.98 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.027 1.331 . . . . 74.31 108.466 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.49 91.78 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.702 2.268 . . . . 63.21 110.373 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.79 115.48 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.227 1.411 . . . . 71.21 107.393 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -47.04 105.61 0.07 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.882 0.873 . . . . 71.21 110.453 166.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -77.14 177.36 7.9 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.357 1.063 . . . . 75.35 108.305 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.32 5.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.43 -0.581 . . . . 73.23 109.43 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -127.92 176.58 7.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.159 0.984 . . . . 74.25 110.473 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.5 ptm -126.74 -7.5 6.17 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.533 1.133 . . . . 72.53 112.655 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 53.63 78.13 0.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.883 0.873 . . . . 74.41 111.324 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.5 m -77.69 -38.65 25.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-O 117.831 -1.08 . . . . 72.12 111.777 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -65.39 131.19 45.83 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 116.722 -1.991 . . . . 64.55 112.165 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 51.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.966 2.506 . . . . 64.14 108.262 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.82 166.06 13.46 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.77 -1.206 . . . . 74.11 110.29 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.52 -50.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.906 2.404 . . . . 75.32 109.783 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -90.71 154.94 45.92 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 125.845 1.658 . . . . 72.53 108.665 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.79 -173.22 1.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.471 2.114 . . . . 71.32 110.798 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p 57.34 60.57 2.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.454 1.502 . . . . 63.33 112.56 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.09 176.35 5.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.224 1.41 . . . . 61.51 110.014 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.61 -172.88 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.251 1.021 . . . . 62.23 110.906 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.19 139.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 125.612 1.565 . . . . 73.14 109.308 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.79 139.51 58.78 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.23 0.923 . . . . 75.34 110.088 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 t -63.15 -26.8 68.98 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.523 -0.736 . . . . 74.32 112.379 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -66.32 -21.26 66.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.855 0.862 . . . . 74.13 111.227 173.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -82.81 -33.04 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.626 -1.296 . . . . 65.34 110.533 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.98 -37.32 47.62 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.764 0.826 . . . . 72.33 112.206 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -60.93 -37.89 83.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.59 -0.522 . . . . 63.23 109.59 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -86.46 11.19 13.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.811 2.044 . . . . 75.14 111.645 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.53 155.69 16.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.008 1.323 . . . . 74.21 111.192 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 140.76 29.8 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.733 0.813 . . . . 74.43 110.064 173.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.57 155.01 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.89 0.852 . . . . 73.11 110.273 168.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.64 130.4 35.33 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 126.377 1.871 . . . . 72.32 108.534 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.59 3.59 4.58 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.473 1.109 . . . . 74.33 110.79 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 p -90.27 -19.11 24.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.705 2.002 . . . . 73.44 111.633 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -135.78 -62.03 0.7 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.59 1.086 . . . . 72.41 112.739 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -153.24 155.35 31.75 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 119.567 1.076 . . . . 71.24 109.902 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.58 112.94 3.19 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.96 1.773 . . . . 71.33 108.313 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.02 165.98 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.257 2.623 . . . . 75.33 109.886 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -90.11 135.19 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.955 -1.128 . . . . 74.43 107.955 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.6 mm -83.49 147.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.261 0.937 . . . . 62.41 110.637 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -137.25 115.76 11.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 71.12 110.122 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.77 87.38 6.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.646 1.578 . . . . 72.14 108.654 170.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mt -86.08 151.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.321 -1.363 . . . . 73.12 107.321 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.63 146.24 24.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.835 0.743 . . . . 44.15 110.337 164.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.69 129.55 34.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.123 0.969 . . . . 71.14 110.011 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 92.13 8.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 105.909 -1.886 . . . . 75.34 105.909 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.95 173.14 6.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.412 1.485 . . . . 75.54 109.636 175.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.57 -16.53 10.42 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.858 1.429 . . . . 74.44 114.858 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -18.72 34.02 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.576 -1.328 . . . . 72.14 112.126 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.62 50.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.807 1.67 . . . . 35.1 111.047 -166.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.41 133.67 49.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.71 -1.589 . . . . 73.43 106.71 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -148.23 -86.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.303 0.954 . . . . 64.32 111.151 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.67 82.66 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.954 2.436 . . . . 71.41 107.596 166.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.09 160.82 9.47 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.381 -0.825 . . . . 62.11 109.539 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -115.34 140.5 49.07 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.424 1.09 . . . . 74.21 108.321 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.77 103.75 14.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 105.604 -1.999 . . . . 73.52 105.604 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.98 152.3 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 75.54 107.098 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.34 121.19 17.56 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.704 -0.68 . . . . 74.33 109.57 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -76.28 84.49 3.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.756 -1.201 . . . . 71.33 107.756 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.92 150.72 48.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.5 -1.296 . . . . 75.11 107.5 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 69.6 27.84 4.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.789 1.235 . . . . 61.42 111.288 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 177.71 0.82 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.174 2.99 . . . . 64.41 113.648 163.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 p -150.5 143.91 25.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.367 1.867 . . . . 71.43 109.989 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 m -58.78 -48.17 82.19 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.193 1.183 . . . . 64.35 114.193 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 69.43 -62.34 0.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.048 2.139 . . . . 75.22 113.621 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.93 83.28 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.479 2.712 . . . . 64.54 110.112 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 p -152.63 104.26 2.87 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.331 -0.856 . . . . 62.43 113.128 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 p -135.58 177.96 7.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.447 1.022 . . . . 53.31 111.218 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -121.81 -61.27 0.22 Allowed Glycine 0 N--CA 1.466 0.699 0 O-C-N 120.764 -1.21 . . . . 64.53 111.28 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.154 1.781 . . . . 73.32 107.777 178.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 109.662 -1.375 . . . . 75.4 109.662 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 79.2 m 50.73 71.33 0.43 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.697 1.999 . . . . 75.24 111.282 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.98 61.34 7.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 118.552 -0.737 . . . . 75.1 109.788 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -84.45 64.02 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.231 2.62 . . . . 75.33 110.483 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.21 167.18 14.91 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.717 -1.353 . . . . 75.4 109.717 -172.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -106.71 147.78 35.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.763 0.825 . . . . 72.44 110.017 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.2 134.49 21.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.963 2.442 . . . . 74.1 108.653 169.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.12 168.07 28.08 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.872 1.701 . . . . 64.42 109.328 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.05 165.76 2.11 Favored Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 125.861 1.664 . . . . 74.34 109.257 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -70.82 142.01 42.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.379 2.052 . . . . 74.2 109.541 149.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.82 175.48 9.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.123 1.369 . . . . 71.54 109.774 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.61 25.69 0.27 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.124 2.969 . . . . 75.44 114.966 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -55.44 143.41 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.829 1.652 . . . . 73.22 109.691 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -139.48 147.95 42.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.539 1.536 . . . . 75.43 108.132 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.87 144.21 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.874 -1.899 . . . . 75.43 105.874 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.1 m -144.79 155.79 43.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.635 1.574 . . . . 72.54 109.083 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.89 168.07 20.19 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.376 -0.827 . . . . 72.32 110.376 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.0 m -150.69 165.2 17.92 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.629 1.972 . . . . 54.23 106.915 170.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 -26.05 24.13 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.578 2.186 . . . . 62.42 110.702 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.73 -64.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.552 1.141 . . . . 63.03 109.183 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.73 -145.82 4.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.559 2.028 . . . . 74.12 108.669 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.04 133.9 55.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.155 0.977 . . . . 42.21 108.723 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.82 135.57 48.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.709 -1.219 . . . . 72.21 107.709 166.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mp -142.01 138.01 31.54 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 119.037 0.835 . . . . 75.2 110.503 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -144.0 153.45 42.25 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.297 -1.001 . . . . 73.4 108.297 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.32 21.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 74.04 108.357 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.11 165.8 16.65 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.124 0.97 . . . . 73.1 110.631 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.25 168.42 17.73 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.715 3.61 . . . . 75.43 113.625 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.27 175.25 11.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.382 2.721 . . . . 75.11 111.629 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.6 24.53 4.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.866 1.266 . . . . 75.41 111.731 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.17 -22.12 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.167 -0.958 . . . . 72.43 111.528 -158.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 t -166.16 162.39 17.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.162 2.185 . . . . 72.33 106.239 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -71.35 -68.93 0.41 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.373 1.069 . . . . 72.11 109.375 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.06 -173.05 10.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.623 -1.391 . . . . 71.04 109.623 -157.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -132.16 83.94 2.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.378 -1.341 . . . . 72.1 107.378 163.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.03 150.72 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.123 -1.066 . . . . 71.44 108.123 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.95 -25.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.788 1.635 . . . . 74.32 111.192 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 -175.86 3.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.35 1.46 . . . . 75.23 108.403 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -140.81 169.6 17.32 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.96 1.704 . . . . 72.4 108.878 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.4 m -152.68 161.16 42.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.439 0.696 . . . . 61.1 111.337 167.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.59 142.61 39.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.82 1.248 . . . . 63.43 108.672 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -127.0 115.83 19.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.929 2.092 . . . . 75.0 105.833 -171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -101.03 122.18 43.09 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.673 -1.602 . . . . 75.44 106.673 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.62 76.81 4.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.088 0.955 . . . . 74.11 109.801 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.25 175.77 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.135 0.974 . . . . 71.43 111.462 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.18 110.15 7.24 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.061 -1.829 . . . . 71.15 106.061 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.2 t -168.41 170.06 10.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.784 0.834 . . . . 72.21 110.145 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 p -152.01 96.47 2.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.879 -1.897 . . . . 63.31 105.879 160.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -160.73 161.68 32.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.069 1.348 . . . . 70.33 108.124 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.32 -179.43 0.22 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.102 2.161 . . . . 65.04 111.791 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -176.49 135.08 0.24 Allowed 'General case' 0 C--O 1.238 0.482 0 N-CA-C 103.428 -2.804 . . . . 74.42 103.428 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.14 99.32 0.16 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 119.106 0.867 . . . . 74.21 111.556 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -122.59 163.91 29.78 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 106.475 -1.676 . . . . 71.23 106.475 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.89 172.65 11.42 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 124.781 3.654 . . . . 72.43 114.286 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -56.75 -8.1 0.54 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.962 1.705 . . . . 71.34 114.68 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -58.41 -9.22 1.47 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.734 1.214 . . . . 73.5 113.296 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m 47.68 64.19 1.71 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.342 1.857 . . . . 73.1 111.937 163.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.66 144.51 53.24 Favored Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 124.832 1.253 . . . . 73.1 108.497 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.29 99.7 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.206 2.604 . . . . 75.4 110.508 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.29 83.21 0.28 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.45 1.1 . . . . 71.23 109.898 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -89.26 143.34 26.91 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.35 0.66 . . . . 73.2 110.546 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.98 175.66 6.2 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.296 1.838 . . . . 75.51 109.883 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.11 119.52 5.99 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.265 1.426 . . . . 61.42 108.847 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -137.69 169.93 16.93 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.751 0.82 . . . . 75.11 109.307 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -12.46 25.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 74.0 113.453 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 43.97 75.36 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.523 1.929 . . . . 73.3 111.531 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.9 m -65.19 -16.01 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.405 1.082 . . . . 63.4 113.343 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -121.24 117.43 27.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.538 0.735 . . . . 75.11 109.975 -169.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.3 m -130.82 137.89 49.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.764 -2.31 . . . . 64.23 104.764 154.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.26 7.94 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.645 1.111 . . . . 72.12 112.496 170.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.97 -14.86 10.8 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.977 3.118 . . . . 75.0 113.385 -170.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.1 m -111.29 85.83 5.91 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.525 1.13 . . . . 75.04 109.489 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.6 67.78 3.7 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.541 2.827 . . . . 75.34 110.646 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -157.13 11.8 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.785 1.234 . . . . 75.11 111.618 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -89.9 161.76 15.77 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.321 1.049 . . . . 74.03 113.27 -165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.05 164.46 17.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.538 1.935 . . . . 75.41 110.393 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.41 125.52 69.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.694 1.598 . . . . 64.43 107.15 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -66.98 160.79 25.69 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.322 1.049 . . . . 71.34 111.561 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -55.05 -33.66 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 71.44 110.391 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -61.06 -12.23 11.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.541 1.536 . . . . 61.43 113.768 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -118.58 7.85 11.86 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.121 1.368 . . . . 74.0 112.053 171.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.51 -12.91 10.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.366 1.466 . . . . 73.54 111.733 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.48 -60.95 2.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.873 1.269 . . . . 74.21 111.5 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -73.29 13.26 0.46 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 118.161 -0.923 . . . . 74.34 112.085 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.76 165.95 2.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.243 1.383 . . . . 63.45 110.122 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.5 108.38 12.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.972 -1.492 . . . . 74.13 106.972 166.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 mm -68.82 140.78 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.075 -1.454 . . . . 75.14 107.075 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -56.85 118.13 4.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.19 0.996 . . . . 75.41 109.085 169.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.41 31.37 6.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.98 1.312 . . . . 71.45 109.076 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -6.36 5.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.667 1.187 . . . . 75.12 110.363 -164.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -159.06 -66.25 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.762 2.825 . . . . 72.43 107.681 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -149.58 151.86 33.97 Favored Pre-proline 0 N--CA 1.463 0.2 0 C-N-CA 125.857 1.663 . . . . 74.34 109.413 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.21 100.78 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.967 2.445 . . . . 75.14 109.89 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.34 152.32 39.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.349 1.459 . . . . 73.5 110.453 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.3 mt -79.98 124.19 37.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.388 -1.708 . . . . 75.55 106.388 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 mm -101.52 101.39 12.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.759 -1.2 . . . . 73.52 107.759 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -79.21 152.62 30.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.156 0.982 . . . . 75.12 109.292 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.17 124.76 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 104.739 -2.319 . . . . 75.42 104.739 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.69 141.98 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 120.674 1.579 . . . . 75.5 108.149 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.42 155.52 45.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.745 0.702 . . . . 62.13 111.231 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 125.0 28.75 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.46 1.504 . . . . 51.2 109.883 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -74.49 101.33 4.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 104.729 -2.323 . . . . 75.43 104.729 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -115.84 174.62 5.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.431 0.634 . . . . 74.23 110.751 168.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.08 -23.94 67.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.274 0.842 . . . . 72.0 113.274 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -57.91 6.4 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.205 1.002 . . . . 74.42 110.653 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 165.5 12.33 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.333 1.921 . . . . 62.41 109.05 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -64.75 137.78 58.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.168 -1.419 . . . . 73.33 107.168 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.61 -64.15 0.01 OUTLIER Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.377 0.989 . . . . 52.1 111.907 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.07 71.65 6.18 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.554 2.836 . . . . 75.42 110.774 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.17 6.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.139 0.576 . . . . 74.4 109.857 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.5 m -81.04 113.12 19.02 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.527 -1.657 . . . . 64.3 106.527 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.8 151.02 27.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.987 -1.116 . . . . 75.54 107.987 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 76.2 t -143.72 143.58 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.018 -1.475 . . . . 75.3 107.018 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.84 154.19 39.98 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.827 0.739 . . . . 74.2 112.31 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -142.71 112.12 6.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.469 1.108 . . . . 72.51 109.774 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.428 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -88.53 3.05 51.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 128.702 2.801 . . . . 75.21 112.286 -172.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.27 18.4 16.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.954 1.702 . . . . 71.34 110.293 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 1.71 8.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.19 0.996 . . . . 64.33 113.493 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 122.65 10.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.299 1.839 . . . . 74.13 108.749 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 t -143.65 -49.87 0.31 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.708 -0.187 . . . . 73.15 111.107 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.97 71.43 10.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.517 -0.549 . . . . 71.52 109.517 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -139.13 143.8 38.37 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.709 -1.589 . . . . 75.45 106.709 167.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 m 48.03 36.23 6.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.311 1.044 . . . . 73.34 112.0 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -7.25 47.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.715 -1.24 . . . . 74.15 112.573 -168.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.55 -63.37 1.12 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 106.985 -2.446 . . . . 71.21 106.985 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.257 1.447 0 C-N-CA 128.807 2.843 . . . . 71.51 104.189 157.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 109.04 -1.624 . . . . 53.34 109.04 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 98.7 m -112.93 -25.51 8.96 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.196 1.399 . . . . 65.22 110.574 154.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 mt 45.23 67.99 3.7 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 127.392 2.277 . . . . 73.21 111.012 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.16 100.08 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.927 2.418 . . . . 74.12 108.784 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.51 151.93 26.7 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 125.344 1.45 . . . . 74.43 110.684 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -124.92 165.5 25.29 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.355 2.262 . . . . 75.31 108.995 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.18 134.95 32.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.221 1.947 . . . . 60.13 113.373 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.39 -179.81 53.33 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.367 1.461 . . . . 61.43 112.301 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 174.49 165.12 0.34 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.272 3.029 . . . . 72.14 110.138 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.34 150.81 81.2 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.624 2.216 . . . . 74.21 109.666 163.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -137.31 174.89 10.12 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.431 1.092 . . . . 72.44 110.606 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.99 10.14 4.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.942 2.497 . . . . 71.21 115.515 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -51.49 111.66 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 125.259 1.424 . . . . 74.43 113.051 -158.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -86.3 136.46 33.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.534 -1.284 . . . . 73.13 107.534 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.23 126.33 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.4 -2.074 . . . . 64.41 105.4 160.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -150.33 173.02 14.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 128.924 2.889 . . . . 62.13 106.227 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -90.05 159.68 16.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.985 -1.117 . . . . 74.25 107.985 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -129.56 160.61 63.66 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.559 -1.645 . . . . 75.31 106.559 157.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -52.65 -45.0 43.29 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 120.91 1.073 . . . . 73.24 109.37 150.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -79.33 26.31 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.59 2.356 . . . . 72.34 113.604 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.74 -113.32 2.35 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.283 0.944 . . . . 73.32 111.119 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.59 -160.95 1.09 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.233 1.813 . . . . 64.11 108.757 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -130.34 33.62 4.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.212 1.405 . . . . 74.03 112.766 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.69 103.42 1.09 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 127.029 2.132 . . . . 75.31 113.038 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -138.97 150.59 46.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.431 1.469 . . . . 72.04 110.424 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.419 ' CE3' HD13 ' A' ' 99' ' ' ILE . 1.1 p90 -139.27 162.62 34.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.382 1.073 . . . . 73.32 110.426 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.75 154.81 87.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.377 -0.374 . . . . 73.42 111.347 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.49 168.16 25.46 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.067 3.178 . . . . 64.02 110.9 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.59 116.13 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.141 2.561 . . . . 73.15 110.341 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.36 60.31 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.685 2.394 . . . . 74.21 106.266 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.48 -62.31 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 124.267 1.027 . . . . 73.24 111.329 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 p -133.38 167.02 21.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.304 -0.872 . . . . 74.21 110.583 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.7 10.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.316 2.246 . . . . 64.43 114.022 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.25 149.01 50.26 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.568 -1.413 . . . . 74.04 109.568 172.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -121.39 92.11 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.473 1.909 . . . . 73.35 106.517 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -73.73 144.49 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 72.25 106.589 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 pt -131.08 -13.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.924 1.69 . . . . 71.51 112.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -168.38 -175.4 2.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.724 2.41 . . . . 74.41 107.345 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.22 170.36 15.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.061 -1.025 . . . . 73.12 109.294 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.4 p -146.62 155.18 42.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.852 0.861 . . . . 71.21 112.898 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.8 t -141.68 137.98 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.466 1.906 . . . . 71.54 106.706 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -128.49 126.75 41.08 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.907 1.683 . . . . 73.43 107.052 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.4 tp -119.79 131.58 55.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.821 1.648 . . . . 75.53 109.911 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.55 135.85 54.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.914 1.234 . . . . 65.32 110.834 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.1 pt -141.11 -173.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.987 1.315 . . . . 73.1 111.003 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -106.96 43.4 1.16 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 72.44 112.503 -168.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.9 m -135.91 -171.25 2.82 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 129.46 3.104 . . . . 73.33 108.601 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 m -135.59 159.01 42.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.024 -1.047 . . . . 74.13 110.702 159.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.29 168.76 20.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.157 2.583 . . . . 74.2 105.793 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.37 165.85 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.827 0.451 . . . . 45.11 110.981 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.66 110.69 9.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.2 -2.148 . . . . 63.52 105.2 -176.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.29 110.53 0.47 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 108.21 -1.956 . . . . 73.42 108.21 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 156.5 81.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.1 0.56 . . . . 73.32 110.395 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -90.0 61.51 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.279 2.653 . . . . 72.43 111.167 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 45.79 48.02 11.88 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.969 1.308 . . . . 73.41 109.476 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 t -79.47 -69.7 0.56 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.698 1.599 . . . . 72.11 107.077 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -173.41 -43.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.166 0.894 . . . . 65.34 111.571 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 t -135.98 144.4 48.23 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.258 -1.015 . . . . 71.01 108.258 -158.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.75 161.25 46.71 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.278 1.986 . . . . 74.14 110.94 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -161.64 104.52 1.22 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.369 1.468 . . . . 74.33 108.661 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.93 116.4 18.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 122.1 0.953 . . . . 74.24 109.668 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.86 153.55 33.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 129.585 3.154 . . . . 74.42 106.741 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.14 108.4 7.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.703 -1.221 . . . . 70.2 107.703 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -118.2 -174.69 2.71 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.826 1.65 . . . . 74.51 108.849 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.4 ttp -121.82 121.72 37.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.892 2.477 . . . . 75.2 107.275 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 107.177 -1.416 . . . . 74.1 107.177 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.2 -28.96 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.804 -0.56 . . . . 73.31 110.67 168.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -99.93 93.86 5.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.562 -0.711 . . . . 75.31 109.117 -159.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.3 71.92 0.85 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.991 1.317 . . . . 75.21 107.657 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.55 168.95 41.58 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.849 -0.9 . . . . 72.42 110.849 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.41 -55.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.565 2.844 . . . . 75.12 112.451 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 m -151.29 73.24 8.39 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.368 1.467 . . . . 73.23 109.763 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.72 -47.87 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-O 116.237 -1.651 . . . . 75.43 110.129 155.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.83 76.6 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.395 1.452 . . . . 71.34 109.451 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.5 t 77.52 83.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 130.051 3.341 . . . . 75.15 111.586 -166.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 97.1 2.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.777 -1.564 . . . . 71.21 106.777 145.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 t -133.35 106.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 120.739 -1.226 . . . . 73.24 108.349 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -61.77 142.3 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.885 1.674 . . . . 72.35 109.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 p -57.78 -26.31 61.74 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.46 0.704 . . . . 72.35 110.815 171.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -53.6 -15.83 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.484 1.914 . . . . 61.11 114.115 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -99.23 -49.75 4.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.532 1.06 . . . . 74.34 109.824 171.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.6 -39.46 94.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.563 1.074 . . . . 72.53 112.261 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.8 t -56.25 -44.59 79.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.985 1.314 . . . . 75.52 109.521 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.19 1.43 44.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 75.12 112.376 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.19 145.96 47.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.779 0.799 . . . . 64.21 109.534 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -69.47 107.4 3.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.096 -1.816 . . . . 74.41 106.096 158.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.01 130.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 106.439 -1.689 . . . . 74.41 106.439 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.49 132.22 53.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.898 1.332 . . . . 71.21 109.246 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.81 32.2 5.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.675 -1.148 . . . . 73.31 108.263 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.66 -84.35 0.64 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.638 -1.986 . . . . 73.44 105.638 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -62.47 -64.34 0.95 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.75 0.82 . . . . 71.12 110.421 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -155.86 155.65 29.64 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 117.747 -1.121 . . . . 74.03 110.766 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.44 97.38 0.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.315 2.01 . . . . 54.5 107.949 169.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.71 169.99 23.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.704 2.002 . . . . 75.31 108.594 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.92 115.45 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.197 -1.779 . . . . 64.43 106.197 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.14 139.61 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.597 -1.26 . . . . 75.31 107.597 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.08 131.31 50.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.055 1.742 . . . . 74.24 107.811 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -103.32 137.72 41.06 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.193 -1.78 . . . . 75.03 106.193 155.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.419 HD13 ' CE3' ' A' ' 26' ' ' TRP . 67.0 mt -130.74 137.75 55.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 104.557 -2.386 . . . . 73.03 104.557 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.4 142.77 23.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.87 0.692 . . . . 75.43 112.87 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.59 128.35 36.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.433 1.893 . . . . 74.41 109.573 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.49 95.71 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.343 -1.725 . . . . 72.12 106.343 173.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.84 166.06 14.29 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.079 1.352 . . . . 75.15 108.297 169.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.24 -35.54 65.08 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.852 0.861 . . . . 74.51 112.438 -171.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -55.37 -21.08 13.9 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.204 1.187 . . . . 75.4 114.204 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.49 176.26 32.72 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.498 -1.441 . . . . 62.53 109.498 -168.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -79.73 55.87 2.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.548 1.166 . . . . 75.35 109.584 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.32 -64.73 3.65 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.632 1.587 . . . . 75.01 109.289 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.58 142.1 25.76 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 CA-C-N 118.942 1.371 . . . . 63.13 109.255 172.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.83 147.79 27.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.075 -1.083 . . . . 74.1 108.075 165.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -78.01 169.73 17.79 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.343 -0.614 . . . . 74.03 109.343 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.58 2.91 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.409 -1.7 . . . . 73.33 106.409 169.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.87 161.08 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.008 -1.479 . . . . 72.05 107.008 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 131.16 22.82 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.034 -1.839 . . . . 75.31 106.034 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -82.76 82.41 8.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.195 -1.039 . . . . 74.03 108.195 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.67 -16.69 63.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.763 0.71 . . . . 74.24 112.519 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.2 -17.66 64.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.284 -0.885 . . . . 72.42 111.269 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -107.15 151.6 25.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.012 1.725 . . . . 75.33 106.547 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.6 m -162.17 141.39 9.5 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.011 1.324 . . . . 75.35 107.509 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 t -64.08 152.21 41.01 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.923 -0.399 . . . . 74.32 109.923 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -149.61 162.22 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.144 2.178 . . . . 75.45 106.087 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 53.58 33.07 15.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.65 1.58 . . . . 73.13 113.576 158.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 t -56.44 156.63 5.81 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.494 1.918 . . . . 65.2 112.517 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.61 -154.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.172 1.389 . . . . 54.24 109.512 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.84 -120.63 0.63 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.067 -1.213 . . . . 72.14 110.067 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.243 0.713 0 C-N-CA 127.853 2.461 . . . . 72.44 106.68 174.064 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.446 0 N-CA-C 110.64 -0.984 . . . . 65.04 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.18 164.54 6.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.256 1.422 . . . . 54.41 111.217 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.74 161.2 32.21 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 127.164 2.186 . . . . 73.31 106.633 170.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.11 173.8 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.291 1.994 . . . . 73.0 113.158 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.57 147.1 0.98 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.975 1.75 . . . . 73.4 111.008 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.72 85.77 49.53 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 107.3 -1.37 . . . . 74.33 107.3 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.39 6.92 1.01 Allowed 'Trans proline' 0 CA--C 1.545 1.035 1 C-N-CA 126.734 4.956 . . . . 61.13 114.464 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.87 -114.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.525 0 O-C-N 120.802 -1.186 . . . . 32.44 111.694 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.27 164.79 0.14 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.121 2.968 . . . . 74.15 111.404 -163.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.36 159.75 11.12 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 124.06 3.173 . . . . 73.32 110.804 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -136.45 -173.93 3.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.378 1.071 . . . . 70.24 110.233 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 33.43 3.49 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.929 2.492 . . . . 74.03 115.151 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.03 139.36 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.385 0.674 . . . . 65.13 109.924 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -124.04 140.13 53.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 125.545 1.538 . . . . 73.33 107.79 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.6 mt -147.3 134.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.83 -1.915 . . . . 74.41 105.83 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.04 163.29 40.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 74.33 108.237 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -81.97 164.1 21.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.144 0.884 . . . . 72.41 109.074 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -138.92 165.54 31.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.774 2.029 . . . . 73.32 106.897 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -64.25 -28.57 64.06 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.695 1.597 . . . . 72.31 111.631 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.52 17.92 11.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.64 1.576 . . . . 73.11 111.268 -163.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.38 -141.94 9.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.47 -1.452 . . . . 53.45 109.47 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.75 163.07 30.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.801 1.301 . . . . 54.54 111.416 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.02 134.76 34.24 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.253 1.821 . . . . 73.11 108.219 168.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 114.86 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.435 1.494 . . . . 73.12 110.152 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.1 p -135.33 168.81 18.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.654 0.661 . . . . 74.41 110.953 166.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -148.21 169.47 20.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 130.171 3.388 . . . . 74.21 107.048 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.04 151.72 42.65 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 123.999 0.92 . . . . 71.41 109.097 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.74 164.61 33.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.802 2.335 . . . . 64.21 111.245 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.88 139.83 90.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.888 3.059 . . . . 62.42 112.679 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.6 t -135.26 16.14 3.46 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.925 . . . . 61.32 113.173 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.91 -45.04 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.236 1.014 . . . . 71.15 110.345 -171.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 p -144.89 174.16 11.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.963 0.905 . . . . 65.41 109.689 168.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -50.4 -56.24 12.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.396 1.878 . . . . 70.32 114.019 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.97 176.76 5.53 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.298 1.904 . . . . 63.23 112.828 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -139.05 93.43 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.606 0.762 . . . . 73.32 109.222 158.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.46 150.95 3.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.264 -1.013 . . . . 74.15 108.264 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.7 -34.64 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.75 1.22 . . . . 65.23 111.644 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -160.43 -179.27 7.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.725 -1.213 . . . . 64.42 107.725 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -136.32 165.48 25.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.306 0.957 . . . . 71.54 110.413 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 t -145.75 153.57 41.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.041 0.936 . . . . 71.42 109.368 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.54 147.9 31.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.767 1.627 . . . . 71.13 107.305 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -133.0 145.53 50.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.275 -1.379 . . . . 72.32 107.275 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.28 134.58 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.713 -1.218 . . . . 72.34 107.713 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.09 131.24 49.91 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.75 -1.119 . . . . 63.24 109.71 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 47' ' ' SER . 11.3 pt -144.31 -174.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.751 -1.203 . . . . 73.14 107.751 168.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -69.74 13.92 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.256 1.823 . . . . 73.31 115.535 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -136.2 111.46 9.07 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 125.475 1.51 . . . . 73.42 111.559 -165.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.24 114.61 29.03 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.973 1.309 . . . . 74.51 111.396 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -144.89 158.07 43.93 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.491 1.117 . . . . 73.24 108.243 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.9 175.18 10.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.136 2.174 . . . . 74.23 109.161 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 t -120.96 -10.55 9.06 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.247 1.819 . . . . 61.51 111.785 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.49 104.01 1.37 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 108.699 -1.761 . . . . 70.32 108.699 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -54.53 162.37 1.73 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.997 1.719 . . . . 71.01 114.921 -168.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.75 77.8 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.525 1 C-N-CA 127.042 5.161 . . . . 52.5 111.627 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? 50.15 38.76 17.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.843 1.257 . . . . 72.32 110.924 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -90.71 -3.71 57.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.098 0.863 . . . . 71.13 111.815 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.42 51.0 6.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.967 2.107 . . . . 72.2 112.145 -170.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 p 43.65 53.89 10.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.842 1.657 . . . . 74.41 112.776 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.28 87.84 1.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.5 2.133 . . . . 63.01 110.347 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 73.72 115.22 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.268 2.227 . . . . 65.02 110.029 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.74 162.94 7.92 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.978 -0.749 . . . . 73.14 108.978 163.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.66 168.77 19.89 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.021 -1.049 . . . . 72.44 112.399 -162.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.34 77.53 1.79 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.61 0.764 . . . . 70.31 111.488 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -139.59 129.97 25.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.998 0.919 . . . . 74.31 109.134 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.8 ttp -76.76 151.08 36.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.844 1.258 . . . . 54.42 109.523 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -79.62 71.39 6.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 73.54 112.784 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.56 -32.03 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 118.763 -0.636 . . . . 72.25 112.63 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -58.92 122.64 14.16 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.34 0.973 . . . . 74.54 110.545 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.9 t -157.18 40.7 0.31 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.676 0.79 . . . . 73.42 110.142 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.33 168.6 32.61 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 119.268 0.94 . . . . 54.14 112.029 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.75 -21.39 6.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.734 2.956 . . . . 71.33 115.438 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 m -82.9 143.47 46.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.315 -0.994 . . . . 73.43 108.315 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.55 -41.52 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.431 1.42 . . . . 72.32 109.563 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.9 m -74.7 79.65 2.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.564 -1.272 . . . . 52.51 107.564 161.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.08 171.76 11.33 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.671 -0.643 . . . . 73.12 110.011 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.13 178.45 6.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.767 0.827 . . . . 74.43 110.583 167.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.5 t -138.83 146.7 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.952 1.701 . . . . 74.33 108.247 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.41 165.41 14.95 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 129.088 2.955 . . . . 74.34 112.93 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -44.98 -47.38 11.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.093 1.357 . . . . 73.53 111.966 162.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.1 m -56.5 -50.67 71.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.144 0.884 . . . . 72.22 112.255 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -71.89 -33.88 68.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.539 0.736 . . . . 71.44 110.561 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.68 -39.8 92.7 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.02 0.928 . . . . 64.22 111.743 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 m -71.66 3.69 3.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 0.817 . . . . 74.24 113.114 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -117.76 -1.93 11.47 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.975 1.31 . . . . 73.25 111.288 166.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.63 118.57 13.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.205 0.911 . . . . 70.45 108.735 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.12 140.65 56.2 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.542 -0.54 . . . . 74.1 109.542 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.05 138.78 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.859 -0.793 . . . . 70.05 108.859 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.0 133.11 49.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.588 0.755 . . . . 72.33 109.185 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.51 3.48 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.282 1.033 . . . . 72.24 112.0 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.2 m -65.46 -31.44 72.53 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.496 1.043 . . . . 71.23 109.589 167.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.86 -69.31 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.825 -0.547 . . . . 71.22 111.38 -162.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.95 145.89 38.21 Favored Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 118.054 -0.974 . . . . 65.31 109.109 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.49 97.47 0.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.343 2.029 . . . . 73.13 108.437 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.22 162.87 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.24 2.616 . . . . 74.14 107.766 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.7 mt -105.02 136.11 40.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.861 -1.163 . . . . 74.01 107.861 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.13 125.75 53.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.147 0.979 . . . . 74.02 110.665 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -109.42 159.95 16.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.672 1.189 . . . . 72.45 109.775 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.0 126.95 44.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.188 -2.152 . . . . 74.35 105.188 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.9 mt -120.54 142.53 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.69 -1.596 . . . . 73.32 106.69 171.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 153.31 38.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.435 0.561 . . . . 74.03 111.56 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.47 131.8 40.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.898 1.279 . . . . 71.21 108.869 163.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -77.83 111.53 13.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.995 -1.854 . . . . 71.44 105.995 157.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -119.48 175.43 5.84 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.427 0.691 . . . . 74.23 111.027 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.27 -45.99 92.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.428 0.691 . . . . 74.41 112.295 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -61.84 -27.64 68.92 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.362 0.983 . . . . 74.42 110.627 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.63 -167.9 29.22 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.375 -1.49 . . . . 72.53 109.375 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.51 12.03 0.11 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.194 1.924 . . . . 74.13 116.194 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.4 -160.82 0.57 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.817 2.151 . . . . 63.31 112.11 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -75.2 178.55 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.542 2.161 . . . . 73.44 109.074 163.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.42 128.63 48.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.334 -0.987 . . . . 64.05 108.334 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.2 m -76.08 105.47 7.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.773 -1.195 . . . . 74.34 107.773 169.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.56 118.21 9.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.344 -1.724 . . . . 74.01 106.344 161.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.54 160.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 O-C-N 121.167 -0.958 . . . . 74.45 109.165 166.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.77 129.81 52.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.961 0.905 . . . . 74.31 109.215 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -85.37 85.45 7.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.396 -0.964 . . . . 73.11 108.396 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.1 mt -66.06 165.66 13.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.036 -0.727 . . . . 74.21 109.036 168.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 75.81 10.92 3.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.278 2.231 . . . . 62.14 113.497 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -57.72 166.79 1.27 Allowed 'General case' 0 C--O 1.246 0.877 0 N-CA-C 113.431 0.9 . . . . 64.13 113.431 161.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.365 2.8 t -150.25 143.81 25.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.273 1.029 . . . . 73.11 110.928 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.8 t -53.37 -61.67 2.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.262 1.825 . . . . 71.23 107.81 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 51.5 42.32 29.3 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.369 1.068 . . . . 74.33 111.07 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.04 112.53 1.72 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.388 2.275 . . . . 64.35 108.027 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.8 p -164.57 174.05 11.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.161 0.984 . . . . 64.12 109.813 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -126.58 -67.81 0.84 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 107.548 -1.278 . . . . 71.42 107.548 169.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.36 -155.45 16.32 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.834 -1.306 . . . . 53.32 109.834 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--O 1.25 1.114 0 N-CA-C 104.656 -2.35 . . . . 74.24 104.656 -178.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 CA-C-O 118.333 -1.26 . . . . 53.22 110.476 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 82.9 m 56.5 89.37 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 75.24 111.524 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -59.51 165.16 4.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.069 0.948 . . . . 75.4 111.675 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.62 87.71 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.324 2.682 . . . . 73.4 110.873 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.18 154.24 7.41 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.059 1.79 . . . . 74.21 110.006 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.05 146.58 33.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.395 0.678 . . . . 75.31 109.212 171.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.13 168.12 22.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.84 2.36 . . . . 62.34 110.313 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.52 -132.64 11.27 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.703 -1.759 . . . . 71.0 108.703 -170.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.11 156.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.321 2.648 . . . . 74.11 111.841 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -68.97 159.23 54.77 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.894 1.729 . . . . 72.13 108.955 167.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.98 174.21 10.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.57 0.7 . . . . 64.11 109.853 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.3 27.28 2.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.094 2.157 . . . . 71.11 114.899 168.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -56.96 137.97 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.28 . . . . 72.4 108.699 -171.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -135.85 141.4 44.64 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.492 -1.299 . . . . 75.22 107.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 115' ' ' TRP . 5.5 mt -142.92 110.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.111 -1.07 . . . . 75.04 108.111 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -106.93 145.3 32.39 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.812 0.845 . . . . 74.22 109.831 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -82.53 158.86 22.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.38 0.672 . . . . 74.32 109.925 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -143.45 163.42 36.89 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.449 2.299 . . . . 74.4 109.545 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.97 -13.9 42.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.763 2.975 . . . . 73.31 113.684 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 2.47 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.411 2.284 . . . . 75.32 111.36 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.86 -127.29 2.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.223 0.92 . . . . 64.03 112.889 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.09 127.67 17.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.721 1.208 . . . . 72.44 108.418 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -70.17 98.62 1.37 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.52 1.528 . . . . 75.0 108.643 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.99 116.47 23.4 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.457 -1.312 . . . . 75.24 107.457 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 p -136.95 160.24 39.48 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.716 -0.615 . . . . 73.44 109.813 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 -178.41 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.192 0.597 . . . . 75.33 110.137 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -133.69 158.65 75.02 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 108.917 -0.771 . . . . 75.21 108.917 165.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.59 160.64 42.22 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.508 1.472 . . . . 71.43 109.525 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.58 170.93 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.308 1.339 . . . . 74.13 111.427 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 t -141.67 70.57 1.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 105.091 -2.189 . . . . 71.04 105.091 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.84 -65.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.124 0.97 . . . . 75.31 110.251 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -135.09 -173.11 3.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.564 1.074 . . . . 63.21 110.302 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -26.06 67.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.833 1.79 . . . . 63.01 115.833 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.36 94.67 0.01 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.721 2.105 . . . . 43.33 115.991 167.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -82.23 64.93 7.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.685 1.194 . . . . 71.1 111.621 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.57 147.43 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.58 -0.896 . . . . 75.33 108.58 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.33 -15.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.312 2.245 . . . . 75.42 112.1 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.19 178.06 10.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.764 1.626 . . . . 72.4 107.019 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.05 168.12 19.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.63 -1.248 . . . . 74.22 107.63 165.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.0 m -134.43 141.45 46.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.568 -0.901 . . . . 73.0 108.568 164.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.5 t -136.61 116.98 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.363 -2.458 . . . . 75.2 104.363 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -120.63 127.38 52.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.267 -1.012 . . . . 64.11 108.267 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -115.28 129.37 56.6 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 105.555 -2.017 . . . . 74.34 105.555 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.32 145.63 33.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 124.021 0.825 . . . . 74.22 109.367 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -145.23 -179.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.169 1.788 . . . . 72.12 107.903 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -71.8 76.3 0.87 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.063 0.545 . . . . 73.11 111.958 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.5 p -158.72 -157.94 0.66 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.17 -0.956 . . . . 71.44 110.252 164.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -140.99 5.34 1.92 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.58 1.952 . . . . 71.24 113.509 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -62.89 152.1 37.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.935 0.894 . . . . 75.32 110.071 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.52 32.08 4.55 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.878 2.071 . . . . 74.31 114.219 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.5 t -73.89 85.61 1.74 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.104 1.761 . . . . 72.32 108.666 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.88 115.26 0.32 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.432 -0.667 . . . . 74.22 111.432 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.86 164.15 41.5 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.028 1.331 . . . . 74.21 108.732 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.96 -164.49 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.272 3.315 . . . . 75.13 112.346 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tttm 66.68 12.59 8.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.68 1.592 . . . . 73.01 111.455 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 m 44.92 44.99 8.39 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.18 1.392 . . . . 55.43 111.415 -165.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -110.98 37.74 2.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.849 0.859 . . . . 73.42 112.631 -170.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.1 p -100.69 85.12 0.52 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.745 1.618 . . . . 72.41 109.802 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.31 122.87 9.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.001 2.467 . . . . 55.43 110.06 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.44 43.05 5.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.54 1.936 . . . . 73.11 113.405 161.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.301 10.6 pt20 43.85 74.57 0.12 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.826 2.05 . . . . 72.22 112.19 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.52 162.59 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.785 -1.552 . . . . 74.41 111.336 153.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.63 148.3 30.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.759 -1.941 . . . . 62.14 105.759 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -143.32 151.14 40.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.691 0.678 . . . . 72.43 110.67 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -112.22 4.95 18.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.6 1.16 . . . . 74.32 113.506 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 49.93 78.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.842 1.657 . . . . 73.0 111.317 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.0 m -77.28 -5.82 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 75.13 112.751 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -56.24 112.69 1.3 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.974 1.31 . . . . 74.42 110.103 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.78 31.41 0.22 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.345 1.458 . . . . 75.42 110.164 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -125.75 75.01 0.41 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.765 1.174 . . . . 75.44 111.29 -170.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -67.33 -17.5 49.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.144 1.896 . . . . 61.44 111.721 165.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -56.58 144.35 64.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.87 1.268 . . . . 61.31 109.515 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.79 -21.02 38.92 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.976 1.784 . . . . 62.03 111.85 -174.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.63 145.85 33.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 128.461 2.704 . . . . 64.04 104.183 163.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -137.7 154.07 49.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.626 1.103 . . . . 72.2 110.242 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.07 163.91 27.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.513 1.149 . . . . 74.44 109.585 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.6 t -139.33 128.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 104.383 -2.451 . . . . 74.3 104.383 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.77 139.2 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.944 0.778 . . . . 64.03 109.502 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -30.27 63.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.843 1.657 . . . . 75.34 111.779 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.4 p -59.18 -14.61 11.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 55.4 113.595 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 t -88.07 -48.14 7.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.026 0.83 . . . . 64.14 108.947 168.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.38 -31.71 72.97 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.009 0.822 . . . . 63.12 112.151 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -44.89 -59.96 2.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.117 2.167 . . . . 74.43 108.386 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.35 0.29 37.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 75.01 111.929 -165.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 153.07 44.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.768 0.827 . . . . 72.43 110.884 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 132.5 36.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.093 -1.077 . . . . 75.0 108.093 165.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -84.06 145.44 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.431 1.092 . . . . 75.12 108.055 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -70.54 132.28 45.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.829 0.852 . . . . 73.34 109.181 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.55 23.72 11.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 75.34 109.995 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.53 -38.06 2.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.553 1.541 . . . . 74.33 111.892 -162.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -136.82 -52.89 0.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.447 1.099 . . . . 72.34 112.462 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -148.02 150.51 35.67 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 120.452 1.478 . . . . 73.11 110.84 158.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.51 95.93 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.816 3.01 . . . . 73.11 109.795 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.48 166.39 33.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.054 1.742 . . . . 64.22 110.6 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.1 mt -86.25 118.98 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.841 1.257 . . . . 63.33 107.735 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.56 145.76 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.52 -0.918 . . . . 73.04 108.52 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -131.92 125.45 31.7 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.682 -1.599 . . . . 71.01 106.682 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.85 126.36 32.88 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.901 -1.888 . . . . 73.2 105.901 164.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 mt -133.22 136.02 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.557 -1.646 . . . . 64.3 106.557 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 158.58 44.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.681 1.192 . . . . 75.32 108.709 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.82 101.38 9.23 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.814 1.246 . . . . 74.11 107.818 -171.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.23 111.03 1.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.958 1.703 . . . . 71.43 107.925 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -136.19 179.11 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.809 1.643 . . . . 44.14 111.378 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.89 -33.11 10.08 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.833 1.653 . . . . 75.04 114.002 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -60.75 -55.31 34.69 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.379 0.991 . . . . 73.32 111.247 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.68 174.55 19.32 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.131 -0.788 . . . . 64.4 111.131 -162.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -73.26 81.84 1.35 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.882 1.273 . . . . 75.24 109.639 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.08 -63.94 0.87 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.263 -1.299 . . . . 42.54 111.522 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.39 155.96 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.158 2.572 . . . . 71.22 109.131 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.58 103.19 1.21 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.96 -0.756 . . . . 73.23 108.96 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -71.82 146.81 47.77 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.459 -0.571 . . . . 73.41 109.459 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.86 83.67 1.8 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.234 1.013 . . . . 74.24 108.351 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.14 152.52 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.004 -1.48 . . . . 60.23 107.004 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.74 50.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.44 1.496 . . . . 75.32 108.284 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.403 ' CD1' ' HB ' ' A' ' 15' ' ' ILE . 16.2 t90 -136.61 111.58 8.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 75.04 110.113 -176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -86.29 -177.55 6.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.711 2.004 . . . . 72.33 110.687 -166.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 76.46 -2.67 2.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.025 2.53 . . . . 73.11 113.572 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.58 90.59 1.78 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.111 0.964 . . . . 75.42 110.063 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.3 p -140.77 94.08 2.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.907 1.283 . . . . 62.34 108.787 167.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.5 m -75.12 77.89 2.27 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.246 -0.909 . . . . 60.14 109.3 164.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -144.91 69.79 1.26 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.065 -0.717 . . . . 73.33 109.065 166.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t0 61.2 177.93 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.858 1.263 . . . . 71.34 111.401 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 t 65.24 122.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.38 1.872 . . . . 73.21 108.748 -155.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.9 p -147.89 162.51 39.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.227 -1.027 . . . . 55.44 108.227 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.84 165.14 52.23 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.001 -0.439 . . . . 64.42 112.001 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.312 -1.328 . . . . 74.31 110.813 161.78 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.692 0 N-CA-C 110.673 -0.971 . . . . 73.04 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 t -142.89 169.15 18.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.774 1.23 . . . . 70.21 108.63 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.26 73.22 1.02 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.249 2.22 . . . . 74.21 112.197 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.75 135.33 27.84 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 71.4 109.709 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.88 -112.48 3.19 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.622 1.106 . . . . 62.23 111.171 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.07 165.34 18.61 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 127.223 2.209 . . . . 73.34 108.408 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.68 7.39 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.073 1 C-N-CA 126.309 4.673 . . . . 72.43 115.463 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.37 -147.06 13.15 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.241 -1.537 . . . . 70.1 111.294 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.54 80.85 0.27 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.697 1.999 . . . . 74.3 112.881 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.88 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.165 . . . . 74.22 110.181 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.0 m -132.25 -177.45 4.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.189 1.396 . . . . 73.32 109.678 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.34 11.74 2.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.716 2.006 . . . . 72.01 114.688 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -56.95 131.98 20.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.665 1.586 . . . . 70.1 110.846 -166.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.73 163.74 22.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.352 1.061 . . . . 71.33 110.408 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.13 158.1 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.851 2.06 . . . . 72.22 106.459 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -144.44 133.91 23.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.236 2.214 . . . . 74.33 107.353 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -64.81 151.65 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.622 -0.881 . . . . 74.02 108.622 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.56 157.51 44.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 126.518 1.927 . . . . 52.44 106.001 176.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.24 -20.12 32.97 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.422 2.081 . . . . 70.31 111.639 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -114.93 13.47 17.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.0 2.92 . . . . 74.22 111.317 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.66 -163.54 30.02 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 118.878 0.763 . . . . 63.24 112.164 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.91 121.18 40.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 120.017 1.909 . . . . 71.33 106.562 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -58.62 124.47 19.77 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.385 -1.339 . . . . 72.33 107.385 165.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.8 mt -120.56 160.79 22.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.321 0.964 . . . . 74.23 109.08 172.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -155.47 165.2 37.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.85 0.75 . . . . 74.1 110.078 166.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.43 172.35 16.1 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 129.138 2.975 . . . . 72.42 108.236 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -129.3 161.74 56.77 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 124.454 1.102 . . . . 73.32 111.347 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.19 161.91 38.18 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.605 2.87 . . . . 74.2 113.392 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.39 143.11 51.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.35 2.033 . . . . 72.43 110.225 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -133.5 61.81 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.252 -1.758 . . . . 61.2 106.252 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.29 -68.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.678 -1.23 . . . . 73.44 107.678 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.6 p -130.22 170.92 13.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.605 1.562 . . . . 71.04 107.622 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -65.01 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.433 1.093 . . . . 71.42 110.414 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 144.48 2.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.665 -1.272 . . . . 71.4 112.18 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -100.47 83.17 2.57 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.776 -0.838 . . . . 74.32 108.747 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.85 143.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.635 -1.246 . . . . 73.31 107.635 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.87 -23.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.331 1.452 . . . . 74.23 111.367 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.66 -170.16 3.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.547 1.067 . . . . 65.03 109.95 171.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.23 175.28 9.25 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.051 1.34 . . . . 74.21 109.383 163.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -152.36 156.61 39.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.11 1.364 . . . . 64.23 109.434 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.4 t -148.0 121.61 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.949 -1.871 . . . . 52.52 105.949 -167.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -131.03 140.6 50.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.003 1.321 . . . . 74.4 109.273 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 125.98 46.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.424 -1.324 . . . . 74.13 107.424 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 116.82 15.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.581 1.552 . . . . 74.24 110.175 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.05 -176.61 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.819 2.048 . . . . 73.14 108.88 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -60.55 153.12 24.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.87 -0.519 . . . . 72.21 112.145 171.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.9 m 54.59 74.19 0.36 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.314 1.446 . . . . 74.31 112.617 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -143.03 148.7 37.17 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.773 1.629 . . . . 53.3 107.138 162.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.73 6.93 13.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.098 0.959 . . . . 72.3 113.203 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.82 160.51 35.41 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.553 1.141 . . . . 63.1 110.361 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m 177.78 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.893 2.077 . . . . 74.31 109.975 172.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.95 -120.95 0.54 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.24 -1.544 . . . . 73.43 109.24 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.81 162.02 50.98 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.976 1.388 . . . . 73.2 110.843 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -65.02 127.23 18.02 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.839 3.693 . . . . 71.24 110.313 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 mttp 59.95 19.72 8.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.377 . . . . 70.41 113.261 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -97.28 -86.62 0.33 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.732 1.151 . . . . 54.2 109.158 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.9 m -135.67 15.89 3.37 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.719 1.599 . . . . 73.31 112.639 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -127.83 59.84 41.71 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.201 -0.937 . . . . 74.13 109.52 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.2 87.15 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.842 1.695 . . . . 65.33 109.488 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.71 14.77 0.23 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.91 1.078 . . . . 72.13 113.91 162.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 57.9 179.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.717 2.007 . . . . 74.41 111.862 -155.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 165.77 20.56 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 125.388 1.475 . . . . 73.04 107.48 -169.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.1 112.63 13.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.52 -0.919 . . . . 73.42 108.52 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.19 150.08 40.56 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.595 1.158 . . . . 70.21 108.391 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.51 4.9 6.64 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.109 1.522 . . . . 73.03 115.109 -167.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 43.96 55.39 5.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.464 1.906 . . . . 64.24 113.172 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.76 -20.9 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.862 1.265 . . . . 74.43 112.671 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -58.76 120.17 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.022 0.828 . . . . 73.23 110.596 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -152.24 83.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.385 1.874 . . . . 72.13 105.969 161.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.91 159.85 28.26 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.252 -0.749 . . . . 73.01 111.474 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.11 -55.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 73.1 111.227 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.54 166.59 14.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.159 2.184 . . . . 70.23 110.509 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.46 169.05 23.23 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.807 1.671 . . . . 70.44 110.848 168.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 39.11 9.23 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.633 1.573 . . . . 72.43 112.145 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.2 m -85.5 175.71 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.337 1.065 . . . . 70.1 110.95 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 168.09 16.91 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.625 1.57 . . . . 74.31 109.333 165.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.1 p -130.64 144.2 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.236 1.414 . . . . 62.31 107.628 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -66.42 147.79 52.8 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.165 0.586 . . . . 52.24 112.285 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -48.47 81.09 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.962 1.705 . . . . 65.32 110.06 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.0 p -44.91 -48.58 11.25 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.573 1.949 . . . . 70.1 111.573 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.4 m -67.62 -42.16 82.81 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.343 -0.844 . . . . 73.01 111.214 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.49 -31.46 72.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.168 0.987 . . . . 73.31 111.407 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -64.39 -0.73 1.39 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.597 1.559 . . . . 72.12 114.283 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -120.62 -6.23 9.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.274 1.397 . . . . 70.42 111.679 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.47 137.75 57.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.788 1.235 . . . . 71.34 111.59 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 161.1 30.39 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.647 -0.872 . . . . 74.22 108.647 168.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.56 143.52 35.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.238 1.015 . . . . 74.04 108.447 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.98 82.45 0.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.768 1.627 . . . . 73.21 111.365 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.68 -18.35 61.56 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.637 -1.29 . . . . 73.43 111.21 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -17.81 64.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.224 1.41 . . . . 72.04 113.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.68 -75.02 0.17 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.433 1.015 . . . . 73.5 110.56 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.25 144.3 27.84 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 117.81 -1.091 . . . . 65.42 108.395 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 100.35 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.907 1.738 . . . . 74.21 109.8 -170.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 157.71 44.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.349 1.86 . . . . 74.33 109.085 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.1 mt -88.38 132.07 34.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.5 1.12 . . . . 73.0 109.168 169.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.6 136.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.777 1.275 . . . . 73.13 110.388 165.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -119.28 116.71 26.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 112.715 -2.039 . . . . 71.2 107.568 165.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -81.21 128.79 34.17 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 106.368 -1.716 . . . . 74.22 106.368 162.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.4 mt -133.62 151.7 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.684 -1.969 . . . . 73.32 105.684 173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.49 151.91 25.0 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.522 0.729 . . . . 62.31 109.721 165.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.44 117.26 13.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.602 1.161 . . . . 74.11 109.97 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.95 99.8 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.643 -1.614 . . . . 74.4 106.643 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.99 172.98 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.688 1.595 . . . . 73.42 109.595 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -25.99 63.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.474 1.287 . . . . 73.04 114.474 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.55 25.45 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.541 -0.911 . . . . 74.04 108.541 174.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.36 167.04 12.89 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.913 -0.875 . . . . 72.43 110.913 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -61.6 117.94 6.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 74.23 106.477 160.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.21 -95.88 2.4 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.455 -1.858 . . . . 74.33 108.455 173.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.91 147.75 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.271 1.981 . . . . 70.4 110.673 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.05 110.48 10.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.601 1.56 . . . . 72.1 108.635 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 m -65.03 123.79 20.39 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.358 -0.978 . . . . 74.14 108.358 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -97.45 89.44 4.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.985 -1.487 . . . . 65.34 106.985 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.87 171.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 120.633 -0.427 . . . . 72.43 110.168 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.39 123.86 19.52 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.504 1.121 . . . . 71.32 108.161 172.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -82.48 87.91 6.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.847 1.259 . . . . 74.31 109.106 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.2 mt -73.93 0.87 12.1 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.319 1.229 . . . . 72.44 114.319 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -115.12 38.4 3.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.423 1.01 . . . . 71.54 108.765 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 107.31 0.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.612 -1.625 . . . . 74.1 106.612 164.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.5 p -131.68 145.63 51.75 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.715 -0.846 . . . . 73.23 108.715 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 t 56.38 -177.43 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.477 1.111 . . . . 74.5 111.763 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -148.87 8.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 120.974 -1.078 . . . . 74.02 111.171 153.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -63.88 156.17 28.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.867 1.267 . . . . 71.04 108.788 172.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 t -144.23 -36.91 0.32 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.516 1.526 . . . . 74.23 111.391 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m 56.0 -7.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.334 1.605 . . . . 72.21 115.334 -165.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.28 163.12 51.72 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 120.827 1.649 . . . . 72.11 110.803 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.245 0.847 0 CA-C-O 116.357 -1.782 . . . . 74.41 108.029 151.34 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 111.305 -0.718 . . . . 62.14 111.305 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.74 49.27 19.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.036 1.734 . . . . 55.41 112.712 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mp -68.38 145.8 97.52 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.97 -1.493 . . . . 74.33 106.97 161.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.53 165.74 30.99 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.167 2.578 . . . . 72.31 113.705 -163.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.97 153.94 3.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.973 1.749 . . . . 72.22 111.434 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -108.35 86.95 3.71 Favored Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 126.968 2.107 . . . . 74.34 106.998 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.66 67.34 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 126.079 4.519 . . . . 75.31 111.865 -168.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 166.35 35.86 Favored Glycine 0 C--N 1.332 0.36 0 O-C-N 121.097 -1.002 . . . . 74.22 111.96 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.29 161.45 7.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.977 2.511 . . . . 75.13 106.873 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.79 159.49 52.48 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.702 2.268 . . . . 62.25 112.139 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -127.27 -178.5 4.47 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 121.45 -0.781 . . . . 54.31 110.664 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.11 23.16 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.916 2.487 . . . . 64.44 114.652 171.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.79 126.83 21.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 118.721 0.691 . . . . 75.54 110.734 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -120.3 143.88 48.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.01 1.324 . . . . 75.34 107.81 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -144.26 126.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.49 -2.041 . . . . 75.41 105.49 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.7 m -143.61 149.77 37.81 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.023 1.329 . . . . 61.22 110.291 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -84.52 153.71 23.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 75.21 110.602 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 166.07 15.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 128.745 2.818 . . . . 61.13 107.119 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.59 -27.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.404 2.069 . . . . 63.12 113.693 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.66 -11.52 51.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.373 1.069 . . . . 75.12 112.164 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.67 -163.31 29.02 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.952 -1.259 . . . . 73.41 109.952 -161.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.62 30.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.061 0.945 . . . . 73.13 111.092 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -78.84 134.6 36.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.846 -1.168 . . . . 75.33 107.846 157.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.72 137.49 45.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.159 1.384 . . . . 75.32 107.761 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -142.92 167.25 22.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.445 1.02 . . . . 73.12 109.856 167.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -160.51 178.4 9.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.822 2.049 . . . . 72.21 109.825 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.6 158.25 66.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.925 -1.036 . . . . 74.03 111.998 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 170.82 18.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.04 3.16 . . . . 75.33 113.85 -168.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.68 166.49 17.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.754 2.303 . . . . 75.2 111.82 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 t -140.46 21.49 2.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.469 1.508 . . . . 74.4 110.128 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.72 -55.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.638 1.175 . . . . 75.2 108.461 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 p -124.46 103.46 8.19 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.511 1.124 . . . . 75.23 109.368 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -64.22 -73.41 0.12 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.995 0.918 . . . . 75.41 110.899 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 1.84 75.57 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 117.587 -1.674 . . . . 43.54 115.14 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt 65.26 83.58 0.17 Allowed 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 132.479 4.311 . . . . 74.01 111.113 -172.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.62 136.5 22.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 107.205 -1.406 . . . . 72.33 107.205 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.7 -17.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.071 1.748 . . . . 72.41 111.142 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 3.2 tp10 -164.58 -164.91 0.87 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.048 1.339 . . . . 75.23 109.237 172.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.427 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 1.1 m-85 -142.25 172.84 12.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.975 1.71 . . . . 73.31 110.527 171.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 p -138.41 167.49 21.77 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.526 1.131 . . . . 75.23 110.744 168.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 t -146.62 124.74 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 103.537 -2.764 . . . . 73.44 103.537 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.03 136.12 50.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.501 -1.296 . . . . 75.04 107.501 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -123.74 120.84 33.85 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.278 1.831 . . . . 74.13 107.278 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.55 145.94 55.46 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.886 -0.783 . . . . 72.11 108.886 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.97 -178.33 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.647 1.979 . . . . 74.31 107.845 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -58.96 136.09 57.8 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.427 -0.796 . . . . 71.12 109.709 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m 70.58 166.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.921 2.089 . . . . 74.21 113.484 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 p -134.06 116.22 15.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.426 1.49 . . . . 72.51 108.853 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.1 70.21 0.92 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.998 1.319 . . . . 70.23 108.84 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.41 156.48 32.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.686 1.194 . . . . 74.34 110.211 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.61 124.1 11.71 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.791 -2.3 . . . . 54.34 104.791 165.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.45 121.48 0.67 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 107.291 -2.324 . . . . 64.42 107.291 -174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -143.53 164.5 30.33 Favored Pre-proline 0 C--O 1.241 0.638 0 C-N-CA 125.14 1.376 . . . . 74.24 111.102 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.1 164.76 0.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.613 2.876 . . . . 61.24 112.965 165.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -83.91 25.97 0.76 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.239 1.016 . . . . 71.4 110.928 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.1 m -93.29 -31.36 14.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.702 -1.142 . . . . 73.04 112.558 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.67 85.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.235 1.414 . . . . 74.33 109.245 -170.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -130.72 144.39 53.23 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.47 0.708 . . . . 74.04 109.376 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 84.92 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.678 2.919 . . . . 63.42 111.182 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.15 83.98 1.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.106 1.763 . . . . 71.33 108.124 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.24 102.17 14.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.216 -1.402 . . . . 74.14 107.216 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.67 155.57 38.98 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.317 -1.734 . . . . 71.44 106.317 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.3 109.06 5.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.341 -1.355 . . . . 73.13 107.341 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -133.49 154.43 50.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.186 1.395 . . . . 74.11 107.286 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.6 ttp -72.44 117.31 13.95 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.282 -1.377 . . . . 74.21 107.282 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -70.26 80.2 0.53 Allowed 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 107.407 -1.331 . . . . 70.14 107.407 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.6 -18.83 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.816 0.847 . . . . 73.35 111.717 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.47 105.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.471 1.108 . . . . 75.34 110.65 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.3 m -140.24 99.21 3.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.776 -1.935 . . . . 75.25 105.776 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.12 28.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.404 -1.078 . . . . 63.34 110.404 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 -15.3 17.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.388 2.725 . . . . 75.35 113.09 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 m -136.46 165.98 31.26 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.702 1.601 . . . . 75.45 110.439 -169.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.48 175.35 0.56 Allowed 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.603 2.869 . . . . 75.42 112.932 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m 56.3 43.21 26.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.995 1.718 . . . . 74.32 112.303 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 99.5 m -65.89 123.3 19.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 74.33 109.522 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 171.73 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.99 0.916 . . . . 75.15 111.465 167.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.7 141.17 39.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.467 -1.309 . . . . 75.25 107.467 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -78.02 162.66 26.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.482 1.113 . . . . 75.42 112.483 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -31.71 71.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.738 1.615 . . . . 71.53 113.489 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.403 ' CB ' ' H ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -64.99 -45.16 86.79 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 120.902 -1.123 . . . . 71.31 112.307 177.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -63.69 -38.19 90.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.859 -0.591 . . . . 64.53 109.536 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.383 0.673 . . . . 60.53 112.086 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -67.42 -44.97 77.46 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.104 1.32 . . . . 55.02 109.666 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -73.87 -18.76 60.88 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 118.601 -0.714 . . . . 62.25 112.863 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.83 133.98 31.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.7 1.6 . . . . 60.35 112.165 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -70.81 127.14 31.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.156 -1.424 . . . . 74.34 107.156 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.61 125.33 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.546 -2.02 . . . . 75.44 105.546 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.63 127.17 30.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.84 -0.8 . . . . 75.15 108.84 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.83 9.84 16.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.918 0.487 . . . . 75.53 110.842 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -89.79 -24.04 21.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 74.21 111.114 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -142.6 -74.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.328 1.051 . . . . 74.35 109.828 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.29 60.81 Favored Pre-proline 0 CA--C 1.513 -0.45 0 C-N-CA 126.541 1.937 . . . . 75.41 109.134 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.23 84.01 1.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 123.166 2.577 . . . . 74.41 106.581 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.86 162.3 35.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.254 2.621 . . . . 63.11 110.678 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.4 mt -81.03 148.42 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 108.471 -0.937 . . . . 75.53 108.471 168.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.07 139.61 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 124.785 1.234 . . . . 71.21 108.919 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.02 138.28 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.671 -1.233 . . . . 75.55 107.671 168.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -94.83 134.47 37.42 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.22 -1.4 . . . . 75.15 107.22 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.3 134.95 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.458 -2.053 . . . . 75.34 105.458 163.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.46 153.45 46.27 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.961 0.904 . . . . 72.35 109.098 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.04 135.22 44.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.348 0.659 . . . . 74.12 109.687 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.89 79.92 9.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 104.607 -2.368 . . . . 73.33 104.607 167.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.04 161.88 13.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.114 0.966 . . . . 73.41 109.387 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.31 -22.46 66.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.814 1.245 . . . . 75.13 112.133 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -65.38 -14.42 60.82 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.338 1.236 . . . . 72.12 114.338 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.75 177.34 28.27 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.696 1.617 . . . . 54.43 110.81 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.93 30.58 1.05 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.56 1.544 . . . . 64.11 114.421 -165.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.97 -77.05 0.16 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.497 1.046 . . . . 71.12 114.27 -159.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -89.17 156.1 5.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.578 2.185 . . . . 75.31 110.629 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.87 156.72 46.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.2 1.0 . . . . 71.04 109.188 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.4 m -82.11 123.64 29.14 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.738 -1.949 . . . . 73.14 105.738 157.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -83.98 119.34 24.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.359 -2.089 . . . . 72.32 105.359 154.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.51 173.98 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 123.674 0.79 . . . . 74.14 109.413 165.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.4 156.41 45.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.85 1.66 . . . . 74.55 109.3 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -139.44 109.64 6.48 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 125.77 1.628 . . . . 75.21 111.366 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -96.54 160.57 14.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.328 2.251 . . . . 74.22 107.872 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 63.06 14.78 7.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.97 1.308 . . . . 73.15 111.493 -168.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -62.2 -25.05 67.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.893 2.077 . . . . 73.55 112.391 162.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.7 119.78 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.499 1.92 . . . . 75.53 109.963 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.3 t -159.76 178.84 9.39 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.669 1.987 . . . . 75.21 106.742 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.02 173.89 11.22 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.091 1.356 . . . . 72.24 110.379 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 58.09 78.69 0.23 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.469 1.908 . . . . 54.31 109.667 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.75 106.78 19.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.726 -1.125 . . . . 75.42 111.59 -161.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t -62.01 173.09 1.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.278 0.631 . . . . 74.52 110.016 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.35 -156.39 21.8 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 121.387 -0.82 . . . . 75.54 111.893 171.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.403 ' H ' ' CB ' ' A' ' 80' ' ' SER . 54.9 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.092 2.557 . . . . 63.12 109.705 -168.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 108.247 -1.941 . . . . 75.41 108.247 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.32 144.48 32.12 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.25 -2.129 . . . . 72.24 105.25 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.24 63.75 44.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.969 -1.122 . . . . 75.51 107.969 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -81.13 5.45 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.93 3.086 . . . . 55.44 112.94 -170.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.66 167.45 17.2 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 127.208 2.337 . . . . 75.21 107.863 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.99 89.8 0.15 Allowed Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 127.036 2.134 . . . . 64.21 112.541 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -60.3 165.33 11.11 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 CA-C-N 121.333 1.512 . . . . 71.11 111.411 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.45 -126.59 7.0 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.698 1.618 . . . . 75.11 109.657 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.81 151.81 0.11 Allowed Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 129.215 3.006 . . . . 64.53 114.376 -171.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.66 155.28 69.38 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 123.652 2.902 . . . . 71.14 111.036 -177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -134.69 -179.47 5.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.699 1.6 . . . . 70.54 110.208 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.4 36.9 17.7 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.087 1.355 . . . . 73.51 112.07 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.63 134.17 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.286 -1.005 . . . . 53.03 108.286 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -131.05 155.53 46.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.452 1.101 . . . . 74.4 109.553 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.06 139.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.499 -2.038 . . . . 73.44 105.499 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -139.74 147.6 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.723 1.609 . . . . 73.33 109.559 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -79.24 143.31 35.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.37 -1.345 . . . . 73.41 107.37 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p -139.03 166.75 22.59 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.701 2.0 . . . . 72.02 108.022 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -56.53 -25.1 56.88 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.619 2.213 . . . . 74.2 113.355 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -87.58 -20.76 25.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.574 1.079 . . . . 73.23 111.558 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.11 -163.78 24.25 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.477 -1.049 . . . . 50.34 110.477 -159.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.65 135.54 36.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.884 0.874 . . . . 74.5 112.093 -166.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -84.58 86.58 7.29 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.941 2.096 . . . . 71.52 110.047 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.85 131.78 35.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.611 0.764 . . . . 74.33 110.247 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -145.85 152.75 39.99 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.269 . . . . 63.42 109.294 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -151.25 179.41 8.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.581 1.553 . . . . 74.44 110.885 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -65.35 160.8 55.83 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.618 0.599 . . . . 73.1 112.618 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.61 156.21 66.31 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.211 1.941 . . . . 63.4 109.13 156.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.95 95.58 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.024 2.483 . . . . 73.1 110.53 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -140.24 22.28 2.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.63 0.604 . . . . 71.14 112.63 -165.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.9 t -99.2 -50.96 10.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 O-C-N 121.742 -0.599 . . . . 74.1 110.158 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.5 p -131.24 164.31 25.86 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.44 1.096 . . . . 74.24 110.118 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -77.64 40.4 0.3 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.237 1.415 . . . . 71.4 111.996 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.12 132.63 15.37 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.516 -2.234 . . . . 74.11 107.516 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -76.86 79.85 3.44 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.681 -1.229 . . . . 74.51 107.681 171.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.65 146.18 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.485 -1.302 . . . . 64.51 107.485 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 pt -141.72 -17.49 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.119 2.168 . . . . 74.21 111.088 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -160.47 -168.79 2.24 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.59 1.086 . . . . 73.3 111.325 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -133.14 162.73 30.98 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.511 1.524 . . . . 75.43 109.805 164.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -142.33 160.17 40.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.784 1.634 . . . . 75.25 108.923 159.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.7 117.39 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.477 -1.675 . . . . 73.34 106.477 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -93.22 144.17 25.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.906 -1.146 . . . . 74.32 107.906 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.2 tp -129.75 132.08 46.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.768 2.027 . . . . 74.55 107.342 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.69 134.12 44.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.147 1.34 . . . . 61.14 109.127 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.34 172.5 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.833 1.253 . . . . 72.53 108.741 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.76 77.14 2.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.27 0.486 . . . . 75.34 110.522 166.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -163.83 -163.82 0.83 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.707 1.203 . . . . 74.11 108.992 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -147.69 134.52 20.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.233 2.213 . . . . 75.24 107.34 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -160.36 152.84 20.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.239 1.382 . . . . 72.21 112.697 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.53 106.0 0.14 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.553 2.341 . . . . 71.51 111.336 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -156.8 134.13 10.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.127 2.171 . . . . 72.35 105.414 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.93 106.26 0.22 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.711 1.148 . . . . 72.21 112.289 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -66.27 160.93 61.72 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.161 -0.611 . . . . 74.54 110.89 168.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.44 74.08 4.34 Favored 'Trans proline' 0 CA--C 1.536 0.578 1 C-N-CA 126.672 4.914 . . . . 75.23 110.138 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 60.72 1.25 0.41 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.155 2.182 . . . . 63.12 114.433 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -61.03 -71.66 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.737 1.153 . . . . 62.53 109.191 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 m -148.63 87.99 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.314 0.961 . . . . 75.44 110.471 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -138.41 57.2 11.61 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.936 1.294 . . . . 75.34 110.548 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -60.99 121.28 9.44 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.008 2.472 . . . . 73.45 110.244 174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.75 48.67 8.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 127.475 2.31 . . . . 62.43 112.915 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 54.71 81.23 0.11 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.578 1.551 . . . . 64.32 110.941 165.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.06 145.83 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.548 1.539 . . . . 75.34 113.197 178.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.38 94.95 4.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.746 -1.946 . . . . 54.43 105.746 167.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.43 145.94 48.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.564 -1.643 . . . . 75.24 106.564 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.5 ttp -96.42 138.15 34.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.405 1.082 . . . . 73.44 109.731 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -79.49 65.51 4.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.774 1.23 . . . . 74.22 110.682 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.59 -32.87 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.882 1.273 . . . . 73.32 112.332 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -80.38 97.08 6.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.095 0.558 . . . . 74.51 112.238 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.31 117.77 25.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.183 -1.414 . . . . 64.32 107.183 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.53 160.98 12.05 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.651 -1.38 . . . . 73.54 109.651 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.29 -55.03 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.955 2.437 . . . . 72.34 112.011 -169.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -84.32 164.85 41.48 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 121.188 -0.945 . . . . 72.12 111.257 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.97 179.22 3.41 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.814 3.009 . . . . 72.14 111.297 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 m 58.47 28.13 16.51 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.627 1.343 . . . . 74.32 114.627 165.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.91 158.36 34.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.334 1.053 . . . . 71.32 111.936 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 169.41 18.28 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.116 0.966 . . . . 73.13 111.821 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.14 111.86 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 125.194 1.398 . . . . 75.43 109.041 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.5 144.53 16.85 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.27 1.428 . . . . 74.11 113.459 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.83 -26.71 68.88 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.281 1.432 . . . . 74.21 113.187 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.7 t -54.34 -54.49 39.66 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.38 -0.825 . . . . 71.02 109.847 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.19 -37.55 87.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.796 0.438 . . . . 75.03 111.075 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.16 -27.81 67.41 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.247 0.476 . . . . 75.34 111.278 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -74.0 -34.78 64.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.479 0.581 . . . . 63.22 111.506 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -76.7 -11.29 59.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.622 0.601 . . . . 55.35 112.622 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 134.74 48.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.837 0.827 . . . . 71.52 109.456 -174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -72.79 112.34 8.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.942 -1.026 . . . . 73.25 109.054 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.4 125.17 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 64.42 106.844 162.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.02 135.06 50.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.999 0.812 . . . . 53.12 109.94 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -130.84 56.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.823 1.249 . . . . 64.43 108.143 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 p -123.41 -21.47 5.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.328 -0.851 . . . . 75.35 112.964 163.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -131.86 -69.88 0.59 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.642 0.777 . . . . 74.23 112.245 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -144.27 158.42 54.78 Favored Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 120.421 -1.424 . . . . 74.24 109.073 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.77 96.99 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.685 2.257 . . . . 75.44 108.46 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.31 37.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.738 1.615 . . . . 73.11 107.753 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.52 120.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.381 -1.711 . . . . 71.22 106.381 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.93 152.7 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.239 -1.022 . . . . 75.21 108.239 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -131.74 152.73 50.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.989 0.915 . . . . 73.51 108.74 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -127.36 87.56 2.65 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 70.7 mt -90.64 133.37 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.27 -2.122 . . . . 63.12 105.27 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.64 131.63 19.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.283 0.563 . . . . 74.51 111.868 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.17 122.45 22.79 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.459 -0.941 . . . . 72.31 108.459 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -77.8 109.8 12.12 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 106.931 -1.507 . . . . 75.22 106.931 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.63 -178.63 5.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.175 0.99 . . . . 74.23 109.55 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.94 1.93 56.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.401 -0.818 . . . . 73.53 112.724 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -66.68 -68.39 0.38 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.384 -1.339 . . . . 73.54 107.384 154.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.34 37.59 0.27 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 119.34 -1.41 . . . . 75.22 115.725 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 59.59 -163.65 0.23 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.609 1.963 . . . . 75.23 109.792 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 161.97 -90.64 0.11 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 105.336 -3.106 . . . . 74.32 105.336 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -62.37 150.79 85.96 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.499 2.133 . . . . 72.52 110.296 172.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.95 112.25 5.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.499 -2.038 . . . . 60.22 105.499 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.8 m -58.83 124.54 20.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.84 0.856 . . . . 64.25 108.992 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -79.42 79.28 5.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.607 1.194 . . . . 75.53 108.379 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.78 146.77 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.243 -1.762 . . . . 75.11 106.243 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.66 128.44 39.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.094 -1.076 . . . . 75.51 108.094 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -92.64 104.82 17.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.211 0.604 . . . . 75.14 110.337 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.15 175.36 10.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.377 1.471 . . . . 72.33 109.427 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.22 14.69 3.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.117 2.167 . . . . 74.12 112.543 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.67 79.45 0.29 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 64.41 110.832 164.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -144.89 103.19 3.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 106.882 -1.525 . . . . 75.12 106.882 158.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.4 m -160.42 157.09 27.13 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.819 1.647 . . . . 75.33 107.83 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -142.81 39.09 1.49 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.582 -0.896 . . . . 75.11 108.582 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.16 -17.92 41.24 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.393 -0.817 . . . . 64.44 112.828 -163.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 71.3 m -58.35 150.98 20.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.92 1.288 . . . . 74.33 112.221 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.2 t -152.44 76.61 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 105.943 -1.873 . . . . 74.41 105.943 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.19 39.73 0.11 Allowed Glycine 0 CA--C 1.522 0.471 0 O-C-N 121.316 -0.865 . . . . 73.13 111.039 -167.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.832 1.653 . . . . 71.03 106.734 176.058 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 110.826 -0.91 . . . . 71.15 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.3 m -71.71 -41.97 67.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.273 1.036 . . . . 74.05 111.989 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.3 mt 43.79 55.72 12.33 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.21 1.804 . . . . 73.02 113.105 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.61 -54.03 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.746 1.631 . . . . 64.05 111.886 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.69 145.7 14.6 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 111.6 -0.6 . . . . 74.14 111.6 -173.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.21 158.69 44.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.321 1.048 . . . . 71.02 109.987 166.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 163.16 36.82 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.014 2.476 . . . . 70.34 110.547 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.31 -117.97 5.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.305 -1.118 . . . . 44.32 110.305 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 160.57 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 128.464 2.706 . . . . 64.13 112.361 -168.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.1 152.36 56.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.696 2.264 . . . . 72.35 109.217 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.17 177.0 8.53 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.861 1.664 . . . . 73.54 108.535 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.71 42.09 5.56 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.44 2.296 . . . . 70.44 111.633 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.95 120.73 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.168 0.987 . . . . 73.44 109.021 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -112.55 133.98 54.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.365 -0.976 . . . . 74.1 108.365 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.7 mt -144.4 124.84 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.728 1.211 . . . . 73.33 108.076 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.0 m -145.41 161.79 38.85 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.611 1.164 . . . . 64.33 112.281 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -83.89 146.01 28.3 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.325 1.05 . . . . 75.43 109.206 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 m -152.08 165.3 17.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.917 1.687 . . . . 73.34 108.204 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.86 -11.18 25.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.209 1.94 . . . . 75.34 113.544 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.72 7.5 8.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.011 0.924 . . . . 75.33 111.523 -164.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 174.0 13.6 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.82 2.153 . . . . 75.1 107.93 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.4 129.46 36.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.566 -1.272 . . . . 74.22 107.566 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -65.89 109.39 2.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.634 -1.247 . . . . 72.4 107.634 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.06 126.82 44.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.317 1.047 . . . . 62.5 108.693 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -139.43 154.18 47.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.331 0.652 . . . . 75.11 109.63 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -142.94 -178.91 6.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.132 1.373 . . . . 75.31 107.675 175.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.19 160.37 52.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.199 0.909 . . . . 74.32 111.22 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.57 156.05 64.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.734 3.623 . . . . 74.44 113.101 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.57 -176.67 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.113 3.209 . . . . 75.35 111.488 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 14.03 3.57 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.647 1.721 . . . . 65.04 115.647 -163.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.8 -54.55 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.774 -0.579 . . . . 72.45 111.468 -160.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -132.9 172.65 12.31 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.967 1.307 . . . . 73.14 107.908 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 m -51.74 -41.86 61.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.606 1.094 . . . . 72.34 112.394 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.71 163.87 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.087 0.851 . . . . 73.33 111.198 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -131.31 74.26 1.58 Allowed 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.512 -0.993 . . . . 74.12 108.641 164.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.22 152.44 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 75.22 106.439 167.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.24 -28.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.121 1.368 . . . . 72.25 110.403 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.39 -169.94 3.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.353 -1.351 . . . . 73.44 107.353 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -128.11 166.27 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.629 -1.248 . . . . 71.32 107.629 159.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -130.72 153.42 49.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.284 -1.376 . . . . 62.33 107.284 164.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 p -153.02 124.64 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 O-C-N 121.942 -0.474 . . . . 75.3 110.475 -171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -99.15 133.98 42.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.943 -1.132 . . . . 75.02 107.943 -171.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -117.63 130.23 56.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.639 2.375 . . . . 72.21 107.564 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.0 136.25 57.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 121.417 1.917 . . . . 71.34 112.992 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 pt -145.11 175.5 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.194 1.398 . . . . 60.21 110.289 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -63.75 67.01 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.317 1.847 . . . . 74.41 112.754 164.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -151.8 -33.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.59 1.556 . . . . 52.21 111.782 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 m 62.05 13.08 5.41 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.807 1.41 . . . . 74.53 114.807 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.48 132.6 2.88 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.69 1.996 . . . . 65.31 108.152 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.92 -175.42 4.94 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.547 1.539 . . . . 63.24 111.017 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.2 m -145.24 131.82 19.85 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.406 2.683 . . . . 75.33 105.699 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.75 -85.19 0.05 OUTLIER Glycine 0 C--O 1.235 0.205 0 C-N-CA 124.733 1.158 . . . . 62.01 110.883 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -63.14 153.19 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.107 0.963 . . . . 72.43 110.482 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -69.14 148.73 69.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.623 2.215 . . . . 73.34 109.892 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -102.2 5.34 40.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.069 0.948 . . . . 70.34 113.047 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.7 m -48.51 -35.01 12.27 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.305 0.957 . . . . 61.23 113.464 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.7 t -136.31 -62.71 0.66 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.104 0.962 . . . . 74.13 110.034 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 t -65.2 144.33 99.0 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.841 -1.17 . . . . 74.44 107.841 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.88 76.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.911 3.074 . . . . 71.14 110.149 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.49 38.85 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.679 2.391 . . . . 63.44 111.999 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -132.64 72.54 1.49 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.541 1.937 . . . . 72.22 107.136 -166.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mt -126.12 -170.95 2.28 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.724 -1.213 . . . . 74.52 107.724 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.19 -154.24 0.06 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.724 -0.671 . . . . 74.25 111.92 162.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 76.69 160.54 0.22 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 131.23 3.812 . . . . 61.33 113.77 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -126.95 147.65 50.09 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.655 1.182 . . . . 74.3 110.068 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.62 93.72 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.203 2.201 . . . . 75.41 112.529 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -94.86 -26.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 116.456 -1.735 . . . . 75.1 110.162 -165.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.0 132.68 54.17 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 120.332 1.424 . . . . 72.13 109.409 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.0 p -155.01 27.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.548 1.139 . . . . 73.31 112.227 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.27 152.67 18.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.978 -0.901 . . . . 74.41 111.195 -168.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.33 -55.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.046 1.831 . . . . 72.14 109.053 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.87 144.95 97.99 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.29 -0.633 . . . . 72.43 109.29 169.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.56 -3.54 13.26 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.613 2.875 . . . . 62.22 112.604 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 p -98.58 44.99 1.02 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.461 1.482 . . . . 73.53 110.419 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.6 t -51.3 111.82 0.64 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.953 1.301 . . . . 71.31 110.706 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.3 130.24 37.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.288 -0.634 . . . . 64.52 109.288 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -76.35 95.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.846 -1.539 . . . . 75.4 106.846 162.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -75.75 163.71 26.99 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.294 -0.866 . . . . 74.43 109.694 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -53.09 -38.35 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.072 1.349 . . . . 73.42 112.115 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -40.09 63.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.784 2.034 . . . . 63.21 111.592 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.3 m -79.21 -36.09 40.65 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.105 -0.372 . . . . 75.23 111.873 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -25.53 68.23 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.85 0.46 . . . . 72.23 111.25 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.1 m -60.84 -10.86 6.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.345 1.239 . . . . 72.54 114.345 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -115.51 -6.66 12.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.644 1.111 . . . . 74.14 111.139 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.1 151.28 45.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.212 1.005 . . . . 73.52 109.997 -171.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -137.24 153.09 50.45 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.721 0.808 . . . . 74.2 112.117 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.419 ' CG2' ' HA ' ' A' ' 93' ' ' PRO . 1.9 mp -88.28 144.54 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.554 1.542 . . . . 73.41 109.593 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 90' ' ' THR . 7.5 t70 -79.16 71.42 5.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.417 1.887 . . . . 72.13 109.656 -172.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -62.33 4.45 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.258 1.023 . . . . 74.24 111.876 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.437 ' H ' ' C ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER -84.57 -20.51 31.38 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.367 0.985 . . . . 74.13 110.258 169.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.8 p -141.66 -85.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.765 1.226 . . . . 73.34 111.286 161.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HE3' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -117.17 153.93 49.91 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 126.421 1.889 . . . . 74.21 112.093 -162.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HA ' ' CG2' ' A' ' 87' ' ' ILE . 83.2 Cg_endo -77.64 78.76 3.41 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.511 1.474 . . . . 74.24 112.765 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.69 157.24 44.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.54 2.736 . . . . 72.33 107.912 175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.3 mt -73.32 -21.3 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.572 0.582 . . . . 73.2 112.572 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.4 mm 60.68 142.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 130.187 3.395 . . . . 72.4 110.04 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -135.98 135.75 39.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.235 -1.394 . . . . 71.44 107.235 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -133.95 90.7 2.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.084 0.865 . . . . 74.53 109.627 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.1 mt -87.41 153.47 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.249 -1.389 . . . . 74.32 107.249 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.76 154.74 37.9 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.967 0.803 . . . . 72.31 111.769 159.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.47 116.22 13.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.217 1.807 . . . . 63.04 108.57 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -79.34 89.26 4.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.074 -2.195 . . . . 75.04 105.074 170.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -115.74 178.92 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.298 1.439 . . . . 64.25 109.972 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.94 -3.12 20.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.629 0.974 . . . . 75.35 113.629 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -91.19 -27.96 18.16 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 120.256 -1.527 . . . . 72.44 109.675 173.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.16 -179.25 20.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.631 1.11 . . . . 52.25 110.98 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -70.7 69.52 0.44 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.068 1.747 . . . . 75.22 109.271 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 -81.99 1.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.114 -1.594 . . . . 70.44 109.114 -169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.61 160.33 25.16 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.091 1.861 . . . . 64.45 109.05 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.71 36.92 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.973 0.909 . . . . 71.11 109.321 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -95.76 154.0 17.45 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.504 -1.295 . . . . 73.13 107.504 156.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -129.72 101.58 5.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.791 -2.3 . . . . 73.23 104.791 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.98 164.31 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.542 -1.281 . . . . 72.31 107.542 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 121.1 24.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.452 1.101 . . . . 74.54 108.095 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -91.74 79.7 5.36 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.316 -1.735 . . . . 74.3 106.316 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.424 HD23 ' HE3' ' A' ' 92' ' ' LYS . 44.5 mt -76.4 170.73 15.82 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.608 -0.886 . . . . 72.43 108.608 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 75.58 -6.14 2.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.895 2.478 . . . . 65.12 113.003 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.91 165.75 3.05 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.428 1.491 . . . . 74.4 113.391 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 144.22 50.52 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.13 1.772 . . . . 74.53 109.857 -171.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 155.12 40.62 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.484 -0.932 . . . . 64.41 108.484 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -149.56 175.68 11.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.283 -1.377 . . . . 73.32 107.283 152.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -147.88 163.56 36.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.474 0.71 . . . . 71.43 110.226 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.3 t -164.9 179.93 6.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.056 1.742 . . . . 73.31 109.255 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -141.41 168.43 19.8 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.549 1.54 . . . . 63.22 108.873 161.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.13 -64.1 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 123.496 0.569 . . . . 75.34 112.923 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.248 1.005 0 N-CA-C 105.05 -2.204 . . . . 75.33 105.05 176.722 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.509 0 N-CA-C 111.006 -0.838 . . . . 72.41 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.4 p -144.08 17.34 1.75 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.704 1.602 . . . . 72.22 111.733 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 mp 63.84 161.43 0.12 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.848 2.059 . . . . 75.0 110.62 -161.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.15 -178.74 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.976 1.784 . . . . 72.43 111.557 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.98 -161.05 0.85 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.555 1.074 . . . . 60.31 111.203 164.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -102.76 87.2 1.13 Allowed Pre-proline 0 N--CA 1.462 0.16 0 C-N-CA 125.265 1.426 . . . . 72.41 108.276 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.4 145.81 83.95 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.084 1.856 . . . . 71.24 109.061 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.9 -133.66 5.07 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.631 -1.387 . . . . 64.34 109.631 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.02 165.06 0.14 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 128.624 2.77 . . . . 75.2 111.249 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.51 156.33 64.17 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.458 2.105 . . . . 72.12 110.201 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.06 -178.97 5.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.837 0.827 . . . . 74.32 112.05 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.28 1.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.838 2.855 . . . . 60.33 115.744 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -44.47 129.67 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.87 2.468 . . . . 74.4 112.626 -154.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -115.01 131.03 57.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.439 1.095 . . . . 75.23 108.913 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.57 93.45 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.964 -1.495 . . . . 72.22 106.964 -175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -96.12 140.35 30.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.581 -1.19 . . . . 62.11 108.991 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -60.68 154.03 22.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.99 -0.744 . . . . 75.13 108.99 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.6 m -144.38 165.28 24.12 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 127.612 2.365 . . . . 74.03 107.963 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.98 -39.31 41.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.098 1.865 . . . . 75.51 112.06 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -106.48 9.79 31.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.732 0.813 . . . . 75.21 111.574 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.02 -137.37 4.76 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 120.414 -1.429 . . . . 62.14 112.185 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.12 144.85 32.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.797 0.839 . . . . 72.44 109.655 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -75.69 155.1 36.04 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 109.24 -0.652 . . . . 73.52 109.24 163.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 107.82 3.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.914 1.686 . . . . 55.33 108.711 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.3 p -123.41 158.6 30.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.034 0.833 . . . . 75.12 110.251 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -146.78 141.86 27.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.964 0.905 . . . . 72.21 111.556 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -76.36 150.9 83.01 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.348 1.059 . . . . 74.12 109.206 165.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.23 168.01 25.3 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.625 3.55 . . . . 74.03 111.126 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 153.11 77.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.198 1.265 . . . . 55.35 110.721 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 t -151.86 73.0 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.738 -1.949 . . . . 74.24 105.738 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -57.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.066 0.946 . . . . 71.12 110.201 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 p -134.86 167.53 20.72 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.448 -0.945 . . . . 73.23 108.448 162.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -47.01 -57.07 5.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.203 1.801 . . . . 73.35 113.132 -168.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.31 176.72 5.96 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.228 1.394 . . . . 64.3 111.103 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -141.27 92.06 2.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.379 -1.711 . . . . 71.25 106.379 157.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.76 145.28 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.632 -1.618 . . . . 75.33 106.632 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.45 -28.26 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.471 1.109 . . . . 71.53 110.932 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.36 -176.26 5.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.663 1.119 . . . . 74.21 110.283 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -139.64 166.11 25.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.355 1.062 . . . . 75.21 110.273 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.48 171.93 19.42 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.287 -0.634 . . . . 73.22 109.287 163.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.02 124.48 26.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.19 -1.781 . . . . 71.34 106.19 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -118.22 119.07 33.57 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.794 -1.928 . . . . 75.43 105.794 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.21 116.03 30.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.285 -1.746 . . . . 73.2 106.285 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.34 136.4 51.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.003 -1.11 . . . . 75.24 108.003 173.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 pt -130.37 -177.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.288 -1.745 . . . . 75.52 106.288 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -44.51 101.17 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.491 1.916 . . . . 71.5 110.858 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.8 m -174.52 173.3 2.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.11 2.564 . . . . 73.51 109.596 -171.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 177.92 0.8 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.682 1.193 . . . . 72.41 112.353 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.81 165.42 24.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.975 1.31 . . . . 71.0 111.845 170.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.85 -178.77 3.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.818 1.647 . . . . 71.13 110.052 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -174.68 135.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.693 1.997 . . . . 75.23 109.369 169.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.03 125.11 1.13 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.958 1.266 . . . . 75.44 112.332 165.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -69.37 159.02 85.22 Favored Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 118.349 1.075 . . . . 71.23 110.381 167.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -58.45 135.35 67.16 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.747 2.298 . . . . 74.3 110.062 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -146.98 37.51 0.96 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.463 1.105 . . . . 75.14 109.721 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m 58.31 1.21 0.15 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 73.22 114.856 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -161.53 -73.42 0.06 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.918 2.087 . . . . 73.31 107.696 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 57.64 166.26 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.127 0.971 . . . . 75.31 110.653 -169.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -79.32 175.05 11.19 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.962 1.775 . . . . 64.23 110.536 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.48 81.58 4.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.189 -1.782 . . . . 61.1 106.189 162.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -121.45 63.51 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.226 1.41 . . . . 55.41 108.156 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 168.77 15.62 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.296 -1.372 . . . . 75.14 107.296 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.13 84.06 1.7 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.417 -0.811 . . . . 54.24 110.287 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.29 158.64 43.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.555 1.142 . . . . 71.21 109.81 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -102.83 7.03 39.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.501 0.926 . . . . 75.13 113.501 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 45.91 61.12 2.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.707 2.003 . . . . 74.5 114.398 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.65 -37.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.666 1.186 . . . . 73.23 113.545 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -64.68 118.81 9.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.969 0.804 . . . . 75.53 109.807 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.7 m -135.58 27.58 3.36 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.537 1.535 . . . . 75.21 109.656 164.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.19 161.05 37.25 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.973 -0.851 . . . . 75.2 110.973 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.83 -55.17 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.578 2.186 . . . . 74.45 110.013 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.86 158.75 31.15 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.864 1.266 . . . . 75.33 110.389 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.82 173.63 10.73 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.883 2.388 . . . . 75.42 110.863 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p 47.87 63.68 1.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.93 1.292 . . . . 71.52 109.782 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.3 p -70.98 -164.82 0.1 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.856 2.062 . . . . 74.5 110.21 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 pp -130.09 -176.49 3.96 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.227 -1.546 . . . . 72.55 108.799 164.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.402 HG13 ' CD2' ' A' ' 82' ' ' LEU . 31.0 t -135.98 148.23 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.632 1.105 . . . . 75.4 109.051 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -89.41 145.12 25.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.004 2.122 . . . . 73.53 111.084 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -62.48 -27.4 69.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.982 2.113 . . . . 73.54 112.83 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.5 p -57.53 -30.03 64.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.116 0.966 . . . . 74.32 111.28 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -78.44 -45.43 22.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.015 1.326 . . . . 72.4 109.298 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.402 ' CD2' HG13 ' A' ' 77' ' ' VAL . 3.5 mm? -58.35 -37.3 74.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.995 1.318 . . . . 75.22 111.87 -175.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -50.08 -48.86 52.95 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.144 0.497 . . . . 62.53 110.531 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -84.32 -5.35 59.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.168 0.987 . . . . 75.41 112.076 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.81 138.07 55.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.083 0.944 . . . . 72.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -71.85 153.5 41.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.074 -1.421 . . . . 73.34 110.446 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -123.25 136.8 58.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.914 1.286 . . . . 71.43 109.261 -166.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.76 68.14 1.68 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 128.128 2.571 . . . . 74.33 112.197 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.71 73.07 0.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.827 1.299 . . . . 61.34 108.443 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.5 p -133.92 -28.5 1.37 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.234 2.213 . . . . 72.11 108.357 165.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.74 -50.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.084 0.954 . . . . 75.31 111.887 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.41 160.1 69.75 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 120.893 1.679 . . . . 73.24 112.541 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.53 74.1 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.579 2.186 . . . . 75.23 109.291 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.96 148.8 45.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.609 0.966 . . . . 63.2 113.609 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -83.98 133.9 28.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.917 1.287 . . . . 62.2 109.251 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -84.29 147.84 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.932 0.893 . . . . 64.21 110.601 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -126.57 145.56 50.49 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 125.331 1.452 . . . . 72.12 109.373 171.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -119.27 98.58 6.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.938 -1.875 . . . . 75.2 105.938 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 mt -113.17 133.14 59.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.456 -2.053 . . . . 74.04 105.456 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 149.86 47.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.85 -1.167 . . . . 75.43 107.85 167.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.03 28.49 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.113 -1.439 . . . . 74.44 107.113 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.87 99.96 3.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.003 -2.221 . . . . 75.41 105.003 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -121.92 163.7 18.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.067 1.347 . . . . 54.02 110.335 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.66 -21.15 62.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.707 -1.133 . . . . 72.23 112.436 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.78 -16.85 44.92 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.36 1.064 . . . . 75.32 112.888 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.58 36.77 4.72 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 118.55 0.614 . . . . 75.33 111.756 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.29 24.83 13.4 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.458 1.903 . . . . 75.22 111.865 165.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.87 -77.98 0.31 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.137 1.351 . . . . 73.0 112.098 -157.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.46 134.69 24.97 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.457 1.438 . . . . 75.33 109.403 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.99 164.07 26.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.074 1.75 . . . . 72.33 107.46 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 m -114.63 135.26 54.34 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.593 -1.632 . . . . 75.03 106.593 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.92 114.9 27.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.371 -2.085 . . . . 75.0 105.371 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 m -113.17 162.67 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 119.16 0.891 . . . . 75.13 108.913 167.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 135.85 52.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.364 -1.347 . . . . 75.32 107.364 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -120.89 102.08 8.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.274 1.035 . . . . 72.03 111.396 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.514 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.58 -10.95 28.18 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.741 2.417 . . . . 75.32 111.885 -169.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 2.21 2.92 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.076 1.75 . . . . 75.32 111.652 170.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -4.24 12.62 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.654 1.57 . . . . 75.12 114.408 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.92 145.93 1.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.069 2.548 . . . . 72.24 112.433 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 p -126.39 94.77 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.291 1.436 . . . . 74.12 108.495 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.0 tptt 71.44 -168.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.707 1.603 . . . . 75.12 109.561 -165.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 55.96 78.49 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.759 2.024 . . . . 74.21 112.96 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m 55.75 -154.97 0.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.878 1.271 . . . . 74.3 111.308 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.3 m 46.74 47.07 15.15 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.844 1.258 . . . . 71.42 113.723 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.42 68.3 0.43 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.185 -1.166 . . . . 71.11 110.185 171.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.258 1.55 0 N-CA-C 102.782 -3.044 . . . . 75.45 102.782 167.58 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 CA-C-O 119.82 -0.433 . . . . 62.14 112.174 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . 0.273 1.8 p 57.23 -169.11 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.322 1.049 . . . . 65.32 108.854 -121.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -129.47 165.57 31.87 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.193 1.397 . . . . 73.32 109.322 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.43 146.3 89.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.2 1.933 . . . . 75.33 110.196 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.01 -173.28 53.85 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 122.397 0.998 . . . . 64.33 111.877 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.4 165.2 34.74 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 127.908 2.483 . . . . 73.52 107.57 -177.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.78 136.51 58.06 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.136 1.224 . . . . 74.33 109.546 164.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.01 112.97 3.66 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 125.13 1.348 . . . . 73.11 114.356 165.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.96 31.01 Favored Pre-proline 0 C--N 1.314 -0.967 0 C-N-CA 127.025 2.13 . . . . 74.23 105.272 158.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.41 159.59 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.065 2.51 . . . . 73.53 111.268 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.1 m -134.41 176.52 8.54 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.662 1.185 . . . . 74.54 109.882 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 18.4 5.9 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.593 2.757 . . . . 65.11 113.758 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.58 120.98 7.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.369 0.668 . . . . 70.31 109.728 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.67 146.38 27.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.247 -1.39 . . . . 74.5 107.247 167.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.8 mt -135.71 133.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.383 -2.08 . . . . 74.13 105.383 161.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 t -146.82 144.51 29.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.434 1.494 . . . . 74.23 109.312 -173.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -80.45 158.26 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.124 0.57 . . . . 64.42 110.261 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.45 165.34 18.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.038 1.335 . . . . 61.0 107.935 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 -15.64 35.46 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.105 2.536 . . . . 70.31 113.464 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -107.74 -26.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.399 1.08 . . . . 70.23 111.66 -168.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.14 -165.61 37.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.582 -1.807 . . . . 63.43 108.582 -167.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.31 133.92 42.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.046 -1.465 . . . . 74.1 107.046 165.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -60.31 115.36 3.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.012 -1.477 . . . . 74.2 107.012 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.42 140.35 38.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.4 -1.704 . . . . 72.1 106.4 168.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 p -150.23 156.56 41.8 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.886 1.221 . . . . 74.14 109.953 164.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -139.91 158.37 44.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.487 1.515 . . . . 71.33 108.921 166.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -87.89 161.67 43.57 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.052 0.541 . . . . 64.23 110.523 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.8 168.08 19.56 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.904 . . . . 74.51 111.341 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.55 156.5 21.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.005 1.803 . . . . 74.51 112.973 -166.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.5 52.86 1.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.028 -1.471 . . . . 74.2 107.028 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.2 t -137.57 -87.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.149 -1.056 . . . . 74.32 108.149 160.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 t -168.68 40.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.968 -1.083 . . . . 71.34 110.037 -173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.4 p -68.23 -6.82 25.74 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.103 -1.623 . . . . 72.3 113.787 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.09 -124.99 6.71 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 120.248 -1.533 . . . . 72.42 111.49 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -109.11 88.43 2.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.351 1.86 . . . . 73.43 110.612 -167.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.04 125.58 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.867 1.667 . . . . 71.42 107.177 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.46 -27.93 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.398 1.079 . . . . 74.24 111.406 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -151.3 -171.44 3.93 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.692 1.597 . . . . 72.3 107.434 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 169.49 17.51 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.472 -1.393 . . . . 74.5 108.749 172.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.9 173.24 16.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.587 0.63 . . . . 72.22 112.6 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.65 99.28 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 128.733 2.813 . . . . 73.31 105.282 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.406 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 42.7 m-85 -82.99 153.34 25.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.957 -1.127 . . . . 73.34 107.957 163.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.3 tp -143.26 128.19 18.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.956 2.102 . . . . 74.24 106.105 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 112.78 13.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.829 0.852 . . . . 63.52 109.143 169.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 pt -86.75 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.155 -1.054 . . . . 72.11 108.155 160.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -48.75 108.61 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.231 1.012 . . . . 64.13 111.139 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.8 p -162.61 109.98 1.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.81 1.244 . . . . 65.23 111.019 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -87.81 4.51 44.17 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.801 0.84 . . . . 75.51 112.615 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -127.21 168.86 14.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.21 1.404 . . . . 73.42 110.514 -162.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.78 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.169 2.188 . . . . 72.31 112.002 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -144.38 129.49 18.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.78 -2.304 . . . . 74.21 104.78 169.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.69 -135.2 1.96 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 108.36 -1.896 . . . . 72.32 108.36 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.11 156.27 60.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 125.277 1.431 . . . . 73.52 109.195 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.92 -176.81 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.953 2.435 . . . . 72.33 110.92 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt 70.08 3.92 4.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.974 1.309 . . . . 71.42 112.601 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.0 m 44.96 45.75 8.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.158 1.783 . . . . 61.31 111.485 -169.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -66.73 -51.16 59.14 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.87 -0.586 . . . . 73.32 109.881 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.6 p -125.44 156.94 69.59 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.084 0.856 . . . . 64.13 109.631 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.38 88.06 1.45 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.187 2.591 . . . . 73.42 112.85 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.86 116.52 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.621 1.968 . . . . 71.44 107.386 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -85.56 -168.43 2.22 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.087 0.955 . . . . 73.34 108.731 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -112.43 171.83 7.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.686 1.194 . . . . 72.45 109.586 -172.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.36 120.93 25.06 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.448 0.536 . . . . 72.22 112.448 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.406 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 37.9 m-85 -148.97 170.91 17.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.268 1.827 . . . . 65.13 110.33 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 ttp -106.45 5.89 29.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.438 1.495 . . . . 73.34 113.225 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 44.44 44.35 6.91 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.772 1.629 . . . . 71.33 115.34 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.6 m -56.4 -9.75 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.446 1.647 . . . . 72.2 115.446 -171.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -53.67 98.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.292 1.044 . . . . 71.32 110.783 165.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.6 t -147.32 24.66 1.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.713 . . . . 72.2 109.145 162.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.79 159.0 53.34 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.123 -0.791 . . . . 52.54 111.123 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -83.49 -7.05 10.82 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.947 3.098 . . . . 73.02 112.372 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -131.86 156.61 79.9 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.431 1.892 . . . . 74.3 109.842 -166.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -4.01 11.96 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.389 3.393 . . . . 72.13 113.551 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 p -120.46 22.47 11.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.666 2.387 . . . . 65.24 110.212 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.25 -174.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.654 2.782 . . . . 74.21 115.34 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.32 102.4 3.06 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 104.881 -2.266 . . . . 71.01 104.881 167.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.55 108.3 20.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.222 -1.029 . . . . 73.03 108.222 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -77.0 165.48 24.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.629 0.728 . . . . 73.11 111.554 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.75 82.08 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.47 1.108 . . . . 72.12 111.956 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -64.42 -20.29 66.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.924 -1.036 . . . . 64.31 112.754 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -75.02 -35.84 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.877 1.217 . . . . 50.53 109.862 172.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.0 -30.58 63.88 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.098 1.359 . . . . 63.35 110.53 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.4 m -47.09 -44.13 20.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.927 1.291 . . . . 74.21 113.033 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -84.55 1.73 44.55 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.167 0.802 . . . . 73.22 113.167 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.0 143.58 55.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.823 0.82 . . . . 72.14 110.376 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -68.74 140.69 55.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.529 -1.214 . . . . 75.24 107.808 162.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.6 mm -101.5 123.51 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.91 -1.515 . . . . 73.41 106.91 172.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.74 145.45 52.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.693 0.621 . . . . 72.25 110.056 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.7 18.66 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.658 0.783 . . . . 75.25 111.307 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 t -110.11 -13.58 14.35 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.658 -0.651 . . . . 72.45 110.908 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -129.02 -63.17 0.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.407 1.483 . . . . 74.44 111.982 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -154.74 155.55 30.57 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 127.062 2.145 . . . . 75.31 108.352 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -60.57 101.82 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.433 2.756 . . . . 70.13 109.516 171.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.94 156.58 41.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 70.12 110.078 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.44 140.71 16.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.824 -1.917 . . . . 73.45 105.824 161.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.8 mm -109.26 115.12 48.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.366 1.466 . . . . 71.41 107.555 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -100.72 148.49 24.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.957 0.903 . . . . 64.23 109.338 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -132.06 94.09 3.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.542 -1.651 . . . . 74.34 106.542 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.1 mt -108.55 136.66 43.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.014 -2.217 . . . . 65.52 105.014 -172.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.52 41.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.909 0.777 . . . . 72.4 110.115 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 114.56 7.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.473 1.509 . . . . 73.34 108.066 172.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 81.55 4.72 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 105.475 -2.046 . . . . 73.13 105.475 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.06 166.02 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.9 1.68 . . . . 74.12 108.347 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mt-10 -74.48 -36.41 63.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.685 -1.143 . . . . 63.34 108.836 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -17.04 64.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 115.718 1.748 . . . . 54.3 115.718 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.82 -97.89 0.13 Allowed Glycine 0 CA--C 1.512 -0.134 0 CA-C-N 120.643 1.565 . . . . 62.11 112.882 -161.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 3.6 t80 55.52 21.86 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.833 2.853 . . . . 72.51 111.561 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.8 1.28 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.532 2.015 . . . . 52.42 108.35 -163.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.0 143.91 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.447 2.098 . . . . 73.12 109.904 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.18 117.65 16.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.386 -2.079 . . . . 72.32 105.386 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 m -53.14 120.99 6.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.924 -1.139 . . . . 71.41 107.924 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -82.64 88.9 6.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.041 -1.837 . . . . 74.52 106.041 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.21 156.58 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.462 -1.681 . . . . 73.13 106.462 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 164.13 28.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.87 -1.159 . . . . 74.5 107.87 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -137.6 114.31 10.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.62 0.724 . . . . 74.23 111.3 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 25.05 5.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.801 1.64 . . . . 74.5 112.19 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -108.97 7.75 26.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.507 1.523 . . . . 74.41 111.508 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -68.6 118.7 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.101 0.953 . . . . 63.54 109.021 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.52 159.02 0.17 Allowed 'General case' 0 C--O 1.242 0.663 1 C-N-CA 133.227 4.611 . . . . 70.55 103.368 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 m -71.3 169.45 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.691 1.132 . . . . 70.14 109.321 165.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -148.6 144.5 27.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.437 -2.061 . . . . 73.32 105.437 160.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.43 169.98 16.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.291 -0.633 . . . . 70.14 109.291 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.27 163.93 23.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.205 1.002 . . . . 62.43 110.176 173.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.98 -58.89 0.11 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.721 0.808 . . . . 74.0 109.315 168.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 162.36 -172.75 38.53 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 118.275 0.489 . . . . 52.44 112.393 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.547 2.339 . . . . 72.33 105.545 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 109.542 -1.423 . . . . 64.42 109.542 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.5 p -66.68 160.19 26.12 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.487 1.144 . . . . 75.02 111.78 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.67 150.28 54.88 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 106.171 -1.788 . . . . 73.21 106.171 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.53 162.8 35.26 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.894 1.73 . . . . 61.24 112.73 -170.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 157.86 32.34 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.266 -0.879 . . . . 73.33 111.101 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -61.39 159.59 30.19 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.025 1.33 . . . . 74.41 112.772 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.31 4.64 3.22 Favored 'Trans proline' 0 CA--C 1.536 0.611 1 C-N-CA 125.596 4.197 . . . . 62.4 114.304 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 140.84 8.3 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 108.089 -2.004 . . . . 75.14 108.089 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.98 161.97 28.27 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.547 2.339 . . . . 73.22 108.321 171.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -63.76 142.15 81.75 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.169 1.913 . . . . 73.44 109.258 160.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.2 m -127.23 170.9 11.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.223 1.409 . . . . 74.21 110.185 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.75 31.78 0.7 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.801 2.441 . . . . 75.42 114.951 169.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.442 HD11 ' H ' ' A' ' 13' ' ' ILE . 3.6 mp -54.96 143.61 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 126.597 1.959 . . . . 74.14 109.004 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -119.15 147.25 44.4 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.573 0.749 . . . . 75.31 109.362 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.4 mt -146.36 126.72 6.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.979 -1.489 . . . . 71.32 106.979 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -141.69 173.83 11.14 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 126.924 2.09 . . . . 75.43 107.752 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -130.64 159.86 35.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.197 0.999 . . . . 71.23 108.946 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 m -152.91 165.54 17.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 125.855 1.662 . . . . 54.21 107.987 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.54 -29.22 84.23 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.093 1.862 . . . . 72.43 112.761 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 -38.22 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.205 0.602 . . . . 73.25 110.702 -169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.34 -165.2 26.34 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.181 1.372 . . . . 71.04 112.965 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.48 140.1 50.05 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.968 1.884 . . . . 73.22 110.258 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -85.5 96.07 9.49 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.645 1.578 . . . . 72.42 109.546 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -98.25 125.26 43.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.26 1.024 . . . . 72.43 108.745 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -137.48 160.81 38.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.765 0.711 . . . . 73.3 109.262 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.11 166.97 31.9 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.896 . . . . 74.04 109.703 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -101.43 159.91 28.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.884 -0.579 . . . . 73.24 111.395 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.35 175.49 9.28 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.697 3.598 . . . . 72.0 113.138 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.57 117.02 4.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.044 1.829 . . . . 74.11 108.707 167.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 m -151.32 19.31 0.75 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.033 1.333 . . . . 75.34 112.816 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -104.5 -62.16 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.44 -1.319 . . . . 71.32 107.44 168.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -116.81 161.57 19.07 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.996 -1.113 . . . . 52.12 107.996 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 m -68.69 -66.66 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.408 0.683 . . . . 72.21 110.367 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 171.86 2.47 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 122.159 0.866 . . . . 43.51 111.793 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -110.85 76.56 0.98 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.671 -1.974 . . . . 75.33 105.671 163.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -64.83 147.42 12.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.117 -1.068 . . . . 75.32 108.117 170.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.5 pt -130.9 -26.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.656 1.982 . . . . 75.12 110.106 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -168.07 -175.33 2.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.871 1.669 . . . . 73.3 107.451 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -127.14 167.89 15.4 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.118 -1.614 . . . . 73.24 109.128 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t -143.67 168.69 19.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.999 -1.063 . . . . 64.12 111.507 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.45 128.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.282 -1.377 . . . . 64.21 107.282 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.62 144.58 43.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.253 1.021 . . . . 74.01 108.594 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -120.73 136.15 54.95 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.342 2.657 . . . . 75.21 107.662 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.13 130.59 41.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.52 1.963 . . . . 73.33 109.249 172.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.7 171.59 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.826 1.25 . . . . 75.01 109.217 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -82.02 100.01 9.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.11 0.964 . . . . 74.45 108.822 161.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.37 -176.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 131.08 3.752 . . . . 64.01 106.481 167.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 t -141.43 -174.81 4.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.356 1.462 . . . . 70.15 109.268 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 64.53 100.18 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.704 2.401 . . . . 73.15 112.624 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.74 173.12 11.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.566 1.946 . . . . 65.35 110.198 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 p 174.9 135.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.058 1.743 . . . . 70.33 110.595 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.89 -3.44 0.03 OUTLIER Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.736 1.454 . . . . 63.04 116.736 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.1 156.9 63.38 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.607 1.704 . . . . 72.31 112.968 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.42 174.92 10.12 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.092 3.195 . . . . 71.42 112.174 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? 62.29 5.49 1.57 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.028 1.731 . . . . 74.41 112.241 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.06 -72.5 0.07 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.746 -1.221 . . . . 65.1 108.164 -155.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 65.32 -74.17 0.06 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.721 2.408 . . . . 60.13 108.191 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 t -165.96 144.43 4.87 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 127.058 2.143 . . . . 73.22 105.565 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.52 82.87 1.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.893 2.395 . . . . 65.33 109.771 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.34 98.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.779 2.432 . . . . 74.14 114.748 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -80.46 34.84 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.54 1.136 . . . . 74.01 111.739 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 mt -152.15 148.02 27.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.27 3.028 . . . . 75.42 103.726 -166.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.23 114.06 24.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.859 -0.793 . . . . 63.32 108.859 171.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -133.82 161.15 35.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.339 1.455 . . . . 74.43 108.812 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.4 ttp -105.5 130.39 53.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.957 1.303 . . . . 65.11 107.629 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -71.95 85.95 0.99 Allowed 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.987 -1.116 . . . . 75.43 107.987 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -65.39 -48.5 82.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.377 0.608 . . . . 75.21 109.857 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.84 104.77 4.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.846 1.258 . . . . 71.02 109.882 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.5 t -160.2 75.93 0.6 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.656 -0.868 . . . . 74.14 108.656 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.24 46.8 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.001 -1.095 . . . . 54.33 114.445 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.66 -7.09 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.935 3.757 . . . . 73.1 112.449 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 m -48.32 144.34 6.37 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.356 1.862 . . . . 71.31 112.362 -169.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.89 109.79 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.339 2.026 . . . . 74.41 109.121 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.57 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.818 1.647 . . . . 71.41 108.943 -170.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.2 t -171.49 159.89 5.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.608 2.004 . . . . 75.24 109.248 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -130.82 97.74 4.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.045 1.738 . . . . 75.01 106.351 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.83 117.03 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 106.855 -1.535 . . . . 75.03 106.855 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -60.66 148.07 39.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.492 0.587 . . . . 73.24 109.951 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -55.23 -32.15 62.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.186 0.994 . . . . 64.41 112.833 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -61.41 -28.32 69.17 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.643 1.111 . . . . 72.14 113.216 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -70.31 -38.16 74.9 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.593 -1.317 . . . . 74.03 109.708 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.04 -40.63 96.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.872 0.869 . . . . 75.45 108.912 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -59.46 -14.24 11.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.584 1.554 . . . . 73.23 115.072 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.82 -3.92 12.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.335 0.97 . . . . 65.45 111.401 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.12 153.12 22.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.016 0.926 . . . . 74.44 110.189 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -137.51 158.14 45.02 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.883 1.273 . . . . 75.25 109.654 -167.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.77 137.35 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.173 0.511 . . . . 72.41 110.92 -149.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.5 48.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.848 1.659 . . . . 74.42 110.8 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -57.85 -12.74 3.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.575 1.15 . . . . 73.53 113.364 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -17.91 60.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.646 1.178 . . . . 64.13 112.107 170.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -130.07 -58.19 1.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.813 1.645 . . . . 72.23 110.134 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -150.79 162.08 28.18 Favored Pre-proline 0 C--N 1.341 0.23 0 C-N-CA 124.753 1.221 . . . . 75.13 110.268 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.71 87.85 0.43 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.477 1.451 . . . . 54.12 108.805 155.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.481 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -151.61 155.45 38.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.74 2.016 . . . . 71.12 110.428 166.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mt -80.67 -25.22 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 116.295 1.961 . . . . 73.04 116.295 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mm 61.19 151.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 130.754 3.622 . . . . 74.25 111.625 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -127.77 145.23 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.65 -1.241 . . . . 75.41 107.65 166.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.53 99.76 8.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.555 -1.646 . . . . 72.34 106.555 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.29 127.46 66.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.811 -2.292 . . . . 64.42 104.811 -170.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.25 163.76 37.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.382 1.087 . . . . 72.2 113.334 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.75 123.63 30.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.777 1.631 . . . . 63.01 107.516 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -76.33 104.97 7.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.489 -1.671 . . . . 72.2 106.489 164.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -123.82 -179.47 4.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.912 1.285 . . . . 74.31 110.155 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.74 -28.62 60.85 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.011 0.745 . . . . 75.12 113.011 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.71 -13.41 59.22 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.933 0.893 . . . . 64.43 111.997 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.38 169.19 45.67 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 124.847 1.213 . . . . 63.2 111.018 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.83 73.9 0.18 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.727 2.011 . . . . 75.04 111.159 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 -64.77 2.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.039 1.78 . . . . 64.21 110.044 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.28 163.64 35.49 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 120.04 1.92 . . . . 73.0 111.493 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.68 100.67 1.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.231 -1.766 . . . . 61.1 106.231 168.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -79.18 93.87 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.104 -1.443 . . . . 75.11 107.104 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.76 84.55 3.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.642 1.577 . . . . 74.12 108.177 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -82.78 167.63 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.942 -1.133 . . . . 74.01 107.942 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 152.01 51.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.702 -0.851 . . . . 73.35 108.702 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.481 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 1.7 t90 -120.7 102.42 8.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.981 1.372 . . . . 75.22 113.297 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.408 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -91.93 14.06 16.78 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.435 -0.802 . . . . 74.14 111.201 -169.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -72.13 -2.0 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.195 -0.907 . . . . 75.24 110.913 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -82.54 52.11 2.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.84 1.655 . . . . 75.44 112.193 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.87 160.68 42.0 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.719 1.208 . . . . 72.21 109.444 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 m -60.52 104.51 0.34 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.26 1.024 . . . . 74.51 109.977 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -146.82 161.93 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.981 1.712 . . . . 74.45 107.292 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -157.55 173.6 16.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.984 1.714 . . . . 64.23 106.424 175.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.8 m 55.94 38.99 30.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.441 1.497 . . . . 62.52 112.028 164.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.7 m -90.16 -44.51 9.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.425 1.49 . . . . 71.53 111.491 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -103.75 -168.24 25.34 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 124.794 1.188 . . . . 72.45 111.856 -165.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.246 0.872 0 C-N-CA 126.006 1.722 . . . . 74.32 106.654 178.189 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.36 -1.496 . . . . 72.3 109.36 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.8 m 71.89 44.82 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.102 2.161 . . . . 73.53 112.898 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mp 65.55 160.49 0.13 Allowed Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 127.434 2.293 . . . . 75.32 112.525 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.14 -55.23 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.644 1.562 . . . . 75.22 110.601 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.92 167.32 38.07 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.066 -1.213 . . . . 62.31 110.066 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.45 154.98 70.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.116 0.967 . . . . 74.22 110.251 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.88 172.03 17.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.287 2.658 . . . . 72.33 111.781 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.01 -113.7 3.72 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.808 -1.717 . . . . 74.2 108.808 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.14 155.18 0.15 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 129.936 3.294 . . . . 73.54 111.0 -162.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.84 141.63 59.85 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.43 1.42 . . . . 65.13 108.924 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -137.5 -169.54 2.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.057 2.143 . . . . 74.24 107.938 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.3 34.8 3.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.108 1.763 . . . . 72.34 112.194 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.06 131.12 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.436 -0.95 . . . . 74.12 108.436 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -133.06 151.31 52.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.848 1.659 . . . . 74.52 108.393 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.8 mt -142.73 91.79 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 105.041 -2.207 . . . . 72.44 105.041 -172.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -88.19 108.32 19.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.251 -1.018 . . . . 71.24 108.251 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 139.71 45.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.315 0.646 . . . . 73.03 109.9 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -148.67 166.52 15.25 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 123.564 0.746 . . . . 74.32 111.056 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -51.42 -46.67 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.9 1.733 . . . . 73.4 111.281 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -28.61 65.11 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.297 1.039 . . . . 72.4 111.424 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -104.31 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.569 -1.413 . . . . 74.3 109.569 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.76 120.97 6.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.793 -1.188 . . . . 73.01 107.793 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.53 134.47 51.34 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.597 1.159 . . . . 71.02 108.903 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.9 mt -116.35 144.23 44.53 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.555 -0.535 . . . . 74.21 109.555 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 p -140.21 160.66 39.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 117.83 -1.081 . . . . 71.01 108.174 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -159.97 173.75 15.41 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.842 1.657 . . . . 71.44 108.875 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.47 162.8 20.06 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.419 1.088 . . . . 72.23 110.263 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.78 155.73 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.748 2.298 . . . . 65.03 111.154 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.62 149.39 23.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.067 2.512 . . . . 74.33 111.573 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 t 76.48 135.6 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.885 2.474 . . . . 72.32 109.466 -160.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.96 -27.53 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 113.821 -1.536 . . . . 73.5 108.48 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.2 p -87.65 175.27 7.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.756 -1.215 . . . . 74.13 110.233 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 p -45.79 -48.98 15.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.692 1.597 . . . . 70.11 114.094 -169.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.94 -169.99 41.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.426 -1.469 . . . . 70.54 109.426 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -142.19 52.31 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.307 1.443 . . . . 74.34 109.493 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.39 142.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.74 -0.837 . . . . 71.24 108.74 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 pt -136.09 -15.59 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.684 1.993 . . . . 74.2 111.651 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -169.42 -168.06 0.77 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.048 2.139 . . . . 74.2 107.602 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.23 -178.6 5.93 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.331 -1.481 . . . . 74.2 110.077 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -145.78 155.33 42.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.258 1.023 . . . . 54.42 111.24 167.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -146.75 93.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.408 2.683 . . . . 74.24 105.15 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -95.98 130.11 43.06 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.825 -1.176 . . . . 73.42 107.825 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.69 124.07 34.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.663 1.119 . . . . 73.04 107.993 -168.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.46 129.49 40.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.733 0.697 . . . . 73.03 110.99 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.2 pt -132.31 171.09 18.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.15 -1.796 . . . . 73.02 106.15 166.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -81.49 88.89 6.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 75.35 108.599 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 t -165.07 -178.63 5.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.669 1.987 . . . . 65.04 107.212 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 t -143.49 165.78 26.61 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.376 -0.972 . . . . 71.41 108.376 153.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -147.09 160.91 41.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.521 1.129 . . . . 73.13 109.914 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.08 81.77 1.75 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 54.21 110.903 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.82 123.88 4.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.925 -2.25 . . . . 73.12 104.925 171.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.64 -128.44 3.49 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 107.385 -2.286 . . . . 54.32 107.385 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -130.93 167.04 23.19 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.249 1.419 . . . . 55.11 109.205 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -62.34 -164.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 125.123 3.882 . . . . 65.24 111.113 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.1 tttt 66.68 47.57 1.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.056 -1.028 . . . . 75.53 111.571 165.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m 58.87 43.86 17.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.613 1.165 . . . . 73.44 110.099 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.1 -36.7 0.37 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.319 3.047 . . . . 64.41 113.609 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.276 13.5 t 48.08 159.11 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.071 1 C-N-CA 132.209 4.203 . . . . 73.1 111.994 -170.634 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.19 171.55 17.62 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.322 2.015 . . . . 74.55 111.291 165.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 56.06 37.76 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.656 1.982 . . . . 75.44 112.854 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -67.55 165.07 17.62 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.501 1.521 . . . . 75.32 108.571 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.83 165.9 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.668 -1.605 . . . . 74.31 106.668 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.68 113.37 7.07 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.143 -0.688 . . . . 72.14 109.143 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -134.0 -179.51 5.6 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.861 1.665 . . . . 72.35 110.506 -165.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.9 ptm -80.94 165.92 21.33 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.895 -1.15 . . . . 72.35 107.895 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -125.42 83.02 2.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.109 -1.441 . . . . 74.33 107.109 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.75 -38.44 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.966 -0.459 . . . . 73.13 110.282 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -54.59 110.57 0.65 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.361 . . . . 74.03 112.533 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.9 p -147.81 24.55 1.07 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.379 0.672 . . . . 74.32 111.883 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.83 163.78 29.72 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.298 -0.723 . . . . 73.13 112.456 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.06 -54.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.376 2.717 . . . . 54.31 110.524 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.18 143.86 96.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.06 -1.089 . . . . 64.4 108.06 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.9 -46.42 1.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.514 2.143 . . . . 65.21 109.935 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -66.04 77.0 0.09 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.399 2.68 . . . . 74.02 108.778 168.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.6 t -96.17 -173.17 2.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.39 2.276 . . . . 63.0 109.54 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.09 159.97 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.786 -1.196 . . . . 74.41 109.656 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.48 115.03 47.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.557 -2.016 . . . . 73.2 105.557 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 151.11 45.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.587 1.155 . . . . 71.2 111.159 -168.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 p -51.82 -43.58 63.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.757 1.623 . . . . 71.34 111.96 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.5 t -51.43 -63.43 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.495 1.518 . . . . 51.25 110.235 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -60.77 -33.93 73.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.051 0.54 . . . . 73.23 110.932 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.2 mt -66.85 -23.11 65.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 117.974 -1.012 . . . . 74.22 111.778 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -56.42 -24.4 44.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.495 1.043 . . . . 72.44 111.884 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -102.83 1.41 34.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.944 0.898 . . . . 73.04 111.687 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.7 120.87 13.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.627 0.649 . . . . 75.41 109.621 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -83.26 148.05 27.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.485 -0.931 . . . . 72.23 108.485 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -110.69 147.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.108 -0.701 . . . . 75.42 109.108 -163.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.65 71.0 0.7 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.854 1.662 . . . . 74.43 111.769 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -76.26 53.0 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.154 1.782 . . . . 74.21 108.238 170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -55.23 0.34 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.067 -1.02 . . . . 73.31 108.734 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -94.08 -68.63 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.808 -0.558 . . . . 75.33 110.121 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -148.14 144.31 18.69 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 125.587 1.555 . . . . 71.44 106.975 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -67.42 108.01 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.959 1.773 . . . . 73.44 111.238 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.264 . . -147.57 165.54 30.05 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 131.318 3.847 . . . . 75.22 107.369 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.23 137.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.606 -1.627 . . . . 74.04 106.606 160.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.9 mm -100.93 152.51 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.373 1.469 . . . . 73.11 109.29 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.73 129.2 34.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.032 1.333 . . . . 74.34 109.162 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -96.14 89.89 5.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.791 -1.559 . . . . 73.4 106.791 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.2 mt -94.33 134.88 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.705 -1.591 . . . . 74.03 106.705 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.7 144.09 25.88 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.528 0.731 . . . . 74.03 109.748 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.61 152.21 37.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.298 0.639 . . . . 73.13 110.448 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.1 98.33 8.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.482 -2.044 . . . . 73.33 105.482 171.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -129.6 -171.02 2.41 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.272 1.429 . . . . 73.44 108.519 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -61.05 -35.36 76.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.485 0.55 . . . . 74.22 112.485 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -60.98 -26.06 67.3 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.882 1.673 . . . . 74.24 112.843 -166.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.37 36.64 3.77 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 117.076 1.59 . . . . 72.32 117.076 156.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 55.47 92.39 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 129.832 3.253 . . . . 74.13 113.187 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -126.36 -70.45 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 126.728 2.108 . . . . 62.14 108.958 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.6 143.05 37.3 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 119.31 1.555 . . . . 73.34 109.479 -171.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.72 142.92 20.34 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.583 -1.266 . . . . 61.4 107.583 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 m -108.05 109.73 21.25 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.861 -0.792 . . . . 75.04 108.861 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -72.4 95.18 1.72 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.226 -1.027 . . . . 73.4 108.226 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.95 151.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.107 -1.072 . . . . 75.33 108.107 166.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.74 139.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.418 1.887 . . . . 74.32 106.751 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -124.18 100.14 6.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.503 0.721 . . . . 75.41 109.943 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 mp -90.18 42.64 1.11 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 122.611 1.196 . . . . 74.21 110.285 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.01 7.83 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.007 2.123 . . . . 71.33 109.38 176.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -27.86 66.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.719 0.691 . . . . 73.13 112.649 176.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.8 m -65.61 152.38 44.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.168 1.787 . . . . 75.42 110.517 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 p -78.92 126.14 30.3 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.495 -0.753 . . . . 72.34 110.847 -165.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.69 -79.05 0.31 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 118.504 -0.76 . . . . 73.34 110.421 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -164.38 -84.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 74.14 109.996 -166.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.6 t 61.77 83.26 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.015 1.726 . . . . 74.0 110.509 -164.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 t -130.65 158.65 39.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.992 -1.114 . . . . 72.3 107.992 158.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 154.93 -170.12 33.13 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.209 -1.957 . . . . 72.11 108.209 -169.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 108.616 -0.883 . . . . 71.41 108.616 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.816 0 N-CA-C 109.663 -1.375 . . . . 43.35 109.663 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 90.7 m -93.23 6.08 49.28 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.216 1.008 . . . . 63.45 113.473 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.1 mt 75.91 149.82 0.13 Allowed Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 128.685 2.794 . . . . 74.34 110.141 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.18 -14.72 35.08 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.097 2.531 . . . . 70.04 114.176 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.69 -178.65 47.42 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 106.863 -2.495 . . . . 72.33 106.863 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -116.54 86.1 17.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.955 0.902 . . . . 71.41 109.585 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.44 -20.61 13.96 Favored 'Trans proline' 0 C--N 1.347 0.472 1 C-N-CA 125.827 4.352 . . . . 73.31 113.048 -166.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.53 156.86 48.29 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.022 -1.231 . . . . 64.12 110.022 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.79 165.57 9.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 126.728 2.011 . . . . 52.23 107.176 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -61.47 146.17 97.32 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.466 1.444 . . . . 74.43 109.723 161.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.7 176.5 7.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.337 1.455 . . . . 71.33 109.422 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.29 31.75 0.61 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 128.815 2.846 . . . . 74.15 113.82 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.97 133.28 27.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.158 -1.053 . . . . 73.45 108.158 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -129.49 142.44 50.78 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 123.546 0.738 . . . . 74.1 109.244 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.53 128.98 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 103.251 -2.87 . . . . 71.43 103.251 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -147.14 137.08 23.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.562 1.145 . . . . 65.21 108.257 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -64.18 144.89 56.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.379 -0.971 . . . . 74.04 108.379 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.0 162.16 53.71 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 126.888 2.075 . . . . 74.03 106.424 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 -10.89 27.65 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.028 1.152 . . . . 71.1 112.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.141 0.882 . . . . 64.43 111.702 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -118.37 0.83 Allowed Glycine 0 C--N 1.342 0.886 0 O-C-N 120.494 -1.379 . . . . 72.4 110.763 -172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.47 132.45 26.08 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.537 1.169 . . . . 44.5 110.963 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.24 149.59 50.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.128 1.371 . . . . 64.11 109.44 162.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 2.9 mp -142.22 123.26 14.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.646 1.578 . . . . 72.23 108.702 166.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -133.35 156.96 46.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.092 -0.707 . . . . 72.31 109.092 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.403 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -148.68 178.57 8.53 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.816 0.446 . . . . 73.43 110.577 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -139.39 159.52 65.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.114 1.766 . . . . 74.14 110.363 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.22 167.35 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.156 2.57 . . . . 73.03 111.05 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.45 -55.58 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.649 2.233 . . . . 73.24 110.71 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.46 39.92 8.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.474 -1.306 . . . . 64.24 107.474 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.07 -49.96 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.99 1.316 . . . . 73.34 113.75 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -64.68 154.66 35.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.099 1.318 . . . . 70.42 109.864 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -95.41 55.43 1.72 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.681 0.792 . . . . 70.14 109.572 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.53 134.18 11.64 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 108.561 -1.815 . . . . 70.23 108.561 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -81.66 82.12 7.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.162 -1.051 . . . . 74.45 108.162 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.72 131.85 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.739 -1.578 . . . . 74.35 106.739 168.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -126.86 -24.24 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.869 1.267 . . . . 73.01 111.36 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -163.3 -170.53 2.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.209 1.404 . . . . 74.41 107.606 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.37 177.54 8.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.665 1.186 . . . . 74.14 110.302 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.453 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -135.43 154.56 51.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.15 1.38 . . . . 70.15 108.601 163.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -143.72 112.24 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.432 -2.062 . . . . 73.12 105.432 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 40' ' ' SER . 87.3 m-85 -110.93 150.95 28.48 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.337 1.055 . . . . 64.25 109.742 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.78 121.31 25.15 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.342 1.857 . . . . 74.41 106.045 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.33 121.81 15.2 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.227 1.011 . . . . 71.02 110.771 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 pt -136.79 -177.11 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.325 1.45 . . . . 72.32 109.084 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . 0.277 3.5 pp0? -130.97 64.36 1.58 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 123.292 1.52 . . . . 74.31 112.767 171.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.0 m -149.94 162.88 39.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.269 1.828 . . . . 73.2 108.591 162.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.9 m 50.7 -154.55 0.14 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 75.04 112.83 159.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -149.91 167.84 25.49 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.44 1.096 . . . . 71.04 109.365 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.67 -174.39 2.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.212 0.605 . . . . 73.43 110.708 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.85 115.86 5.29 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.224 -2.139 . . . . 71.32 105.224 173.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.22 114.68 0.92 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.793 1.179 . . . . 64.44 110.363 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.19 164.77 20.32 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 127.058 2.143 . . . . 73.02 108.356 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.75 -170.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.02 2.48 . . . . 74.32 110.49 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -83.19 48.55 1.4 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.72 2.008 . . . . 73.12 107.795 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.0 t 70.8 84.9 0.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.719 2.407 . . . . 65.23 108.556 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -144.48 16.1 1.65 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 72.25 111.799 169.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.2 m -121.66 80.56 39.87 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-N 119.614 1.097 . . . . 74.35 109.087 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.47 64.22 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.933 2.422 . . . . 74.02 109.96 169.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.45 93.7 0.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 127.818 2.447 . . . . 74.33 105.46 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.17 138.41 58.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.643 -0.503 . . . . 74.12 109.643 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.01 160.94 39.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.766 0.826 . . . . 72.11 110.589 -175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.78 102.85 4.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.856 1.262 . . . . 72.33 109.655 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -132.37 152.36 51.48 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.881 1.272 . . . . 52.44 109.58 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.1 ttp -78.34 5.0 11.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.457 1.28 . . . . 74.34 114.457 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.39 58.65 3.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.403 1.481 . . . . 65.03 112.155 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.79 -13.34 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.542 0.737 . . . . 64.34 112.9 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.21 -177.05 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.009 1.323 . . . . 64.33 112.063 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 44.7 m 62.57 42.69 8.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.455 1.902 . . . . 73.41 109.7 -168.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 155.88 42.04 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.111 -1.196 . . . . 72.0 110.111 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.74 -20.41 52.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.546 2.831 . . . . 74.44 112.692 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -135.05 149.37 70.11 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.95 1.3 . . . . 72.04 110.573 167.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.7 176.82 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 124.484 3.456 . . . . 42.51 111.86 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.6 p 46.63 40.71 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.45 1.5 . . . . 72.11 110.707 -170.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.66 123.88 23.5 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.22 1.808 . . . . 71.32 112.139 -167.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.39 147.37 26.29 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.933 1.293 . . . . 72.11 108.403 159.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.45 115.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.08 2.152 . . . . 72.24 105.711 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -65.53 154.38 38.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.801 0.84 . . . . 74.43 110.776 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -63.63 -19.25 64.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.633 1.173 . . . . 74.3 112.145 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -37.67 69.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.108 1.763 . . . . 73.4 111.204 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 m -71.64 -41.9 68.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.775 0.83 . . . . 73.12 111.267 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -26.19 67.23 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.4 1.08 . . . . 74.44 111.931 -175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.49 -33.33 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.233 1.413 . . . . 64.33 110.602 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.31 -18.82 23.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.113 1.365 . . . . 71.32 112.267 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.71 9.94 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.16 1.384 . . . . 74.01 109.665 -170.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 147.49 23.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.675 0.79 . . . . 73.0 109.207 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -103.13 140.73 20.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.443 0.64 . . . . 74.21 109.305 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -59.2 110.45 1.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.576 1.95 . . . . 74.34 109.643 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -112.93 14.29 19.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.205 1.002 . . . . 72.44 110.512 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 82.6 p -102.53 -18.85 15.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.947 1.299 . . . . 73.02 112.696 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.91 -81.03 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 74.43 108.67 172.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -142.86 149.13 48.58 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 117.044 -1.455 . . . . 72.21 109.352 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.67 98.56 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 73.31 110.869 -171.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.97 164.74 35.67 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.475 1.91 . . . . 65.04 108.969 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.1 mt -83.83 128.21 39.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.381 -1.711 . . . . 72.42 106.381 167.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.8 mm -76.88 132.07 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.683 -1.228 . . . . 73.43 107.683 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -118.2 143.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.5 -1.296 . . . . 74.34 107.5 168.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.16 119.83 35.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 106.365 -1.717 . . . . 71.44 106.365 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.44 137.06 58.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.302 -1.74 . . . . 72.35 106.302 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 144.89 27.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.415 0.686 . . . . 71.25 110.493 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.42 121.38 20.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.626 1.17 . . . . 72.44 109.915 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.64 81.3 6.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 104.946 -2.242 . . . . 71.11 104.946 166.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.12 165.62 11.81 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.273 -0.639 . . . . 74.12 109.273 164.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.9 -18.82 5.42 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.527 1.677 . . . . 74.45 115.527 -167.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -86.88 -13.05 45.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.778 -1.106 . . . . 74.05 113.316 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.26 172.91 16.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.566 1.075 . . . . 71.14 112.761 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -73.17 57.3 0.48 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.997 1.319 . . . . 74.03 109.977 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.05 3.9 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.031 -0.871 . . . . 73.11 111.116 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.29 158.47 57.44 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.64 1.56 . . . . 71.45 109.532 171.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.33 122.14 10.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.463 -1.68 . . . . 65.01 106.463 169.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.6 m -92.86 108.98 20.41 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.556 -1.646 . . . . 73.02 106.556 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -67.51 128.55 36.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.156 -1.794 . . . . 72.43 106.156 163.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.2 154.19 31.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.082 -1.821 . . . . 74.33 106.082 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.11 157.33 39.96 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.225 -1.028 . . . . 72.44 108.225 163.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -108.35 91.28 3.58 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 74.2 106.669 172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.2 mt -75.9 175.15 9.06 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.685 -0.857 . . . . 72.31 108.685 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 76.24 13.16 2.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.177 2.191 . . . . 74.22 112.637 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.11 162.31 17.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.698 1.237 . . . . 70.2 111.572 165.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 p -145.64 172.23 13.57 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 129.191 2.997 . . . . 72.2 106.833 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 m -51.87 -61.85 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.607 1.163 . . . . 73.02 111.653 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.4 tttt 50.37 -179.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.691 2.396 . . . . 65.42 113.023 -174.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -161.69 111.46 1.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.56 2.344 . . . . 71.34 106.332 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.1 t -172.69 157.23 3.74 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.447 2.299 . . . . 70.34 107.177 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.4 t -124.79 -170.53 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.576 1.15 . . . . 72.0 110.207 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -127.26 -126.79 2.95 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.903 1.239 . . . . 74.34 110.696 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.878 1.671 . . . . 71.1 106.646 -179.31 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.591 0 N-CA-C 110.502 -1.039 . . . . 73.13 110.502 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 87.5 m -78.09 177.28 8.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.045 0.938 . . . . 75.33 112.135 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -98.57 155.54 36.67 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.203 1.801 . . . . 73.32 109.08 166.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.05 64.78 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.253 2.635 . . . . 71.32 111.72 -175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.18 156.65 25.87 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.665 -1.374 . . . . 73.3 109.665 171.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.36 163.5 39.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.722 -0.473 . . . . 72.11 109.722 168.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.84 84.18 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.096 2.531 . . . . 64.5 111.826 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.08 123.92 0.83 Allowed Glycine 0 C--N 1.338 0.668 0 O-C-N 121.005 -1.059 . . . . 75.11 115.73 171.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.71 157.83 40.54 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.294 1.438 . . . . 74.11 109.646 166.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.27 164.25 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.702 3.601 . . . . 74.43 112.419 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.5 m -137.58 -174.48 3.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 61.51 110.005 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.42 14.68 3.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.931 2.492 . . . . 75.55 116.986 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.453 HD11 ' H ' ' A' ' 13' ' ' ILE . 3.7 mp -56.48 141.28 13.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 126.558 1.943 . . . . 75.53 112.031 -168.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -139.82 116.52 10.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.331 1.452 . . . . 73.21 110.609 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -115.96 131.48 68.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.842 -2.651 . . . . 72.23 103.842 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 m -143.28 149.12 37.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.625 0.726 . . . . 63.53 110.346 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -74.06 159.24 32.94 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.506 -0.924 . . . . 74.55 108.506 162.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.533 ' HG ' ' CD2' ' A' ' 23' ' ' HIS . 74.2 m -143.77 166.32 20.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 130.208 3.403 . . . . 73.15 105.607 170.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -54.42 -44.08 52.81 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.678 1.585 . . . . 63.12 111.781 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -12.18 59.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.9 1.68 . . . . 72.15 113.501 -170.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.89 -160.72 29.88 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.123 -1.191 . . . . 53.14 110.123 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.69 116.15 30.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.228 1.011 . . . . 64.44 109.216 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.533 ' CD2' ' HG ' ' A' ' 18' ' ' SER . 10.5 m170 -69.25 140.23 54.46 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 129.603 3.161 . . . . 71.44 111.454 173.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.27 128.86 42.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.927 -1.138 . . . . 73.51 107.927 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -133.03 150.25 52.15 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.637 -0.875 . . . . 71.32 108.637 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.99 173.89 11.5 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.286 0.366 . . . . 74.33 110.272 173.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -66.85 154.62 91.66 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 119.806 -0.758 . . . . 74.33 112.277 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.36 160.84 44.01 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.752 2.302 . . . . 75.2 111.586 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -71.27 89.58 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.905 3.07 . . . . 73.11 112.182 -172.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -152.76 23.7 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.042 0.756 . . . . 61.3 113.042 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.4 t -126.23 -86.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.011 -0.995 . . . . 74.44 110.894 -171.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -131.75 -4.11 3.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.344 1.429 . . . . 75.4 110.978 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 p -55.66 -19.32 10.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.356 3.062 . . . . 73.43 116.179 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.4 -159.66 31.05 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 121.962 2.165 . . . . 61.11 111.675 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -79.52 93.64 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.822 1.649 . . . . 73.34 109.677 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.4 142.23 15.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.579 -1.267 . . . . 72.42 107.579 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.9 pt -135.49 -17.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.783 1.633 . . . . 74.41 111.464 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -159.93 -171.71 3.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.326 1.851 . . . . 72.5 107.434 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 16.9 m-85 -134.38 174.33 10.65 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.354 -1.467 . . . . 75.14 108.937 162.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 m -144.01 155.4 44.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.334 -0.854 . . . . 74.24 108.799 159.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -140.06 119.35 12.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 104.747 -2.316 . . . . 73.13 104.747 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -116.47 87.4 2.68 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.122 0.963 . . . . 73.41 109.814 -176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 tp -62.63 135.31 57.32 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.1 -1.444 . . . . 74.22 107.1 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.23 148.04 25.3 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.854 -0.795 . . . . 74.21 108.854 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.74 -165.9 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.223 1.809 . . . . 74.24 107.306 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -58.08 179.36 0.07 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 74.51 112.509 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 m 64.7 -158.2 0.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.118 1.767 . . . . 74.21 111.357 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -158.41 23.02 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.848 -1.158 . . . . 73.51 112.747 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -131.12 177.58 7.35 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.179 -0.951 . . . . 64.24 110.376 -166.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 50.88 61.67 3.12 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.866 2.066 . . . . 70.35 112.583 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.5 p -158.91 121.05 3.52 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.655 1.582 . . . . 53.01 107.846 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.27 96.75 0.1 Allowed Glycine 0 C--O 1.235 0.191 0 N-CA-C 109.021 -1.632 . . . . 62.13 109.021 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.02 154.44 92.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.79 0.836 . . . . 72.52 111.308 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.17 67.13 8.68 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.924 3.083 . . . . 71.14 110.353 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -110.18 6.17 22.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.191 0.997 . . . . 74.44 111.197 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.2 t 64.22 -1.77 0.67 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.754 2.022 . . . . 54.24 113.151 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -157.89 110.61 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.529 3.131 . . . . 73.54 104.265 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -127.78 68.83 75.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.971 0.908 . . . . 71.5 109.46 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.15 65.52 8.39 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.225 3.284 . . . . 74.53 112.073 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.78 105.0 1.98 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.875 2.07 . . . . 64.31 108.335 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -89.1 79.69 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.356 -1.35 . . . . 74.25 107.356 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -69.84 -171.35 0.4 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.059 1.744 . . . . 73.55 109.768 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.32 123.39 22.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.112 -0.699 . . . . 65.22 109.112 172.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -141.11 155.66 46.09 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.188 0.595 . . . . 74.51 112.22 -176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ttp -89.25 -39.36 13.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.81 0.844 . . . . 52.12 112.493 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 58.01 86.19 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.282 1.433 . . . . 73.31 109.085 -159.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.77 -5.91 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.904 -0.589 . . . . 73.11 112.067 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.3 103.07 7.74 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.584 0.629 . . . . 71.12 110.798 -163.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -137.17 53.67 1.88 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.03 1.332 . . . . 71.43 109.026 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.34 160.5 29.55 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.311 -0.868 . . . . 74.23 111.228 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -4.68 12.0 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.745 3.63 . . . . 72.22 112.591 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.0 m -43.46 89.31 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 130.047 3.339 . . . . 72.32 113.263 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -60.62 148.98 89.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.186 1.257 . . . . 73.14 111.139 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 p 46.21 47.36 13.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.838 1.255 . . . . 75.44 111.987 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.37 152.37 43.24 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.625 -1.297 . . . . 61.55 110.462 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.08 170.35 14.91 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.656 0.782 . . . . 64.35 110.883 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.55 122.57 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.033 1.733 . . . . 73.45 106.539 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.44 145.9 52.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.059 0.944 . . . . 73.13 109.657 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.8 p -54.28 -37.89 65.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.621 1.169 . . . . 45.03 111.649 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.77 -47.97 41.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.458 1.503 . . . . 74.42 111.268 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -78.99 -9.71 59.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.509 1.124 . . . . 53.04 112.899 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.5 mt -82.03 -34.55 29.46 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.579 1.081 . . . . 74.22 110.658 171.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -66.91 1.53 1.85 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 117.276 2.324 . . . . 73.44 117.276 -163.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -123.38 12.28 9.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.95 1.25 . . . . 72.14 111.505 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.01 156.72 37.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 122.478 1.132 . . . . 74.25 113.53 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 101.72 3.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.808 -1.182 . . . . 74.22 107.808 162.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.07 120.82 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.254 -1.758 . . . . 75.32 106.254 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.21 131.8 51.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 112.799 -2.0 . . . . 75.51 108.987 166.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.61 9.76 13.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.52 1.128 . . . . 75.54 111.162 171.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -6.5 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.799 -1.188 . . . . 71.14 113.942 -162.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.045 2.138 . . . . 73.33 111.026 173.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -151.8 156.18 34.21 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.604 1.561 . . . . 75.22 108.009 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.41 122.35 9.57 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.7 2.267 . . . . 72.41 108.748 164.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.47 -170.44 2.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.669 2.387 . . . . 73.31 108.645 161.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.9 mt -129.48 129.2 66.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 75.54 108.53 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.5 mm -72.49 142.19 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.507 1.523 . . . . 71.54 110.088 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -128.21 162.25 27.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.26 1.024 . . . . 75.51 108.934 167.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -134.98 84.72 2.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.327 1.851 . . . . 74.43 106.472 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.28 133.44 42.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.032 -1.469 . . . . 75.21 107.032 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.41 156.98 44.09 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.575 0.547 . . . . 54.01 110.497 161.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . . . -92.35 109.44 20.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.458 1.103 . . . . 64.14 109.758 -171.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HA ' ' CG ' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -69.09 97.98 0.94 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.811 0.844 . . . . 74.31 109.142 -170.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -122.54 177.17 5.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.706 2.002 . . . . 61.22 110.824 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.63 -30.97 63.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.927 1.691 . . . . 74.12 113.821 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -8.96 58.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.207 1.188 . . . . 74.21 114.207 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.42 2.26 87.51 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.834 -1.166 . . . . 70.5 113.263 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 102' ' ' ARG . 19.4 p90 45.59 36.16 2.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.064 1.746 . . . . 74.33 115.448 156.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.75 -66.5 2.8 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.519 2.009 . . . . 73.21 113.455 -165.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.84 152.07 81.16 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.158 1.906 . . . . 73.11 110.241 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.35 169.86 14.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.584 1.154 . . . . 64.53 108.865 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.1 m -97.26 113.99 25.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.303 0.641 . . . . 75.14 110.045 -176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.49 75.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.505 1.522 . . . . 75.14 110.04 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.9 155.14 7.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.858 -1.164 . . . . 75.43 107.858 164.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -121.74 124.59 44.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.705 -1.591 . . . . 73.21 106.705 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.405 ' C ' ' H ' ' A' ' 117' ' ' GLN . 14.3 t90 -75.17 82.73 2.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.132 0.424 . . . . 74.33 109.859 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.7 mt -71.47 15.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.773 1.027 . . . . 74.14 113.773 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 115' ' ' TRP . 1.9 tt0 -95.74 -1.83 49.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.097 1.359 . . . . 72.14 111.637 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -109.22 161.78 14.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.835 1.198 . . . . 72.22 110.449 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.53 158.65 15.95 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.659 1.584 . . . . 73.34 106.875 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 54.2 p -87.48 11.42 14.77 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.974 1.31 . . . . 74.33 112.333 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -68.95 -59.96 2.69 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.622 -1.299 . . . . 75.11 111.684 -165.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -163.73 164.28 23.85 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.492 1.917 . . . . 73.35 108.154 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.6 m -146.45 131.58 18.35 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 120.051 1.296 . . . . 74.31 111.142 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.7 m -151.4 -65.42 0.18 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.257 1.023 . . . . 72.34 109.614 162.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.22 3.83 1.59 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.791 -1.56 . . . . 64.31 115.568 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.201 1 C-N-CA 133.071 4.549 . . . . 74.54 107.185 -170.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.513 0 N-CA-C 109.919 -1.273 . . . . 64.33 109.919 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 65.3 m -67.86 146.76 53.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.681 0.792 . . . . 72.53 109.606 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.7 tp -149.03 72.45 10.26 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.199 0.6 . . . . 74.21 109.675 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.69 157.67 60.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.258 1.306 . . . . 64.23 109.139 163.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.16 66.28 1.71 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.616 -0.993 . . . . 73.51 110.616 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.24 161.96 75.95 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.336 0.654 . . . . 75.35 110.634 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.03 6.53 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.735 3.624 . . . . 64.13 114.581 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.2 143.77 15.32 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 107.958 -2.057 . . . . 71.24 107.958 170.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.3 154.7 36.42 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.053 1.341 . . . . 74.34 108.278 162.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.59 158.85 30.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.296 1.998 . . . . 71.52 111.934 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -133.09 -178.09 4.81 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.527 1.531 . . . . 75.33 109.414 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.21 12.98 4.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.54 1.536 . . . . 53.33 114.823 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.22 132.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.948 1.299 . . . . 71.43 110.049 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.8 152.76 45.45 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.534 1.133 . . . . 61.34 110.934 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -142.17 115.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.541 -1.651 . . . . 72.43 106.541 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -111.35 -167.7 1.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.442 2.297 . . . . 72.14 110.629 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -143.22 146.51 33.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.903 -1.147 . . . . 75.15 107.903 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -146.45 160.15 42.75 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 126.234 1.814 . . . . 75.33 106.95 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.99 73.44 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.777 1.652 . . . . 74.24 111.594 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.79 -59.73 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 128.807 2.843 . . . . 75.4 105.692 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.15 -166.15 38.56 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.683 -1.367 . . . . 62.03 109.683 -163.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.14 113.72 26.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.731 1.612 . . . . 53.32 110.583 -165.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 78.42 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.772 3.229 . . . . 73.02 112.187 164.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.87 110.29 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.873 -1.142 . . . . 75.04 108.41 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -130.27 158.22 40.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.595 0.634 . . . . 63.32 111.621 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 25.6 p90 -173.64 175.7 2.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.23 2.612 . . . . 63.11 110.377 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -115.46 165.21 14.9 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.964 0.906 . . . . 71.13 111.932 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.14 156.97 51.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.685 2.923 . . . . 72.13 111.226 167.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.64 139.64 70.71 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.9 1.733 . . . . 64.41 109.596 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 t -127.67 58.95 1.47 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.77 -2.308 . . . . 64.34 104.77 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.39 -85.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.164 -1.791 . . . . 75.43 106.164 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.1 p -112.86 166.11 11.69 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.344 0.52 . . . . 74.33 110.425 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 m -56.67 -72.92 0.07 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.568 1.547 . . . . 72.52 111.546 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.43 -173.8 11.1 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.474 -1.45 . . . . 74.11 109.474 -164.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -137.23 68.54 1.41 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.649 1.58 . . . . 74.53 107.881 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.8 140.52 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.702 -0.851 . . . . 73.4 108.702 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 pt -135.89 -21.65 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.514 1.526 . . . . 72.14 111.34 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -158.02 174.8 14.68 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.117 1.767 . . . . 72.4 106.929 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.75 163.63 32.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.084 0.954 . . . . 74.1 108.973 174.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -150.61 153.05 34.99 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.119 -0.988 . . . . 74.14 112.496 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.47 142.56 43.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 126.095 1.758 . . . . 63.03 107.533 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.7 120.22 40.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.562 -2.014 . . . . 71.31 105.562 170.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.36 132.93 53.67 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.257 1.423 . . . . 74.25 107.198 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.44 131.19 40.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 118.17 -0.919 . . . . 73.23 109.178 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.91 179.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.725 1.21 . . . . 74.11 110.79 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 79.85 1.26 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.253 1.821 . . . . 73.25 109.614 167.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.7 p -159.06 163.21 36.5 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.445 -0.576 . . . . 62.25 109.445 166.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.5 m -75.53 -175.48 2.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.005 0.522 . . . . 72.23 110.079 170.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 66.14 87.2 0.12 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.029 1.731 . . . . 73.42 111.633 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 138.35 43.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.109 1.364 . . . . 75.33 108.286 164.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 173.95 135.58 0.04 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 129.558 3.143 . . . . 73.42 107.572 161.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.02 21.05 0.07 OUTLIER Glycine 0 C--N 1.336 0.541 0 CA-C-O 118.662 -1.077 . . . . 73.35 115.013 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.34 161.78 45.83 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.194 1.398 . . . . 62.32 112.132 -163.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.55 179.3 5.27 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.849 2.366 . . . . 75.11 111.346 167.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? 53.14 62.21 2.78 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.201 1.801 . . . . 74.51 111.748 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.6 m -71.94 45.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.054 1.741 . . . . 73.32 113.796 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.68 6.59 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.313 2.245 . . . . 72.52 109.945 168.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -68.91 153.54 95.93 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.795 -0.817 . . . . 74.34 108.795 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.16 155.33 35.03 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.538 2.158 . . . . 75.23 111.152 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.46 60.21 4.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.497 1.519 . . . . 73.12 110.878 -171.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -84.86 149.65 25.54 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.464 0.706 . . . . 75.51 109.47 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt 50.04 -157.11 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.47 . . . . 73.14 109.842 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 174.64 104.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.098 2.159 . . . . 73.23 107.039 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -127.1 146.56 50.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.939 1.296 . . . . 75.23 110.106 -166.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttp -77.67 130.25 36.58 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.591 -1.263 . . . . 74.21 107.591 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -79.13 60.17 2.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.57 1.148 . . . . 75.03 109.551 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -53.19 -27.21 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 126.501 1.92 . . . . 71.32 113.903 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.0 121.71 27.03 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.45 -2.426 . . . . 73.24 104.45 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.5 t -152.03 79.59 1.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.733 -1.951 . . . . 74.24 105.733 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.93 176.56 45.0 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.717 -0.614 . . . . 75.43 112.358 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.26 -8.98 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.367 3.378 . . . . 73.33 112.64 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.38 158.14 8.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.59 1.556 . . . . 54.11 112.358 -172.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.16 -171.18 1.01 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.819 3.013 . . . . 71.04 110.653 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.83 110.76 0.25 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.806 2.442 . . . . 53.33 110.486 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.6 m -104.81 135.42 46.22 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.841 0.746 . . . . 72.12 110.261 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.48 119.96 10.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.335 1.054 . . . . 75.21 109.515 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.56 114.41 9.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.109 -1.812 . . . . 75.45 106.109 167.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.42 158.23 27.27 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.804 0.842 . . . . 72.34 110.744 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -50.06 -49.49 51.03 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.931 0.892 . . . . 64.41 112.318 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 p -59.99 -25.52 65.33 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.508 1.049 . . . . 61.33 113.697 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -40.01 32.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.845 1.202 . . . . 75.33 110.431 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.39 -45.31 94.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.319 1.047 . . . . 75.14 110.711 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -62.72 -24.18 67.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.513 1.525 . . . . 64.13 112.75 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -92.38 -9.52 41.44 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.211 1.004 . . . . 72.13 112.033 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.43 147.27 49.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.547 1.067 . . . . 75.23 111.232 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -93.62 129.3 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.382 1.073 . . . . 73.11 111.226 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -68.68 133.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 126.216 1.806 . . . . 75.52 109.331 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.47 111.29 3.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.856 -0.794 . . . . 61.51 108.856 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -103.62 64.1 0.8 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.144 0.973 . . . . 75.44 108.761 165.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 -26.77 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.029 -0.987 . . . . 74.44 113.616 171.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -146.52 -55.36 0.26 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.23 0.923 . . . . 73.34 111.266 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -149.53 144.53 17.94 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 117.161 -1.399 . . . . 75.12 108.19 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.63 97.37 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.144 2.563 . . . . 42.01 109.883 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.98 152.43 39.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.312 2.245 . . . . 75.13 109.2 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.5 mt -72.16 133.76 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.964 -1.495 . . . . 74.45 106.964 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.7 mm -81.61 136.07 23.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.068 0.947 . . . . 63.15 108.992 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -122.15 150.4 42.27 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.104 1.761 . . . . 75.12 107.785 165.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -133.26 132.96 42.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.169 -1.789 . . . . 75.53 106.169 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.8 mt -131.6 140.46 48.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.41 -0.959 . . . . 75.21 108.41 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.08 153.79 34.66 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.612 1.165 . . . . 74.33 110.497 170.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.14 141.38 41.93 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.734 0.813 . . . . 62.2 109.812 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.4 tpt85 -86.04 108.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 105.967 -1.864 . . . . 75.14 105.967 164.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -114.57 -176.15 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.398 -0.964 . . . . 71.41 108.398 165.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -52.51 -39.38 61.24 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.726 2.01 . . . . 72.0 112.048 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -47.7 53.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.28 -0.637 . . . . 73.43 109.28 -166.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.29 174.75 21.05 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.46 -0.656 . . . . 72.52 111.46 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -75.45 102.88 5.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.646 -1.612 . . . . 74.32 106.646 163.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.36 -64.71 0.86 Allowed Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.324 -1.265 . . . . 72.45 112.126 -171.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.73 179.02 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.21 2.607 . . . . 73.54 110.002 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.74 107.01 1.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.749 0.82 . . . . 73.41 109.159 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 m -71.53 110.13 5.92 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.386 -0.968 . . . . 74.14 108.386 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -82.08 103.12 11.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.451 1.5 . . . . 75.55 109.205 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.3 159.51 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.282 1.433 . . . . 55.14 107.747 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.43 155.45 45.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.724 -0.61 . . . . 72.21 110.325 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -138.32 109.56 6.88 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.107 0.963 . . . . 74.13 112.078 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.32 -177.93 5.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 128.732 2.813 . . . . 74.42 109.299 -177.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 73.72 9.84 4.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.14 1.776 . . . . 71.14 112.193 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.88 15.71 2.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.185 2.194 . . . . 74.42 114.417 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.1 m -104.25 78.88 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 119.002 -2.311 . . . . 62.33 109.636 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 t -166.67 84.44 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.83 1.252 . . . . 61.21 109.536 159.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -173.16 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.747 1.219 . . . . 73.04 111.691 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.52 55.22 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.66 1.584 . . . . 74.21 111.263 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.5 t 45.63 68.98 0.5 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.119 1.768 . . . . 74.04 113.307 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 p -64.77 -80.09 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.61 1.564 . . . . 72.14 110.799 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.39 156.87 7.08 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 127.135 2.302 . . . . 60.34 109.893 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.25 1.124 0 N-CA-C 106.156 -1.794 . . . . 72.03 106.156 167.67 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.034 -1.226 . . . . 72.44 110.034 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 99.5 m -63.4 -54.08 42.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.57 1.548 . . . . 62.45 113.61 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 45.11 75.1 0.69 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.106 1.363 . . . . 73.12 110.861 -161.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.72 -35.66 7.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.177 1.251 . . . . 61.25 112.535 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.63 84.96 0.97 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 124.749 1.166 . . . . 65.23 110.851 -172.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -111.07 87.41 7.11 Favored Pre-proline 0 C--O 1.223 -0.325 0 C-N-CA 127.77 2.428 . . . . 72.44 110.694 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.55 96.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.376 2.717 . . . . 71.35 110.927 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.48 113.78 0.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 124.117 0.865 . . . . 65.24 111.457 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.36 153.46 8.81 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.09 1.756 . . . . 72.11 109.14 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.33 166.9 19.95 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 124.976 3.784 . . . . 74.22 114.396 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -136.59 -179.12 5.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.383 2.273 . . . . 51.31 110.447 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.82 14.93 5.51 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 128.627 2.771 . . . . 74.22 115.386 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 131.65 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.219 0.608 . . . . 73.32 111.197 -162.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -125.17 148.5 48.57 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.715 1.206 . . . . 73.43 108.728 173.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -148.02 141.57 19.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.31 -1.737 . . . . 72.34 106.31 168.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -150.17 23.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.218 1.407 . . . . 74.24 112.962 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 tttm 48.68 -173.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.611 3.164 . . . . 73.21 112.944 -173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.87 165.13 19.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.192 1.397 . . . . 74.34 107.57 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.91 -24.41 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.82 2.347 . . . . 70.42 112.345 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.06 -9.92 16.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.984 2.114 . . . . 71.43 111.182 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.03 -123.08 1.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.686 -1.366 . . . . 50.24 109.686 -174.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.36 124.54 24.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.636 -0.697 . . . . 74.21 110.457 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -67.12 90.69 0.2 Allowed 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.448 0.699 . . . . 74.31 109.427 168.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.84 164.11 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.0 0.92 . . . . 73.22 108.558 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.96 157.87 16.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.017 1.727 . . . . 71.51 109.668 168.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -171.65 -179.73 2.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.74 2.016 . . . . 74.25 109.527 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -127.59 165.21 31.3 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 127.159 2.184 . . . . 73.33 109.432 169.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -66.21 168.49 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.668 2.912 . . . . 74.24 110.735 165.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.02 152.86 80.23 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.098 1.198 . . . . 72.15 109.861 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 p -118.68 17.61 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.542 1.137 . . . . 71.15 111.821 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.02 -45.25 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.825 1.25 . . . . 70.54 110.533 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.4 p -148.37 167.09 26.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.633 1.573 . . . . 71.45 107.926 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -46.23 -61.18 1.89 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.307 1.843 . . . . 71.12 111.945 -174.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.06 113.12 0.06 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.899 1.238 . . . . 72.51 112.943 174.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -89.35 66.38 7.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.006 0.922 . . . . 70.15 109.419 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -71.03 151.64 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.15 -1.426 . . . . 64.13 107.15 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.3 pt -135.42 -21.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.376 1.87 . . . . 74.12 111.836 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.72 -167.36 1.52 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.813 0.845 . . . . 71.15 109.486 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -152.04 172.91 15.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.658 1.983 . . . . 72.33 108.365 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -150.29 175.68 11.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.812 0.733 . . . . 53.34 111.212 163.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -144.24 129.74 14.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.605 1.962 . . . . 73.11 107.222 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.405 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -119.71 119.37 33.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.558 -1.645 . . . . 73.04 106.558 165.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 tp -87.22 126.83 35.06 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.634 -1.987 . . . . 74.31 105.634 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.11 138.82 50.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.397 0.544 . . . . 74.21 110.524 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 pt -126.72 -178.84 2.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 125.925 1.69 . . . . 73.25 109.786 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 93.77 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.68 1.592 . . . . 75.14 109.2 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 p -163.39 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.54 1.936 . . . . 70.11 109.1 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.2 m 45.07 67.89 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.509 1.924 . . . . 73.45 112.508 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -149.72 112.45 4.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.36 1.464 . . . . 74.25 109.658 -170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -163.1 120.06 1.87 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.701 1.2 . . . . 74.23 109.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.8 m -157.16 40.98 0.32 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.554 1.141 . . . . 63.42 112.421 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.82 113.13 0.56 Allowed Glycine 0 C--N 1.343 0.956 0 O-C-N 120.139 -1.601 . . . . 70.53 113.037 -169.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.15 165.57 13.16 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.647 1.579 . . . . 64.53 111.785 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.58 -164.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 1 C-N-CA 126.271 4.647 . . . . 61.44 111.598 167.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.96 19.18 11.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.33 1.852 . . . . 73.15 113.875 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m 51.09 76.21 0.17 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.649 1.58 . . . . 75.01 111.533 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 m -118.24 -40.39 2.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.091 -1.413 . . . . 75.13 109.419 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -150.46 144.4 17.37 Favored Pre-proline 0 C--O 1.241 0.648 0 O-C-N 120.903 -1.123 . . . . 75.54 110.565 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.65 79.96 2.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.534 2.823 . . . . 74.04 109.468 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.87 37.76 0.81 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.675 1.59 . . . . 73.23 109.576 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -79.47 62.41 3.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.213 1.805 . . . . 75.04 110.64 -165.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mp 44.58 -170.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 C-N-CA 132.968 4.507 . . . . 65.13 112.921 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.19 135.05 15.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.42 -0.809 . . . . 63.25 109.865 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.405 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 78.5 m-85 -149.23 -164.16 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.234 2.613 . . . . 75.41 107.846 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.9 ttp -112.48 -6.69 13.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.592 1.157 . . . . 75.33 113.153 166.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 44.23 66.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.373 2.269 . . . . 64.32 111.614 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.34 -13.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 113.554 0.946 . . . . 74.32 113.554 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -57.13 135.72 56.37 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.087 -1.008 . . . . 73.34 112.027 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -142.37 97.68 3.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.761 2.024 . . . . 74.15 107.73 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 166.94 5.9 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.215 0.912 . . . . 72.15 113.376 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 -57.4 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.791 1.661 . . . . 74.05 113.716 -166.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.0 m 57.33 167.66 0.06 OUTLIER Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.208 0.913 . . . . 73.42 112.872 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.99 -24.23 45.77 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.465 1.443 . . . . 73.42 112.293 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 p -167.35 41.56 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.913 0.885 . . . . 64.14 109.33 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 16.2 p 45.11 -166.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.44 1.896 . . . . 53.4 112.432 -161.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.09 115.05 5.71 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.268 -0.895 . . . . 74.31 109.326 149.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.53 124.28 45.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 126.116 1.766 . . . . 70.41 107.502 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.19 49.04 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.212 1.805 . . . . 74.33 110.938 169.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t -70.46 -16.91 62.98 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.019 1.728 . . . . 70.03 112.311 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t -46.13 -53.83 9.7 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.008 0.822 . . . . 75.02 109.489 165.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -72.43 -19.96 61.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.192 0.812 . . . . 74.23 113.192 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.25 -34.02 65.62 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.547 0.612 . . . . 71.33 110.868 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -54.18 -47.46 72.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.849 0.459 . . . . 73.24 109.768 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.46 -7.48 38.32 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.771 1.628 . . . . 65.05 113.216 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.64 164.82 7.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.347 1.07 . . . . 74.44 110.713 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -128.12 160.23 32.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.842 -0.799 . . . . 72.13 108.842 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.56 123.38 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 106.964 -1.495 . . . . 70.15 106.964 -165.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.92 127.81 33.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.894 -1.151 . . . . 71.15 107.894 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.32 31.98 5.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.804 -1.184 . . . . 73.25 107.804 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.61 -11.87 7.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.967 1.307 . . . . 71.34 110.344 -171.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 p -142.25 -66.08 0.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.395 1.478 . . . . 74.11 109.861 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -150.48 152.92 33.71 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 127.802 2.441 . . . . 72.32 107.576 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.12 104.63 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.689 2.926 . . . . 73.25 109.556 173.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.74 153.1 38.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.17 1.388 . . . . 65.55 109.839 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 130.12 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.105 -1.813 . . . . 74.31 106.105 158.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.12 136.57 22.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.954 -1.499 . . . . 74.44 106.954 166.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.32 159.33 20.34 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.025 0.917 . . . . 74.01 110.25 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -131.19 100.73 5.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.859 1.664 . . . . 74.33 106.879 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.36 129.59 75.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 104.316 -2.475 . . . . 72.21 104.316 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.67 163.94 31.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.625 0.726 . . . . 74.21 109.863 171.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.99 132.7 34.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.821 -1.081 . . . . 73.41 108.286 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -84.5 105.49 15.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.334 -1.728 . . . . 74.21 106.334 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -115.18 -179.19 3.56 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.009 0.924 . . . . 73.14 110.484 173.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.34 -35.07 71.36 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.031 1.733 . . . . 73.11 114.526 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.11 -54.95 6.26 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 125.61 1.564 . . . . 73.51 108.957 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 159.34 164.39 14.59 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.414 -1.074 . . . . 70.52 110.414 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -87.49 45.54 1.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.616 1.566 . . . . 74.14 110.136 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.28 -87.14 0.07 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.295 1.902 . . . . 74.12 111.671 -156.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.46 163.48 38.89 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.151 1.901 . . . . 54.02 109.773 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.75 148.66 35.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.415 -0.957 . . . . 70.45 108.415 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.8 m -75.88 132.84 40.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.261 -1.755 . . . . 61.44 106.261 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -113.83 86.61 2.44 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 105.799 -1.926 . . . . 71.34 105.799 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.75 156.73 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 73.42 108.618 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.79 116.4 28.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.921 -1.511 . . . . 71.24 106.921 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -72.99 75.66 1.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.76 -1.2 . . . . 73.44 107.76 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.4 mt -70.99 150.79 45.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.5 -1.667 . . . . 72.24 106.5 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 66.29 24.29 10.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 63.51 111.146 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.4 173.92 8.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.792 -0.567 . . . . 65.51 111.76 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.9 m -144.78 125.95 14.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.439 1.496 . . . . 72.34 107.847 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.08 163.58 26.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.813 1.245 . . . . 74.34 113.527 -166.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.04 60.71 2.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.997 2.119 . . . . 73.03 109.814 -166.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -107.71 145.91 32.8 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.755 0.822 . . . . 64.22 111.746 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.7 m 59.79 174.39 0.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.015 2.526 . . . . 71.11 113.45 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.8 t -80.0 -30.23 39.58 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 63.03 109.824 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 79.22 -52.69 4.09 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.407 -1.218 . . . . 74.3 111.071 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.259 1.567 0 C-N-CA 125.28 1.432 . . . . 74.3 108.352 176.454 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 108.359 -1.896 . . . . 71.53 108.359 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.2 t -145.64 22.5 1.45 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.697 1.199 . . . . 74.2 110.588 -175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.72 82.38 34.34 Favored Pre-proline 0 C--O 1.237 0.431 0 N-CA-C 107.296 -1.372 . . . . 74.14 107.296 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.58 64.84 8.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.378 2.052 . . . . 63.5 111.56 -171.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.43 159.12 24.24 Favored Glycine 0 C--O 1.242 0.595 0 N-CA-C 111.001 -0.84 . . . . 60.21 111.001 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -76.14 159.51 80.2 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 117.255 0.528 . . . . 70.52 110.124 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.97 5.66 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 125.149 3.9 . . . . 71.15 116.55 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.4 173.12 49.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.675 1.131 . . . . 74.44 112.394 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.3 161.02 24.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.225 1.41 . . . . 64.44 111.25 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.37 153.86 65.81 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.02 2.48 . . . . 74.15 110.989 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.4 m -137.38 -174.67 3.82 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.272 1.429 . . . . 74.15 110.605 -171.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.02 25.62 12.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.205 2.202 . . . . 71.41 114.205 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.25 141.12 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.681 1.192 . . . . 73.34 110.81 -172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -125.17 149.53 47.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.297 1.439 . . . . 75.22 109.007 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.0 mt -152.01 95.84 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.268 -1.753 . . . . 74.22 106.268 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 p -74.7 163.01 28.19 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.517 -0.92 . . . . 71.33 108.517 164.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -91.38 157.75 16.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.28 -1.378 . . . . 74.33 107.28 156.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 m -146.97 165.2 19.9 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.393 -1.336 . . . . 65.11 107.393 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.31 -37.43 61.28 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.324 1.35 . . . . 72.31 112.696 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.99 -47.99 14.06 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.331 -0.855 . . . . 74.52 110.682 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.74 -146.38 4.33 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.585 -0.606 . . . . 61.24 111.585 -156.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.03 133.8 32.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.321 1.448 . . . . 74.41 107.743 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -78.11 79.81 4.56 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.318 -0.623 . . . . 65.13 109.318 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.43 132.17 52.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.357 -1.349 . . . . 72.41 107.357 164.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -144.64 152.14 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.391 1.451 . . . . 72.35 109.255 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -137.56 167.57 21.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.206 1.403 . . . . 74.44 110.565 172.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.77 163.28 69.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.04 0.936 . . . . 74.34 112.328 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.11 164.83 26.2 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.391 2.727 . . . . 73.24 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.67 77.39 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.432 2.755 . . . . 65.21 110.359 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 t -133.02 24.73 4.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.293 2.237 . . . . 73.24 109.422 -171.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.53 -40.93 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.926 1.291 . . . . 74.14 107.95 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.0 p -149.45 174.08 12.87 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.017 1.727 . . . . 71.52 110.419 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -64.24 19.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.572 3.149 . . . . 72.42 114.88 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.59 -168.15 35.84 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 120.597 -1.314 . . . . 73.45 114.037 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -135.65 113.4 10.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.193 -1.004 . . . . 74.42 109.505 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -109.67 133.63 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.084 1.754 . . . . 64.13 108.144 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -131.62 -11.42 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 72.12 112.33 -163.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -160.45 -169.51 2.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.222 2.209 . . . . 65.22 106.685 163.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -128.4 169.27 14.47 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.22 -1.55 . . . . 74.35 108.879 165.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.0 m -145.03 156.93 44.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.171 -0.956 . . . . 72.41 110.526 166.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.66 125.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 105.618 -1.993 . . . . 74.11 105.618 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.23 127.33 55.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.735 -1.58 . . . . 74.11 106.735 171.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -121.85 130.54 53.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.983 1.713 . . . . 74.42 107.574 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.21 126.03 28.28 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.907 0.883 . . . . 71.42 113.068 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.53 -170.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.769 2.428 . . . . 74.53 109.236 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -87.88 95.06 9.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.046 1.738 . . . . 73.51 110.695 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t 174.65 162.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.742 3.217 . . . . 74.14 108.121 160.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.1 t -146.78 141.36 26.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.815 1.246 . . . . 74.2 108.503 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -157.35 164.14 37.89 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.612 0.642 . . . . 74.51 111.05 170.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.38 168.36 18.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.115 2.566 . . . . 72.3 108.138 155.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 m -151.42 123.1 7.98 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.07 1.348 . . . . 73.23 107.572 166.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.97 83.26 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.943 1.735 . . . . 62.4 113.846 165.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.41 163.83 47.7 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.204 1.002 . . . . 74.41 111.807 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 172.32 11.57 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.167 2.578 . . . . 74.33 111.803 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 67.49 85.4 0.14 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 127.394 2.278 . . . . 54.4 107.926 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.1 m -63.69 74.18 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.203 1.801 . . . . 73.12 110.833 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -165.15 -62.67 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.804 1.242 . . . . 75.33 108.557 -163.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.262 73.0 p 50.74 163.2 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.865 2.466 . . . . 73.54 114.011 -161.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.38 -175.75 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.631 2.221 . . . . 74.11 110.24 165.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.07 67.05 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 61.2 108.674 166.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 43.7 76.87 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.287 3.035 . . . . 74.51 111.935 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.07 163.9 0.33 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.396 1.878 . . . . 74.55 113.512 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.27 82.72 1.97 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.333 0.587 . . . . 64.12 111.17 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -130.74 150.41 51.93 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.308 1.043 . . . . 73.31 108.911 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ttp -113.99 133.84 55.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.107 1.763 . . . . 72.44 108.233 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -82.19 56.73 3.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.606 1.562 . . . . 74.25 112.331 -167.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.66 -19.61 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 115.924 1.824 . . . . 73.34 115.924 -167.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.08 118.63 7.03 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.842 1.201 . . . . 73.51 110.032 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.6 m -152.13 73.69 1.06 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 127.172 2.189 . . . . 63.21 107.625 164.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.44 166.06 25.91 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 121.562 -0.711 . . . . 70.25 111.799 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 -55.64 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.614 2.21 . . . . 72.51 109.836 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -76.57 144.51 73.82 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.247 0.619 . . . . 74.35 109.785 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 -26.15 16.68 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.235 1.957 . . . . 73.53 112.882 -168.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p -80.88 68.9 7.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.232 0.924 . . . . 74.24 110.216 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.2 m -69.3 115.45 8.59 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.391 -0.818 . . . . 74.24 110.675 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.8 -178.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.977 2.111 . . . . 71.54 112.528 159.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.74 146.69 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.521 1.528 . . . . 71.21 108.222 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -96.26 161.81 13.78 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.601 2.36 . . . . 61.22 112.778 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -45.87 67.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.961 1.304 . . . . 63.24 111.72 169.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -62.37 -28.16 69.58 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.615 0.643 . . . . 64.12 111.623 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -80.36 -46.56 15.86 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.327 -0.858 . . . . 54.22 109.046 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.1 mt -52.83 -26.7 15.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.193 1.797 . . . . 71.55 112.926 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.4 m -45.36 -33.88 2.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.12 1.368 . . . . 70.12 113.232 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -95.0 -10.87 29.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.323 0.649 . . . . 72.21 111.263 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.66 24.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.061 0.846 . . . . 71.45 110.123 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.68 120.39 27.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.101 0.96 . . . . 73.35 109.819 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.08 138.24 21.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.992 1.717 . . . . 73.12 109.287 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.95 111.33 4.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.816 0.846 . . . . 74.33 111.006 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -100.65 20.09 15.78 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.461 -0.774 . . . . 73.03 110.993 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -4.01 6.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.456 0.909 . . . . 75.03 113.456 -163.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 -63.31 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.275 1.43 . . . . 75.23 108.492 161.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -153.68 154.19 29.95 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 106.536 -1.653 . . . . 72.45 106.536 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.29 110.16 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.389 2.059 . . . . 74.41 109.544 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.92 168.56 21.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.72 2.008 . . . . 73.32 109.301 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.7 mt -101.74 140.05 21.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.274 -1.75 . . . . 73.01 106.274 166.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.42 124.52 73.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.273 1.029 . . . . 72.03 110.085 -163.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.47 137.55 54.77 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.848 0.859 . . . . 63.52 112.488 -167.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -112.78 99.29 7.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.773 1.629 . . . . 72.14 108.057 167.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -98.34 144.75 10.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.396 -1.705 . . . . 72.54 106.396 174.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.23 142.28 29.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.284 1.034 . . . . 74.25 109.65 168.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.94 122.51 23.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.338 1.055 . . . . 74.41 108.87 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -72.89 117.83 15.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.856 -1.535 . . . . 74.23 106.856 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -131.59 -176.92 4.19 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 127.582 2.353 . . . . 74.54 109.502 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.78 -27.94 69.53 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.503 0.557 . . . . 74.11 112.503 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -74.48 -32.13 62.45 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.158 -0.964 . . . . 73.41 113.05 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.73 166.8 38.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.597 -1.001 . . . . 63.31 110.597 -166.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.08 64.14 3.2 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.563 1.545 . . . . 74.51 111.689 -170.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.43 -75.44 0.35 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.291 -1.124 . . . . 74.44 110.291 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.99 167.65 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.06 3.173 . . . . 73.51 110.21 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 162.86 39.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.025 2.13 . . . . 71.24 107.192 165.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.2 t -79.95 179.32 7.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.161 -0.681 . . . . 71.23 109.161 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -150.54 73.01 1.11 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.143 0.577 . . . . 75.23 110.031 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.3 m -93.24 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.473 -0.767 . . . . 72.45 110.424 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 112.24 13.46 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.888 1.275 . . . . 75.35 110.232 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -71.65 82.68 0.85 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.73 0.812 . . . . 73.23 110.704 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.83 53.9 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.796 1.638 . . . . 74.24 108.68 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 17.67 2.99 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.874 1.27 . . . . 75.14 109.609 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.17 168.94 18.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.034 0.445 . . . . 72.24 110.271 164.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -155.3 129.2 8.68 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.624 -1.991 . . . . 61.34 105.624 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 m 53.93 30.44 11.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.359 1.064 . . . . 53.34 113.788 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -53.37 -57.73 9.57 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 117.723 -1.132 . . . . 73.45 112.181 -163.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.3 158.28 26.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.192 0.906 . . . . 64.01 110.59 160.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.2 p -78.63 -21.77 47.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.374 1.25 . . . . 53.54 114.374 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 m 48.76 82.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.242 1.417 . . . . 65.24 111.995 -175.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -46.62 -38.55 9.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.808 1.194 . . . . 45.04 114.043 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.51 1.524 . . . . 74.23 109.885 177.396 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.683 0 N-CA-C 110.259 -1.136 . . . . 61.0 110.259 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.3 t -150.65 15.86 0.78 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.278 1.831 . . . . 71.44 110.466 163.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.18 151.36 46.58 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 105.812 -1.922 . . . . 74.33 105.812 156.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.96 106.77 1.57 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.601 2.868 . . . . 71.5 110.533 -174.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.59 -9.01 87.41 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.28 -0.888 . . . . 72.24 112.747 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -123.3 163.36 34.54 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 127.379 2.272 . . . . 74.33 108.273 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -55.48 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.76 2.307 . . . . 71.43 112.868 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.73 41.58 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.733 -1.747 . . . . 62.24 108.733 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.27 159.42 32.11 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.755 1.622 . . . . 72.32 109.353 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.06 154.27 75.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.232 1.288 . . . . 65.44 111.719 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.3 m -142.41 -174.65 4.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.614 1.566 . . . . 74.34 109.488 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.84 37.79 10.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.034 2.534 . . . . 74.3 113.193 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.52 126.45 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.506 -1.294 . . . . 75.34 107.506 -171.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -137.56 150.76 47.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.669 -0.863 . . . . 73.51 108.669 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.86 149.74 30.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.459 -2.052 . . . . 74.33 105.459 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.81 135.84 36.65 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.309 -1.367 . . . . 70.31 107.309 174.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -72.01 143.85 49.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.398 -1.334 . . . . 73.12 107.398 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -126.34 165.64 26.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 125.877 1.671 . . . . 72.32 108.023 169.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.65 -15.2 40.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.359 2.04 . . . . 64.42 112.353 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.24 -29.22 13.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.753 1.221 . . . . 74.43 110.787 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.14 -152.37 16.94 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 116.377 -2.346 . . . . 63.14 110.539 -164.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.2 127.95 54.23 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 121.147 2.474 . . . . 71.14 108.731 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.49 126.14 26.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.214 -1.032 . . . . 74.13 108.214 164.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -113.12 145.33 41.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.031 -1.099 . . . . 72.4 108.031 170.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 t -150.28 171.82 16.35 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.415 0.552 . . . . 65.5 111.234 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.434 ' CE3' HD11 ' A' ' 99' ' ' ILE . 15.3 p90 -173.45 -171.57 0.7 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.765 2.026 . . . . 74.3 111.189 -172.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -111.57 165.49 12.72 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 127.948 2.499 . . . . 73.41 110.639 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -66.64 166.68 21.33 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.956 3.104 . . . . 53.3 112.598 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.46 -4.64 14.35 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 124.018 3.145 . . . . 72.41 111.773 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -148.25 138.43 22.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.916 -1.513 . . . . 54.11 106.916 -174.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.48 -49.53 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.498 0.666 . . . . 75.52 110.621 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 t -65.22 158.97 24.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.39 1.076 . . . . 63.13 109.907 163.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.8 m -54.86 -45.0 74.49 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.409 1.263 . . . . 73.31 114.409 -163.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.5 -171.48 46.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.965 0.802 . . . . 64.14 111.566 -171.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -116.42 56.19 0.79 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.571 1.549 . . . . 74.44 109.187 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.47 140.08 20.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 72.3 106.245 168.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.96 -23.03 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.573 1.149 . . . . 72.33 110.609 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -161.24 -175.53 4.9 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.285 1.434 . . . . 74.23 108.515 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -171.0 2.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.784 1.234 . . . . 74.13 109.469 170.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . 12.4 p -138.15 155.92 48.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.753 1.621 . . . . 71.01 107.917 157.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.64 112.43 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.197 -2.519 . . . . 73.42 104.197 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -111.51 160.24 17.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.758 0.823 . . . . 74.41 108.983 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 tp -149.96 139.47 21.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.79 2.036 . . . . 72.53 106.004 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.33 137.58 42.93 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.389 1.076 . . . . 74.32 110.34 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -141.76 -165.59 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.528 1.531 . . . . 72.43 110.343 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 81.16 1.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.083 2.153 . . . . 73.55 110.305 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -146.79 -70.48 0.24 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.757 1.223 . . . . 63.02 109.547 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.402 ' H ' ' H ' ' A' ' 49' ' ' GLN . 2.8 m -157.49 -15.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.636 1.347 . . . . 73.24 114.636 159.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' H ' ' H ' ' A' ' 48' ' ' SER . 6.2 mp0 -66.66 130.64 43.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.144 -0.48 . . . . 74.21 111.11 -147.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.68 49.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.232 -1.025 . . . . 72.13 108.232 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p 174.56 135.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.373 3.069 . . . . 72.34 104.663 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.94 4.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.636 -1.091 . . . . 71.23 115.75 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.24 151.95 79.73 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 120.56 2.18 . . . . 74.03 113.743 -152.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.21 166.82 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.07 2.513 . . . . 65.13 112.769 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -66.95 6.11 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.242 2.617 . . . . 74.1 113.324 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 m -62.94 -42.24 99.75 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.498 1.119 . . . . 73.42 111.2 -173.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -177.43 11.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.736 1.214 . . . . 72.03 112.403 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.0 m 45.02 72.96 1.06 Allowed Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.627 1.571 . . . . 70.32 112.589 -171.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.12 159.84 48.88 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.484 2.123 . . . . 74.4 112.888 166.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.81 52.57 0.54 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.457 1.903 . . . . 74.02 111.959 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -76.2 102.59 5.86 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.269 -1.011 . . . . 71.44 108.269 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 mp 58.29 -159.79 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.955 2.902 . . . . 73.33 108.524 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.98 123.93 3.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 65.14 109.558 170.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -146.06 162.26 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.008 0.923 . . . . 74.53 111.333 -173.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.6 ttt -69.35 -29.83 67.72 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.042 1.337 . . . . 71.33 113.899 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 65.79 80.57 0.22 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.639 1.576 . . . . 74.01 110.516 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.72 -14.62 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.961 0.904 . . . . 74.41 112.488 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -54.34 116.13 2.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.406 1.482 . . . . 73.12 110.266 166.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -157.9 23.94 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.36 0.504 . . . . 72.41 112.36 157.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 154.54 29.69 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.918 -1.273 . . . . 73.3 109.918 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.06 -26.28 21.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.342 2.028 . . . . 65.34 111.845 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -122.81 163.53 32.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.472 1.509 . . . . 74.02 109.307 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.93 173.46 12.75 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.983 1.789 . . . . 74.34 111.027 170.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 t 50.46 59.91 4.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.03 1.332 . . . . 73.21 110.624 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.63 171.53 7.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.88 0.872 . . . . 73.11 110.673 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -76.29 171.65 14.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.624 1.342 . . . . 72.11 114.624 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 82' ' ' LEU . 2.9 p -130.25 109.43 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 C-N-CA 126.973 2.109 . . . . 73.11 111.266 171.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -57.43 146.75 28.4 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.246 2.219 . . . . 73.23 111.472 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 p -66.47 -23.68 66.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.737 1.014 . . . . 71.51 113.737 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 5.5 0.91 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.614 1.566 . . . . 73.43 113.599 167.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -108.64 -36.69 6.11 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.063 -1.023 . . . . 74.21 110.055 164.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' CD2' HG22 ' A' ' 77' ' ' VAL . 1.9 mm? -69.27 -37.39 77.86 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.421 1.088 . . . . 72.31 111.232 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -61.79 -0.86 0.51 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.693 1.597 . . . . 73.35 113.109 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -129.98 2.15 4.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.954 2.102 . . . . 70.24 110.255 -167.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.21 132.8 55.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.982 2.113 . . . . 72.51 109.125 -169.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -87.39 158.17 19.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.978 0.418 . . . . 65.53 110.875 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -84.43 146.94 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.898 1.279 . . . . 73.45 108.365 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.45 118.49 20.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.875 -1.157 . . . . 73.32 107.875 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 24.32 11.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.256 1.023 . . . . 73.43 109.789 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -100.65 -53.95 2.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.719 -1.215 . . . . 71.23 107.719 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.8 m -111.08 -54.26 2.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.178 1.791 . . . . 73.35 109.488 -166.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -160.47 150.08 14.32 Favored Pre-proline 0 C--N 1.343 0.298 0 C-N-CA 127.528 2.331 . . . . 63.14 109.87 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.86 101.56 0.23 Allowed 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 124.494 3.463 . . . . 71.21 109.89 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.0 172.9 15.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.95 1.7 . . . . 74.51 111.199 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.51 132.35 42.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.759 -1.571 . . . . 72.51 106.759 167.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.97 118.85 49.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 124.103 0.961 . . . . 73.51 109.488 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -93.08 178.34 5.78 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.771 1.228 . . . . 73.32 111.679 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.19 128.5 14.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 126.453 1.901 . . . . 65.2 106.638 167.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.434 HD11 ' CE3' ' A' ' 26' ' ' TRP . 34.1 mt -132.14 153.93 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 119.528 1.058 . . . . 73.23 109.512 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -167.78 136.6 2.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.536 2.334 . . . . 74.3 110.374 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.2 133.3 55.01 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.605 1.562 . . . . 65.34 112.849 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 92.11 9.02 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.747 -1.946 . . . . 73.23 105.747 161.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -101.34 -179.23 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.333 -0.988 . . . . 73.31 108.333 153.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -57.95 -21.77 45.7 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.105 1.15 . . . . 74.24 114.105 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -37.26 38.88 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.402 -0.811 . . . . 71.34 110.181 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.17 -171.8 13.97 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.162 1.363 . . . . 74.14 112.999 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 14.3 m-85 -81.7 66.1 7.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.969 1.708 . . . . 72.22 111.285 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.28 -74.22 1.08 Allowed Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.002 -1.061 . . . . 64.42 111.563 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.81 167.23 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.381 2.72 . . . . 72.14 110.118 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.46 152.17 44.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.725 0.774 . . . . 73.12 110.049 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.3 m -142.01 109.44 5.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.159 -1.793 . . . . 74.43 106.159 167.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -94.38 139.44 31.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.111 -1.44 . . . . 73.32 107.111 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -125.24 171.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.081 0.952 . . . . 73.42 110.43 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 113.46 14.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.525 1.53 . . . . 74.23 108.21 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -79.03 93.4 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.48 -1.304 . . . . 72.41 107.48 172.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.39 165.25 24.65 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.326 -1.361 . . . . 73.24 107.326 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.06 29.51 19.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.667 0.787 . . . . 75.43 109.892 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -9.88 59.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.246 -1.534 . . . . 74.32 114.503 -172.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 m -77.14 80.74 3.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.859 1.264 . . . . 72.13 110.786 -160.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.4 t -144.14 98.68 3.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.789 -1.189 . . . . 74.53 107.789 -171.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 65.6 -165.53 0.23 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.895 0.878 . . . . 74.33 109.848 -174.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 63.19 36.82 11.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.28 2.232 . . . . 72.32 110.73 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.5 p -84.01 12.22 6.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.267 1.58 . . . . 50.35 115.267 -165.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t 65.71 -178.34 0.19 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.143 0.977 . . . . 53.04 110.108 -158.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 150.7 -14.21 0.91 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.016 0.817 . . . . 73.34 114.589 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.254 1.301 0 CA-C-N 119.69 1.745 . . . . 74.41 108.775 168.391 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 CA-C-O 119.274 -0.737 . . . . 75.13 111.276 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 t 75.22 90.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.793 2.437 . . . . 74.44 107.701 -160.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 159.79 39.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.932 1.693 . . . . 73.2 108.996 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.02 176.81 8.58 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.497 2.131 . . . . 61.11 112.478 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.01 84.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.364 -1.094 . . . . 74.54 110.364 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.56 160.28 32.31 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.464 1.106 . . . . 73.33 108.922 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.75 114.28 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.105 2.537 . . . . 74.24 109.751 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.01 -161.83 35.12 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.147 -1.181 . . . . 72.53 110.147 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.06 82.86 0.21 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 127.092 2.157 . . . . 64.51 111.891 -163.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.31 165.59 24.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.165 2.577 . . . . 73.34 110.891 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.8 m -135.57 -175.59 4.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.265 1.426 . . . . 71.54 112.106 -173.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.8 25.95 2.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.673 2.789 . . . . 63.23 115.202 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.64 132.69 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.417 -0.802 . . . . 71.24 110.87 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -117.22 149.37 40.53 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.219 1.008 . . . . 75.01 109.073 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.6 mt -145.65 141.73 22.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 105.673 -1.973 . . . . 72.02 105.673 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.8 p -152.29 170.98 18.7 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.087 1.755 . . . . 73.32 108.861 168.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -95.37 160.02 14.73 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.804 0.729 . . . . 72.53 109.441 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.41 ' HG ' ' CD2' ' A' ' 23' ' ' HIS . 3.4 m -145.56 165.75 20.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.472 2.309 . . . . 73.23 109.391 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -70.66 -4.37 14.5 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.1 2.533 . . . . 73.43 112.349 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -131.85 29.13 4.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.45 1.5 . . . . 71.44 110.655 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.48 -158.36 21.18 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.377 -0.827 . . . . 63.51 112.739 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 153.03 23.77 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.484 1.142 . . . . 71.24 108.294 162.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.41 ' CD2' ' HG ' ' A' ' 18' ' ' SER . 0.9 OUTLIER -101.19 96.9 7.51 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.747 2.419 . . . . 73.44 109.167 -169.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.96 125.47 53.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.226 2.211 . . . . 73.51 110.061 -159.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -157.97 152.42 24.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.662 1.574 . . . . 51.21 114.427 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -149.28 -179.62 7.2 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 127.226 2.21 . . . . 72.21 113.151 -171.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -115.56 160.36 34.96 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 126.703 2.001 . . . . 70.25 112.756 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.52 176.24 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 126.647 4.898 . . . . 74.21 112.171 -176.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.75 113.52 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 108.083 -1.545 . . . . 71.54 108.083 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -103.47 13.95 32.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.952 0.901 . . . . 74.41 110.387 168.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 32' ' ' THR . 2.4 m -100.44 -84.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 127.536 2.334 . . . . 74.32 109.702 -174.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 31' ' ' VAL . 50.8 p -122.25 166.3 14.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.893 0.769 . . . . 75.3 109.364 170.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -60.0 -56.79 17.35 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.493 1.117 . . . . 73.1 110.205 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.13 -171.54 23.38 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.109 -0.796 . . . . 61.32 111.109 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -133.06 80.31 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.388 -0.967 . . . . 72.31 108.388 166.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -76.95 145.42 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.46 -1.311 . . . . 73.3 107.46 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -133.04 -24.49 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.342 1.457 . . . . 73.44 111.434 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 1.5 tp10 -168.1 -175.09 2.52 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 105.762 -1.94 . . . . 71.5 105.762 -174.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.472 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 75.2 m-85 -136.97 -166.15 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.546 -1.346 . . . . 72.22 109.913 175.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.96 159.71 41.73 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.35 2.26 . . . . 70.22 109.549 165.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.47 119.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 103.84 -2.652 . . . . 62.54 103.84 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -114.41 151.9 32.39 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.709 -0.849 . . . . 74.15 108.709 173.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 tp -136.25 117.86 14.93 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.627 1.971 . . . . 74.33 107.338 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.6 151.4 28.99 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.229 0.611 . . . . 63.51 111.623 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.38 172.49 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.571 1.148 . . . . 74.45 111.953 -169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -66.62 154.72 39.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.757 1.223 . . . . 70.33 109.955 156.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t 70.11 -175.41 0.19 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.594 2.358 . . . . 45.42 112.498 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 p -114.96 166.07 12.18 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.455 1.902 . . . . 72.12 110.463 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -164.42 -179.99 6.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.458 1.503 . . . . 73.35 109.311 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.32 163.29 13.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.329 1.451 . . . . 71.4 111.82 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.85 136.05 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.913 2.485 . . . . 54.02 107.701 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.85 93.7 0.1 OUTLIER Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.343 -1.103 . . . . 53.43 110.343 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.04 165.17 14.03 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.184 1.794 . . . . 73.24 112.27 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.71 99.34 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 125.14 3.893 . . . . 74.22 111.7 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp 58.62 34.67 24.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.546 1.539 . . . . 65.31 112.541 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 t -45.1 -68.64 0.18 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.15 2.18 . . . . 61.11 110.636 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 65.25 15.88 10.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 73.11 112.764 176.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 t -135.81 152.3 75.65 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.432 1.093 . . . . 71.2 108.628 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.11 -169.23 0.75 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.399 2.733 . . . . 72.22 111.597 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 61.87 33.83 17.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.641 1.576 . . . . 74.31 112.91 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -72.14 169.04 16.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.377 1.071 . . . . 54.14 108.988 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 mt -104.58 -171.09 1.86 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.339 1.056 . . . . 73.22 110.549 -161.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 87.93 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.479 0.581 . . . . 71.52 110.788 172.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 44' ' ' ALA . 13.5 m-30 -117.87 155.13 30.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.337 1.055 . . . . 74.13 110.052 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.7 ttp -87.03 146.9 25.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.632 0.773 . . . . 74.41 109.405 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.59 93.39 8.36 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.636 1.208 . . . . 62.35 110.961 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -71.61 1.16 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 124.599 1.16 . . . . 73.31 112.74 168.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -91.22 -163.92 1.1 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.992 1.717 . . . . 74.33 110.38 174.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.3 m 57.91 35.31 25.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.729 1.612 . . . . 74.24 110.829 -158.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.29 -177.48 9.89 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 110.167 -1.173 . . . . 71.21 110.167 163.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -26.08 28.71 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.432 1.421 . . . . 74.51 111.182 173.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.74 17.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.094 1.358 . . . . 73.12 109.541 -170.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.25 165.45 28.61 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.414 2.076 . . . . 74.44 109.745 160.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m 49.35 36.35 9.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.992 1.317 . . . . 62.51 113.034 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -88.9 162.28 16.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.653 1.216 . . . . 71.54 111.224 170.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.25 175.04 1.8 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.06 2.944 . . . . 74.15 113.705 172.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -135.8 119.68 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.236 1.014 . . . . 63.35 111.953 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -54.82 140.33 36.87 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.735 0.814 . . . . 73.32 111.599 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 p -56.14 -34.09 65.79 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.104 0.962 . . . . 72.55 112.799 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -55.17 -39.24 69.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.072 0.949 . . . . 72.55 111.583 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 t -74.55 -34.65 62.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.165 -0.959 . . . . 73.34 110.641 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.3 -33.77 76.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.633 0.651 . . . . 72.41 110.0 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -58.51 -37.21 75.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.633 1.573 . . . . 71.33 111.406 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.57 -5.58 59.26 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.068 -1.02 . . . . 72.52 112.711 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 149.82 21.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.607 -0.683 . . . . 72.44 111.166 -159.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 108.84 20.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.528 1.531 . . . . 74.43 109.693 -175.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -69.78 157.71 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.466 -0.938 . . . . 70.31 108.466 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -132.54 82.85 2.03 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.989 1.316 . . . . 63.13 108.656 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.96 121.61 5.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.438 1.273 . . . . 75.31 114.438 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 -22.62 43.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.63 -2.077 . . . . 75.44 112.894 159.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 p -143.67 -62.37 0.4 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.314 1.416 . . . . 74.31 112.797 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -104.49 141.86 23.41 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 116.811 -1.566 . . . . 75.43 109.218 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.48 120.58 7.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.229 1.953 . . . . 55.12 109.311 -176.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.95 147.71 50.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.604 -0.887 . . . . 64.23 108.604 160.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.3 mt -91.76 130.43 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 126.945 2.098 . . . . 74.33 105.768 168.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.4 mm -82.81 138.13 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.768 -1.197 . . . . 72.53 107.768 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.5 133.56 55.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.634 -1.247 . . . . 74.52 107.634 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -98.64 133.01 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 106.56 -1.645 . . . . 63.52 106.56 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 53.6 mt -135.87 140.27 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 105.686 -1.968 . . . . 62.24 105.686 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.27 164.48 35.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.511 0.724 . . . . 64.1 110.243 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.48 125.19 40.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.472 1.509 . . . . 70.53 111.15 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.473 ' HD3' ' CZ ' ' A' ' 107' ' ' TYR . 6.1 tpt180 -76.56 112.77 13.45 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.062 -1.459 . . . . 74.2 107.062 171.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 167.45 16.93 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.037 0.535 . . . . 71.41 111.346 162.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.66 -27.3 66.26 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.075 -0.391 . . . . 74.42 111.895 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -53.99 -40.02 66.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.336 1.454 . . . . 70.22 111.925 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.72 -173.37 27.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.632 2.063 . . . . 65.5 108.189 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.473 ' CZ ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -76.14 -5.05 44.91 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.126 1.528 . . . . 74.43 115.126 178.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.22 178.52 8.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.952 0.786 . . . . 42.44 111.958 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.95 148.13 63.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.584 1.523 . . . . 73.5 108.911 162.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 150.46 20.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.699 0.799 . . . . 71.32 109.485 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -68.27 166.26 16.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.071 0.948 . . . . 71.43 110.5 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -120.55 86.45 2.57 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.712 -1.958 . . . . 74.44 105.712 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.7 t -89.44 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 106.945 -1.502 . . . . 74.52 106.945 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.66 160.97 30.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.734 1.214 . . . . 74.04 107.945 165.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -119.27 80.13 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.637 1.575 . . . . 75.23 107.985 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.9 mt -64.73 -21.74 66.82 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.896 0.702 . . . . 72.32 112.896 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.27 28.19 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.103 1.361 . . . . 73.04 111.622 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.473 ' C ' ' HG1' ' A' ' 119' ' ' THR . 1.2 tm-20 -58.56 106.09 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.496 -1.298 . . . . 60.03 107.496 164.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -170.9 172.51 5.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 128.508 2.723 . . . . 72.34 105.069 172.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.6 t 69.76 165.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.12 1.368 . . . . 71.21 111.017 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -149.57 22.95 0.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 130.11 3.364 . . . . 72.42 108.429 161.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 t70 60.43 19.6 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.183 2.193 . . . . 73.44 115.587 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 -176.47 0.15 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.878 -1.139 . . . . 74.14 111.756 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.9 m 55.2 -168.86 0.08 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.904 1.282 . . . . 71.25 113.136 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.85 171.15 32.55 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.074 1.797 . . . . 62.15 109.707 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.26 1.624 0 C-N-CA 125.102 1.361 . . . . 74.44 108.496 -172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.05 -1.463 . . . . 75.25 107.05 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.18 6.15 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.095 2.53 . . . . 64.420000000000002 114.528 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.62 -171.77 16.78 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.595 -1.802 . . . . 53.310000000000002 108.595 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.33 163.34 34.68 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.871 1.668 . . . . 44.310000000000002 109.609 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.15 152.12 81.3 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.651 1.568 . . . . 73.239999999999995 111.287 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.9 m -133.61 -173.93 3.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.854 2.462 . . . . 72.319999999999993 108.627 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 45.91 27.32 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.898 2.879 . . . . 54.409999999999997 114.868 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.73 137.71 23.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.036 -0.727 . . . . 63.240000000000002 109.036 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -134.04 159.23 41.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.797 0.839 . . . . 73.140000000000001 111.227 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -144.18 138.95 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.864 -1.902 . . . . 72.310000000000002 105.864 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -135.47 159.99 39.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.675 1.99 . . . . 74.420000000000002 108.404 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -83.69 170.92 13.73 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.987 -1.071 . . . . 61.509999999999998 108.4 171.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 161.6 29.15 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 123.888 0.875 . . . . 42.509999999999998 110.26 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.72 -27.77 52.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.57 1.513 . . . . 72.430000000000007 110.968 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.55 23.37 13.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.114 1.366 . . . . 75.420000000000002 110.854 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.24 -149.1 21.03 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.652 -1.28 . . . . 73.140000000000001 111.791 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 144.32 40.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.507 2.153 . . . . 61.520000000000003 107.5 152.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -80.13 141.67 35.52 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.947 1.299 . . . . 62.520000000000003 108.084 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.97 174.65 10.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.003 0.819 . . . . 71.409999999999997 110.015 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -175.31 155.91 1.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.013 2.525 . . . . 74.230000000000004 108.059 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -158.57 167.08 30.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.323 1.449 . . . . 72.519999999999996 109.316 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 7.0 mt-10 -138.65 162.99 49.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 125.866 1.666 . . . . 64.439999999999998 111.682 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.91 174.79 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.186 3.258 . . . . 52.119999999999997 113.808 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.92 179.01 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.88 3.054 . . . . 60.450000000000003 113.646 168.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.0 t -138.36 73.27 1.43 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 105.069 -2.197 . . . . 65.140000000000001 105.069 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 m -141.48 -66.34 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 107.736 -1.209 . . . . 65.319999999999993 107.736 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 173.64 6.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.814 2.045 . . . . 31.309999999999999 109.441 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 m -49.35 -57.77 6.29 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.267 1.427 . . . . 63.240000000000002 110.289 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.84 118.0 0.12 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.777 0.703 . . . . 65.150000000000006 111.379 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -102.4 73.81 1.36 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.617 -0.883 . . . . 75.129999999999995 108.617 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.26 149.91 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.384 -1.71 . . . . 62.119999999999997 106.384 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.81 -23.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.279 1.431 . . . . 45.43 112.639 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 -170.91 3.5 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 105.41 -2.07 . . . . 52.009999999999998 105.41 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.33 -178.56 5.54 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.211 -2.181 . . . . 72.230000000000004 111.599 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.98 162.47 40.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.648 0.779 . . . . 63.210000000000001 111.558 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 68' ' ' TYR . 2.2 p -148.35 115.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.728 2.011 . . . . 62.119999999999997 112.154 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -99.69 88.37 3.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 74.439999999999998 108.664 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.58 135.52 54.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.496 -1.298 . . . . 64.209999999999994 107.496 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 150.81 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.121 1.368 . . . . 63.509999999999998 111.002 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 pt -152.03 168.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.997 1.719 . . . . 74.129999999999995 110.394 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.411 0 N-CA-C 107.016 -1.475 . . . . 75.510000000000005 107.016 160.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.469 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 18.6 mt . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 108.305 -0.998 . . . . 75.349999999999994 108.305 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.32 5.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.43 -0.581 . . . . 72.319999999999993 109.43 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 17.5 m-85 -127.92 176.58 7.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.159 0.984 . . . . 72.450000000000003 110.473 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.5 ptm -126.74 -7.5 6.17 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.533 1.133 . . . . 72.409999999999997 112.655 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 53.63 78.13 0.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.883 0.873 . . . . 74.409999999999997 111.324 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 41' ' ' VAL . 13.5 m -77.69 -38.65 25.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-O 117.831 -1.08 . . . . 72.120000000000005 111.777 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.879 ' HB2' HG12 ' A' ' 41' ' ' VAL . 24.9 t80 -65.39 131.19 45.83 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 116.722 -1.991 . . . . 64.549999999999997 112.165 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 51.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.966 2.506 . . . . 64.140000000000001 108.262 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.82 166.06 13.46 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.77 -1.206 . . . . 74.109999999999999 110.29 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.52 -50.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.906 2.404 . . . . 75.319999999999993 109.783 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -90.71 154.94 45.92 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 125.845 1.658 . . . . 65.310000000000002 108.665 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.79 -173.22 1.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.471 2.114 . . . . 65.129999999999995 110.798 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p 57.34 60.57 2.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.454 1.502 . . . . 44.149999999999999 112.56 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.09 176.35 5.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.224 1.41 . . . . 61.509999999999998 110.014 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.61 -172.88 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.251 1.021 . . . . 51.130000000000003 110.906 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.19 139.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 125.612 1.565 . . . . 73.140000000000001 109.308 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.79 139.51 58.78 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.23 0.923 . . . . 75.340000000000003 110.088 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 t -63.15 -26.8 68.98 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.523 -0.736 . . . . 62.32 112.379 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -66.32 -21.26 66.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.855 0.862 . . . . 71.239999999999995 111.227 173.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -82.81 -33.04 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.626 -1.296 . . . . 64.420000000000002 110.533 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.98 -37.32 47.62 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.764 0.826 . . . . 72.329999999999998 112.206 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -60.93 -37.89 83.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.59 -0.522 . . . . 43.25 109.59 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -86.46 11.19 13.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.811 2.044 . . . . 73.310000000000002 111.645 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.53 155.69 16.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.008 1.323 . . . . 65.209999999999994 111.192 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 140.76 29.8 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.733 0.813 . . . . 52.030000000000001 110.064 173.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.57 155.01 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.89 0.852 . . . . 73.109999999999999 110.273 168.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.453 ' OD2' HD11 ' A' ' 96' ' ' ILE . 9.2 t70 -79.64 130.4 35.33 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 126.377 1.871 . . . . 72.319999999999993 108.534 173.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.59 3.59 4.58 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.473 1.109 . . . . 65.219999999999999 110.79 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 p -90.27 -19.11 24.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.705 2.002 . . . . 73.439999999999998 111.633 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -135.78 -62.03 0.7 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.59 1.086 . . . . 72.409999999999997 112.739 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -153.24 155.35 31.75 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 119.567 1.076 . . . . 71.239999999999995 109.902 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.58 112.94 3.19 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.96 1.773 . . . . 71.329999999999998 108.313 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.651 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -164.02 165.98 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.257 2.623 . . . . 62.109999999999999 109.886 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -90.11 135.19 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.955 -1.128 . . . . 62.420000000000002 107.955 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.453 HD11 ' OD2' ' A' ' 88' ' ' ASP . 45.6 mm -83.49 147.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.261 0.937 . . . . 62.409999999999997 110.637 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -137.25 115.76 11.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 61.450000000000003 110.122 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.77 87.38 6.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.646 1.578 . . . . 72.140000000000001 108.654 170.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.485 HG13 HG23 ' A' ' 41' ' ' VAL . 4.7 mt -86.08 151.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.321 -1.363 . . . . 71.209999999999994 107.321 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.63 146.24 24.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.835 0.743 . . . . 35.109999999999999 110.337 164.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.69 129.55 34.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.123 0.969 . . . . 63.130000000000003 110.011 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 92.13 8.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 105.909 -1.886 . . . . 75.340000000000003 105.909 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -117.95 173.14 6.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.412 1.485 . . . . 75.540000000000006 109.636 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.57 -16.53 10.42 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.858 1.429 . . . . 74.439999999999998 114.858 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -18.72 34.02 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.576 -1.328 . . . . 62.350000000000001 112.126 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.62 50.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.807 1.67 . . . . 35.100000000000001 111.047 -166.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.41 133.67 49.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.71 -1.589 . . . . 73.430000000000007 106.71 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -148.23 -86.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.303 0.954 . . . . 64.319999999999993 111.151 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.67 82.66 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.954 2.436 . . . . 51.039999999999999 107.596 166.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.09 160.82 9.47 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.381 -0.825 . . . . 62.109999999999999 109.539 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -115.34 140.5 49.07 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.424 1.09 . . . . 74.209999999999994 108.321 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.77 103.75 14.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 105.604 -1.999 . . . . 73.519999999999996 105.604 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.98 152.3 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 75.540000000000006 107.098 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.34 121.19 17.56 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.704 -0.68 . . . . 73.25 109.57 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -76.28 84.49 3.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.756 -1.201 . . . . 65.519999999999996 107.756 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 94' ' ' ALA . 19.9 mt -65.92 150.72 48.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.5 -1.296 . . . . 75.109999999999999 107.5 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 69.6 27.84 4.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.789 1.235 . . . . 60.219999999999999 111.288 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 129.174 2.99 . . . . 64.409999999999997 113.648 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.017 -0.364 . . . . 72.439999999999998 110.017 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' HG21 ' A' ' 32' ' ' THR . 85.0 Cg_endo -73.2 134.49 21.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.963 2.442 . . . . 74.099999999999994 108.653 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.12 168.07 28.08 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.872 1.701 . . . . 64.420000000000002 109.328 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.05 165.76 2.11 Favored Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 125.861 1.664 . . . . 42.140000000000001 109.257 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -70.82 142.01 42.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.379 2.052 . . . . 74.200000000000003 109.541 149.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.82 175.48 9.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.123 1.369 . . . . 40.340000000000003 109.774 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.61 25.69 0.27 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.124 2.969 . . . . 75.439999999999998 114.966 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -55.44 143.41 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.829 1.652 . . . . 73.219999999999999 109.691 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -139.48 147.95 42.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.539 1.536 . . . . 75.430000000000007 108.132 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.87 144.21 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.874 -1.899 . . . . 74.230000000000004 105.874 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.1 m -144.79 155.79 43.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.635 1.574 . . . . 72.540000000000006 109.083 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.89 168.07 20.19 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.376 -0.827 . . . . 64.519999999999996 110.376 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.0 m -150.69 165.2 17.92 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.629 1.972 . . . . 54.229999999999997 106.915 170.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 -26.05 24.13 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.578 2.186 . . . . 54.399999999999999 110.702 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.73 -64.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.552 1.141 . . . . 62.039999999999999 109.183 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.73 -145.82 4.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.559 2.028 . . . . 51.439999999999998 108.669 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.04 133.9 55.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.155 0.977 . . . . 40.200000000000003 108.723 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.82 135.57 48.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.709 -1.219 . . . . 72.209999999999994 107.709 166.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mp -142.01 138.01 31.54 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 119.037 0.835 . . . . 75.200000000000003 110.503 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -144.0 153.45 42.25 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.297 -1.001 . . . . 73.400000000000006 108.297 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.32 21.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 74.040000000000006 108.357 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.11 165.8 16.65 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.124 0.97 . . . . 73.099999999999994 110.631 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.25 168.42 17.73 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.715 3.61 . . . . 75.430000000000007 113.625 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.27 175.25 11.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.382 2.721 . . . . 75.109999999999999 111.629 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.6 24.53 4.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.866 1.266 . . . . 75.409999999999997 111.731 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.17 -22.12 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.167 -0.958 . . . . 72.430000000000007 111.528 -158.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 7' ' ' PRO . 13.3 t -166.16 162.39 17.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.162 2.185 . . . . 72.329999999999998 106.239 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -71.35 -68.93 0.41 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.373 1.069 . . . . 71.329999999999998 109.375 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.06 -173.05 10.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.623 -1.391 . . . . 71.040000000000006 109.623 -157.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -132.16 83.94 2.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.378 -1.341 . . . . 72.099999999999994 107.378 163.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.03 150.72 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.123 -1.066 . . . . 62.310000000000002 108.123 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.95 -25.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.788 1.635 . . . . 72.409999999999997 111.192 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 -175.86 3.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.35 1.46 . . . . 75.230000000000004 108.403 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -140.81 169.6 17.32 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.96 1.704 . . . . 72.040000000000006 108.878 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.4 m -152.68 161.16 42.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.439 0.696 . . . . 61.100000000000001 111.337 167.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.59 142.61 39.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.82 1.248 . . . . 63.43 108.672 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -127.0 115.83 19.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.929 2.092 . . . . 75.0 105.833 -171.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -101.03 122.18 43.09 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.673 -1.602 . . . . 75.439999999999998 106.673 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 98' ' ' ARG . . . -77.62 76.81 4.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.088 0.955 . . . . 53.009999999999998 109.801 -177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.25 175.77 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.135 0.974 . . . . 52.520000000000003 111.462 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.243 0 N-CA-C 106.061 -1.829 . . . . 71.150000000000006 106.061 169.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.311 0.577 . . . . 75.510000000000005 109.883 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.11 119.52 5.99 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.265 1.426 . . . . 61.420000000000002 108.847 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 6.7 m-85 -137.69 169.93 16.93 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.751 0.82 . . . . 73.209999999999994 109.307 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -12.46 25.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 74.0 113.453 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 43.97 75.36 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.523 1.929 . . . . 73.209999999999994 111.531 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.9 m -65.19 -16.01 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.405 1.082 . . . . 55.409999999999997 113.343 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -121.24 117.43 27.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.538 0.735 . . . . 75.109999999999999 109.975 -169.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.3 m -130.82 137.89 49.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.764 -2.31 . . . . 64.230000000000004 104.764 154.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.26 7.94 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.645 1.111 . . . . 72.120000000000005 112.496 170.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.97 -14.86 10.8 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.977 3.118 . . . . 75.0 113.385 -170.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.1 m -111.29 85.83 5.91 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.525 1.13 . . . . 74.420000000000002 109.489 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.6 67.78 3.7 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.541 2.827 . . . . 75.340000000000003 110.646 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -157.13 11.8 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.785 1.234 . . . . 71.129999999999995 111.618 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -89.9 161.76 15.77 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.321 1.049 . . . . 74.030000000000001 113.27 -165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.05 164.46 17.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.538 1.935 . . . . 72.329999999999998 110.393 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.41 125.52 69.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.694 1.598 . . . . 64.430000000000007 107.15 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -66.98 160.79 25.69 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.322 1.049 . . . . 71.340000000000003 111.561 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -55.05 -33.66 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 42.130000000000003 110.391 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -61.06 -12.23 11.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.541 1.536 . . . . 43.140000000000001 113.768 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -118.58 7.85 11.86 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.121 1.368 . . . . 72.0 112.053 171.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.51 -12.91 10.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.366 1.466 . . . . 73.540000000000006 111.733 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.48 -60.95 2.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.873 1.269 . . . . 72.319999999999993 111.5 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -73.29 13.26 0.46 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 118.161 -0.923 . . . . 74.340000000000003 112.085 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.76 165.95 2.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.243 1.383 . . . . 60.119999999999997 110.122 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -124.5 108.38 12.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.972 -1.492 . . . . 74.129999999999995 106.972 166.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 mm -68.82 140.78 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.075 -1.454 . . . . 75.140000000000001 107.075 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -56.85 118.13 4.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.19 0.996 . . . . 75.409999999999997 109.085 169.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.41 31.37 6.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.98 1.312 . . . . 61.32 109.076 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -6.36 5.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.667 1.187 . . . . 71.349999999999994 110.363 -164.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -159.06 -66.25 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.762 2.825 . . . . 72.430000000000007 107.681 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -149.58 151.86 33.97 Favored Pre-proline 0 N--CA 1.463 0.2 0 C-N-CA 125.857 1.663 . . . . 74.340000000000003 109.413 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.21 100.78 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.967 2.445 . . . . 75.140000000000001 109.89 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -145.34 152.32 39.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.349 1.459 . . . . 63.32 110.453 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.3 mt -79.98 124.19 37.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.388 -1.708 . . . . 72.519999999999996 106.388 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 mm -101.52 101.39 12.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.759 -1.2 . . . . 63.520000000000003 107.759 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -79.21 152.62 30.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.156 0.982 . . . . 75.120000000000005 109.292 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HE ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -136.17 124.76 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 104.739 -2.319 . . . . 75.099999999999994 104.739 176.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.69 141.98 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 120.674 1.579 . . . . 75.5 108.149 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.42 155.52 45.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.745 0.702 . . . . 62.130000000000003 111.231 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 125.0 28.75 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.46 1.504 . . . . 51.200000000000003 109.883 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -74.49 101.33 4.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 104.729 -2.323 . . . . 75.430000000000007 104.729 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -115.84 174.62 5.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.431 0.634 . . . . 73.409999999999997 110.751 168.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.08 -23.94 67.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.274 0.842 . . . . 72.0 113.274 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -57.91 6.4 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.205 1.002 . . . . 74.420000000000002 110.653 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 165.5 12.33 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.333 1.921 . . . . 62.409999999999997 109.05 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -64.75 137.78 58.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.168 -1.419 . . . . 61.32 107.168 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.61 -64.15 0.01 OUTLIER Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.377 0.989 . . . . 52.100000000000001 111.907 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.07 71.65 6.18 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.554 2.836 . . . . 73.209999999999994 110.774 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.17 6.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.139 0.576 . . . . 60.32 109.857 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.5 m -81.04 113.12 19.02 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.527 -1.657 . . . . 64.299999999999997 106.527 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.8 151.02 27.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.987 -1.116 . . . . 75.540000000000006 107.987 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 76.2 t -143.72 143.58 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.018 -1.475 . . . . 31.350000000000001 107.018 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.84 154.19 39.98 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.827 0.739 . . . . 71.200000000000003 112.31 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -142.71 112.12 6.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.469 1.108 . . . . 61.119999999999997 109.774 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -88.53 3.05 51.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 128.702 2.801 . . . . 71.140000000000001 112.286 -172.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.27 18.4 16.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.954 1.702 . . . . 71.340000000000003 110.293 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 124.19 0.996 . . . . 64.329999999999998 113.493 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 108.995 -0.743 . . . . 75.310000000000002 108.995 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.18 134.95 32.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.221 1.947 . . . . 40.310000000000002 113.373 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.39 -179.81 53.33 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.367 1.461 . . . . 61.43 112.301 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 174.49 165.12 0.34 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.272 3.029 . . . . 71.409999999999997 110.138 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.34 150.81 81.2 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.624 2.216 . . . . 55.420000000000002 109.666 163.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -137.31 174.89 10.12 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.431 1.092 . . . . 72.439999999999998 110.606 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.99 10.14 4.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.942 2.497 . . . . 71.209999999999994 115.515 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -51.49 111.66 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 125.259 1.424 . . . . 72.319999999999993 113.051 -158.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -86.3 136.46 33.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.534 -1.284 . . . . 62.450000000000003 107.534 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.23 126.33 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.4 -2.074 . . . . 63.030000000000001 105.4 160.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -150.33 173.02 14.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 128.924 2.889 . . . . 62.130000000000003 106.227 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -90.05 159.68 16.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.985 -1.117 . . . . 72.430000000000007 107.985 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -129.56 160.61 63.66 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.559 -1.645 . . . . 71.439999999999998 106.559 157.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -52.65 -45.0 43.29 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 120.91 1.073 . . . . 63.25 109.37 150.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -79.33 26.31 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.59 2.356 . . . . 71.109999999999999 113.604 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.74 -113.32 2.35 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.283 0.944 . . . . 44.310000000000002 111.119 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.59 -160.95 1.09 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.233 1.813 . . . . 35.409999999999997 108.757 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -130.34 33.62 4.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.212 1.405 . . . . 74.030000000000001 112.766 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.69 103.42 1.09 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 127.029 2.132 . . . . 63.039999999999999 113.038 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -138.97 150.59 46.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.431 1.469 . . . . 72.040000000000006 110.424 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.401 ' CE3' HD13 ' A' ' 99' ' ' ILE . 1.1 p90 -139.27 162.62 34.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.382 1.073 . . . . 73.319999999999993 110.426 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.75 154.81 87.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.377 -0.374 . . . . 73.420000000000002 111.347 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.49 168.16 25.46 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.067 3.178 . . . . 53.240000000000002 110.9 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.59 116.13 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.141 2.561 . . . . 73.150000000000006 110.341 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.36 60.31 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.685 2.394 . . . . 73.349999999999994 106.266 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.48 -62.31 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 124.267 1.027 . . . . 73.239999999999995 111.329 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 p -133.38 167.02 21.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.304 -0.872 . . . . 74.209999999999994 110.583 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.7 10.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.316 2.246 . . . . 64.239999999999995 114.022 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.25 149.01 50.26 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.568 -1.413 . . . . 74.040000000000006 109.568 172.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -121.39 92.11 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.473 1.909 . . . . 73.349999999999994 106.517 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -73.73 144.49 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 62.240000000000002 106.589 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 pt -131.08 -13.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.924 1.69 . . . . 63.130000000000003 112.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -168.38 -175.4 2.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.724 2.41 . . . . 74.409999999999997 107.345 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.22 170.36 15.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.061 -1.025 . . . . 73.120000000000005 109.294 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.4 p -146.62 155.18 42.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.852 0.861 . . . . 64.519999999999996 112.898 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.8 t -141.68 137.98 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.466 1.906 . . . . 71.540000000000006 106.706 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -128.49 126.75 41.08 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.907 1.683 . . . . 73.430000000000007 107.052 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.4 tp -119.79 131.58 55.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.821 1.648 . . . . 75.409999999999997 109.911 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.55 135.85 54.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.914 1.234 . . . . 62.240000000000002 110.834 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.1 pt -141.11 -173.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.987 1.315 . . . . 73.099999999999994 111.003 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 65.140000000000001 112.503 -168.735 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 106.741 -1.577 . . . . 64.239999999999995 106.741 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.14 108.4 7.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.703 -1.221 . . . . 61.140000000000001 107.703 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -118.2 -174.69 2.71 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.826 1.65 . . . . 64.230000000000004 108.849 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.4 ttp -121.82 121.72 37.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.892 2.477 . . . . 75.200000000000003 107.275 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 107.177 -1.416 . . . . 74.099999999999994 107.177 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.2 -28.96 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.804 -0.56 . . . . 73.310000000000002 110.67 168.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 73' ' ' PRO . 4.6 t80 -99.93 93.86 5.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.562 -0.711 . . . . 75.310000000000002 109.117 -159.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.3 71.92 0.85 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.991 1.317 . . . . 75.209999999999994 107.657 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.55 168.95 41.58 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.849 -0.9 . . . . 64.540000000000006 110.849 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.41 -55.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.565 2.844 . . . . 64.439999999999998 112.451 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 m -151.29 73.24 8.39 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.368 1.467 . . . . 72.120000000000005 109.763 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 19.4 Cg_endo -65.72 -47.87 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-O 116.237 -1.651 . . . . 75.430000000000007 110.129 155.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.83 76.6 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.395 1.452 . . . . 71.340000000000003 109.451 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.5 t 77.52 83.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 130.051 3.341 . . . . 75.150000000000006 111.586 -166.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 97.1 2.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.777 -1.564 . . . . 51.439999999999998 106.777 145.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' A' ' 82' ' ' LEU . 29.2 t -133.35 106.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 120.739 -1.226 . . . . 71.549999999999997 108.349 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -61.77 142.3 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.885 1.674 . . . . 51.140000000000001 109.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 p -57.78 -26.31 61.74 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.46 0.704 . . . . 72.349999999999994 110.815 171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -53.6 -15.83 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.484 1.914 . . . . 61.109999999999999 114.115 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -99.23 -49.75 4.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.532 1.06 . . . . 73.230000000000004 109.824 171.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' CD2' HG12 ' A' ' 77' ' ' VAL . 2.4 mm? -63.6 -39.46 94.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.563 1.074 . . . . 63.420000000000002 112.261 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.8 t -56.25 -44.59 79.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.985 1.314 . . . . 75.519999999999996 109.521 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.19 1.43 44.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 75.120000000000005 112.376 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.19 145.96 47.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.779 0.799 . . . . 54.200000000000003 109.534 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -69.47 107.4 3.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.096 -1.816 . . . . 74.409999999999997 106.096 158.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.01 130.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 106.439 -1.689 . . . . 74.409999999999997 106.439 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.49 132.22 53.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.898 1.332 . . . . 71.209999999999994 109.246 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.81 32.2 5.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.675 -1.148 . . . . 73.310000000000002 108.263 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.66 -84.35 0.64 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.638 -1.986 . . . . 71.329999999999998 105.638 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -62.47 -64.34 0.95 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.75 0.82 . . . . 64.129999999999995 110.421 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -155.86 155.65 29.64 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 117.747 -1.121 . . . . 74.030000000000001 110.766 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.44 97.38 0.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.315 2.01 . . . . 54.5 107.949 169.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -155.71 169.99 23.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.704 2.002 . . . . 73.310000000000002 108.594 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.92 115.45 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.197 -1.779 . . . . 64.430000000000007 106.197 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.14 139.61 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.597 -1.26 . . . . 75.310000000000002 107.597 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.08 131.31 50.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.055 1.742 . . . . 53.32 107.811 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -103.32 137.72 41.06 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.193 -1.78 . . . . 74.420000000000002 106.193 155.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.401 HD13 ' CE3' ' A' ' 26' ' ' TRP . 67.0 mt -130.74 137.75 55.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 104.557 -2.386 . . . . 73.030000000000001 104.557 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.4 142.77 23.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.87 0.692 . . . . 75.430000000000007 112.87 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.59 128.35 36.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.433 1.893 . . . . 73.450000000000003 109.573 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.49 95.71 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.343 -1.725 . . . . 62.140000000000001 106.343 173.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -120.84 166.06 14.29 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.079 1.352 . . . . 75.150000000000006 108.297 169.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.24 -35.54 65.08 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.852 0.861 . . . . 53.130000000000003 112.438 -171.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -55.37 -21.08 13.9 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.204 1.187 . . . . 71.019999999999996 114.204 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.49 176.26 32.72 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.498 -1.441 . . . . 62.530000000000001 109.498 -168.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -79.73 55.87 2.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.548 1.166 . . . . 75.349999999999994 109.584 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.32 -64.73 3.65 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.632 1.587 . . . . 75.010000000000005 109.289 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.58 142.1 25.76 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 CA-C-N 118.942 1.371 . . . . 51.43 109.255 172.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.83 147.79 27.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.075 -1.083 . . . . 62.340000000000003 108.075 165.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -78.01 169.73 17.79 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.343 -0.614 . . . . 71.129999999999995 109.343 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.58 2.91 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.409 -1.7 . . . . 64.019999999999996 106.409 169.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.87 161.08 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.008 -1.479 . . . . 52.149999999999999 107.008 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 131.16 22.82 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.034 -1.839 . . . . 73.409999999999997 106.034 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -82.76 82.41 8.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.195 -1.039 . . . . 74.030000000000001 108.195 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 94' ' ' ALA . 12.4 mt -68.67 -16.69 63.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.763 0.71 . . . . 74.239999999999995 112.519 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.2 -17.66 64.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.284 -0.885 . . . . 72.420000000000002 111.269 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.444 -0.735 0 C-N-CA 126.012 1.725 . . . . 74.450000000000003 106.547 -174.226 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 107.3 -1.37 . . . . 74.019999999999996 107.3 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.39 6.92 1.01 Allowed 'Trans proline' 0 CA--C 1.545 1.035 1 C-N-CA 126.734 4.956 . . . . 50.25 114.464 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.87 -114.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.525 0 O-C-N 120.802 -1.186 . . . . 30.030000000000001 111.694 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 109' ' ' PRO . . . 75.27 164.79 0.14 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.121 2.968 . . . . 72.310000000000002 111.404 -163.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.36 159.75 11.12 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 124.06 3.173 . . . . 70.340000000000003 110.804 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -136.45 -173.93 3.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.378 1.071 . . . . 70.239999999999995 110.233 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 33.43 3.49 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.929 2.492 . . . . 62.039999999999999 115.151 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.03 139.36 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.385 0.674 . . . . 65.129999999999995 109.924 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -124.04 140.13 53.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 125.545 1.538 . . . . 73.329999999999998 107.79 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.6 mt -147.3 134.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.83 -1.915 . . . . 74.409999999999997 105.83 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.04 163.29 40.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 74.310000000000002 108.237 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -81.97 164.1 21.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.144 0.884 . . . . 72.409999999999997 109.074 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -138.92 165.54 31.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.774 2.029 . . . . 44.32 106.897 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -64.25 -28.57 64.06 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.695 1.597 . . . . 72.310000000000002 111.631 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.52 17.92 11.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.64 1.576 . . . . 73.109999999999999 111.268 -163.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.38 -141.94 9.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.47 -1.452 . . . . 53.450000000000003 109.47 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.75 163.07 30.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.801 1.301 . . . . 42.350000000000001 111.416 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.02 134.76 34.24 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.253 1.821 . . . . 73.109999999999999 108.219 168.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 114.86 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.435 1.494 . . . . 54.539999999999999 110.152 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.1 p -135.33 168.81 18.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.654 0.661 . . . . 74.329999999999998 110.953 166.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -148.21 169.47 20.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 130.171 3.388 . . . . 74.209999999999994 107.048 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.04 151.72 42.65 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 123.999 0.92 . . . . 71.409999999999997 109.097 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.74 164.61 33.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.802 2.335 . . . . 64.209999999999994 111.245 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.88 139.83 90.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.888 3.059 . . . . 62.420000000000002 112.679 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.6 t -135.26 16.14 3.46 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.925 . . . . 61.32 113.173 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.91 -45.04 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.236 1.014 . . . . 54.420000000000002 110.345 -171.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 p -144.89 174.16 11.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.963 0.905 . . . . 63.350000000000001 109.689 168.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -50.4 -56.24 12.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.396 1.878 . . . . 42.520000000000003 114.019 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.97 176.76 5.53 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.298 1.904 . . . . 63.229999999999997 112.828 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -139.05 93.43 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.606 0.762 . . . . 51.340000000000003 109.222 158.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.46 150.95 3.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.264 -1.013 . . . . 74.150000000000006 108.264 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.7 -34.64 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.75 1.22 . . . . 64.219999999999999 111.644 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -160.43 -179.27 7.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.725 -1.213 . . . . 64.420000000000002 107.725 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -136.32 165.48 25.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.306 0.957 . . . . 65.349999999999994 110.413 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 t -145.75 153.57 41.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.041 0.936 . . . . 71.420000000000002 109.368 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.54 147.9 31.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.767 1.627 . . . . 71.129999999999995 107.305 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -133.0 145.53 50.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.275 -1.379 . . . . 72.319999999999993 107.275 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD21 ' CG2' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -126.28 134.58 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.713 -1.218 . . . . 62.119999999999997 107.713 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.09 131.24 49.91 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.75 -1.119 . . . . 63.240000000000002 109.71 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 pt -144.31 -174.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.751 -1.203 . . . . 45.030000000000001 107.751 168.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 126.256 1.823 . . . . 71.209999999999994 115.535 -176.9 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 112.399 0.518 . . . . 70.030000000000001 112.399 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.34 77.53 1.79 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.61 0.764 . . . . 70.310000000000002 111.488 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 6.5 m-85 -139.59 129.97 25.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.998 0.919 . . . . 74.310000000000002 109.134 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.8 ttp -76.76 151.08 36.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.844 1.258 . . . . 54.030000000000001 109.523 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -79.62 71.39 6.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 71.340000000000003 112.784 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.56 -32.03 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 118.763 -0.636 . . . . 71.519999999999996 112.63 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -58.92 122.64 14.16 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.34 0.973 . . . . 74.540000000000006 110.545 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.9 t -157.18 40.7 0.31 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.676 0.79 . . . . 73.420000000000002 110.142 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.33 168.6 32.61 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 119.268 0.94 . . . . 54.140000000000001 112.029 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.75 -21.39 6.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.734 2.956 . . . . 71.329999999999998 115.438 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 m -82.9 143.47 46.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.315 -0.994 . . . . 73.430000000000007 108.315 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.55 -41.52 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.431 1.42 . . . . 72.319999999999993 109.563 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.9 m -74.7 79.65 2.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.564 -1.272 . . . . 51.039999999999999 107.564 161.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.08 171.76 11.33 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.671 -0.643 . . . . 73.120000000000005 110.011 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.13 178.45 6.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.767 0.827 . . . . 74.409999999999997 110.583 167.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.5 t -138.83 146.7 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.952 1.701 . . . . 70.219999999999999 108.247 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.41 165.41 14.95 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 129.088 2.955 . . . . 73.439999999999998 112.93 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -44.98 -47.38 11.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.093 1.357 . . . . 70.129999999999995 111.966 162.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.1 m -56.5 -50.67 71.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.144 0.884 . . . . 72.219999999999999 112.255 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -71.89 -33.88 68.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.539 0.736 . . . . 25.140000000000001 110.561 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.68 -39.8 92.7 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.02 0.928 . . . . 64.219999999999999 111.743 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 m -71.66 3.69 3.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 0.817 . . . . 70.340000000000003 113.114 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -117.76 -1.93 11.47 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.975 1.31 . . . . 73.25 111.288 166.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.63 118.57 13.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.205 0.911 . . . . 70.450000000000003 108.735 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.12 140.65 56.2 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.542 -0.54 . . . . 74.099999999999994 109.542 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.05 138.78 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.859 -0.793 . . . . 70.049999999999997 108.859 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.0 133.11 49.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.588 0.755 . . . . 65.230000000000004 109.185 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.51 3.48 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.282 1.033 . . . . 72.239999999999995 112.0 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.2 m -65.46 -31.44 72.53 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.496 1.043 . . . . 71.230000000000004 109.589 167.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.86 -69.31 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.825 -0.547 . . . . 65.239999999999995 111.38 -162.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.59 ' HE3' HD22 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -141.95 145.89 38.21 Favored Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 118.054 -0.974 . . . . 53.32 109.109 -173.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.49 97.47 0.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.343 2.029 . . . . 73.129999999999995 108.437 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.491 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -148.22 162.87 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.24 2.616 . . . . 74.140000000000001 107.766 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CG2' HD21 ' A' ' 43' ' ' LEU . 64.7 mt -105.02 136.11 40.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.861 -1.163 . . . . 74.010000000000005 107.861 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.13 125.75 53.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.147 0.979 . . . . 74.019999999999996 110.665 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.423 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 95.9 m-85 -109.42 159.95 16.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.672 1.189 . . . . 72.450000000000003 109.775 170.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.0 126.95 44.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.188 -2.152 . . . . 64.209999999999994 105.188 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.9 mt -120.54 142.53 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.69 -1.596 . . . . 63.25 106.69 171.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 153.31 38.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.435 0.561 . . . . 74.030000000000001 111.56 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.47 131.8 40.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.898 1.279 . . . . 53.43 108.869 163.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -77.83 111.53 13.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.995 -1.854 . . . . 71.439999999999998 105.995 157.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -119.48 175.43 5.84 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.427 0.691 . . . . 73.319999999999993 111.027 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.27 -45.99 92.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.428 0.691 . . . . 74.409999999999997 112.295 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -61.84 -27.64 68.92 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.362 0.983 . . . . 74.420000000000002 110.627 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.63 -167.9 29.22 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.375 -1.49 . . . . 65.120000000000005 109.375 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.51 12.03 0.11 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.194 1.924 . . . . 52.130000000000003 116.194 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.4 -160.82 0.57 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.817 2.151 . . . . 44.310000000000002 112.11 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.521 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 24.2 Cg_endo -75.2 178.55 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.542 2.161 . . . . 73.439999999999998 109.074 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.42 128.63 48.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.334 -0.987 . . . . 62.25 108.334 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.402 ' OG1' ' HB1' ' A' ' 9' ' ' ALA . 97.2 m -76.08 105.47 7.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.773 -1.195 . . . . 74.340000000000003 107.773 169.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.56 118.21 9.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.344 -1.724 . . . . 72.010000000000005 106.344 161.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 97' ' ' PHE . 34.9 m -116.54 160.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 O-C-N 121.167 -0.958 . . . . 53.130000000000003 109.165 166.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.77 129.81 52.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.961 0.905 . . . . 71.450000000000003 109.215 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -85.37 85.45 7.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.396 -0.964 . . . . 63.140000000000001 108.396 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.59 HD22 ' HE3' ' A' ' 92' ' ' LYS . 66.1 mt -66.06 165.66 13.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.036 -0.727 . . . . 73.049999999999997 109.036 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 75.81 10.92 3.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.278 2.231 . . . . 50.539999999999999 113.497 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.246 0.877 0 N-CA-C 113.431 0.9 . . . . 52.549999999999997 113.431 161.172 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 109.212 -0.662 . . . . 72.329999999999998 109.212 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.13 168.12 22.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.84 2.36 . . . . 62.340000000000003 110.313 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.52 -132.64 11.27 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.703 -1.759 . . . . 71.0 108.703 -170.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.11 156.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.321 2.648 . . . . 74.109999999999999 111.841 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -68.97 159.23 54.77 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.894 1.729 . . . . 64.319999999999993 108.955 167.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.98 174.21 10.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.57 0.7 . . . . 53.140000000000001 109.853 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 50.3 27.28 2.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.094 2.157 . . . . 71.109999999999999 114.899 168.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -56.96 137.97 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.28 . . . . 72.400000000000006 108.699 -171.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -135.85 141.4 44.64 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.492 -1.299 . . . . 53.520000000000003 107.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mt -142.92 110.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.111 -1.07 . . . . 63.030000000000001 108.111 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -106.93 145.3 32.39 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.812 0.845 . . . . 74.219999999999999 109.831 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -82.53 158.86 22.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.38 0.672 . . . . 74.319999999999993 109.925 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -143.45 163.42 36.89 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.449 2.299 . . . . 74.400000000000006 109.545 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.97 -13.9 42.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.763 2.975 . . . . 63.140000000000001 113.684 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 2.47 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.411 2.284 . . . . 75.319999999999993 111.36 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.86 -127.29 2.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.223 0.92 . . . . 64.030000000000001 112.889 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.09 127.67 17.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.721 1.208 . . . . 62.439999999999998 108.418 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -70.17 98.62 1.37 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.52 1.528 . . . . 75.0 108.643 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.99 116.47 23.4 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.457 -1.312 . . . . 71.400000000000006 107.457 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 p -136.95 160.24 39.48 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.716 -0.615 . . . . 73.439999999999998 109.813 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 -178.41 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.192 0.597 . . . . 75.329999999999998 110.137 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 51.8 mt-10 -133.69 158.65 75.02 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 108.917 -0.771 . . . . 75.209999999999994 108.917 165.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.59 160.64 42.22 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.508 1.472 . . . . 71.430000000000007 109.525 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.58 170.93 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.308 1.339 . . . . 74.129999999999995 111.427 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 t -141.67 70.57 1.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 105.091 -2.189 . . . . 71.040000000000006 105.091 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.84 -65.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.124 0.97 . . . . 73.140000000000001 110.251 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -135.09 -173.11 3.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.564 1.074 . . . . 53.439999999999998 110.302 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -26.06 67.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.833 1.79 . . . . 63.009999999999998 115.833 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.36 94.67 0.01 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.721 2.105 . . . . 43.329999999999998 115.991 167.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -82.23 64.93 7.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.685 1.194 . . . . 71.099999999999994 111.621 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.57 147.43 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.58 -0.896 . . . . 73.040000000000006 108.58 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.33 -15.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.312 2.245 . . . . 22.039999999999999 112.1 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.19 178.06 10.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.764 1.626 . . . . 72.400000000000006 107.019 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.05 168.12 19.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.63 -1.248 . . . . 74.219999999999999 107.63 165.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 42' ' ' TYR . 56.0 m -134.43 141.45 46.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.568 -0.901 . . . . 73.0 108.568 164.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.5 t -136.61 116.98 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.363 -2.458 . . . . 75.200000000000003 104.363 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.479 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 11.2 m-85 -120.63 127.38 52.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.267 -1.012 . . . . 60.329999999999998 108.267 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -115.28 129.37 56.6 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 105.555 -2.017 . . . . 74.340000000000003 105.555 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.32 145.63 33.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 124.021 0.825 . . . . 74.219999999999999 109.367 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -145.23 -179.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.169 1.788 . . . . 64.409999999999997 107.903 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 123.063 0.545 . . . . 73.109999999999999 111.958 171.267 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 122.584 1.183 . . . . 74.409999999999997 111.336 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.63 148.3 30.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.759 -1.941 . . . . 62.140000000000001 105.759 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 23.0 m-85 -143.32 151.14 40.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.691 0.678 . . . . 72.430000000000007 110.67 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -112.22 4.95 18.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.6 1.16 . . . . 74.319999999999993 113.506 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 49.93 78.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.842 1.657 . . . . 73.0 111.317 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.0 m -77.28 -5.82 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 73.400000000000006 112.751 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -56.24 112.69 1.3 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.974 1.31 . . . . 74.420000000000002 110.103 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.78 31.41 0.22 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.345 1.458 . . . . 75.420000000000002 110.164 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -125.75 75.01 0.41 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.765 1.174 . . . . 74.209999999999994 111.29 -170.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -67.33 -17.5 49.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.144 1.896 . . . . 61.340000000000003 111.721 165.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -56.58 144.35 64.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.87 1.268 . . . . 61.310000000000002 109.515 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.79 -21.02 38.92 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.976 1.784 . . . . 43.210000000000001 111.85 -174.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.63 145.85 33.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 128.461 2.704 . . . . 63.32 104.183 163.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -137.7 154.07 49.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.626 1.103 . . . . 72.200000000000003 110.242 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.07 163.91 27.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.585 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.6 t -139.33 128.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 104.383 -2.451 . . . . 73.430000000000007 104.383 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.77 139.2 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.944 0.778 . . . . 62.310000000000002 109.502 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -30.27 63.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.843 1.657 . . . . 75.340000000000003 111.779 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.4 p -59.18 -14.61 11.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 55.399999999999999 113.595 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 t -88.07 -48.14 7.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.026 0.83 . . . . 64.140000000000001 108.947 168.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.38 -31.71 72.97 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.009 0.822 . . . . 63.119999999999997 112.151 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -44.89 -59.96 2.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.117 2.167 . . . . 62.020000000000003 108.386 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.35 0.29 37.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 62.439999999999998 111.929 -165.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 153.07 44.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.768 0.827 . . . . 72.430000000000007 110.884 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 132.5 36.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.093 -1.077 . . . . 75.0 108.093 165.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -84.06 145.44 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.431 1.092 . . . . 75.120000000000005 108.055 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -70.54 132.28 45.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.829 0.852 . . . . 73.340000000000003 109.181 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.55 23.72 11.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 75.340000000000003 109.995 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.53 -38.06 2.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.553 1.541 . . . . 53.100000000000001 111.892 -162.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -136.82 -52.89 0.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.447 1.099 . . . . 72.340000000000003 112.462 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -148.02 150.51 35.67 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 120.452 1.478 . . . . 71.239999999999995 110.84 158.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.51 95.93 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.816 3.01 . . . . 73.109999999999999 109.795 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -155.48 166.39 33.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.054 1.742 . . . . 61.039999999999999 110.6 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.1 mt -86.25 118.98 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.841 1.257 . . . . 63.329999999999998 107.735 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.56 145.76 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.52 -0.918 . . . . 73.040000000000006 108.52 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -131.92 125.45 31.7 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.682 -1.599 . . . . 63.329999999999998 106.682 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.85 126.36 32.88 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.901 -1.888 . . . . 73.200000000000003 105.901 164.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 mt -133.22 136.02 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.557 -1.646 . . . . 64.299999999999997 106.557 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 158.58 44.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.681 1.192 . . . . 75.319999999999993 108.709 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.82 101.38 9.23 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.814 1.246 . . . . 74.109999999999999 107.818 -171.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.23 111.03 1.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.958 1.703 . . . . 64.299999999999997 107.925 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -136.19 179.11 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.809 1.643 . . . . 44.140000000000001 111.378 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.89 -33.11 10.08 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.833 1.653 . . . . 63.119999999999997 114.002 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -60.75 -55.31 34.69 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.379 0.991 . . . . 73.319999999999993 111.247 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.68 174.55 19.32 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.131 -0.788 . . . . 64.400000000000006 111.131 -162.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -73.26 81.84 1.35 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.882 1.273 . . . . 75.239999999999995 109.639 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.08 -63.94 0.87 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.263 -1.299 . . . . 41.520000000000003 111.522 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.39 155.96 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.158 2.572 . . . . 32.240000000000002 109.131 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.58 103.19 1.21 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.96 -0.756 . . . . 63.109999999999999 108.96 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -71.82 146.81 47.77 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.459 -0.571 . . . . 73.040000000000006 109.459 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.86 83.67 1.8 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.234 1.013 . . . . 74.239999999999995 108.351 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.14 152.52 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.004 -1.48 . . . . 51.539999999999999 107.004 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.74 50.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.44 1.496 . . . . 75.319999999999993 108.284 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -136.61 111.58 8.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 75.040000000000006 110.113 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.642 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -86.29 -177.55 6.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.711 2.004 . . . . 72.129999999999995 110.687 -166.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 76.46 -2.67 2.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.025 2.53 . . . . 64.019999999999996 113.572 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 C--O 1.238 0.483 0 C-N-CA 124.111 0.964 . . . . 75.420000000000002 110.063 -179.745 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 108.408 -0.96 . . . . 73.340000000000003 108.408 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.68 7.39 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.073 1 C-N-CA 126.309 4.673 . . . . 72.430000000000007 115.463 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.37 -147.06 13.15 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.241 -1.537 . . . . 53.5 111.294 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.54 80.85 0.27 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.697 1.999 . . . . 61.439999999999998 112.881 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.88 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.165 . . . . 63.020000000000003 110.181 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.0 m -132.25 -177.45 4.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.189 1.396 . . . . 73.319999999999993 109.678 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.34 11.74 2.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.716 2.006 . . . . 72.010000000000005 114.688 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -56.95 131.98 20.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.665 1.586 . . . . 53.310000000000002 110.846 -166.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.73 163.74 22.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.352 1.061 . . . . 51.409999999999997 110.408 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.45 HG23 ' CD2' ' A' ' 24' ' ' LEU . 4.2 mp -140.13 158.1 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.851 2.06 . . . . 54.539999999999999 106.459 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -144.44 133.91 23.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.236 2.214 . . . . 74.329999999999998 107.353 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -64.81 151.65 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.622 -0.881 . . . . 62.140000000000001 108.622 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.56 157.51 44.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 126.518 1.927 . . . . 52.439999999999998 106.001 176.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.24 -20.12 32.97 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.422 2.081 . . . . 70.310000000000002 111.639 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -114.93 13.47 17.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.0 2.92 . . . . 74.219999999999999 111.317 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.66 -163.54 30.02 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 118.878 0.763 . . . . 51.329999999999998 112.164 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.91 121.18 40.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 120.017 1.909 . . . . 71.329999999999998 106.562 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -58.62 124.47 19.77 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.385 -1.339 . . . . 72.329999999999998 107.385 165.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 15' ' ' ILE . 11.8 mt -120.56 160.79 22.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.321 0.964 . . . . 74.230000000000004 109.08 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -155.47 165.2 37.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.85 0.75 . . . . 73.340000000000003 110.078 166.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.516 ' CE3' HD13 ' A' ' 99' ' ' ILE . 0.5 OUTLIER -151.43 172.35 16.1 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 129.138 2.975 . . . . 72.420000000000002 108.236 177.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -129.3 161.74 56.77 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 124.454 1.102 . . . . 73.319999999999993 111.347 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.19 161.91 38.18 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.605 2.87 . . . . 70.420000000000002 113.392 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.39 143.11 51.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.35 2.033 . . . . 72.430000000000007 110.225 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -133.5 61.81 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.252 -1.758 . . . . 61.200000000000003 106.252 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -133.29 -68.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.678 -1.23 . . . . 73.439999999999998 107.678 174.308 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 31' ' ' VAL . 64.6 p -130.22 170.92 13.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.605 1.562 . . . . 62.200000000000003 107.622 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -65.01 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.433 1.093 . . . . 71.420000000000002 110.414 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 144.48 2.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.665 -1.272 . . . . 71.400000000000006 112.18 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -100.47 83.17 2.57 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.776 -0.838 . . . . 74.319999999999993 108.747 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.85 143.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.635 -1.246 . . . . 62.030000000000001 107.635 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.87 -23.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.331 1.452 . . . . 74.230000000000004 111.367 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.66 -170.16 3.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.547 1.067 . . . . 65.030000000000001 109.95 171.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.23 175.28 9.25 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.051 1.34 . . . . 74.209999999999994 109.383 163.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -152.36 156.61 39.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.11 1.364 . . . . 64.230000000000004 109.434 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.4 t -148.0 121.61 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.949 -1.871 . . . . 44.509999999999998 105.949 -167.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -131.03 140.6 50.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.003 1.321 . . . . 74.400000000000006 109.273 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 125.98 46.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.424 -1.324 . . . . 65.010000000000005 107.424 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 116.82 15.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.581 1.552 . . . . 44.109999999999999 110.175 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.05 -176.61 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.819 2.048 . . . . 63.119999999999997 108.88 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 CA--C 1.537 0.46 0 O-C-N 121.87 -0.519 . . . . 54.229999999999997 112.145 171.626 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 107.48 -1.304 . . . . 52.32 107.48 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.1 112.63 13.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.52 -0.919 . . . . 72.140000000000001 108.52 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.19 150.08 40.56 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.595 1.158 . . . . 70.209999999999994 108.391 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.51 4.9 6.64 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.109 1.522 . . . . 73.030000000000001 115.109 -167.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 43.96 55.39 5.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.464 1.906 . . . . 64.239999999999995 113.172 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.76 -20.9 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.862 1.265 . . . . 74.430000000000007 112.671 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -58.76 120.17 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.022 0.828 . . . . 73.129999999999995 110.596 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -152.24 83.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.385 1.874 . . . . 63.0 105.969 161.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.91 159.85 28.26 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.252 -0.749 . . . . 73.010000000000005 111.474 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.11 -55.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 73.099999999999994 111.227 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.54 166.59 14.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.159 2.184 . . . . 70.230000000000004 110.509 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.46 169.05 23.23 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.807 1.671 . . . . 70.439999999999998 110.848 168.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 39.11 9.23 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.633 1.573 . . . . 72.430000000000007 112.145 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.2 m -85.5 175.71 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.337 1.065 . . . . 62.340000000000003 110.95 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 168.09 16.91 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.625 1.57 . . . . 74.310000000000002 109.333 165.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.1 p -130.64 144.2 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.236 1.414 . . . . 62.310000000000002 107.628 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -66.42 147.79 52.8 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.165 0.586 . . . . 50.140000000000001 112.285 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -48.47 81.09 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.962 1.705 . . . . 64.120000000000005 110.06 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.0 p -44.91 -48.58 11.25 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.573 1.949 . . . . 52.140000000000001 111.573 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.4 m -67.62 -42.16 82.81 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.343 -0.844 . . . . 73.010000000000005 111.214 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.49 -31.46 72.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.168 0.987 . . . . 73.310000000000002 111.407 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -64.39 -0.73 1.39 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.597 1.559 . . . . 70.329999999999998 114.283 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -120.62 -6.23 9.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.274 1.397 . . . . 70.420000000000002 111.679 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.47 137.75 57.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.788 1.235 . . . . 71.340000000000003 111.59 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 161.1 30.39 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.647 -0.872 . . . . 70.439999999999998 108.647 168.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.56 143.52 35.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.238 1.015 . . . . 70.120000000000005 108.447 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.98 82.45 0.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.768 1.627 . . . . 73.209999999999994 111.365 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.68 -18.35 61.56 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.637 -1.29 . . . . 51.149999999999999 111.21 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -17.81 64.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.224 1.41 . . . . 64.420000000000002 113.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.68 -75.02 0.17 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.433 1.015 . . . . 73.5 110.56 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.25 144.3 27.84 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 117.81 -1.091 . . . . 65.420000000000002 108.395 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 100.35 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.907 1.738 . . . . 74.209999999999994 109.8 -170.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 157.71 44.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.349 1.86 . . . . 32.350000000000001 109.085 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.1 mt -88.38 132.07 34.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.5 1.12 . . . . 73.0 109.168 169.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.6 136.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.777 1.275 . . . . 62.229999999999997 110.388 165.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -119.28 116.71 26.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 112.715 -2.039 . . . . 71.200000000000003 107.568 165.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -81.21 128.79 34.17 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 106.368 -1.716 . . . . 74.219999999999999 106.368 162.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.516 HD13 ' CE3' ' A' ' 26' ' ' TRP . 16.4 mt -133.62 151.7 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.684 -1.969 . . . . 65.310000000000002 105.684 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.49 151.91 25.0 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.522 0.729 . . . . 62.310000000000002 109.721 165.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.44 117.26 13.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.602 1.161 . . . . 62.210000000000001 109.97 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.95 99.8 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.643 -1.614 . . . . 73.310000000000002 106.643 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.99 172.98 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.688 1.595 . . . . 73.420000000000002 109.595 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -25.99 63.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.474 1.287 . . . . 62.439999999999998 114.474 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.55 25.45 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.541 -0.911 . . . . 70.010000000000005 108.541 174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.36 167.04 12.89 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.913 -0.875 . . . . 45.310000000000002 110.913 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -61.6 117.94 6.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 74.019999999999996 106.477 160.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.21 -95.88 2.4 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.455 -1.858 . . . . 22.140000000000001 108.455 173.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.91 147.75 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.271 1.981 . . . . 64.040000000000006 110.673 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.05 110.48 10.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.601 1.56 . . . . 53.340000000000003 108.635 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 m -65.03 123.79 20.39 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.358 -0.978 . . . . 74.140000000000001 108.358 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -97.45 89.44 4.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.985 -1.487 . . . . 65.340000000000003 106.985 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.87 171.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 120.633 -0.427 . . . . 71.109999999999999 110.168 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.39 123.86 19.52 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.504 1.121 . . . . 71.319999999999993 108.161 172.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -82.48 87.91 6.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.847 1.259 . . . . 72.120000000000005 109.106 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.2 mt -73.93 0.87 12.1 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.319 1.229 . . . . 72.439999999999998 114.319 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -115.12 38.4 3.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.423 1.01 . . . . 71.219999999999999 108.765 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 106.612 -1.625 . . . . 50.539999999999999 106.612 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 N--CA 1.466 0.358 0 N-CA-C 106.998 -1.482 . . . . 74.340000000000003 106.998 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.66 67.34 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 126.079 4.519 . . . . 75.310000000000002 111.865 -168.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 166.35 35.86 Favored Glycine 0 C--N 1.332 0.36 0 O-C-N 121.097 -1.002 . . . . 55.240000000000002 111.96 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.29 161.45 7.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.977 2.511 . . . . 35.130000000000003 106.873 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.79 159.49 52.48 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.702 2.268 . . . . 62.25 112.139 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -127.27 -178.5 4.47 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 121.45 -0.781 . . . . 54.310000000000002 110.664 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.11 23.16 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.916 2.487 . . . . 64.439999999999998 114.652 171.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.79 126.83 21.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 118.721 0.691 . . . . 75.540000000000006 110.734 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -120.3 143.88 48.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.01 1.324 . . . . 63.140000000000001 107.81 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -144.26 126.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.49 -2.041 . . . . 75.409999999999997 105.49 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.7 m -143.61 149.77 37.81 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.023 1.329 . . . . 61.219999999999999 110.291 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -84.52 153.71 23.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 72.530000000000001 110.602 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 166.07 15.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 128.745 2.818 . . . . 54.420000000000002 107.119 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.59 -27.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.404 2.069 . . . . 60.530000000000001 113.693 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.66 -11.52 51.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.373 1.069 . . . . 72.430000000000007 112.164 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.67 -163.31 29.02 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.952 -1.259 . . . . 73.409999999999997 109.952 -161.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.62 30.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.061 0.945 . . . . 73.129999999999995 111.092 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -78.84 134.6 36.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.846 -1.168 . . . . 75.329999999999998 107.846 157.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.72 137.49 45.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.159 1.384 . . . . 53.350000000000001 107.761 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -142.92 167.25 22.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.445 1.02 . . . . 73.120000000000005 109.856 167.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.441 ' CE3' HD13 ' A' ' 99' ' ' ILE . 4.0 p90 -160.51 178.4 9.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.822 2.049 . . . . 63.450000000000003 109.825 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.6 158.25 66.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.925 -1.036 . . . . 74.030000000000001 111.998 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 170.82 18.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.04 3.16 . . . . 73.209999999999994 113.85 -168.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.68 166.49 17.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.754 2.303 . . . . 75.200000000000003 111.82 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 t -140.46 21.49 2.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.469 1.508 . . . . 74.400000000000006 110.128 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.72 -55.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.638 1.175 . . . . 73.319999999999993 108.461 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 p -124.46 103.46 8.19 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.511 1.124 . . . . 75.230000000000004 109.368 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -64.22 -73.41 0.12 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.995 0.918 . . . . 43.409999999999997 110.899 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 1.84 75.57 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 117.587 -1.674 . . . . 43.539999999999999 115.14 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt 65.26 83.58 0.17 Allowed 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 132.479 4.311 . . . . 74.010000000000005 111.113 -172.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.62 136.5 22.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 107.205 -1.406 . . . . 53.200000000000003 107.205 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.7 -17.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.071 1.748 . . . . 72.409999999999997 111.142 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 3.2 tp10 -164.58 -164.91 0.87 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.048 1.339 . . . . 75.230000000000004 109.237 172.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.418 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 1.1 m-85 -142.25 172.84 12.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.975 1.71 . . . . 73.310000000000002 110.527 171.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 p -138.41 167.49 21.77 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.526 1.131 . . . . 75.230000000000004 110.744 168.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 t -146.62 124.74 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 103.537 -2.764 . . . . 73.439999999999998 103.537 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.03 136.12 50.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.501 -1.296 . . . . 75.040000000000006 107.501 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -123.74 120.84 33.85 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.278 1.831 . . . . 74.129999999999995 107.278 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.55 145.94 55.46 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.886 -0.783 . . . . 72.109999999999999 108.886 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 45' ' ' ILE . 0.1 OUTLIER -137.97 -178.33 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.647 1.979 . . . . 74.310000000000002 107.845 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--O 1.235 0.305 0 O-C-N 121.427 -0.796 . . . . 65.439999999999998 109.709 170.339 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.408 0 N-CA-C 106.317 -1.734 . . . . 65.420000000000002 106.317 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.3 109.06 5.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.341 -1.355 . . . . 73.120000000000005 107.341 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -133.49 154.43 50.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.186 1.395 . . . . 74.109999999999999 107.286 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.6 ttp -72.44 117.31 13.95 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.282 -1.377 . . . . 71.230000000000004 107.282 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -70.26 80.2 0.53 Allowed 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 107.407 -1.331 . . . . 70.140000000000001 107.407 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.6 -18.83 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.816 0.847 . . . . 43.539999999999999 111.717 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.47 105.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.471 1.108 . . . . 64.319999999999993 110.65 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.3 m -140.24 99.21 3.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.776 -1.935 . . . . 75.25 105.776 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.12 28.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.404 -1.078 . . . . 63.340000000000003 110.404 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 -15.3 17.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.388 2.725 . . . . 61.210000000000001 113.09 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 m -136.46 165.98 31.26 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.702 1.601 . . . . 75.450000000000003 110.439 -169.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.48 175.35 0.56 Allowed 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.603 2.869 . . . . 75.420000000000002 112.932 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m 56.3 43.21 26.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.995 1.718 . . . . 72.219999999999999 112.303 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 99.5 m -65.89 123.3 19.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 74.329999999999998 109.522 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 171.73 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.99 0.916 . . . . 64.230000000000004 111.465 167.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.7 141.17 39.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.467 -1.309 . . . . 75.25 107.467 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -78.02 162.66 26.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.482 1.113 . . . . 75.420000000000002 112.483 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -31.71 71.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.738 1.615 . . . . 71.530000000000001 113.489 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.99 -45.16 86.79 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 120.902 -1.123 . . . . 64.510000000000005 112.307 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -63.69 -38.19 90.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.859 -0.591 . . . . 64.530000000000001 109.536 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.383 0.673 . . . . 60.140000000000001 112.086 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -67.42 -44.97 77.46 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.104 1.32 . . . . 55.020000000000003 109.666 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -73.87 -18.76 60.88 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 118.601 -0.714 . . . . 52.049999999999997 112.863 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.83 133.98 31.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.7 1.6 . . . . 53.329999999999998 112.165 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -70.81 127.14 31.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.156 -1.424 . . . . 64.319999999999993 107.156 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.61 125.33 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.546 -2.02 . . . . 75.439999999999998 105.546 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.63 127.17 30.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.84 -0.8 . . . . 75.150000000000006 108.84 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.83 9.84 16.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.918 0.487 . . . . 75.530000000000001 110.842 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -89.79 -24.04 21.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 74.209999999999994 111.114 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -142.6 -74.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.328 1.051 . . . . 74.349999999999994 109.828 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.29 60.81 Favored Pre-proline 0 CA--C 1.513 -0.45 0 C-N-CA 126.541 1.937 . . . . 75.409999999999997 109.134 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.23 84.01 1.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 123.166 2.577 . . . . 73.510000000000005 106.581 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.86 162.3 35.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.254 2.621 . . . . 63.109999999999999 110.678 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG13 ' HG3' ' A' ' 118' ' ' GLU . 50.4 mt -81.03 148.42 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 108.471 -0.937 . . . . 73.319999999999993 108.471 168.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.07 139.61 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 124.785 1.234 . . . . 71.209999999999994 108.919 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.02 138.28 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.671 -1.233 . . . . 75.549999999999997 107.671 168.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -94.83 134.47 37.42 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.22 -1.4 . . . . 75.150000000000006 107.22 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.441 HD13 ' CE3' ' A' ' 26' ' ' TRP . 13.8 mt -127.3 134.95 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.458 -2.053 . . . . 75.010000000000005 105.458 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.46 153.45 46.27 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.961 0.904 . . . . 60.210000000000001 109.098 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.04 135.22 44.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.348 0.659 . . . . 72.140000000000001 109.687 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.4 HH11 ' CB ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -85.89 79.92 9.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 104.607 -2.368 . . . . 62.219999999999999 104.607 167.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.04 161.88 13.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.114 0.966 . . . . 73.409999999999997 109.387 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.31 -22.46 66.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.814 1.245 . . . . 75.129999999999995 112.133 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -65.38 -14.42 60.82 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.338 1.236 . . . . 53.310000000000002 114.338 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.75 177.34 28.27 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.696 1.617 . . . . 54.43 110.81 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.93 30.58 1.05 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.56 1.544 . . . . 63.119999999999997 114.421 -165.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.97 -77.05 0.16 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.497 1.046 . . . . 71.120000000000005 114.27 -159.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -89.17 156.1 5.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.578 2.185 . . . . 71.209999999999994 110.629 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.87 156.72 46.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.2 1.0 . . . . 62.32 109.188 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.404 HG22 HG13 ' A' ' 113' ' ' VAL . 87.4 m -82.11 123.64 29.14 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.738 -1.949 . . . . 73.140000000000001 105.738 157.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -83.98 119.34 24.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.359 -2.089 . . . . 72.319999999999993 105.359 154.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 111' ' ' THR . 22.1 m -110.51 173.98 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 123.674 0.79 . . . . 71.319999999999993 109.413 165.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.4 156.41 45.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.85 1.66 . . . . 74.549999999999997 109.3 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -139.44 109.64 6.48 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 125.77 1.628 . . . . 75.209999999999994 111.366 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.906 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -96.54 160.57 14.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.328 2.251 . . . . 63.439999999999998 107.872 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 63.06 14.78 7.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.97 1.308 . . . . 73.150000000000006 111.493 -168.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HG3' HG13 ' A' ' 95' ' ' ILE . 2.2 pm0 . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.893 2.077 . . . . 73.549999999999997 112.391 162.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 117.289 -1.339 . . . . 64.209999999999994 112.541 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -60.3 165.33 11.11 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 CA-C-N 121.333 1.512 . . . . 71.109999999999999 111.411 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.45 -126.59 7.0 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.698 1.618 . . . . 52.350000000000001 109.657 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HB2' ' HG2' ' A' ' 109' ' ' PRO . . . 63.81 151.81 0.11 Allowed Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 129.215 3.006 . . . . 53.32 114.376 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HG3' HG22 ' A' ' 99' ' ' ILE . 59.3 Cg_endo -68.66 155.28 69.38 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 123.652 2.902 . . . . 71.140000000000001 111.036 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -134.69 -179.47 5.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.699 1.6 . . . . 70.540000000000006 110.208 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.4 36.9 17.7 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.087 1.355 . . . . 73.510000000000005 112.07 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.63 134.17 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.286 -1.005 . . . . 44.030000000000001 108.286 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -131.05 155.53 46.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.452 1.101 . . . . 74.400000000000006 109.553 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.06 139.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.499 -2.038 . . . . 61.100000000000001 105.499 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -139.74 147.6 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.723 1.609 . . . . 71.530000000000001 109.559 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -79.24 143.31 35.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.37 -1.345 . . . . 73.409999999999997 107.37 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p -139.03 166.75 22.59 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.701 2.0 . . . . 72.019999999999996 108.022 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -56.53 -25.1 56.88 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.619 2.213 . . . . 72.010000000000005 113.355 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -87.58 -20.76 25.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.574 1.079 . . . . 65.310000000000002 111.558 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.11 -163.78 24.25 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.477 -1.049 . . . . 12.550000000000001 110.477 -159.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.65 135.54 36.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.884 0.874 . . . . 73.140000000000001 112.093 -166.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -84.58 86.58 7.29 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.941 2.096 . . . . 71.329999999999998 110.047 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.85 131.78 35.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.611 0.764 . . . . 72.140000000000001 110.247 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -145.85 152.75 39.99 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.269 . . . . 63.420000000000002 109.294 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -151.25 179.41 8.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.581 1.553 . . . . 74.439999999999998 110.885 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -65.35 160.8 55.83 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.618 0.599 . . . . 73.099999999999994 112.618 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.61 156.21 66.31 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.211 1.941 . . . . 63.399999999999999 109.13 156.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.95 95.58 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.024 2.483 . . . . 73.099999999999994 110.53 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -140.24 22.28 2.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.63 0.604 . . . . 71.140000000000001 112.63 -165.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.9 t -99.2 -50.96 10.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 O-C-N 121.742 -0.599 . . . . 71.540000000000006 110.158 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.5 p -131.24 164.31 25.86 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.44 1.096 . . . . 74.219999999999999 110.118 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -77.64 40.4 0.3 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.237 1.415 . . . . 71.400000000000006 111.996 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.12 132.63 15.37 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.516 -2.234 . . . . 74.109999999999999 107.516 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -76.86 79.85 3.44 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.681 -1.229 . . . . 74.510000000000005 107.681 171.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.65 146.18 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.485 -1.302 . . . . 64.510000000000005 107.485 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 pt -141.72 -17.49 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.119 2.168 . . . . 74.209999999999994 111.088 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -160.47 -168.79 2.24 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.59 1.086 . . . . 73.299999999999997 111.325 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -133.14 162.73 30.98 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.511 1.524 . . . . 75.430000000000007 109.805 164.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -142.33 160.17 40.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.784 1.634 . . . . 75.109999999999999 108.923 159.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.7 117.39 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.477 -1.675 . . . . 62.310000000000002 106.477 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -93.22 144.17 25.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.906 -1.146 . . . . 74.319999999999993 107.906 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.2 tp -129.75 132.08 46.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.768 2.027 . . . . 74.549999999999997 107.342 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.69 134.12 44.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.147 1.34 . . . . 61.140000000000001 109.127 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.34 172.5 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.833 1.253 . . . . 72.530000000000001 108.741 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 118.27 0.486 . . . . 75.340000000000003 110.522 166.008 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 122.066 0.936 . . . . 75.340000000000003 113.197 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.38 94.95 4.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.746 -1.946 . . . . 54.43 105.746 167.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.43 145.94 48.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.564 -1.643 . . . . 75.239999999999995 106.564 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.5 ttp -96.42 138.15 34.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.405 1.082 . . . . 73.439999999999998 109.731 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -79.49 65.51 4.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.774 1.23 . . . . 64.540000000000006 110.682 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.59 -32.87 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.882 1.273 . . . . 71.420000000000002 112.332 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -80.38 97.08 6.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.095 0.558 . . . . 74.510000000000005 112.238 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.31 117.77 25.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.183 -1.414 . . . . 52.219999999999999 107.183 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.53 160.98 12.05 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.651 -1.38 . . . . 41.039999999999999 109.651 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.29 -55.03 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.955 2.437 . . . . 65.530000000000001 112.011 -169.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -84.32 164.85 41.48 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 121.188 -0.945 . . . . 62.340000000000003 111.257 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.97 179.22 3.41 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.814 3.009 . . . . 72.140000000000001 111.297 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 m 58.47 28.13 16.51 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.627 1.343 . . . . 74.319999999999993 114.627 165.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.91 158.36 34.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.334 1.053 . . . . 71.319999999999993 111.936 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 169.41 18.28 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.116 0.966 . . . . 63.539999999999999 111.821 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.14 111.86 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 125.194 1.398 . . . . 75.430000000000007 109.041 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.5 144.53 16.85 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.27 1.428 . . . . 74.109999999999999 113.459 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.83 -26.71 68.88 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.281 1.432 . . . . 74.209999999999994 113.187 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.7 t -54.34 -54.49 39.66 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.38 -0.825 . . . . 71.019999999999996 109.847 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.19 -37.55 87.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.796 0.438 . . . . 55.219999999999999 111.075 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.16 -27.81 67.41 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.247 0.476 . . . . 75.340000000000003 111.278 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -74.0 -34.78 64.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.479 0.581 . . . . 55.310000000000002 111.506 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -76.7 -11.29 59.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.622 0.601 . . . . 54.350000000000001 112.622 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 134.74 48.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.837 0.827 . . . . 43.32 109.456 -174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -72.79 112.34 8.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.942 -1.026 . . . . 60.240000000000002 109.054 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.4 125.17 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 64.420000000000002 106.844 162.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.02 135.06 50.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.999 0.812 . . . . 53.119999999999997 109.94 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -130.84 56.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.823 1.249 . . . . 64.430000000000007 108.143 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 p -123.41 -21.47 5.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.328 -0.851 . . . . 55.450000000000003 112.964 163.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -131.86 -69.88 0.59 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.642 0.777 . . . . 73.140000000000001 112.245 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -144.27 158.42 54.78 Favored Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 120.421 -1.424 . . . . 74.239999999999995 109.073 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.77 96.99 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.685 2.257 . . . . 75.310000000000002 108.46 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.31 37.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.738 1.615 . . . . 73.109999999999999 107.753 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.52 120.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.381 -1.711 . . . . 71.219999999999999 106.381 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.93 152.7 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.239 -1.022 . . . . 61.420000000000002 108.239 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -131.74 152.73 50.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.989 0.915 . . . . 73.510000000000005 108.74 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -127.36 87.56 2.65 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.446 HG22 ' HG3' ' A' ' 10' ' ' PRO . 70.7 mt -90.64 133.37 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.27 -2.122 . . . . 63.119999999999997 105.27 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.64 131.63 19.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.283 0.563 . . . . 60.409999999999997 111.868 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.17 122.45 22.79 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.459 -0.941 . . . . 72.310000000000002 108.459 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -77.8 109.8 12.12 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 106.931 -1.507 . . . . 61.530000000000001 106.931 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.63 -178.63 5.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.175 0.99 . . . . 64.450000000000003 109.55 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.94 1.93 56.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.401 -0.818 . . . . 73.530000000000001 112.724 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -66.68 -68.39 0.38 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.384 -1.339 . . . . 73.140000000000001 107.384 154.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.34 37.59 0.27 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 119.34 -1.41 . . . . 72.349999999999994 115.725 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 59.59 -163.65 0.23 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.609 1.963 . . . . 75.230000000000004 109.792 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 161.97 -90.64 0.11 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 105.336 -3.106 . . . . 74.319999999999993 105.336 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 79.2 Cg_endo -62.37 150.79 85.96 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.499 2.133 . . . . 72.519999999999996 110.296 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.95 112.25 5.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.499 -2.038 . . . . 60.219999999999999 105.499 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.8 m -58.83 124.54 20.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.84 0.856 . . . . 64.150000000000006 108.992 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -79.42 79.28 5.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.607 1.194 . . . . 75.530000000000001 108.379 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.78 146.77 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.243 -1.762 . . . . 62.450000000000003 106.243 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.66 128.44 39.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.094 -1.076 . . . . 55.039999999999999 108.094 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -92.64 104.82 17.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.211 0.604 . . . . 75.140000000000001 110.337 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.15 175.36 10.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.377 1.471 . . . . 72.329999999999998 109.427 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.22 14.69 3.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.117 2.167 . . . . 54.039999999999999 112.543 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 64.340000000000003 110.832 164.907 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 109.987 -0.375 . . . . 71.019999999999996 109.987 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 163.16 36.82 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.014 2.476 . . . . 70.340000000000003 110.547 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.31 -117.97 5.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.305 -1.118 . . . . 44.32 110.305 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 160.57 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 128.464 2.706 . . . . 63.109999999999999 112.361 -168.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.1 152.36 56.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.696 2.264 . . . . 72.349999999999994 109.217 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.17 177.0 8.53 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.861 1.664 . . . . 73.540000000000006 108.535 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.71 42.09 5.56 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.44 2.296 . . . . 70.439999999999998 111.633 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.446 HG23 ' CD1' ' A' ' 26' ' ' TRP . 2.4 mp -67.95 120.73 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.168 0.987 . . . . 61.140000000000001 109.021 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -112.55 133.98 54.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.365 -0.976 . . . . 63.399999999999999 108.365 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' A' ' 97' ' ' PHE . 22.7 mt -144.4 124.84 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.728 1.211 . . . . 73.219999999999999 108.076 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.0 m -145.41 161.79 38.85 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.611 1.164 . . . . 64.329999999999998 112.281 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -83.89 146.01 28.3 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.325 1.05 . . . . 75.430000000000007 109.206 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 m -152.08 165.3 17.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.917 1.687 . . . . 73.340000000000003 108.204 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.86 -11.18 25.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.209 1.94 . . . . 75.340000000000003 113.544 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.72 7.5 8.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.011 0.924 . . . . 75.329999999999998 111.523 -164.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 174.0 13.6 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.82 2.153 . . . . 75.099999999999994 107.93 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.4 129.46 36.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.566 -1.272 . . . . 62.219999999999999 107.566 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -65.89 109.39 2.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.634 -1.247 . . . . 72.400000000000006 107.634 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 5.3 mp -126.06 126.82 44.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.317 1.047 . . . . 62.119999999999997 108.693 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -139.43 154.18 47.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.331 0.652 . . . . 75.109999999999999 109.63 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CD1' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -142.94 -178.91 6.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.132 1.373 . . . . 75.310000000000002 107.675 175.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.19 160.37 52.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.199 0.909 . . . . 74.319999999999993 111.22 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.57 156.05 64.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.734 3.623 . . . . 74.439999999999998 113.101 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.57 -176.67 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.113 3.209 . . . . 75.349999999999994 111.488 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 14.03 3.57 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.647 1.721 . . . . 63.049999999999997 115.647 -163.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.8 -54.55 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.774 -0.579 . . . . 72.450000000000003 111.468 -160.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -132.9 172.65 12.31 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.967 1.307 . . . . 60.030000000000001 107.908 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 m -51.74 -41.86 61.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.606 1.094 . . . . 72.340000000000003 112.394 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.71 163.87 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.087 0.851 . . . . 60.25 111.198 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -131.31 74.26 1.58 Allowed 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.512 -0.993 . . . . 73.010000000000005 108.641 164.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.22 152.44 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 75.219999999999999 106.439 167.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.24 -28.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.121 1.368 . . . . 61.119999999999997 110.403 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.39 -169.94 3.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.353 -1.351 . . . . 73.439999999999998 107.353 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 102' ' ' ARG . 34.8 m-85 -128.11 166.27 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.629 -1.248 . . . . 71.319999999999993 107.629 159.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -130.72 153.42 49.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.284 -1.376 . . . . 62.329999999999998 107.284 164.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.932 HG12 ' HB2' ' A' ' 68' ' ' TYR . 3.6 p -153.02 124.64 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 O-C-N 121.942 -0.474 . . . . 51.310000000000002 110.475 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -99.15 133.98 42.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.943 -1.132 . . . . 75.019999999999996 107.943 -171.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 85' ' ' ALA . 10.5 tp -117.63 130.23 56.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.639 2.375 . . . . 72.209999999999994 107.564 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . . . -63.0 136.25 57.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 121.417 1.917 . . . . 64.219999999999999 112.992 169.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.447 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.3 pt -145.11 175.5 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.194 1.398 . . . . 52.420000000000002 110.289 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 126.317 1.847 . . . . 74.409999999999997 112.754 164.328 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.24 0.562 0 N-CA-C 107.724 -1.213 . . . . 74.519999999999996 107.724 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.19 -154.24 0.06 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.724 -0.671 . . . . 74.120000000000005 111.92 162.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER 76.69 160.54 0.22 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 131.23 3.812 . . . . 61.329999999999998 113.77 173.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.447 ' SD ' HD13 ' A' ' 45' ' ' ILE . 9.8 ptt? -126.95 147.65 50.09 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.655 1.182 . . . . 55.219999999999999 110.068 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.62 93.72 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.203 2.201 . . . . 75.409999999999997 112.529 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -94.86 -26.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 116.456 -1.735 . . . . 75.099999999999994 110.162 -165.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.932 ' HB2' HG12 ' A' ' 41' ' ' VAL . 26.3 t80 -58.0 132.68 54.17 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 120.332 1.424 . . . . 72.129999999999995 109.409 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.0 p -155.01 27.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.548 1.139 . . . . 73.239999999999995 112.227 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.27 152.67 18.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.978 -0.901 . . . . 61.210000000000001 111.195 -168.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.33 -55.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.046 1.831 . . . . 72.140000000000001 109.053 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.87 144.95 97.99 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.29 -0.633 . . . . 64.209999999999994 109.29 169.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.56 -3.54 13.26 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.613 2.875 . . . . 55.340000000000003 112.604 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 p -98.58 44.99 1.02 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.461 1.482 . . . . 73.530000000000001 110.419 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.6 t -51.3 111.82 0.64 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.953 1.301 . . . . 62.100000000000001 110.706 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.3 130.24 37.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.288 -0.634 . . . . 63.140000000000001 109.288 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -76.35 95.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.846 -1.539 . . . . 72.340000000000003 106.846 162.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -75.75 163.71 26.99 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.294 -0.866 . . . . 54.299999999999997 109.694 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -53.09 -38.35 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.072 1.349 . . . . 73.420000000000002 112.115 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -40.09 63.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.784 2.034 . . . . 63.210000000000001 111.592 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.3 m -79.21 -36.09 40.65 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.105 -0.372 . . . . 75.230000000000004 111.873 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -25.53 68.23 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.85 0.46 . . . . 72.230000000000004 111.25 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.1 m -60.84 -10.86 6.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.345 1.239 . . . . 55.0 114.345 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -115.51 -6.66 12.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.644 1.111 . . . . 74.140000000000001 111.139 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 43' ' ' LEU . . . -70.1 151.28 45.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.212 1.005 . . . . 72.430000000000007 109.997 -171.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -137.24 153.09 50.45 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.721 0.808 . . . . 74.200000000000003 112.117 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 93' ' ' PRO . 1.9 mp -88.28 144.54 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.554 1.542 . . . . 64.230000000000004 109.593 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.16 71.42 5.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.417 1.887 . . . . 54.32 109.656 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -62.33 4.45 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.258 1.023 . . . . 74.239999999999995 111.876 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -20.51 31.38 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.367 0.985 . . . . 41.299999999999997 110.258 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.8 p -141.66 -85.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.765 1.226 . . . . 65.400000000000006 111.286 161.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HE3' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -117.17 153.93 49.91 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 126.421 1.889 . . . . 73.140000000000001 112.093 -162.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 87' ' ' ILE . 83.2 Cg_endo -77.64 78.76 3.41 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.511 1.474 . . . . 72.319999999999993 112.765 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.653 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -143.69 157.24 44.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.54 2.736 . . . . 53.020000000000003 107.912 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.3 mt -73.32 -21.3 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.572 0.582 . . . . 72.140000000000001 112.572 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.4 mm 60.68 142.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 130.187 3.395 . . . . 65.540000000000006 110.04 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CD2' HD13 ' A' ' 15' ' ' ILE . 10.5 m-85 -135.98 135.75 39.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.235 -1.394 . . . . 71.439999999999998 107.235 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -133.95 90.7 2.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.084 0.865 . . . . 74.530000000000001 109.627 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.544 ' HA ' HG23 ' A' ' 41' ' ' VAL . 1.1 mt -87.41 153.47 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.249 -1.389 . . . . 74.219999999999999 107.249 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.76 154.74 37.9 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.967 0.803 . . . . 61.020000000000003 111.769 159.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.47 116.22 13.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.217 1.807 . . . . 63.039999999999999 108.57 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.419 ' H ' ' HA ' ' A' ' 39' ' ' TYR . 1.4 tmm_? -79.34 89.26 4.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.074 -2.195 . . . . 74.219999999999999 105.074 170.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -115.74 178.92 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.298 1.439 . . . . 64.25 109.972 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.94 -3.12 20.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.629 0.974 . . . . 75.349999999999994 113.629 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -91.19 -27.96 18.16 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 120.256 -1.527 . . . . 61.450000000000003 109.675 173.159 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.16 -179.25 20.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.631 1.11 . . . . 51.119999999999997 110.98 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -70.7 69.52 0.44 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.068 1.747 . . . . 75.219999999999999 109.271 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 -81.99 1.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.114 -1.594 . . . . 70.439999999999998 109.114 -169.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.61 160.33 25.16 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.091 1.861 . . . . 64.450000000000003 109.05 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.71 36.92 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.973 0.909 . . . . 71.109999999999999 109.321 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -95.76 154.0 17.45 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.504 -1.295 . . . . 73.129999999999995 107.504 156.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -129.72 101.58 5.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.791 -2.3 . . . . 73.230000000000004 104.791 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.98 164.31 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.542 -1.281 . . . . 63.299999999999997 107.542 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 121.1 24.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.452 1.101 . . . . 74.540000000000006 108.095 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -91.74 79.7 5.36 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.316 -1.735 . . . . 74.299999999999997 106.316 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.759 HD21 ' HE3' ' A' ' 92' ' ' LYS . 44.5 mt -76.4 170.73 15.82 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.608 -0.886 . . . . 71.129999999999995 108.608 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 75.58 -6.14 2.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.895 2.478 . . . . 63.5 113.003 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--O 1.241 0.608 0 C-N-CA 125.428 1.491 . . . . 74.400000000000006 113.391 171.413 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 108.276 -1.009 . . . . 72.409999999999997 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.4 145.81 83.95 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.084 1.856 . . . . 61.310000000000002 109.061 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.9 -133.66 5.07 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.631 -1.387 . . . . 64.340000000000003 109.631 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.02 165.06 0.14 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 128.624 2.77 . . . . 75.200000000000003 111.249 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.51 156.33 64.17 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.458 2.105 . . . . 44.240000000000002 110.201 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.06 -178.97 5.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.837 0.827 . . . . 74.319999999999993 112.05 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.28 1.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.838 2.855 . . . . 60.329999999999998 115.744 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.4 mp -44.47 129.67 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.87 2.468 . . . . 61.020000000000003 112.626 -154.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 14' ' ' LYS . 8.0 mmpt? -115.01 131.03 57.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.439 1.095 . . . . 71.319999999999993 108.913 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.57 93.45 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.964 -1.495 . . . . 71.209999999999994 106.964 -175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -96.12 140.35 30.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.581 -1.19 . . . . 34.009999999999998 108.991 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -60.68 154.03 22.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.99 -0.744 . . . . 75.129999999999995 108.99 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.6 m -144.38 165.28 24.12 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 127.612 2.365 . . . . 73.209999999999994 107.963 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.98 -39.31 41.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.098 1.865 . . . . 75.510000000000005 112.06 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -106.48 9.79 31.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.732 0.813 . . . . 75.209999999999994 111.574 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.02 -137.37 4.76 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 120.414 -1.429 . . . . 62.140000000000001 112.185 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.12 144.85 32.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.797 0.839 . . . . 51.520000000000003 109.655 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -75.69 155.1 36.04 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 109.24 -0.652 . . . . 73.519999999999996 109.24 163.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 107.82 3.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.914 1.686 . . . . 55.329999999999998 108.711 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.3 p -123.41 158.6 30.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.034 0.833 . . . . 75.120000000000005 110.251 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CZ3' HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -146.78 141.86 27.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.964 0.905 . . . . 72.209999999999994 111.556 176.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -76.36 150.9 83.01 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.348 1.059 . . . . 74.120000000000005 109.206 165.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.23 168.01 25.3 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.625 3.55 . . . . 73.150000000000006 111.126 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 153.11 77.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.198 1.265 . . . . 55.350000000000001 110.721 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 t -151.86 73.0 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.738 -1.949 . . . . 74.239999999999995 105.738 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -57.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.066 0.946 . . . . 60.340000000000003 110.201 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 p -134.86 167.53 20.72 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.448 -0.945 . . . . 73.230000000000004 108.448 162.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -47.01 -57.07 5.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.203 1.801 . . . . 73.349999999999994 113.132 -168.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.31 176.72 5.96 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.228 1.394 . . . . 64.299999999999997 111.103 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -141.27 92.06 2.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.379 -1.711 . . . . 71.209999999999994 106.379 157.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.76 145.28 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.632 -1.618 . . . . 75.329999999999998 106.632 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.45 -28.26 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.471 1.109 . . . . 71.530000000000001 110.932 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.36 -176.26 5.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.663 1.119 . . . . 74.209999999999994 110.283 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -139.64 166.11 25.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.355 1.062 . . . . 51.130000000000003 110.273 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.48 171.93 19.42 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.287 -0.634 . . . . 73.219999999999999 109.287 163.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.02 124.48 26.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.19 -1.781 . . . . 71.120000000000005 106.19 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -118.22 119.07 33.57 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.794 -1.928 . . . . 75.430000000000007 105.794 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.21 116.03 30.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.285 -1.746 . . . . 71.099999999999994 106.285 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.34 136.4 51.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.003 -1.11 . . . . 61.409999999999997 108.003 173.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 pt -130.37 -177.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.288 -1.745 . . . . 64.540000000000006 106.288 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.491 1.916 . . . . 71.5 110.858 178.191 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.412 0 N-CA-C 107.296 -1.372 . . . . 55.420000000000002 107.296 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.13 84.06 1.7 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.417 -0.811 . . . . 54.240000000000002 110.287 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.29 158.64 43.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.555 1.142 . . . . 71.209999999999994 109.81 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -102.83 7.03 39.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.501 0.926 . . . . 75.129999999999995 113.501 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 45.91 61.12 2.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.707 2.003 . . . . 74.5 114.398 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.65 -37.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.666 1.186 . . . . 71.5 113.545 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -64.68 118.81 9.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.969 0.804 . . . . 73.120000000000005 109.807 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.7 m -135.58 27.58 3.36 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.537 1.535 . . . . 75.209999999999994 109.656 164.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.19 161.05 37.25 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.973 -0.851 . . . . 75.200000000000003 110.973 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.83 -55.17 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.578 2.186 . . . . 74.239999999999995 110.013 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.86 158.75 31.15 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.864 1.266 . . . . 72.319999999999993 110.389 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.82 173.63 10.73 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.883 2.388 . . . . 75.420000000000002 110.863 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p 47.87 63.68 1.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.93 1.292 . . . . 64.430000000000007 109.782 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.3 p -70.98 -164.82 0.1 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.856 2.062 . . . . 74.5 110.21 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 77' ' ' VAL . 3.2 pp -130.09 -176.49 3.96 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.227 -1.546 . . . . 72.549999999999997 108.799 164.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.437 ' N ' HD12 ' A' ' 76' ' ' LEU . 31.0 t -135.98 148.23 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.632 1.105 . . . . 74.230000000000004 109.051 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -89.41 145.12 25.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.004 2.122 . . . . 73.530000000000001 111.084 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -62.48 -27.4 69.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.982 2.113 . . . . 73.540000000000006 112.83 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.5 p -57.53 -30.03 64.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.116 0.966 . . . . 74.319999999999993 111.28 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -78.44 -45.43 22.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.015 1.326 . . . . 52.420000000000002 109.298 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.35 -37.3 74.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.995 1.318 . . . . 75.219999999999999 111.87 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -50.08 -48.86 52.95 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.144 0.497 . . . . 62.530000000000001 110.531 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -84.32 -5.35 59.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.168 0.987 . . . . 62.409999999999997 112.076 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.81 138.07 55.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.083 0.944 . . . . 72.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -71.85 153.5 41.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.074 -1.421 . . . . 73.120000000000005 110.446 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -123.25 136.8 58.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.914 1.286 . . . . 71.430000000000007 109.261 -166.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.76 68.14 1.68 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 128.128 2.571 . . . . 74.329999999999998 112.197 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.71 73.07 0.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.827 1.299 . . . . 61.340000000000003 108.443 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.5 p -133.92 -28.5 1.37 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.234 2.213 . . . . 72.109999999999999 108.357 165.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.74 -50.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.084 0.954 . . . . 62.399999999999999 111.887 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.41 160.1 69.75 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 120.893 1.679 . . . . 73.129999999999995 112.541 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.53 74.1 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.579 2.186 . . . . 75.230000000000004 109.291 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.96 148.8 45.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.609 0.966 . . . . 53.109999999999999 113.609 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -83.98 133.9 28.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.917 1.287 . . . . 62.200000000000003 109.251 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -84.29 147.84 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.932 0.893 . . . . 61.409999999999997 110.601 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -126.57 145.56 50.49 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 125.331 1.452 . . . . 60.340000000000003 109.373 171.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -119.27 98.58 6.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.938 -1.875 . . . . 72.230000000000004 105.938 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.484 HD13 ' CZ3' ' A' ' 26' ' ' TRP . 17.4 mt -113.17 133.14 59.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.456 -2.053 . . . . 74.040000000000006 105.456 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 149.86 47.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.85 -1.167 . . . . 53.130000000000003 107.85 167.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.03 28.49 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.113 -1.439 . . . . 74.439999999999998 107.113 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG2' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.87 99.96 3.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.003 -2.221 . . . . 75.409999999999997 105.003 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -121.92 163.7 18.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.067 1.347 . . . . 53.409999999999997 110.335 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.66 -21.15 62.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.707 -1.133 . . . . 72.230000000000004 112.436 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.78 -16.85 44.92 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.36 1.064 . . . . 75.140000000000001 112.888 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.58 36.77 4.72 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 118.55 0.614 . . . . 75.329999999999998 111.756 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER 64.29 24.83 13.4 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.458 1.903 . . . . 75.219999999999999 111.865 165.365 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.87 -77.98 0.31 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.137 1.351 . . . . 73.0 112.098 -157.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.46 134.69 24.97 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.457 1.438 . . . . 75.329999999999998 109.403 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.99 164.07 26.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.074 1.75 . . . . 64.219999999999999 107.46 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 m -114.63 135.26 54.34 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.593 -1.632 . . . . 74.200000000000003 106.593 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.92 114.9 27.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.371 -2.085 . . . . 72.109999999999999 105.371 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 m -113.17 162.67 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 119.16 0.891 . . . . 75.129999999999995 108.913 167.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 135.85 52.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.364 -1.347 . . . . 75.319999999999993 107.364 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -120.89 102.08 8.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.274 1.035 . . . . 72.030000000000001 111.396 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.832 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.58 -10.95 28.18 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.741 2.417 . . . . 75.319999999999993 111.885 -169.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 2.21 2.92 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.076 1.75 . . . . 75.129999999999995 111.652 170.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.651 0 CA-C-N 120.654 1.57 . . . . 75.120000000000005 114.408 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.657 0 N-CA-C 107.57 -1.271 . . . . 72.319999999999993 107.57 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.78 136.51 58.06 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.136 1.224 . . . . 74.329999999999998 109.546 164.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.01 112.97 3.66 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 125.13 1.348 . . . . 32.520000000000003 114.356 165.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.96 31.01 Favored Pre-proline 0 C--N 1.314 -0.967 0 C-N-CA 127.025 2.13 . . . . 72.120000000000005 105.272 158.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HG3' HG22 ' A' ' 99' ' ' ILE . 37.9 Cg_endo -63.41 159.59 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.065 2.51 . . . . 73.530000000000001 111.268 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.1 m -134.41 176.52 8.54 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.662 1.185 . . . . 74.540000000000006 109.882 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 18.4 5.9 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.593 2.757 . . . . 23.219999999999999 113.758 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.58 120.98 7.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.369 0.668 . . . . 62.130000000000003 109.728 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.67 146.38 27.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.247 -1.39 . . . . 74.140000000000001 107.247 167.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.416 HG12 HD13 ' A' ' 24' ' ' LEU . 9.8 mt -135.71 133.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.383 -2.08 . . . . 74.129999999999995 105.383 161.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 t -146.82 144.51 29.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.434 1.494 . . . . 74.230000000000004 109.312 -173.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -80.45 158.26 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.124 0.57 . . . . 64.420000000000002 110.261 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.45 165.34 18.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.038 1.335 . . . . 61.0 107.935 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 -15.64 35.46 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.105 2.536 . . . . 70.310000000000002 113.464 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -107.74 -26.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.399 1.08 . . . . 70.230000000000004 111.66 -168.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.14 -165.61 37.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.582 -1.807 . . . . 51.520000000000003 108.582 -167.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.31 133.92 42.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.046 -1.465 . . . . 74.099999999999994 107.046 165.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -60.31 115.36 3.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.012 -1.477 . . . . 74.200000000000003 107.012 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD13 HG12 ' A' ' 15' ' ' ILE . 3.9 mm? -105.42 140.35 38.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.4 -1.704 . . . . 71.540000000000006 106.4 168.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 p -150.23 156.56 41.8 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.886 1.221 . . . . 71.439999999999998 109.953 164.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -139.91 158.37 44.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.487 1.515 . . . . 70.319999999999993 108.921 166.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -87.89 161.67 43.57 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.052 0.541 . . . . 61.340000000000003 110.523 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.8 168.08 19.56 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.904 . . . . 74.510000000000005 111.341 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.55 156.5 21.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.005 1.803 . . . . 74.510000000000005 112.973 -166.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.5 52.86 1.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.028 -1.471 . . . . 74.200000000000003 107.028 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG12 HG22 ' A' ' 32' ' ' THR . 33.2 t -137.57 -87.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.149 -1.056 . . . . 71.219999999999999 108.149 160.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.473 HG22 HG12 ' A' ' 31' ' ' VAL . 12.1 t -168.68 40.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.968 -1.083 . . . . 53.32 110.037 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.4 p -68.23 -6.82 25.74 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.103 -1.623 . . . . 71.299999999999997 113.787 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.09 -124.99 6.71 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 120.248 -1.533 . . . . 72.420000000000002 111.49 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -109.11 88.43 2.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.351 1.86 . . . . 62.530000000000001 110.612 -167.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.04 125.58 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.867 1.667 . . . . 63.530000000000001 107.177 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.46 -27.93 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.398 1.079 . . . . 74.239999999999995 111.406 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -151.3 -171.44 3.93 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.692 1.597 . . . . 72.299999999999997 107.434 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 169.49 17.51 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.472 -1.393 . . . . 74.5 108.749 172.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.9 173.24 16.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.587 0.63 . . . . 72.219999999999999 112.6 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.65 99.28 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 128.733 2.813 . . . . 73.310000000000002 105.282 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 42.7 m-85 -82.99 153.34 25.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.957 -1.127 . . . . 73.340000000000003 107.957 163.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.3 tp -143.26 128.19 18.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.956 2.102 . . . . 74.239999999999995 106.105 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 112.78 13.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.829 0.852 . . . . 63.520000000000003 109.143 169.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 pt -86.75 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.155 -1.054 . . . . 63.240000000000002 108.155 160.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 124.231 1.012 . . . . 62.140000000000001 111.139 174.009 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--O 1.241 0.649 0 N-CA-C 109.586 -0.524 . . . . 45.020000000000003 109.586 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.36 120.93 25.06 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.448 0.536 . . . . 70.510000000000005 112.448 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.435 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 37.9 m-85 -148.97 170.91 17.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.268 1.827 . . . . 65.120000000000005 110.33 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 ttp -106.45 5.89 29.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.438 1.495 . . . . 73.340000000000003 113.225 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 44.44 44.35 6.91 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.772 1.629 . . . . 71.329999999999998 115.34 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.6 m -56.4 -9.75 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.446 1.647 . . . . 64.129999999999995 115.446 -171.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -53.67 98.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.292 1.044 . . . . 65.230000000000004 110.783 165.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.6 t -147.32 24.66 1.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.713 . . . . 64.099999999999994 109.145 162.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.79 159.0 53.34 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.123 -0.791 . . . . 52.539999999999999 111.123 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -83.49 -7.05 10.82 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.947 3.098 . . . . 71.200000000000003 112.372 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -131.86 156.61 79.9 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.431 1.892 . . . . 71.219999999999999 109.842 -166.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -4.01 11.96 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.389 3.393 . . . . 70.219999999999999 113.551 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 p -120.46 22.47 11.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.666 2.387 . . . . 65.239999999999995 110.212 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.25 -174.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.654 2.782 . . . . 64.340000000000003 115.34 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.32 102.4 3.06 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 104.881 -2.266 . . . . 71.010000000000005 104.881 167.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.55 108.3 20.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.222 -1.029 . . . . 63.409999999999997 108.222 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -77.0 165.48 24.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.629 0.728 . . . . 73.109999999999999 111.554 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.75 82.08 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.47 1.108 . . . . 72.120000000000005 111.956 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -64.42 -20.29 66.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.924 -1.036 . . . . 54.210000000000001 112.754 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -75.02 -35.84 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.877 1.217 . . . . 50.530000000000001 109.862 172.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.0 -30.58 63.88 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.098 1.359 . . . . 51.200000000000003 110.53 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.4 m -47.09 -44.13 20.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.927 1.291 . . . . 74.209999999999994 113.033 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -84.55 1.73 44.55 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.167 0.802 . . . . 73.219999999999999 113.167 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.0 143.58 55.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.823 0.82 . . . . 72.140000000000001 110.376 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -68.74 140.69 55.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.529 -1.214 . . . . 73.319999999999993 107.808 162.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.6 mm -101.5 123.51 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.91 -1.515 . . . . 73.409999999999997 106.91 172.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.74 145.45 52.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.693 0.621 . . . . 54.409999999999997 110.056 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.7 18.66 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.658 0.783 . . . . 75.150000000000006 111.307 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 t -110.11 -13.58 14.35 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.658 -0.651 . . . . 72.450000000000003 110.908 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -129.02 -63.17 0.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.407 1.483 . . . . 60.420000000000002 111.982 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -154.74 155.55 30.57 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 127.062 2.145 . . . . 73.230000000000004 108.352 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -60.57 101.82 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.433 2.756 . . . . 70.129999999999995 109.516 171.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.515 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -149.94 156.58 41.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 70.120000000000005 110.078 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.44 140.71 16.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.824 -1.917 . . . . 73.450000000000003 105.824 161.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.8 mm -109.26 115.12 48.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.366 1.466 . . . . 63.25 107.555 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -100.72 148.49 24.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.957 0.903 . . . . 64.230000000000004 109.338 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -132.06 94.09 3.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.542 -1.651 . . . . 74.340000000000003 106.542 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 10' ' ' PRO . 31.1 mt -108.55 136.66 43.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.014 -2.217 . . . . 63.229999999999997 105.014 -172.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.52 41.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.909 0.777 . . . . 72.400000000000006 110.115 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 114.56 7.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.473 1.509 . . . . 73.329999999999998 108.066 172.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 81.55 4.72 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 105.475 -2.046 . . . . 73.129999999999995 105.475 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.06 166.02 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.9 1.68 . . . . 70.439999999999998 108.347 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mt-10 -74.48 -36.41 63.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.685 -1.143 . . . . 63.340000000000003 108.836 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -17.04 64.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 115.718 1.748 . . . . 53.399999999999999 115.718 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.82 -97.89 0.13 Allowed Glycine 0 CA--C 1.512 -0.134 0 CA-C-N 120.643 1.565 . . . . 43.219999999999999 112.882 -161.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 3.6 t80 55.52 21.86 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.833 2.853 . . . . 71.099999999999994 111.561 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.8 1.28 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.532 2.015 . . . . 41.210000000000001 108.35 -163.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.0 143.91 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.447 2.098 . . . . 70.209999999999994 109.904 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.18 117.65 16.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.386 -2.079 . . . . 64.299999999999997 105.386 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 m -53.14 120.99 6.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.924 -1.139 . . . . 71.409999999999997 107.924 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -82.64 88.9 6.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.041 -1.837 . . . . 74.519999999999996 106.041 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.21 156.58 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.462 -1.681 . . . . 63.240000000000002 106.462 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 164.13 28.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.87 -1.159 . . . . 64.120000000000005 107.87 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.515 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 19.3 t90 -137.6 114.31 10.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.62 0.724 . . . . 65.299999999999997 111.3 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 25.05 5.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.801 1.64 . . . . 64.200000000000003 112.19 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -108.97 7.75 26.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.507 1.523 . . . . 74.409999999999997 111.508 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 122.101 0.953 . . . . 63.539999999999999 109.021 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 112.772 0.656 . . . . 74.409999999999997 112.772 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.31 4.64 3.22 Favored 'Trans proline' 0 CA--C 1.536 0.611 1 C-N-CA 125.596 4.197 . . . . 62.399999999999999 114.304 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 140.84 8.3 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 108.089 -2.004 . . . . 61.210000000000001 108.089 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.98 161.97 28.27 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.547 2.339 . . . . 64.420000000000002 108.321 171.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' CG ' HG22 ' A' ' 99' ' ' ILE . 11.7 Cg_endo -63.76 142.15 81.75 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.169 1.913 . . . . 73.439999999999998 109.258 160.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.2 m -127.23 170.9 11.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.223 1.409 . . . . 52.119999999999997 110.185 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.75 31.78 0.7 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.801 2.441 . . . . 75.420000000000002 114.951 169.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.486 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.6 mp -54.96 143.61 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 126.597 1.959 . . . . 74.140000000000001 109.004 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -119.15 147.25 44.4 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.573 0.749 . . . . 75.310000000000002 109.362 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.4 mt -146.36 126.72 6.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.979 -1.489 . . . . 71.319999999999993 106.979 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -141.69 173.83 11.14 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 126.924 2.09 . . . . 75.430000000000007 107.752 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -130.64 159.86 35.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.197 0.999 . . . . 60.149999999999999 108.946 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 m -152.91 165.54 17.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 125.855 1.662 . . . . 51.310000000000002 107.987 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.54 -29.22 84.23 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.093 1.862 . . . . 72.430000000000007 112.761 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 -38.22 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.205 0.602 . . . . 73.25 110.702 -169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.34 -165.2 26.34 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.181 1.372 . . . . 71.040000000000006 112.965 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.48 140.1 50.05 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.968 1.884 . . . . 73.219999999999999 110.258 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -85.5 96.07 9.49 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.645 1.578 . . . . 72.420000000000002 109.546 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -98.25 125.26 43.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.26 1.024 . . . . 72.430000000000007 108.745 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -137.48 160.81 38.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.765 0.711 . . . . 63.109999999999999 109.262 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.11 166.97 31.9 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.896 . . . . 74.040000000000006 109.703 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -101.43 159.91 28.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.884 -0.579 . . . . 73.239999999999995 111.395 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.35 175.49 9.28 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.697 3.598 . . . . 55.539999999999999 113.138 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.57 117.02 4.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.044 1.829 . . . . 74.109999999999999 108.707 167.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 m -151.32 19.31 0.75 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.033 1.333 . . . . 75.340000000000003 112.816 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -104.5 -62.16 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.44 -1.319 . . . . 64.400000000000006 107.44 168.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -116.81 161.57 19.07 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.996 -1.113 . . . . 51.299999999999997 107.996 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 m -68.69 -66.66 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.408 0.683 . . . . 72.209999999999994 110.367 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 171.86 2.47 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 122.159 0.866 . . . . 43.509999999999998 111.793 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -110.85 76.56 0.98 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.671 -1.974 . . . . 74.340000000000003 105.671 163.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -64.83 147.42 12.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.117 -1.068 . . . . 75.319999999999993 108.117 170.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.5 pt -130.9 -26.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.656 1.982 . . . . 75.120000000000005 110.106 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -168.07 -175.33 2.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.871 1.669 . . . . 73.299999999999997 107.451 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -127.14 167.89 15.4 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.118 -1.614 . . . . 73.239999999999995 109.128 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t -143.67 168.69 19.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.999 -1.063 . . . . 64.120000000000005 111.507 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.413 HG13 HG12 ' A' ' 99' ' ' ILE . 21.7 t -149.45 128.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.282 -1.377 . . . . 40.329999999999998 107.282 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.62 144.58 43.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.253 1.021 . . . . 74.010000000000005 108.594 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.418 HD22 HG11 ' A' ' 67' ' ' VAL . 14.3 tp -120.73 136.15 54.95 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.342 2.657 . . . . 75.209999999999994 107.662 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.13 130.59 41.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.52 1.963 . . . . 73.329999999999998 109.249 172.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.7 171.59 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.826 1.25 . . . . 75.010000000000005 109.217 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.11 0.964 . . . . 74.450000000000003 108.822 161.047 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.41 HD13 ' CE2' ' A' ' 64' ' ' PHE . 1.4 mt . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 103.726 -2.694 . . . . 75.420000000000002 103.726 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.23 114.06 24.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.859 -0.793 . . . . 63.32 108.859 171.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CE2' HD13 ' A' ' 62' ' ' LEU . 17.4 m-85 -133.82 161.15 35.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.339 1.455 . . . . 74.430000000000007 108.812 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.4 ttp -105.5 130.39 53.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.957 1.303 . . . . 64.040000000000006 107.629 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -71.95 85.95 0.99 Allowed 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.987 -1.116 . . . . 74.109999999999999 107.987 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG11 HD22 ' A' ' 43' ' ' LEU . 3.5 m -65.39 -48.5 82.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.377 0.608 . . . . 63.409999999999997 109.857 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.84 104.77 4.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.846 1.258 . . . . 71.019999999999996 109.882 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.5 t -160.2 75.93 0.6 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.656 -0.868 . . . . 74.140000000000001 108.656 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.24 46.8 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.001 -1.095 . . . . 45.240000000000002 114.445 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.66 -7.09 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.935 3.757 . . . . 73.099999999999994 112.449 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 m -48.32 144.34 6.37 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.356 1.862 . . . . 62.119999999999997 112.362 -169.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.89 109.79 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.339 2.026 . . . . 73.239999999999995 109.121 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.57 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.818 1.647 . . . . 71.409999999999997 108.943 -170.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.2 t -171.49 159.89 5.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.608 2.004 . . . . 74.209999999999994 109.248 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -130.82 97.74 4.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.045 1.738 . . . . 74.019999999999996 106.351 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.83 117.03 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 106.855 -1.535 . . . . 73.430000000000007 106.855 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -60.66 148.07 39.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.492 0.587 . . . . 73.239999999999995 109.951 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -55.23 -32.15 62.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.186 0.994 . . . . 64.409999999999997 112.833 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -61.41 -28.32 69.17 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.643 1.111 . . . . 72.140000000000001 113.216 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -70.31 -38.16 74.9 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.593 -1.317 . . . . 74.030000000000001 109.708 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.04 -40.63 96.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.872 0.869 . . . . 73.349999999999994 108.912 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -59.46 -14.24 11.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.584 1.554 . . . . 60.030000000000001 115.072 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.82 -3.92 12.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.335 0.97 . . . . 54.219999999999999 111.401 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.12 153.12 22.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.016 0.926 . . . . 74.439999999999998 110.189 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -137.51 158.14 45.02 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.883 1.273 . . . . 75.25 109.654 -167.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.77 137.35 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 110.92 -149.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.5 48.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.848 1.659 . . . . 74.420000000000002 110.8 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -57.85 -12.74 3.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.575 1.15 . . . . 73.530000000000001 113.364 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -17.91 60.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.646 1.178 . . . . 64.129999999999995 112.107 170.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -130.07 -58.19 1.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.813 1.645 . . . . 72.230000000000004 110.134 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -150.79 162.08 28.18 Favored Pre-proline 0 C--N 1.341 0.23 0 C-N-CA 124.753 1.221 . . . . 75.129999999999995 110.268 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.71 87.85 0.43 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.477 1.451 . . . . 54.119999999999997 108.805 155.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -151.61 155.45 38.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.74 2.016 . . . . 54.439999999999998 110.428 166.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mt -80.67 -25.22 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 116.295 1.961 . . . . 73.040000000000006 116.295 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mm 61.19 151.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 130.754 3.622 . . . . 71.409999999999997 111.625 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -127.77 145.23 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.65 -1.241 . . . . 75.319999999999993 107.65 166.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.53 99.76 8.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.555 -1.646 . . . . 72.019999999999996 106.555 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 26' ' ' TRP . 44.0 mt -109.29 127.46 66.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.811 -2.292 . . . . 61.399999999999999 104.811 -170.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . . . -150.25 163.76 37.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.382 1.087 . . . . 72.200000000000003 113.334 171.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.75 123.63 30.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.777 1.631 . . . . 51.210000000000001 107.516 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -76.33 104.97 7.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.489 -1.671 . . . . 72.200000000000003 106.489 164.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -123.82 -179.47 4.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.912 1.285 . . . . 74.310000000000002 110.155 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.74 -28.62 60.85 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.011 0.745 . . . . 75.120000000000005 113.011 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.71 -13.41 59.22 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.933 0.893 . . . . 64.430000000000007 111.997 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.38 169.19 45.67 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 124.847 1.213 . . . . 60.409999999999997 111.018 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -67.83 73.9 0.18 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.727 2.011 . . . . 75.040000000000006 111.159 178.539 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 -64.77 2.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.039 1.78 . . . . 55.399999999999999 110.044 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.28 163.64 35.49 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 120.04 1.92 . . . . 73.0 111.493 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.68 100.67 1.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.231 -1.766 . . . . 61.100000000000001 106.231 168.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -79.18 93.87 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.104 -1.443 . . . . 72.340000000000003 107.104 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.76 84.55 3.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.642 1.577 . . . . 42.149999999999999 108.177 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -82.78 167.63 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.942 -1.133 . . . . 72.200000000000003 107.942 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 152.01 51.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.702 -0.851 . . . . 73.349999999999994 108.702 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.546 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 1.7 t90 -120.7 102.42 8.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.981 1.372 . . . . 73.25 113.297 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -91.93 14.06 16.78 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.435 -0.802 . . . . 53.030000000000001 111.201 -169.014 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -72.13 -2.0 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.195 -0.907 . . . . 75.239999999999995 110.913 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 120.84 1.655 . . . . 75.439999999999998 112.193 -177.343 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.251 -0.277 . . . . 74.219999999999999 110.251 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.88 172.03 17.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.287 2.658 . . . . 72.329999999999998 111.781 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.01 -113.7 3.72 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.808 -1.717 . . . . 74.200000000000003 108.808 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.14 155.18 0.15 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 129.936 3.294 . . . . 73.540000000000006 111.0 -162.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.84 141.63 59.85 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.43 1.42 . . . . 65.129999999999995 108.924 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -137.5 -169.54 2.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.057 2.143 . . . . 74.239999999999995 107.938 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.3 34.8 3.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.108 1.763 . . . . 52.200000000000003 112.194 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.06 131.12 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.436 -0.95 . . . . 70.230000000000004 108.436 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -133.06 151.31 52.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.848 1.659 . . . . 74.519999999999996 108.393 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 24' ' ' LEU . 30.8 mt -142.73 91.79 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 105.041 -2.207 . . . . 72.439999999999998 105.041 -172.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -88.19 108.32 19.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.251 -1.018 . . . . 64.129999999999995 108.251 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 139.71 45.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.315 0.646 . . . . 73.030000000000001 109.9 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -148.67 166.52 15.25 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 123.564 0.746 . . . . 65.430000000000007 111.056 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -51.42 -46.67 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.9 1.733 . . . . 73.400000000000006 111.281 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -28.61 65.11 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.297 1.039 . . . . 72.400000000000006 111.424 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -104.31 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.569 -1.413 . . . . 74.299999999999997 109.569 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.76 120.97 6.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.793 -1.188 . . . . 45.32 107.793 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.53 134.47 51.34 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.597 1.159 . . . . 71.019999999999996 108.903 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' CD2' HG23 ' A' ' 15' ' ' ILE . 13.9 mt -116.35 144.23 44.53 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.555 -0.535 . . . . 73.329999999999998 109.555 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 p -140.21 160.66 39.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 117.83 -1.081 . . . . 71.010000000000005 108.174 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -159.97 173.75 15.41 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.842 1.657 . . . . 71.439999999999998 108.875 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.47 162.8 20.06 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.419 1.088 . . . . 72.230000000000004 110.263 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.78 155.73 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.748 2.298 . . . . 45.43 111.154 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.62 149.39 23.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.067 2.512 . . . . 74.329999999999998 111.573 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 t 76.48 135.6 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.885 2.474 . . . . 72.319999999999993 109.466 -160.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.96 -27.53 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 113.821 -1.536 . . . . 65.219999999999999 108.48 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.2 p -87.65 175.27 7.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.756 -1.215 . . . . 74.129999999999995 110.233 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 p -45.79 -48.98 15.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.692 1.597 . . . . 65.5 114.094 -169.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.94 -169.99 41.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.426 -1.469 . . . . 61.130000000000003 109.426 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -142.19 52.31 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.307 1.443 . . . . 74.340000000000003 109.493 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.39 142.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.74 -0.837 . . . . 71.239999999999995 108.74 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 pt -136.09 -15.59 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.684 1.993 . . . . 71.340000000000003 111.651 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -169.42 -168.06 0.77 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.048 2.139 . . . . 74.010000000000005 107.602 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.23 -178.6 5.93 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.331 -1.481 . . . . 74.200000000000003 110.077 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -145.78 155.33 42.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.258 1.023 . . . . 54.100000000000001 111.24 167.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -146.75 93.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.408 2.683 . . . . 74.239999999999995 105.15 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -95.98 130.11 43.06 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.825 -1.176 . . . . 65.200000000000003 107.825 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.69 124.07 34.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.663 1.119 . . . . 73.040000000000006 107.993 -168.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.46 129.49 40.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.733 0.697 . . . . 73.030000000000001 110.99 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.2 pt -132.31 171.09 18.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.15 -1.796 . . . . 73.019999999999996 106.15 166.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 73.219999999999999 108.599 172.336 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.293 0 N-CA-C 106.668 -1.605 . . . . 74.310000000000002 106.668 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.68 113.37 7.07 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.143 -0.688 . . . . 62.210000000000001 109.143 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -134.0 -179.51 5.6 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.861 1.665 . . . . 72.349999999999994 110.506 -165.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.9 ptm -80.94 165.92 21.33 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.895 -1.15 . . . . 72.349999999999994 107.895 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -125.42 83.02 2.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.109 -1.441 . . . . 74.329999999999998 107.109 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.75 -38.44 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.966 -0.459 . . . . 73.129999999999995 110.282 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -54.59 110.57 0.65 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.361 . . . . 70.400000000000006 112.533 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.9 p -147.81 24.55 1.07 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.379 0.672 . . . . 74.319999999999993 111.883 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.83 163.78 29.72 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.298 -0.723 . . . . 31.010000000000002 112.456 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.06 -54.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.376 2.717 . . . . 54.310000000000002 110.524 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.18 143.86 96.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.06 -1.089 . . . . 64.400000000000006 108.06 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.9 -46.42 1.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.514 2.143 . . . . 65.209999999999994 109.935 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -66.04 77.0 0.09 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.399 2.68 . . . . 74.019999999999996 108.778 168.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.6 t -96.17 -173.17 2.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.39 2.276 . . . . 51.539999999999999 109.54 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.09 159.97 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.786 -1.196 . . . . 74.219999999999999 109.656 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.48 115.03 47.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.557 -2.016 . . . . 61.219999999999999 105.557 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 151.11 45.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.587 1.155 . . . . 71.200000000000003 111.159 -168.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 p -51.82 -43.58 63.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.757 1.623 . . . . 71.340000000000003 111.96 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.5 t -51.43 -63.43 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.495 1.518 . . . . 51.25 110.235 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -60.77 -33.93 73.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.051 0.54 . . . . 73.230000000000004 110.932 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.2 mt -66.85 -23.11 65.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 117.974 -1.012 . . . . 74.109999999999999 111.778 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -56.42 -24.4 44.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.495 1.043 . . . . 72.25 111.884 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -102.83 1.41 34.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.944 0.898 . . . . 73.040000000000006 111.687 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.7 120.87 13.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.627 0.649 . . . . 75.409999999999997 109.621 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -83.26 148.05 27.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.485 -0.931 . . . . 72.230000000000004 108.485 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -110.69 147.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.108 -0.701 . . . . 75.420000000000002 109.108 -163.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.65 71.0 0.7 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.854 1.662 . . . . 72.430000000000007 111.769 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -76.26 53.0 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.154 1.782 . . . . 74.209999999999994 108.238 170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -55.23 0.34 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.067 -1.02 . . . . 63.219999999999999 108.734 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -94.08 -68.63 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.808 -0.558 . . . . 75.329999999999998 110.121 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -148.14 144.31 18.69 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 125.587 1.555 . . . . 55.32 106.975 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -67.42 108.01 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.959 1.773 . . . . 73.439999999999998 111.238 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 116' ' ' LEU 0.264 . . -147.57 165.54 30.05 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 131.318 3.847 . . . . 75.109999999999999 107.369 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.23 137.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.606 -1.627 . . . . 74.040000000000006 106.606 160.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.9 mm -100.93 152.51 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.373 1.469 . . . . 63.240000000000002 109.29 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.73 129.2 34.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.032 1.333 . . . . 73.010000000000005 109.162 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -96.14 89.89 5.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.791 -1.559 . . . . 73.129999999999995 106.791 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.2 mt -94.33 134.88 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.705 -1.591 . . . . 74.030000000000001 106.705 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.7 144.09 25.88 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.528 0.731 . . . . 74.030000000000001 109.748 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.61 152.21 37.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.298 0.639 . . . . 73.129999999999995 110.448 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.1 98.33 8.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.482 -2.044 . . . . 71.099999999999994 105.482 171.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -129.6 -171.02 2.41 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.272 1.429 . . . . 73.439999999999998 108.519 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -61.05 -35.36 76.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.485 0.55 . . . . 73.310000000000002 112.485 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -60.98 -26.06 67.3 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.882 1.673 . . . . 74.209999999999994 112.843 -166.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.37 36.64 3.77 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 117.076 1.59 . . . . 72.319999999999993 117.076 156.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 55.47 92.39 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 129.832 3.253 . . . . 74.129999999999995 113.187 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.484 ' H ' ' HD2' ' A' ' 109' ' ' PRO . . . -126.36 -70.45 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 126.728 2.108 . . . . 62.140000000000001 108.958 172.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 108' ' ' GLY . 85.9 Cg_endo -72.6 143.05 37.3 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 119.31 1.555 . . . . 73.340000000000003 109.479 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.72 142.92 20.34 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.583 -1.266 . . . . 61.399999999999999 107.583 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 m -108.05 109.73 21.25 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.861 -0.792 . . . . 75.040000000000006 108.861 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -72.4 95.18 1.72 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.226 -1.027 . . . . 73.400000000000006 108.226 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.95 151.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.107 -1.072 . . . . 75.329999999999998 108.107 166.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.74 139.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.418 1.887 . . . . 74.310000000000002 106.751 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -124.18 100.14 6.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.503 0.721 . . . . 75.409999999999997 109.943 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 6.2 mp -90.18 42.64 1.11 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 122.611 1.196 . . . . 74.209999999999994 110.285 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -125.01 7.83 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.007 2.123 . . . . 71.329999999999998 109.38 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 118.719 0.691 . . . . 73.129999999999995 112.649 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 109.585 -0.524 . . . . 71.409999999999997 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.44 -20.61 13.96 Favored 'Trans proline' 0 C--N 1.347 0.472 1 C-N-CA 125.827 4.352 . . . . 72.150000000000006 113.048 -166.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.53 156.86 48.29 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.022 -1.231 . . . . 64.120000000000005 110.022 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.79 165.57 9.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 126.728 2.011 . . . . 52.229999999999997 107.176 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -61.47 146.17 97.32 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.466 1.444 . . . . 72.030000000000001 109.723 161.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.7 176.5 7.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.337 1.455 . . . . 71.329999999999998 109.422 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 44.29 31.75 0.61 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 128.815 2.846 . . . . 73.299999999999997 113.82 174.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.97 133.28 27.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.158 -1.053 . . . . 72.010000000000005 108.158 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -129.49 142.44 50.78 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 123.546 0.738 . . . . 73.340000000000003 109.244 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.53 128.98 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 103.251 -2.87 . . . . 71.430000000000007 103.251 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -147.14 137.08 23.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.562 1.145 . . . . 65.209999999999994 108.257 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -64.18 144.89 56.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.379 -0.971 . . . . 63.409999999999997 108.379 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.0 162.16 53.71 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 126.888 2.075 . . . . 72.420000000000002 106.424 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 -10.89 27.65 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.028 1.152 . . . . 65.299999999999997 112.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.141 0.882 . . . . 64.430000000000007 111.702 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -118.37 0.83 Allowed Glycine 0 C--N 1.342 0.886 0 O-C-N 120.494 -1.379 . . . . 62.140000000000001 110.763 -172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.47 132.45 26.08 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.537 1.169 . . . . 32.049999999999997 110.963 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.24 149.59 50.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.128 1.371 . . . . 41.340000000000003 109.44 162.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 2.9 mp -142.22 123.26 14.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.646 1.578 . . . . 72.230000000000004 108.702 166.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -133.35 156.96 46.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.092 -0.707 . . . . 53.420000000000002 109.092 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -148.68 178.57 8.53 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.816 0.446 . . . . 73.299999999999997 110.577 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 9.2 mm-40 -139.39 159.52 65.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.114 1.766 . . . . 71.140000000000001 110.363 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.22 167.35 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.156 2.57 . . . . 73.030000000000001 111.05 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.45 -55.58 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.649 2.233 . . . . 73.239999999999995 110.71 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.46 39.92 8.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.474 -1.306 . . . . 64.239999999999995 107.474 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.07 -49.96 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.99 1.316 . . . . 73.340000000000003 113.75 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -64.68 154.66 35.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.099 1.318 . . . . 70.420000000000002 109.864 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -95.41 55.43 1.72 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.681 0.792 . . . . 70.140000000000001 109.572 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.53 134.18 11.64 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 108.561 -1.815 . . . . 70.230000000000004 108.561 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -81.66 82.12 7.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.162 -1.051 . . . . 65.340000000000003 108.162 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.72 131.85 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.739 -1.578 . . . . 74.349999999999994 106.739 168.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -126.86 -24.24 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.869 1.267 . . . . 65.239999999999995 111.36 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -163.3 -170.53 2.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.209 1.404 . . . . 74.409999999999997 107.606 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.37 177.54 8.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.665 1.186 . . . . 73.040000000000006 110.302 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.48 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -135.43 154.56 51.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.15 1.38 . . . . 70.150000000000006 108.601 163.401 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -143.72 112.24 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.432 -2.062 . . . . 70.120000000000005 105.432 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 40' ' ' SER . 87.3 m-85 -110.93 150.95 28.48 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.337 1.055 . . . . 64.25 109.742 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.78 121.31 25.15 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.342 1.857 . . . . 74.409999999999997 106.045 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.33 121.81 15.2 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.227 1.011 . . . . 71.019999999999996 110.771 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 pt -136.79 -177.11 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.325 1.45 . . . . 61.009999999999998 109.084 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . 0.277 3.5 pp0? . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 123.292 1.52 . . . . 74.310000000000002 112.767 171.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.402 HD22 ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.164 0.507 . . . . 72.109999999999999 110.589 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.78 102.85 4.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.856 1.262 . . . . 72.329999999999998 109.655 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 62' ' ' LEU . 22.6 m-85 -132.37 152.36 51.48 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.881 1.272 . . . . 52.439999999999998 109.58 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.1 ttp -78.34 5.0 11.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.457 1.28 . . . . 74.340000000000003 114.457 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.39 58.65 3.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.403 1.481 . . . . 65.030000000000001 112.155 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.79 -13.34 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.542 0.737 . . . . 62.200000000000003 112.9 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.21 -177.05 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.009 1.323 . . . . 64.109999999999999 112.063 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 44.7 m 62.57 42.69 8.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.455 1.902 . . . . 63.439999999999998 109.7 -168.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 155.88 42.04 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.111 -1.196 . . . . 72.0 110.111 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.74 -20.41 52.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.546 2.831 . . . . 74.439999999999998 112.692 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -135.05 149.37 70.11 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.95 1.3 . . . . 72.040000000000006 110.573 167.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.7 176.82 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 124.484 3.456 . . . . 42.109999999999999 111.86 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.6 p 46.63 40.71 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.45 1.5 . . . . 54.310000000000002 110.707 -170.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.66 123.88 23.5 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.22 1.808 . . . . 52.399999999999999 112.139 -167.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.39 147.37 26.29 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.933 1.293 . . . . 71.099999999999994 108.403 159.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.45 115.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.08 2.152 . . . . 71.340000000000003 105.711 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -65.53 154.38 38.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.801 0.84 . . . . 71.129999999999995 110.776 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -63.63 -19.25 64.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.633 1.173 . . . . 54.310000000000002 112.145 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -37.67 69.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.108 1.763 . . . . 73.400000000000006 111.204 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 m -71.64 -41.9 68.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.775 0.83 . . . . 73.120000000000005 111.267 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -26.19 67.23 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.4 1.08 . . . . 74.439999999999998 111.931 -175.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.49 -33.33 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.233 1.413 . . . . 52.530000000000001 110.602 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.31 -18.82 23.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.113 1.365 . . . . 71.319999999999993 112.267 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.71 9.94 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.16 1.384 . . . . 74.010000000000005 109.665 -170.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 147.49 23.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.675 0.79 . . . . 73.0 109.207 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -103.13 140.73 20.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.443 0.64 . . . . 74.209999999999994 109.305 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -59.2 110.45 1.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.576 1.95 . . . . 74.340000000000003 109.643 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -112.93 14.29 19.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.205 1.002 . . . . 70.129999999999995 110.512 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 82.6 p -102.53 -18.85 15.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.947 1.299 . . . . 51.229999999999997 112.696 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.91 -81.03 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 70.310000000000002 108.67 172.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -142.86 149.13 48.58 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 117.044 -1.455 . . . . 70.420000000000002 109.352 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.67 98.56 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 64.140000000000001 110.869 -171.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -150.97 164.74 35.67 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.475 1.91 . . . . 65.040000000000006 108.969 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.418 HD12 ' CE3' ' A' ' 115' ' ' TRP . 88.1 mt -83.83 128.21 39.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.381 -1.711 . . . . 64.299999999999997 106.381 167.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.8 mm -76.88 132.07 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.683 -1.228 . . . . 73.430000000000007 107.683 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -118.2 143.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.5 -1.296 . . . . 74.340000000000003 107.5 168.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.16 119.83 35.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 106.365 -1.717 . . . . 71.439999999999998 106.365 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.44 137.06 58.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.302 -1.74 . . . . 64.030000000000001 106.302 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 144.89 27.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.415 0.686 . . . . 71.25 110.493 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.42 121.38 20.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.626 1.17 . . . . 63.32 109.915 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.64 81.3 6.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 104.946 -2.242 . . . . 71.109999999999999 104.946 166.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -98.12 165.62 11.81 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.273 -0.639 . . . . 74.120000000000005 109.273 164.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.9 -18.82 5.42 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.527 1.677 . . . . 74.450000000000003 115.527 -167.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -86.88 -13.05 45.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.778 -1.106 . . . . 74.049999999999997 113.316 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.26 172.91 16.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.566 1.075 . . . . 71.140000000000001 112.761 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -73.17 57.3 0.48 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.997 1.319 . . . . 74.030000000000001 109.977 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.05 3.9 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.031 -0.871 . . . . 73.109999999999999 111.116 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.29 158.47 57.44 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.64 1.56 . . . . 71.450000000000003 109.532 171.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.33 122.14 10.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.463 -1.68 . . . . 65.010000000000005 106.463 169.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.6 m -92.86 108.98 20.41 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.556 -1.646 . . . . 72.030000000000001 106.556 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -67.51 128.55 36.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.156 -1.794 . . . . 72.430000000000007 106.156 163.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.2 154.19 31.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.082 -1.821 . . . . 74.329999999999998 106.082 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.11 157.33 39.96 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.225 -1.028 . . . . 72.439999999999998 108.225 163.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.418 ' CE3' HD12 ' A' ' 95' ' ' ILE . 18.1 t90 -108.35 91.28 3.58 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 74.200000000000003 106.669 172.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 94' ' ' ALA . 17.2 mt -75.9 175.15 9.06 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.685 -0.857 . . . . 65.109999999999999 108.685 175.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 76.24 13.16 2.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.177 2.191 . . . . 74.219999999999999 112.637 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 122.698 1.237 . . . . 61.119999999999997 111.572 165.623 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.87 0 N-CA-C 109.722 -0.473 . . . . 72.109999999999999 109.722 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.84 84.18 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.096 2.531 . . . . 64.5 111.826 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.08 123.92 0.83 Allowed Glycine 0 C--N 1.338 0.668 0 O-C-N 121.005 -1.059 . . . . 75.109999999999999 115.73 171.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.71 157.83 40.54 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.294 1.438 . . . . 74.109999999999999 109.646 166.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.27 164.25 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.702 3.601 . . . . 74.430000000000007 112.419 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.5 m -137.58 -174.48 3.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 61.509999999999998 110.005 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . . . 58.42 14.68 3.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.931 2.492 . . . . 75.549999999999997 116.986 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.491 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.7 mp -56.48 141.28 13.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 126.558 1.943 . . . . 75.530000000000001 112.031 -168.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -139.82 116.52 10.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.331 1.452 . . . . 72.109999999999999 110.609 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -115.96 131.48 68.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.842 -2.651 . . . . 55.329999999999998 103.842 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 m -143.28 149.12 37.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.625 0.726 . . . . 63.530000000000001 110.346 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -74.06 159.24 32.94 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.506 -0.924 . . . . 74.549999999999997 108.506 162.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 m -143.77 166.32 20.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 130.208 3.403 . . . . 55.049999999999997 105.607 170.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -54.42 -44.08 52.81 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.678 1.585 . . . . 63.119999999999997 111.781 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -12.18 59.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.9 1.68 . . . . 72.150000000000006 113.501 -170.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.89 -160.72 29.88 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.123 -1.191 . . . . 53.140000000000001 110.123 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.69 116.15 30.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.228 1.011 . . . . 61.450000000000003 109.216 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -69.25 140.23 54.46 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 129.603 3.161 . . . . 71.439999999999998 111.454 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.27 128.86 42.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.927 -1.138 . . . . 73.510000000000005 107.927 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -133.03 150.25 52.15 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.637 -0.875 . . . . 71.319999999999993 108.637 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.422 ' CD1' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.99 173.89 11.5 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.286 0.366 . . . . 74.329999999999998 110.272 173.246 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 25.2 pt-20 -66.85 154.62 91.66 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 119.806 -0.758 . . . . 74.329999999999998 112.277 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.36 160.84 44.01 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.752 2.302 . . . . 75.200000000000003 111.586 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HB2' HD13 ' A' ' 36' ' ' ILE . 62.6 Cg_endo -71.27 89.58 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.905 3.07 . . . . 60.240000000000002 112.182 -172.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -152.76 23.7 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.042 0.756 . . . . 55.219999999999999 113.042 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.4 t -126.23 -86.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.011 -0.995 . . . . 74.439999999999998 110.894 -171.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -131.75 -4.11 3.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.344 1.429 . . . . 75.400000000000006 110.978 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 36' ' ' ILE . 12.2 p -55.66 -19.32 10.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.356 3.062 . . . . 73.430000000000007 116.179 -172.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.4 -159.66 31.05 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 121.962 2.165 . . . . 61.109999999999999 111.675 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -79.52 93.64 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.822 1.649 . . . . 63.109999999999999 109.677 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 33' ' ' SER . 2.3 mp -71.4 142.23 15.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.579 -1.267 . . . . 72.230000000000004 107.579 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.9 pt -135.49 -17.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.783 1.633 . . . . 72.439999999999998 111.464 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -159.93 -171.71 3.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.326 1.851 . . . . 72.5 107.434 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 16.9 m-85 -134.38 174.33 10.65 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.354 -1.467 . . . . 75.140000000000001 108.937 162.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 m -144.01 155.4 44.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.334 -0.854 . . . . 74.239999999999995 108.799 159.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -140.06 119.35 12.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 104.747 -2.316 . . . . 73.129999999999995 104.747 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.413 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 13.6 m-85 -116.47 87.4 2.68 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.122 0.963 . . . . 72.409999999999997 109.814 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 tp -62.63 135.31 57.32 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.1 -1.444 . . . . 74.219999999999999 107.1 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.23 148.04 25.3 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.854 -0.795 . . . . 74.209999999999994 108.854 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.74 -165.9 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.223 1.809 . . . . 65.409999999999997 107.306 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 71.540000000000006 112.509 169.837 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 109.768 -0.456 . . . . 64.150000000000006 109.768 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.32 123.39 22.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.112 -0.699 . . . . 65.219999999999999 109.112 172.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 16.7 m-85 -141.11 155.66 46.09 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.188 0.595 . . . . 74.510000000000005 112.22 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ttp -89.25 -39.36 13.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.81 0.844 . . . . 51.240000000000002 112.493 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 58.01 86.19 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.282 1.433 . . . . 73.310000000000002 109.085 -159.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.77 -5.91 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.904 -0.589 . . . . 72.409999999999997 112.067 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.3 103.07 7.74 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.584 0.629 . . . . 63.43 110.798 -163.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -137.17 53.67 1.88 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.03 1.332 . . . . 71.430000000000007 109.026 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.34 160.5 29.55 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.311 -0.868 . . . . 54.140000000000001 111.228 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -4.68 12.0 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.745 3.63 . . . . 72.219999999999999 112.591 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.0 m -43.46 89.31 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 130.047 3.339 . . . . 72.319999999999993 113.263 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -60.62 148.98 89.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.186 1.257 . . . . 73.140000000000001 111.139 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 p 46.21 47.36 13.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.838 1.255 . . . . 74.230000000000004 111.987 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.37 152.37 43.24 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.625 -1.297 . . . . 42.049999999999997 110.462 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.08 170.35 14.91 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.656 0.782 . . . . 63.409999999999997 110.883 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.55 122.57 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.033 1.733 . . . . 73.25 106.539 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.44 145.9 52.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.059 0.944 . . . . 73.129999999999995 109.657 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.428 ' HA ' HD12 ' A' ' 82' ' ' LEU . 9.8 p -54.28 -37.89 65.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.621 1.169 . . . . 32.210000000000001 111.649 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.77 -47.97 41.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.458 1.503 . . . . 74.420000000000002 111.268 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -78.99 -9.71 59.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.509 1.124 . . . . 24.440000000000001 112.899 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 79' ' ' SER . 74.5 mt -82.03 -34.55 29.46 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.579 1.081 . . . . 65.209999999999994 110.658 171.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -66.91 1.53 1.85 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 117.276 2.324 . . . . 73.409999999999997 117.276 -163.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -123.38 12.28 9.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.95 1.25 . . . . 72.140000000000001 111.505 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.01 156.72 37.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 122.478 1.132 . . . . 72.219999999999999 113.53 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 101.72 3.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.808 -1.182 . . . . 71.530000000000001 107.808 162.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.07 120.82 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.254 -1.758 . . . . 75.319999999999993 106.254 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.21 131.8 51.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 112.799 -2.0 . . . . 75.510000000000005 108.987 166.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.61 9.76 13.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.52 1.128 . . . . 75.540000000000006 111.162 171.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -6.5 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.799 -1.188 . . . . 71.140000000000001 113.942 -162.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.045 2.138 . . . . 73.329999999999998 111.026 173.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -151.8 156.18 34.21 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.604 1.561 . . . . 71.420000000000002 108.009 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.41 122.35 9.57 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.7 2.267 . . . . 72.409999999999997 108.748 164.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -160.47 -170.44 2.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.669 2.387 . . . . 61.450000000000003 108.645 161.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.9 mt -129.48 129.2 66.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 75.540000000000006 108.53 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.5 mm -72.49 142.19 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.507 1.523 . . . . 62.210000000000001 110.088 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -128.21 162.25 27.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.26 1.024 . . . . 61.420000000000002 108.934 167.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -134.98 84.72 2.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.327 1.851 . . . . 71.340000000000003 106.472 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.28 133.44 42.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.032 -1.469 . . . . 75.209999999999994 107.032 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.41 156.98 44.09 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.575 0.547 . . . . 54.009999999999998 110.497 161.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . . . -92.35 109.44 20.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.458 1.103 . . . . 62.340000000000003 109.758 -171.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -69.09 97.98 0.94 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.811 0.844 . . . . 74.310000000000002 109.142 -170.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -122.54 177.17 5.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.706 2.002 . . . . 61.219999999999999 110.824 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.63 -30.97 63.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.927 1.691 . . . . 74.120000000000005 113.821 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -8.96 58.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.207 1.188 . . . . 74.209999999999994 114.207 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.42 2.26 87.51 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.834 -1.166 . . . . 70.5 113.263 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' A' ' 102' ' ' ARG . 19.4 p90 45.59 36.16 2.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.064 1.746 . . . . 74.329999999999998 115.448 156.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.75 -66.5 2.8 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.519 2.009 . . . . 62.409999999999997 113.455 -165.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.84 152.07 81.16 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.158 1.906 . . . . 64.439999999999998 110.241 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.35 169.86 14.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.584 1.154 . . . . 55.130000000000003 108.865 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.1 m -97.26 113.99 25.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.303 0.641 . . . . 75.140000000000001 110.045 -176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.49 75.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.505 1.522 . . . . 75.140000000000001 110.04 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.9 155.14 7.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.858 -1.164 . . . . 75.430000000000007 107.858 164.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -121.74 124.59 44.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.705 -1.591 . . . . 62.409999999999997 106.705 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -75.17 82.73 2.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.132 0.424 . . . . 74.329999999999998 109.859 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 94' ' ' ALA . 27.7 mt -71.47 15.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.773 1.027 . . . . 74.129999999999995 113.773 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -95.74 -1.83 49.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.097 1.359 . . . . 72.140000000000001 111.637 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 C--O 1.234 0.274 0 CA-C-N 119.835 1.198 . . . . 72.219999999999999 110.449 -179.627 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.634 -0.135 . . . . 75.349999999999994 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.03 6.53 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.735 3.624 . . . . 64.129999999999995 114.581 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.2 143.77 15.32 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 107.958 -2.057 . . . . 71.239999999999995 107.958 170.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.3 154.7 36.42 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.053 1.341 . . . . 74.340000000000003 108.278 162.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.59 158.85 30.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.296 1.998 . . . . 71.519999999999996 111.934 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -133.09 -178.09 4.81 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.527 1.531 . . . . 75.329999999999998 109.414 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.21 12.98 4.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.54 1.536 . . . . 51.219999999999999 114.823 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.22 132.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.948 1.299 . . . . 61.409999999999997 110.049 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.8 152.76 45.45 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.534 1.133 . . . . 53.0 110.934 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -142.17 115.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.541 -1.651 . . . . 61.240000000000002 106.541 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -111.35 -167.7 1.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.442 2.297 . . . . 71.439999999999998 110.629 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -143.22 146.51 33.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.903 -1.147 . . . . 75.150000000000006 107.903 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -146.45 160.15 42.75 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 126.234 1.814 . . . . 75.329999999999998 106.95 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.99 73.44 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.777 1.652 . . . . 71.409999999999997 111.594 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.79 -59.73 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 128.807 2.843 . . . . 61.43 105.692 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.15 -166.15 38.56 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.683 -1.367 . . . . 62.030000000000001 109.683 -163.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.14 113.72 26.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.731 1.612 . . . . 53.32 110.583 -165.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 78.42 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.772 3.229 . . . . 73.019999999999996 112.187 164.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.87 110.29 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.873 -1.142 . . . . 75.040000000000006 108.41 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -130.27 158.22 40.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.595 0.634 . . . . 44.039999999999999 111.621 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.503 ' CE3' HD13 ' A' ' 99' ' ' ILE . 25.6 p90 -173.64 175.7 2.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.23 2.612 . . . . 55.140000000000001 110.377 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -115.46 165.21 14.9 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.964 0.906 . . . . 71.129999999999995 111.932 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.14 156.97 51.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.685 2.923 . . . . 72.129999999999995 111.226 167.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.64 139.64 70.71 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.9 1.733 . . . . 60.109999999999999 109.596 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 t -127.67 58.95 1.47 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.77 -2.308 . . . . 64.340000000000003 104.77 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.39 -85.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.164 -1.791 . . . . 71.239999999999995 106.164 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.1 p -112.86 166.11 11.69 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.344 0.52 . . . . 74.329999999999998 110.425 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 m -56.67 -72.92 0.07 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.568 1.547 . . . . 64.140000000000001 111.546 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.43 -173.8 11.1 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.474 -1.45 . . . . 61.399999999999999 109.474 -164.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -137.23 68.54 1.41 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.649 1.58 . . . . 74.230000000000004 107.881 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.8 140.52 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.702 -0.851 . . . . 60.530000000000001 108.702 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 pt -135.89 -21.65 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.514 1.526 . . . . 71.129999999999995 111.34 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -158.02 174.8 14.68 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.117 1.767 . . . . 72.400000000000006 106.929 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.75 163.63 32.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.084 0.954 . . . . 74.099999999999994 108.973 174.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -150.61 153.05 34.99 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.119 -0.988 . . . . 54.43 112.496 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.47 142.56 43.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 126.095 1.758 . . . . 63.030000000000001 107.533 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.7 120.22 40.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.562 -2.014 . . . . 62.240000000000002 105.562 170.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.36 132.93 53.67 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.257 1.423 . . . . 64.349999999999994 107.198 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.44 131.19 40.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 118.17 -0.919 . . . . 73.230000000000004 109.178 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.91 179.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.725 1.21 . . . . 74.109999999999999 110.79 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 C-N-CA 126.253 1.821 . . . . 73.25 109.614 167.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 64' ' ' PHE . 10.0 mt . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 118.815 -0.612 . . . . 61.439999999999998 109.842 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 174.64 104.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.098 2.159 . . . . 73.230000000000004 107.039 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CE2' HD13 ' A' ' 62' ' ' LEU . 21.7 m-30 -127.1 146.56 50.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.939 1.296 . . . . 75.230000000000004 110.106 -166.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttp -77.67 130.25 36.58 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.591 -1.263 . . . . 74.010000000000005 107.591 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -79.13 60.17 2.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.57 1.148 . . . . 73.310000000000002 109.551 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -53.19 -27.21 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 126.501 1.92 . . . . 63.109999999999999 113.903 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.0 121.71 27.03 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.45 -2.426 . . . . 73.239999999999995 104.45 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.5 t -152.03 79.59 1.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.733 -1.951 . . . . 74.239999999999995 105.733 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.93 176.56 45.0 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.717 -0.614 . . . . 75.430000000000007 112.358 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.26 -8.98 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.367 3.378 . . . . 73.329999999999998 112.64 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.38 158.14 8.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.59 1.556 . . . . 54.109999999999999 112.358 -172.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.16 -171.18 1.01 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.819 3.013 . . . . 71.040000000000006 110.653 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.83 110.76 0.25 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.806 2.442 . . . . 53.329999999999998 110.486 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.6 m -104.81 135.42 46.22 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.841 0.746 . . . . 51.509999999999998 110.261 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.48 119.96 10.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.335 1.054 . . . . 60.210000000000001 109.515 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.56 114.41 9.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.109 -1.812 . . . . 75.450000000000003 106.109 167.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.42 158.23 27.27 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.804 0.842 . . . . 53.310000000000002 110.744 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -50.06 -49.49 51.03 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.931 0.892 . . . . 44.109999999999999 112.318 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 p -59.99 -25.52 65.33 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.508 1.049 . . . . 61.329999999999998 113.697 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -40.01 32.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.845 1.202 . . . . 71.219999999999999 110.431 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.39 -45.31 94.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.319 1.047 . . . . 75.140000000000001 110.711 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -62.72 -24.18 67.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.513 1.525 . . . . 64.129999999999995 112.75 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -92.38 -9.52 41.44 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.211 1.004 . . . . 55.439999999999998 112.033 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.43 147.27 49.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.547 1.067 . . . . 73.329999999999998 111.232 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -93.62 129.3 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.382 1.073 . . . . 62.43 111.226 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -68.68 133.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 126.216 1.806 . . . . 75.519999999999996 109.331 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.47 111.29 3.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.856 -0.794 . . . . 61.310000000000002 108.856 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -103.62 64.1 0.8 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.144 0.973 . . . . 73.519999999999996 108.761 165.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 -26.77 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.029 -0.987 . . . . 74.439999999999998 113.616 171.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -146.52 -55.36 0.26 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.23 0.923 . . . . 73.150000000000006 111.266 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -149.53 144.53 17.94 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 117.161 -1.399 . . . . 75.120000000000005 108.19 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.63 97.37 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.144 2.563 . . . . 42.009999999999998 109.883 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -145.98 152.43 39.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.312 2.245 . . . . 72.430000000000007 109.2 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.5 mt -72.16 133.76 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.964 -1.495 . . . . 73.109999999999999 106.964 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.7 mm -81.61 136.07 23.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.068 0.947 . . . . 42.020000000000003 108.992 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -122.15 150.4 42.27 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.104 1.761 . . . . 75.120000000000005 107.785 165.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -133.26 132.96 42.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.169 -1.789 . . . . 74.140000000000001 106.169 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.503 HD13 ' CE3' ' A' ' 26' ' ' TRP . 20.8 mt -131.6 140.46 48.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.41 -0.959 . . . . 75.209999999999994 108.41 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.08 153.79 34.66 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.612 1.165 . . . . 73.549999999999997 110.497 170.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.14 141.38 41.93 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.734 0.813 . . . . 53.200000000000003 109.812 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.4 tpt85 -86.04 108.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 105.967 -1.864 . . . . 72.129999999999995 105.967 164.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -114.57 -176.15 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.398 -0.964 . . . . 61.32 108.398 165.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -52.51 -39.38 61.24 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.726 2.01 . . . . 71.540000000000006 112.048 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -47.7 53.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.28 -0.637 . . . . 63.539999999999999 109.28 -166.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.29 174.75 21.05 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.46 -0.656 . . . . 72.519999999999996 111.46 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -75.45 102.88 5.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.646 -1.612 . . . . 72.349999999999994 106.646 163.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.36 -64.71 0.86 Allowed Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.324 -1.265 . . . . 72.450000000000003 112.126 -171.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.73 179.02 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.21 2.607 . . . . 73.540000000000006 110.002 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.74 107.01 1.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.749 0.82 . . . . 60.450000000000003 109.159 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 m -71.53 110.13 5.92 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.386 -0.968 . . . . 64.510000000000005 108.386 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -82.08 103.12 11.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.451 1.5 . . . . 75.549999999999997 109.205 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.3 159.51 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.282 1.433 . . . . 55.140000000000001 107.747 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.43 155.45 45.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.724 -0.61 . . . . 72.209999999999994 110.325 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -138.32 109.56 6.88 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.107 0.963 . . . . 74.129999999999995 112.078 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.774 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.32 -177.93 5.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 128.732 2.813 . . . . 53.439999999999998 109.299 -177.203 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 73.72 9.84 4.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.14 1.776 . . . . 71.140000000000001 112.193 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.543 0.692 0 C-N-CA 127.185 2.194 . . . . 74.420000000000002 114.417 178.327 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 . . . . . 0 C--O 1.223 -0.325 0 CA-C-O 118.654 -0.688 . . . . 72.430000000000007 110.694 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.55 96.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.376 2.717 . . . . 71.349999999999994 110.927 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.48 113.78 0.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 124.117 0.865 . . . . 65.239999999999995 111.457 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.36 153.46 8.81 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.09 1.756 . . . . 71.430000000000007 109.14 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.33 166.9 19.95 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 124.976 3.784 . . . . 74.219999999999999 114.396 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -136.59 -179.12 5.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.383 2.273 . . . . 51.310000000000002 110.447 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.82 14.93 5.51 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 128.627 2.771 . . . . 74.219999999999999 115.386 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 131.65 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.219 0.608 . . . . 71.530000000000001 111.197 -162.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -125.17 148.5 48.57 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.715 1.206 . . . . 73.430000000000007 108.728 173.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -148.02 141.57 19.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.31 -1.737 . . . . 72.340000000000003 106.31 168.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -150.17 23.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.218 1.407 . . . . 64.140000000000001 112.962 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 4.3 tttm 48.68 -173.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.611 3.164 . . . . 72.030000000000001 112.944 -173.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.87 165.13 19.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.192 1.397 . . . . 71.140000000000001 107.57 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.91 -24.41 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.82 2.347 . . . . 70.019999999999996 112.345 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.06 -9.92 16.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.984 2.114 . . . . 71.430000000000007 111.182 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.03 -123.08 1.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.686 -1.366 . . . . 50.240000000000002 109.686 -174.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . . . -135.36 124.54 24.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.636 -0.697 . . . . 74.209999999999994 110.457 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -67.12 90.69 0.2 Allowed 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.448 0.699 . . . . 74.310000000000002 109.427 168.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.84 164.11 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.0 0.92 . . . . 45.32 108.558 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.96 157.87 16.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.017 1.727 . . . . 61.229999999999997 109.668 168.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -171.65 -179.73 2.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.74 2.016 . . . . 74.219999999999999 109.527 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -127.59 165.21 31.3 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 127.159 2.184 . . . . 73.329999999999998 109.432 169.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -66.21 168.49 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.668 2.912 . . . . 72.530000000000001 110.735 165.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.02 152.86 80.23 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.098 1.198 . . . . 72.150000000000006 109.861 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 p -118.68 17.61 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.542 1.137 . . . . 71.150000000000006 111.821 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.02 -45.25 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.825 1.25 . . . . 70.540000000000006 110.533 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.4 p -148.37 167.09 26.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.633 1.573 . . . . 63.229999999999997 107.926 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -46.23 -61.18 1.89 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.307 1.843 . . . . 71.120000000000005 111.945 -174.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.06 113.12 0.06 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.899 1.238 . . . . 71.510000000000005 112.943 174.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -89.35 66.38 7.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.006 0.922 . . . . 65.140000000000001 109.419 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -71.03 151.64 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.15 -1.426 . . . . 63.149999999999999 107.15 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.3 pt -135.42 -21.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.376 1.87 . . . . 65.25 111.836 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.72 -167.36 1.52 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.813 0.845 . . . . 71.150000000000006 109.486 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -152.04 172.91 15.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.658 1.983 . . . . 71.329999999999998 108.365 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -150.29 175.68 11.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.812 0.733 . . . . 33.030000000000001 111.212 163.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -144.24 129.74 14.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.605 1.962 . . . . 73.109999999999999 107.222 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.496 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -119.71 119.37 33.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.558 -1.645 . . . . 65.230000000000004 106.558 165.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 tp -87.22 126.83 35.06 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.634 -1.987 . . . . 74.310000000000002 105.634 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.11 138.82 50.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.397 0.544 . . . . 74.209999999999994 110.524 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 pt -126.72 -178.84 2.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 125.925 1.69 . . . . 72.040000000000006 109.786 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 125.68 1.592 . . . . 75.140000000000001 109.2 173.784 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 65.129999999999995 112.921 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.19 135.05 15.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.42 -0.809 . . . . 63.25 109.865 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 78.5 m-85 -149.23 -164.16 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.234 2.613 . . . . 75.409999999999997 107.846 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.9 ttp -112.48 -6.69 13.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.592 1.157 . . . . 75.329999999999998 113.153 166.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 44.23 66.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.373 2.269 . . . . 64.319999999999993 111.614 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.34 -13.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 113.554 0.946 . . . . 64.329999999999998 113.554 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -57.13 135.72 56.37 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.087 -1.008 . . . . 73.340000000000003 112.027 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -142.37 97.68 3.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.761 2.024 . . . . 74.150000000000006 107.73 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 166.94 5.9 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.215 0.912 . . . . 72.150000000000006 113.376 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 -57.4 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.791 1.661 . . . . 70.030000000000001 113.716 -166.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.0 m 57.33 167.66 0.06 OUTLIER Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.208 0.913 . . . . 73.420000000000002 112.872 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.99 -24.23 45.77 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.465 1.443 . . . . 73.209999999999994 112.293 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 p -167.35 41.56 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.913 0.885 . . . . 64.140000000000001 109.33 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 16.2 p 45.11 -166.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.44 1.896 . . . . 53.399999999999999 112.432 -161.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.09 115.05 5.71 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.268 -0.895 . . . . 74.310000000000002 109.326 149.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.53 124.28 45.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 126.116 1.766 . . . . 70.230000000000004 107.502 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.19 49.04 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.212 1.805 . . . . 74.329999999999998 110.938 169.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t -70.46 -16.91 62.98 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.019 1.728 . . . . 70.030000000000001 112.311 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t -46.13 -53.83 9.7 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.008 0.822 . . . . 72.019999999999996 109.489 165.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -72.43 -19.96 61.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.192 0.812 . . . . 71.099999999999994 113.192 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.25 -34.02 65.62 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.547 0.612 . . . . 53.130000000000003 110.868 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -54.18 -47.46 72.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.849 0.459 . . . . 71.340000000000003 109.768 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.46 -7.48 38.32 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.771 1.628 . . . . 64.010000000000005 113.216 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.64 164.82 7.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.347 1.07 . . . . 65.129999999999995 110.713 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -128.12 160.23 32.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.842 -0.799 . . . . 72.129999999999995 108.842 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.56 123.38 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 106.964 -1.495 . . . . 62.329999999999998 106.964 -165.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.92 127.81 33.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.894 -1.151 . . . . 71.150000000000006 107.894 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.32 31.98 5.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.804 -1.184 . . . . 73.25 107.804 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.61 -11.87 7.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.967 1.307 . . . . 71.340000000000003 110.344 -171.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 p -142.25 -66.08 0.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.395 1.478 . . . . 74.109999999999999 109.861 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -150.48 152.92 33.71 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 127.802 2.441 . . . . 71.420000000000002 107.576 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.12 104.63 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.689 2.926 . . . . 73.25 109.556 173.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -147.74 153.1 38.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.17 1.388 . . . . 64.140000000000001 109.839 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 130.12 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.105 -1.813 . . . . 74.310000000000002 106.105 158.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.12 136.57 22.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.954 -1.499 . . . . 44.329999999999998 106.954 166.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.32 159.33 20.34 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.025 0.917 . . . . 74.010000000000005 110.25 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -131.19 100.73 5.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.859 1.664 . . . . 74.329999999999998 106.879 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.36 129.59 75.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 104.316 -2.475 . . . . 65.209999999999994 104.316 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . . . -142.67 163.94 31.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 109.863 171.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.99 132.7 34.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.821 -1.081 . . . . 73.409999999999997 108.286 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -84.5 105.49 15.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.334 -1.728 . . . . 72.030000000000001 106.334 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -115.18 -179.19 3.56 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.009 0.924 . . . . 73.140000000000001 110.484 173.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.34 -35.07 71.36 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.031 1.733 . . . . 73.109999999999999 114.526 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.11 -54.95 6.26 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 125.61 1.564 . . . . 63.229999999999997 108.957 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 159.34 164.39 14.59 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.414 -1.074 . . . . 70.519999999999996 110.414 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 100' ' ' ALA . 9.1 t80 -87.49 45.54 1.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.616 1.566 . . . . 74.140000000000001 110.136 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.28 -87.14 0.07 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.295 1.902 . . . . 74.120000000000005 111.671 -156.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.46 163.48 38.89 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.151 1.901 . . . . 54.020000000000003 109.773 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.75 148.66 35.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.415 -0.957 . . . . 70.450000000000003 108.415 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.8 m -75.88 132.84 40.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.261 -1.755 . . . . 61.439999999999998 106.261 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -113.83 86.61 2.44 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 105.799 -1.926 . . . . 53.149999999999999 105.799 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.75 156.73 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 73.420000000000002 108.618 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.79 116.4 28.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.921 -1.511 . . . . 53.240000000000002 106.921 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -72.99 75.66 1.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.76 -1.2 . . . . 71.129999999999995 107.76 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 94' ' ' ALA . 14.4 mt -70.99 150.79 45.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.5 -1.667 . . . . 70.200000000000003 106.5 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 66.29 24.29 10.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 63.509999999999998 111.146 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 O-C-N 121.792 -0.567 . . . . 65.510000000000005 111.76 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 110.124 -0.325 . . . . 64.450000000000003 110.124 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.97 5.66 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 125.149 3.9 . . . . 63.119999999999997 116.55 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.4 173.12 49.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.675 1.131 . . . . 70.310000000000002 112.394 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.3 161.02 24.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.225 1.41 . . . . 51.25 111.25 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.37 153.86 65.81 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.02 2.48 . . . . 74.150000000000006 110.989 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.4 m -137.38 -174.67 3.82 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.272 1.429 . . . . 60.240000000000002 110.605 -171.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.02 25.62 12.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.205 2.202 . . . . 71.230000000000004 114.205 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.25 141.12 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.681 1.192 . . . . 73.120000000000005 110.81 -172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -125.17 149.53 47.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.297 1.439 . . . . 63.32 109.007 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.0 mt -152.01 95.84 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.268 -1.753 . . . . 74.219999999999999 106.268 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 p -74.7 163.01 28.19 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.517 -0.92 . . . . 71.329999999999998 108.517 164.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -91.38 157.75 16.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.28 -1.378 . . . . 70.319999999999993 107.28 156.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 m -146.97 165.2 19.9 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.393 -1.336 . . . . 62.32 107.393 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.31 -37.43 61.28 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.324 1.35 . . . . 51.030000000000001 112.696 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.99 -47.99 14.06 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.331 -0.855 . . . . 74.519999999999996 110.682 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.74 -146.38 4.33 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.585 -0.606 . . . . 61.240000000000002 111.585 -156.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.03 133.8 32.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.321 1.448 . . . . 74.329999999999998 107.743 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -78.11 79.81 4.56 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.318 -0.623 . . . . 62.219999999999999 109.318 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.43 132.17 52.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.357 -1.349 . . . . 72.409999999999997 107.357 164.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -144.64 152.14 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.391 1.451 . . . . 72.349999999999994 109.255 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.416 ' CE3' HD13 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -137.56 167.57 21.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.206 1.403 . . . . 74.129999999999995 110.565 172.341 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.77 163.28 69.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.04 0.936 . . . . 74.340000000000003 112.328 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.11 164.83 26.2 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.391 2.727 . . . . 73.239999999999995 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.67 77.39 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.432 2.755 . . . . 53.240000000000002 110.359 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 t -133.02 24.73 4.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.293 2.237 . . . . 73.239999999999995 109.422 -171.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.53 -40.93 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.926 1.291 . . . . 53.210000000000001 107.95 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.0 p -149.45 174.08 12.87 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.017 1.727 . . . . 64.140000000000001 110.419 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -64.24 19.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.572 3.149 . . . . 72.420000000000002 114.88 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.59 -168.15 35.84 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 120.597 -1.314 . . . . 65.439999999999998 114.037 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -135.65 113.4 10.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.193 -1.004 . . . . 74.420000000000002 109.505 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.479 HG12 ' HB1' ' A' ' 101' ' ' ALA . 1.9 mp -109.67 133.63 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.084 1.754 . . . . 64.129999999999995 108.144 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -131.62 -11.42 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 72.120000000000005 112.33 -163.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 39' ' ' TYR . 10.8 tt0 -160.45 -169.51 2.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.222 2.209 . . . . 65.219999999999999 106.685 163.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.441 ' H ' ' HG2' ' A' ' 38' ' ' GLU . 1.4 m-85 -128.4 169.27 14.47 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.22 -1.55 . . . . 74.349999999999994 108.879 165.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.0 m -145.03 156.93 44.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.171 -0.956 . . . . 72.409999999999997 110.526 166.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.66 125.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 105.618 -1.993 . . . . 74.109999999999999 105.618 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.23 127.33 55.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.735 -1.58 . . . . 74.109999999999999 106.735 171.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -121.85 130.54 53.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.983 1.713 . . . . 74.420000000000002 107.574 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.21 126.03 28.28 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.907 0.883 . . . . 71.420000000000002 113.068 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.53 -170.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.769 2.428 . . . . 74.530000000000001 109.236 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 126.046 1.738 . . . . 73.510000000000005 110.695 161.586 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 113.512 0.93 . . . . 63.5 113.512 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.27 82.72 1.97 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.333 0.587 . . . . 64.120000000000005 111.17 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -130.74 150.41 51.93 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.308 1.043 . . . . 73.310000000000002 108.911 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ttp -113.99 133.84 55.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.107 1.763 . . . . 51.340000000000003 108.233 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -82.19 56.73 3.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.606 1.562 . . . . 74.25 112.331 -167.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.66 -19.61 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 115.924 1.824 . . . . 72.530000000000001 115.924 -167.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.08 118.63 7.03 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.842 1.201 . . . . 73.510000000000005 110.032 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.6 m -152.13 73.69 1.06 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 127.172 2.189 . . . . 63.210000000000001 107.625 164.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.44 166.06 25.91 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 121.562 -0.711 . . . . 70.25 111.799 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 -55.64 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.614 2.21 . . . . 72.510000000000005 109.836 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -76.57 144.51 73.82 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.247 0.619 . . . . 70.420000000000002 109.785 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 -26.15 16.68 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.235 1.957 . . . . 73.530000000000001 112.882 -168.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p -80.88 68.9 7.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.232 0.924 . . . . 61.109999999999999 110.216 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.2 m -69.3 115.45 8.59 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.391 -0.818 . . . . 54.329999999999998 110.675 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.8 -178.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.977 2.111 . . . . 54.240000000000002 112.528 159.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.74 146.69 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.521 1.528 . . . . 71.209999999999994 108.222 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -96.26 161.81 13.78 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.601 2.36 . . . . 61.219999999999999 112.778 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -45.87 67.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.961 1.304 . . . . 62.310000000000002 111.72 169.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -62.37 -28.16 69.58 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.615 0.643 . . . . 63.130000000000003 111.623 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -80.36 -46.56 15.86 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.327 -0.858 . . . . 54.219999999999999 109.046 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.1 mt -52.83 -26.7 15.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.193 1.797 . . . . 71.549999999999997 112.926 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.4 m -45.36 -33.88 2.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.12 1.368 . . . . 70.120000000000005 113.232 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -95.0 -10.87 29.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.323 0.649 . . . . 65.230000000000004 111.263 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.66 24.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.061 0.846 . . . . 71.450000000000003 110.123 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.68 120.39 27.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.101 0.96 . . . . 73.349999999999994 109.819 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.08 138.24 21.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.992 1.717 . . . . 73.120000000000005 109.287 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.95 111.33 4.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.816 0.846 . . . . 74.329999999999998 111.006 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -100.65 20.09 15.78 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.461 -0.774 . . . . 73.030000000000001 110.993 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -4.01 6.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.456 0.909 . . . . 63.32 113.456 -163.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 -63.31 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.275 1.43 . . . . 75.230000000000004 108.492 161.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -153.68 154.19 29.95 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 106.536 -1.653 . . . . 72.450000000000003 106.536 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.29 110.16 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.389 2.059 . . . . 64.120000000000005 109.544 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.92 168.56 21.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.72 2.008 . . . . 73.319999999999993 109.301 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.7 mt -101.74 140.05 21.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.274 -1.75 . . . . 73.010000000000005 106.274 166.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.42 124.52 73.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.273 1.029 . . . . 72.010000000000005 110.085 -163.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.47 137.55 54.77 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.848 0.859 . . . . 63.520000000000003 112.488 -167.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -112.78 99.29 7.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.773 1.629 . . . . 62.439999999999998 108.057 167.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.416 HD13 ' CE3' ' A' ' 26' ' ' TRP . 9.7 mt -98.34 144.75 10.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.396 -1.705 . . . . 72.540000000000006 106.396 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.23 142.28 29.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.284 1.034 . . . . 74.25 109.65 168.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB1' HG12 ' A' ' 36' ' ' ILE . . . -74.94 122.51 23.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.338 1.055 . . . . 72.439999999999998 108.87 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -72.89 117.83 15.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.856 -1.535 . . . . 72.349999999999994 106.856 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -131.59 -176.92 4.19 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 127.582 2.353 . . . . 73.430000000000007 109.502 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.78 -27.94 69.53 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.503 0.557 . . . . 74.109999999999999 112.503 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -74.48 -32.13 62.45 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.158 -0.964 . . . . 73.409999999999997 113.05 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.73 166.8 38.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.597 -1.001 . . . . 63.310000000000002 110.597 -166.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.08 64.14 3.2 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.563 1.545 . . . . 62.350000000000001 111.689 -170.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.43 -75.44 0.35 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.291 -1.124 . . . . 63.340000000000003 110.291 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.99 167.65 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.06 3.173 . . . . 73.510000000000005 110.21 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 162.86 39.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.025 2.13 . . . . 71.239999999999995 107.192 165.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.2 t -79.95 179.32 7.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.161 -0.681 . . . . 71.230000000000004 109.161 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -150.54 73.01 1.11 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.143 0.577 . . . . 75.230000000000004 110.031 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.3 m -93.24 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.473 -0.767 . . . . 63.450000000000003 110.424 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 112.24 13.46 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.888 1.275 . . . . 75.349999999999994 110.232 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -71.65 82.68 0.85 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.73 0.812 . . . . 73.230000000000004 110.704 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.83 53.9 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.796 1.638 . . . . 61.450000000000003 108.68 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 17.67 2.99 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.874 1.27 . . . . 75.140000000000001 109.609 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.034 0.445 . . . . 72.150000000000006 110.271 164.165 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 28.6 m-85 . . . . . 0 N--CA 1.44 -0.954 0 N-CA-C 108.273 -1.01 . . . . 74.329999999999998 108.273 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -55.48 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.76 2.307 . . . . 54.420000000000002 112.868 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.73 41.58 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.733 -1.747 . . . . 62.240000000000002 108.733 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.27 159.42 32.11 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.755 1.622 . . . . 71.420000000000002 109.353 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.06 154.27 75.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.232 1.288 . . . . 65.439999999999998 111.719 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.3 m -142.41 -174.65 4.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.614 1.566 . . . . 71.200000000000003 109.488 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.84 37.79 10.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.034 2.534 . . . . 74.299999999999997 113.193 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.52 126.45 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.506 -1.294 . . . . 74.340000000000003 107.506 -171.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -137.56 150.76 47.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.669 -0.863 . . . . 43.140000000000001 108.669 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 24' ' ' LEU . 4.0 mp -125.86 149.74 30.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.459 -2.052 . . . . 53.439999999999998 105.459 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.81 135.84 36.65 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.309 -1.367 . . . . 70.310000000000002 107.309 174.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -72.01 143.85 49.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.398 -1.334 . . . . 73.120000000000005 107.398 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -126.34 165.64 26.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 125.877 1.671 . . . . 71.420000000000002 108.023 169.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.65 -15.2 40.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.359 2.04 . . . . 54.32 112.353 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.24 -29.22 13.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.753 1.221 . . . . 74.430000000000007 110.787 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.14 -152.37 16.94 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 116.377 -2.346 . . . . 63.140000000000001 110.539 -164.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.2 127.95 54.23 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 121.147 2.474 . . . . 71.140000000000001 108.731 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.49 126.14 26.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.214 -1.032 . . . . 74.129999999999995 108.214 164.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' CD2' HG23 ' A' ' 15' ' ' ILE . 5.4 mt -113.12 145.33 41.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.031 -1.099 . . . . 64.239999999999995 108.031 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 t -150.28 171.82 16.35 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.415 0.552 . . . . 65.140000000000001 111.234 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CE3' HD13 ' A' ' 99' ' ' ILE . 15.3 p90 -173.45 -171.57 0.7 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.765 2.026 . . . . 74.299999999999997 111.189 -172.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -111.57 165.49 12.72 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 127.948 2.499 . . . . 73.230000000000004 110.639 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -66.64 166.68 21.33 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.956 3.104 . . . . 53.299999999999997 112.598 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.46 -4.64 14.35 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 124.018 3.145 . . . . 64.409999999999997 111.773 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -148.25 138.43 22.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.916 -1.513 . . . . 54.109999999999999 106.916 -174.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.48 -49.53 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.498 0.666 . . . . 61.020000000000003 110.621 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 t -65.22 158.97 24.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.39 1.076 . . . . 42.229999999999997 109.907 163.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.8 m -54.86 -45.0 74.49 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.409 1.263 . . . . 73.310000000000002 114.409 -163.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.5 -171.48 46.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.965 0.802 . . . . 43.439999999999998 111.566 -171.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -116.42 56.19 0.79 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.571 1.549 . . . . 74.439999999999998 109.187 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.47 140.08 20.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 72.299999999999997 106.245 168.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.96 -23.03 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.573 1.149 . . . . 72.329999999999998 110.609 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -161.24 -175.53 4.9 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.285 1.434 . . . . 74.230000000000004 108.515 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -171.0 2.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.784 1.234 . . . . 74.129999999999995 109.469 170.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . 12.4 p -138.15 155.92 48.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.753 1.621 . . . . 53.100000000000001 107.917 157.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.64 112.43 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.197 -2.519 . . . . 64.0 104.197 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.404 ' HB3' ' CB ' ' A' ' 64' ' ' PHE . 67.7 m-85 -111.51 160.24 17.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.758 0.823 . . . . 74.409999999999997 108.983 175.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 tp -149.96 139.47 21.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.79 2.036 . . . . 72.530000000000001 106.004 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.33 137.58 42.93 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.389 1.076 . . . . 73.319999999999993 110.34 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -141.76 -165.59 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.528 1.531 . . . . 72.430000000000007 110.343 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 127.083 2.153 . . . . 73.549999999999997 110.305 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 62' ' ' LEU . 2.4 mp . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 108.524 -0.917 . . . . 65.319999999999993 108.524 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.98 123.93 3.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 45.140000000000001 109.558 170.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 27.7 m-85 -146.06 162.26 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.008 0.923 . . . . 74.530000000000001 111.333 -173.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.6 ttt -69.35 -29.83 67.72 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.042 1.337 . . . . 71.329999999999998 113.899 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 65.79 80.57 0.22 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.639 1.576 . . . . 61.409999999999997 110.516 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.72 -14.62 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.961 0.904 . . . . 52.549999999999997 112.488 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -54.34 116.13 2.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.406 1.482 . . . . 73.120000000000005 110.266 166.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -157.9 23.94 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.36 0.504 . . . . 72.409999999999997 112.36 157.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 154.54 29.69 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.918 -1.273 . . . . 73.299999999999997 109.918 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.06 -26.28 21.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.342 2.028 . . . . 54.299999999999997 111.845 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -122.81 163.53 32.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.472 1.509 . . . . 74.019999999999996 109.307 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.93 173.46 12.75 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.983 1.789 . . . . 74.340000000000003 111.027 170.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 t 50.46 59.91 4.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.03 1.332 . . . . 73.209999999999994 110.624 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.63 171.53 7.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.88 0.872 . . . . 73.109999999999999 110.673 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.594 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.0 pt? -76.29 171.65 14.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.624 1.342 . . . . 54.310000000000002 114.624 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.25 109.43 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 C-N-CA 126.973 2.109 . . . . 70.430000000000007 111.266 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -57.43 146.75 28.4 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.246 2.219 . . . . 73.019999999999996 111.472 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 p -66.47 -23.68 66.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.737 1.014 . . . . 71.510000000000005 113.737 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 5.5 0.91 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.614 1.566 . . . . 73.430000000000007 113.599 167.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -108.64 -36.69 6.11 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.063 -1.023 . . . . 74.209999999999994 110.055 164.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.27 -37.39 77.86 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.421 1.088 . . . . 72.310000000000002 111.232 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -61.79 -0.86 0.51 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.693 1.597 . . . . 73.349999999999994 113.109 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -129.98 2.15 4.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.954 2.102 . . . . 65.430000000000007 110.255 -167.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.21 132.8 55.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.982 2.113 . . . . 44.310000000000002 109.125 -169.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -87.39 158.17 19.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.978 0.418 . . . . 65.530000000000001 110.875 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -84.43 146.94 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.898 1.279 . . . . 63.409999999999997 108.365 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.45 118.49 20.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.875 -1.157 . . . . 73.319999999999993 107.875 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 24.32 11.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.256 1.023 . . . . 70.209999999999994 109.789 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -100.65 -53.95 2.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.719 -1.215 . . . . 71.230000000000004 107.719 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.8 m -111.08 -54.26 2.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.178 1.791 . . . . 71.549999999999997 109.488 -166.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -160.47 150.08 14.32 Favored Pre-proline 0 C--N 1.343 0.298 0 C-N-CA 127.528 2.331 . . . . 63.140000000000001 109.87 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.86 101.56 0.23 Allowed 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 124.494 3.463 . . . . 64.120000000000005 109.89 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.626 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -162.0 172.9 15.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.95 1.7 . . . . 74.510000000000005 111.199 175.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.51 132.35 42.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.759 -1.571 . . . . 72.510000000000005 106.759 167.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.97 118.85 49.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 124.103 0.961 . . . . 73.510000000000005 109.488 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -93.08 178.34 5.78 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.771 1.228 . . . . 72.299999999999997 111.679 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.19 128.5 14.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 126.453 1.901 . . . . 65.200000000000003 106.638 167.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.505 HD13 ' CE3' ' A' ' 26' ' ' TRP . 34.1 mt -132.14 153.93 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 119.528 1.058 . . . . 63.329999999999998 109.512 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -167.78 136.6 2.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.536 2.334 . . . . 71.140000000000001 110.374 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.2 133.3 55.01 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.605 1.562 . . . . 65.329999999999998 112.849 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 92.11 9.02 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.747 -1.946 . . . . 70.120000000000005 105.747 161.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -101.34 -179.23 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.333 -0.988 . . . . 62.020000000000003 108.333 153.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -57.95 -21.77 45.7 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.105 1.15 . . . . 74.239999999999995 114.105 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -37.26 38.88 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.402 -0.811 . . . . 63.409999999999997 110.181 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.17 -171.8 13.97 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.162 1.363 . . . . 74.140000000000001 112.999 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 14.3 m-85 -81.7 66.1 7.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.969 1.708 . . . . 72.219999999999999 111.285 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.28 -74.22 1.08 Allowed Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.002 -1.061 . . . . 23.449999999999999 111.563 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 56.6 Cg_endo -68.81 167.23 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.381 2.72 . . . . 50.340000000000003 110.118 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.46 152.17 44.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.725 0.774 . . . . 73.120000000000005 110.049 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.3 m -142.01 109.44 5.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.159 -1.793 . . . . 61.530000000000001 106.159 167.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -94.38 139.44 31.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.111 -1.44 . . . . 73.319999999999993 107.111 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -125.24 171.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.081 0.952 . . . . 44.340000000000003 110.43 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 113.46 14.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.525 1.53 . . . . 74.230000000000004 108.21 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -79.03 93.4 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.48 -1.304 . . . . 72.129999999999995 107.48 172.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 94' ' ' ALA . 16.2 mt -77.39 165.25 24.65 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.326 -1.361 . . . . 61.439999999999998 107.326 173.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.06 29.51 19.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.667 0.787 . . . . 75.430000000000007 109.892 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 O-C-N 120.246 -1.534 . . . . 74.319999999999993 114.503 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 108.922 -0.77 . . . . 73.329999999999998 108.922 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.75 114.28 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.105 2.537 . . . . 74.239999999999995 109.751 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.01 -161.83 35.12 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.147 -1.181 . . . . 64.109999999999999 110.147 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.06 82.86 0.21 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 127.092 2.157 . . . . 45.140000000000001 111.891 -163.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.31 165.59 24.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.165 2.577 . . . . 73.340000000000003 110.891 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.8 m -135.57 -175.59 4.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.265 1.426 . . . . 35.109999999999999 112.106 -173.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.8 25.95 2.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.673 2.789 . . . . 63.229999999999997 115.202 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.64 132.69 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.417 -0.802 . . . . 61.420000000000002 110.87 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -117.22 149.37 40.53 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.219 1.008 . . . . 73.510000000000005 109.073 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.6 mt -145.65 141.73 22.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 105.673 -1.973 . . . . 72.019999999999996 105.673 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.8 p -152.29 170.98 18.7 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.087 1.755 . . . . 73.319999999999993 108.861 168.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -95.37 160.02 14.73 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.804 0.729 . . . . 71.140000000000001 109.441 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.4 m -145.56 165.75 20.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.472 2.309 . . . . 73.230000000000004 109.391 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -70.66 -4.37 14.5 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.1 2.533 . . . . 73.430000000000007 112.349 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -131.85 29.13 4.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.45 1.5 . . . . 71.439999999999998 110.655 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.48 -158.36 21.18 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.377 -0.827 . . . . 23.539999999999999 112.739 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 153.03 23.77 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.484 1.142 . . . . 51.039999999999999 108.294 162.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.19 96.9 7.51 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.747 2.419 . . . . 70.450000000000003 109.167 -169.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.96 125.47 53.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.226 2.211 . . . . 73.510000000000005 110.061 -159.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -157.97 152.42 24.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.662 1.574 . . . . 33.119999999999997 114.427 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CE3' HD13 ' A' ' 99' ' ' ILE . 4.2 p90 -149.28 -179.62 7.2 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 127.226 2.21 . . . . 72.209999999999994 113.151 -171.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 1.6 pp20? -115.56 160.36 34.96 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 126.703 2.001 . . . . 70.25 112.756 -170.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 92.1 Cg_endo -69.52 176.24 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 126.647 4.898 . . . . 74.209999999999994 112.171 -176.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.75 113.52 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 108.083 -1.545 . . . . 65.120000000000005 108.083 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -103.47 13.95 32.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.952 0.901 . . . . 55.219999999999999 110.387 168.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 32' ' ' THR . 2.4 m -100.44 -84.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 127.536 2.334 . . . . 60.219999999999999 109.702 -174.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.402 ' H ' HG23 ' A' ' 31' ' ' VAL . 50.8 p -122.25 166.3 14.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.893 0.769 . . . . 54.32 109.364 170.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -60.0 -56.79 17.35 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.493 1.117 . . . . 73.099999999999994 110.205 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.13 -171.54 23.38 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.109 -0.796 . . . . 61.32 111.109 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -133.06 80.31 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.388 -0.967 . . . . 72.310000000000002 108.388 166.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -76.95 145.42 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.46 -1.311 . . . . 73.209999999999994 107.46 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -133.04 -24.49 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.342 1.457 . . . . 72.099999999999994 111.434 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 1.5 tp10 -168.1 -175.09 2.52 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 105.762 -1.94 . . . . 71.5 105.762 -174.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.465 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 75.2 m-85 -136.97 -166.15 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.546 -1.346 . . . . 65.209999999999994 109.913 175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.96 159.71 41.73 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.35 2.26 . . . . 70.219999999999999 109.549 165.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.47 119.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 103.84 -2.652 . . . . 62.409999999999997 103.84 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -114.41 151.9 32.39 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.709 -0.849 . . . . 73.430000000000007 108.709 173.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 tp -136.25 117.86 14.93 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.627 1.971 . . . . 74.329999999999998 107.338 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.6 151.4 28.99 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.229 0.611 . . . . 44.32 111.623 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.38 172.49 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.571 1.148 . . . . 74.450000000000003 111.953 -169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.757 1.223 . . . . 64.329999999999998 109.955 156.831 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 1.7 mt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.676 -0.202 . . . . 73.219999999999999 110.549 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 87.93 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.479 0.581 . . . . 63.140000000000001 110.788 172.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 13.5 m-30 -117.87 155.13 30.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.337 1.055 . . . . 74.129999999999995 110.052 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.7 ttp -87.03 146.9 25.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.632 0.773 . . . . 74.409999999999997 109.405 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.59 93.39 8.36 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.636 1.208 . . . . 61.520000000000003 110.961 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -71.61 1.16 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 124.599 1.16 . . . . 73.310000000000002 112.74 168.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -91.22 -163.92 1.1 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.992 1.717 . . . . 74.329999999999998 110.38 174.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.3 m 57.91 35.31 25.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.729 1.612 . . . . 63.549999999999997 110.829 -158.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.29 -177.48 9.89 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 110.167 -1.173 . . . . 53.049999999999997 110.167 163.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -26.08 28.71 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.432 1.421 . . . . 74.510000000000005 111.182 173.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.74 17.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.094 1.358 . . . . 65.420000000000002 109.541 -170.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.25 165.45 28.61 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.414 2.076 . . . . 74.439999999999998 109.745 160.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m 49.35 36.35 9.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.992 1.317 . . . . 61.539999999999999 113.034 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -88.9 162.28 16.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.653 1.216 . . . . 71.540000000000006 111.224 170.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.576 ' H ' HD23 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.25 175.04 1.8 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.06 2.944 . . . . 61.119999999999997 113.705 172.562 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -135.8 119.68 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.236 1.014 . . . . 53.049999999999997 111.953 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -54.82 140.33 36.87 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.735 0.814 . . . . 73.319999999999993 111.599 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 p -56.14 -34.09 65.79 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.104 0.962 . . . . 72.549999999999997 112.799 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -55.17 -39.24 69.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.072 0.949 . . . . 72.549999999999997 111.583 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 t -74.55 -34.65 62.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.165 -0.959 . . . . 73.340000000000003 110.641 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.3 -33.77 76.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.633 0.651 . . . . 71.310000000000002 110.0 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -58.51 -37.21 75.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.633 1.573 . . . . 53.32 111.406 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.57 -5.58 59.26 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.068 -1.02 . . . . 65.140000000000001 112.711 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 149.82 21.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.607 -0.683 . . . . 53.439999999999998 111.166 -159.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 108.84 20.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.528 1.531 . . . . 74.430000000000007 109.693 -175.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -69.78 157.71 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.466 -0.938 . . . . 70.310000000000002 108.466 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -132.54 82.85 2.03 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.989 1.316 . . . . 63.130000000000003 108.656 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.96 121.61 5.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.438 1.273 . . . . 75.310000000000002 114.438 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 -22.62 43.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.63 -2.077 . . . . 73.319999999999993 112.894 159.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 p -143.67 -62.37 0.4 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.314 1.416 . . . . 74.120000000000005 112.797 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -104.49 141.86 23.41 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 116.811 -1.566 . . . . 72.209999999999994 109.218 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.48 120.58 7.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.229 1.953 . . . . 55.119999999999997 109.311 -176.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -128.95 147.71 50.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.604 -0.887 . . . . 64.230000000000004 108.604 160.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.3 mt -91.76 130.43 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 126.945 2.098 . . . . 74.329999999999998 105.768 168.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.4 mm -82.81 138.13 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.768 -1.197 . . . . 72.530000000000001 107.768 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.5 133.56 55.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.634 -1.247 . . . . 74.519999999999996 107.634 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -98.64 133.01 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 106.56 -1.645 . . . . 61.520000000000003 106.56 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.47 HD13 ' CE3' ' A' ' 26' ' ' TRP . 53.6 mt -135.87 140.27 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 105.686 -1.968 . . . . 62.240000000000002 105.686 175.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.27 164.48 35.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.511 0.724 . . . . 64.099999999999994 110.243 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.48 125.19 40.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.472 1.509 . . . . 65.519999999999996 111.15 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.48 ' HD3' ' CZ ' ' A' ' 107' ' ' TYR . 6.1 tpt180 -76.56 112.77 13.45 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.062 -1.459 . . . . 74.200000000000003 107.062 171.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 167.45 16.93 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.037 0.535 . . . . 71.409999999999997 111.346 162.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.66 -27.3 66.26 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.075 -0.391 . . . . 74.420000000000002 111.895 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -53.99 -40.02 66.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.336 1.454 . . . . 70.219999999999999 111.925 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.72 -173.37 27.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.632 2.063 . . . . 65.5 108.189 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -76.14 -5.05 44.91 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.126 1.528 . . . . 74.430000000000007 115.126 178.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.22 178.52 8.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.952 0.786 . . . . 42.439999999999998 111.958 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.95 148.13 63.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.584 1.523 . . . . 70.120000000000005 108.911 162.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 150.46 20.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.699 0.799 . . . . 71.319999999999993 109.485 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -68.27 166.26 16.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.071 0.948 . . . . 32.32 110.5 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -120.55 86.45 2.57 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.712 -1.958 . . . . 73.409999999999997 105.712 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.7 t -89.44 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 106.945 -1.502 . . . . 64.430000000000007 106.945 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.534 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -128.66 160.97 30.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.734 1.214 . . . . 74.040000000000006 107.945 165.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -119.27 80.13 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.637 1.575 . . . . 75.230000000000004 107.985 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 94' ' ' ALA . 36.9 mt -64.73 -21.74 66.82 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.896 0.702 . . . . 64.150000000000006 112.896 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.27 28.19 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.103 1.361 . . . . 73.040000000000006 111.622 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.496 -1.298 . . . . 60.030000000000001 107.496 164.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.457 0 CA-C-O 118.595 -1.114 . . . . 44.119999999999997 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 71.4 m -116.97 -41.79 2.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.018 1.409 . . . . 53.25 111.27 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 149.49 94.57 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 120.089 -0.645 . . . . 53.32 110.366 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.68 -18.12 29.04 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.691 2.928 . . . . 71.209999999999994 113.498 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.84 -165.01 10.91 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.158 -1.177 . . . . 75.450000000000003 110.158 -167.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -88.43 165.3 28.96 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.05 -1.463 . . . . 75.25 107.05 169.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.18 6.15 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.095 2.53 . . . . 64.420000000000002 114.528 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.62 -171.77 16.78 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.595 -1.802 . . . . 53.310000000000002 108.595 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.33 163.34 34.68 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.871 1.668 . . . . 44.310000000000002 109.609 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.15 152.12 81.3 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.651 1.568 . . . . 73.239999999999995 111.287 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.9 m -133.61 -173.93 3.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.854 2.462 . . . . 72.319999999999993 108.627 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 45.91 27.32 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.898 2.879 . . . . 54.409999999999997 114.868 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.73 137.71 23.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.036 -0.727 . . . . 63.240000000000002 109.036 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -134.04 159.23 41.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.797 0.839 . . . . 73.140000000000001 111.227 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -144.18 138.95 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.864 -1.902 . . . . 72.310000000000002 105.864 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -135.47 159.99 39.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.675 1.99 . . . . 74.420000000000002 108.404 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -83.69 170.92 13.73 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.987 -1.071 . . . . 61.509999999999998 108.4 171.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 161.6 29.15 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 123.888 0.875 . . . . 42.509999999999998 110.26 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.72 -27.77 52.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.57 1.513 . . . . 72.430000000000007 110.968 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.55 23.37 13.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.114 1.366 . . . . 75.420000000000002 110.854 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.24 -149.1 21.03 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.652 -1.28 . . . . 73.140000000000001 111.791 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 144.32 40.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.507 2.153 . . . . 61.520000000000003 107.5 152.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -80.13 141.67 35.52 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.947 1.299 . . . . 62.520000000000003 108.084 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.97 174.65 10.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.003 0.819 . . . . 71.409999999999997 110.015 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -175.31 155.91 1.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.013 2.525 . . . . 74.230000000000004 108.059 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -158.57 167.08 30.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.323 1.449 . . . . 72.519999999999996 109.316 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 7.0 mt-10 -138.65 162.99 49.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 125.866 1.666 . . . . 64.439999999999998 111.682 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.91 174.79 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.186 3.258 . . . . 52.119999999999997 113.808 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.92 179.01 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.88 3.054 . . . . 60.450000000000003 113.646 168.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.0 t -138.36 73.27 1.43 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 105.069 -2.197 . . . . 65.140000000000001 105.069 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 m -141.48 -66.34 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 107.736 -1.209 . . . . 65.319999999999993 107.736 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 173.64 6.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.814 2.045 . . . . 31.309999999999999 109.441 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 m -49.35 -57.77 6.29 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.267 1.427 . . . . 63.240000000000002 110.289 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.84 118.0 0.12 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.777 0.703 . . . . 65.150000000000006 111.379 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -102.4 73.81 1.36 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.617 -0.883 . . . . 75.129999999999995 108.617 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.26 149.91 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.384 -1.71 . . . . 62.119999999999997 106.384 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.81 -23.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.279 1.431 . . . . 45.43 112.639 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 -170.91 3.5 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 105.41 -2.07 . . . . 52.009999999999998 105.41 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.33 -178.56 5.54 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.211 -2.181 . . . . 72.230000000000004 111.599 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.98 162.47 40.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.648 0.779 . . . . 63.210000000000001 111.558 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 68' ' ' TYR . 2.2 p -148.35 115.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.728 2.011 . . . . 62.119999999999997 112.154 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -99.69 88.37 3.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 74.439999999999998 108.664 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.58 135.52 54.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.496 -1.298 . . . . 64.209999999999994 107.496 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 150.81 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.121 1.368 . . . . 63.509999999999998 111.002 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 pt -152.03 168.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.997 1.719 . . . . 74.129999999999995 110.394 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 92.23 7.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.016 -1.475 . . . . 75.510000000000005 107.016 160.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 t -162.97 172.77 14.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.781 -0.822 . . . . 54.149999999999999 108.781 149.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.3 m -73.0 150.22 42.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.9 -0.5 . . . . 74.540000000000006 109.796 159.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.81 178.47 9.86 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.309 -0.997 . . . . 72.340000000000003 108.309 169.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.91 166.41 11.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.843 0.857 . . . . 60.240000000000002 110.913 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 p -159.92 116.24 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.274 1.83 . . . . 72.230000000000004 106.202 -169.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.82 110.44 0.36 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.654 -0.978 . . . . 62.509999999999998 110.654 -169.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.31 152.88 68.54 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 117.666 0.733 . . . . 72.150000000000006 111.293 -163.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.33 122.9 11.52 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.474 2.116 . . . . 61.450000000000003 110.298 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 tptt 70.99 -3.43 2.03 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.437 2.295 . . . . 74.319999999999993 114.892 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m 52.19 86.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 123.001 1.382 . . . . 71.120000000000005 107.606 -150.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -133.13 36.87 3.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.374 -0.83 . . . . 72.450000000000003 109.593 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.96 68.9 0.98 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.027 1.331 . . . . 73.540000000000006 108.466 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.49 91.78 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.702 2.268 . . . . 63.210000000000001 110.373 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.79 115.48 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.227 1.411 . . . . 71.209999999999994 107.393 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -47.04 105.61 0.07 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.882 0.873 . . . . 63.119999999999997 110.453 166.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.469 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 18.6 mt -77.14 177.36 7.9 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.357 1.063 . . . . 75.349999999999994 108.305 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.32 5.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.43 -0.581 . . . . 72.319999999999993 109.43 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 17.5 m-85 -127.92 176.58 7.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.159 0.984 . . . . 72.450000000000003 110.473 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.5 ptm -126.74 -7.5 6.17 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.533 1.133 . . . . 72.409999999999997 112.655 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 53.63 78.13 0.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.883 0.873 . . . . 74.409999999999997 111.324 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 41' ' ' VAL . 13.5 m -77.69 -38.65 25.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-O 117.831 -1.08 . . . . 72.120000000000005 111.777 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.879 ' HB2' HG12 ' A' ' 41' ' ' VAL . 24.9 t80 -65.39 131.19 45.83 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 116.722 -1.991 . . . . 64.549999999999997 112.165 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 51.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.966 2.506 . . . . 64.140000000000001 108.262 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.82 166.06 13.46 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.77 -1.206 . . . . 74.109999999999999 110.29 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.52 -50.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.906 2.404 . . . . 75.319999999999993 109.783 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -90.71 154.94 45.92 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 125.845 1.658 . . . . 65.310000000000002 108.665 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.79 -173.22 1.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.471 2.114 . . . . 65.129999999999995 110.798 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p 57.34 60.57 2.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.454 1.502 . . . . 44.149999999999999 112.56 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.09 176.35 5.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.224 1.41 . . . . 61.509999999999998 110.014 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.61 -172.88 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.251 1.021 . . . . 51.130000000000003 110.906 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.19 139.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 125.612 1.565 . . . . 73.140000000000001 109.308 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.79 139.51 58.78 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.23 0.923 . . . . 75.340000000000003 110.088 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 t -63.15 -26.8 68.98 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.523 -0.736 . . . . 62.32 112.379 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -66.32 -21.26 66.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.855 0.862 . . . . 71.239999999999995 111.227 173.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -82.81 -33.04 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.626 -1.296 . . . . 64.420000000000002 110.533 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.98 -37.32 47.62 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.764 0.826 . . . . 72.329999999999998 112.206 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -60.93 -37.89 83.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.59 -0.522 . . . . 43.25 109.59 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -86.46 11.19 13.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.811 2.044 . . . . 73.310000000000002 111.645 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.53 155.69 16.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.008 1.323 . . . . 65.209999999999994 111.192 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 140.76 29.8 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.733 0.813 . . . . 52.030000000000001 110.064 173.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.57 155.01 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.89 0.852 . . . . 73.109999999999999 110.273 168.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.453 ' OD2' HD11 ' A' ' 96' ' ' ILE . 9.2 t70 -79.64 130.4 35.33 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 126.377 1.871 . . . . 72.319999999999993 108.534 173.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.59 3.59 4.58 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.473 1.109 . . . . 65.219999999999999 110.79 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 p -90.27 -19.11 24.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.705 2.002 . . . . 73.439999999999998 111.633 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -135.78 -62.03 0.7 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.59 1.086 . . . . 72.409999999999997 112.739 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -153.24 155.35 31.75 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 119.567 1.076 . . . . 71.239999999999995 109.902 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.58 112.94 3.19 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.96 1.773 . . . . 71.329999999999998 108.313 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.651 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -164.02 165.98 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.257 2.623 . . . . 62.109999999999999 109.886 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -90.11 135.19 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.955 -1.128 . . . . 62.420000000000002 107.955 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.453 HD11 ' OD2' ' A' ' 88' ' ' ASP . 45.6 mm -83.49 147.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.261 0.937 . . . . 62.409999999999997 110.637 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -137.25 115.76 11.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 61.450000000000003 110.122 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.77 87.38 6.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.646 1.578 . . . . 72.140000000000001 108.654 170.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.485 HG13 HG23 ' A' ' 41' ' ' VAL . 4.7 mt -86.08 151.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.321 -1.363 . . . . 71.209999999999994 107.321 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.63 146.24 24.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.835 0.743 . . . . 35.109999999999999 110.337 164.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.69 129.55 34.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.123 0.969 . . . . 63.130000000000003 110.011 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 92.13 8.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 105.909 -1.886 . . . . 75.340000000000003 105.909 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -117.95 173.14 6.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.412 1.485 . . . . 75.540000000000006 109.636 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.57 -16.53 10.42 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.858 1.429 . . . . 74.439999999999998 114.858 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -18.72 34.02 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.576 -1.328 . . . . 62.350000000000001 112.126 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.62 50.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.807 1.67 . . . . 35.100000000000001 111.047 -166.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.41 133.67 49.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.71 -1.589 . . . . 73.430000000000007 106.71 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -148.23 -86.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.303 0.954 . . . . 64.319999999999993 111.151 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.67 82.66 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.954 2.436 . . . . 51.039999999999999 107.596 166.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.09 160.82 9.47 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.381 -0.825 . . . . 62.109999999999999 109.539 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -115.34 140.5 49.07 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.424 1.09 . . . . 74.209999999999994 108.321 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.77 103.75 14.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 105.604 -1.999 . . . . 73.519999999999996 105.604 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.98 152.3 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 75.540000000000006 107.098 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.34 121.19 17.56 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.704 -0.68 . . . . 73.25 109.57 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -76.28 84.49 3.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.756 -1.201 . . . . 65.519999999999996 107.756 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 94' ' ' ALA . 19.9 mt -65.92 150.72 48.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.5 -1.296 . . . . 75.109999999999999 107.5 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 69.6 27.84 4.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.789 1.235 . . . . 60.219999999999999 111.288 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 177.71 0.82 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.174 2.99 . . . . 64.409999999999997 113.648 163.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 p -150.5 143.91 25.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.367 1.867 . . . . 71.129999999999995 109.989 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 m -58.78 -48.17 82.19 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.193 1.183 . . . . 32.130000000000003 114.193 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 69.43 -62.34 0.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.048 2.139 . . . . 75.219999999999999 113.621 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.93 83.28 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.479 2.712 . . . . 64.540000000000006 110.112 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 p -152.63 104.26 2.87 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.331 -0.856 . . . . 62.43 113.128 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 p -135.58 177.96 7.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.447 1.022 . . . . 14.41 111.218 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -121.81 -61.27 0.22 Allowed Glycine 0 N--CA 1.466 0.699 0 O-C-N 120.764 -1.21 . . . . 64.530000000000001 111.28 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.154 1.781 . . . . 71.319999999999993 107.777 178.852 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 109.662 -1.375 . . . . 75.400000000000006 109.662 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 79.2 m 50.73 71.33 0.43 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.697 1.999 . . . . 75.239999999999995 111.282 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.98 61.34 7.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 118.552 -0.737 . . . . 71.120000000000005 109.788 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -84.45 64.02 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.231 2.62 . . . . 75.329999999999998 110.483 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.21 167.18 14.91 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.717 -1.353 . . . . 75.400000000000006 109.717 -172.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -106.71 147.78 35.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.763 0.825 . . . . 72.439999999999998 110.017 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' HG21 ' A' ' 32' ' ' THR . 85.0 Cg_endo -73.2 134.49 21.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.963 2.442 . . . . 74.099999999999994 108.653 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.12 168.07 28.08 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.872 1.701 . . . . 64.420000000000002 109.328 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.05 165.76 2.11 Favored Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 125.861 1.664 . . . . 42.140000000000001 109.257 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -70.82 142.01 42.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.379 2.052 . . . . 74.200000000000003 109.541 149.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.82 175.48 9.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.123 1.369 . . . . 40.340000000000003 109.774 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.61 25.69 0.27 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.124 2.969 . . . . 75.439999999999998 114.966 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -55.44 143.41 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.829 1.652 . . . . 73.219999999999999 109.691 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -139.48 147.95 42.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.539 1.536 . . . . 75.430000000000007 108.132 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.87 144.21 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.874 -1.899 . . . . 74.230000000000004 105.874 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.1 m -144.79 155.79 43.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.635 1.574 . . . . 72.540000000000006 109.083 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.89 168.07 20.19 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.376 -0.827 . . . . 64.519999999999996 110.376 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.0 m -150.69 165.2 17.92 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.629 1.972 . . . . 54.229999999999997 106.915 170.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 -26.05 24.13 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.578 2.186 . . . . 54.399999999999999 110.702 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.73 -64.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.552 1.141 . . . . 62.039999999999999 109.183 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.73 -145.82 4.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.559 2.028 . . . . 51.439999999999998 108.669 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.04 133.9 55.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.155 0.977 . . . . 40.200000000000003 108.723 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.82 135.57 48.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.709 -1.219 . . . . 72.209999999999994 107.709 166.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mp -142.01 138.01 31.54 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 119.037 0.835 . . . . 75.200000000000003 110.503 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -144.0 153.45 42.25 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.297 -1.001 . . . . 73.400000000000006 108.297 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.32 21.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 74.040000000000006 108.357 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.11 165.8 16.65 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.124 0.97 . . . . 73.099999999999994 110.631 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.25 168.42 17.73 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.715 3.61 . . . . 75.430000000000007 113.625 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.27 175.25 11.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.382 2.721 . . . . 75.109999999999999 111.629 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.6 24.53 4.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.866 1.266 . . . . 75.409999999999997 111.731 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.17 -22.12 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.167 -0.958 . . . . 72.430000000000007 111.528 -158.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 7' ' ' PRO . 13.3 t -166.16 162.39 17.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.162 2.185 . . . . 72.329999999999998 106.239 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -71.35 -68.93 0.41 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.373 1.069 . . . . 71.329999999999998 109.375 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.06 -173.05 10.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.623 -1.391 . . . . 71.040000000000006 109.623 -157.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -132.16 83.94 2.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.378 -1.341 . . . . 72.099999999999994 107.378 163.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.03 150.72 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.123 -1.066 . . . . 62.310000000000002 108.123 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.95 -25.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.788 1.635 . . . . 72.409999999999997 111.192 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 -175.86 3.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.35 1.46 . . . . 75.230000000000004 108.403 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -140.81 169.6 17.32 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.96 1.704 . . . . 72.040000000000006 108.878 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.4 m -152.68 161.16 42.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.439 0.696 . . . . 61.100000000000001 111.337 167.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.59 142.61 39.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.82 1.248 . . . . 63.43 108.672 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -127.0 115.83 19.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.929 2.092 . . . . 75.0 105.833 -171.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -101.03 122.18 43.09 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.673 -1.602 . . . . 75.439999999999998 106.673 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 98' ' ' ARG . . . -77.62 76.81 4.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.088 0.955 . . . . 53.009999999999998 109.801 -177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.25 175.77 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.135 0.974 . . . . 52.520000000000003 111.462 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.18 110.15 7.24 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.061 -1.829 . . . . 71.150000000000006 106.061 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.2 t -168.41 170.06 10.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.784 0.834 . . . . 72.209999999999994 110.145 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 p -152.01 96.47 2.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.879 -1.897 . . . . 63.310000000000002 105.879 160.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -160.73 161.68 32.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.069 1.348 . . . . 70.329999999999998 108.124 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.32 -179.43 0.22 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.102 2.161 . . . . 65.040000000000006 111.791 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -176.49 135.08 0.24 Allowed 'General case' 0 C--O 1.238 0.482 0 N-CA-C 103.428 -2.804 . . . . 74.420000000000002 103.428 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.14 99.32 0.16 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 119.106 0.867 . . . . 32.210000000000001 111.556 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -122.59 163.91 29.78 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 106.475 -1.676 . . . . 71.230000000000004 106.475 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.89 172.65 11.42 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 124.781 3.654 . . . . 72.430000000000007 114.286 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -56.75 -8.1 0.54 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.962 1.705 . . . . 71.340000000000003 114.68 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -58.41 -9.22 1.47 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.734 1.214 . . . . 72.030000000000001 113.296 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m 47.68 64.19 1.71 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.342 1.857 . . . . 54.109999999999999 111.937 163.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.66 144.51 53.24 Favored Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 124.832 1.253 . . . . 73.099999999999994 108.497 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.29 99.7 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.206 2.604 . . . . 75.400000000000006 110.508 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.29 83.21 0.28 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.45 1.1 . . . . 60.509999999999998 109.898 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -89.26 143.34 26.91 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.35 0.66 . . . . 64.120000000000005 110.546 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.98 175.66 6.2 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.296 1.838 . . . . 75.510000000000005 109.883 -174.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.11 119.52 5.99 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.265 1.426 . . . . 61.420000000000002 108.847 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 6.7 m-85 -137.69 169.93 16.93 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.751 0.82 . . . . 73.209999999999994 109.307 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -12.46 25.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 74.0 113.453 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 43.97 75.36 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.523 1.929 . . . . 73.209999999999994 111.531 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.9 m -65.19 -16.01 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.405 1.082 . . . . 55.409999999999997 113.343 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -121.24 117.43 27.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.538 0.735 . . . . 75.109999999999999 109.975 -169.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.3 m -130.82 137.89 49.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.764 -2.31 . . . . 64.230000000000004 104.764 154.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.26 7.94 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.645 1.111 . . . . 72.120000000000005 112.496 170.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.97 -14.86 10.8 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.977 3.118 . . . . 75.0 113.385 -170.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.1 m -111.29 85.83 5.91 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.525 1.13 . . . . 74.420000000000002 109.489 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.6 67.78 3.7 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.541 2.827 . . . . 75.340000000000003 110.646 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -157.13 11.8 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.785 1.234 . . . . 71.129999999999995 111.618 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -89.9 161.76 15.77 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.321 1.049 . . . . 74.030000000000001 113.27 -165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.05 164.46 17.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.538 1.935 . . . . 72.329999999999998 110.393 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.41 125.52 69.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.694 1.598 . . . . 64.430000000000007 107.15 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -66.98 160.79 25.69 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.322 1.049 . . . . 71.340000000000003 111.561 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -55.05 -33.66 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 42.130000000000003 110.391 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -61.06 -12.23 11.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.541 1.536 . . . . 43.140000000000001 113.768 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -118.58 7.85 11.86 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.121 1.368 . . . . 72.0 112.053 171.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.51 -12.91 10.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.366 1.466 . . . . 73.540000000000006 111.733 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.48 -60.95 2.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.873 1.269 . . . . 72.319999999999993 111.5 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -73.29 13.26 0.46 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 118.161 -0.923 . . . . 74.340000000000003 112.085 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.76 165.95 2.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.243 1.383 . . . . 60.119999999999997 110.122 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -124.5 108.38 12.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.972 -1.492 . . . . 74.129999999999995 106.972 166.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 mm -68.82 140.78 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.075 -1.454 . . . . 75.140000000000001 107.075 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -56.85 118.13 4.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.19 0.996 . . . . 75.409999999999997 109.085 169.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.41 31.37 6.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.98 1.312 . . . . 61.32 109.076 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -6.36 5.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.667 1.187 . . . . 71.349999999999994 110.363 -164.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -159.06 -66.25 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.762 2.825 . . . . 72.430000000000007 107.681 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -149.58 151.86 33.97 Favored Pre-proline 0 N--CA 1.463 0.2 0 C-N-CA 125.857 1.663 . . . . 74.340000000000003 109.413 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.21 100.78 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.967 2.445 . . . . 75.140000000000001 109.89 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -145.34 152.32 39.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.349 1.459 . . . . 63.32 110.453 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.3 mt -79.98 124.19 37.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.388 -1.708 . . . . 72.519999999999996 106.388 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 mm -101.52 101.39 12.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.759 -1.2 . . . . 63.520000000000003 107.759 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -79.21 152.62 30.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.156 0.982 . . . . 75.120000000000005 109.292 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HE ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -136.17 124.76 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 104.739 -2.319 . . . . 75.099999999999994 104.739 176.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.69 141.98 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 120.674 1.579 . . . . 75.5 108.149 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.42 155.52 45.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.745 0.702 . . . . 62.130000000000003 111.231 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 125.0 28.75 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.46 1.504 . . . . 51.200000000000003 109.883 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -74.49 101.33 4.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 104.729 -2.323 . . . . 75.430000000000007 104.729 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -115.84 174.62 5.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.431 0.634 . . . . 73.409999999999997 110.751 168.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.08 -23.94 67.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.274 0.842 . . . . 72.0 113.274 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -57.91 6.4 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.205 1.002 . . . . 74.420000000000002 110.653 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 165.5 12.33 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.333 1.921 . . . . 62.409999999999997 109.05 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -64.75 137.78 58.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.168 -1.419 . . . . 61.32 107.168 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.61 -64.15 0.01 OUTLIER Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.377 0.989 . . . . 52.100000000000001 111.907 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.07 71.65 6.18 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.554 2.836 . . . . 73.209999999999994 110.774 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.17 6.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.139 0.576 . . . . 60.32 109.857 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.5 m -81.04 113.12 19.02 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.527 -1.657 . . . . 64.299999999999997 106.527 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.8 151.02 27.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.987 -1.116 . . . . 75.540000000000006 107.987 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 76.2 t -143.72 143.58 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.018 -1.475 . . . . 31.350000000000001 107.018 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.84 154.19 39.98 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.827 0.739 . . . . 71.200000000000003 112.31 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -142.71 112.12 6.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.469 1.108 . . . . 61.119999999999997 109.774 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -88.53 3.05 51.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 128.702 2.801 . . . . 71.140000000000001 112.286 -172.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.27 18.4 16.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.954 1.702 . . . . 71.340000000000003 110.293 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 1.71 8.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.19 0.996 . . . . 64.329999999999998 113.493 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 122.65 10.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.299 1.839 . . . . 74.129999999999995 108.749 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 t -143.65 -49.87 0.31 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.708 -0.187 . . . . 73.150000000000006 111.107 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.97 71.43 10.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.517 -0.549 . . . . 71.519999999999996 109.517 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -139.13 143.8 38.37 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.709 -1.589 . . . . 75.450000000000003 106.709 167.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 m 48.03 36.23 6.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.311 1.044 . . . . 72.450000000000003 112.0 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -7.25 47.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.715 -1.24 . . . . 54.210000000000001 112.573 -168.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.55 -63.37 1.12 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 106.985 -2.446 . . . . 43.439999999999998 106.985 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.257 1.447 0 C-N-CA 128.807 2.843 . . . . 51.310000000000002 104.189 157.921 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 109.04 -1.624 . . . . 51.43 109.04 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 98.7 m -112.93 -25.51 8.96 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.196 1.399 . . . . 65.219999999999999 110.574 154.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 mt 45.23 67.99 3.7 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 127.392 2.277 . . . . 73.209999999999994 111.012 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.16 100.08 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.927 2.418 . . . . 72.129999999999995 108.784 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.51 151.93 26.7 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 125.344 1.45 . . . . 44.240000000000002 110.684 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -124.92 165.5 25.29 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.355 2.262 . . . . 75.310000000000002 108.995 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.18 134.95 32.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.221 1.947 . . . . 40.310000000000002 113.373 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.39 -179.81 53.33 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.367 1.461 . . . . 61.43 112.301 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 174.49 165.12 0.34 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.272 3.029 . . . . 71.409999999999997 110.138 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.34 150.81 81.2 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.624 2.216 . . . . 55.420000000000002 109.666 163.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -137.31 174.89 10.12 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.431 1.092 . . . . 72.439999999999998 110.606 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.99 10.14 4.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.942 2.497 . . . . 71.209999999999994 115.515 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -51.49 111.66 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 125.259 1.424 . . . . 72.319999999999993 113.051 -158.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -86.3 136.46 33.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.534 -1.284 . . . . 62.450000000000003 107.534 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.23 126.33 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.4 -2.074 . . . . 63.030000000000001 105.4 160.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -150.33 173.02 14.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 128.924 2.889 . . . . 62.130000000000003 106.227 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -90.05 159.68 16.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.985 -1.117 . . . . 72.430000000000007 107.985 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -129.56 160.61 63.66 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.559 -1.645 . . . . 71.439999999999998 106.559 157.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -52.65 -45.0 43.29 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 120.91 1.073 . . . . 63.25 109.37 150.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -79.33 26.31 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.59 2.356 . . . . 71.109999999999999 113.604 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.74 -113.32 2.35 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.283 0.944 . . . . 44.310000000000002 111.119 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.59 -160.95 1.09 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.233 1.813 . . . . 35.409999999999997 108.757 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -130.34 33.62 4.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.212 1.405 . . . . 74.030000000000001 112.766 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.69 103.42 1.09 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 127.029 2.132 . . . . 63.039999999999999 113.038 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -138.97 150.59 46.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.431 1.469 . . . . 72.040000000000006 110.424 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.401 ' CE3' HD13 ' A' ' 99' ' ' ILE . 1.1 p90 -139.27 162.62 34.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.382 1.073 . . . . 73.319999999999993 110.426 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.75 154.81 87.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.377 -0.374 . . . . 73.420000000000002 111.347 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.49 168.16 25.46 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.067 3.178 . . . . 53.240000000000002 110.9 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.59 116.13 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.141 2.561 . . . . 73.150000000000006 110.341 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.36 60.31 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.685 2.394 . . . . 73.349999999999994 106.266 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.48 -62.31 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 124.267 1.027 . . . . 73.239999999999995 111.329 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 p -133.38 167.02 21.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.304 -0.872 . . . . 74.209999999999994 110.583 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.7 10.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.316 2.246 . . . . 64.239999999999995 114.022 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.25 149.01 50.26 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.568 -1.413 . . . . 74.040000000000006 109.568 172.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -121.39 92.11 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.473 1.909 . . . . 73.349999999999994 106.517 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -73.73 144.49 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 62.240000000000002 106.589 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 pt -131.08 -13.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.924 1.69 . . . . 63.130000000000003 112.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -168.38 -175.4 2.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.724 2.41 . . . . 74.409999999999997 107.345 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.22 170.36 15.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.061 -1.025 . . . . 73.120000000000005 109.294 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.4 p -146.62 155.18 42.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.852 0.861 . . . . 64.519999999999996 112.898 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.8 t -141.68 137.98 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.466 1.906 . . . . 71.540000000000006 106.706 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -128.49 126.75 41.08 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.907 1.683 . . . . 73.430000000000007 107.052 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.4 tp -119.79 131.58 55.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.821 1.648 . . . . 75.409999999999997 109.911 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.55 135.85 54.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.914 1.234 . . . . 62.240000000000002 110.834 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.1 pt -141.11 -173.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.987 1.315 . . . . 73.099999999999994 111.003 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -106.96 43.4 1.16 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 65.140000000000001 112.503 -168.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.9 m -135.91 -171.25 2.82 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 129.46 3.104 . . . . 73.329999999999998 108.601 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 m -135.59 159.01 42.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.024 -1.047 . . . . 74.129999999999995 110.702 159.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.29 168.76 20.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.157 2.583 . . . . 72.299999999999997 105.793 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.37 165.85 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.827 0.451 . . . . 45.109999999999999 110.981 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.66 110.69 9.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.2 -2.148 . . . . 63.520000000000003 105.2 -176.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.29 110.53 0.47 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 108.21 -1.956 . . . . 73.420000000000002 108.21 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 156.5 81.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.1 0.56 . . . . 73.319999999999993 110.395 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -90.0 61.51 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.279 2.653 . . . . 53.420000000000002 111.167 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 45.79 48.02 11.88 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.969 1.308 . . . . 73.409999999999997 109.476 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 t -79.47 -69.7 0.56 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.698 1.599 . . . . 72.109999999999999 107.077 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -173.41 -43.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.166 0.894 . . . . 65.340000000000003 111.571 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 t -135.98 144.4 48.23 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.258 -1.015 . . . . 71.010000000000005 108.258 -158.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.75 161.25 46.71 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.278 1.986 . . . . 74.140000000000001 110.94 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -161.64 104.52 1.22 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.369 1.468 . . . . 63.109999999999999 108.661 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.93 116.4 18.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 122.1 0.953 . . . . 71.430000000000007 109.668 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.86 153.55 33.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 129.585 3.154 . . . . 64.239999999999995 106.741 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.14 108.4 7.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.703 -1.221 . . . . 61.140000000000001 107.703 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -118.2 -174.69 2.71 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.826 1.65 . . . . 64.230000000000004 108.849 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.4 ttp -121.82 121.72 37.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.892 2.477 . . . . 75.200000000000003 107.275 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 107.177 -1.416 . . . . 74.099999999999994 107.177 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.2 -28.96 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.804 -0.56 . . . . 73.310000000000002 110.67 168.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 73' ' ' PRO . 4.6 t80 -99.93 93.86 5.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.562 -0.711 . . . . 75.310000000000002 109.117 -159.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.3 71.92 0.85 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.991 1.317 . . . . 75.209999999999994 107.657 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.55 168.95 41.58 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.849 -0.9 . . . . 64.540000000000006 110.849 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.41 -55.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.565 2.844 . . . . 64.439999999999998 112.451 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 m -151.29 73.24 8.39 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.368 1.467 . . . . 72.120000000000005 109.763 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 19.4 Cg_endo -65.72 -47.87 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-O 116.237 -1.651 . . . . 75.430000000000007 110.129 155.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.83 76.6 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.395 1.452 . . . . 71.340000000000003 109.451 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.5 t 77.52 83.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 130.051 3.341 . . . . 75.150000000000006 111.586 -166.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 97.1 2.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.777 -1.564 . . . . 51.439999999999998 106.777 145.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' A' ' 82' ' ' LEU . 29.2 t -133.35 106.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 120.739 -1.226 . . . . 71.549999999999997 108.349 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -61.77 142.3 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.885 1.674 . . . . 51.140000000000001 109.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 p -57.78 -26.31 61.74 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.46 0.704 . . . . 72.349999999999994 110.815 171.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -53.6 -15.83 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.484 1.914 . . . . 61.109999999999999 114.115 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -99.23 -49.75 4.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.532 1.06 . . . . 73.230000000000004 109.824 171.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' CD2' HG12 ' A' ' 77' ' ' VAL . 2.4 mm? -63.6 -39.46 94.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.563 1.074 . . . . 63.420000000000002 112.261 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.8 t -56.25 -44.59 79.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.985 1.314 . . . . 75.519999999999996 109.521 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.19 1.43 44.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 75.120000000000005 112.376 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.19 145.96 47.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.779 0.799 . . . . 54.200000000000003 109.534 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -69.47 107.4 3.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.096 -1.816 . . . . 74.409999999999997 106.096 158.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.01 130.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 106.439 -1.689 . . . . 74.409999999999997 106.439 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.49 132.22 53.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.898 1.332 . . . . 71.209999999999994 109.246 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.81 32.2 5.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.675 -1.148 . . . . 73.310000000000002 108.263 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.66 -84.35 0.64 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.638 -1.986 . . . . 71.329999999999998 105.638 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -62.47 -64.34 0.95 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.75 0.82 . . . . 64.129999999999995 110.421 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -155.86 155.65 29.64 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 117.747 -1.121 . . . . 74.030000000000001 110.766 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.44 97.38 0.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.315 2.01 . . . . 54.5 107.949 169.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -155.71 169.99 23.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.704 2.002 . . . . 73.310000000000002 108.594 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.92 115.45 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.197 -1.779 . . . . 64.430000000000007 106.197 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.14 139.61 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.597 -1.26 . . . . 75.310000000000002 107.597 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.08 131.31 50.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.055 1.742 . . . . 53.32 107.811 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -103.32 137.72 41.06 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.193 -1.78 . . . . 74.420000000000002 106.193 155.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.401 HD13 ' CE3' ' A' ' 26' ' ' TRP . 67.0 mt -130.74 137.75 55.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 104.557 -2.386 . . . . 73.030000000000001 104.557 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.4 142.77 23.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.87 0.692 . . . . 75.430000000000007 112.87 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.59 128.35 36.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.433 1.893 . . . . 73.450000000000003 109.573 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.49 95.71 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.343 -1.725 . . . . 62.140000000000001 106.343 173.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -120.84 166.06 14.29 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.079 1.352 . . . . 75.150000000000006 108.297 169.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.24 -35.54 65.08 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.852 0.861 . . . . 53.130000000000003 112.438 -171.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -55.37 -21.08 13.9 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.204 1.187 . . . . 71.019999999999996 114.204 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.49 176.26 32.72 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.498 -1.441 . . . . 62.530000000000001 109.498 -168.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -79.73 55.87 2.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.548 1.166 . . . . 75.349999999999994 109.584 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.32 -64.73 3.65 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.632 1.587 . . . . 75.010000000000005 109.289 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.58 142.1 25.76 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 CA-C-N 118.942 1.371 . . . . 51.43 109.255 172.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.83 147.79 27.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.075 -1.083 . . . . 62.340000000000003 108.075 165.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -78.01 169.73 17.79 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.343 -0.614 . . . . 71.129999999999995 109.343 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.58 2.91 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.409 -1.7 . . . . 64.019999999999996 106.409 169.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.87 161.08 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.008 -1.479 . . . . 52.149999999999999 107.008 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 131.16 22.82 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.034 -1.839 . . . . 73.409999999999997 106.034 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -82.76 82.41 8.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.195 -1.039 . . . . 74.030000000000001 108.195 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 94' ' ' ALA . 12.4 mt -68.67 -16.69 63.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.763 0.71 . . . . 74.239999999999995 112.519 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.2 -17.66 64.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.284 -0.885 . . . . 72.420000000000002 111.269 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -107.15 151.6 25.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.012 1.725 . . . . 74.450000000000003 106.547 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.6 m -162.17 141.39 9.5 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.011 1.324 . . . . 75.349999999999994 107.509 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 t -64.08 152.21 41.01 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.923 -0.399 . . . . 73.120000000000005 109.923 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -149.61 162.22 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.144 2.178 . . . . 75.450000000000003 106.087 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 53.58 33.07 15.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.65 1.58 . . . . 73.129999999999995 113.576 158.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 t -56.44 156.63 5.81 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.494 1.918 . . . . 52.140000000000001 112.517 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.61 -154.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.172 1.389 . . . . 54.240000000000002 109.512 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.84 -120.63 0.63 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.067 -1.213 . . . . 34.549999999999997 110.067 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.243 0.713 0 C-N-CA 127.853 2.461 . . . . 65.329999999999998 106.68 174.064 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.446 0 N-CA-C 110.64 -0.984 . . . . 61.420000000000002 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.18 164.54 6.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.256 1.422 . . . . 52.299999999999997 111.217 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.74 161.2 32.21 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 127.164 2.186 . . . . 71.430000000000007 106.633 170.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.11 173.8 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.291 1.994 . . . . 72.030000000000001 113.158 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.57 147.1 0.98 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.975 1.75 . . . . 61.439999999999998 111.008 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.72 85.77 49.53 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 107.3 -1.37 . . . . 74.019999999999996 107.3 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.39 6.92 1.01 Allowed 'Trans proline' 0 CA--C 1.545 1.035 1 C-N-CA 126.734 4.956 . . . . 50.25 114.464 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.87 -114.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.525 0 O-C-N 120.802 -1.186 . . . . 30.030000000000001 111.694 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 109' ' ' PRO . . . 75.27 164.79 0.14 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.121 2.968 . . . . 72.310000000000002 111.404 -163.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.36 159.75 11.12 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 124.06 3.173 . . . . 70.340000000000003 110.804 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -136.45 -173.93 3.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.378 1.071 . . . . 70.239999999999995 110.233 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 33.43 3.49 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.929 2.492 . . . . 62.039999999999999 115.151 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.03 139.36 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.385 0.674 . . . . 65.129999999999995 109.924 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -124.04 140.13 53.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 125.545 1.538 . . . . 73.329999999999998 107.79 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.6 mt -147.3 134.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.83 -1.915 . . . . 74.409999999999997 105.83 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.04 163.29 40.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 74.310000000000002 108.237 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -81.97 164.1 21.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.144 0.884 . . . . 72.409999999999997 109.074 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -138.92 165.54 31.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.774 2.029 . . . . 44.32 106.897 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -64.25 -28.57 64.06 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.695 1.597 . . . . 72.310000000000002 111.631 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.52 17.92 11.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.64 1.576 . . . . 73.109999999999999 111.268 -163.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.38 -141.94 9.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.47 -1.452 . . . . 53.450000000000003 109.47 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.75 163.07 30.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.801 1.301 . . . . 42.350000000000001 111.416 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.02 134.76 34.24 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.253 1.821 . . . . 73.109999999999999 108.219 168.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 114.86 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.435 1.494 . . . . 54.539999999999999 110.152 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.1 p -135.33 168.81 18.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.654 0.661 . . . . 74.329999999999998 110.953 166.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -148.21 169.47 20.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 130.171 3.388 . . . . 74.209999999999994 107.048 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.04 151.72 42.65 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 123.999 0.92 . . . . 71.409999999999997 109.097 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.74 164.61 33.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.802 2.335 . . . . 64.209999999999994 111.245 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.88 139.83 90.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.888 3.059 . . . . 62.420000000000002 112.679 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.6 t -135.26 16.14 3.46 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.925 . . . . 61.32 113.173 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.91 -45.04 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.236 1.014 . . . . 54.420000000000002 110.345 -171.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 p -144.89 174.16 11.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.963 0.905 . . . . 63.350000000000001 109.689 168.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -50.4 -56.24 12.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.396 1.878 . . . . 42.520000000000003 114.019 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.97 176.76 5.53 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.298 1.904 . . . . 63.229999999999997 112.828 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -139.05 93.43 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.606 0.762 . . . . 51.340000000000003 109.222 158.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.46 150.95 3.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.264 -1.013 . . . . 74.150000000000006 108.264 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.7 -34.64 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.75 1.22 . . . . 64.219999999999999 111.644 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -160.43 -179.27 7.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.725 -1.213 . . . . 64.420000000000002 107.725 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -136.32 165.48 25.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.306 0.957 . . . . 65.349999999999994 110.413 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 t -145.75 153.57 41.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.041 0.936 . . . . 71.420000000000002 109.368 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.54 147.9 31.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.767 1.627 . . . . 71.129999999999995 107.305 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -133.0 145.53 50.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.275 -1.379 . . . . 72.319999999999993 107.275 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD21 ' CG2' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -126.28 134.58 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.713 -1.218 . . . . 62.119999999999997 107.713 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.09 131.24 49.91 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.75 -1.119 . . . . 63.240000000000002 109.71 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 pt -144.31 -174.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.751 -1.203 . . . . 45.030000000000001 107.751 168.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -69.74 13.92 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.256 1.823 . . . . 71.209999999999994 115.535 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.2 111.46 9.07 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 125.475 1.51 . . . . 73.319999999999993 111.559 -165.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -103.24 114.61 29.03 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.973 1.309 . . . . 74.510000000000005 111.396 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -144.89 158.07 43.93 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.491 1.117 . . . . 73.239999999999995 108.243 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.9 175.18 10.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.136 2.174 . . . . 74.230000000000004 109.161 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 t -120.96 -10.55 9.06 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.247 1.819 . . . . 44.200000000000003 111.785 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.49 104.01 1.37 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 108.699 -1.761 . . . . 53.200000000000003 108.699 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 4.5 mm-40 -54.53 162.37 1.73 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.997 1.719 . . . . 71.010000000000005 114.921 -168.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 53' ' ' GLU . 94.6 Cg_endo -70.75 77.8 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.525 1 C-N-CA 127.042 5.161 . . . . 52.5 111.627 177.214 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? 50.15 38.76 17.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.843 1.257 . . . . 72.319999999999993 110.924 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -90.71 -3.71 57.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.098 0.863 . . . . 64.430000000000007 111.815 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.42 51.0 6.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.967 2.107 . . . . 72.200000000000003 112.145 -170.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 p 43.65 53.89 10.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.842 1.657 . . . . 70.409999999999997 112.776 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.28 87.84 1.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.5 2.133 . . . . 63.009999999999998 110.347 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 73.72 115.22 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.268 2.227 . . . . 64.219999999999999 110.029 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.74 162.94 7.92 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.978 -0.749 . . . . 73.140000000000001 108.978 163.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -145.66 168.77 19.89 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.021 -1.049 . . . . 70.030000000000001 112.399 -162.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' SER . . . -129.34 77.53 1.79 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.61 0.764 . . . . 70.310000000000002 111.488 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 6.5 m-85 -139.59 129.97 25.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.998 0.919 . . . . 74.310000000000002 109.134 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.8 ttp -76.76 151.08 36.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.844 1.258 . . . . 54.030000000000001 109.523 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -79.62 71.39 6.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 71.340000000000003 112.784 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.56 -32.03 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 118.763 -0.636 . . . . 71.519999999999996 112.63 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -58.92 122.64 14.16 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.34 0.973 . . . . 74.540000000000006 110.545 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.9 t -157.18 40.7 0.31 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.676 0.79 . . . . 73.420000000000002 110.142 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.33 168.6 32.61 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 119.268 0.94 . . . . 54.140000000000001 112.029 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.75 -21.39 6.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.734 2.956 . . . . 71.329999999999998 115.438 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 m -82.9 143.47 46.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.315 -0.994 . . . . 73.430000000000007 108.315 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.55 -41.52 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.431 1.42 . . . . 72.319999999999993 109.563 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.9 m -74.7 79.65 2.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.564 -1.272 . . . . 51.039999999999999 107.564 161.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.08 171.76 11.33 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.671 -0.643 . . . . 73.120000000000005 110.011 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.13 178.45 6.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.767 0.827 . . . . 74.409999999999997 110.583 167.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.5 t -138.83 146.7 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.952 1.701 . . . . 70.219999999999999 108.247 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.41 165.41 14.95 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 129.088 2.955 . . . . 73.439999999999998 112.93 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -44.98 -47.38 11.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.093 1.357 . . . . 70.129999999999995 111.966 162.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.1 m -56.5 -50.67 71.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.144 0.884 . . . . 72.219999999999999 112.255 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -71.89 -33.88 68.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.539 0.736 . . . . 25.140000000000001 110.561 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.68 -39.8 92.7 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.02 0.928 . . . . 64.219999999999999 111.743 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 m -71.66 3.69 3.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 0.817 . . . . 70.340000000000003 113.114 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -117.76 -1.93 11.47 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.975 1.31 . . . . 73.25 111.288 166.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.63 118.57 13.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.205 0.911 . . . . 70.450000000000003 108.735 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.12 140.65 56.2 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.542 -0.54 . . . . 74.099999999999994 109.542 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.05 138.78 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.859 -0.793 . . . . 70.049999999999997 108.859 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.0 133.11 49.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.588 0.755 . . . . 65.230000000000004 109.185 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.51 3.48 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.282 1.033 . . . . 72.239999999999995 112.0 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.2 m -65.46 -31.44 72.53 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.496 1.043 . . . . 71.230000000000004 109.589 167.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.86 -69.31 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.825 -0.547 . . . . 65.239999999999995 111.38 -162.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.59 ' HE3' HD22 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -141.95 145.89 38.21 Favored Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 118.054 -0.974 . . . . 53.32 109.109 -173.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.49 97.47 0.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.343 2.029 . . . . 73.129999999999995 108.437 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.491 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -148.22 162.87 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.24 2.616 . . . . 74.140000000000001 107.766 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CG2' HD21 ' A' ' 43' ' ' LEU . 64.7 mt -105.02 136.11 40.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.861 -1.163 . . . . 74.010000000000005 107.861 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.13 125.75 53.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.147 0.979 . . . . 74.019999999999996 110.665 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.423 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 95.9 m-85 -109.42 159.95 16.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.672 1.189 . . . . 72.450000000000003 109.775 170.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.0 126.95 44.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.188 -2.152 . . . . 64.209999999999994 105.188 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.9 mt -120.54 142.53 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.69 -1.596 . . . . 63.25 106.69 171.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 153.31 38.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.435 0.561 . . . . 74.030000000000001 111.56 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.47 131.8 40.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.898 1.279 . . . . 53.43 108.869 163.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -77.83 111.53 13.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.995 -1.854 . . . . 71.439999999999998 105.995 157.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -119.48 175.43 5.84 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.427 0.691 . . . . 73.319999999999993 111.027 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.27 -45.99 92.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.428 0.691 . . . . 74.409999999999997 112.295 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -61.84 -27.64 68.92 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.362 0.983 . . . . 74.420000000000002 110.627 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.63 -167.9 29.22 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.375 -1.49 . . . . 65.120000000000005 109.375 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.51 12.03 0.11 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.194 1.924 . . . . 52.130000000000003 116.194 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.4 -160.82 0.57 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.817 2.151 . . . . 44.310000000000002 112.11 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.521 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 24.2 Cg_endo -75.2 178.55 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.542 2.161 . . . . 73.439999999999998 109.074 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.42 128.63 48.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.334 -0.987 . . . . 62.25 108.334 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.402 ' OG1' ' HB1' ' A' ' 9' ' ' ALA . 97.2 m -76.08 105.47 7.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.773 -1.195 . . . . 74.340000000000003 107.773 169.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.56 118.21 9.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.344 -1.724 . . . . 72.010000000000005 106.344 161.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 97' ' ' PHE . 34.9 m -116.54 160.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 O-C-N 121.167 -0.958 . . . . 53.130000000000003 109.165 166.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.77 129.81 52.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.961 0.905 . . . . 71.450000000000003 109.215 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -85.37 85.45 7.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.396 -0.964 . . . . 63.140000000000001 108.396 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.59 HD22 ' HE3' ' A' ' 92' ' ' LYS . 66.1 mt -66.06 165.66 13.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.036 -0.727 . . . . 73.049999999999997 109.036 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 75.81 10.92 3.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.278 2.231 . . . . 50.539999999999999 113.497 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -57.72 166.79 1.27 Allowed 'General case' 0 C--O 1.246 0.877 0 N-CA-C 113.431 0.9 . . . . 52.549999999999997 113.431 161.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.365 2.8 t -150.25 143.81 25.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.273 1.029 . . . . 71.450000000000003 110.928 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.8 t -53.37 -61.67 2.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.262 1.825 . . . . 71.230000000000004 107.81 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 51.5 42.32 29.3 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.369 1.068 . . . . 63.25 111.07 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.04 112.53 1.72 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.388 2.275 . . . . 64.349999999999994 108.027 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.8 p -164.57 174.05 11.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.161 0.984 . . . . 64.120000000000005 109.813 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -126.58 -67.81 0.84 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 107.548 -1.278 . . . . 71.420000000000002 107.548 169.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.36 -155.45 16.32 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.834 -1.306 . . . . 23.23 109.834 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--O 1.25 1.114 0 N-CA-C 104.656 -2.35 . . . . 74.239999999999995 104.656 -178.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 CA-C-O 118.333 -1.26 . . . . 53.219999999999999 110.476 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 82.9 m 56.5 89.37 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 75.239999999999995 111.524 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -59.51 165.16 4.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.069 0.948 . . . . 75.340000000000003 111.675 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.62 87.71 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.324 2.682 . . . . 73.400000000000006 110.873 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.18 154.24 7.41 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.059 1.79 . . . . 74.209999999999994 110.006 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.05 146.58 33.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.395 0.678 . . . . 72.329999999999998 109.212 171.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.13 168.12 22.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.84 2.36 . . . . 62.340000000000003 110.313 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.52 -132.64 11.27 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.703 -1.759 . . . . 71.0 108.703 -170.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.11 156.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.321 2.648 . . . . 74.109999999999999 111.841 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -68.97 159.23 54.77 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.894 1.729 . . . . 64.319999999999993 108.955 167.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.98 174.21 10.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.57 0.7 . . . . 53.140000000000001 109.853 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 50.3 27.28 2.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.094 2.157 . . . . 71.109999999999999 114.899 168.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -56.96 137.97 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.28 . . . . 72.400000000000006 108.699 -171.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -135.85 141.4 44.64 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.492 -1.299 . . . . 53.520000000000003 107.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mt -142.92 110.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.111 -1.07 . . . . 63.030000000000001 108.111 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -106.93 145.3 32.39 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.812 0.845 . . . . 74.219999999999999 109.831 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -82.53 158.86 22.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.38 0.672 . . . . 74.319999999999993 109.925 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -143.45 163.42 36.89 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.449 2.299 . . . . 74.400000000000006 109.545 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.97 -13.9 42.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.763 2.975 . . . . 63.140000000000001 113.684 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 2.47 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.411 2.284 . . . . 75.319999999999993 111.36 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.86 -127.29 2.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.223 0.92 . . . . 64.030000000000001 112.889 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.09 127.67 17.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.721 1.208 . . . . 62.439999999999998 108.418 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -70.17 98.62 1.37 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.52 1.528 . . . . 75.0 108.643 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.99 116.47 23.4 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.457 -1.312 . . . . 71.400000000000006 107.457 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 p -136.95 160.24 39.48 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.716 -0.615 . . . . 73.439999999999998 109.813 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 -178.41 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.192 0.597 . . . . 75.329999999999998 110.137 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 51.8 mt-10 -133.69 158.65 75.02 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 108.917 -0.771 . . . . 75.209999999999994 108.917 165.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.59 160.64 42.22 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.508 1.472 . . . . 71.430000000000007 109.525 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.58 170.93 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.308 1.339 . . . . 74.129999999999995 111.427 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 t -141.67 70.57 1.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 105.091 -2.189 . . . . 71.040000000000006 105.091 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.84 -65.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.124 0.97 . . . . 73.140000000000001 110.251 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -135.09 -173.11 3.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.564 1.074 . . . . 53.439999999999998 110.302 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -26.06 67.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.833 1.79 . . . . 63.009999999999998 115.833 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.36 94.67 0.01 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.721 2.105 . . . . 43.329999999999998 115.991 167.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -82.23 64.93 7.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.685 1.194 . . . . 71.099999999999994 111.621 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.57 147.43 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.58 -0.896 . . . . 73.040000000000006 108.58 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.33 -15.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.312 2.245 . . . . 22.039999999999999 112.1 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.19 178.06 10.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.764 1.626 . . . . 72.400000000000006 107.019 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.05 168.12 19.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.63 -1.248 . . . . 74.219999999999999 107.63 165.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 42' ' ' TYR . 56.0 m -134.43 141.45 46.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.568 -0.901 . . . . 73.0 108.568 164.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.5 t -136.61 116.98 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.363 -2.458 . . . . 75.200000000000003 104.363 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.479 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 11.2 m-85 -120.63 127.38 52.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.267 -1.012 . . . . 60.329999999999998 108.267 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -115.28 129.37 56.6 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 105.555 -2.017 . . . . 74.340000000000003 105.555 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.32 145.63 33.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 124.021 0.825 . . . . 74.219999999999999 109.367 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -145.23 -179.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.169 1.788 . . . . 64.409999999999997 107.903 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -71.8 76.3 0.87 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.063 0.545 . . . . 73.109999999999999 111.958 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.5 p -158.72 -157.94 0.66 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.17 -0.956 . . . . 71.439999999999998 110.252 164.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 58.5 m -140.99 5.34 1.92 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.58 1.952 . . . . 52.409999999999997 113.509 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -62.89 152.1 37.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.935 0.894 . . . . 75.319999999999993 110.071 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.52 32.08 4.55 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.878 2.071 . . . . 74.310000000000002 114.219 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.5 t -73.89 85.61 1.74 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.104 1.761 . . . . 72.319999999999993 108.666 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.88 115.26 0.32 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.432 -0.667 . . . . 74.219999999999999 111.432 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 12.8 pt-20 -138.86 164.15 41.5 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.028 1.331 . . . . 71.310000000000002 108.732 173.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 53' ' ' GLU . 93.2 Cg_endo -73.96 -164.49 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.272 3.315 . . . . 75.129999999999995 112.346 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tttm 66.68 12.59 8.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.68 1.592 . . . . 61.039999999999999 111.455 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 m 44.92 44.99 8.39 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.18 1.392 . . . . 55.43 111.415 -165.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -110.98 37.74 2.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.849 0.859 . . . . 73.420000000000002 112.631 -170.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.1 p -100.69 85.12 0.52 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.745 1.618 . . . . 72.409999999999997 109.802 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.31 122.87 9.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.001 2.467 . . . . 55.43 110.06 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.44 43.05 5.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.54 1.936 . . . . 54.439999999999998 113.405 161.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.301 10.6 pt20 43.85 74.57 0.12 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.826 2.05 . . . . 72.219999999999999 112.19 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -44.52 162.59 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.785 -1.552 . . . . 74.409999999999997 111.336 153.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 48' ' ' SER . . . -147.63 148.3 30.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.759 -1.941 . . . . 62.140000000000001 105.759 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 23.0 m-85 -143.32 151.14 40.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.691 0.678 . . . . 72.430000000000007 110.67 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -112.22 4.95 18.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.6 1.16 . . . . 74.319999999999993 113.506 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 49.93 78.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.842 1.657 . . . . 73.0 111.317 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.0 m -77.28 -5.82 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 73.400000000000006 112.751 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -56.24 112.69 1.3 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.974 1.31 . . . . 74.420000000000002 110.103 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.78 31.41 0.22 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.345 1.458 . . . . 75.420000000000002 110.164 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -125.75 75.01 0.41 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.765 1.174 . . . . 74.209999999999994 111.29 -170.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -67.33 -17.5 49.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.144 1.896 . . . . 61.340000000000003 111.721 165.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -56.58 144.35 64.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.87 1.268 . . . . 61.310000000000002 109.515 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.79 -21.02 38.92 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.976 1.784 . . . . 43.210000000000001 111.85 -174.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.63 145.85 33.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 128.461 2.704 . . . . 63.32 104.183 163.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -137.7 154.07 49.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.626 1.103 . . . . 72.200000000000003 110.242 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.07 163.91 27.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.585 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.6 t -139.33 128.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 104.383 -2.451 . . . . 73.430000000000007 104.383 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.77 139.2 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.944 0.778 . . . . 62.310000000000002 109.502 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -30.27 63.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.843 1.657 . . . . 75.340000000000003 111.779 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.4 p -59.18 -14.61 11.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 55.399999999999999 113.595 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 t -88.07 -48.14 7.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.026 0.83 . . . . 64.140000000000001 108.947 168.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.38 -31.71 72.97 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.009 0.822 . . . . 63.119999999999997 112.151 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -44.89 -59.96 2.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.117 2.167 . . . . 62.020000000000003 108.386 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.35 0.29 37.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 62.439999999999998 111.929 -165.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 153.07 44.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.768 0.827 . . . . 72.430000000000007 110.884 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 132.5 36.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.093 -1.077 . . . . 75.0 108.093 165.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -84.06 145.44 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.431 1.092 . . . . 75.120000000000005 108.055 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -70.54 132.28 45.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.829 0.852 . . . . 73.340000000000003 109.181 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.55 23.72 11.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 75.340000000000003 109.995 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.53 -38.06 2.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.553 1.541 . . . . 53.100000000000001 111.892 -162.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -136.82 -52.89 0.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.447 1.099 . . . . 72.340000000000003 112.462 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -148.02 150.51 35.67 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 120.452 1.478 . . . . 71.239999999999995 110.84 158.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.51 95.93 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.816 3.01 . . . . 73.109999999999999 109.795 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -155.48 166.39 33.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.054 1.742 . . . . 61.039999999999999 110.6 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.1 mt -86.25 118.98 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.841 1.257 . . . . 63.329999999999998 107.735 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.56 145.76 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.52 -0.918 . . . . 73.040000000000006 108.52 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -131.92 125.45 31.7 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.682 -1.599 . . . . 63.329999999999998 106.682 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.85 126.36 32.88 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.901 -1.888 . . . . 73.200000000000003 105.901 164.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 mt -133.22 136.02 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.557 -1.646 . . . . 64.299999999999997 106.557 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 158.58 44.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.681 1.192 . . . . 75.319999999999993 108.709 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.82 101.38 9.23 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.814 1.246 . . . . 74.109999999999999 107.818 -171.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.23 111.03 1.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.958 1.703 . . . . 64.299999999999997 107.925 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -136.19 179.11 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.809 1.643 . . . . 44.140000000000001 111.378 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.89 -33.11 10.08 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.833 1.653 . . . . 63.119999999999997 114.002 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -60.75 -55.31 34.69 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.379 0.991 . . . . 73.319999999999993 111.247 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.68 174.55 19.32 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.131 -0.788 . . . . 64.400000000000006 111.131 -162.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -73.26 81.84 1.35 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.882 1.273 . . . . 75.239999999999995 109.639 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.08 -63.94 0.87 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.263 -1.299 . . . . 41.520000000000003 111.522 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.39 155.96 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.158 2.572 . . . . 32.240000000000002 109.131 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.58 103.19 1.21 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.96 -0.756 . . . . 63.109999999999999 108.96 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -71.82 146.81 47.77 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.459 -0.571 . . . . 73.040000000000006 109.459 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.86 83.67 1.8 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.234 1.013 . . . . 74.239999999999995 108.351 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.14 152.52 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.004 -1.48 . . . . 51.539999999999999 107.004 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.74 50.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.44 1.496 . . . . 75.319999999999993 108.284 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -136.61 111.58 8.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 75.040000000000006 110.113 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.642 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -86.29 -177.55 6.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.711 2.004 . . . . 72.129999999999995 110.687 -166.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 76.46 -2.67 2.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.025 2.53 . . . . 64.019999999999996 113.572 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.58 90.59 1.78 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.111 0.964 . . . . 75.420000000000002 110.063 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.3 p -140.77 94.08 2.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.907 1.283 . . . . 54.420000000000002 108.787 167.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.5 m -75.12 77.89 2.27 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.246 -0.909 . . . . 60.140000000000001 109.3 164.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -144.91 69.79 1.26 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.065 -0.717 . . . . 63.130000000000003 109.065 166.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t0 61.2 177.93 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.858 1.263 . . . . 71.340000000000003 111.401 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 t 65.24 122.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.38 1.872 . . . . 72.409999999999997 108.748 -155.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.9 p -147.89 162.51 39.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.227 -1.027 . . . . 44.439999999999998 108.227 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.84 165.14 52.23 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.001 -0.439 . . . . 35.149999999999999 112.001 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.312 -1.328 . . . . 62.020000000000003 110.813 161.78 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.692 0 N-CA-C 110.673 -0.971 . . . . 73.040000000000006 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 t -142.89 169.15 18.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.774 1.23 . . . . 70.140000000000001 108.63 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.26 73.22 1.02 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.249 2.22 . . . . 63.240000000000002 112.197 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.75 135.33 27.84 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 62.020000000000003 109.709 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.88 -112.48 3.19 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.622 1.106 . . . . 41.130000000000003 111.171 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.07 165.34 18.61 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 127.223 2.209 . . . . 73.340000000000003 108.408 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.68 7.39 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.073 1 C-N-CA 126.309 4.673 . . . . 72.430000000000007 115.463 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.37 -147.06 13.15 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.241 -1.537 . . . . 53.5 111.294 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.54 80.85 0.27 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.697 1.999 . . . . 61.439999999999998 112.881 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.88 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.165 . . . . 63.020000000000003 110.181 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.0 m -132.25 -177.45 4.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.189 1.396 . . . . 73.319999999999993 109.678 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.34 11.74 2.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.716 2.006 . . . . 72.010000000000005 114.688 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -56.95 131.98 20.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.665 1.586 . . . . 53.310000000000002 110.846 -166.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.73 163.74 22.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.352 1.061 . . . . 51.409999999999997 110.408 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.45 HG23 ' CD2' ' A' ' 24' ' ' LEU . 4.2 mp -140.13 158.1 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.851 2.06 . . . . 54.539999999999999 106.459 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -144.44 133.91 23.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.236 2.214 . . . . 74.329999999999998 107.353 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -64.81 151.65 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.622 -0.881 . . . . 62.140000000000001 108.622 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.56 157.51 44.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 126.518 1.927 . . . . 52.439999999999998 106.001 176.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.24 -20.12 32.97 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.422 2.081 . . . . 70.310000000000002 111.639 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -114.93 13.47 17.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.0 2.92 . . . . 74.219999999999999 111.317 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.66 -163.54 30.02 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 118.878 0.763 . . . . 51.329999999999998 112.164 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.91 121.18 40.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 120.017 1.909 . . . . 71.329999999999998 106.562 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -58.62 124.47 19.77 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.385 -1.339 . . . . 72.329999999999998 107.385 165.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 15' ' ' ILE . 11.8 mt -120.56 160.79 22.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.321 0.964 . . . . 74.230000000000004 109.08 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -155.47 165.2 37.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.85 0.75 . . . . 73.340000000000003 110.078 166.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.516 ' CE3' HD13 ' A' ' 99' ' ' ILE . 0.5 OUTLIER -151.43 172.35 16.1 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 129.138 2.975 . . . . 72.420000000000002 108.236 177.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -129.3 161.74 56.77 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 124.454 1.102 . . . . 73.319999999999993 111.347 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.19 161.91 38.18 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.605 2.87 . . . . 70.420000000000002 113.392 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.39 143.11 51.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.35 2.033 . . . . 72.430000000000007 110.225 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -133.5 61.81 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.252 -1.758 . . . . 61.200000000000003 106.252 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -133.29 -68.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.678 -1.23 . . . . 73.439999999999998 107.678 174.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 31' ' ' VAL . 64.6 p -130.22 170.92 13.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.605 1.562 . . . . 62.200000000000003 107.622 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -65.01 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.433 1.093 . . . . 71.420000000000002 110.414 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 144.48 2.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.665 -1.272 . . . . 71.400000000000006 112.18 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -100.47 83.17 2.57 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.776 -0.838 . . . . 74.319999999999993 108.747 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.85 143.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.635 -1.246 . . . . 62.030000000000001 107.635 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.87 -23.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.331 1.452 . . . . 74.230000000000004 111.367 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.66 -170.16 3.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.547 1.067 . . . . 65.030000000000001 109.95 171.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.23 175.28 9.25 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.051 1.34 . . . . 74.209999999999994 109.383 163.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -152.36 156.61 39.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.11 1.364 . . . . 64.230000000000004 109.434 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.4 t -148.0 121.61 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.949 -1.871 . . . . 44.509999999999998 105.949 -167.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -131.03 140.6 50.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.003 1.321 . . . . 74.400000000000006 109.273 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 125.98 46.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.424 -1.324 . . . . 65.010000000000005 107.424 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 116.82 15.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.581 1.552 . . . . 44.109999999999999 110.175 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.05 -176.61 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.819 2.048 . . . . 63.119999999999997 108.88 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -60.55 153.12 24.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.87 -0.519 . . . . 54.229999999999997 112.145 171.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.9 m 54.59 74.19 0.36 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.314 1.446 . . . . 73.129999999999995 112.617 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -143.03 148.7 37.17 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.773 1.629 . . . . 53.299999999999997 107.138 162.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.73 6.93 13.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.098 0.959 . . . . 72.299999999999997 113.203 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.82 160.51 35.41 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.553 1.141 . . . . 43.299999999999997 110.361 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m 177.78 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.893 2.077 . . . . 62.109999999999999 109.975 172.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.95 -120.95 0.54 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.24 -1.544 . . . . 71.010000000000005 109.24 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 35.1 mt-10 -140.81 162.02 50.98 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.976 1.388 . . . . 71.310000000000002 110.843 172.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 53' ' ' GLU . 54.0 Cg_endo -65.02 127.23 18.02 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.839 3.693 . . . . 71.239999999999995 110.313 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 mttp 59.95 19.72 8.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.377 . . . . 65.420000000000002 113.261 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -97.28 -86.62 0.33 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.732 1.151 . . . . 50.439999999999998 109.158 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.9 m -135.67 15.89 3.37 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.719 1.599 . . . . 73.310000000000002 112.639 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -127.83 59.84 41.71 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.201 -0.937 . . . . 74.019999999999996 109.52 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.2 87.15 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.842 1.695 . . . . 65.329999999999998 109.488 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.71 14.77 0.23 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.91 1.078 . . . . 62.409999999999997 113.91 162.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 57.9 179.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.717 2.007 . . . . 74.409999999999997 111.862 -155.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 165.77 20.56 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 125.388 1.475 . . . . 52.32 107.48 -169.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.1 112.63 13.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.52 -0.919 . . . . 72.140000000000001 108.52 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.19 150.08 40.56 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.595 1.158 . . . . 70.209999999999994 108.391 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.51 4.9 6.64 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.109 1.522 . . . . 73.030000000000001 115.109 -167.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 43.96 55.39 5.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.464 1.906 . . . . 64.239999999999995 113.172 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.76 -20.9 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.862 1.265 . . . . 74.430000000000007 112.671 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -58.76 120.17 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.022 0.828 . . . . 73.129999999999995 110.596 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -152.24 83.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.385 1.874 . . . . 63.0 105.969 161.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.91 159.85 28.26 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.252 -0.749 . . . . 73.010000000000005 111.474 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.11 -55.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 73.099999999999994 111.227 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.54 166.59 14.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.159 2.184 . . . . 70.230000000000004 110.509 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.46 169.05 23.23 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.807 1.671 . . . . 70.439999999999998 110.848 168.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 39.11 9.23 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.633 1.573 . . . . 72.430000000000007 112.145 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.2 m -85.5 175.71 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.337 1.065 . . . . 62.340000000000003 110.95 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 168.09 16.91 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.625 1.57 . . . . 74.310000000000002 109.333 165.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.1 p -130.64 144.2 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.236 1.414 . . . . 62.310000000000002 107.628 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -66.42 147.79 52.8 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.165 0.586 . . . . 50.140000000000001 112.285 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -48.47 81.09 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.962 1.705 . . . . 64.120000000000005 110.06 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.0 p -44.91 -48.58 11.25 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.573 1.949 . . . . 52.140000000000001 111.573 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.4 m -67.62 -42.16 82.81 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.343 -0.844 . . . . 73.010000000000005 111.214 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.49 -31.46 72.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.168 0.987 . . . . 73.310000000000002 111.407 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -64.39 -0.73 1.39 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.597 1.559 . . . . 70.329999999999998 114.283 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -120.62 -6.23 9.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.274 1.397 . . . . 70.420000000000002 111.679 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.47 137.75 57.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.788 1.235 . . . . 71.340000000000003 111.59 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 161.1 30.39 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.647 -0.872 . . . . 70.439999999999998 108.647 168.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.56 143.52 35.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.238 1.015 . . . . 70.120000000000005 108.447 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.98 82.45 0.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.768 1.627 . . . . 73.209999999999994 111.365 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.68 -18.35 61.56 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.637 -1.29 . . . . 51.149999999999999 111.21 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -17.81 64.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.224 1.41 . . . . 64.420000000000002 113.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.68 -75.02 0.17 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.433 1.015 . . . . 73.5 110.56 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.25 144.3 27.84 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 117.81 -1.091 . . . . 65.420000000000002 108.395 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 100.35 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.907 1.738 . . . . 74.209999999999994 109.8 -170.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 157.71 44.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.349 1.86 . . . . 32.350000000000001 109.085 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.1 mt -88.38 132.07 34.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.5 1.12 . . . . 73.0 109.168 169.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.6 136.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.777 1.275 . . . . 62.229999999999997 110.388 165.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -119.28 116.71 26.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 112.715 -2.039 . . . . 71.200000000000003 107.568 165.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -81.21 128.79 34.17 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 106.368 -1.716 . . . . 74.219999999999999 106.368 162.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.516 HD13 ' CE3' ' A' ' 26' ' ' TRP . 16.4 mt -133.62 151.7 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.684 -1.969 . . . . 65.310000000000002 105.684 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.49 151.91 25.0 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.522 0.729 . . . . 62.310000000000002 109.721 165.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.44 117.26 13.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.602 1.161 . . . . 62.210000000000001 109.97 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.95 99.8 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.643 -1.614 . . . . 73.310000000000002 106.643 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.99 172.98 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.688 1.595 . . . . 73.420000000000002 109.595 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -25.99 63.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.474 1.287 . . . . 62.439999999999998 114.474 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.55 25.45 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.541 -0.911 . . . . 70.010000000000005 108.541 174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.36 167.04 12.89 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.913 -0.875 . . . . 45.310000000000002 110.913 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -61.6 117.94 6.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 74.019999999999996 106.477 160.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.21 -95.88 2.4 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.455 -1.858 . . . . 22.140000000000001 108.455 173.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.91 147.75 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.271 1.981 . . . . 64.040000000000006 110.673 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.05 110.48 10.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.601 1.56 . . . . 53.340000000000003 108.635 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 m -65.03 123.79 20.39 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.358 -0.978 . . . . 74.140000000000001 108.358 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -97.45 89.44 4.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.985 -1.487 . . . . 65.340000000000003 106.985 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.87 171.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 120.633 -0.427 . . . . 71.109999999999999 110.168 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.39 123.86 19.52 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.504 1.121 . . . . 71.319999999999993 108.161 172.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -82.48 87.91 6.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.847 1.259 . . . . 72.120000000000005 109.106 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.2 mt -73.93 0.87 12.1 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.319 1.229 . . . . 72.439999999999998 114.319 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -115.12 38.4 3.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.423 1.01 . . . . 71.219999999999999 108.765 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 107.31 0.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.612 -1.625 . . . . 50.539999999999999 106.612 164.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.5 p -131.68 145.63 51.75 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.715 -0.846 . . . . 63.240000000000002 108.715 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 t 56.38 -177.43 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.477 1.111 . . . . 74.5 111.763 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -148.87 8.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 120.974 -1.078 . . . . 74.019999999999996 111.171 153.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -63.88 156.17 28.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.867 1.267 . . . . 71.040000000000006 108.788 172.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 t -144.23 -36.91 0.32 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.516 1.526 . . . . 74.230000000000004 111.391 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m 56.0 -7.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.334 1.605 . . . . 62.299999999999997 115.334 -165.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.28 163.12 51.72 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 120.827 1.649 . . . . 72.109999999999999 110.803 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.245 0.847 0 CA-C-O 116.357 -1.782 . . . . 31.02 108.029 151.34 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 111.305 -0.718 . . . . 62.0 111.305 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.74 49.27 19.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.036 1.734 . . . . 55.409999999999997 112.712 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mp -68.38 145.8 97.52 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.97 -1.493 . . . . 60.210000000000001 106.97 161.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.53 165.74 30.99 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.167 2.578 . . . . 72.310000000000002 113.705 -163.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.97 153.94 3.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.973 1.749 . . . . 24.420000000000002 111.434 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -108.35 86.95 3.71 Favored Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 126.968 2.107 . . . . 74.340000000000003 106.998 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.66 67.34 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 126.079 4.519 . . . . 75.310000000000002 111.865 -168.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 166.35 35.86 Favored Glycine 0 C--N 1.332 0.36 0 O-C-N 121.097 -1.002 . . . . 55.240000000000002 111.96 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.29 161.45 7.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.977 2.511 . . . . 35.130000000000003 106.873 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.79 159.49 52.48 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.702 2.268 . . . . 62.25 112.139 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -127.27 -178.5 4.47 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 121.45 -0.781 . . . . 54.310000000000002 110.664 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.11 23.16 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.916 2.487 . . . . 64.439999999999998 114.652 171.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.79 126.83 21.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 118.721 0.691 . . . . 75.540000000000006 110.734 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -120.3 143.88 48.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.01 1.324 . . . . 63.140000000000001 107.81 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -144.26 126.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.49 -2.041 . . . . 75.409999999999997 105.49 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.7 m -143.61 149.77 37.81 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.023 1.329 . . . . 61.219999999999999 110.291 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -84.52 153.71 23.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 72.530000000000001 110.602 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 166.07 15.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 128.745 2.818 . . . . 54.420000000000002 107.119 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.59 -27.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.404 2.069 . . . . 60.530000000000001 113.693 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.66 -11.52 51.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.373 1.069 . . . . 72.430000000000007 112.164 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.67 -163.31 29.02 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.952 -1.259 . . . . 73.409999999999997 109.952 -161.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.62 30.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.061 0.945 . . . . 73.129999999999995 111.092 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -78.84 134.6 36.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.846 -1.168 . . . . 75.329999999999998 107.846 157.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.72 137.49 45.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.159 1.384 . . . . 53.350000000000001 107.761 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -142.92 167.25 22.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.445 1.02 . . . . 73.120000000000005 109.856 167.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.441 ' CE3' HD13 ' A' ' 99' ' ' ILE . 4.0 p90 -160.51 178.4 9.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.822 2.049 . . . . 63.450000000000003 109.825 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.6 158.25 66.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.925 -1.036 . . . . 74.030000000000001 111.998 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 170.82 18.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.04 3.16 . . . . 73.209999999999994 113.85 -168.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.68 166.49 17.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.754 2.303 . . . . 75.200000000000003 111.82 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 t -140.46 21.49 2.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.469 1.508 . . . . 74.400000000000006 110.128 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.72 -55.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.638 1.175 . . . . 73.319999999999993 108.461 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 p -124.46 103.46 8.19 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.511 1.124 . . . . 75.230000000000004 109.368 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -64.22 -73.41 0.12 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.995 0.918 . . . . 43.409999999999997 110.899 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 1.84 75.57 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 117.587 -1.674 . . . . 43.539999999999999 115.14 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt 65.26 83.58 0.17 Allowed 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 132.479 4.311 . . . . 74.010000000000005 111.113 -172.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.62 136.5 22.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 107.205 -1.406 . . . . 53.200000000000003 107.205 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.7 -17.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.071 1.748 . . . . 72.409999999999997 111.142 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 3.2 tp10 -164.58 -164.91 0.87 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.048 1.339 . . . . 75.230000000000004 109.237 172.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.418 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 1.1 m-85 -142.25 172.84 12.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.975 1.71 . . . . 73.310000000000002 110.527 171.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 p -138.41 167.49 21.77 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.526 1.131 . . . . 75.230000000000004 110.744 168.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 t -146.62 124.74 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 103.537 -2.764 . . . . 73.439999999999998 103.537 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.03 136.12 50.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.501 -1.296 . . . . 75.040000000000006 107.501 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -123.74 120.84 33.85 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.278 1.831 . . . . 74.129999999999995 107.278 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.55 145.94 55.46 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.886 -0.783 . . . . 72.109999999999999 108.886 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 45' ' ' ILE . 0.1 OUTLIER -137.97 -178.33 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.647 1.979 . . . . 74.310000000000002 107.845 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -58.96 136.09 57.8 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.427 -0.796 . . . . 65.439999999999998 109.709 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m 70.58 166.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.921 2.089 . . . . 50.25 113.484 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 p -134.06 116.22 15.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.426 1.49 . . . . 72.439999999999998 108.853 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.1 70.21 0.92 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.998 1.319 . . . . 70.230000000000004 108.84 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.41 156.48 32.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.686 1.194 . . . . 64.450000000000003 110.211 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.61 124.1 11.71 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.791 -2.3 . . . . 54.340000000000003 104.791 165.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.45 121.48 0.67 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 107.291 -2.324 . . . . 43.149999999999999 107.291 -174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -143.53 164.5 30.33 Favored Pre-proline 0 C--O 1.241 0.638 0 C-N-CA 125.14 1.376 . . . . 74.239999999999995 111.102 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.1 164.76 0.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.613 2.876 . . . . 54.32 112.965 165.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -83.91 25.97 0.76 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.239 1.016 . . . . 54.329999999999998 110.928 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.1 m -93.29 -31.36 14.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.702 -1.142 . . . . 73.040000000000006 112.558 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.67 85.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.235 1.414 . . . . 41.409999999999997 109.245 -170.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -130.72 144.39 53.23 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.47 0.708 . . . . 74.040000000000006 109.376 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 84.92 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.678 2.919 . . . . 63.420000000000002 111.182 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.15 83.98 1.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.106 1.763 . . . . 71.329999999999998 108.124 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.24 102.17 14.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.216 -1.402 . . . . 74.140000000000001 107.216 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.67 155.57 38.98 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.317 -1.734 . . . . 65.420000000000002 106.317 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.3 109.06 5.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.341 -1.355 . . . . 73.120000000000005 107.341 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -133.49 154.43 50.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.186 1.395 . . . . 74.109999999999999 107.286 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.6 ttp -72.44 117.31 13.95 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.282 -1.377 . . . . 71.230000000000004 107.282 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -70.26 80.2 0.53 Allowed 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 107.407 -1.331 . . . . 70.140000000000001 107.407 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.6 -18.83 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.816 0.847 . . . . 43.539999999999999 111.717 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.47 105.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.471 1.108 . . . . 64.319999999999993 110.65 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.3 m -140.24 99.21 3.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.776 -1.935 . . . . 75.25 105.776 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.12 28.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.404 -1.078 . . . . 63.340000000000003 110.404 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 -15.3 17.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.388 2.725 . . . . 61.210000000000001 113.09 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 m -136.46 165.98 31.26 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.702 1.601 . . . . 75.450000000000003 110.439 -169.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.48 175.35 0.56 Allowed 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.603 2.869 . . . . 75.420000000000002 112.932 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m 56.3 43.21 26.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.995 1.718 . . . . 72.219999999999999 112.303 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 99.5 m -65.89 123.3 19.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 74.329999999999998 109.522 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 171.73 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.99 0.916 . . . . 64.230000000000004 111.465 167.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.7 141.17 39.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.467 -1.309 . . . . 75.25 107.467 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -78.02 162.66 26.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.482 1.113 . . . . 75.420000000000002 112.483 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -31.71 71.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.738 1.615 . . . . 71.530000000000001 113.489 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -64.99 -45.16 86.79 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 120.902 -1.123 . . . . 64.510000000000005 112.307 177.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -63.69 -38.19 90.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.859 -0.591 . . . . 64.530000000000001 109.536 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.383 0.673 . . . . 60.140000000000001 112.086 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -67.42 -44.97 77.46 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.104 1.32 . . . . 55.020000000000003 109.666 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -73.87 -18.76 60.88 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 118.601 -0.714 . . . . 52.049999999999997 112.863 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.83 133.98 31.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.7 1.6 . . . . 53.329999999999998 112.165 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -70.81 127.14 31.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.156 -1.424 . . . . 64.319999999999993 107.156 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.61 125.33 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.546 -2.02 . . . . 75.439999999999998 105.546 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.63 127.17 30.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.84 -0.8 . . . . 75.150000000000006 108.84 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.83 9.84 16.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.918 0.487 . . . . 75.530000000000001 110.842 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -89.79 -24.04 21.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 74.209999999999994 111.114 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -142.6 -74.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.328 1.051 . . . . 74.349999999999994 109.828 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.29 60.81 Favored Pre-proline 0 CA--C 1.513 -0.45 0 C-N-CA 126.541 1.937 . . . . 75.409999999999997 109.134 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.23 84.01 1.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 123.166 2.577 . . . . 73.510000000000005 106.581 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.86 162.3 35.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.254 2.621 . . . . 63.109999999999999 110.678 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG13 ' HG3' ' A' ' 118' ' ' GLU . 50.4 mt -81.03 148.42 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 108.471 -0.937 . . . . 73.319999999999993 108.471 168.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.07 139.61 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 124.785 1.234 . . . . 71.209999999999994 108.919 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.02 138.28 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.671 -1.233 . . . . 75.549999999999997 107.671 168.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -94.83 134.47 37.42 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.22 -1.4 . . . . 75.150000000000006 107.22 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.441 HD13 ' CE3' ' A' ' 26' ' ' TRP . 13.8 mt -127.3 134.95 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.458 -2.053 . . . . 75.010000000000005 105.458 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.46 153.45 46.27 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.961 0.904 . . . . 60.210000000000001 109.098 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.04 135.22 44.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.348 0.659 . . . . 72.140000000000001 109.687 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.4 HH11 ' CB ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -85.89 79.92 9.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 104.607 -2.368 . . . . 62.219999999999999 104.607 167.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.04 161.88 13.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.114 0.966 . . . . 73.409999999999997 109.387 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.31 -22.46 66.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.814 1.245 . . . . 75.129999999999995 112.133 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -65.38 -14.42 60.82 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.338 1.236 . . . . 53.310000000000002 114.338 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.75 177.34 28.27 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.696 1.617 . . . . 54.43 110.81 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.93 30.58 1.05 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.56 1.544 . . . . 63.119999999999997 114.421 -165.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.97 -77.05 0.16 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.497 1.046 . . . . 71.120000000000005 114.27 -159.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -89.17 156.1 5.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.578 2.185 . . . . 71.209999999999994 110.629 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.87 156.72 46.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.2 1.0 . . . . 62.32 109.188 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.404 HG22 HG13 ' A' ' 113' ' ' VAL . 87.4 m -82.11 123.64 29.14 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.738 -1.949 . . . . 73.140000000000001 105.738 157.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -83.98 119.34 24.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.359 -2.089 . . . . 72.319999999999993 105.359 154.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 111' ' ' THR . 22.1 m -110.51 173.98 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 123.674 0.79 . . . . 71.319999999999993 109.413 165.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.4 156.41 45.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.85 1.66 . . . . 74.549999999999997 109.3 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -139.44 109.64 6.48 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 125.77 1.628 . . . . 75.209999999999994 111.366 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.906 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -96.54 160.57 14.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.328 2.251 . . . . 63.439999999999998 107.872 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 63.06 14.78 7.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.97 1.308 . . . . 73.150000000000006 111.493 -168.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HG3' HG13 ' A' ' 95' ' ' ILE . 2.2 pm0 -62.2 -25.05 67.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.893 2.077 . . . . 73.549999999999997 112.391 162.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.7 119.78 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.499 1.92 . . . . 53.009999999999998 109.963 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.3 t -159.76 178.84 9.39 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.669 1.987 . . . . 63.450000000000003 106.742 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.02 173.89 11.22 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.091 1.356 . . . . 72.239999999999995 110.379 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 58.09 78.69 0.23 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.469 1.908 . . . . 54.310000000000002 109.667 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.75 106.78 19.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.726 -1.125 . . . . 75.420000000000002 111.59 -161.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t -62.01 173.09 1.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.278 0.631 . . . . 74.519999999999996 110.016 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.35 -156.39 21.8 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 121.387 -0.82 . . . . 75.540000000000006 111.893 171.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.45 ' H ' ' HB3' ' A' ' 80' ' ' SER . 54.9 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.092 2.557 . . . . 53.409999999999997 109.705 -168.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 108.247 -1.941 . . . . 75.409999999999997 108.247 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.32 144.48 32.12 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.25 -2.129 . . . . 72.239999999999995 105.25 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.24 63.75 44.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.969 -1.122 . . . . 75.510000000000005 107.969 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -81.13 5.45 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.93 3.086 . . . . 55.439999999999998 112.94 -170.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.66 167.45 17.2 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 127.208 2.337 . . . . 75.209999999999994 107.863 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.99 89.8 0.15 Allowed Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 127.036 2.134 . . . . 64.209999999999994 112.541 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -60.3 165.33 11.11 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 CA-C-N 121.333 1.512 . . . . 71.109999999999999 111.411 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.45 -126.59 7.0 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.698 1.618 . . . . 52.350000000000001 109.657 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HB2' ' HG2' ' A' ' 109' ' ' PRO . . . 63.81 151.81 0.11 Allowed Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 129.215 3.006 . . . . 53.32 114.376 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HG3' HG22 ' A' ' 99' ' ' ILE . 59.3 Cg_endo -68.66 155.28 69.38 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 123.652 2.902 . . . . 71.140000000000001 111.036 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -134.69 -179.47 5.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.699 1.6 . . . . 70.540000000000006 110.208 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.4 36.9 17.7 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.087 1.355 . . . . 73.510000000000005 112.07 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.63 134.17 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.286 -1.005 . . . . 44.030000000000001 108.286 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -131.05 155.53 46.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.452 1.101 . . . . 74.400000000000006 109.553 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.06 139.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.499 -2.038 . . . . 61.100000000000001 105.499 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -139.74 147.6 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.723 1.609 . . . . 71.530000000000001 109.559 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -79.24 143.31 35.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.37 -1.345 . . . . 73.409999999999997 107.37 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p -139.03 166.75 22.59 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.701 2.0 . . . . 72.019999999999996 108.022 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -56.53 -25.1 56.88 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.619 2.213 . . . . 72.010000000000005 113.355 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -87.58 -20.76 25.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.574 1.079 . . . . 65.310000000000002 111.558 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.11 -163.78 24.25 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.477 -1.049 . . . . 12.550000000000001 110.477 -159.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.65 135.54 36.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.884 0.874 . . . . 73.140000000000001 112.093 -166.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -84.58 86.58 7.29 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.941 2.096 . . . . 71.329999999999998 110.047 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.85 131.78 35.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.611 0.764 . . . . 72.140000000000001 110.247 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -145.85 152.75 39.99 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.269 . . . . 63.420000000000002 109.294 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -151.25 179.41 8.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.581 1.553 . . . . 74.439999999999998 110.885 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -65.35 160.8 55.83 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.618 0.599 . . . . 73.099999999999994 112.618 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.61 156.21 66.31 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.211 1.941 . . . . 63.399999999999999 109.13 156.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.95 95.58 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.024 2.483 . . . . 73.099999999999994 110.53 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -140.24 22.28 2.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.63 0.604 . . . . 71.140000000000001 112.63 -165.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.9 t -99.2 -50.96 10.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 O-C-N 121.742 -0.599 . . . . 71.540000000000006 110.158 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.5 p -131.24 164.31 25.86 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.44 1.096 . . . . 74.219999999999999 110.118 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -77.64 40.4 0.3 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.237 1.415 . . . . 71.400000000000006 111.996 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.12 132.63 15.37 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.516 -2.234 . . . . 74.109999999999999 107.516 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -76.86 79.85 3.44 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.681 -1.229 . . . . 74.510000000000005 107.681 171.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.65 146.18 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.485 -1.302 . . . . 64.510000000000005 107.485 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 pt -141.72 -17.49 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.119 2.168 . . . . 74.209999999999994 111.088 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -160.47 -168.79 2.24 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.59 1.086 . . . . 73.299999999999997 111.325 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -133.14 162.73 30.98 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.511 1.524 . . . . 75.430000000000007 109.805 164.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -142.33 160.17 40.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.784 1.634 . . . . 75.109999999999999 108.923 159.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.7 117.39 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.477 -1.675 . . . . 62.310000000000002 106.477 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -93.22 144.17 25.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.906 -1.146 . . . . 74.319999999999993 107.906 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.2 tp -129.75 132.08 46.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.768 2.027 . . . . 74.549999999999997 107.342 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.69 134.12 44.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.147 1.34 . . . . 61.140000000000001 109.127 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.34 172.5 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.833 1.253 . . . . 72.530000000000001 108.741 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.76 77.14 2.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.27 0.486 . . . . 75.340000000000003 110.522 166.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -163.83 -163.82 0.83 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.707 1.203 . . . . 54.450000000000003 108.992 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.407 ' HA ' ' HB1' ' A' ' 63' ' ' ALA . 1.4 m -147.69 134.52 20.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.233 2.213 . . . . 64.150000000000006 107.34 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -160.36 152.84 20.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.239 1.382 . . . . 72.209999999999994 112.697 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.53 106.0 0.14 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.553 2.341 . . . . 71.510000000000005 111.336 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -156.8 134.13 10.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.127 2.171 . . . . 72.349999999999994 105.414 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.93 106.26 0.22 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.711 1.148 . . . . 71.409999999999997 112.289 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 47.7 mm-40 -66.27 160.93 61.72 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.161 -0.611 . . . . 74.540000000000006 110.89 168.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 53' ' ' GLU . 49.4 Cg_endo -75.44 74.08 4.34 Favored 'Trans proline' 0 CA--C 1.536 0.578 1 C-N-CA 126.672 4.914 . . . . 60.420000000000002 110.138 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 60.72 1.25 0.41 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.155 2.182 . . . . 63.119999999999997 114.433 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -61.03 -71.66 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.737 1.153 . . . . 62.530000000000001 109.191 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 m -148.63 87.99 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.314 0.961 . . . . 75.439999999999998 110.471 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -138.41 57.2 11.61 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.936 1.294 . . . . 64.340000000000003 110.548 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -60.99 121.28 9.44 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.008 2.472 . . . . 73.450000000000003 110.244 174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.75 48.67 8.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 127.475 2.31 . . . . 62.43 112.915 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 54.71 81.23 0.11 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.578 1.551 . . . . 63.530000000000001 110.941 165.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.06 145.83 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.548 1.539 . . . . 75.340000000000003 113.197 178.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 48' ' ' SER . . . -122.38 94.95 4.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.746 -1.946 . . . . 54.43 105.746 167.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.43 145.94 48.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.564 -1.643 . . . . 75.239999999999995 106.564 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.5 ttp -96.42 138.15 34.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.405 1.082 . . . . 73.439999999999998 109.731 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -79.49 65.51 4.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.774 1.23 . . . . 64.540000000000006 110.682 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.59 -32.87 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.882 1.273 . . . . 71.420000000000002 112.332 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -80.38 97.08 6.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.095 0.558 . . . . 74.510000000000005 112.238 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.31 117.77 25.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.183 -1.414 . . . . 52.219999999999999 107.183 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.53 160.98 12.05 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.651 -1.38 . . . . 41.039999999999999 109.651 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.29 -55.03 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.955 2.437 . . . . 65.530000000000001 112.011 -169.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -84.32 164.85 41.48 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 121.188 -0.945 . . . . 62.340000000000003 111.257 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.97 179.22 3.41 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.814 3.009 . . . . 72.140000000000001 111.297 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 m 58.47 28.13 16.51 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.627 1.343 . . . . 74.319999999999993 114.627 165.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.91 158.36 34.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.334 1.053 . . . . 71.319999999999993 111.936 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 169.41 18.28 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.116 0.966 . . . . 63.539999999999999 111.821 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.14 111.86 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 125.194 1.398 . . . . 75.430000000000007 109.041 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.5 144.53 16.85 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.27 1.428 . . . . 74.109999999999999 113.459 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.83 -26.71 68.88 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.281 1.432 . . . . 74.209999999999994 113.187 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.7 t -54.34 -54.49 39.66 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.38 -0.825 . . . . 71.019999999999996 109.847 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.19 -37.55 87.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.796 0.438 . . . . 55.219999999999999 111.075 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.16 -27.81 67.41 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.247 0.476 . . . . 75.340000000000003 111.278 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -74.0 -34.78 64.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.479 0.581 . . . . 55.310000000000002 111.506 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -76.7 -11.29 59.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.622 0.601 . . . . 54.350000000000001 112.622 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 134.74 48.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.837 0.827 . . . . 43.32 109.456 -174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -72.79 112.34 8.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.942 -1.026 . . . . 60.240000000000002 109.054 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.4 125.17 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 64.420000000000002 106.844 162.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.02 135.06 50.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.999 0.812 . . . . 53.119999999999997 109.94 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -130.84 56.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.823 1.249 . . . . 64.430000000000007 108.143 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 p -123.41 -21.47 5.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.328 -0.851 . . . . 55.450000000000003 112.964 163.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -131.86 -69.88 0.59 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.642 0.777 . . . . 73.140000000000001 112.245 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -144.27 158.42 54.78 Favored Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 120.421 -1.424 . . . . 74.239999999999995 109.073 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.77 96.99 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.685 2.257 . . . . 75.310000000000002 108.46 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.31 37.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.738 1.615 . . . . 73.109999999999999 107.753 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.52 120.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.381 -1.711 . . . . 71.219999999999999 106.381 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.93 152.7 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.239 -1.022 . . . . 61.420000000000002 108.239 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -131.74 152.73 50.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.989 0.915 . . . . 73.510000000000005 108.74 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -127.36 87.56 2.65 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.446 HG22 ' HG3' ' A' ' 10' ' ' PRO . 70.7 mt -90.64 133.37 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.27 -2.122 . . . . 63.119999999999997 105.27 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.64 131.63 19.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.283 0.563 . . . . 60.409999999999997 111.868 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.17 122.45 22.79 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.459 -0.941 . . . . 72.310000000000002 108.459 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -77.8 109.8 12.12 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 106.931 -1.507 . . . . 61.530000000000001 106.931 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.63 -178.63 5.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.175 0.99 . . . . 64.450000000000003 109.55 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.94 1.93 56.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.401 -0.818 . . . . 73.530000000000001 112.724 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -66.68 -68.39 0.38 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.384 -1.339 . . . . 73.140000000000001 107.384 154.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.34 37.59 0.27 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 119.34 -1.41 . . . . 72.349999999999994 115.725 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 59.59 -163.65 0.23 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.609 1.963 . . . . 75.230000000000004 109.792 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 161.97 -90.64 0.11 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 105.336 -3.106 . . . . 74.319999999999993 105.336 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 79.2 Cg_endo -62.37 150.79 85.96 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.499 2.133 . . . . 72.519999999999996 110.296 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.95 112.25 5.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.499 -2.038 . . . . 60.219999999999999 105.499 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.8 m -58.83 124.54 20.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.84 0.856 . . . . 64.150000000000006 108.992 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -79.42 79.28 5.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.607 1.194 . . . . 75.530000000000001 108.379 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.78 146.77 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.243 -1.762 . . . . 62.450000000000003 106.243 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.66 128.44 39.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.094 -1.076 . . . . 55.039999999999999 108.094 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -92.64 104.82 17.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.211 0.604 . . . . 75.140000000000001 110.337 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.15 175.36 10.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.377 1.471 . . . . 72.329999999999998 109.427 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.22 14.69 3.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.117 2.167 . . . . 54.039999999999999 112.543 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.67 79.45 0.29 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 64.340000000000003 110.832 164.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -144.89 103.19 3.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 106.882 -1.525 . . . . 73.219999999999999 106.882 158.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.4 m -160.42 157.09 27.13 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.819 1.647 . . . . 75.329999999999998 107.83 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -142.81 39.09 1.49 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.582 -0.896 . . . . 75.109999999999999 108.582 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.16 -17.92 41.24 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.393 -0.817 . . . . 64.439999999999998 112.828 -163.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 71.3 m -58.35 150.98 20.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.92 1.288 . . . . 74.329999999999998 112.221 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.2 t -152.44 76.61 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 105.943 -1.873 . . . . 64.450000000000003 105.943 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.19 39.73 0.11 Allowed Glycine 0 CA--C 1.522 0.471 0 O-C-N 121.316 -0.865 . . . . 54.219999999999999 111.039 -167.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.832 1.653 . . . . 64.030000000000001 106.734 176.058 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 110.826 -0.91 . . . . 70.409999999999997 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.3 m -71.71 -41.97 67.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.273 1.036 . . . . 74.049999999999997 111.989 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.3 mt 43.79 55.72 12.33 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.21 1.804 . . . . 70.209999999999994 113.105 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.61 -54.03 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.746 1.631 . . . . 50.130000000000003 111.886 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.69 145.7 14.6 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 111.6 -0.6 . . . . 74.140000000000001 111.6 -173.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.21 158.69 44.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.321 1.048 . . . . 71.019999999999996 109.987 166.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 163.16 36.82 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.014 2.476 . . . . 70.340000000000003 110.547 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.31 -117.97 5.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.305 -1.118 . . . . 44.32 110.305 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 160.57 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 128.464 2.706 . . . . 63.109999999999999 112.361 -168.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.1 152.36 56.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.696 2.264 . . . . 72.349999999999994 109.217 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.17 177.0 8.53 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.861 1.664 . . . . 73.540000000000006 108.535 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.71 42.09 5.56 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.44 2.296 . . . . 70.439999999999998 111.633 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.446 HG23 ' CD1' ' A' ' 26' ' ' TRP . 2.4 mp -67.95 120.73 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.168 0.987 . . . . 61.140000000000001 109.021 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -112.55 133.98 54.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.365 -0.976 . . . . 63.399999999999999 108.365 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' A' ' 97' ' ' PHE . 22.7 mt -144.4 124.84 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.728 1.211 . . . . 73.219999999999999 108.076 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.0 m -145.41 161.79 38.85 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.611 1.164 . . . . 64.329999999999998 112.281 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -83.89 146.01 28.3 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.325 1.05 . . . . 75.430000000000007 109.206 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 m -152.08 165.3 17.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.917 1.687 . . . . 73.340000000000003 108.204 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.86 -11.18 25.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.209 1.94 . . . . 75.340000000000003 113.544 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.72 7.5 8.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.011 0.924 . . . . 75.329999999999998 111.523 -164.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 174.0 13.6 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.82 2.153 . . . . 75.099999999999994 107.93 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.4 129.46 36.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.566 -1.272 . . . . 62.219999999999999 107.566 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -65.89 109.39 2.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.634 -1.247 . . . . 72.400000000000006 107.634 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 5.3 mp -126.06 126.82 44.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.317 1.047 . . . . 62.119999999999997 108.693 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -139.43 154.18 47.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.331 0.652 . . . . 75.109999999999999 109.63 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CD1' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -142.94 -178.91 6.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.132 1.373 . . . . 75.310000000000002 107.675 175.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.19 160.37 52.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.199 0.909 . . . . 74.319999999999993 111.22 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.57 156.05 64.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.734 3.623 . . . . 74.439999999999998 113.101 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.57 -176.67 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.113 3.209 . . . . 75.349999999999994 111.488 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 14.03 3.57 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.647 1.721 . . . . 63.049999999999997 115.647 -163.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.8 -54.55 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.774 -0.579 . . . . 72.450000000000003 111.468 -160.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -132.9 172.65 12.31 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.967 1.307 . . . . 60.030000000000001 107.908 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 m -51.74 -41.86 61.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.606 1.094 . . . . 72.340000000000003 112.394 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.71 163.87 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.087 0.851 . . . . 60.25 111.198 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -131.31 74.26 1.58 Allowed 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.512 -0.993 . . . . 73.010000000000005 108.641 164.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.22 152.44 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 75.219999999999999 106.439 167.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.24 -28.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.121 1.368 . . . . 61.119999999999997 110.403 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.39 -169.94 3.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.353 -1.351 . . . . 73.439999999999998 107.353 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 102' ' ' ARG . 34.8 m-85 -128.11 166.27 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.629 -1.248 . . . . 71.319999999999993 107.629 159.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -130.72 153.42 49.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.284 -1.376 . . . . 62.329999999999998 107.284 164.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.932 HG12 ' HB2' ' A' ' 68' ' ' TYR . 3.6 p -153.02 124.64 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 O-C-N 121.942 -0.474 . . . . 51.310000000000002 110.475 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -99.15 133.98 42.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.943 -1.132 . . . . 75.019999999999996 107.943 -171.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 85' ' ' ALA . 10.5 tp -117.63 130.23 56.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.639 2.375 . . . . 72.209999999999994 107.564 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . . . -63.0 136.25 57.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 121.417 1.917 . . . . 64.219999999999999 112.992 169.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.447 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.3 pt -145.11 175.5 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.194 1.398 . . . . 52.420000000000002 110.289 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -63.75 67.01 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.317 1.847 . . . . 74.409999999999997 112.754 164.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -151.8 -33.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.59 1.556 . . . . 52.210000000000001 111.782 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 m 62.05 13.08 5.41 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.807 1.41 . . . . 52.439999999999998 114.807 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.48 132.6 2.88 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.69 1.996 . . . . 64.510000000000005 108.152 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.92 -175.42 4.94 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.547 1.539 . . . . 63.240000000000002 111.017 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.2 m -145.24 131.82 19.85 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.406 2.683 . . . . 75.329999999999998 105.699 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.75 -85.19 0.05 OUTLIER Glycine 0 C--O 1.235 0.205 0 C-N-CA 124.733 1.158 . . . . 55.420000000000002 110.883 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -63.14 153.19 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.107 0.963 . . . . 72.430000000000007 110.482 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -69.14 148.73 69.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.623 2.215 . . . . 73.340000000000003 109.892 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -102.2 5.34 40.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.069 0.948 . . . . 70.340000000000003 113.047 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.7 m -48.51 -35.01 12.27 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.305 0.957 . . . . 61.229999999999997 113.464 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.7 t -136.31 -62.71 0.66 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.104 0.962 . . . . 74.129999999999995 110.034 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 t -65.2 144.33 99.0 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.841 -1.17 . . . . 74.439999999999998 107.841 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.88 76.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.911 3.074 . . . . 54.219999999999999 110.149 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.49 38.85 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.679 2.391 . . . . 45.140000000000001 111.999 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -132.64 72.54 1.49 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.541 1.937 . . . . 65.329999999999998 107.136 -166.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mt -126.12 -170.95 2.28 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.724 -1.213 . . . . 74.519999999999996 107.724 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.19 -154.24 0.06 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.724 -0.671 . . . . 74.120000000000005 111.92 162.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER 76.69 160.54 0.22 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 131.23 3.812 . . . . 61.329999999999998 113.77 173.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.447 ' SD ' HD13 ' A' ' 45' ' ' ILE . 9.8 ptt? -126.95 147.65 50.09 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.655 1.182 . . . . 55.219999999999999 110.068 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.62 93.72 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.203 2.201 . . . . 75.409999999999997 112.529 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -94.86 -26.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 116.456 -1.735 . . . . 75.099999999999994 110.162 -165.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.932 ' HB2' HG12 ' A' ' 41' ' ' VAL . 26.3 t80 -58.0 132.68 54.17 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 120.332 1.424 . . . . 72.129999999999995 109.409 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.0 p -155.01 27.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.548 1.139 . . . . 73.239999999999995 112.227 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.27 152.67 18.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.978 -0.901 . . . . 61.210000000000001 111.195 -168.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.33 -55.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.046 1.831 . . . . 72.140000000000001 109.053 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.87 144.95 97.99 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.29 -0.633 . . . . 64.209999999999994 109.29 169.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.56 -3.54 13.26 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.613 2.875 . . . . 55.340000000000003 112.604 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 p -98.58 44.99 1.02 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.461 1.482 . . . . 73.530000000000001 110.419 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.6 t -51.3 111.82 0.64 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.953 1.301 . . . . 62.100000000000001 110.706 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.3 130.24 37.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.288 -0.634 . . . . 63.140000000000001 109.288 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -76.35 95.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.846 -1.539 . . . . 72.340000000000003 106.846 162.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -75.75 163.71 26.99 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.294 -0.866 . . . . 54.299999999999997 109.694 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -53.09 -38.35 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.072 1.349 . . . . 73.420000000000002 112.115 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -40.09 63.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.784 2.034 . . . . 63.210000000000001 111.592 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.3 m -79.21 -36.09 40.65 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.105 -0.372 . . . . 75.230000000000004 111.873 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -25.53 68.23 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.85 0.46 . . . . 72.230000000000004 111.25 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.1 m -60.84 -10.86 6.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.345 1.239 . . . . 55.0 114.345 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -115.51 -6.66 12.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.644 1.111 . . . . 74.140000000000001 111.139 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 43' ' ' LEU . . . -70.1 151.28 45.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.212 1.005 . . . . 72.430000000000007 109.997 -171.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -137.24 153.09 50.45 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.721 0.808 . . . . 74.200000000000003 112.117 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 93' ' ' PRO . 1.9 mp -88.28 144.54 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.554 1.542 . . . . 64.230000000000004 109.593 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.16 71.42 5.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.417 1.887 . . . . 54.32 109.656 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -62.33 4.45 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.258 1.023 . . . . 74.239999999999995 111.876 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -20.51 31.38 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.367 0.985 . . . . 41.299999999999997 110.258 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.8 p -141.66 -85.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.765 1.226 . . . . 65.400000000000006 111.286 161.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HE3' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -117.17 153.93 49.91 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 126.421 1.889 . . . . 73.140000000000001 112.093 -162.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 87' ' ' ILE . 83.2 Cg_endo -77.64 78.76 3.41 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.511 1.474 . . . . 72.319999999999993 112.765 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.653 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -143.69 157.24 44.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.54 2.736 . . . . 53.020000000000003 107.912 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.3 mt -73.32 -21.3 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.572 0.582 . . . . 72.140000000000001 112.572 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.4 mm 60.68 142.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 130.187 3.395 . . . . 65.540000000000006 110.04 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CD2' HD13 ' A' ' 15' ' ' ILE . 10.5 m-85 -135.98 135.75 39.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.235 -1.394 . . . . 71.439999999999998 107.235 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -133.95 90.7 2.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.084 0.865 . . . . 74.530000000000001 109.627 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.544 ' HA ' HG23 ' A' ' 41' ' ' VAL . 1.1 mt -87.41 153.47 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.249 -1.389 . . . . 74.219999999999999 107.249 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.76 154.74 37.9 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.967 0.803 . . . . 61.020000000000003 111.769 159.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.47 116.22 13.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.217 1.807 . . . . 63.039999999999999 108.57 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.419 ' H ' ' HA ' ' A' ' 39' ' ' TYR . 1.4 tmm_? -79.34 89.26 4.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.074 -2.195 . . . . 74.219999999999999 105.074 170.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -115.74 178.92 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.298 1.439 . . . . 64.25 109.972 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.94 -3.12 20.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.629 0.974 . . . . 75.349999999999994 113.629 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -91.19 -27.96 18.16 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 120.256 -1.527 . . . . 61.450000000000003 109.675 173.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.16 -179.25 20.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.631 1.11 . . . . 51.119999999999997 110.98 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -70.7 69.52 0.44 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.068 1.747 . . . . 75.219999999999999 109.271 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 -81.99 1.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.114 -1.594 . . . . 70.439999999999998 109.114 -169.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.61 160.33 25.16 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.091 1.861 . . . . 64.450000000000003 109.05 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.71 36.92 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.973 0.909 . . . . 71.109999999999999 109.321 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -95.76 154.0 17.45 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.504 -1.295 . . . . 73.129999999999995 107.504 156.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -129.72 101.58 5.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.791 -2.3 . . . . 73.230000000000004 104.791 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.98 164.31 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.542 -1.281 . . . . 63.299999999999997 107.542 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 121.1 24.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.452 1.101 . . . . 74.540000000000006 108.095 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -91.74 79.7 5.36 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.316 -1.735 . . . . 74.299999999999997 106.316 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.759 HD21 ' HE3' ' A' ' 92' ' ' LYS . 44.5 mt -76.4 170.73 15.82 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.608 -0.886 . . . . 71.129999999999995 108.608 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 75.58 -6.14 2.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.895 2.478 . . . . 63.5 113.003 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.91 165.75 3.05 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.428 1.491 . . . . 74.400000000000006 113.391 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 144.22 50.52 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.13 1.772 . . . . 72.5 109.857 -171.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 155.12 40.62 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.484 -0.932 . . . . 44.130000000000003 108.484 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -149.56 175.68 11.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.283 -1.377 . . . . 73.319999999999993 107.283 152.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -147.88 163.56 36.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.474 0.71 . . . . 71.430000000000007 110.226 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.3 t -164.9 179.93 6.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.056 1.742 . . . . 62.229999999999997 109.255 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -141.41 168.43 19.8 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.549 1.54 . . . . 63.130000000000003 108.873 161.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.13 -64.1 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 123.496 0.569 . . . . 75.340000000000003 112.923 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.248 1.005 0 N-CA-C 105.05 -2.204 . . . . 75.329999999999998 105.05 176.722 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.509 0 N-CA-C 111.006 -0.838 . . . . 71.439999999999998 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.4 p -144.08 17.34 1.75 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.704 1.602 . . . . 40.219999999999999 111.733 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 mp 63.84 161.43 0.12 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.848 2.059 . . . . 72.040000000000006 110.62 -161.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.15 -178.74 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.976 1.784 . . . . 61.200000000000003 111.557 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.98 -161.05 0.85 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.555 1.074 . . . . 22.309999999999999 111.203 164.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -102.76 87.2 1.13 Allowed Pre-proline 0 N--CA 1.462 0.16 0 C-N-CA 125.265 1.426 . . . . 72.409999999999997 108.276 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.4 145.81 83.95 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.084 1.856 . . . . 61.310000000000002 109.061 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.9 -133.66 5.07 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.631 -1.387 . . . . 64.340000000000003 109.631 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.02 165.06 0.14 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 128.624 2.77 . . . . 75.200000000000003 111.249 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.51 156.33 64.17 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.458 2.105 . . . . 44.240000000000002 110.201 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.06 -178.97 5.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.837 0.827 . . . . 74.319999999999993 112.05 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.28 1.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.838 2.855 . . . . 60.329999999999998 115.744 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.4 mp -44.47 129.67 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.87 2.468 . . . . 61.020000000000003 112.626 -154.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 14' ' ' LYS . 8.0 mmpt? -115.01 131.03 57.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.439 1.095 . . . . 71.319999999999993 108.913 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.57 93.45 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.964 -1.495 . . . . 71.209999999999994 106.964 -175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -96.12 140.35 30.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.581 -1.19 . . . . 34.009999999999998 108.991 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -60.68 154.03 22.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.99 -0.744 . . . . 75.129999999999995 108.99 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.6 m -144.38 165.28 24.12 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 127.612 2.365 . . . . 73.209999999999994 107.963 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.98 -39.31 41.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.098 1.865 . . . . 75.510000000000005 112.06 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -106.48 9.79 31.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.732 0.813 . . . . 75.209999999999994 111.574 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.02 -137.37 4.76 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 120.414 -1.429 . . . . 62.140000000000001 112.185 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.12 144.85 32.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.797 0.839 . . . . 51.520000000000003 109.655 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -75.69 155.1 36.04 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 109.24 -0.652 . . . . 73.519999999999996 109.24 163.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 107.82 3.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.914 1.686 . . . . 55.329999999999998 108.711 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.3 p -123.41 158.6 30.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.034 0.833 . . . . 75.120000000000005 110.251 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CZ3' HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -146.78 141.86 27.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.964 0.905 . . . . 72.209999999999994 111.556 176.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -76.36 150.9 83.01 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.348 1.059 . . . . 74.120000000000005 109.206 165.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.23 168.01 25.3 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.625 3.55 . . . . 73.150000000000006 111.126 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 153.11 77.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.198 1.265 . . . . 55.350000000000001 110.721 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 t -151.86 73.0 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.738 -1.949 . . . . 74.239999999999995 105.738 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -57.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.066 0.946 . . . . 60.340000000000003 110.201 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 p -134.86 167.53 20.72 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.448 -0.945 . . . . 73.230000000000004 108.448 162.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -47.01 -57.07 5.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.203 1.801 . . . . 73.349999999999994 113.132 -168.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.31 176.72 5.96 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.228 1.394 . . . . 64.299999999999997 111.103 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -141.27 92.06 2.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.379 -1.711 . . . . 71.209999999999994 106.379 157.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.76 145.28 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.632 -1.618 . . . . 75.329999999999998 106.632 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.45 -28.26 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.471 1.109 . . . . 71.530000000000001 110.932 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.36 -176.26 5.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.663 1.119 . . . . 74.209999999999994 110.283 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -139.64 166.11 25.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.355 1.062 . . . . 51.130000000000003 110.273 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.48 171.93 19.42 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.287 -0.634 . . . . 73.219999999999999 109.287 163.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.02 124.48 26.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.19 -1.781 . . . . 71.120000000000005 106.19 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -118.22 119.07 33.57 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.794 -1.928 . . . . 75.430000000000007 105.794 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.21 116.03 30.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.285 -1.746 . . . . 71.099999999999994 106.285 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.34 136.4 51.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.003 -1.11 . . . . 61.409999999999997 108.003 173.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 pt -130.37 -177.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.288 -1.745 . . . . 64.540000000000006 106.288 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -44.51 101.17 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.491 1.916 . . . . 71.5 110.858 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.8 m -174.52 173.3 2.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.11 2.564 . . . . 62.399999999999999 109.596 -171.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 177.92 0.8 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.682 1.193 . . . . 72.099999999999994 112.353 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.81 165.42 24.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.975 1.31 . . . . 71.0 111.845 170.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.85 -178.77 3.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.818 1.647 . . . . 61.240000000000002 110.052 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -174.68 135.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.693 1.997 . . . . 75.230000000000004 109.369 169.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.03 125.11 1.13 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.958 1.266 . . . . 75.439999999999998 112.332 165.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' HG21 ' A' ' 58' ' ' THR . 10.2 mt-10 -69.37 159.02 85.22 Favored Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 118.349 1.075 . . . . 71.230000000000004 110.381 167.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -58.45 135.35 67.16 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.747 2.298 . . . . 74.239999999999995 110.062 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -146.98 37.51 0.96 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.463 1.105 . . . . 75.140000000000001 109.721 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m 58.31 1.21 0.15 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 73.219999999999999 114.856 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -161.53 -73.42 0.06 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.918 2.087 . . . . 73.310000000000002 107.696 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER 57.64 166.26 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.127 0.971 . . . . 75.310000000000002 110.653 -169.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.441 ' HD2' HG22 ' A' ' 58' ' ' THR . 43.2 Cg_endo -79.32 175.05 11.19 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.962 1.775 . . . . 64.230000000000004 110.536 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.48 81.58 4.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.189 -1.782 . . . . 60.530000000000001 106.189 162.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -121.45 63.51 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.226 1.41 . . . . 55.409999999999997 108.156 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 168.77 15.62 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.296 -1.372 . . . . 55.420000000000002 107.296 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.13 84.06 1.7 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.417 -0.811 . . . . 54.240000000000002 110.287 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.29 158.64 43.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.555 1.142 . . . . 71.209999999999994 109.81 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -102.83 7.03 39.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.501 0.926 . . . . 75.129999999999995 113.501 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 45.91 61.12 2.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.707 2.003 . . . . 74.5 114.398 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.65 -37.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.666 1.186 . . . . 71.5 113.545 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -64.68 118.81 9.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.969 0.804 . . . . 73.120000000000005 109.807 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.7 m -135.58 27.58 3.36 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.537 1.535 . . . . 75.209999999999994 109.656 164.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.19 161.05 37.25 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.973 -0.851 . . . . 75.200000000000003 110.973 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.83 -55.17 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.578 2.186 . . . . 74.239999999999995 110.013 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.86 158.75 31.15 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.864 1.266 . . . . 72.319999999999993 110.389 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.82 173.63 10.73 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.883 2.388 . . . . 75.420000000000002 110.863 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p 47.87 63.68 1.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.93 1.292 . . . . 64.430000000000007 109.782 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.3 p -70.98 -164.82 0.1 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.856 2.062 . . . . 74.5 110.21 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 77' ' ' VAL . 3.2 pp -130.09 -176.49 3.96 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.227 -1.546 . . . . 72.549999999999997 108.799 164.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.437 ' N ' HD12 ' A' ' 76' ' ' LEU . 31.0 t -135.98 148.23 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.632 1.105 . . . . 74.230000000000004 109.051 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -89.41 145.12 25.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.004 2.122 . . . . 73.530000000000001 111.084 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -62.48 -27.4 69.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.982 2.113 . . . . 73.540000000000006 112.83 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.5 p -57.53 -30.03 64.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.116 0.966 . . . . 74.319999999999993 111.28 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -78.44 -45.43 22.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.015 1.326 . . . . 52.420000000000002 109.298 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.35 -37.3 74.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.995 1.318 . . . . 75.219999999999999 111.87 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -50.08 -48.86 52.95 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.144 0.497 . . . . 62.530000000000001 110.531 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -84.32 -5.35 59.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.168 0.987 . . . . 62.409999999999997 112.076 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.81 138.07 55.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.083 0.944 . . . . 72.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -71.85 153.5 41.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.074 -1.421 . . . . 73.120000000000005 110.446 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -123.25 136.8 58.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.914 1.286 . . . . 71.430000000000007 109.261 -166.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.76 68.14 1.68 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 128.128 2.571 . . . . 74.329999999999998 112.197 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.71 73.07 0.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.827 1.299 . . . . 61.340000000000003 108.443 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.5 p -133.92 -28.5 1.37 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.234 2.213 . . . . 72.109999999999999 108.357 165.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.74 -50.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.084 0.954 . . . . 62.399999999999999 111.887 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.41 160.1 69.75 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 120.893 1.679 . . . . 73.129999999999995 112.541 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.53 74.1 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.579 2.186 . . . . 75.230000000000004 109.291 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.96 148.8 45.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.609 0.966 . . . . 53.109999999999999 113.609 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -83.98 133.9 28.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.917 1.287 . . . . 62.200000000000003 109.251 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -84.29 147.84 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.932 0.893 . . . . 61.409999999999997 110.601 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -126.57 145.56 50.49 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 125.331 1.452 . . . . 60.340000000000003 109.373 171.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -119.27 98.58 6.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.938 -1.875 . . . . 72.230000000000004 105.938 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.484 HD13 ' CZ3' ' A' ' 26' ' ' TRP . 17.4 mt -113.17 133.14 59.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.456 -2.053 . . . . 74.040000000000006 105.456 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 149.86 47.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.85 -1.167 . . . . 53.130000000000003 107.85 167.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.03 28.49 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.113 -1.439 . . . . 74.439999999999998 107.113 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG2' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.87 99.96 3.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.003 -2.221 . . . . 75.409999999999997 105.003 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -121.92 163.7 18.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.067 1.347 . . . . 53.409999999999997 110.335 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.66 -21.15 62.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.707 -1.133 . . . . 72.230000000000004 112.436 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.78 -16.85 44.92 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.36 1.064 . . . . 75.140000000000001 112.888 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.58 36.77 4.72 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 118.55 0.614 . . . . 75.329999999999998 111.756 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER 64.29 24.83 13.4 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.458 1.903 . . . . 75.219999999999999 111.865 165.365 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.87 -77.98 0.31 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.137 1.351 . . . . 73.0 112.098 -157.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.46 134.69 24.97 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.457 1.438 . . . . 75.329999999999998 109.403 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.99 164.07 26.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.074 1.75 . . . . 64.219999999999999 107.46 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 m -114.63 135.26 54.34 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.593 -1.632 . . . . 74.200000000000003 106.593 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.92 114.9 27.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.371 -2.085 . . . . 72.109999999999999 105.371 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 m -113.17 162.67 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 119.16 0.891 . . . . 75.129999999999995 108.913 167.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 135.85 52.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.364 -1.347 . . . . 75.319999999999993 107.364 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -120.89 102.08 8.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.274 1.035 . . . . 72.030000000000001 111.396 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.832 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.58 -10.95 28.18 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.741 2.417 . . . . 75.319999999999993 111.885 -169.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 2.21 2.92 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.076 1.75 . . . . 75.129999999999995 111.652 170.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -4.24 12.62 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.654 1.57 . . . . 75.120000000000005 114.408 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.92 145.93 1.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.069 2.548 . . . . 63.420000000000002 112.433 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 p -126.39 94.77 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.291 1.436 . . . . 74.120000000000005 108.495 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.0 tptt 71.44 -168.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.707 1.603 . . . . 75.120000000000005 109.561 -165.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 55.96 78.49 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.759 2.024 . . . . 74.209999999999994 112.96 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m 55.75 -154.97 0.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.878 1.271 . . . . 60.119999999999997 111.308 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.3 m 46.74 47.07 15.15 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.844 1.258 . . . . 71.109999999999999 113.723 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.42 68.3 0.43 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.185 -1.166 . . . . 35.439999999999998 110.185 171.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.258 1.55 0 N-CA-C 102.782 -3.044 . . . . 75.450000000000003 102.782 167.58 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 CA-C-O 119.82 -0.433 . . . . 62.140000000000001 112.174 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . 0.273 1.8 p 57.23 -169.11 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.322 1.049 . . . . 65.319999999999993 108.854 -121.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -129.47 165.57 31.87 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.193 1.397 . . . . 64.129999999999995 109.322 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.43 146.3 89.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.2 1.933 . . . . 70.099999999999994 110.196 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.01 -173.28 53.85 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 122.397 0.998 . . . . 43.100000000000001 111.877 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.4 165.2 34.74 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 127.908 2.483 . . . . 72.319999999999993 107.57 -177.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.78 136.51 58.06 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.136 1.224 . . . . 74.329999999999998 109.546 164.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.01 112.97 3.66 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 125.13 1.348 . . . . 32.520000000000003 114.356 165.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.96 31.01 Favored Pre-proline 0 C--N 1.314 -0.967 0 C-N-CA 127.025 2.13 . . . . 72.120000000000005 105.272 158.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HG3' HG22 ' A' ' 99' ' ' ILE . 37.9 Cg_endo -63.41 159.59 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.065 2.51 . . . . 73.530000000000001 111.268 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.1 m -134.41 176.52 8.54 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.662 1.185 . . . . 74.540000000000006 109.882 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 18.4 5.9 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.593 2.757 . . . . 23.219999999999999 113.758 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.58 120.98 7.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.369 0.668 . . . . 62.130000000000003 109.728 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.67 146.38 27.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.247 -1.39 . . . . 74.140000000000001 107.247 167.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.416 HG12 HD13 ' A' ' 24' ' ' LEU . 9.8 mt -135.71 133.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.383 -2.08 . . . . 74.129999999999995 105.383 161.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 t -146.82 144.51 29.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.434 1.494 . . . . 74.230000000000004 109.312 -173.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -80.45 158.26 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.124 0.57 . . . . 64.420000000000002 110.261 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.45 165.34 18.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.038 1.335 . . . . 61.0 107.935 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 -15.64 35.46 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.105 2.536 . . . . 70.310000000000002 113.464 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -107.74 -26.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.399 1.08 . . . . 70.230000000000004 111.66 -168.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.14 -165.61 37.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.582 -1.807 . . . . 51.520000000000003 108.582 -167.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.31 133.92 42.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.046 -1.465 . . . . 74.099999999999994 107.046 165.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -60.31 115.36 3.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.012 -1.477 . . . . 74.200000000000003 107.012 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD13 HG12 ' A' ' 15' ' ' ILE . 3.9 mm? -105.42 140.35 38.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.4 -1.704 . . . . 71.540000000000006 106.4 168.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 p -150.23 156.56 41.8 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.886 1.221 . . . . 71.439999999999998 109.953 164.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -139.91 158.37 44.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.487 1.515 . . . . 70.319999999999993 108.921 166.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -87.89 161.67 43.57 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.052 0.541 . . . . 61.340000000000003 110.523 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.8 168.08 19.56 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.904 . . . . 74.510000000000005 111.341 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.55 156.5 21.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.005 1.803 . . . . 74.510000000000005 112.973 -166.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.5 52.86 1.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.028 -1.471 . . . . 74.200000000000003 107.028 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG12 HG22 ' A' ' 32' ' ' THR . 33.2 t -137.57 -87.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.149 -1.056 . . . . 71.219999999999999 108.149 160.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.473 HG22 HG12 ' A' ' 31' ' ' VAL . 12.1 t -168.68 40.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.968 -1.083 . . . . 53.32 110.037 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.4 p -68.23 -6.82 25.74 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.103 -1.623 . . . . 71.299999999999997 113.787 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.09 -124.99 6.71 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 120.248 -1.533 . . . . 72.420000000000002 111.49 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -109.11 88.43 2.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.351 1.86 . . . . 62.530000000000001 110.612 -167.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.04 125.58 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.867 1.667 . . . . 63.530000000000001 107.177 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.46 -27.93 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.398 1.079 . . . . 74.239999999999995 111.406 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -151.3 -171.44 3.93 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.692 1.597 . . . . 72.299999999999997 107.434 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 169.49 17.51 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.472 -1.393 . . . . 74.5 108.749 172.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.9 173.24 16.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.587 0.63 . . . . 72.219999999999999 112.6 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.65 99.28 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 128.733 2.813 . . . . 73.310000000000002 105.282 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 42.7 m-85 -82.99 153.34 25.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.957 -1.127 . . . . 73.340000000000003 107.957 163.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.3 tp -143.26 128.19 18.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.956 2.102 . . . . 74.239999999999995 106.105 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 112.78 13.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.829 0.852 . . . . 63.520000000000003 109.143 169.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 pt -86.75 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.155 -1.054 . . . . 63.240000000000002 108.155 160.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -48.75 108.61 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.231 1.012 . . . . 62.140000000000001 111.139 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.8 p -162.61 109.98 1.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.81 1.244 . . . . 54.340000000000003 111.019 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -87.81 4.51 44.17 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.801 0.84 . . . . 64.549999999999997 112.615 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -127.21 168.86 14.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.21 1.404 . . . . 70.219999999999999 110.514 -162.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.78 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.169 2.188 . . . . 72.310000000000002 112.002 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -144.38 129.49 18.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.78 -2.304 . . . . 74.209999999999994 104.78 169.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.69 -135.2 1.96 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 108.36 -1.896 . . . . 72.319999999999993 108.36 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.11 156.27 60.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 125.277 1.431 . . . . 70.430000000000007 109.195 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.92 -176.81 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.953 2.435 . . . . 70.540000000000006 110.92 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt 70.08 3.92 4.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.974 1.309 . . . . 70.329999999999998 112.601 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.0 m 44.96 45.75 8.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.158 1.783 . . . . 51.329999999999998 111.485 -169.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -66.73 -51.16 59.14 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.87 -0.586 . . . . 34.530000000000001 109.881 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.6 p -125.44 156.94 69.59 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.084 0.856 . . . . 64.129999999999995 109.631 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.38 88.06 1.45 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.187 2.591 . . . . 73.420000000000002 112.85 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.86 116.52 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.621 1.968 . . . . 65.129999999999995 107.386 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -85.56 -168.43 2.22 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.087 0.955 . . . . 64.239999999999995 108.731 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -112.43 171.83 7.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.686 1.194 . . . . 45.020000000000003 109.586 -172.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.36 120.93 25.06 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.448 0.536 . . . . 70.510000000000005 112.448 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.435 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 37.9 m-85 -148.97 170.91 17.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.268 1.827 . . . . 65.120000000000005 110.33 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 ttp -106.45 5.89 29.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.438 1.495 . . . . 73.340000000000003 113.225 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 44.44 44.35 6.91 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.772 1.629 . . . . 71.329999999999998 115.34 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.6 m -56.4 -9.75 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.446 1.647 . . . . 64.129999999999995 115.446 -171.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -53.67 98.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.292 1.044 . . . . 65.230000000000004 110.783 165.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.6 t -147.32 24.66 1.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.713 . . . . 64.099999999999994 109.145 162.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.79 159.0 53.34 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.123 -0.791 . . . . 52.539999999999999 111.123 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -83.49 -7.05 10.82 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.947 3.098 . . . . 71.200000000000003 112.372 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -131.86 156.61 79.9 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.431 1.892 . . . . 71.219999999999999 109.842 -166.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -4.01 11.96 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.389 3.393 . . . . 70.219999999999999 113.551 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 p -120.46 22.47 11.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.666 2.387 . . . . 65.239999999999995 110.212 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.25 -174.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.654 2.782 . . . . 64.340000000000003 115.34 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.32 102.4 3.06 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 104.881 -2.266 . . . . 71.010000000000005 104.881 167.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.55 108.3 20.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.222 -1.029 . . . . 63.409999999999997 108.222 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -77.0 165.48 24.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.629 0.728 . . . . 73.109999999999999 111.554 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.75 82.08 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.47 1.108 . . . . 72.120000000000005 111.956 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -64.42 -20.29 66.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.924 -1.036 . . . . 54.210000000000001 112.754 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -75.02 -35.84 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.877 1.217 . . . . 50.530000000000001 109.862 172.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.0 -30.58 63.88 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.098 1.359 . . . . 51.200000000000003 110.53 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.4 m -47.09 -44.13 20.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.927 1.291 . . . . 74.209999999999994 113.033 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -84.55 1.73 44.55 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.167 0.802 . . . . 73.219999999999999 113.167 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.0 143.58 55.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.823 0.82 . . . . 72.140000000000001 110.376 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -68.74 140.69 55.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.529 -1.214 . . . . 73.319999999999993 107.808 162.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.6 mm -101.5 123.51 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.91 -1.515 . . . . 73.409999999999997 106.91 172.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.74 145.45 52.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.693 0.621 . . . . 54.409999999999997 110.056 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.7 18.66 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.658 0.783 . . . . 75.150000000000006 111.307 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 t -110.11 -13.58 14.35 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.658 -0.651 . . . . 72.450000000000003 110.908 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -129.02 -63.17 0.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.407 1.483 . . . . 60.420000000000002 111.982 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -154.74 155.55 30.57 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 127.062 2.145 . . . . 73.230000000000004 108.352 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -60.57 101.82 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.433 2.756 . . . . 70.129999999999995 109.516 171.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.515 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -149.94 156.58 41.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 70.120000000000005 110.078 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.44 140.71 16.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.824 -1.917 . . . . 73.450000000000003 105.824 161.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.8 mm -109.26 115.12 48.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.366 1.466 . . . . 63.25 107.555 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -100.72 148.49 24.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.957 0.903 . . . . 64.230000000000004 109.338 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -132.06 94.09 3.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.542 -1.651 . . . . 74.340000000000003 106.542 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 10' ' ' PRO . 31.1 mt -108.55 136.66 43.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.014 -2.217 . . . . 63.229999999999997 105.014 -172.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.52 41.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.909 0.777 . . . . 72.400000000000006 110.115 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 114.56 7.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.473 1.509 . . . . 73.329999999999998 108.066 172.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 81.55 4.72 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 105.475 -2.046 . . . . 73.129999999999995 105.475 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.06 166.02 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.9 1.68 . . . . 70.439999999999998 108.347 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mt-10 -74.48 -36.41 63.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.685 -1.143 . . . . 63.340000000000003 108.836 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -17.04 64.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 115.718 1.748 . . . . 53.399999999999999 115.718 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.82 -97.89 0.13 Allowed Glycine 0 CA--C 1.512 -0.134 0 CA-C-N 120.643 1.565 . . . . 43.219999999999999 112.882 -161.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 3.6 t80 55.52 21.86 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.833 2.853 . . . . 71.099999999999994 111.561 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.8 1.28 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.532 2.015 . . . . 41.210000000000001 108.35 -163.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.0 143.91 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.447 2.098 . . . . 70.209999999999994 109.904 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.18 117.65 16.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.386 -2.079 . . . . 64.299999999999997 105.386 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 m -53.14 120.99 6.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.924 -1.139 . . . . 71.409999999999997 107.924 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -82.64 88.9 6.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.041 -1.837 . . . . 74.519999999999996 106.041 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.21 156.58 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.462 -1.681 . . . . 63.240000000000002 106.462 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 164.13 28.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.87 -1.159 . . . . 64.120000000000005 107.87 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.515 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 19.3 t90 -137.6 114.31 10.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.62 0.724 . . . . 65.299999999999997 111.3 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 25.05 5.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.801 1.64 . . . . 64.200000000000003 112.19 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -108.97 7.75 26.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.507 1.523 . . . . 74.409999999999997 111.508 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -68.6 118.7 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.101 0.953 . . . . 63.539999999999999 109.021 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.52 159.02 0.17 Allowed 'General case' 0 C--O 1.242 0.663 1 C-N-CA 133.227 4.611 . . . . 65.450000000000003 103.368 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 m -71.3 169.45 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.691 1.132 . . . . 70.140000000000001 109.321 165.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -148.6 144.5 27.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.437 -2.061 . . . . 73.319999999999993 105.437 160.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.43 169.98 16.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.291 -0.633 . . . . 70.140000000000001 109.291 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.27 163.93 23.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.205 1.002 . . . . 62.43 110.176 173.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.98 -58.89 0.11 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.721 0.808 . . . . 33.240000000000002 109.315 168.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 162.36 -172.75 38.53 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 118.275 0.489 . . . . 32.049999999999997 112.393 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.547 2.339 . . . . 52.310000000000002 105.545 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 109.542 -1.423 . . . . 61.420000000000002 109.542 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.5 p -66.68 160.19 26.12 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.487 1.144 . . . . 73.040000000000006 111.78 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.67 150.28 54.88 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 106.171 -1.788 . . . . 73.209999999999994 106.171 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.53 162.8 35.26 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.894 1.73 . . . . 43.100000000000001 112.73 -170.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 157.86 32.34 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.266 -0.879 . . . . 60.210000000000001 111.101 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -61.39 159.59 30.19 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.025 1.33 . . . . 74.409999999999997 112.772 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.31 4.64 3.22 Favored 'Trans proline' 0 CA--C 1.536 0.611 1 C-N-CA 125.596 4.197 . . . . 62.399999999999999 114.304 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 140.84 8.3 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 108.089 -2.004 . . . . 61.210000000000001 108.089 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.98 161.97 28.27 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.547 2.339 . . . . 64.420000000000002 108.321 171.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' CG ' HG22 ' A' ' 99' ' ' ILE . 11.7 Cg_endo -63.76 142.15 81.75 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.169 1.913 . . . . 73.439999999999998 109.258 160.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.2 m -127.23 170.9 11.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.223 1.409 . . . . 52.119999999999997 110.185 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.75 31.78 0.7 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.801 2.441 . . . . 75.420000000000002 114.951 169.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.486 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.6 mp -54.96 143.61 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 126.597 1.959 . . . . 74.140000000000001 109.004 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -119.15 147.25 44.4 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.573 0.749 . . . . 75.310000000000002 109.362 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.4 mt -146.36 126.72 6.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.979 -1.489 . . . . 71.319999999999993 106.979 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -141.69 173.83 11.14 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 126.924 2.09 . . . . 75.430000000000007 107.752 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -130.64 159.86 35.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.197 0.999 . . . . 60.149999999999999 108.946 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 m -152.91 165.54 17.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 125.855 1.662 . . . . 51.310000000000002 107.987 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.54 -29.22 84.23 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.093 1.862 . . . . 72.430000000000007 112.761 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 -38.22 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.205 0.602 . . . . 73.25 110.702 -169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.34 -165.2 26.34 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.181 1.372 . . . . 71.040000000000006 112.965 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.48 140.1 50.05 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.968 1.884 . . . . 73.219999999999999 110.258 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -85.5 96.07 9.49 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.645 1.578 . . . . 72.420000000000002 109.546 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -98.25 125.26 43.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.26 1.024 . . . . 72.430000000000007 108.745 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -137.48 160.81 38.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.765 0.711 . . . . 63.109999999999999 109.262 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.11 166.97 31.9 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.896 . . . . 74.040000000000006 109.703 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -101.43 159.91 28.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.884 -0.579 . . . . 73.239999999999995 111.395 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.35 175.49 9.28 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.697 3.598 . . . . 55.539999999999999 113.138 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.57 117.02 4.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.044 1.829 . . . . 74.109999999999999 108.707 167.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 m -151.32 19.31 0.75 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.033 1.333 . . . . 75.340000000000003 112.816 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -104.5 -62.16 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.44 -1.319 . . . . 64.400000000000006 107.44 168.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -116.81 161.57 19.07 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.996 -1.113 . . . . 51.299999999999997 107.996 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 m -68.69 -66.66 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.408 0.683 . . . . 72.209999999999994 110.367 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 171.86 2.47 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 122.159 0.866 . . . . 43.509999999999998 111.793 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -110.85 76.56 0.98 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.671 -1.974 . . . . 74.340000000000003 105.671 163.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -64.83 147.42 12.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.117 -1.068 . . . . 75.319999999999993 108.117 170.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.5 pt -130.9 -26.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.656 1.982 . . . . 75.120000000000005 110.106 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -168.07 -175.33 2.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.871 1.669 . . . . 73.299999999999997 107.451 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -127.14 167.89 15.4 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.118 -1.614 . . . . 73.239999999999995 109.128 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t -143.67 168.69 19.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.999 -1.063 . . . . 64.120000000000005 111.507 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG13 HG12 ' A' ' 99' ' ' ILE . 21.7 t -149.45 128.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.282 -1.377 . . . . 40.329999999999998 107.282 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.62 144.58 43.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.253 1.021 . . . . 74.010000000000005 108.594 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.418 HD22 HG11 ' A' ' 67' ' ' VAL . 14.3 tp -120.73 136.15 54.95 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.342 2.657 . . . . 75.209999999999994 107.662 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.13 130.59 41.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.52 1.963 . . . . 73.329999999999998 109.249 172.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.7 171.59 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.826 1.25 . . . . 75.010000000000005 109.217 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -82.02 100.01 9.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.11 0.964 . . . . 74.450000000000003 108.822 161.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.37 -176.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 131.08 3.752 . . . . 64.010000000000005 106.481 167.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 t -141.43 -174.81 4.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.356 1.462 . . . . 70.150000000000006 109.268 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 64.53 100.18 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.704 2.401 . . . . 71.319999999999993 112.624 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.74 173.12 11.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.566 1.946 . . . . 65.349999999999994 110.198 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 p 174.9 135.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.058 1.743 . . . . 70.329999999999998 110.595 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.89 -3.44 0.03 OUTLIER Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.736 1.454 . . . . 63.039999999999999 116.736 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.1 156.9 63.38 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.607 1.704 . . . . 72.310000000000002 112.968 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.42 174.92 10.12 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.092 3.195 . . . . 64.439999999999998 112.174 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? 62.29 5.49 1.57 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.028 1.731 . . . . 54.439999999999998 112.241 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.06 -72.5 0.07 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.746 -1.221 . . . . 65.099999999999994 108.164 -155.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 65.32 -74.17 0.06 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.721 2.408 . . . . 42.130000000000003 108.191 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 t -165.96 144.43 4.87 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 127.058 2.143 . . . . 73.219999999999999 105.565 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.52 82.87 1.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.893 2.395 . . . . 63.210000000000001 109.771 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.34 98.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.779 2.432 . . . . 74.140000000000001 114.748 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -80.46 34.84 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.54 1.136 . . . . 74.010000000000005 111.739 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.41 HD13 ' CE2' ' A' ' 64' ' ' PHE . 1.4 mt -152.15 148.02 27.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.27 3.028 . . . . 75.420000000000002 103.726 -166.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.23 114.06 24.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.859 -0.793 . . . . 63.32 108.859 171.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CE2' HD13 ' A' ' 62' ' ' LEU . 17.4 m-85 -133.82 161.15 35.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.339 1.455 . . . . 74.430000000000007 108.812 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.4 ttp -105.5 130.39 53.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.957 1.303 . . . . 64.040000000000006 107.629 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -71.95 85.95 0.99 Allowed 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.987 -1.116 . . . . 74.109999999999999 107.987 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG11 HD22 ' A' ' 43' ' ' LEU . 3.5 m -65.39 -48.5 82.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.377 0.608 . . . . 63.409999999999997 109.857 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.84 104.77 4.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.846 1.258 . . . . 71.019999999999996 109.882 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.5 t -160.2 75.93 0.6 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.656 -0.868 . . . . 74.140000000000001 108.656 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.24 46.8 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.001 -1.095 . . . . 45.240000000000002 114.445 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.66 -7.09 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.935 3.757 . . . . 73.099999999999994 112.449 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 m -48.32 144.34 6.37 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.356 1.862 . . . . 62.119999999999997 112.362 -169.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.89 109.79 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.339 2.026 . . . . 73.239999999999995 109.121 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.57 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.818 1.647 . . . . 71.409999999999997 108.943 -170.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.2 t -171.49 159.89 5.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.608 2.004 . . . . 74.209999999999994 109.248 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -130.82 97.74 4.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.045 1.738 . . . . 74.019999999999996 106.351 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.83 117.03 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 106.855 -1.535 . . . . 73.430000000000007 106.855 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -60.66 148.07 39.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.492 0.587 . . . . 73.239999999999995 109.951 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -55.23 -32.15 62.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.186 0.994 . . . . 64.409999999999997 112.833 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -61.41 -28.32 69.17 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.643 1.111 . . . . 72.140000000000001 113.216 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -70.31 -38.16 74.9 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.593 -1.317 . . . . 74.030000000000001 109.708 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.04 -40.63 96.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.872 0.869 . . . . 73.349999999999994 108.912 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -59.46 -14.24 11.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.584 1.554 . . . . 60.030000000000001 115.072 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.82 -3.92 12.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.335 0.97 . . . . 54.219999999999999 111.401 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.12 153.12 22.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.016 0.926 . . . . 74.439999999999998 110.189 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -137.51 158.14 45.02 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.883 1.273 . . . . 75.25 109.654 -167.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.77 137.35 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 110.92 -149.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.5 48.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.848 1.659 . . . . 74.420000000000002 110.8 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -57.85 -12.74 3.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.575 1.15 . . . . 73.530000000000001 113.364 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -17.91 60.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.646 1.178 . . . . 64.129999999999995 112.107 170.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -130.07 -58.19 1.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.813 1.645 . . . . 72.230000000000004 110.134 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -150.79 162.08 28.18 Favored Pre-proline 0 C--N 1.341 0.23 0 C-N-CA 124.753 1.221 . . . . 75.129999999999995 110.268 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.71 87.85 0.43 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.477 1.451 . . . . 54.119999999999997 108.805 155.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -151.61 155.45 38.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.74 2.016 . . . . 54.439999999999998 110.428 166.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mt -80.67 -25.22 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 116.295 1.961 . . . . 73.040000000000006 116.295 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mm 61.19 151.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 130.754 3.622 . . . . 71.409999999999997 111.625 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -127.77 145.23 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.65 -1.241 . . . . 75.319999999999993 107.65 166.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.53 99.76 8.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.555 -1.646 . . . . 72.019999999999996 106.555 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 26' ' ' TRP . 44.0 mt -109.29 127.46 66.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.811 -2.292 . . . . 61.399999999999999 104.811 -170.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . . . -150.25 163.76 37.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.382 1.087 . . . . 72.200000000000003 113.334 171.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.75 123.63 30.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.777 1.631 . . . . 51.210000000000001 107.516 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -76.33 104.97 7.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.489 -1.671 . . . . 72.200000000000003 106.489 164.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -123.82 -179.47 4.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.912 1.285 . . . . 74.310000000000002 110.155 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.74 -28.62 60.85 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.011 0.745 . . . . 75.120000000000005 113.011 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.71 -13.41 59.22 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.933 0.893 . . . . 64.430000000000007 111.997 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.38 169.19 45.67 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 124.847 1.213 . . . . 60.409999999999997 111.018 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -67.83 73.9 0.18 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.727 2.011 . . . . 75.040000000000006 111.159 178.539 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 -64.77 2.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.039 1.78 . . . . 55.399999999999999 110.044 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.28 163.64 35.49 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 120.04 1.92 . . . . 73.0 111.493 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.68 100.67 1.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.231 -1.766 . . . . 61.100000000000001 106.231 168.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -79.18 93.87 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.104 -1.443 . . . . 72.340000000000003 107.104 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.76 84.55 3.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.642 1.577 . . . . 42.149999999999999 108.177 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -82.78 167.63 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.942 -1.133 . . . . 72.200000000000003 107.942 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 152.01 51.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.702 -0.851 . . . . 73.349999999999994 108.702 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.546 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 1.7 t90 -120.7 102.42 8.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.981 1.372 . . . . 73.25 113.297 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -91.93 14.06 16.78 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.435 -0.802 . . . . 53.030000000000001 111.201 -169.014 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -72.13 -2.0 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.195 -0.907 . . . . 75.239999999999995 110.913 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -82.54 52.11 2.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.84 1.655 . . . . 75.439999999999998 112.193 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.87 160.68 42.0 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.719 1.208 . . . . 72.209999999999994 109.444 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 m -60.52 104.51 0.34 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.26 1.024 . . . . 74.510000000000005 109.977 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -146.82 161.93 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.981 1.712 . . . . 72.549999999999997 107.292 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -157.55 173.6 16.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.984 1.714 . . . . 64.230000000000004 106.424 175.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.8 m 55.94 38.99 30.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.441 1.497 . . . . 53.140000000000001 112.028 164.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.7 m -90.16 -44.51 9.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.425 1.49 . . . . 64.409999999999997 111.491 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -103.75 -168.24 25.34 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 124.794 1.188 . . . . 72.450000000000003 111.856 -165.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.246 0.872 0 C-N-CA 126.006 1.722 . . . . 74.319999999999993 106.654 178.189 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.36 -1.496 . . . . 72.299999999999997 109.36 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.8 m 71.89 44.82 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.102 2.161 . . . . 73.530000000000001 112.898 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mp 65.55 160.49 0.13 Allowed Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 127.434 2.293 . . . . 60.329999999999998 112.525 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.14 -55.23 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.644 1.562 . . . . 71.140000000000001 110.601 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.92 167.32 38.07 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.066 -1.213 . . . . 55.420000000000002 110.066 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.45 154.98 70.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.116 0.967 . . . . 74.219999999999999 110.251 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.88 172.03 17.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.287 2.658 . . . . 72.329999999999998 111.781 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.01 -113.7 3.72 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.808 -1.717 . . . . 74.200000000000003 108.808 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.14 155.18 0.15 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 129.936 3.294 . . . . 73.540000000000006 111.0 -162.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.84 141.63 59.85 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.43 1.42 . . . . 65.129999999999995 108.924 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -137.5 -169.54 2.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.057 2.143 . . . . 74.239999999999995 107.938 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.3 34.8 3.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.108 1.763 . . . . 52.200000000000003 112.194 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.06 131.12 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.436 -0.95 . . . . 70.230000000000004 108.436 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -133.06 151.31 52.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.848 1.659 . . . . 74.519999999999996 108.393 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 24' ' ' LEU . 30.8 mt -142.73 91.79 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 105.041 -2.207 . . . . 72.439999999999998 105.041 -172.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -88.19 108.32 19.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.251 -1.018 . . . . 64.129999999999995 108.251 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 139.71 45.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.315 0.646 . . . . 73.030000000000001 109.9 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -148.67 166.52 15.25 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 123.564 0.746 . . . . 65.430000000000007 111.056 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -51.42 -46.67 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.9 1.733 . . . . 73.400000000000006 111.281 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -28.61 65.11 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.297 1.039 . . . . 72.400000000000006 111.424 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -104.31 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.569 -1.413 . . . . 74.299999999999997 109.569 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.76 120.97 6.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.793 -1.188 . . . . 45.32 107.793 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.53 134.47 51.34 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.597 1.159 . . . . 71.019999999999996 108.903 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' CD2' HG23 ' A' ' 15' ' ' ILE . 13.9 mt -116.35 144.23 44.53 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.555 -0.535 . . . . 73.329999999999998 109.555 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 p -140.21 160.66 39.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 117.83 -1.081 . . . . 71.010000000000005 108.174 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -159.97 173.75 15.41 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.842 1.657 . . . . 71.439999999999998 108.875 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.47 162.8 20.06 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.419 1.088 . . . . 72.230000000000004 110.263 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.78 155.73 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.748 2.298 . . . . 45.43 111.154 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.62 149.39 23.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.067 2.512 . . . . 74.329999999999998 111.573 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 t 76.48 135.6 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.885 2.474 . . . . 72.319999999999993 109.466 -160.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.96 -27.53 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 113.821 -1.536 . . . . 65.219999999999999 108.48 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.2 p -87.65 175.27 7.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.756 -1.215 . . . . 74.129999999999995 110.233 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 p -45.79 -48.98 15.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.692 1.597 . . . . 65.5 114.094 -169.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.94 -169.99 41.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.426 -1.469 . . . . 61.130000000000003 109.426 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -142.19 52.31 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.307 1.443 . . . . 74.340000000000003 109.493 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.39 142.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.74 -0.837 . . . . 71.239999999999995 108.74 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 pt -136.09 -15.59 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.684 1.993 . . . . 71.340000000000003 111.651 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -169.42 -168.06 0.77 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.048 2.139 . . . . 74.010000000000005 107.602 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.23 -178.6 5.93 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.331 -1.481 . . . . 74.200000000000003 110.077 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -145.78 155.33 42.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.258 1.023 . . . . 54.100000000000001 111.24 167.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -146.75 93.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.408 2.683 . . . . 74.239999999999995 105.15 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -95.98 130.11 43.06 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.825 -1.176 . . . . 65.200000000000003 107.825 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.69 124.07 34.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.663 1.119 . . . . 73.040000000000006 107.993 -168.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.46 129.49 40.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.733 0.697 . . . . 73.030000000000001 110.99 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.2 pt -132.31 171.09 18.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.15 -1.796 . . . . 73.019999999999996 106.15 166.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -81.49 88.89 6.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 73.219999999999999 108.599 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 t -165.07 -178.63 5.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.669 1.987 . . . . 65.040000000000006 107.212 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 t -143.49 165.78 26.61 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.376 -0.972 . . . . 71.409999999999997 108.376 153.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -147.09 160.91 41.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.521 1.129 . . . . 54.109999999999999 109.914 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.08 81.77 1.75 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 54.210000000000001 110.903 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.82 123.88 4.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.925 -2.25 . . . . 73.120000000000005 104.925 171.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.64 -128.44 3.49 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 107.385 -2.286 . . . . 54.32 107.385 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 5.3 mt-10 -130.93 167.04 23.19 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.249 1.419 . . . . 54.509999999999998 109.205 168.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 53' ' ' GLU . 87.6 Cg_endo -62.34 -164.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 125.123 3.882 . . . . 64.0 111.113 169.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.1 tttt 66.68 47.57 1.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.056 -1.028 . . . . 73.5 111.571 165.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m 58.87 43.86 17.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.613 1.165 . . . . 73.439999999999998 110.099 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.1 -36.7 0.37 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.319 3.047 . . . . 64.409999999999997 113.609 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.276 13.5 t 48.08 159.11 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.071 1 C-N-CA 132.209 4.203 . . . . 64.140000000000001 111.994 -170.634 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.19 171.55 17.62 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.322 2.015 . . . . 61.310000000000002 111.291 165.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 56.06 37.76 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.656 1.982 . . . . 75.439999999999998 112.854 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -67.55 165.07 17.62 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.501 1.521 . . . . 75.319999999999993 108.571 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.83 165.9 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.668 -1.605 . . . . 74.310000000000002 106.668 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.68 113.37 7.07 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.143 -0.688 . . . . 62.210000000000001 109.143 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -134.0 -179.51 5.6 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.861 1.665 . . . . 72.349999999999994 110.506 -165.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.9 ptm -80.94 165.92 21.33 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.895 -1.15 . . . . 72.349999999999994 107.895 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -125.42 83.02 2.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.109 -1.441 . . . . 74.329999999999998 107.109 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.75 -38.44 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.966 -0.459 . . . . 73.129999999999995 110.282 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -54.59 110.57 0.65 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.361 . . . . 70.400000000000006 112.533 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.9 p -147.81 24.55 1.07 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.379 0.672 . . . . 74.319999999999993 111.883 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.83 163.78 29.72 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.298 -0.723 . . . . 31.010000000000002 112.456 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.06 -54.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.376 2.717 . . . . 54.310000000000002 110.524 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.18 143.86 96.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.06 -1.089 . . . . 64.400000000000006 108.06 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.9 -46.42 1.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.514 2.143 . . . . 65.209999999999994 109.935 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -66.04 77.0 0.09 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.399 2.68 . . . . 74.019999999999996 108.778 168.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.6 t -96.17 -173.17 2.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.39 2.276 . . . . 51.539999999999999 109.54 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.09 159.97 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.786 -1.196 . . . . 74.219999999999999 109.656 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.48 115.03 47.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.557 -2.016 . . . . 61.219999999999999 105.557 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 151.11 45.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.587 1.155 . . . . 71.200000000000003 111.159 -168.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 p -51.82 -43.58 63.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.757 1.623 . . . . 71.340000000000003 111.96 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.5 t -51.43 -63.43 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.495 1.518 . . . . 51.25 110.235 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -60.77 -33.93 73.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.051 0.54 . . . . 73.230000000000004 110.932 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.2 mt -66.85 -23.11 65.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 117.974 -1.012 . . . . 74.109999999999999 111.778 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -56.42 -24.4 44.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.495 1.043 . . . . 72.25 111.884 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -102.83 1.41 34.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.944 0.898 . . . . 73.040000000000006 111.687 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.7 120.87 13.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.627 0.649 . . . . 75.409999999999997 109.621 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -83.26 148.05 27.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.485 -0.931 . . . . 72.230000000000004 108.485 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -110.69 147.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.108 -0.701 . . . . 75.420000000000002 109.108 -163.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.65 71.0 0.7 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.854 1.662 . . . . 72.430000000000007 111.769 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -76.26 53.0 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.154 1.782 . . . . 74.209999999999994 108.238 170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -55.23 0.34 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.067 -1.02 . . . . 63.219999999999999 108.734 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -94.08 -68.63 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.808 -0.558 . . . . 75.329999999999998 110.121 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -148.14 144.31 18.69 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 125.587 1.555 . . . . 55.32 106.975 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -67.42 108.01 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.959 1.773 . . . . 73.439999999999998 111.238 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 116' ' ' LEU 0.264 . . -147.57 165.54 30.05 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 131.318 3.847 . . . . 75.109999999999999 107.369 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.23 137.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.606 -1.627 . . . . 74.040000000000006 106.606 160.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.9 mm -100.93 152.51 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.373 1.469 . . . . 63.240000000000002 109.29 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.73 129.2 34.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.032 1.333 . . . . 73.010000000000005 109.162 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -96.14 89.89 5.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.791 -1.559 . . . . 73.129999999999995 106.791 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.2 mt -94.33 134.88 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.705 -1.591 . . . . 74.030000000000001 106.705 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.7 144.09 25.88 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.528 0.731 . . . . 74.030000000000001 109.748 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.61 152.21 37.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.298 0.639 . . . . 73.129999999999995 110.448 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.1 98.33 8.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.482 -2.044 . . . . 71.099999999999994 105.482 171.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -129.6 -171.02 2.41 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.272 1.429 . . . . 73.439999999999998 108.519 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -61.05 -35.36 76.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.485 0.55 . . . . 73.310000000000002 112.485 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -60.98 -26.06 67.3 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.882 1.673 . . . . 74.209999999999994 112.843 -166.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.37 36.64 3.77 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 117.076 1.59 . . . . 72.319999999999993 117.076 156.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 55.47 92.39 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 129.832 3.253 . . . . 74.129999999999995 113.187 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' H ' ' HD2' ' A' ' 109' ' ' PRO . . . -126.36 -70.45 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 126.728 2.108 . . . . 62.140000000000001 108.958 172.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 108' ' ' GLY . 85.9 Cg_endo -72.6 143.05 37.3 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 119.31 1.555 . . . . 73.340000000000003 109.479 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.72 142.92 20.34 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.583 -1.266 . . . . 61.399999999999999 107.583 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 m -108.05 109.73 21.25 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.861 -0.792 . . . . 75.040000000000006 108.861 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -72.4 95.18 1.72 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.226 -1.027 . . . . 73.400000000000006 108.226 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.95 151.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.107 -1.072 . . . . 75.329999999999998 108.107 166.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.74 139.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.418 1.887 . . . . 74.310000000000002 106.751 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -124.18 100.14 6.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.503 0.721 . . . . 75.409999999999997 109.943 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 6.2 mp -90.18 42.64 1.11 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 122.611 1.196 . . . . 74.209999999999994 110.285 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -125.01 7.83 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.007 2.123 . . . . 71.329999999999998 109.38 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -27.86 66.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.719 0.691 . . . . 73.129999999999995 112.649 176.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.8 m -65.61 152.38 44.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.168 1.787 . . . . 62.25 110.517 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 p -78.92 126.14 30.3 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.495 -0.753 . . . . 72.340000000000003 110.847 -165.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.69 -79.05 0.31 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 118.504 -0.76 . . . . 63.420000000000002 110.421 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -164.38 -84.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 74.140000000000001 109.996 -166.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.6 t 61.77 83.26 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.015 1.726 . . . . 74.0 110.509 -164.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 t -130.65 158.65 39.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.992 -1.114 . . . . 72.299999999999997 107.992 158.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 154.93 -170.12 33.13 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.209 -1.957 . . . . 61.0 108.209 -169.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 108.616 -0.883 . . . . 71.409999999999997 108.616 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.816 0 N-CA-C 109.663 -1.375 . . . . 43.350000000000001 109.663 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 90.7 m -93.23 6.08 49.28 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.216 1.008 . . . . 63.450000000000003 113.473 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.1 mt 75.91 149.82 0.13 Allowed Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 128.685 2.794 . . . . 74.109999999999999 110.141 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.18 -14.72 35.08 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.097 2.531 . . . . 70.040000000000006 114.176 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.69 -178.65 47.42 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 106.863 -2.495 . . . . 72.329999999999998 106.863 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -116.54 86.1 17.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.955 0.902 . . . . 71.409999999999997 109.585 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.44 -20.61 13.96 Favored 'Trans proline' 0 C--N 1.347 0.472 1 C-N-CA 125.827 4.352 . . . . 72.150000000000006 113.048 -166.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.53 156.86 48.29 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.022 -1.231 . . . . 64.120000000000005 110.022 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.79 165.57 9.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 126.728 2.011 . . . . 52.229999999999997 107.176 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -61.47 146.17 97.32 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.466 1.444 . . . . 72.030000000000001 109.723 161.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.7 176.5 7.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.337 1.455 . . . . 71.329999999999998 109.422 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 44.29 31.75 0.61 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 128.815 2.846 . . . . 73.299999999999997 113.82 174.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.97 133.28 27.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.158 -1.053 . . . . 72.010000000000005 108.158 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -129.49 142.44 50.78 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 123.546 0.738 . . . . 73.340000000000003 109.244 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.53 128.98 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 103.251 -2.87 . . . . 71.430000000000007 103.251 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -147.14 137.08 23.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.562 1.145 . . . . 65.209999999999994 108.257 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -64.18 144.89 56.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.379 -0.971 . . . . 63.409999999999997 108.379 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.0 162.16 53.71 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 126.888 2.075 . . . . 72.420000000000002 106.424 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 -10.89 27.65 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.028 1.152 . . . . 65.299999999999997 112.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.141 0.882 . . . . 64.430000000000007 111.702 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -118.37 0.83 Allowed Glycine 0 C--N 1.342 0.886 0 O-C-N 120.494 -1.379 . . . . 62.140000000000001 110.763 -172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.47 132.45 26.08 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.537 1.169 . . . . 32.049999999999997 110.963 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.24 149.59 50.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.128 1.371 . . . . 41.340000000000003 109.44 162.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 2.9 mp -142.22 123.26 14.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.646 1.578 . . . . 72.230000000000004 108.702 166.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -133.35 156.96 46.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.092 -0.707 . . . . 53.420000000000002 109.092 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -148.68 178.57 8.53 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.816 0.446 . . . . 73.299999999999997 110.577 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 9.2 mm-40 -139.39 159.52 65.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.114 1.766 . . . . 71.140000000000001 110.363 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.22 167.35 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.156 2.57 . . . . 73.030000000000001 111.05 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.45 -55.58 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.649 2.233 . . . . 73.239999999999995 110.71 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.46 39.92 8.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.474 -1.306 . . . . 64.239999999999995 107.474 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.07 -49.96 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.99 1.316 . . . . 73.340000000000003 113.75 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -64.68 154.66 35.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.099 1.318 . . . . 70.420000000000002 109.864 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -95.41 55.43 1.72 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.681 0.792 . . . . 70.140000000000001 109.572 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.53 134.18 11.64 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 108.561 -1.815 . . . . 70.230000000000004 108.561 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -81.66 82.12 7.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.162 -1.051 . . . . 65.340000000000003 108.162 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.72 131.85 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.739 -1.578 . . . . 74.349999999999994 106.739 168.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -126.86 -24.24 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.869 1.267 . . . . 65.239999999999995 111.36 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -163.3 -170.53 2.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.209 1.404 . . . . 74.409999999999997 107.606 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.37 177.54 8.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.665 1.186 . . . . 73.040000000000006 110.302 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.48 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -135.43 154.56 51.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.15 1.38 . . . . 70.150000000000006 108.601 163.401 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -143.72 112.24 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.432 -2.062 . . . . 70.120000000000005 105.432 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 40' ' ' SER . 87.3 m-85 -110.93 150.95 28.48 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.337 1.055 . . . . 64.25 109.742 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.78 121.31 25.15 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.342 1.857 . . . . 74.409999999999997 106.045 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.33 121.81 15.2 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.227 1.011 . . . . 71.019999999999996 110.771 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 pt -136.79 -177.11 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.325 1.45 . . . . 61.009999999999998 109.084 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . 0.277 3.5 pp0? -130.97 64.36 1.58 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 123.292 1.52 . . . . 74.310000000000002 112.767 171.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.0 m -149.94 162.88 39.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.269 1.828 . . . . 73.200000000000003 108.591 162.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.9 m 50.7 -154.55 0.14 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 75.040000000000006 112.83 159.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -149.91 167.84 25.49 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.44 1.096 . . . . 71.040000000000006 109.365 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.67 -174.39 2.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.212 0.605 . . . . 73.430000000000007 110.708 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.85 115.86 5.29 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.224 -2.139 . . . . 71.319999999999993 105.224 173.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.22 114.68 0.92 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.793 1.179 . . . . 64.439999999999998 110.363 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.19 164.77 20.32 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 127.058 2.143 . . . . 70.409999999999997 108.356 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.75 -170.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.02 2.48 . . . . 74.319999999999993 110.49 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -83.19 48.55 1.4 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.72 2.008 . . . . 73.120000000000005 107.795 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.0 t 70.8 84.9 0.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.719 2.407 . . . . 54.43 108.556 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -144.48 16.1 1.65 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 71.230000000000004 111.799 169.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.2 m -121.66 80.56 39.87 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-N 119.614 1.097 . . . . 54.509999999999998 109.087 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.47 64.22 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.933 2.422 . . . . 74.019999999999996 109.96 169.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.45 93.7 0.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 127.818 2.447 . . . . 74.329999999999998 105.46 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.17 138.41 58.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.643 -0.503 . . . . 72.230000000000004 109.643 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.402 HD22 ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -144.01 160.94 39.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.766 0.826 . . . . 72.109999999999999 110.589 -175.083 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.78 102.85 4.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.856 1.262 . . . . 72.329999999999998 109.655 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 62' ' ' LEU . 22.6 m-85 -132.37 152.36 51.48 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.881 1.272 . . . . 52.439999999999998 109.58 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.1 ttp -78.34 5.0 11.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.457 1.28 . . . . 74.340000000000003 114.457 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.39 58.65 3.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.403 1.481 . . . . 65.030000000000001 112.155 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.79 -13.34 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.542 0.737 . . . . 62.200000000000003 112.9 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.21 -177.05 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.009 1.323 . . . . 64.109999999999999 112.063 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 44.7 m 62.57 42.69 8.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.455 1.902 . . . . 63.439999999999998 109.7 -168.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 155.88 42.04 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.111 -1.196 . . . . 72.0 110.111 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.74 -20.41 52.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.546 2.831 . . . . 74.439999999999998 112.692 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -135.05 149.37 70.11 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.95 1.3 . . . . 72.040000000000006 110.573 167.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.7 176.82 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 124.484 3.456 . . . . 42.109999999999999 111.86 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.6 p 46.63 40.71 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.45 1.5 . . . . 54.310000000000002 110.707 -170.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.66 123.88 23.5 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.22 1.808 . . . . 52.399999999999999 112.139 -167.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.39 147.37 26.29 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.933 1.293 . . . . 71.099999999999994 108.403 159.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.45 115.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.08 2.152 . . . . 71.340000000000003 105.711 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -65.53 154.38 38.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.801 0.84 . . . . 71.129999999999995 110.776 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -63.63 -19.25 64.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.633 1.173 . . . . 54.310000000000002 112.145 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -37.67 69.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.108 1.763 . . . . 73.400000000000006 111.204 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 m -71.64 -41.9 68.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.775 0.83 . . . . 73.120000000000005 111.267 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -26.19 67.23 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.4 1.08 . . . . 74.439999999999998 111.931 -175.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.49 -33.33 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.233 1.413 . . . . 52.530000000000001 110.602 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.31 -18.82 23.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.113 1.365 . . . . 71.319999999999993 112.267 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.71 9.94 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.16 1.384 . . . . 74.010000000000005 109.665 -170.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 147.49 23.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.675 0.79 . . . . 73.0 109.207 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -103.13 140.73 20.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.443 0.64 . . . . 74.209999999999994 109.305 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -59.2 110.45 1.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.576 1.95 . . . . 74.340000000000003 109.643 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -112.93 14.29 19.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.205 1.002 . . . . 70.129999999999995 110.512 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 82.6 p -102.53 -18.85 15.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.947 1.299 . . . . 51.229999999999997 112.696 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.91 -81.03 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 70.310000000000002 108.67 172.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -142.86 149.13 48.58 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 117.044 -1.455 . . . . 70.420000000000002 109.352 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.67 98.56 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 64.140000000000001 110.869 -171.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -150.97 164.74 35.67 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.475 1.91 . . . . 65.040000000000006 108.969 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.418 HD12 ' CE3' ' A' ' 115' ' ' TRP . 88.1 mt -83.83 128.21 39.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.381 -1.711 . . . . 64.299999999999997 106.381 167.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.8 mm -76.88 132.07 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.683 -1.228 . . . . 73.430000000000007 107.683 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -118.2 143.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.5 -1.296 . . . . 74.340000000000003 107.5 168.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.16 119.83 35.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 106.365 -1.717 . . . . 71.439999999999998 106.365 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.44 137.06 58.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.302 -1.74 . . . . 64.030000000000001 106.302 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 144.89 27.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.415 0.686 . . . . 71.25 110.493 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.42 121.38 20.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.626 1.17 . . . . 63.32 109.915 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.64 81.3 6.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 104.946 -2.242 . . . . 71.109999999999999 104.946 166.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -98.12 165.62 11.81 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.273 -0.639 . . . . 74.120000000000005 109.273 164.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.9 -18.82 5.42 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.527 1.677 . . . . 74.450000000000003 115.527 -167.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -86.88 -13.05 45.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.778 -1.106 . . . . 74.049999999999997 113.316 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.26 172.91 16.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.566 1.075 . . . . 71.140000000000001 112.761 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -73.17 57.3 0.48 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.997 1.319 . . . . 74.030000000000001 109.977 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.05 3.9 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.031 -0.871 . . . . 73.109999999999999 111.116 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.29 158.47 57.44 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.64 1.56 . . . . 71.450000000000003 109.532 171.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.33 122.14 10.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.463 -1.68 . . . . 65.010000000000005 106.463 169.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.6 m -92.86 108.98 20.41 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.556 -1.646 . . . . 72.030000000000001 106.556 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -67.51 128.55 36.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.156 -1.794 . . . . 72.430000000000007 106.156 163.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.2 154.19 31.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.082 -1.821 . . . . 74.329999999999998 106.082 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.11 157.33 39.96 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.225 -1.028 . . . . 72.439999999999998 108.225 163.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.418 ' CE3' HD12 ' A' ' 95' ' ' ILE . 18.1 t90 -108.35 91.28 3.58 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 74.200000000000003 106.669 172.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 94' ' ' ALA . 17.2 mt -75.9 175.15 9.06 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.685 -0.857 . . . . 65.109999999999999 108.685 175.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 76.24 13.16 2.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.177 2.191 . . . . 74.219999999999999 112.637 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.11 162.31 17.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.698 1.237 . . . . 61.119999999999997 111.572 165.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 p -145.64 172.23 13.57 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 129.191 2.997 . . . . 72.200000000000003 106.833 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 m -51.87 -61.85 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.607 1.163 . . . . 73.019999999999996 111.653 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.546 ' HG2' ' H ' ' A' ' 122' ' ' ASP . 20.4 tttt 50.37 -179.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.691 2.396 . . . . 65.420000000000002 113.023 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.546 ' H ' ' HG2' ' A' ' 121' ' ' LYS . 8.8 p-10 -161.69 111.46 1.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.56 2.344 . . . . 70.420000000000002 106.332 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.1 t -172.69 157.23 3.74 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.447 2.299 . . . . 70.340000000000003 107.177 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.4 t -124.79 -170.53 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.576 1.15 . . . . 72.0 110.207 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -127.26 -126.79 2.95 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.903 1.239 . . . . 74.340000000000003 110.696 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.878 1.671 . . . . 50.509999999999998 106.646 -179.31 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.591 0 N-CA-C 110.502 -1.039 . . . . 73.129999999999995 110.502 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 87.5 m -78.09 177.28 8.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.045 0.938 . . . . 75.329999999999998 112.135 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.589 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.7 pt? -98.57 155.54 36.67 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.203 1.801 . . . . 64.5 109.08 166.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.05 64.78 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.253 2.635 . . . . 64.230000000000004 111.72 -175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.18 156.65 25.87 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.665 -1.374 . . . . 73.299999999999997 109.665 171.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.36 163.5 39.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.722 -0.473 . . . . 72.109999999999999 109.722 168.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.84 84.18 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.096 2.531 . . . . 64.5 111.826 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.08 123.92 0.83 Allowed Glycine 0 C--N 1.338 0.668 0 O-C-N 121.005 -1.059 . . . . 75.109999999999999 115.73 171.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.71 157.83 40.54 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.294 1.438 . . . . 74.109999999999999 109.646 166.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.27 164.25 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.702 3.601 . . . . 74.430000000000007 112.419 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.5 m -137.58 -174.48 3.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 61.509999999999998 110.005 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . . . 58.42 14.68 3.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.931 2.492 . . . . 75.549999999999997 116.986 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.491 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.7 mp -56.48 141.28 13.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 126.558 1.943 . . . . 75.530000000000001 112.031 -168.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -139.82 116.52 10.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.331 1.452 . . . . 72.109999999999999 110.609 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -115.96 131.48 68.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.842 -2.651 . . . . 55.329999999999998 103.842 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 m -143.28 149.12 37.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.625 0.726 . . . . 63.530000000000001 110.346 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -74.06 159.24 32.94 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.506 -0.924 . . . . 74.549999999999997 108.506 162.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 m -143.77 166.32 20.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 130.208 3.403 . . . . 55.049999999999997 105.607 170.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -54.42 -44.08 52.81 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.678 1.585 . . . . 63.119999999999997 111.781 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -12.18 59.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.9 1.68 . . . . 72.150000000000006 113.501 -170.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.89 -160.72 29.88 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.123 -1.191 . . . . 53.140000000000001 110.123 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.69 116.15 30.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.228 1.011 . . . . 61.450000000000003 109.216 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -69.25 140.23 54.46 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 129.603 3.161 . . . . 71.439999999999998 111.454 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.27 128.86 42.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.927 -1.138 . . . . 73.510000000000005 107.927 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -133.03 150.25 52.15 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.637 -0.875 . . . . 71.319999999999993 108.637 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.422 ' CD1' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.99 173.89 11.5 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.286 0.366 . . . . 74.329999999999998 110.272 173.246 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 25.2 pt-20 -66.85 154.62 91.66 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 119.806 -0.758 . . . . 74.329999999999998 112.277 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.36 160.84 44.01 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.752 2.302 . . . . 75.200000000000003 111.586 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HB2' HD13 ' A' ' 36' ' ' ILE . 62.6 Cg_endo -71.27 89.58 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.905 3.07 . . . . 60.240000000000002 112.182 -172.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -152.76 23.7 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.042 0.756 . . . . 55.219999999999999 113.042 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.4 t -126.23 -86.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.011 -0.995 . . . . 74.439999999999998 110.894 -171.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -131.75 -4.11 3.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.344 1.429 . . . . 75.400000000000006 110.978 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 36' ' ' ILE . 12.2 p -55.66 -19.32 10.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.356 3.062 . . . . 73.430000000000007 116.179 -172.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.4 -159.66 31.05 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 121.962 2.165 . . . . 61.109999999999999 111.675 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -79.52 93.64 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.822 1.649 . . . . 63.109999999999999 109.677 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 33' ' ' SER . 2.3 mp -71.4 142.23 15.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.579 -1.267 . . . . 72.230000000000004 107.579 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.9 pt -135.49 -17.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.783 1.633 . . . . 72.439999999999998 111.464 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -159.93 -171.71 3.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.326 1.851 . . . . 72.5 107.434 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 16.9 m-85 -134.38 174.33 10.65 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.354 -1.467 . . . . 75.140000000000001 108.937 162.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 m -144.01 155.4 44.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.334 -0.854 . . . . 74.239999999999995 108.799 159.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -140.06 119.35 12.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 104.747 -2.316 . . . . 73.129999999999995 104.747 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.413 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 13.6 m-85 -116.47 87.4 2.68 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.122 0.963 . . . . 72.409999999999997 109.814 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 tp -62.63 135.31 57.32 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.1 -1.444 . . . . 74.219999999999999 107.1 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.23 148.04 25.3 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.854 -0.795 . . . . 74.209999999999994 108.854 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.74 -165.9 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.223 1.809 . . . . 65.409999999999997 107.306 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -58.08 179.36 0.07 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 71.540000000000006 112.509 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 m 64.7 -158.2 0.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.118 1.767 . . . . 73.150000000000006 111.357 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -158.41 23.02 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.848 -1.158 . . . . 73.409999999999997 112.747 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -131.12 177.58 7.35 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.179 -0.951 . . . . 64.239999999999995 110.376 -166.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 50.88 61.67 3.12 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.866 2.066 . . . . 70.349999999999994 112.583 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.5 p -158.91 121.05 3.52 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.655 1.582 . . . . 53.009999999999998 107.846 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.27 96.75 0.1 Allowed Glycine 0 C--O 1.235 0.191 0 N-CA-C 109.021 -1.632 . . . . 62.130000000000003 109.021 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.02 154.44 92.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.79 0.836 . . . . 72.519999999999996 111.308 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.17 67.13 8.68 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.924 3.083 . . . . 65.540000000000006 110.353 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -110.18 6.17 22.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.191 0.997 . . . . 70.510000000000005 111.197 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.2 t 64.22 -1.77 0.67 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.754 2.022 . . . . 54.240000000000002 113.151 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -157.89 110.61 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.529 3.131 . . . . 73.540000000000006 104.265 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -127.78 68.83 75.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.971 0.908 . . . . 71.219999999999999 109.46 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.15 65.52 8.39 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.225 3.284 . . . . 70.439999999999998 112.073 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.419 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -157.78 105.0 1.98 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.875 2.07 . . . . 33.5 108.335 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -89.1 79.69 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.356 -1.35 . . . . 73.150000000000006 107.356 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.419 HD21 ' HB1' ' A' ' 60' ' ' ALA . 11.1 mt -69.84 -171.35 0.4 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.059 1.744 . . . . 64.150000000000006 109.768 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.32 123.39 22.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.112 -0.699 . . . . 65.219999999999999 109.112 172.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 16.7 m-85 -141.11 155.66 46.09 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.188 0.595 . . . . 74.510000000000005 112.22 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ttp -89.25 -39.36 13.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.81 0.844 . . . . 51.240000000000002 112.493 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 58.01 86.19 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.282 1.433 . . . . 73.310000000000002 109.085 -159.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.77 -5.91 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.904 -0.589 . . . . 72.409999999999997 112.067 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.3 103.07 7.74 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.584 0.629 . . . . 63.43 110.798 -163.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -137.17 53.67 1.88 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.03 1.332 . . . . 71.430000000000007 109.026 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.34 160.5 29.55 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.311 -0.868 . . . . 54.140000000000001 111.228 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -4.68 12.0 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.745 3.63 . . . . 72.219999999999999 112.591 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.0 m -43.46 89.31 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 130.047 3.339 . . . . 72.319999999999993 113.263 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -60.62 148.98 89.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.186 1.257 . . . . 73.140000000000001 111.139 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 p 46.21 47.36 13.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.838 1.255 . . . . 74.230000000000004 111.987 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.37 152.37 43.24 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.625 -1.297 . . . . 42.049999999999997 110.462 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.08 170.35 14.91 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.656 0.782 . . . . 63.409999999999997 110.883 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.55 122.57 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.033 1.733 . . . . 73.25 106.539 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.44 145.9 52.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.059 0.944 . . . . 73.129999999999995 109.657 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.428 ' HA ' HD12 ' A' ' 82' ' ' LEU . 9.8 p -54.28 -37.89 65.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.621 1.169 . . . . 32.210000000000001 111.649 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.77 -47.97 41.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.458 1.503 . . . . 74.420000000000002 111.268 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -78.99 -9.71 59.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.509 1.124 . . . . 24.440000000000001 112.899 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 79' ' ' SER . 74.5 mt -82.03 -34.55 29.46 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.579 1.081 . . . . 65.209999999999994 110.658 171.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -66.91 1.53 1.85 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 117.276 2.324 . . . . 73.409999999999997 117.276 -163.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -123.38 12.28 9.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.95 1.25 . . . . 72.140000000000001 111.505 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.01 156.72 37.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 122.478 1.132 . . . . 72.219999999999999 113.53 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 101.72 3.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.808 -1.182 . . . . 71.530000000000001 107.808 162.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.07 120.82 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.254 -1.758 . . . . 75.319999999999993 106.254 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.21 131.8 51.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 112.799 -2.0 . . . . 75.510000000000005 108.987 166.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.61 9.76 13.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.52 1.128 . . . . 75.540000000000006 111.162 171.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -6.5 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.799 -1.188 . . . . 71.140000000000001 113.942 -162.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.045 2.138 . . . . 73.329999999999998 111.026 173.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -151.8 156.18 34.21 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.604 1.561 . . . . 71.420000000000002 108.009 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.41 122.35 9.57 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.7 2.267 . . . . 72.409999999999997 108.748 164.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -160.47 -170.44 2.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.669 2.387 . . . . 61.450000000000003 108.645 161.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.9 mt -129.48 129.2 66.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 75.540000000000006 108.53 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.5 mm -72.49 142.19 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.507 1.523 . . . . 62.210000000000001 110.088 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -128.21 162.25 27.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.26 1.024 . . . . 61.420000000000002 108.934 167.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -134.98 84.72 2.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.327 1.851 . . . . 71.340000000000003 106.472 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.28 133.44 42.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.032 -1.469 . . . . 75.209999999999994 107.032 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.41 156.98 44.09 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.575 0.547 . . . . 54.009999999999998 110.497 161.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . . . -92.35 109.44 20.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.458 1.103 . . . . 62.340000000000003 109.758 -171.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -69.09 97.98 0.94 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.811 0.844 . . . . 74.310000000000002 109.142 -170.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -122.54 177.17 5.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.706 2.002 . . . . 61.219999999999999 110.824 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.63 -30.97 63.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.927 1.691 . . . . 74.120000000000005 113.821 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -8.96 58.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.207 1.188 . . . . 74.209999999999994 114.207 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.42 2.26 87.51 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.834 -1.166 . . . . 70.5 113.263 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' A' ' 102' ' ' ARG . 19.4 p90 45.59 36.16 2.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.064 1.746 . . . . 74.329999999999998 115.448 156.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.75 -66.5 2.8 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.519 2.009 . . . . 62.409999999999997 113.455 -165.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.84 152.07 81.16 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.158 1.906 . . . . 64.439999999999998 110.241 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.35 169.86 14.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.584 1.154 . . . . 55.130000000000003 108.865 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.1 m -97.26 113.99 25.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.303 0.641 . . . . 75.140000000000001 110.045 -176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.49 75.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.505 1.522 . . . . 75.140000000000001 110.04 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.9 155.14 7.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.858 -1.164 . . . . 75.430000000000007 107.858 164.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -121.74 124.59 44.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.705 -1.591 . . . . 62.409999999999997 106.705 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -75.17 82.73 2.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.132 0.424 . . . . 74.329999999999998 109.859 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 94' ' ' ALA . 27.7 mt -71.47 15.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.773 1.027 . . . . 74.129999999999995 113.773 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -95.74 -1.83 49.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.097 1.359 . . . . 72.140000000000001 111.637 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -109.22 161.78 14.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.835 1.198 . . . . 72.219999999999999 110.449 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.53 158.65 15.95 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.659 1.584 . . . . 64.510000000000005 106.875 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 54.2 p -87.48 11.42 14.77 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.974 1.31 . . . . 55.119999999999997 112.333 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -68.95 -59.96 2.69 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.622 -1.299 . . . . 71.150000000000006 111.684 -165.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -163.73 164.28 23.85 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.492 1.917 . . . . 73.349999999999994 108.154 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.6 m -146.45 131.58 18.35 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 120.051 1.296 . . . . 74.310000000000002 111.142 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.7 m -151.4 -65.42 0.18 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.257 1.023 . . . . 72.340000000000003 109.614 162.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.22 3.83 1.59 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.791 -1.56 . . . . 54.310000000000002 115.568 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.201 1 C-N-CA 133.071 4.549 . . . . 74.540000000000006 107.185 -170.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.513 0 N-CA-C 109.919 -1.273 . . . . 42.32 109.919 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 65.3 m -67.86 146.76 53.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.681 0.792 . . . . 72.530000000000001 109.606 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.7 tp -149.03 72.45 10.26 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.199 0.6 . . . . 74.209999999999994 109.675 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.69 157.67 60.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.258 1.306 . . . . 61.439999999999998 109.139 163.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.16 66.28 1.71 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.616 -0.993 . . . . 73.510000000000005 110.616 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.24 161.96 75.95 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.336 0.654 . . . . 75.349999999999994 110.634 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.03 6.53 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.735 3.624 . . . . 64.129999999999995 114.581 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.2 143.77 15.32 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 107.958 -2.057 . . . . 71.239999999999995 107.958 170.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.3 154.7 36.42 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.053 1.341 . . . . 74.340000000000003 108.278 162.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.59 158.85 30.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.296 1.998 . . . . 71.519999999999996 111.934 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -133.09 -178.09 4.81 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.527 1.531 . . . . 75.329999999999998 109.414 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.21 12.98 4.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.54 1.536 . . . . 51.219999999999999 114.823 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.22 132.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.948 1.299 . . . . 61.409999999999997 110.049 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.8 152.76 45.45 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.534 1.133 . . . . 53.0 110.934 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -142.17 115.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.541 -1.651 . . . . 61.240000000000002 106.541 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -111.35 -167.7 1.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.442 2.297 . . . . 71.439999999999998 110.629 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -143.22 146.51 33.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.903 -1.147 . . . . 75.150000000000006 107.903 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -146.45 160.15 42.75 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 126.234 1.814 . . . . 75.329999999999998 106.95 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.99 73.44 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.777 1.652 . . . . 71.409999999999997 111.594 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.79 -59.73 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 128.807 2.843 . . . . 61.43 105.692 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.15 -166.15 38.56 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.683 -1.367 . . . . 62.030000000000001 109.683 -163.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.14 113.72 26.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.731 1.612 . . . . 53.32 110.583 -165.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 78.42 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.772 3.229 . . . . 73.019999999999996 112.187 164.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.87 110.29 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.873 -1.142 . . . . 75.040000000000006 108.41 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -130.27 158.22 40.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.595 0.634 . . . . 44.039999999999999 111.621 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.503 ' CE3' HD13 ' A' ' 99' ' ' ILE . 25.6 p90 -173.64 175.7 2.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.23 2.612 . . . . 55.140000000000001 110.377 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -115.46 165.21 14.9 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.964 0.906 . . . . 71.129999999999995 111.932 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.14 156.97 51.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.685 2.923 . . . . 72.129999999999995 111.226 167.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.64 139.64 70.71 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.9 1.733 . . . . 60.109999999999999 109.596 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 t -127.67 58.95 1.47 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.77 -2.308 . . . . 64.340000000000003 104.77 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.39 -85.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.164 -1.791 . . . . 71.239999999999995 106.164 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.1 p -112.86 166.11 11.69 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.344 0.52 . . . . 74.329999999999998 110.425 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 m -56.67 -72.92 0.07 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.568 1.547 . . . . 64.140000000000001 111.546 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.43 -173.8 11.1 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.474 -1.45 . . . . 61.399999999999999 109.474 -164.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -137.23 68.54 1.41 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.649 1.58 . . . . 74.230000000000004 107.881 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.8 140.52 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.702 -0.851 . . . . 60.530000000000001 108.702 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 pt -135.89 -21.65 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.514 1.526 . . . . 71.129999999999995 111.34 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -158.02 174.8 14.68 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.117 1.767 . . . . 72.400000000000006 106.929 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.75 163.63 32.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.084 0.954 . . . . 74.099999999999994 108.973 174.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -150.61 153.05 34.99 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.119 -0.988 . . . . 54.43 112.496 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.47 142.56 43.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 126.095 1.758 . . . . 63.030000000000001 107.533 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.7 120.22 40.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.562 -2.014 . . . . 62.240000000000002 105.562 170.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.36 132.93 53.67 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.257 1.423 . . . . 64.349999999999994 107.198 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.44 131.19 40.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 118.17 -0.919 . . . . 73.230000000000004 109.178 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.91 179.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.725 1.21 . . . . 74.109999999999999 110.79 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 79.85 1.26 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.253 1.821 . . . . 73.25 109.614 167.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.7 p -159.06 163.21 36.5 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.445 -0.576 . . . . 62.25 109.445 166.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.5 m -75.53 -175.48 2.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.005 0.522 . . . . 60.130000000000003 110.079 170.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 66.14 87.2 0.12 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.029 1.731 . . . . 73.420000000000002 111.633 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 138.35 43.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.109 1.364 . . . . 75.329999999999998 108.286 164.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 173.95 135.58 0.04 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 129.558 3.143 . . . . 73.420000000000002 107.572 161.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.02 21.05 0.07 OUTLIER Glycine 0 C--N 1.336 0.541 0 CA-C-O 118.662 -1.077 . . . . 72.430000000000007 115.013 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.34 161.78 45.83 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.194 1.398 . . . . 62.32 112.132 -163.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.55 179.3 5.27 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.849 2.366 . . . . 75.109999999999999 111.346 167.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? 53.14 62.21 2.78 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.201 1.801 . . . . 74.150000000000006 111.748 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.6 m -71.94 45.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.054 1.741 . . . . 52.450000000000003 113.796 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.68 6.59 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.313 2.245 . . . . 72.519999999999996 109.945 168.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -68.91 153.54 95.93 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.795 -0.817 . . . . 73.349999999999994 108.795 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.16 155.33 35.03 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.538 2.158 . . . . 75.230000000000004 111.152 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.46 60.21 4.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.497 1.519 . . . . 24.43 110.878 -171.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -84.86 149.65 25.54 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.464 0.706 . . . . 75.510000000000005 109.47 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 64' ' ' PHE . 10.0 mt 50.04 -157.11 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.47 . . . . 61.439999999999998 109.842 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 174.64 104.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.098 2.159 . . . . 73.230000000000004 107.039 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CE2' HD13 ' A' ' 62' ' ' LEU . 21.7 m-30 -127.1 146.56 50.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.939 1.296 . . . . 75.230000000000004 110.106 -166.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttp -77.67 130.25 36.58 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.591 -1.263 . . . . 74.010000000000005 107.591 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -79.13 60.17 2.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.57 1.148 . . . . 73.310000000000002 109.551 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -53.19 -27.21 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 126.501 1.92 . . . . 63.109999999999999 113.903 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.0 121.71 27.03 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.45 -2.426 . . . . 73.239999999999995 104.45 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.5 t -152.03 79.59 1.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.733 -1.951 . . . . 74.239999999999995 105.733 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.93 176.56 45.0 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.717 -0.614 . . . . 75.430000000000007 112.358 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.26 -8.98 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.367 3.378 . . . . 73.329999999999998 112.64 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.38 158.14 8.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.59 1.556 . . . . 54.109999999999999 112.358 -172.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.16 -171.18 1.01 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.819 3.013 . . . . 71.040000000000006 110.653 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.83 110.76 0.25 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.806 2.442 . . . . 53.329999999999998 110.486 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.6 m -104.81 135.42 46.22 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.841 0.746 . . . . 51.509999999999998 110.261 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.48 119.96 10.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.335 1.054 . . . . 60.210000000000001 109.515 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.56 114.41 9.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.109 -1.812 . . . . 75.450000000000003 106.109 167.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.42 158.23 27.27 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.804 0.842 . . . . 53.310000000000002 110.744 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -50.06 -49.49 51.03 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.931 0.892 . . . . 44.109999999999999 112.318 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 p -59.99 -25.52 65.33 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.508 1.049 . . . . 61.329999999999998 113.697 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -40.01 32.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.845 1.202 . . . . 71.219999999999999 110.431 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.39 -45.31 94.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.319 1.047 . . . . 75.140000000000001 110.711 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -62.72 -24.18 67.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.513 1.525 . . . . 64.129999999999995 112.75 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -92.38 -9.52 41.44 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.211 1.004 . . . . 55.439999999999998 112.033 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.43 147.27 49.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.547 1.067 . . . . 73.329999999999998 111.232 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -93.62 129.3 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.382 1.073 . . . . 62.43 111.226 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -68.68 133.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 126.216 1.806 . . . . 75.519999999999996 109.331 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.47 111.29 3.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.856 -0.794 . . . . 61.310000000000002 108.856 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -103.62 64.1 0.8 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.144 0.973 . . . . 73.519999999999996 108.761 165.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 -26.77 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.029 -0.987 . . . . 74.439999999999998 113.616 171.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -146.52 -55.36 0.26 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.23 0.923 . . . . 73.150000000000006 111.266 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -149.53 144.53 17.94 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 117.161 -1.399 . . . . 75.120000000000005 108.19 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.63 97.37 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.144 2.563 . . . . 42.009999999999998 109.883 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -145.98 152.43 39.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.312 2.245 . . . . 72.430000000000007 109.2 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.5 mt -72.16 133.76 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.964 -1.495 . . . . 73.109999999999999 106.964 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.7 mm -81.61 136.07 23.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.068 0.947 . . . . 42.020000000000003 108.992 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -122.15 150.4 42.27 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.104 1.761 . . . . 75.120000000000005 107.785 165.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -133.26 132.96 42.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.169 -1.789 . . . . 74.140000000000001 106.169 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.503 HD13 ' CE3' ' A' ' 26' ' ' TRP . 20.8 mt -131.6 140.46 48.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.41 -0.959 . . . . 75.209999999999994 108.41 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.08 153.79 34.66 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.612 1.165 . . . . 73.549999999999997 110.497 170.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.14 141.38 41.93 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.734 0.813 . . . . 53.200000000000003 109.812 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.4 tpt85 -86.04 108.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 105.967 -1.864 . . . . 72.129999999999995 105.967 164.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -114.57 -176.15 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.398 -0.964 . . . . 61.32 108.398 165.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -52.51 -39.38 61.24 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.726 2.01 . . . . 71.540000000000006 112.048 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -47.7 53.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.28 -0.637 . . . . 63.539999999999999 109.28 -166.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.29 174.75 21.05 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.46 -0.656 . . . . 72.519999999999996 111.46 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -75.45 102.88 5.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.646 -1.612 . . . . 72.349999999999994 106.646 163.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.36 -64.71 0.86 Allowed Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.324 -1.265 . . . . 72.450000000000003 112.126 -171.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.73 179.02 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.21 2.607 . . . . 73.540000000000006 110.002 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.74 107.01 1.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.749 0.82 . . . . 60.450000000000003 109.159 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 m -71.53 110.13 5.92 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.386 -0.968 . . . . 64.510000000000005 108.386 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -82.08 103.12 11.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.451 1.5 . . . . 75.549999999999997 109.205 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.3 159.51 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.282 1.433 . . . . 55.140000000000001 107.747 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.43 155.45 45.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.724 -0.61 . . . . 72.209999999999994 110.325 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -138.32 109.56 6.88 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.107 0.963 . . . . 74.129999999999995 112.078 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.774 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.32 -177.93 5.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 128.732 2.813 . . . . 53.439999999999998 109.299 -177.203 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 73.72 9.84 4.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.14 1.776 . . . . 71.140000000000001 112.193 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.88 15.71 2.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.185 2.194 . . . . 74.420000000000002 114.417 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.1 m -104.25 78.88 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 119.002 -2.311 . . . . 55.25 109.636 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 t -166.67 84.44 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.83 1.252 . . . . 60.439999999999998 109.536 159.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -173.16 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.747 1.219 . . . . 73.040000000000006 111.691 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.52 55.22 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.66 1.584 . . . . 74.209999999999994 111.263 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.5 t 45.63 68.98 0.5 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.119 1.768 . . . . 35.020000000000003 113.307 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 p -64.77 -80.09 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.61 1.564 . . . . 72.140000000000001 110.799 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.39 156.87 7.08 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 127.135 2.302 . . . . 60.340000000000003 109.893 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.25 1.124 0 N-CA-C 106.156 -1.794 . . . . 54.119999999999997 106.156 167.67 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.034 -1.226 . . . . 72.439999999999998 110.034 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 99.5 m -63.4 -54.08 42.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.57 1.548 . . . . 62.450000000000003 113.61 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 45.11 75.1 0.69 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.106 1.363 . . . . 61.229999999999997 110.861 -161.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.72 -35.66 7.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.177 1.251 . . . . 61.25 112.535 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.63 84.96 0.97 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 124.749 1.166 . . . . 54.25 110.851 -172.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -111.07 87.41 7.11 Favored Pre-proline 0 C--O 1.223 -0.325 0 C-N-CA 127.77 2.428 . . . . 72.430000000000007 110.694 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.55 96.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.376 2.717 . . . . 71.349999999999994 110.927 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.48 113.78 0.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 124.117 0.865 . . . . 65.239999999999995 111.457 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.36 153.46 8.81 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.09 1.756 . . . . 71.430000000000007 109.14 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.33 166.9 19.95 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 124.976 3.784 . . . . 74.219999999999999 114.396 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -136.59 -179.12 5.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.383 2.273 . . . . 51.310000000000002 110.447 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.82 14.93 5.51 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 128.627 2.771 . . . . 74.219999999999999 115.386 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 131.65 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.219 0.608 . . . . 71.530000000000001 111.197 -162.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -125.17 148.5 48.57 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.715 1.206 . . . . 73.430000000000007 108.728 173.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -148.02 141.57 19.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.31 -1.737 . . . . 72.340000000000003 106.31 168.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -150.17 23.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.218 1.407 . . . . 64.140000000000001 112.962 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 4.3 tttm 48.68 -173.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.611 3.164 . . . . 72.030000000000001 112.944 -173.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.87 165.13 19.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.192 1.397 . . . . 71.140000000000001 107.57 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.91 -24.41 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.82 2.347 . . . . 70.019999999999996 112.345 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.06 -9.92 16.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.984 2.114 . . . . 71.430000000000007 111.182 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.03 -123.08 1.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.686 -1.366 . . . . 50.240000000000002 109.686 -174.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . . . -135.36 124.54 24.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.636 -0.697 . . . . 74.209999999999994 110.457 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -67.12 90.69 0.2 Allowed 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.448 0.699 . . . . 74.310000000000002 109.427 168.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.84 164.11 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.0 0.92 . . . . 45.32 108.558 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.96 157.87 16.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.017 1.727 . . . . 61.229999999999997 109.668 168.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -171.65 -179.73 2.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.74 2.016 . . . . 74.219999999999999 109.527 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -127.59 165.21 31.3 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 127.159 2.184 . . . . 73.329999999999998 109.432 169.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -66.21 168.49 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.668 2.912 . . . . 72.530000000000001 110.735 165.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.02 152.86 80.23 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.098 1.198 . . . . 72.150000000000006 109.861 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 p -118.68 17.61 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.542 1.137 . . . . 71.150000000000006 111.821 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.02 -45.25 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.825 1.25 . . . . 70.540000000000006 110.533 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.4 p -148.37 167.09 26.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.633 1.573 . . . . 63.229999999999997 107.926 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -46.23 -61.18 1.89 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.307 1.843 . . . . 71.120000000000005 111.945 -174.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.06 113.12 0.06 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.899 1.238 . . . . 71.510000000000005 112.943 174.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -89.35 66.38 7.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.006 0.922 . . . . 65.140000000000001 109.419 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -71.03 151.64 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.15 -1.426 . . . . 63.149999999999999 107.15 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.3 pt -135.42 -21.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.376 1.87 . . . . 65.25 111.836 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.72 -167.36 1.52 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.813 0.845 . . . . 71.150000000000006 109.486 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -152.04 172.91 15.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.658 1.983 . . . . 71.329999999999998 108.365 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -150.29 175.68 11.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.812 0.733 . . . . 33.030000000000001 111.212 163.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -144.24 129.74 14.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.605 1.962 . . . . 73.109999999999999 107.222 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.496 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -119.71 119.37 33.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.558 -1.645 . . . . 65.230000000000004 106.558 165.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 tp -87.22 126.83 35.06 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.634 -1.987 . . . . 74.310000000000002 105.634 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.11 138.82 50.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.397 0.544 . . . . 74.209999999999994 110.524 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 pt -126.72 -178.84 2.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 125.925 1.69 . . . . 72.040000000000006 109.786 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -58.78 93.77 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.68 1.592 . . . . 75.140000000000001 109.2 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 p -163.39 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.54 1.936 . . . . 70.109999999999999 109.1 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.2 m 45.07 67.89 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.509 1.924 . . . . 73.450000000000003 112.508 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -149.72 112.45 4.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.36 1.464 . . . . 74.25 109.658 -170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -163.1 120.06 1.87 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.701 1.2 . . . . 70.109999999999999 109.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.8 m -157.16 40.98 0.32 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.554 1.141 . . . . 63.420000000000002 112.421 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.82 113.13 0.56 Allowed Glycine 0 C--N 1.343 0.956 0 O-C-N 120.139 -1.601 . . . . 51.210000000000001 113.037 -169.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.6 mt-10 -64.15 165.57 13.16 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.647 1.579 . . . . 64.530000000000001 111.785 170.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 53' ' ' GLU . 71.9 Cg_endo -67.58 -164.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 1 C-N-CA 126.271 4.647 . . . . 61.439999999999998 111.598 167.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.96 19.18 11.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.33 1.852 . . . . 61.340000000000003 113.875 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m 51.09 76.21 0.17 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.649 1.58 . . . . 62.109999999999999 111.533 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 m -118.24 -40.39 2.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.091 -1.413 . . . . 63.43 109.419 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -150.46 144.4 17.37 Favored Pre-proline 0 C--O 1.241 0.648 0 O-C-N 120.903 -1.123 . . . . 53.420000000000002 110.565 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.65 79.96 2.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.534 2.823 . . . . 74.040000000000006 109.468 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.87 37.76 0.81 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.675 1.59 . . . . 61.43 109.576 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -79.47 62.41 3.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.213 1.805 . . . . 75.040000000000006 110.64 -165.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mp 44.58 -170.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 C-N-CA 132.968 4.507 . . . . 65.129999999999995 112.921 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.19 135.05 15.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.42 -0.809 . . . . 63.25 109.865 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 78.5 m-85 -149.23 -164.16 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.234 2.613 . . . . 75.409999999999997 107.846 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.9 ttp -112.48 -6.69 13.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.592 1.157 . . . . 75.329999999999998 113.153 166.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 44.23 66.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.373 2.269 . . . . 64.319999999999993 111.614 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.34 -13.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 113.554 0.946 . . . . 64.329999999999998 113.554 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -57.13 135.72 56.37 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.087 -1.008 . . . . 73.340000000000003 112.027 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -142.37 97.68 3.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.761 2.024 . . . . 74.150000000000006 107.73 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 166.94 5.9 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.215 0.912 . . . . 72.150000000000006 113.376 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 -57.4 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.791 1.661 . . . . 70.030000000000001 113.716 -166.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.0 m 57.33 167.66 0.06 OUTLIER Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.208 0.913 . . . . 73.420000000000002 112.872 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.99 -24.23 45.77 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.465 1.443 . . . . 73.209999999999994 112.293 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 p -167.35 41.56 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.913 0.885 . . . . 64.140000000000001 109.33 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 16.2 p 45.11 -166.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.44 1.896 . . . . 53.399999999999999 112.432 -161.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.09 115.05 5.71 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.268 -0.895 . . . . 74.310000000000002 109.326 149.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.53 124.28 45.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 126.116 1.766 . . . . 70.230000000000004 107.502 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.19 49.04 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.212 1.805 . . . . 74.329999999999998 110.938 169.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t -70.46 -16.91 62.98 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.019 1.728 . . . . 70.030000000000001 112.311 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t -46.13 -53.83 9.7 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.008 0.822 . . . . 72.019999999999996 109.489 165.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -72.43 -19.96 61.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.192 0.812 . . . . 71.099999999999994 113.192 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.25 -34.02 65.62 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.547 0.612 . . . . 53.130000000000003 110.868 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -54.18 -47.46 72.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.849 0.459 . . . . 71.340000000000003 109.768 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.46 -7.48 38.32 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.771 1.628 . . . . 64.010000000000005 113.216 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.64 164.82 7.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.347 1.07 . . . . 65.129999999999995 110.713 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -128.12 160.23 32.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.842 -0.799 . . . . 72.129999999999995 108.842 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.56 123.38 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 106.964 -1.495 . . . . 62.329999999999998 106.964 -165.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.92 127.81 33.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.894 -1.151 . . . . 71.150000000000006 107.894 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.32 31.98 5.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.804 -1.184 . . . . 73.25 107.804 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.61 -11.87 7.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.967 1.307 . . . . 71.340000000000003 110.344 -171.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 p -142.25 -66.08 0.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.395 1.478 . . . . 74.109999999999999 109.861 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -150.48 152.92 33.71 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 127.802 2.441 . . . . 71.420000000000002 107.576 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.12 104.63 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.689 2.926 . . . . 73.25 109.556 173.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -147.74 153.1 38.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.17 1.388 . . . . 64.140000000000001 109.839 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 130.12 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.105 -1.813 . . . . 74.310000000000002 106.105 158.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.12 136.57 22.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.954 -1.499 . . . . 44.329999999999998 106.954 166.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.32 159.33 20.34 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.025 0.917 . . . . 74.010000000000005 110.25 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -131.19 100.73 5.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.859 1.664 . . . . 74.329999999999998 106.879 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.36 129.59 75.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 104.316 -2.475 . . . . 65.209999999999994 104.316 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . . . -142.67 163.94 31.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 109.863 171.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.99 132.7 34.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.821 -1.081 . . . . 73.409999999999997 108.286 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -84.5 105.49 15.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.334 -1.728 . . . . 72.030000000000001 106.334 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -115.18 -179.19 3.56 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.009 0.924 . . . . 73.140000000000001 110.484 173.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.34 -35.07 71.36 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.031 1.733 . . . . 73.109999999999999 114.526 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.11 -54.95 6.26 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 125.61 1.564 . . . . 63.229999999999997 108.957 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 159.34 164.39 14.59 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.414 -1.074 . . . . 70.519999999999996 110.414 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 100' ' ' ALA . 9.1 t80 -87.49 45.54 1.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.616 1.566 . . . . 74.140000000000001 110.136 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.28 -87.14 0.07 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.295 1.902 . . . . 74.120000000000005 111.671 -156.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.46 163.48 38.89 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.151 1.901 . . . . 54.020000000000003 109.773 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.75 148.66 35.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.415 -0.957 . . . . 70.450000000000003 108.415 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.8 m -75.88 132.84 40.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.261 -1.755 . . . . 61.439999999999998 106.261 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -113.83 86.61 2.44 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 105.799 -1.926 . . . . 53.149999999999999 105.799 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.75 156.73 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 73.420000000000002 108.618 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.79 116.4 28.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.921 -1.511 . . . . 53.240000000000002 106.921 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -72.99 75.66 1.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.76 -1.2 . . . . 71.129999999999995 107.76 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 94' ' ' ALA . 14.4 mt -70.99 150.79 45.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.5 -1.667 . . . . 70.200000000000003 106.5 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 66.29 24.29 10.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 63.509999999999998 111.146 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.4 173.92 8.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.792 -0.567 . . . . 65.510000000000005 111.76 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.9 m -144.78 125.95 14.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.439 1.496 . . . . 64.310000000000002 107.847 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.08 163.58 26.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.813 1.245 . . . . 54.5 113.527 -166.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.04 60.71 2.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.997 2.119 . . . . 71.0 109.814 -166.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -107.71 145.91 32.8 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.755 0.822 . . . . 61.229999999999997 111.746 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.7 m 59.79 174.39 0.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.015 2.526 . . . . 71.109999999999999 113.45 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.8 t -80.0 -30.23 39.58 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 63.030000000000001 109.824 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 79.22 -52.69 4.09 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.407 -1.218 . . . . 74.299999999999997 111.071 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.259 1.567 0 C-N-CA 125.28 1.432 . . . . 74.239999999999995 108.352 176.454 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 108.359 -1.896 . . . . 71.530000000000001 108.359 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.2 t -145.64 22.5 1.45 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.697 1.199 . . . . 74.200000000000003 110.588 -175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.72 82.38 34.34 Favored Pre-proline 0 C--O 1.237 0.431 0 N-CA-C 107.296 -1.372 . . . . 61.229999999999997 107.296 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.58 64.84 8.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.378 2.052 . . . . 62.210000000000001 111.56 -171.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.43 159.12 24.24 Favored Glycine 0 C--O 1.242 0.595 0 N-CA-C 111.001 -0.84 . . . . 33.520000000000003 111.001 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -76.14 159.51 80.2 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 117.255 0.528 . . . . 64.450000000000003 110.124 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.97 5.66 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 125.149 3.9 . . . . 63.119999999999997 116.55 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.4 173.12 49.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.675 1.131 . . . . 70.310000000000002 112.394 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.3 161.02 24.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.225 1.41 . . . . 51.25 111.25 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.37 153.86 65.81 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.02 2.48 . . . . 74.150000000000006 110.989 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.4 m -137.38 -174.67 3.82 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.272 1.429 . . . . 60.240000000000002 110.605 -171.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.02 25.62 12.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.205 2.202 . . . . 71.230000000000004 114.205 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.25 141.12 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.681 1.192 . . . . 73.120000000000005 110.81 -172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -125.17 149.53 47.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.297 1.439 . . . . 63.32 109.007 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.0 mt -152.01 95.84 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.268 -1.753 . . . . 74.219999999999999 106.268 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 p -74.7 163.01 28.19 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.517 -0.92 . . . . 71.329999999999998 108.517 164.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -91.38 157.75 16.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.28 -1.378 . . . . 70.319999999999993 107.28 156.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 m -146.97 165.2 19.9 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.393 -1.336 . . . . 62.32 107.393 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.31 -37.43 61.28 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.324 1.35 . . . . 51.030000000000001 112.696 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.99 -47.99 14.06 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.331 -0.855 . . . . 74.519999999999996 110.682 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.74 -146.38 4.33 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.585 -0.606 . . . . 61.240000000000002 111.585 -156.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.03 133.8 32.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.321 1.448 . . . . 74.329999999999998 107.743 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -78.11 79.81 4.56 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.318 -0.623 . . . . 62.219999999999999 109.318 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.43 132.17 52.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.357 -1.349 . . . . 72.409999999999997 107.357 164.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -144.64 152.14 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.391 1.451 . . . . 72.349999999999994 109.255 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.416 ' CE3' HD13 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -137.56 167.57 21.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.206 1.403 . . . . 74.129999999999995 110.565 172.341 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.77 163.28 69.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.04 0.936 . . . . 74.340000000000003 112.328 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.11 164.83 26.2 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.391 2.727 . . . . 73.239999999999995 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.67 77.39 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.432 2.755 . . . . 53.240000000000002 110.359 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 t -133.02 24.73 4.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.293 2.237 . . . . 73.239999999999995 109.422 -171.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.53 -40.93 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.926 1.291 . . . . 53.210000000000001 107.95 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.0 p -149.45 174.08 12.87 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.017 1.727 . . . . 64.140000000000001 110.419 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -64.24 19.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.572 3.149 . . . . 72.420000000000002 114.88 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.59 -168.15 35.84 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 120.597 -1.314 . . . . 65.439999999999998 114.037 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -135.65 113.4 10.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.193 -1.004 . . . . 74.420000000000002 109.505 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.479 HG12 ' HB1' ' A' ' 101' ' ' ALA . 1.9 mp -109.67 133.63 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.084 1.754 . . . . 64.129999999999995 108.144 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -131.62 -11.42 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 72.120000000000005 112.33 -163.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 39' ' ' TYR . 10.8 tt0 -160.45 -169.51 2.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.222 2.209 . . . . 65.219999999999999 106.685 163.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.441 ' H ' ' HG2' ' A' ' 38' ' ' GLU . 1.4 m-85 -128.4 169.27 14.47 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.22 -1.55 . . . . 74.349999999999994 108.879 165.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.0 m -145.03 156.93 44.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.171 -0.956 . . . . 72.409999999999997 110.526 166.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.66 125.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 105.618 -1.993 . . . . 74.109999999999999 105.618 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.23 127.33 55.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.735 -1.58 . . . . 74.109999999999999 106.735 171.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -121.85 130.54 53.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.983 1.713 . . . . 74.420000000000002 107.574 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.21 126.03 28.28 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.907 0.883 . . . . 71.420000000000002 113.068 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.53 -170.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.769 2.428 . . . . 74.530000000000001 109.236 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -87.88 95.06 9.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.046 1.738 . . . . 73.510000000000005 110.695 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t 174.65 162.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.742 3.217 . . . . 44.32 108.121 160.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.1 t -146.78 141.36 26.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.815 1.246 . . . . 71.109999999999999 108.503 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -157.35 164.14 37.89 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.612 0.642 . . . . 74.510000000000005 111.05 170.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.38 168.36 18.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.115 2.566 . . . . 72.299999999999997 108.138 155.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 m -151.42 123.1 7.98 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.07 1.348 . . . . 65.540000000000006 107.572 166.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.97 83.26 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.943 1.735 . . . . 62.399999999999999 113.846 165.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.41 163.83 47.7 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.204 1.002 . . . . 74.409999999999997 111.807 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 172.32 11.57 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.167 2.578 . . . . 74.329999999999998 111.803 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 67.49 85.4 0.14 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 127.394 2.278 . . . . 54.219999999999999 107.926 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.1 m -63.69 74.18 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.203 1.801 . . . . 72.310000000000002 110.833 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -165.15 -62.67 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.804 1.242 . . . . 32.350000000000001 108.557 -163.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 59' ' ' PRO 0.262 73.0 p 50.74 163.2 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.865 2.466 . . . . 41.100000000000001 114.011 -161.203 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 74.3 Cg_endo -68.38 -175.75 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.631 2.221 . . . . 74.109999999999999 110.24 165.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.07 67.05 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 61.200000000000003 108.674 166.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 43.7 76.87 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.287 3.035 . . . . 74.510000000000005 111.935 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.07 163.9 0.33 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.396 1.878 . . . . 63.5 113.512 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.27 82.72 1.97 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.333 0.587 . . . . 64.120000000000005 111.17 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -130.74 150.41 51.93 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.308 1.043 . . . . 73.310000000000002 108.911 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ttp -113.99 133.84 55.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.107 1.763 . . . . 51.340000000000003 108.233 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -82.19 56.73 3.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.606 1.562 . . . . 74.25 112.331 -167.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.66 -19.61 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 115.924 1.824 . . . . 72.530000000000001 115.924 -167.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.08 118.63 7.03 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.842 1.201 . . . . 73.510000000000005 110.032 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.6 m -152.13 73.69 1.06 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 127.172 2.189 . . . . 63.210000000000001 107.625 164.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.44 166.06 25.91 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 121.562 -0.711 . . . . 70.25 111.799 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 -55.64 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.614 2.21 . . . . 72.510000000000005 109.836 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -76.57 144.51 73.82 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.247 0.619 . . . . 70.420000000000002 109.785 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 -26.15 16.68 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.235 1.957 . . . . 73.530000000000001 112.882 -168.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p -80.88 68.9 7.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.232 0.924 . . . . 61.109999999999999 110.216 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.2 m -69.3 115.45 8.59 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.391 -0.818 . . . . 54.329999999999998 110.675 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.8 -178.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.977 2.111 . . . . 54.240000000000002 112.528 159.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.74 146.69 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.521 1.528 . . . . 71.209999999999994 108.222 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -96.26 161.81 13.78 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.601 2.36 . . . . 61.219999999999999 112.778 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -45.87 67.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.961 1.304 . . . . 62.310000000000002 111.72 169.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -62.37 -28.16 69.58 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.615 0.643 . . . . 63.130000000000003 111.623 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -80.36 -46.56 15.86 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.327 -0.858 . . . . 54.219999999999999 109.046 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.1 mt -52.83 -26.7 15.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.193 1.797 . . . . 71.549999999999997 112.926 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.4 m -45.36 -33.88 2.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.12 1.368 . . . . 70.120000000000005 113.232 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -95.0 -10.87 29.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.323 0.649 . . . . 65.230000000000004 111.263 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.66 24.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.061 0.846 . . . . 71.450000000000003 110.123 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.68 120.39 27.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.101 0.96 . . . . 73.349999999999994 109.819 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.08 138.24 21.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.992 1.717 . . . . 73.120000000000005 109.287 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.95 111.33 4.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.816 0.846 . . . . 74.329999999999998 111.006 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -100.65 20.09 15.78 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.461 -0.774 . . . . 73.030000000000001 110.993 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -4.01 6.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.456 0.909 . . . . 63.32 113.456 -163.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 -63.31 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.275 1.43 . . . . 75.230000000000004 108.492 161.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -153.68 154.19 29.95 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 106.536 -1.653 . . . . 72.450000000000003 106.536 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.29 110.16 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.389 2.059 . . . . 64.120000000000005 109.544 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.92 168.56 21.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.72 2.008 . . . . 73.319999999999993 109.301 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.7 mt -101.74 140.05 21.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.274 -1.75 . . . . 73.010000000000005 106.274 166.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.42 124.52 73.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.273 1.029 . . . . 72.010000000000005 110.085 -163.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.47 137.55 54.77 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.848 0.859 . . . . 63.520000000000003 112.488 -167.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -112.78 99.29 7.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.773 1.629 . . . . 62.439999999999998 108.057 167.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.416 HD13 ' CE3' ' A' ' 26' ' ' TRP . 9.7 mt -98.34 144.75 10.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.396 -1.705 . . . . 72.540000000000006 106.396 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.23 142.28 29.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.284 1.034 . . . . 74.25 109.65 168.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB1' HG12 ' A' ' 36' ' ' ILE . . . -74.94 122.51 23.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.338 1.055 . . . . 72.439999999999998 108.87 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -72.89 117.83 15.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.856 -1.535 . . . . 72.349999999999994 106.856 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -131.59 -176.92 4.19 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 127.582 2.353 . . . . 73.430000000000007 109.502 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.78 -27.94 69.53 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.503 0.557 . . . . 74.109999999999999 112.503 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -74.48 -32.13 62.45 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.158 -0.964 . . . . 73.409999999999997 113.05 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.73 166.8 38.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.597 -1.001 . . . . 63.310000000000002 110.597 -166.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.08 64.14 3.2 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.563 1.545 . . . . 62.350000000000001 111.689 -170.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.43 -75.44 0.35 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.291 -1.124 . . . . 63.340000000000003 110.291 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.99 167.65 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.06 3.173 . . . . 73.510000000000005 110.21 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 162.86 39.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.025 2.13 . . . . 71.239999999999995 107.192 165.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.2 t -79.95 179.32 7.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.161 -0.681 . . . . 71.230000000000004 109.161 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -150.54 73.01 1.11 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.143 0.577 . . . . 75.230000000000004 110.031 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.3 m -93.24 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.473 -0.767 . . . . 63.450000000000003 110.424 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 112.24 13.46 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.888 1.275 . . . . 75.349999999999994 110.232 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -71.65 82.68 0.85 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.73 0.812 . . . . 73.230000000000004 110.704 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.83 53.9 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.796 1.638 . . . . 61.450000000000003 108.68 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 17.67 2.99 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.874 1.27 . . . . 75.140000000000001 109.609 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.17 168.94 18.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.034 0.445 . . . . 72.150000000000006 110.271 164.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -155.3 129.2 8.68 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.624 -1.991 . . . . 61.340000000000003 105.624 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 m 53.93 30.44 11.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.359 1.064 . . . . 53.340000000000003 113.788 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -53.37 -57.73 9.57 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 117.723 -1.132 . . . . 73.450000000000003 112.181 -163.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.3 158.28 26.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.192 0.906 . . . . 42.409999999999997 110.59 160.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.2 p -78.63 -21.77 47.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.374 1.25 . . . . 53.539999999999999 114.374 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 m 48.76 82.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.242 1.417 . . . . 65.239999999999995 111.995 -175.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -46.62 -38.55 9.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.808 1.194 . . . . 45.039999999999999 114.043 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.51 1.524 . . . . 74.230000000000004 109.885 177.396 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.683 0 N-CA-C 110.259 -1.136 . . . . 44.420000000000002 110.259 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.3 t -150.65 15.86 0.78 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.278 1.831 . . . . 50.340000000000003 110.466 163.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.18 151.36 46.58 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 105.812 -1.922 . . . . 74.329999999999998 105.812 156.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.96 106.77 1.57 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.601 2.868 . . . . 71.5 110.533 -174.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.59 -9.01 87.41 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.28 -0.888 . . . . 50.310000000000002 112.747 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 28.6 m-85 -123.3 163.36 34.54 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 127.379 2.272 . . . . 74.329999999999998 108.273 -177.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -55.48 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.76 2.307 . . . . 54.420000000000002 112.868 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.73 41.58 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.733 -1.747 . . . . 62.240000000000002 108.733 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.27 159.42 32.11 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.755 1.622 . . . . 71.420000000000002 109.353 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.06 154.27 75.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.232 1.288 . . . . 65.439999999999998 111.719 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.3 m -142.41 -174.65 4.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.614 1.566 . . . . 71.200000000000003 109.488 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.84 37.79 10.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.034 2.534 . . . . 74.299999999999997 113.193 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.52 126.45 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.506 -1.294 . . . . 74.340000000000003 107.506 -171.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -137.56 150.76 47.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.669 -0.863 . . . . 43.140000000000001 108.669 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 24' ' ' LEU . 4.0 mp -125.86 149.74 30.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.459 -2.052 . . . . 53.439999999999998 105.459 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.81 135.84 36.65 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.309 -1.367 . . . . 70.310000000000002 107.309 174.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 120' ' ' SER . 13.0 tppt? -72.01 143.85 49.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.398 -1.334 . . . . 73.120000000000005 107.398 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -126.34 165.64 26.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 125.877 1.671 . . . . 71.420000000000002 108.023 169.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.65 -15.2 40.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.359 2.04 . . . . 54.32 112.353 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.24 -29.22 13.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.753 1.221 . . . . 74.430000000000007 110.787 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.14 -152.37 16.94 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 116.377 -2.346 . . . . 63.140000000000001 110.539 -164.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.2 127.95 54.23 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 121.147 2.474 . . . . 71.140000000000001 108.731 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.49 126.14 26.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.214 -1.032 . . . . 74.129999999999995 108.214 164.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' CD2' HG23 ' A' ' 15' ' ' ILE . 5.4 mt -113.12 145.33 41.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.031 -1.099 . . . . 64.239999999999995 108.031 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 t -150.28 171.82 16.35 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.415 0.552 . . . . 65.140000000000001 111.234 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CE3' HD13 ' A' ' 99' ' ' ILE . 15.3 p90 -173.45 -171.57 0.7 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.765 2.026 . . . . 74.299999999999997 111.189 -172.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -111.57 165.49 12.72 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 127.948 2.499 . . . . 73.230000000000004 110.639 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -66.64 166.68 21.33 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.956 3.104 . . . . 53.299999999999997 112.598 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.46 -4.64 14.35 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 124.018 3.145 . . . . 64.409999999999997 111.773 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -148.25 138.43 22.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.916 -1.513 . . . . 54.109999999999999 106.916 -174.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.48 -49.53 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.498 0.666 . . . . 61.020000000000003 110.621 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 t -65.22 158.97 24.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.39 1.076 . . . . 42.229999999999997 109.907 163.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.8 m -54.86 -45.0 74.49 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.409 1.263 . . . . 73.310000000000002 114.409 -163.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.5 -171.48 46.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.965 0.802 . . . . 43.439999999999998 111.566 -171.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -116.42 56.19 0.79 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.571 1.549 . . . . 74.439999999999998 109.187 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.47 140.08 20.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 72.299999999999997 106.245 168.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.96 -23.03 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.573 1.149 . . . . 72.329999999999998 110.609 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -161.24 -175.53 4.9 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.285 1.434 . . . . 74.230000000000004 108.515 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -171.0 2.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.784 1.234 . . . . 74.129999999999995 109.469 170.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . 12.4 p -138.15 155.92 48.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.753 1.621 . . . . 53.100000000000001 107.917 157.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.64 112.43 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.197 -2.519 . . . . 64.0 104.197 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' HB3' ' CB ' ' A' ' 64' ' ' PHE . 67.7 m-85 -111.51 160.24 17.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.758 0.823 . . . . 74.409999999999997 108.983 175.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 tp -149.96 139.47 21.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.79 2.036 . . . . 72.530000000000001 106.004 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.33 137.58 42.93 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.389 1.076 . . . . 73.319999999999993 110.34 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -141.76 -165.59 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.528 1.531 . . . . 72.430000000000007 110.343 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 81.16 1.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.083 2.153 . . . . 73.549999999999997 110.305 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -146.79 -70.48 0.24 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.757 1.223 . . . . 41.539999999999999 109.547 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.8 m -157.49 -15.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.636 1.347 . . . . 73.239999999999995 114.636 159.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -66.66 130.64 43.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 111.11 -147.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.68 49.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.232 -1.025 . . . . 63.420000000000002 108.232 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p 174.56 135.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.373 3.069 . . . . 72.340000000000003 104.663 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.94 4.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.636 -1.091 . . . . 54.200000000000003 115.75 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.24 151.95 79.73 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 120.56 2.18 . . . . 74.030000000000001 113.743 -152.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.21 166.82 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.07 2.513 . . . . 65.129999999999995 112.769 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -66.95 6.11 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.242 2.617 . . . . 74.099999999999994 113.324 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 m -62.94 -42.24 99.75 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.498 1.119 . . . . 73.420000000000002 111.2 -173.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -177.43 11.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.736 1.214 . . . . 72.030000000000001 112.403 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.0 m 45.02 72.96 1.06 Allowed Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.627 1.571 . . . . 70.319999999999993 112.589 -171.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.12 159.84 48.88 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.484 2.123 . . . . 74.400000000000006 112.888 166.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.81 52.57 0.54 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.457 1.903 . . . . 31.34 111.959 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.454 ' C ' HD12 ' A' ' 62' ' ' LEU . 11.9 mm100 -76.2 102.59 5.86 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.269 -1.011 . . . . 71.439999999999998 108.269 174.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 61' ' ' GLN . 2.4 mp 58.29 -159.79 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.955 2.902 . . . . 65.319999999999993 108.524 177.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.98 123.93 3.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 45.140000000000001 109.558 170.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 27.7 m-85 -146.06 162.26 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.008 0.923 . . . . 74.530000000000001 111.333 -173.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.6 ttt -69.35 -29.83 67.72 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.042 1.337 . . . . 71.329999999999998 113.899 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 65.79 80.57 0.22 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.639 1.576 . . . . 61.409999999999997 110.516 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.72 -14.62 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.961 0.904 . . . . 52.549999999999997 112.488 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -54.34 116.13 2.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.406 1.482 . . . . 73.120000000000005 110.266 166.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -157.9 23.94 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.36 0.504 . . . . 72.409999999999997 112.36 157.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 154.54 29.69 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.918 -1.273 . . . . 73.299999999999997 109.918 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.06 -26.28 21.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.342 2.028 . . . . 54.299999999999997 111.845 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -122.81 163.53 32.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.472 1.509 . . . . 74.019999999999996 109.307 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.93 173.46 12.75 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.983 1.789 . . . . 74.340000000000003 111.027 170.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 t 50.46 59.91 4.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.03 1.332 . . . . 73.209999999999994 110.624 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.63 171.53 7.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.88 0.872 . . . . 73.109999999999999 110.673 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.594 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.0 pt? -76.29 171.65 14.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.624 1.342 . . . . 54.310000000000002 114.624 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.25 109.43 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 C-N-CA 126.973 2.109 . . . . 70.430000000000007 111.266 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -57.43 146.75 28.4 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.246 2.219 . . . . 73.019999999999996 111.472 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 p -66.47 -23.68 66.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.737 1.014 . . . . 71.510000000000005 113.737 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 5.5 0.91 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.614 1.566 . . . . 73.430000000000007 113.599 167.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -108.64 -36.69 6.11 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.063 -1.023 . . . . 74.209999999999994 110.055 164.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.27 -37.39 77.86 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.421 1.088 . . . . 72.310000000000002 111.232 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -61.79 -0.86 0.51 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.693 1.597 . . . . 73.349999999999994 113.109 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -129.98 2.15 4.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.954 2.102 . . . . 65.430000000000007 110.255 -167.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.21 132.8 55.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.982 2.113 . . . . 44.310000000000002 109.125 -169.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -87.39 158.17 19.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.978 0.418 . . . . 65.530000000000001 110.875 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -84.43 146.94 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.898 1.279 . . . . 63.409999999999997 108.365 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.45 118.49 20.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.875 -1.157 . . . . 73.319999999999993 107.875 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 24.32 11.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.256 1.023 . . . . 70.209999999999994 109.789 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -100.65 -53.95 2.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.719 -1.215 . . . . 71.230000000000004 107.719 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.8 m -111.08 -54.26 2.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.178 1.791 . . . . 71.549999999999997 109.488 -166.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -160.47 150.08 14.32 Favored Pre-proline 0 C--N 1.343 0.298 0 C-N-CA 127.528 2.331 . . . . 63.140000000000001 109.87 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.86 101.56 0.23 Allowed 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 124.494 3.463 . . . . 64.120000000000005 109.89 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.626 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -162.0 172.9 15.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.95 1.7 . . . . 74.510000000000005 111.199 175.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.51 132.35 42.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.759 -1.571 . . . . 72.510000000000005 106.759 167.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.97 118.85 49.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 124.103 0.961 . . . . 73.510000000000005 109.488 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -93.08 178.34 5.78 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.771 1.228 . . . . 72.299999999999997 111.679 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.19 128.5 14.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 126.453 1.901 . . . . 65.200000000000003 106.638 167.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.505 HD13 ' CE3' ' A' ' 26' ' ' TRP . 34.1 mt -132.14 153.93 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 119.528 1.058 . . . . 63.329999999999998 109.512 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -167.78 136.6 2.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.536 2.334 . . . . 71.140000000000001 110.374 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.2 133.3 55.01 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.605 1.562 . . . . 65.329999999999998 112.849 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 92.11 9.02 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.747 -1.946 . . . . 70.120000000000005 105.747 161.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -101.34 -179.23 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.333 -0.988 . . . . 62.020000000000003 108.333 153.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -57.95 -21.77 45.7 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.105 1.15 . . . . 74.239999999999995 114.105 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -37.26 38.88 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.402 -0.811 . . . . 63.409999999999997 110.181 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.17 -171.8 13.97 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.162 1.363 . . . . 74.140000000000001 112.999 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 14.3 m-85 -81.7 66.1 7.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.969 1.708 . . . . 72.219999999999999 111.285 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.28 -74.22 1.08 Allowed Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.002 -1.061 . . . . 23.449999999999999 111.563 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 56.6 Cg_endo -68.81 167.23 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.381 2.72 . . . . 50.340000000000003 110.118 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.46 152.17 44.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.725 0.774 . . . . 73.120000000000005 110.049 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.3 m -142.01 109.44 5.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.159 -1.793 . . . . 61.530000000000001 106.159 167.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -94.38 139.44 31.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.111 -1.44 . . . . 73.319999999999993 107.111 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -125.24 171.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.081 0.952 . . . . 44.340000000000003 110.43 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 113.46 14.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.525 1.53 . . . . 74.230000000000004 108.21 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -79.03 93.4 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.48 -1.304 . . . . 72.129999999999995 107.48 172.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 94' ' ' ALA . 16.2 mt -77.39 165.25 24.65 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.326 -1.361 . . . . 61.439999999999998 107.326 173.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.06 29.51 19.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.667 0.787 . . . . 75.430000000000007 109.892 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -9.88 59.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.246 -1.534 . . . . 74.319999999999993 114.503 -172.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 m -77.14 80.74 3.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.859 1.264 . . . . 72.129999999999995 110.786 -160.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 47.4 t -144.14 98.68 3.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.789 -1.189 . . . . 74.530000000000001 107.789 -171.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 65.6 -165.53 0.23 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.895 0.878 . . . . 71.239999999999995 109.848 -174.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 63.19 36.82 11.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.28 2.232 . . . . 72.319999999999993 110.73 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.5 p -84.01 12.22 6.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.267 1.58 . . . . 50.350000000000001 115.267 -165.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t 65.71 -178.34 0.19 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.143 0.977 . . . . 52.229999999999997 110.108 -158.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 150.7 -14.21 0.91 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.016 0.817 . . . . 73.340000000000003 114.589 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.254 1.301 0 CA-C-N 119.69 1.745 . . . . 74.409999999999997 108.775 168.391 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 CA-C-O 119.274 -0.737 . . . . 52.530000000000001 111.276 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 t 75.22 90.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.793 2.437 . . . . 74.439999999999998 107.701 -160.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 159.79 39.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.932 1.693 . . . . 73.200000000000003 108.996 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.02 176.81 8.58 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.497 2.131 . . . . 60.439999999999998 112.478 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.01 84.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.364 -1.094 . . . . 74.540000000000006 110.364 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.56 160.28 32.31 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.464 1.106 . . . . 73.329999999999998 108.922 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.75 114.28 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.105 2.537 . . . . 74.239999999999995 109.751 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.01 -161.83 35.12 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.147 -1.181 . . . . 64.109999999999999 110.147 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.06 82.86 0.21 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 127.092 2.157 . . . . 45.140000000000001 111.891 -163.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.31 165.59 24.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.165 2.577 . . . . 73.340000000000003 110.891 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.8 m -135.57 -175.59 4.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.265 1.426 . . . . 35.109999999999999 112.106 -173.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.8 25.95 2.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.673 2.789 . . . . 63.229999999999997 115.202 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.64 132.69 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.417 -0.802 . . . . 61.420000000000002 110.87 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -117.22 149.37 40.53 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.219 1.008 . . . . 73.510000000000005 109.073 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.6 mt -145.65 141.73 22.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 105.673 -1.973 . . . . 72.019999999999996 105.673 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.8 p -152.29 170.98 18.7 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.087 1.755 . . . . 73.319999999999993 108.861 168.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -95.37 160.02 14.73 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.804 0.729 . . . . 71.140000000000001 109.441 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.4 m -145.56 165.75 20.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.472 2.309 . . . . 73.230000000000004 109.391 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -70.66 -4.37 14.5 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.1 2.533 . . . . 73.430000000000007 112.349 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -131.85 29.13 4.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.45 1.5 . . . . 71.439999999999998 110.655 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.48 -158.36 21.18 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.377 -0.827 . . . . 23.539999999999999 112.739 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 153.03 23.77 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.484 1.142 . . . . 51.039999999999999 108.294 162.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.19 96.9 7.51 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.747 2.419 . . . . 70.450000000000003 109.167 -169.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.96 125.47 53.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.226 2.211 . . . . 73.510000000000005 110.061 -159.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -157.97 152.42 24.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.662 1.574 . . . . 33.119999999999997 114.427 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CE3' HD13 ' A' ' 99' ' ' ILE . 4.2 p90 -149.28 -179.62 7.2 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 127.226 2.21 . . . . 72.209999999999994 113.151 -171.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 1.6 pp20? -115.56 160.36 34.96 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 126.703 2.001 . . . . 70.25 112.756 -170.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 92.1 Cg_endo -69.52 176.24 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 126.647 4.898 . . . . 74.209999999999994 112.171 -176.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.75 113.52 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 108.083 -1.545 . . . . 65.120000000000005 108.083 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -103.47 13.95 32.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.952 0.901 . . . . 55.219999999999999 110.387 168.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 32' ' ' THR . 2.4 m -100.44 -84.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 127.536 2.334 . . . . 60.219999999999999 109.702 -174.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.402 ' H ' HG23 ' A' ' 31' ' ' VAL . 50.8 p -122.25 166.3 14.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.893 0.769 . . . . 54.32 109.364 170.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -60.0 -56.79 17.35 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.493 1.117 . . . . 73.099999999999994 110.205 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.13 -171.54 23.38 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.109 -0.796 . . . . 61.32 111.109 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -133.06 80.31 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.388 -0.967 . . . . 72.310000000000002 108.388 166.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -76.95 145.42 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.46 -1.311 . . . . 73.209999999999994 107.46 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -133.04 -24.49 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.342 1.457 . . . . 72.099999999999994 111.434 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 1.5 tp10 -168.1 -175.09 2.52 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 105.762 -1.94 . . . . 71.5 105.762 -174.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.465 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 75.2 m-85 -136.97 -166.15 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.546 -1.346 . . . . 65.209999999999994 109.913 175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.96 159.71 41.73 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.35 2.26 . . . . 70.219999999999999 109.549 165.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.47 119.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 103.84 -2.652 . . . . 62.409999999999997 103.84 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -114.41 151.9 32.39 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.709 -0.849 . . . . 73.430000000000007 108.709 173.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 tp -136.25 117.86 14.93 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.627 1.971 . . . . 74.329999999999998 107.338 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.6 151.4 28.99 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.229 0.611 . . . . 44.32 111.623 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.38 172.49 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.571 1.148 . . . . 74.450000000000003 111.953 -169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -66.62 154.72 39.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.757 1.223 . . . . 64.329999999999998 109.955 156.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t 70.11 -175.41 0.19 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.594 2.358 . . . . 45.420000000000002 112.498 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 p -114.96 166.07 12.18 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.455 1.902 . . . . 65.239999999999995 110.463 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -164.42 -179.99 6.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.458 1.503 . . . . 73.349999999999994 109.311 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.32 163.29 13.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.329 1.451 . . . . 52.039999999999999 111.82 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.85 136.05 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.913 2.485 . . . . 54.020000000000003 107.701 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.85 93.7 0.1 OUTLIER Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.343 -1.103 . . . . 53.43 110.343 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -64.04 165.17 14.03 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.184 1.794 . . . . 73.239999999999995 112.27 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 53' ' ' GLU . 55.3 Cg_endo -62.71 99.34 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 125.14 3.893 . . . . 70.540000000000006 111.7 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp 58.62 34.67 24.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.546 1.539 . . . . 62.109999999999999 112.541 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 t -45.1 -68.64 0.18 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.15 2.18 . . . . 41.039999999999999 110.636 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 65.25 15.88 10.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 73.109999999999999 112.764 176.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 t -135.81 152.3 75.65 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.432 1.093 . . . . 65.209999999999994 108.628 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.11 -169.23 0.75 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.399 2.733 . . . . 70.140000000000001 111.597 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 61.87 33.83 17.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.641 1.576 . . . . 73.140000000000001 112.91 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -72.14 169.04 16.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.377 1.071 . . . . 42.009999999999998 108.988 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 1.7 mt -104.58 -171.09 1.86 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.339 1.056 . . . . 73.219999999999999 110.549 -161.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 87.93 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.479 0.581 . . . . 63.140000000000001 110.788 172.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 13.5 m-30 -117.87 155.13 30.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.337 1.055 . . . . 74.129999999999995 110.052 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.7 ttp -87.03 146.9 25.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.632 0.773 . . . . 74.409999999999997 109.405 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.59 93.39 8.36 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.636 1.208 . . . . 61.520000000000003 110.961 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -71.61 1.16 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 124.599 1.16 . . . . 73.310000000000002 112.74 168.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -91.22 -163.92 1.1 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.992 1.717 . . . . 74.329999999999998 110.38 174.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.3 m 57.91 35.31 25.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.729 1.612 . . . . 63.549999999999997 110.829 -158.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.29 -177.48 9.89 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 110.167 -1.173 . . . . 53.049999999999997 110.167 163.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -26.08 28.71 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.432 1.421 . . . . 74.510000000000005 111.182 173.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.74 17.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.094 1.358 . . . . 65.420000000000002 109.541 -170.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.25 165.45 28.61 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.414 2.076 . . . . 74.439999999999998 109.745 160.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m 49.35 36.35 9.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.992 1.317 . . . . 61.539999999999999 113.034 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -88.9 162.28 16.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.653 1.216 . . . . 71.540000000000006 111.224 170.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.576 ' H ' HD23 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.25 175.04 1.8 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.06 2.944 . . . . 61.119999999999997 113.705 172.562 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -135.8 119.68 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.236 1.014 . . . . 53.049999999999997 111.953 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -54.82 140.33 36.87 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.735 0.814 . . . . 73.319999999999993 111.599 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 p -56.14 -34.09 65.79 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.104 0.962 . . . . 72.549999999999997 112.799 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -55.17 -39.24 69.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.072 0.949 . . . . 72.549999999999997 111.583 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 t -74.55 -34.65 62.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.165 -0.959 . . . . 73.340000000000003 110.641 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.3 -33.77 76.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.633 0.651 . . . . 71.310000000000002 110.0 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -58.51 -37.21 75.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.633 1.573 . . . . 53.32 111.406 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.57 -5.58 59.26 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.068 -1.02 . . . . 65.140000000000001 112.711 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 149.82 21.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.607 -0.683 . . . . 53.439999999999998 111.166 -159.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 108.84 20.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.528 1.531 . . . . 74.430000000000007 109.693 -175.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -69.78 157.71 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.466 -0.938 . . . . 70.310000000000002 108.466 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -132.54 82.85 2.03 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.989 1.316 . . . . 63.130000000000003 108.656 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.96 121.61 5.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.438 1.273 . . . . 75.310000000000002 114.438 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 -22.62 43.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.63 -2.077 . . . . 73.319999999999993 112.894 159.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 p -143.67 -62.37 0.4 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.314 1.416 . . . . 74.120000000000005 112.797 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -104.49 141.86 23.41 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 116.811 -1.566 . . . . 72.209999999999994 109.218 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.48 120.58 7.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.229 1.953 . . . . 55.119999999999997 109.311 -176.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -128.95 147.71 50.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.604 -0.887 . . . . 64.230000000000004 108.604 160.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.3 mt -91.76 130.43 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 126.945 2.098 . . . . 74.329999999999998 105.768 168.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.4 mm -82.81 138.13 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.768 -1.197 . . . . 72.530000000000001 107.768 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.5 133.56 55.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.634 -1.247 . . . . 74.519999999999996 107.634 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -98.64 133.01 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 106.56 -1.645 . . . . 61.520000000000003 106.56 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.47 HD13 ' CE3' ' A' ' 26' ' ' TRP . 53.6 mt -135.87 140.27 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 105.686 -1.968 . . . . 62.240000000000002 105.686 175.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.27 164.48 35.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.511 0.724 . . . . 64.099999999999994 110.243 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.48 125.19 40.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.472 1.509 . . . . 65.519999999999996 111.15 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.48 ' HD3' ' CZ ' ' A' ' 107' ' ' TYR . 6.1 tpt180 -76.56 112.77 13.45 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.062 -1.459 . . . . 74.200000000000003 107.062 171.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 167.45 16.93 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.037 0.535 . . . . 71.409999999999997 111.346 162.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.66 -27.3 66.26 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.075 -0.391 . . . . 74.420000000000002 111.895 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -53.99 -40.02 66.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.336 1.454 . . . . 70.219999999999999 111.925 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.72 -173.37 27.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.632 2.063 . . . . 65.5 108.189 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -76.14 -5.05 44.91 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.126 1.528 . . . . 74.430000000000007 115.126 178.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.22 178.52 8.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.952 0.786 . . . . 42.439999999999998 111.958 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.95 148.13 63.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.584 1.523 . . . . 70.120000000000005 108.911 162.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 150.46 20.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.699 0.799 . . . . 71.319999999999993 109.485 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -68.27 166.26 16.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.071 0.948 . . . . 32.32 110.5 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -120.55 86.45 2.57 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.712 -1.958 . . . . 73.409999999999997 105.712 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.7 t -89.44 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 106.945 -1.502 . . . . 64.430000000000007 106.945 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.534 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -128.66 160.97 30.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.734 1.214 . . . . 74.040000000000006 107.945 165.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -119.27 80.13 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.637 1.575 . . . . 75.230000000000004 107.985 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 94' ' ' ALA . 36.9 mt -64.73 -21.74 66.82 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.896 0.702 . . . . 64.150000000000006 112.896 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.27 28.19 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.103 1.361 . . . . 73.040000000000006 111.622 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -58.56 106.09 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.496 -1.298 . . . . 60.030000000000001 107.496 164.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.9 172.51 5.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 128.508 2.723 . . . . 71.109999999999999 105.069 172.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.6 t 69.76 165.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.12 1.368 . . . . 52.109999999999999 111.017 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -149.57 22.95 0.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 130.11 3.364 . . . . 72.420000000000002 108.429 161.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 t70 60.43 19.6 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.183 2.193 . . . . 73.439999999999998 115.587 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 -176.47 0.15 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.878 -1.139 . . . . 74.140000000000001 111.756 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.9 m 55.2 -168.86 0.08 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.904 1.282 . . . . 71.25 113.136 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.85 171.15 32.55 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.074 1.797 . . . . 62.149999999999999 109.707 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.26 1.624 0 C-N-CA 125.102 1.361 . . . . 65.239999999999995 108.496 -172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.05 -1.463 . . . . 75.25 107.05 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.18 6.15 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.095 2.53 . . . . 64.420000000000002 114.528 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.62 -171.77 16.78 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.595 -1.802 . . . . 53.310000000000002 108.595 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.33 163.34 34.68 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.871 1.668 . . . . 44.310000000000002 109.609 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.15 152.12 81.3 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.651 1.568 . . . . 73.239999999999995 111.287 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.9 m -133.61 -173.93 3.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.854 2.462 . . . . 72.319999999999993 108.627 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 45.91 27.32 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.898 2.879 . . . . 54.409999999999997 114.868 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.73 137.71 23.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.036 -0.727 . . . . 63.240000000000002 109.036 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -134.04 159.23 41.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.797 0.839 . . . . 73.140000000000001 111.227 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -144.18 138.95 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.864 -1.902 . . . . 72.310000000000002 105.864 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -135.47 159.99 39.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.675 1.99 . . . . 74.420000000000002 108.404 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -83.69 170.92 13.73 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.987 -1.071 . . . . 61.509999999999998 108.4 171.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 161.6 29.15 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 123.888 0.875 . . . . 42.509999999999998 110.26 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.72 -27.77 52.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.57 1.513 . . . . 72.430000000000007 110.968 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.55 23.37 13.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.114 1.366 . . . . 75.420000000000002 110.854 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.24 -149.1 21.03 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.652 -1.28 . . . . 73.140000000000001 111.791 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 144.32 40.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.507 2.153 . . . . 61.520000000000003 107.5 152.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -80.13 141.67 35.52 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.947 1.299 . . . . 62.520000000000003 108.084 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.97 174.65 10.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.003 0.819 . . . . 71.409999999999997 110.015 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -175.31 155.91 1.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.013 2.525 . . . . 74.230000000000004 108.059 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -158.57 167.08 30.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.323 1.449 . . . . 72.519999999999996 109.316 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 7.0 mt-10 -138.65 162.99 49.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 125.866 1.666 . . . . 64.439999999999998 111.682 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.91 174.79 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.186 3.258 . . . . 52.119999999999997 113.808 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.92 179.01 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.88 3.054 . . . . 60.450000000000003 113.646 168.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.0 t -138.36 73.27 1.43 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 105.069 -2.197 . . . . 65.140000000000001 105.069 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 m -141.48 -66.34 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 107.736 -1.209 . . . . 65.319999999999993 107.736 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 173.64 6.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.814 2.045 . . . . 31.309999999999999 109.441 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 m -49.35 -57.77 6.29 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.267 1.427 . . . . 63.240000000000002 110.289 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.84 118.0 0.12 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.777 0.703 . . . . 65.150000000000006 111.379 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -102.4 73.81 1.36 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.617 -0.883 . . . . 75.129999999999995 108.617 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.26 149.91 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.384 -1.71 . . . . 62.119999999999997 106.384 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.81 -23.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.279 1.431 . . . . 45.43 112.639 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 -170.91 3.5 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 105.41 -2.07 . . . . 52.009999999999998 105.41 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.33 -178.56 5.54 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.211 -2.181 . . . . 72.230000000000004 111.599 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.98 162.47 40.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.648 0.779 . . . . 63.210000000000001 111.558 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 68' ' ' TYR . 2.2 p -148.35 115.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.728 2.011 . . . . 62.119999999999997 112.154 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -99.69 88.37 3.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 74.439999999999998 108.664 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.58 135.52 54.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.496 -1.298 . . . . 64.209999999999994 107.496 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 150.81 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.121 1.368 . . . . 63.509999999999998 111.002 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 pt -152.03 168.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.997 1.719 . . . . 74.129999999999995 110.394 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.411 0 N-CA-C 107.016 -1.475 . . . . 75.510000000000005 107.016 160.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.469 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 18.6 mt . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 108.305 -0.998 . . . . 75.349999999999994 108.305 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.32 5.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.43 -0.581 . . . . 72.319999999999993 109.43 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 17.5 m-85 -127.92 176.58 7.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.159 0.984 . . . . 72.450000000000003 110.473 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.5 ptm -126.74 -7.5 6.17 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.533 1.133 . . . . 72.409999999999997 112.655 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 53.63 78.13 0.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.883 0.873 . . . . 74.409999999999997 111.324 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 41' ' ' VAL . 13.5 m -77.69 -38.65 25.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-O 117.831 -1.08 . . . . 72.120000000000005 111.777 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.879 ' HB2' HG12 ' A' ' 41' ' ' VAL . 24.9 t80 -65.39 131.19 45.83 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 116.722 -1.991 . . . . 64.549999999999997 112.165 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 51.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.966 2.506 . . . . 64.140000000000001 108.262 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.82 166.06 13.46 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.77 -1.206 . . . . 74.109999999999999 110.29 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.52 -50.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.906 2.404 . . . . 75.319999999999993 109.783 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -90.71 154.94 45.92 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 125.845 1.658 . . . . 65.310000000000002 108.665 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.79 -173.22 1.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.471 2.114 . . . . 65.129999999999995 110.798 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p 57.34 60.57 2.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.454 1.502 . . . . 44.149999999999999 112.56 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.09 176.35 5.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.224 1.41 . . . . 61.509999999999998 110.014 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.61 -172.88 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.251 1.021 . . . . 51.130000000000003 110.906 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.19 139.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 125.612 1.565 . . . . 73.140000000000001 109.308 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.79 139.51 58.78 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.23 0.923 . . . . 75.340000000000003 110.088 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 t -63.15 -26.8 68.98 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.523 -0.736 . . . . 62.32 112.379 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -66.32 -21.26 66.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.855 0.862 . . . . 71.239999999999995 111.227 173.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -82.81 -33.04 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.626 -1.296 . . . . 64.420000000000002 110.533 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.98 -37.32 47.62 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.764 0.826 . . . . 72.329999999999998 112.206 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -60.93 -37.89 83.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.59 -0.522 . . . . 43.25 109.59 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -86.46 11.19 13.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.811 2.044 . . . . 73.310000000000002 111.645 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.53 155.69 16.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.008 1.323 . . . . 65.209999999999994 111.192 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 140.76 29.8 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.733 0.813 . . . . 52.030000000000001 110.064 173.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.57 155.01 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.89 0.852 . . . . 73.109999999999999 110.273 168.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.453 ' OD2' HD11 ' A' ' 96' ' ' ILE . 9.2 t70 -79.64 130.4 35.33 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 126.377 1.871 . . . . 72.319999999999993 108.534 173.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.59 3.59 4.58 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.473 1.109 . . . . 65.219999999999999 110.79 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 p -90.27 -19.11 24.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.705 2.002 . . . . 73.439999999999998 111.633 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -135.78 -62.03 0.7 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.59 1.086 . . . . 72.409999999999997 112.739 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -153.24 155.35 31.75 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 119.567 1.076 . . . . 71.239999999999995 109.902 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.58 112.94 3.19 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.96 1.773 . . . . 71.329999999999998 108.313 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.651 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -164.02 165.98 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.257 2.623 . . . . 62.109999999999999 109.886 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -90.11 135.19 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.955 -1.128 . . . . 62.420000000000002 107.955 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.453 HD11 ' OD2' ' A' ' 88' ' ' ASP . 45.6 mm -83.49 147.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.261 0.937 . . . . 62.409999999999997 110.637 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -137.25 115.76 11.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 61.450000000000003 110.122 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.77 87.38 6.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.646 1.578 . . . . 72.140000000000001 108.654 170.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.485 HG13 HG23 ' A' ' 41' ' ' VAL . 4.7 mt -86.08 151.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.321 -1.363 . . . . 71.209999999999994 107.321 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.63 146.24 24.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.835 0.743 . . . . 35.109999999999999 110.337 164.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.69 129.55 34.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.123 0.969 . . . . 63.130000000000003 110.011 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 92.13 8.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 105.909 -1.886 . . . . 75.340000000000003 105.909 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.95 173.14 6.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.412 1.485 . . . . 75.540000000000006 109.636 175.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.57 -16.53 10.42 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.858 1.429 . . . . 74.439999999999998 114.858 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -18.72 34.02 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.576 -1.328 . . . . 62.350000000000001 112.126 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.62 50.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.807 1.67 . . . . 35.100000000000001 111.047 -166.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.41 133.67 49.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.71 -1.589 . . . . 73.430000000000007 106.71 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -148.23 -86.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.303 0.954 . . . . 64.319999999999993 111.151 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.67 82.66 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.954 2.436 . . . . 51.039999999999999 107.596 166.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.09 160.82 9.47 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.381 -0.825 . . . . 62.109999999999999 109.539 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -115.34 140.5 49.07 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.424 1.09 . . . . 74.209999999999994 108.321 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.77 103.75 14.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 105.604 -1.999 . . . . 73.519999999999996 105.604 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.98 152.3 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 75.540000000000006 107.098 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.34 121.19 17.56 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.704 -0.68 . . . . 73.25 109.57 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -76.28 84.49 3.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.756 -1.201 . . . . 65.519999999999996 107.756 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 94' ' ' ALA . 19.9 mt -65.92 150.72 48.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.5 -1.296 . . . . 75.109999999999999 107.5 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 69.6 27.84 4.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.789 1.235 . . . . 60.219999999999999 111.288 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 129.174 2.99 . . . . 64.409999999999997 113.648 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.017 -0.364 . . . . 72.439999999999998 110.017 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' HG21 ' A' ' 32' ' ' THR . 85.0 Cg_endo -73.2 134.49 21.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.963 2.442 . . . . 74.099999999999994 108.653 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.12 168.07 28.08 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.872 1.701 . . . . 64.420000000000002 109.328 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.05 165.76 2.11 Favored Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 125.861 1.664 . . . . 42.140000000000001 109.257 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -70.82 142.01 42.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.379 2.052 . . . . 74.200000000000003 109.541 149.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.82 175.48 9.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.123 1.369 . . . . 40.340000000000003 109.774 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.61 25.69 0.27 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.124 2.969 . . . . 75.439999999999998 114.966 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -55.44 143.41 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.829 1.652 . . . . 73.219999999999999 109.691 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -139.48 147.95 42.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.539 1.536 . . . . 75.430000000000007 108.132 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.87 144.21 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.874 -1.899 . . . . 74.230000000000004 105.874 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.1 m -144.79 155.79 43.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.635 1.574 . . . . 72.540000000000006 109.083 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.89 168.07 20.19 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.376 -0.827 . . . . 64.519999999999996 110.376 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.0 m -150.69 165.2 17.92 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.629 1.972 . . . . 54.229999999999997 106.915 170.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 -26.05 24.13 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.578 2.186 . . . . 54.399999999999999 110.702 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.73 -64.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.552 1.141 . . . . 62.039999999999999 109.183 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.73 -145.82 4.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.559 2.028 . . . . 51.439999999999998 108.669 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.04 133.9 55.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.155 0.977 . . . . 40.200000000000003 108.723 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.82 135.57 48.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.709 -1.219 . . . . 72.209999999999994 107.709 166.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mp -142.01 138.01 31.54 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 119.037 0.835 . . . . 75.200000000000003 110.503 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -144.0 153.45 42.25 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.297 -1.001 . . . . 73.400000000000006 108.297 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.32 21.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 74.040000000000006 108.357 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.11 165.8 16.65 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.124 0.97 . . . . 73.099999999999994 110.631 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.25 168.42 17.73 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.715 3.61 . . . . 75.430000000000007 113.625 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.27 175.25 11.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.382 2.721 . . . . 75.109999999999999 111.629 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.6 24.53 4.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.866 1.266 . . . . 75.409999999999997 111.731 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.17 -22.12 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.167 -0.958 . . . . 72.430000000000007 111.528 -158.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 7' ' ' PRO . 13.3 t -166.16 162.39 17.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.162 2.185 . . . . 72.329999999999998 106.239 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -71.35 -68.93 0.41 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.373 1.069 . . . . 71.329999999999998 109.375 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.06 -173.05 10.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.623 -1.391 . . . . 71.040000000000006 109.623 -157.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -132.16 83.94 2.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.378 -1.341 . . . . 72.099999999999994 107.378 163.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.03 150.72 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.123 -1.066 . . . . 62.310000000000002 108.123 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.95 -25.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.788 1.635 . . . . 72.409999999999997 111.192 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 -175.86 3.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.35 1.46 . . . . 75.230000000000004 108.403 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -140.81 169.6 17.32 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.96 1.704 . . . . 72.040000000000006 108.878 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.4 m -152.68 161.16 42.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.439 0.696 . . . . 61.100000000000001 111.337 167.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.59 142.61 39.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.82 1.248 . . . . 63.43 108.672 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -127.0 115.83 19.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.929 2.092 . . . . 75.0 105.833 -171.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -101.03 122.18 43.09 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.673 -1.602 . . . . 75.439999999999998 106.673 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 98' ' ' ARG . . . -77.62 76.81 4.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.088 0.955 . . . . 53.009999999999998 109.801 -177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.25 175.77 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.135 0.974 . . . . 52.520000000000003 111.462 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.243 0 N-CA-C 106.061 -1.829 . . . . 71.150000000000006 106.061 169.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.311 0.577 . . . . 75.510000000000005 109.883 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.11 119.52 5.99 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.265 1.426 . . . . 61.420000000000002 108.847 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 6.7 m-85 -137.69 169.93 16.93 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.751 0.82 . . . . 73.209999999999994 109.307 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -12.46 25.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 74.0 113.453 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 43.97 75.36 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.523 1.929 . . . . 73.209999999999994 111.531 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.9 m -65.19 -16.01 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.405 1.082 . . . . 55.409999999999997 113.343 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -121.24 117.43 27.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.538 0.735 . . . . 75.109999999999999 109.975 -169.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.3 m -130.82 137.89 49.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.764 -2.31 . . . . 64.230000000000004 104.764 154.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.26 7.94 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.645 1.111 . . . . 72.120000000000005 112.496 170.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.97 -14.86 10.8 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.977 3.118 . . . . 75.0 113.385 -170.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.1 m -111.29 85.83 5.91 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.525 1.13 . . . . 74.420000000000002 109.489 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.6 67.78 3.7 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.541 2.827 . . . . 75.340000000000003 110.646 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -157.13 11.8 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.785 1.234 . . . . 71.129999999999995 111.618 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -89.9 161.76 15.77 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.321 1.049 . . . . 74.030000000000001 113.27 -165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.05 164.46 17.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.538 1.935 . . . . 72.329999999999998 110.393 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.41 125.52 69.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.694 1.598 . . . . 64.430000000000007 107.15 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -66.98 160.79 25.69 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.322 1.049 . . . . 71.340000000000003 111.561 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -55.05 -33.66 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 42.130000000000003 110.391 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -61.06 -12.23 11.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.541 1.536 . . . . 43.140000000000001 113.768 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -118.58 7.85 11.86 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.121 1.368 . . . . 72.0 112.053 171.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.51 -12.91 10.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.366 1.466 . . . . 73.540000000000006 111.733 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.48 -60.95 2.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.873 1.269 . . . . 72.319999999999993 111.5 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -73.29 13.26 0.46 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 118.161 -0.923 . . . . 74.340000000000003 112.085 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.76 165.95 2.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.243 1.383 . . . . 60.119999999999997 110.122 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.5 108.38 12.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.972 -1.492 . . . . 74.129999999999995 106.972 166.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 mm -68.82 140.78 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.075 -1.454 . . . . 75.140000000000001 107.075 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -56.85 118.13 4.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.19 0.996 . . . . 75.409999999999997 109.085 169.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.41 31.37 6.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.98 1.312 . . . . 61.32 109.076 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -6.36 5.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.667 1.187 . . . . 71.349999999999994 110.363 -164.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -159.06 -66.25 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.762 2.825 . . . . 72.430000000000007 107.681 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -149.58 151.86 33.97 Favored Pre-proline 0 N--CA 1.463 0.2 0 C-N-CA 125.857 1.663 . . . . 74.340000000000003 109.413 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.21 100.78 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.967 2.445 . . . . 75.140000000000001 109.89 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -145.34 152.32 39.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.349 1.459 . . . . 63.32 110.453 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.3 mt -79.98 124.19 37.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.388 -1.708 . . . . 72.519999999999996 106.388 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 mm -101.52 101.39 12.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.759 -1.2 . . . . 63.520000000000003 107.759 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -79.21 152.62 30.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.156 0.982 . . . . 75.120000000000005 109.292 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HE ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -136.17 124.76 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 104.739 -2.319 . . . . 75.099999999999994 104.739 176.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.69 141.98 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 120.674 1.579 . . . . 75.5 108.149 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.42 155.52 45.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.745 0.702 . . . . 62.130000000000003 111.231 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 125.0 28.75 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.46 1.504 . . . . 51.200000000000003 109.883 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -74.49 101.33 4.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 104.729 -2.323 . . . . 75.430000000000007 104.729 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -115.84 174.62 5.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.431 0.634 . . . . 73.409999999999997 110.751 168.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.08 -23.94 67.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.274 0.842 . . . . 72.0 113.274 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -57.91 6.4 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.205 1.002 . . . . 74.420000000000002 110.653 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 165.5 12.33 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.333 1.921 . . . . 62.409999999999997 109.05 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -64.75 137.78 58.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.168 -1.419 . . . . 61.32 107.168 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.61 -64.15 0.01 OUTLIER Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.377 0.989 . . . . 52.100000000000001 111.907 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.07 71.65 6.18 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.554 2.836 . . . . 73.209999999999994 110.774 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.17 6.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.139 0.576 . . . . 60.32 109.857 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.5 m -81.04 113.12 19.02 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.527 -1.657 . . . . 64.299999999999997 106.527 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.8 151.02 27.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.987 -1.116 . . . . 75.540000000000006 107.987 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 76.2 t -143.72 143.58 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.018 -1.475 . . . . 31.350000000000001 107.018 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.84 154.19 39.98 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.827 0.739 . . . . 71.200000000000003 112.31 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -142.71 112.12 6.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.469 1.108 . . . . 61.119999999999997 109.774 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -88.53 3.05 51.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 128.702 2.801 . . . . 71.140000000000001 112.286 -172.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.27 18.4 16.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.954 1.702 . . . . 71.340000000000003 110.293 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 124.19 0.996 . . . . 64.329999999999998 113.493 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 108.995 -0.743 . . . . 75.310000000000002 108.995 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.18 134.95 32.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.221 1.947 . . . . 40.310000000000002 113.373 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.39 -179.81 53.33 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.367 1.461 . . . . 61.43 112.301 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 174.49 165.12 0.34 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.272 3.029 . . . . 71.409999999999997 110.138 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.34 150.81 81.2 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.624 2.216 . . . . 55.420000000000002 109.666 163.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -137.31 174.89 10.12 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.431 1.092 . . . . 72.439999999999998 110.606 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.99 10.14 4.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.942 2.497 . . . . 71.209999999999994 115.515 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -51.49 111.66 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 125.259 1.424 . . . . 72.319999999999993 113.051 -158.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -86.3 136.46 33.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.534 -1.284 . . . . 62.450000000000003 107.534 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.23 126.33 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.4 -2.074 . . . . 63.030000000000001 105.4 160.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -150.33 173.02 14.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 128.924 2.889 . . . . 62.130000000000003 106.227 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -90.05 159.68 16.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.985 -1.117 . . . . 72.430000000000007 107.985 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -129.56 160.61 63.66 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.559 -1.645 . . . . 71.439999999999998 106.559 157.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -52.65 -45.0 43.29 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 120.91 1.073 . . . . 63.25 109.37 150.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -79.33 26.31 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.59 2.356 . . . . 71.109999999999999 113.604 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.74 -113.32 2.35 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.283 0.944 . . . . 44.310000000000002 111.119 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.59 -160.95 1.09 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.233 1.813 . . . . 35.409999999999997 108.757 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -130.34 33.62 4.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.212 1.405 . . . . 74.030000000000001 112.766 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.69 103.42 1.09 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 127.029 2.132 . . . . 63.039999999999999 113.038 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -138.97 150.59 46.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.431 1.469 . . . . 72.040000000000006 110.424 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.401 ' CE3' HD13 ' A' ' 99' ' ' ILE . 1.1 p90 -139.27 162.62 34.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.382 1.073 . . . . 73.319999999999993 110.426 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.75 154.81 87.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.377 -0.374 . . . . 73.420000000000002 111.347 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.49 168.16 25.46 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.067 3.178 . . . . 53.240000000000002 110.9 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.59 116.13 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.141 2.561 . . . . 73.150000000000006 110.341 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.36 60.31 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.685 2.394 . . . . 73.349999999999994 106.266 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.48 -62.31 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 124.267 1.027 . . . . 73.239999999999995 111.329 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 p -133.38 167.02 21.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.304 -0.872 . . . . 74.209999999999994 110.583 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.7 10.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.316 2.246 . . . . 64.239999999999995 114.022 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.25 149.01 50.26 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.568 -1.413 . . . . 74.040000000000006 109.568 172.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -121.39 92.11 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.473 1.909 . . . . 73.349999999999994 106.517 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -73.73 144.49 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 62.240000000000002 106.589 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 pt -131.08 -13.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.924 1.69 . . . . 63.130000000000003 112.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -168.38 -175.4 2.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.724 2.41 . . . . 74.409999999999997 107.345 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.22 170.36 15.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.061 -1.025 . . . . 73.120000000000005 109.294 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.4 p -146.62 155.18 42.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.852 0.861 . . . . 64.519999999999996 112.898 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.8 t -141.68 137.98 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.466 1.906 . . . . 71.540000000000006 106.706 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -128.49 126.75 41.08 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.907 1.683 . . . . 73.430000000000007 107.052 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.4 tp -119.79 131.58 55.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.821 1.648 . . . . 75.409999999999997 109.911 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.55 135.85 54.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.914 1.234 . . . . 62.240000000000002 110.834 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.1 pt -141.11 -173.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.987 1.315 . . . . 73.099999999999994 111.003 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 65.140000000000001 112.503 -168.735 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 106.741 -1.577 . . . . 64.239999999999995 106.741 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.14 108.4 7.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.703 -1.221 . . . . 61.140000000000001 107.703 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -118.2 -174.69 2.71 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.826 1.65 . . . . 64.230000000000004 108.849 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.4 ttp -121.82 121.72 37.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.892 2.477 . . . . 75.200000000000003 107.275 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 107.177 -1.416 . . . . 74.099999999999994 107.177 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.2 -28.96 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.804 -0.56 . . . . 73.310000000000002 110.67 168.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 73' ' ' PRO . 4.6 t80 -99.93 93.86 5.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.562 -0.711 . . . . 75.310000000000002 109.117 -159.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.3 71.92 0.85 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.991 1.317 . . . . 75.209999999999994 107.657 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.55 168.95 41.58 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.849 -0.9 . . . . 64.540000000000006 110.849 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.41 -55.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.565 2.844 . . . . 64.439999999999998 112.451 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 m -151.29 73.24 8.39 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.368 1.467 . . . . 72.120000000000005 109.763 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 19.4 Cg_endo -65.72 -47.87 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-O 116.237 -1.651 . . . . 75.430000000000007 110.129 155.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.83 76.6 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.395 1.452 . . . . 71.340000000000003 109.451 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.5 t 77.52 83.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 130.051 3.341 . . . . 75.150000000000006 111.586 -166.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 97.1 2.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.777 -1.564 . . . . 51.439999999999998 106.777 145.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' A' ' 82' ' ' LEU . 29.2 t -133.35 106.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 120.739 -1.226 . . . . 71.549999999999997 108.349 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -61.77 142.3 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.885 1.674 . . . . 51.140000000000001 109.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 p -57.78 -26.31 61.74 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.46 0.704 . . . . 72.349999999999994 110.815 171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -53.6 -15.83 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.484 1.914 . . . . 61.109999999999999 114.115 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -99.23 -49.75 4.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.532 1.06 . . . . 73.230000000000004 109.824 171.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' CD2' HG12 ' A' ' 77' ' ' VAL . 2.4 mm? -63.6 -39.46 94.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.563 1.074 . . . . 63.420000000000002 112.261 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.8 t -56.25 -44.59 79.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.985 1.314 . . . . 75.519999999999996 109.521 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.19 1.43 44.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 75.120000000000005 112.376 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.19 145.96 47.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.779 0.799 . . . . 54.200000000000003 109.534 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -69.47 107.4 3.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.096 -1.816 . . . . 74.409999999999997 106.096 158.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.01 130.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 106.439 -1.689 . . . . 74.409999999999997 106.439 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.49 132.22 53.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.898 1.332 . . . . 71.209999999999994 109.246 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.81 32.2 5.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.675 -1.148 . . . . 73.310000000000002 108.263 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.66 -84.35 0.64 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.638 -1.986 . . . . 71.329999999999998 105.638 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -62.47 -64.34 0.95 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.75 0.82 . . . . 64.129999999999995 110.421 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -155.86 155.65 29.64 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 117.747 -1.121 . . . . 74.030000000000001 110.766 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.44 97.38 0.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.315 2.01 . . . . 54.5 107.949 169.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -155.71 169.99 23.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.704 2.002 . . . . 73.310000000000002 108.594 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.92 115.45 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.197 -1.779 . . . . 64.430000000000007 106.197 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.14 139.61 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.597 -1.26 . . . . 75.310000000000002 107.597 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.08 131.31 50.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.055 1.742 . . . . 53.32 107.811 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -103.32 137.72 41.06 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.193 -1.78 . . . . 74.420000000000002 106.193 155.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.401 HD13 ' CE3' ' A' ' 26' ' ' TRP . 67.0 mt -130.74 137.75 55.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 104.557 -2.386 . . . . 73.030000000000001 104.557 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.4 142.77 23.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.87 0.692 . . . . 75.430000000000007 112.87 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.59 128.35 36.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.433 1.893 . . . . 73.450000000000003 109.573 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.49 95.71 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.343 -1.725 . . . . 62.140000000000001 106.343 173.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.41 ' C ' HD22 ' A' ' 103' ' ' ASN . 0.4 OUTLIER -120.84 166.06 14.29 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.079 1.352 . . . . 75.150000000000006 108.297 169.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.24 -35.54 65.08 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.852 0.861 . . . . 53.130000000000003 112.438 -171.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -55.37 -21.08 13.9 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.204 1.187 . . . . 71.019999999999996 114.204 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.49 176.26 32.72 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.498 -1.441 . . . . 62.530000000000001 109.498 -168.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -79.73 55.87 2.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.548 1.166 . . . . 75.349999999999994 109.584 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.32 -64.73 3.65 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.632 1.587 . . . . 75.010000000000005 109.289 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.58 142.1 25.76 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 CA-C-N 118.942 1.371 . . . . 51.43 109.255 172.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.83 147.79 27.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.075 -1.083 . . . . 62.340000000000003 108.075 165.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -78.01 169.73 17.79 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.343 -0.614 . . . . 71.129999999999995 109.343 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.58 2.91 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.409 -1.7 . . . . 64.019999999999996 106.409 169.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.87 161.08 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.008 -1.479 . . . . 52.149999999999999 107.008 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 131.16 22.82 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.034 -1.839 . . . . 73.409999999999997 106.034 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -82.76 82.41 8.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.195 -1.039 . . . . 74.030000000000001 108.195 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 94' ' ' ALA . 12.4 mt -68.67 -16.69 63.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.763 0.71 . . . . 74.239999999999995 112.519 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.2 -17.66 64.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.284 -0.885 . . . . 72.420000000000002 111.269 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.444 -0.735 0 C-N-CA 126.012 1.725 . . . . 74.450000000000003 106.547 -174.226 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 107.3 -1.37 . . . . 74.019999999999996 107.3 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.39 6.92 1.01 Allowed 'Trans proline' 0 CA--C 1.545 1.035 1 C-N-CA 126.734 4.956 . . . . 50.25 114.464 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.87 -114.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.525 0 O-C-N 120.802 -1.186 . . . . 30.030000000000001 111.694 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 109' ' ' PRO . . . 75.27 164.79 0.14 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.121 2.968 . . . . 72.310000000000002 111.404 -163.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.36 159.75 11.12 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 124.06 3.173 . . . . 70.340000000000003 110.804 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -136.45 -173.93 3.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.378 1.071 . . . . 70.239999999999995 110.233 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 33.43 3.49 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.929 2.492 . . . . 62.039999999999999 115.151 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.03 139.36 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.385 0.674 . . . . 65.129999999999995 109.924 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -124.04 140.13 53.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 125.545 1.538 . . . . 73.329999999999998 107.79 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.6 mt -147.3 134.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.83 -1.915 . . . . 74.409999999999997 105.83 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.04 163.29 40.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 74.310000000000002 108.237 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -81.97 164.1 21.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.144 0.884 . . . . 72.409999999999997 109.074 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -138.92 165.54 31.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.774 2.029 . . . . 44.32 106.897 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -64.25 -28.57 64.06 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.695 1.597 . . . . 72.310000000000002 111.631 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.52 17.92 11.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.64 1.576 . . . . 73.109999999999999 111.268 -163.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.38 -141.94 9.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.47 -1.452 . . . . 53.450000000000003 109.47 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.75 163.07 30.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.801 1.301 . . . . 42.350000000000001 111.416 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.02 134.76 34.24 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.253 1.821 . . . . 73.109999999999999 108.219 168.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 114.86 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.435 1.494 . . . . 54.539999999999999 110.152 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.1 p -135.33 168.81 18.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.654 0.661 . . . . 74.329999999999998 110.953 166.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -148.21 169.47 20.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 130.171 3.388 . . . . 74.209999999999994 107.048 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.04 151.72 42.65 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 123.999 0.92 . . . . 71.409999999999997 109.097 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.74 164.61 33.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.802 2.335 . . . . 64.209999999999994 111.245 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.88 139.83 90.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.888 3.059 . . . . 62.420000000000002 112.679 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.6 t -135.26 16.14 3.46 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.925 . . . . 61.32 113.173 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.91 -45.04 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.236 1.014 . . . . 54.420000000000002 110.345 -171.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 p -144.89 174.16 11.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.963 0.905 . . . . 63.350000000000001 109.689 168.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -50.4 -56.24 12.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.396 1.878 . . . . 42.520000000000003 114.019 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.97 176.76 5.53 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.298 1.904 . . . . 63.229999999999997 112.828 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -139.05 93.43 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.606 0.762 . . . . 51.340000000000003 109.222 158.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.46 150.95 3.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.264 -1.013 . . . . 74.150000000000006 108.264 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.7 -34.64 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.75 1.22 . . . . 64.219999999999999 111.644 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -160.43 -179.27 7.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.725 -1.213 . . . . 64.420000000000002 107.725 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -136.32 165.48 25.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.306 0.957 . . . . 65.349999999999994 110.413 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 t -145.75 153.57 41.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.041 0.936 . . . . 71.420000000000002 109.368 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.54 147.9 31.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.767 1.627 . . . . 71.129999999999995 107.305 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -133.0 145.53 50.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.275 -1.379 . . . . 72.319999999999993 107.275 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD21 ' CG2' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -126.28 134.58 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.713 -1.218 . . . . 62.119999999999997 107.713 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.09 131.24 49.91 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.75 -1.119 . . . . 63.240000000000002 109.71 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 pt -144.31 -174.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.751 -1.203 . . . . 45.030000000000001 107.751 168.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 126.256 1.823 . . . . 71.209999999999994 115.535 -176.9 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 112.399 0.518 . . . . 70.030000000000001 112.399 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.34 77.53 1.79 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.61 0.764 . . . . 70.310000000000002 111.488 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 6.5 m-85 -139.59 129.97 25.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.998 0.919 . . . . 74.310000000000002 109.134 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.8 ttp -76.76 151.08 36.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.844 1.258 . . . . 54.030000000000001 109.523 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -79.62 71.39 6.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 71.340000000000003 112.784 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.56 -32.03 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 118.763 -0.636 . . . . 71.519999999999996 112.63 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -58.92 122.64 14.16 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.34 0.973 . . . . 74.540000000000006 110.545 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.9 t -157.18 40.7 0.31 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.676 0.79 . . . . 73.420000000000002 110.142 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.33 168.6 32.61 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 119.268 0.94 . . . . 54.140000000000001 112.029 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.75 -21.39 6.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.734 2.956 . . . . 71.329999999999998 115.438 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 m -82.9 143.47 46.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.315 -0.994 . . . . 73.430000000000007 108.315 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.55 -41.52 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.431 1.42 . . . . 72.319999999999993 109.563 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.9 m -74.7 79.65 2.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.564 -1.272 . . . . 51.039999999999999 107.564 161.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.08 171.76 11.33 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.671 -0.643 . . . . 73.120000000000005 110.011 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.13 178.45 6.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.767 0.827 . . . . 74.409999999999997 110.583 167.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.5 t -138.83 146.7 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.952 1.701 . . . . 70.219999999999999 108.247 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.41 165.41 14.95 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 129.088 2.955 . . . . 73.439999999999998 112.93 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -44.98 -47.38 11.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.093 1.357 . . . . 70.129999999999995 111.966 162.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.1 m -56.5 -50.67 71.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.144 0.884 . . . . 72.219999999999999 112.255 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -71.89 -33.88 68.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.539 0.736 . . . . 25.140000000000001 110.561 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.68 -39.8 92.7 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.02 0.928 . . . . 64.219999999999999 111.743 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 m -71.66 3.69 3.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 0.817 . . . . 70.340000000000003 113.114 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -117.76 -1.93 11.47 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.975 1.31 . . . . 73.25 111.288 166.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.63 118.57 13.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.205 0.911 . . . . 70.450000000000003 108.735 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.12 140.65 56.2 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.542 -0.54 . . . . 74.099999999999994 109.542 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.05 138.78 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.859 -0.793 . . . . 70.049999999999997 108.859 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.0 133.11 49.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.588 0.755 . . . . 65.230000000000004 109.185 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.51 3.48 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.282 1.033 . . . . 72.239999999999995 112.0 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.2 m -65.46 -31.44 72.53 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.496 1.043 . . . . 71.230000000000004 109.589 167.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.86 -69.31 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.825 -0.547 . . . . 65.239999999999995 111.38 -162.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.59 ' HE3' HD22 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -141.95 145.89 38.21 Favored Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 118.054 -0.974 . . . . 53.32 109.109 -173.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.49 97.47 0.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.343 2.029 . . . . 73.129999999999995 108.437 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.491 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -148.22 162.87 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.24 2.616 . . . . 74.140000000000001 107.766 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CG2' HD21 ' A' ' 43' ' ' LEU . 64.7 mt -105.02 136.11 40.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.861 -1.163 . . . . 74.010000000000005 107.861 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.13 125.75 53.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.147 0.979 . . . . 74.019999999999996 110.665 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.423 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 95.9 m-85 -109.42 159.95 16.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.672 1.189 . . . . 72.450000000000003 109.775 170.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.0 126.95 44.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.188 -2.152 . . . . 64.209999999999994 105.188 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.9 mt -120.54 142.53 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.69 -1.596 . . . . 63.25 106.69 171.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 153.31 38.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.435 0.561 . . . . 74.030000000000001 111.56 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.47 131.8 40.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.898 1.279 . . . . 53.43 108.869 163.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -77.83 111.53 13.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.995 -1.854 . . . . 71.439999999999998 105.995 157.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -119.48 175.43 5.84 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.427 0.691 . . . . 73.319999999999993 111.027 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.27 -45.99 92.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.428 0.691 . . . . 74.409999999999997 112.295 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -61.84 -27.64 68.92 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.362 0.983 . . . . 74.420000000000002 110.627 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.63 -167.9 29.22 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.375 -1.49 . . . . 65.120000000000005 109.375 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.51 12.03 0.11 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.194 1.924 . . . . 52.130000000000003 116.194 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.4 -160.82 0.57 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.817 2.151 . . . . 44.310000000000002 112.11 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.521 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 24.2 Cg_endo -75.2 178.55 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.542 2.161 . . . . 73.439999999999998 109.074 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.42 128.63 48.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.334 -0.987 . . . . 62.25 108.334 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.402 ' OG1' ' HB1' ' A' ' 9' ' ' ALA . 97.2 m -76.08 105.47 7.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.773 -1.195 . . . . 74.340000000000003 107.773 169.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.56 118.21 9.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.344 -1.724 . . . . 72.010000000000005 106.344 161.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 97' ' ' PHE . 34.9 m -116.54 160.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 O-C-N 121.167 -0.958 . . . . 53.130000000000003 109.165 166.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.77 129.81 52.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.961 0.905 . . . . 71.450000000000003 109.215 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -85.37 85.45 7.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.396 -0.964 . . . . 63.140000000000001 108.396 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.59 HD22 ' HE3' ' A' ' 92' ' ' LYS . 66.1 mt -66.06 165.66 13.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.036 -0.727 . . . . 73.049999999999997 109.036 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 75.81 10.92 3.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.278 2.231 . . . . 50.539999999999999 113.497 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.246 0.877 0 N-CA-C 113.431 0.9 . . . . 52.549999999999997 113.431 161.172 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 109.212 -0.662 . . . . 72.329999999999998 109.212 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.13 168.12 22.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.84 2.36 . . . . 62.340000000000003 110.313 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.52 -132.64 11.27 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.703 -1.759 . . . . 71.0 108.703 -170.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.11 156.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.321 2.648 . . . . 74.109999999999999 111.841 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -68.97 159.23 54.77 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.894 1.729 . . . . 64.319999999999993 108.955 167.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.98 174.21 10.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.57 0.7 . . . . 53.140000000000001 109.853 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 50.3 27.28 2.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.094 2.157 . . . . 71.109999999999999 114.899 168.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -56.96 137.97 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.28 . . . . 72.400000000000006 108.699 -171.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -135.85 141.4 44.64 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.492 -1.299 . . . . 53.520000000000003 107.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mt -142.92 110.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.111 -1.07 . . . . 63.030000000000001 108.111 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -106.93 145.3 32.39 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.812 0.845 . . . . 74.219999999999999 109.831 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -82.53 158.86 22.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.38 0.672 . . . . 74.319999999999993 109.925 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -143.45 163.42 36.89 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.449 2.299 . . . . 74.400000000000006 109.545 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.97 -13.9 42.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.763 2.975 . . . . 63.140000000000001 113.684 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 2.47 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.411 2.284 . . . . 75.319999999999993 111.36 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.86 -127.29 2.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.223 0.92 . . . . 64.030000000000001 112.889 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.09 127.67 17.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.721 1.208 . . . . 62.439999999999998 108.418 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -70.17 98.62 1.37 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.52 1.528 . . . . 75.0 108.643 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.99 116.47 23.4 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.457 -1.312 . . . . 71.400000000000006 107.457 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 p -136.95 160.24 39.48 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.716 -0.615 . . . . 73.439999999999998 109.813 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 -178.41 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.192 0.597 . . . . 75.329999999999998 110.137 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 51.8 mt-10 -133.69 158.65 75.02 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 108.917 -0.771 . . . . 75.209999999999994 108.917 165.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.59 160.64 42.22 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.508 1.472 . . . . 71.430000000000007 109.525 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.58 170.93 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.308 1.339 . . . . 74.129999999999995 111.427 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 t -141.67 70.57 1.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 105.091 -2.189 . . . . 71.040000000000006 105.091 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.84 -65.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.124 0.97 . . . . 73.140000000000001 110.251 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -135.09 -173.11 3.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.564 1.074 . . . . 53.439999999999998 110.302 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -26.06 67.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.833 1.79 . . . . 63.009999999999998 115.833 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.36 94.67 0.01 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.721 2.105 . . . . 43.329999999999998 115.991 167.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -82.23 64.93 7.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.685 1.194 . . . . 71.099999999999994 111.621 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.57 147.43 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.58 -0.896 . . . . 73.040000000000006 108.58 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.33 -15.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.312 2.245 . . . . 22.039999999999999 112.1 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.19 178.06 10.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.764 1.626 . . . . 72.400000000000006 107.019 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.05 168.12 19.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.63 -1.248 . . . . 74.219999999999999 107.63 165.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 42' ' ' TYR . 56.0 m -134.43 141.45 46.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.568 -0.901 . . . . 73.0 108.568 164.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.5 t -136.61 116.98 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.363 -2.458 . . . . 75.200000000000003 104.363 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.479 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 11.2 m-85 -120.63 127.38 52.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.267 -1.012 . . . . 60.329999999999998 108.267 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -115.28 129.37 56.6 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 105.555 -2.017 . . . . 74.340000000000003 105.555 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.32 145.63 33.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 124.021 0.825 . . . . 74.219999999999999 109.367 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -145.23 -179.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.169 1.788 . . . . 64.409999999999997 107.903 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 123.063 0.545 . . . . 73.109999999999999 111.958 171.267 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 122.584 1.183 . . . . 74.409999999999997 111.336 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.63 148.3 30.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.759 -1.941 . . . . 62.140000000000001 105.759 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 23.0 m-85 -143.32 151.14 40.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.691 0.678 . . . . 72.430000000000007 110.67 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -112.22 4.95 18.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.6 1.16 . . . . 74.319999999999993 113.506 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 49.93 78.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.842 1.657 . . . . 73.0 111.317 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.0 m -77.28 -5.82 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 73.400000000000006 112.751 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -56.24 112.69 1.3 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.974 1.31 . . . . 74.420000000000002 110.103 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.78 31.41 0.22 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.345 1.458 . . . . 75.420000000000002 110.164 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -125.75 75.01 0.41 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.765 1.174 . . . . 74.209999999999994 111.29 -170.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -67.33 -17.5 49.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.144 1.896 . . . . 61.340000000000003 111.721 165.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -56.58 144.35 64.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.87 1.268 . . . . 61.310000000000002 109.515 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.79 -21.02 38.92 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.976 1.784 . . . . 43.210000000000001 111.85 -174.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.63 145.85 33.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 128.461 2.704 . . . . 63.32 104.183 163.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -137.7 154.07 49.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.626 1.103 . . . . 72.200000000000003 110.242 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.07 163.91 27.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.585 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.6 t -139.33 128.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 104.383 -2.451 . . . . 73.430000000000007 104.383 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.77 139.2 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.944 0.778 . . . . 62.310000000000002 109.502 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -30.27 63.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.843 1.657 . . . . 75.340000000000003 111.779 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.4 p -59.18 -14.61 11.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 55.399999999999999 113.595 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 t -88.07 -48.14 7.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.026 0.83 . . . . 64.140000000000001 108.947 168.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.38 -31.71 72.97 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.009 0.822 . . . . 63.119999999999997 112.151 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -44.89 -59.96 2.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.117 2.167 . . . . 62.020000000000003 108.386 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.35 0.29 37.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 62.439999999999998 111.929 -165.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 153.07 44.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.768 0.827 . . . . 72.430000000000007 110.884 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 132.5 36.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.093 -1.077 . . . . 75.0 108.093 165.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -84.06 145.44 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.431 1.092 . . . . 75.120000000000005 108.055 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -70.54 132.28 45.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.829 0.852 . . . . 73.340000000000003 109.181 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.55 23.72 11.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 75.340000000000003 109.995 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.53 -38.06 2.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.553 1.541 . . . . 53.100000000000001 111.892 -162.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -136.82 -52.89 0.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.447 1.099 . . . . 72.340000000000003 112.462 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -148.02 150.51 35.67 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 120.452 1.478 . . . . 71.239999999999995 110.84 158.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.51 95.93 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.816 3.01 . . . . 73.109999999999999 109.795 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -155.48 166.39 33.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.054 1.742 . . . . 61.039999999999999 110.6 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.1 mt -86.25 118.98 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.841 1.257 . . . . 63.329999999999998 107.735 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.56 145.76 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.52 -0.918 . . . . 73.040000000000006 108.52 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -131.92 125.45 31.7 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.682 -1.599 . . . . 63.329999999999998 106.682 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.85 126.36 32.88 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.901 -1.888 . . . . 73.200000000000003 105.901 164.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 mt -133.22 136.02 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.557 -1.646 . . . . 64.299999999999997 106.557 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 158.58 44.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.681 1.192 . . . . 75.319999999999993 108.709 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.82 101.38 9.23 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.814 1.246 . . . . 74.109999999999999 107.818 -171.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.23 111.03 1.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.958 1.703 . . . . 64.299999999999997 107.925 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -136.19 179.11 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.809 1.643 . . . . 44.140000000000001 111.378 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.89 -33.11 10.08 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.833 1.653 . . . . 63.119999999999997 114.002 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -60.75 -55.31 34.69 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.379 0.991 . . . . 73.319999999999993 111.247 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.68 174.55 19.32 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.131 -0.788 . . . . 64.400000000000006 111.131 -162.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -73.26 81.84 1.35 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.882 1.273 . . . . 75.239999999999995 109.639 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.08 -63.94 0.87 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.263 -1.299 . . . . 41.520000000000003 111.522 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.39 155.96 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.158 2.572 . . . . 32.240000000000002 109.131 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.58 103.19 1.21 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.96 -0.756 . . . . 63.109999999999999 108.96 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -71.82 146.81 47.77 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.459 -0.571 . . . . 73.040000000000006 109.459 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.86 83.67 1.8 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.234 1.013 . . . . 74.239999999999995 108.351 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.14 152.52 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.004 -1.48 . . . . 51.539999999999999 107.004 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.74 50.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.44 1.496 . . . . 75.319999999999993 108.284 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -136.61 111.58 8.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 75.040000000000006 110.113 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.642 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -86.29 -177.55 6.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.711 2.004 . . . . 72.129999999999995 110.687 -166.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 76.46 -2.67 2.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.025 2.53 . . . . 64.019999999999996 113.572 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 C--O 1.238 0.483 0 C-N-CA 124.111 0.964 . . . . 75.420000000000002 110.063 -179.745 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 108.408 -0.96 . . . . 73.340000000000003 108.408 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.68 7.39 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.073 1 C-N-CA 126.309 4.673 . . . . 72.430000000000007 115.463 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.37 -147.06 13.15 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.241 -1.537 . . . . 53.5 111.294 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.54 80.85 0.27 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.697 1.999 . . . . 61.439999999999998 112.881 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.88 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.165 . . . . 63.020000000000003 110.181 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.0 m -132.25 -177.45 4.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.189 1.396 . . . . 73.319999999999993 109.678 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.34 11.74 2.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.716 2.006 . . . . 72.010000000000005 114.688 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -56.95 131.98 20.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.665 1.586 . . . . 53.310000000000002 110.846 -166.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.73 163.74 22.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.352 1.061 . . . . 51.409999999999997 110.408 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.45 HG23 ' CD2' ' A' ' 24' ' ' LEU . 4.2 mp -140.13 158.1 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.851 2.06 . . . . 54.539999999999999 106.459 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -144.44 133.91 23.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.236 2.214 . . . . 74.329999999999998 107.353 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -64.81 151.65 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.622 -0.881 . . . . 62.140000000000001 108.622 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.56 157.51 44.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 126.518 1.927 . . . . 52.439999999999998 106.001 176.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.24 -20.12 32.97 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.422 2.081 . . . . 70.310000000000002 111.639 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -114.93 13.47 17.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.0 2.92 . . . . 74.219999999999999 111.317 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.66 -163.54 30.02 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 118.878 0.763 . . . . 51.329999999999998 112.164 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.91 121.18 40.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 120.017 1.909 . . . . 71.329999999999998 106.562 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -58.62 124.47 19.77 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.385 -1.339 . . . . 72.329999999999998 107.385 165.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 15' ' ' ILE . 11.8 mt -120.56 160.79 22.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.321 0.964 . . . . 74.230000000000004 109.08 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -155.47 165.2 37.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.85 0.75 . . . . 73.340000000000003 110.078 166.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.516 ' CE3' HD13 ' A' ' 99' ' ' ILE . 0.5 OUTLIER -151.43 172.35 16.1 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 129.138 2.975 . . . . 72.420000000000002 108.236 177.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -129.3 161.74 56.77 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 124.454 1.102 . . . . 73.319999999999993 111.347 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.19 161.91 38.18 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.605 2.87 . . . . 70.420000000000002 113.392 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.39 143.11 51.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.35 2.033 . . . . 72.430000000000007 110.225 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -133.5 61.81 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.252 -1.758 . . . . 61.200000000000003 106.252 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -133.29 -68.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.678 -1.23 . . . . 73.439999999999998 107.678 174.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 31' ' ' VAL . 64.6 p -130.22 170.92 13.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.605 1.562 . . . . 62.200000000000003 107.622 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -65.01 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.433 1.093 . . . . 71.420000000000002 110.414 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 144.48 2.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.665 -1.272 . . . . 71.400000000000006 112.18 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -100.47 83.17 2.57 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.776 -0.838 . . . . 74.319999999999993 108.747 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.85 143.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.635 -1.246 . . . . 62.030000000000001 107.635 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.87 -23.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.331 1.452 . . . . 74.230000000000004 111.367 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.66 -170.16 3.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.547 1.067 . . . . 65.030000000000001 109.95 171.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.23 175.28 9.25 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.051 1.34 . . . . 74.209999999999994 109.383 163.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -152.36 156.61 39.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.11 1.364 . . . . 64.230000000000004 109.434 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.4 t -148.0 121.61 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.949 -1.871 . . . . 44.509999999999998 105.949 -167.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -131.03 140.6 50.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.003 1.321 . . . . 74.400000000000006 109.273 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 125.98 46.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.424 -1.324 . . . . 65.010000000000005 107.424 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 116.82 15.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.581 1.552 . . . . 44.109999999999999 110.175 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.05 -176.61 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.819 2.048 . . . . 63.119999999999997 108.88 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 CA--C 1.537 0.46 0 O-C-N 121.87 -0.519 . . . . 54.229999999999997 112.145 171.626 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 107.48 -1.304 . . . . 52.32 107.48 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.1 112.63 13.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.52 -0.919 . . . . 72.140000000000001 108.52 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.19 150.08 40.56 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.595 1.158 . . . . 70.209999999999994 108.391 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.51 4.9 6.64 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.109 1.522 . . . . 73.030000000000001 115.109 -167.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 43.96 55.39 5.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.464 1.906 . . . . 64.239999999999995 113.172 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.76 -20.9 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.862 1.265 . . . . 74.430000000000007 112.671 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -58.76 120.17 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.022 0.828 . . . . 73.129999999999995 110.596 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -152.24 83.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.385 1.874 . . . . 63.0 105.969 161.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.91 159.85 28.26 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.252 -0.749 . . . . 73.010000000000005 111.474 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.11 -55.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 73.099999999999994 111.227 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.54 166.59 14.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.159 2.184 . . . . 70.230000000000004 110.509 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.46 169.05 23.23 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.807 1.671 . . . . 70.439999999999998 110.848 168.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 39.11 9.23 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.633 1.573 . . . . 72.430000000000007 112.145 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.2 m -85.5 175.71 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.337 1.065 . . . . 62.340000000000003 110.95 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 168.09 16.91 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.625 1.57 . . . . 74.310000000000002 109.333 165.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.1 p -130.64 144.2 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.236 1.414 . . . . 62.310000000000002 107.628 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -66.42 147.79 52.8 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.165 0.586 . . . . 50.140000000000001 112.285 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -48.47 81.09 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.962 1.705 . . . . 64.120000000000005 110.06 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.0 p -44.91 -48.58 11.25 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.573 1.949 . . . . 52.140000000000001 111.573 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.4 m -67.62 -42.16 82.81 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.343 -0.844 . . . . 73.010000000000005 111.214 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.49 -31.46 72.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.168 0.987 . . . . 73.310000000000002 111.407 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -64.39 -0.73 1.39 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.597 1.559 . . . . 70.329999999999998 114.283 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -120.62 -6.23 9.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.274 1.397 . . . . 70.420000000000002 111.679 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.47 137.75 57.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.788 1.235 . . . . 71.340000000000003 111.59 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 161.1 30.39 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.647 -0.872 . . . . 70.439999999999998 108.647 168.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.56 143.52 35.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.238 1.015 . . . . 70.120000000000005 108.447 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.98 82.45 0.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.768 1.627 . . . . 73.209999999999994 111.365 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.68 -18.35 61.56 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.637 -1.29 . . . . 51.149999999999999 111.21 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -17.81 64.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.224 1.41 . . . . 64.420000000000002 113.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.68 -75.02 0.17 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.433 1.015 . . . . 73.5 110.56 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.25 144.3 27.84 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 117.81 -1.091 . . . . 65.420000000000002 108.395 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 100.35 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.907 1.738 . . . . 74.209999999999994 109.8 -170.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 157.71 44.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.349 1.86 . . . . 32.350000000000001 109.085 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.1 mt -88.38 132.07 34.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.5 1.12 . . . . 73.0 109.168 169.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.6 136.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.777 1.275 . . . . 62.229999999999997 110.388 165.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -119.28 116.71 26.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 112.715 -2.039 . . . . 71.200000000000003 107.568 165.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -81.21 128.79 34.17 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 106.368 -1.716 . . . . 74.219999999999999 106.368 162.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.516 HD13 ' CE3' ' A' ' 26' ' ' TRP . 16.4 mt -133.62 151.7 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.684 -1.969 . . . . 65.310000000000002 105.684 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.49 151.91 25.0 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.522 0.729 . . . . 62.310000000000002 109.721 165.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.44 117.26 13.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.602 1.161 . . . . 62.210000000000001 109.97 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.95 99.8 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.643 -1.614 . . . . 73.310000000000002 106.643 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.99 172.98 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.688 1.595 . . . . 73.420000000000002 109.595 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -25.99 63.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.474 1.287 . . . . 62.439999999999998 114.474 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.55 25.45 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.541 -0.911 . . . . 70.010000000000005 108.541 174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.36 167.04 12.89 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.913 -0.875 . . . . 45.310000000000002 110.913 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -61.6 117.94 6.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 74.019999999999996 106.477 160.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.21 -95.88 2.4 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.455 -1.858 . . . . 22.140000000000001 108.455 173.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.91 147.75 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.271 1.981 . . . . 64.040000000000006 110.673 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.05 110.48 10.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.601 1.56 . . . . 53.340000000000003 108.635 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 m -65.03 123.79 20.39 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.358 -0.978 . . . . 74.140000000000001 108.358 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -97.45 89.44 4.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.985 -1.487 . . . . 65.340000000000003 106.985 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.87 171.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 120.633 -0.427 . . . . 71.109999999999999 110.168 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.39 123.86 19.52 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.504 1.121 . . . . 71.319999999999993 108.161 172.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -82.48 87.91 6.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.847 1.259 . . . . 72.120000000000005 109.106 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.2 mt -73.93 0.87 12.1 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.319 1.229 . . . . 72.439999999999998 114.319 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -115.12 38.4 3.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.423 1.01 . . . . 71.219999999999999 108.765 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 106.612 -1.625 . . . . 50.539999999999999 106.612 164.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 N--CA 1.466 0.358 0 N-CA-C 106.998 -1.482 . . . . 74.340000000000003 106.998 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.66 67.34 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 126.079 4.519 . . . . 75.310000000000002 111.865 -168.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 166.35 35.86 Favored Glycine 0 C--N 1.332 0.36 0 O-C-N 121.097 -1.002 . . . . 55.240000000000002 111.96 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.29 161.45 7.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.977 2.511 . . . . 35.130000000000003 106.873 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.79 159.49 52.48 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.702 2.268 . . . . 62.25 112.139 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -127.27 -178.5 4.47 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 121.45 -0.781 . . . . 54.310000000000002 110.664 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.11 23.16 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.916 2.487 . . . . 64.439999999999998 114.652 171.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.79 126.83 21.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 118.721 0.691 . . . . 75.540000000000006 110.734 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -120.3 143.88 48.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.01 1.324 . . . . 63.140000000000001 107.81 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -144.26 126.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.49 -2.041 . . . . 75.409999999999997 105.49 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.7 m -143.61 149.77 37.81 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.023 1.329 . . . . 61.219999999999999 110.291 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -84.52 153.71 23.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 72.530000000000001 110.602 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 166.07 15.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 128.745 2.818 . . . . 54.420000000000002 107.119 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.59 -27.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.404 2.069 . . . . 60.530000000000001 113.693 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.66 -11.52 51.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.373 1.069 . . . . 72.430000000000007 112.164 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.67 -163.31 29.02 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.952 -1.259 . . . . 73.409999999999997 109.952 -161.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.62 30.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.061 0.945 . . . . 73.129999999999995 111.092 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -78.84 134.6 36.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.846 -1.168 . . . . 75.329999999999998 107.846 157.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.72 137.49 45.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.159 1.384 . . . . 53.350000000000001 107.761 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -142.92 167.25 22.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.445 1.02 . . . . 73.120000000000005 109.856 167.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.441 ' CE3' HD13 ' A' ' 99' ' ' ILE . 4.0 p90 -160.51 178.4 9.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.822 2.049 . . . . 63.450000000000003 109.825 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.6 158.25 66.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.925 -1.036 . . . . 74.030000000000001 111.998 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 170.82 18.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.04 3.16 . . . . 73.209999999999994 113.85 -168.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.68 166.49 17.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.754 2.303 . . . . 75.200000000000003 111.82 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 t -140.46 21.49 2.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.469 1.508 . . . . 74.400000000000006 110.128 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.72 -55.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.638 1.175 . . . . 73.319999999999993 108.461 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 p -124.46 103.46 8.19 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.511 1.124 . . . . 75.230000000000004 109.368 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -64.22 -73.41 0.12 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.995 0.918 . . . . 43.409999999999997 110.899 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 1.84 75.57 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 117.587 -1.674 . . . . 43.539999999999999 115.14 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt 65.26 83.58 0.17 Allowed 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 132.479 4.311 . . . . 74.010000000000005 111.113 -172.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.62 136.5 22.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 107.205 -1.406 . . . . 53.200000000000003 107.205 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.7 -17.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.071 1.748 . . . . 72.409999999999997 111.142 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 3.2 tp10 -164.58 -164.91 0.87 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.048 1.339 . . . . 75.230000000000004 109.237 172.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.418 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 1.1 m-85 -142.25 172.84 12.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.975 1.71 . . . . 73.310000000000002 110.527 171.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 p -138.41 167.49 21.77 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.526 1.131 . . . . 75.230000000000004 110.744 168.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 t -146.62 124.74 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 103.537 -2.764 . . . . 73.439999999999998 103.537 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.03 136.12 50.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.501 -1.296 . . . . 75.040000000000006 107.501 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -123.74 120.84 33.85 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.278 1.831 . . . . 74.129999999999995 107.278 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.55 145.94 55.46 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.886 -0.783 . . . . 72.109999999999999 108.886 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 45' ' ' ILE . 0.1 OUTLIER -137.97 -178.33 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.647 1.979 . . . . 74.310000000000002 107.845 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 C--O 1.235 0.305 0 O-C-N 121.427 -0.796 . . . . 65.439999999999998 109.709 170.339 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.408 0 N-CA-C 106.317 -1.734 . . . . 65.420000000000002 106.317 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.3 109.06 5.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.341 -1.355 . . . . 73.120000000000005 107.341 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -133.49 154.43 50.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.186 1.395 . . . . 74.109999999999999 107.286 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.6 ttp -72.44 117.31 13.95 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.282 -1.377 . . . . 71.230000000000004 107.282 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -70.26 80.2 0.53 Allowed 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 107.407 -1.331 . . . . 70.140000000000001 107.407 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.6 -18.83 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.816 0.847 . . . . 43.539999999999999 111.717 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.47 105.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.471 1.108 . . . . 64.319999999999993 110.65 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.3 m -140.24 99.21 3.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.776 -1.935 . . . . 75.25 105.776 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.12 28.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.404 -1.078 . . . . 63.340000000000003 110.404 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 -15.3 17.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.388 2.725 . . . . 61.210000000000001 113.09 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 m -136.46 165.98 31.26 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.702 1.601 . . . . 75.450000000000003 110.439 -169.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.48 175.35 0.56 Allowed 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.603 2.869 . . . . 75.420000000000002 112.932 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m 56.3 43.21 26.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.995 1.718 . . . . 72.219999999999999 112.303 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 99.5 m -65.89 123.3 19.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 74.329999999999998 109.522 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 171.73 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.99 0.916 . . . . 64.230000000000004 111.465 167.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.7 141.17 39.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.467 -1.309 . . . . 75.25 107.467 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -78.02 162.66 26.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.482 1.113 . . . . 75.420000000000002 112.483 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -31.71 71.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.738 1.615 . . . . 71.530000000000001 113.489 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.99 -45.16 86.79 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 120.902 -1.123 . . . . 64.510000000000005 112.307 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -63.69 -38.19 90.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.859 -0.591 . . . . 64.530000000000001 109.536 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.383 0.673 . . . . 60.140000000000001 112.086 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -67.42 -44.97 77.46 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.104 1.32 . . . . 55.020000000000003 109.666 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -73.87 -18.76 60.88 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 118.601 -0.714 . . . . 52.049999999999997 112.863 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.83 133.98 31.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.7 1.6 . . . . 53.329999999999998 112.165 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -70.81 127.14 31.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.156 -1.424 . . . . 64.319999999999993 107.156 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.61 125.33 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.546 -2.02 . . . . 75.439999999999998 105.546 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.63 127.17 30.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.84 -0.8 . . . . 75.150000000000006 108.84 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.83 9.84 16.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.918 0.487 . . . . 75.530000000000001 110.842 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -89.79 -24.04 21.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 74.209999999999994 111.114 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -142.6 -74.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.328 1.051 . . . . 74.349999999999994 109.828 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.29 60.81 Favored Pre-proline 0 CA--C 1.513 -0.45 0 C-N-CA 126.541 1.937 . . . . 75.409999999999997 109.134 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.23 84.01 1.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 123.166 2.577 . . . . 73.510000000000005 106.581 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.86 162.3 35.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.254 2.621 . . . . 63.109999999999999 110.678 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG13 ' HG3' ' A' ' 118' ' ' GLU . 50.4 mt -81.03 148.42 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 108.471 -0.937 . . . . 73.319999999999993 108.471 168.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.07 139.61 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 124.785 1.234 . . . . 71.209999999999994 108.919 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.02 138.28 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.671 -1.233 . . . . 75.549999999999997 107.671 168.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -94.83 134.47 37.42 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.22 -1.4 . . . . 75.150000000000006 107.22 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.441 HD13 ' CE3' ' A' ' 26' ' ' TRP . 13.8 mt -127.3 134.95 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.458 -2.053 . . . . 75.010000000000005 105.458 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.46 153.45 46.27 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.961 0.904 . . . . 60.210000000000001 109.098 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.04 135.22 44.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.348 0.659 . . . . 72.140000000000001 109.687 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.4 HH11 ' CB ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -85.89 79.92 9.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 104.607 -2.368 . . . . 62.219999999999999 104.607 167.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.04 161.88 13.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.114 0.966 . . . . 73.409999999999997 109.387 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.31 -22.46 66.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.814 1.245 . . . . 75.129999999999995 112.133 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -65.38 -14.42 60.82 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.338 1.236 . . . . 53.310000000000002 114.338 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.75 177.34 28.27 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.696 1.617 . . . . 54.43 110.81 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.93 30.58 1.05 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.56 1.544 . . . . 63.119999999999997 114.421 -165.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.97 -77.05 0.16 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.497 1.046 . . . . 71.120000000000005 114.27 -159.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -89.17 156.1 5.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.578 2.185 . . . . 71.209999999999994 110.629 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.87 156.72 46.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.2 1.0 . . . . 62.32 109.188 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.404 HG22 HG13 ' A' ' 113' ' ' VAL . 87.4 m -82.11 123.64 29.14 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.738 -1.949 . . . . 73.140000000000001 105.738 157.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -83.98 119.34 24.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.359 -2.089 . . . . 72.319999999999993 105.359 154.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 111' ' ' THR . 22.1 m -110.51 173.98 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 123.674 0.79 . . . . 71.319999999999993 109.413 165.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.4 156.41 45.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.85 1.66 . . . . 74.549999999999997 109.3 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -139.44 109.64 6.48 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 125.77 1.628 . . . . 75.209999999999994 111.366 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.906 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -96.54 160.57 14.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.328 2.251 . . . . 63.439999999999998 107.872 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 63.06 14.78 7.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.97 1.308 . . . . 73.150000000000006 111.493 -168.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HG3' HG13 ' A' ' 95' ' ' ILE . 2.2 pm0 . . . . . 0 N--CA 1.449 -0.504 0 C-N-CA 126.893 2.077 . . . . 73.549999999999997 112.391 162.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.327 0 CA-C-O 117.289 -1.339 . . . . 64.209999999999994 112.541 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -60.3 165.33 11.11 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 CA-C-N 121.333 1.512 . . . . 71.109999999999999 111.411 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.45 -126.59 7.0 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.698 1.618 . . . . 52.350000000000001 109.657 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HB2' ' HG2' ' A' ' 109' ' ' PRO . . . 63.81 151.81 0.11 Allowed Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 129.215 3.006 . . . . 53.32 114.376 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HG3' HG22 ' A' ' 99' ' ' ILE . 59.3 Cg_endo -68.66 155.28 69.38 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 123.652 2.902 . . . . 71.140000000000001 111.036 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -134.69 -179.47 5.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.699 1.6 . . . . 70.540000000000006 110.208 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.4 36.9 17.7 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.087 1.355 . . . . 73.510000000000005 112.07 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.63 134.17 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.286 -1.005 . . . . 44.030000000000001 108.286 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -131.05 155.53 46.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.452 1.101 . . . . 74.400000000000006 109.553 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.06 139.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.499 -2.038 . . . . 61.100000000000001 105.499 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -139.74 147.6 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.723 1.609 . . . . 71.530000000000001 109.559 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -79.24 143.31 35.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.37 -1.345 . . . . 73.409999999999997 107.37 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p -139.03 166.75 22.59 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.701 2.0 . . . . 72.019999999999996 108.022 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -56.53 -25.1 56.88 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.619 2.213 . . . . 72.010000000000005 113.355 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -87.58 -20.76 25.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.574 1.079 . . . . 65.310000000000002 111.558 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.11 -163.78 24.25 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.477 -1.049 . . . . 12.550000000000001 110.477 -159.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.65 135.54 36.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.884 0.874 . . . . 73.140000000000001 112.093 -166.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -84.58 86.58 7.29 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.941 2.096 . . . . 71.329999999999998 110.047 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.85 131.78 35.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.611 0.764 . . . . 72.140000000000001 110.247 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -145.85 152.75 39.99 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.269 . . . . 63.420000000000002 109.294 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -151.25 179.41 8.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.581 1.553 . . . . 74.439999999999998 110.885 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -65.35 160.8 55.83 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.618 0.599 . . . . 73.099999999999994 112.618 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.61 156.21 66.31 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.211 1.941 . . . . 63.399999999999999 109.13 156.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.95 95.58 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.024 2.483 . . . . 73.099999999999994 110.53 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -140.24 22.28 2.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.63 0.604 . . . . 71.140000000000001 112.63 -165.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.9 t -99.2 -50.96 10.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 O-C-N 121.742 -0.599 . . . . 71.540000000000006 110.158 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.5 p -131.24 164.31 25.86 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.44 1.096 . . . . 74.219999999999999 110.118 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -77.64 40.4 0.3 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.237 1.415 . . . . 71.400000000000006 111.996 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.12 132.63 15.37 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.516 -2.234 . . . . 74.109999999999999 107.516 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -76.86 79.85 3.44 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.681 -1.229 . . . . 74.510000000000005 107.681 171.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.65 146.18 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.485 -1.302 . . . . 64.510000000000005 107.485 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 pt -141.72 -17.49 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.119 2.168 . . . . 74.209999999999994 111.088 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -160.47 -168.79 2.24 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.59 1.086 . . . . 73.299999999999997 111.325 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -133.14 162.73 30.98 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.511 1.524 . . . . 75.430000000000007 109.805 164.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -142.33 160.17 40.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.784 1.634 . . . . 75.109999999999999 108.923 159.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.7 117.39 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.477 -1.675 . . . . 62.310000000000002 106.477 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -93.22 144.17 25.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.906 -1.146 . . . . 74.319999999999993 107.906 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.2 tp -129.75 132.08 46.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.768 2.027 . . . . 74.549999999999997 107.342 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.69 134.12 44.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.147 1.34 . . . . 61.140000000000001 109.127 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.34 172.5 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.833 1.253 . . . . 72.530000000000001 108.741 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 118.27 0.486 . . . . 75.340000000000003 110.522 166.008 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 122.066 0.936 . . . . 75.340000000000003 113.197 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.38 94.95 4.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.746 -1.946 . . . . 54.43 105.746 167.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.43 145.94 48.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.564 -1.643 . . . . 75.239999999999995 106.564 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.5 ttp -96.42 138.15 34.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.405 1.082 . . . . 73.439999999999998 109.731 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -79.49 65.51 4.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.774 1.23 . . . . 64.540000000000006 110.682 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.59 -32.87 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.882 1.273 . . . . 71.420000000000002 112.332 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -80.38 97.08 6.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.095 0.558 . . . . 74.510000000000005 112.238 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.31 117.77 25.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.183 -1.414 . . . . 52.219999999999999 107.183 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.53 160.98 12.05 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.651 -1.38 . . . . 41.039999999999999 109.651 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.29 -55.03 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.955 2.437 . . . . 65.530000000000001 112.011 -169.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -84.32 164.85 41.48 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 121.188 -0.945 . . . . 62.340000000000003 111.257 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.97 179.22 3.41 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.814 3.009 . . . . 72.140000000000001 111.297 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 m 58.47 28.13 16.51 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.627 1.343 . . . . 74.319999999999993 114.627 165.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.91 158.36 34.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.334 1.053 . . . . 71.319999999999993 111.936 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 169.41 18.28 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.116 0.966 . . . . 63.539999999999999 111.821 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.14 111.86 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 125.194 1.398 . . . . 75.430000000000007 109.041 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.5 144.53 16.85 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.27 1.428 . . . . 74.109999999999999 113.459 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.83 -26.71 68.88 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.281 1.432 . . . . 74.209999999999994 113.187 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.7 t -54.34 -54.49 39.66 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.38 -0.825 . . . . 71.019999999999996 109.847 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.19 -37.55 87.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.796 0.438 . . . . 55.219999999999999 111.075 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.16 -27.81 67.41 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.247 0.476 . . . . 75.340000000000003 111.278 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -74.0 -34.78 64.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.479 0.581 . . . . 55.310000000000002 111.506 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -76.7 -11.29 59.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.622 0.601 . . . . 54.350000000000001 112.622 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 134.74 48.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.837 0.827 . . . . 43.32 109.456 -174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -72.79 112.34 8.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.942 -1.026 . . . . 60.240000000000002 109.054 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.4 125.17 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 64.420000000000002 106.844 162.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.02 135.06 50.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.999 0.812 . . . . 53.119999999999997 109.94 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -130.84 56.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.823 1.249 . . . . 64.430000000000007 108.143 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 p -123.41 -21.47 5.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.328 -0.851 . . . . 55.450000000000003 112.964 163.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -131.86 -69.88 0.59 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.642 0.777 . . . . 73.140000000000001 112.245 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -144.27 158.42 54.78 Favored Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 120.421 -1.424 . . . . 74.239999999999995 109.073 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.77 96.99 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.685 2.257 . . . . 75.310000000000002 108.46 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.31 37.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.738 1.615 . . . . 73.109999999999999 107.753 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.52 120.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.381 -1.711 . . . . 71.219999999999999 106.381 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.93 152.7 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.239 -1.022 . . . . 61.420000000000002 108.239 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -131.74 152.73 50.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.989 0.915 . . . . 73.510000000000005 108.74 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -127.36 87.56 2.65 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.446 HG22 ' HG3' ' A' ' 10' ' ' PRO . 70.7 mt -90.64 133.37 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.27 -2.122 . . . . 63.119999999999997 105.27 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.64 131.63 19.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.283 0.563 . . . . 60.409999999999997 111.868 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.17 122.45 22.79 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.459 -0.941 . . . . 72.310000000000002 108.459 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -77.8 109.8 12.12 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 106.931 -1.507 . . . . 61.530000000000001 106.931 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.63 -178.63 5.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.175 0.99 . . . . 64.450000000000003 109.55 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.94 1.93 56.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.401 -0.818 . . . . 73.530000000000001 112.724 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -66.68 -68.39 0.38 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.384 -1.339 . . . . 73.140000000000001 107.384 154.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.34 37.59 0.27 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 119.34 -1.41 . . . . 72.349999999999994 115.725 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 59.59 -163.65 0.23 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.609 1.963 . . . . 75.230000000000004 109.792 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 161.97 -90.64 0.11 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 105.336 -3.106 . . . . 74.319999999999993 105.336 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 79.2 Cg_endo -62.37 150.79 85.96 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.499 2.133 . . . . 72.519999999999996 110.296 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.95 112.25 5.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.499 -2.038 . . . . 60.219999999999999 105.499 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.8 m -58.83 124.54 20.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.84 0.856 . . . . 64.150000000000006 108.992 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -79.42 79.28 5.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.607 1.194 . . . . 75.530000000000001 108.379 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.78 146.77 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.243 -1.762 . . . . 62.450000000000003 106.243 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.66 128.44 39.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.094 -1.076 . . . . 55.039999999999999 108.094 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -92.64 104.82 17.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.211 0.604 . . . . 75.140000000000001 110.337 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.15 175.36 10.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.377 1.471 . . . . 72.329999999999998 109.427 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.22 14.69 3.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.117 2.167 . . . . 54.039999999999999 112.543 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 64.340000000000003 110.832 164.907 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 109.987 -0.375 . . . . 71.019999999999996 109.987 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 163.16 36.82 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.014 2.476 . . . . 70.340000000000003 110.547 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.31 -117.97 5.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.305 -1.118 . . . . 44.32 110.305 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 160.57 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 128.464 2.706 . . . . 63.109999999999999 112.361 -168.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.1 152.36 56.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.696 2.264 . . . . 72.349999999999994 109.217 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.17 177.0 8.53 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.861 1.664 . . . . 73.540000000000006 108.535 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.71 42.09 5.56 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.44 2.296 . . . . 70.439999999999998 111.633 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.446 HG23 ' CD1' ' A' ' 26' ' ' TRP . 2.4 mp -67.95 120.73 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.168 0.987 . . . . 61.140000000000001 109.021 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -112.55 133.98 54.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.365 -0.976 . . . . 63.399999999999999 108.365 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' A' ' 97' ' ' PHE . 22.7 mt -144.4 124.84 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.728 1.211 . . . . 73.219999999999999 108.076 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.0 m -145.41 161.79 38.85 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.611 1.164 . . . . 64.329999999999998 112.281 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -83.89 146.01 28.3 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.325 1.05 . . . . 75.430000000000007 109.206 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 m -152.08 165.3 17.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.917 1.687 . . . . 73.340000000000003 108.204 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.86 -11.18 25.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.209 1.94 . . . . 75.340000000000003 113.544 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.72 7.5 8.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.011 0.924 . . . . 75.329999999999998 111.523 -164.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 174.0 13.6 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.82 2.153 . . . . 75.099999999999994 107.93 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.4 129.46 36.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.566 -1.272 . . . . 62.219999999999999 107.566 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -65.89 109.39 2.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.634 -1.247 . . . . 72.400000000000006 107.634 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 5.3 mp -126.06 126.82 44.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.317 1.047 . . . . 62.119999999999997 108.693 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -139.43 154.18 47.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.331 0.652 . . . . 75.109999999999999 109.63 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CD1' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -142.94 -178.91 6.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.132 1.373 . . . . 75.310000000000002 107.675 175.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.19 160.37 52.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.199 0.909 . . . . 74.319999999999993 111.22 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.57 156.05 64.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.734 3.623 . . . . 74.439999999999998 113.101 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.57 -176.67 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.113 3.209 . . . . 75.349999999999994 111.488 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 14.03 3.57 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.647 1.721 . . . . 63.049999999999997 115.647 -163.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.8 -54.55 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.774 -0.579 . . . . 72.450000000000003 111.468 -160.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -132.9 172.65 12.31 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.967 1.307 . . . . 60.030000000000001 107.908 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 m -51.74 -41.86 61.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.606 1.094 . . . . 72.340000000000003 112.394 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.71 163.87 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.087 0.851 . . . . 60.25 111.198 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -131.31 74.26 1.58 Allowed 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.512 -0.993 . . . . 73.010000000000005 108.641 164.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.22 152.44 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 75.219999999999999 106.439 167.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.24 -28.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.121 1.368 . . . . 61.119999999999997 110.403 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.39 -169.94 3.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.353 -1.351 . . . . 73.439999999999998 107.353 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 102' ' ' ARG . 34.8 m-85 -128.11 166.27 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.629 -1.248 . . . . 71.319999999999993 107.629 159.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -130.72 153.42 49.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.284 -1.376 . . . . 62.329999999999998 107.284 164.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.932 HG12 ' HB2' ' A' ' 68' ' ' TYR . 3.6 p -153.02 124.64 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 O-C-N 121.942 -0.474 . . . . 51.310000000000002 110.475 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -99.15 133.98 42.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.943 -1.132 . . . . 75.019999999999996 107.943 -171.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 85' ' ' ALA . 10.5 tp -117.63 130.23 56.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.639 2.375 . . . . 72.209999999999994 107.564 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . . . -63.0 136.25 57.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 121.417 1.917 . . . . 64.219999999999999 112.992 169.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.447 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.3 pt -145.11 175.5 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.194 1.398 . . . . 52.420000000000002 110.289 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 126.317 1.847 . . . . 74.409999999999997 112.754 164.328 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.24 0.562 0 N-CA-C 107.724 -1.213 . . . . 74.519999999999996 107.724 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.19 -154.24 0.06 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.724 -0.671 . . . . 74.120000000000005 111.92 162.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER 76.69 160.54 0.22 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 131.23 3.812 . . . . 61.329999999999998 113.77 173.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.447 ' SD ' HD13 ' A' ' 45' ' ' ILE . 9.8 ptt? -126.95 147.65 50.09 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.655 1.182 . . . . 55.219999999999999 110.068 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.62 93.72 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.203 2.201 . . . . 75.409999999999997 112.529 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -94.86 -26.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 116.456 -1.735 . . . . 75.099999999999994 110.162 -165.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.932 ' HB2' HG12 ' A' ' 41' ' ' VAL . 26.3 t80 -58.0 132.68 54.17 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 120.332 1.424 . . . . 72.129999999999995 109.409 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.0 p -155.01 27.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.548 1.139 . . . . 73.239999999999995 112.227 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.27 152.67 18.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.978 -0.901 . . . . 61.210000000000001 111.195 -168.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.33 -55.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.046 1.831 . . . . 72.140000000000001 109.053 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.87 144.95 97.99 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.29 -0.633 . . . . 64.209999999999994 109.29 169.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.56 -3.54 13.26 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.613 2.875 . . . . 55.340000000000003 112.604 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 p -98.58 44.99 1.02 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.461 1.482 . . . . 73.530000000000001 110.419 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.6 t -51.3 111.82 0.64 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.953 1.301 . . . . 62.100000000000001 110.706 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.3 130.24 37.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.288 -0.634 . . . . 63.140000000000001 109.288 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -76.35 95.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.846 -1.539 . . . . 72.340000000000003 106.846 162.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -75.75 163.71 26.99 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.294 -0.866 . . . . 54.299999999999997 109.694 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -53.09 -38.35 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.072 1.349 . . . . 73.420000000000002 112.115 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -40.09 63.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.784 2.034 . . . . 63.210000000000001 111.592 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.3 m -79.21 -36.09 40.65 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.105 -0.372 . . . . 75.230000000000004 111.873 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -25.53 68.23 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.85 0.46 . . . . 72.230000000000004 111.25 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.1 m -60.84 -10.86 6.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.345 1.239 . . . . 55.0 114.345 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -115.51 -6.66 12.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.644 1.111 . . . . 74.140000000000001 111.139 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 43' ' ' LEU . . . -70.1 151.28 45.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.212 1.005 . . . . 72.430000000000007 109.997 -171.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -137.24 153.09 50.45 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.721 0.808 . . . . 74.200000000000003 112.117 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 93' ' ' PRO . 1.9 mp -88.28 144.54 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.554 1.542 . . . . 64.230000000000004 109.593 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.16 71.42 5.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.417 1.887 . . . . 54.32 109.656 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -62.33 4.45 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.258 1.023 . . . . 74.239999999999995 111.876 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -20.51 31.38 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.367 0.985 . . . . 41.299999999999997 110.258 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.8 p -141.66 -85.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.765 1.226 . . . . 65.400000000000006 111.286 161.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HE3' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -117.17 153.93 49.91 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 126.421 1.889 . . . . 73.140000000000001 112.093 -162.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 87' ' ' ILE . 83.2 Cg_endo -77.64 78.76 3.41 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.511 1.474 . . . . 72.319999999999993 112.765 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.653 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -143.69 157.24 44.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.54 2.736 . . . . 53.020000000000003 107.912 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.3 mt -73.32 -21.3 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.572 0.582 . . . . 72.140000000000001 112.572 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.4 mm 60.68 142.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 130.187 3.395 . . . . 65.540000000000006 110.04 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CD2' HD13 ' A' ' 15' ' ' ILE . 10.5 m-85 -135.98 135.75 39.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.235 -1.394 . . . . 71.439999999999998 107.235 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -133.95 90.7 2.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.084 0.865 . . . . 74.530000000000001 109.627 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.544 ' HA ' HG23 ' A' ' 41' ' ' VAL . 1.1 mt -87.41 153.47 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.249 -1.389 . . . . 74.219999999999999 107.249 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.76 154.74 37.9 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.967 0.803 . . . . 61.020000000000003 111.769 159.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.47 116.22 13.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.217 1.807 . . . . 63.039999999999999 108.57 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.419 ' H ' ' HA ' ' A' ' 39' ' ' TYR . 1.4 tmm_? -79.34 89.26 4.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.074 -2.195 . . . . 74.219999999999999 105.074 170.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -115.74 178.92 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.298 1.439 . . . . 64.25 109.972 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.94 -3.12 20.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.629 0.974 . . . . 75.349999999999994 113.629 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -91.19 -27.96 18.16 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 120.256 -1.527 . . . . 61.450000000000003 109.675 173.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.16 -179.25 20.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.631 1.11 . . . . 51.119999999999997 110.98 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -70.7 69.52 0.44 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.068 1.747 . . . . 75.219999999999999 109.271 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 -81.99 1.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.114 -1.594 . . . . 70.439999999999998 109.114 -169.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.61 160.33 25.16 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.091 1.861 . . . . 64.450000000000003 109.05 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.71 36.92 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.973 0.909 . . . . 71.109999999999999 109.321 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -95.76 154.0 17.45 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.504 -1.295 . . . . 73.129999999999995 107.504 156.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -129.72 101.58 5.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.791 -2.3 . . . . 73.230000000000004 104.791 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.98 164.31 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.542 -1.281 . . . . 63.299999999999997 107.542 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 121.1 24.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.452 1.101 . . . . 74.540000000000006 108.095 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -91.74 79.7 5.36 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.316 -1.735 . . . . 74.299999999999997 106.316 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.759 HD21 ' HE3' ' A' ' 92' ' ' LYS . 44.5 mt -76.4 170.73 15.82 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.608 -0.886 . . . . 71.129999999999995 108.608 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 75.58 -6.14 2.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.895 2.478 . . . . 63.5 113.003 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--O 1.241 0.608 0 C-N-CA 125.428 1.491 . . . . 74.400000000000006 113.391 171.413 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 108.276 -1.009 . . . . 72.409999999999997 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.4 145.81 83.95 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.084 1.856 . . . . 61.310000000000002 109.061 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.9 -133.66 5.07 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.631 -1.387 . . . . 64.340000000000003 109.631 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.02 165.06 0.14 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 128.624 2.77 . . . . 75.200000000000003 111.249 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.51 156.33 64.17 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.458 2.105 . . . . 44.240000000000002 110.201 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.06 -178.97 5.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.837 0.827 . . . . 74.319999999999993 112.05 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.28 1.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.838 2.855 . . . . 60.329999999999998 115.744 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.4 mp -44.47 129.67 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.87 2.468 . . . . 61.020000000000003 112.626 -154.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 14' ' ' LYS . 8.0 mmpt? -115.01 131.03 57.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.439 1.095 . . . . 71.319999999999993 108.913 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.57 93.45 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.964 -1.495 . . . . 71.209999999999994 106.964 -175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -96.12 140.35 30.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.581 -1.19 . . . . 34.009999999999998 108.991 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -60.68 154.03 22.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.99 -0.744 . . . . 75.129999999999995 108.99 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.6 m -144.38 165.28 24.12 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 127.612 2.365 . . . . 73.209999999999994 107.963 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.98 -39.31 41.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.098 1.865 . . . . 75.510000000000005 112.06 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -106.48 9.79 31.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.732 0.813 . . . . 75.209999999999994 111.574 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.02 -137.37 4.76 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 120.414 -1.429 . . . . 62.140000000000001 112.185 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.12 144.85 32.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.797 0.839 . . . . 51.520000000000003 109.655 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -75.69 155.1 36.04 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 109.24 -0.652 . . . . 73.519999999999996 109.24 163.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 107.82 3.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.914 1.686 . . . . 55.329999999999998 108.711 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.3 p -123.41 158.6 30.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.034 0.833 . . . . 75.120000000000005 110.251 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CZ3' HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -146.78 141.86 27.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.964 0.905 . . . . 72.209999999999994 111.556 176.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -76.36 150.9 83.01 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.348 1.059 . . . . 74.120000000000005 109.206 165.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.23 168.01 25.3 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.625 3.55 . . . . 73.150000000000006 111.126 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 153.11 77.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.198 1.265 . . . . 55.350000000000001 110.721 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 t -151.86 73.0 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.738 -1.949 . . . . 74.239999999999995 105.738 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -57.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.066 0.946 . . . . 60.340000000000003 110.201 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 p -134.86 167.53 20.72 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.448 -0.945 . . . . 73.230000000000004 108.448 162.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -47.01 -57.07 5.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.203 1.801 . . . . 73.349999999999994 113.132 -168.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.31 176.72 5.96 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.228 1.394 . . . . 64.299999999999997 111.103 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -141.27 92.06 2.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.379 -1.711 . . . . 71.209999999999994 106.379 157.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.76 145.28 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.632 -1.618 . . . . 75.329999999999998 106.632 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.45 -28.26 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.471 1.109 . . . . 71.530000000000001 110.932 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.36 -176.26 5.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.663 1.119 . . . . 74.209999999999994 110.283 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -139.64 166.11 25.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.355 1.062 . . . . 51.130000000000003 110.273 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.48 171.93 19.42 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.287 -0.634 . . . . 73.219999999999999 109.287 163.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.02 124.48 26.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.19 -1.781 . . . . 71.120000000000005 106.19 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -118.22 119.07 33.57 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.794 -1.928 . . . . 75.430000000000007 105.794 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.21 116.03 30.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.285 -1.746 . . . . 71.099999999999994 106.285 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.34 136.4 51.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.003 -1.11 . . . . 61.409999999999997 108.003 173.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 pt -130.37 -177.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.288 -1.745 . . . . 64.540000000000006 106.288 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.491 1.916 . . . . 71.5 110.858 178.191 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.412 0 N-CA-C 107.296 -1.372 . . . . 55.420000000000002 107.296 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.13 84.06 1.7 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.417 -0.811 . . . . 54.240000000000002 110.287 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.29 158.64 43.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.555 1.142 . . . . 71.209999999999994 109.81 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -102.83 7.03 39.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.501 0.926 . . . . 75.129999999999995 113.501 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 45.91 61.12 2.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.707 2.003 . . . . 74.5 114.398 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.65 -37.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.666 1.186 . . . . 71.5 113.545 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -64.68 118.81 9.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.969 0.804 . . . . 73.120000000000005 109.807 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.7 m -135.58 27.58 3.36 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.537 1.535 . . . . 75.209999999999994 109.656 164.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.19 161.05 37.25 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.973 -0.851 . . . . 75.200000000000003 110.973 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.83 -55.17 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.578 2.186 . . . . 74.239999999999995 110.013 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.86 158.75 31.15 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.864 1.266 . . . . 72.319999999999993 110.389 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.82 173.63 10.73 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.883 2.388 . . . . 75.420000000000002 110.863 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p 47.87 63.68 1.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.93 1.292 . . . . 64.430000000000007 109.782 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.3 p -70.98 -164.82 0.1 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.856 2.062 . . . . 74.5 110.21 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 77' ' ' VAL . 3.2 pp -130.09 -176.49 3.96 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.227 -1.546 . . . . 72.549999999999997 108.799 164.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.437 ' N ' HD12 ' A' ' 76' ' ' LEU . 31.0 t -135.98 148.23 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.632 1.105 . . . . 74.230000000000004 109.051 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -89.41 145.12 25.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.004 2.122 . . . . 73.530000000000001 111.084 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -62.48 -27.4 69.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.982 2.113 . . . . 73.540000000000006 112.83 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.5 p -57.53 -30.03 64.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.116 0.966 . . . . 74.319999999999993 111.28 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -78.44 -45.43 22.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.015 1.326 . . . . 52.420000000000002 109.298 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.35 -37.3 74.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.995 1.318 . . . . 75.219999999999999 111.87 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -50.08 -48.86 52.95 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.144 0.497 . . . . 62.530000000000001 110.531 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -84.32 -5.35 59.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.168 0.987 . . . . 62.409999999999997 112.076 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.81 138.07 55.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.083 0.944 . . . . 72.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -71.85 153.5 41.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.074 -1.421 . . . . 73.120000000000005 110.446 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -123.25 136.8 58.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.914 1.286 . . . . 71.430000000000007 109.261 -166.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.76 68.14 1.68 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 128.128 2.571 . . . . 74.329999999999998 112.197 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.71 73.07 0.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.827 1.299 . . . . 61.340000000000003 108.443 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.5 p -133.92 -28.5 1.37 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.234 2.213 . . . . 72.109999999999999 108.357 165.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.74 -50.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.084 0.954 . . . . 62.399999999999999 111.887 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.41 160.1 69.75 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 120.893 1.679 . . . . 73.129999999999995 112.541 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.53 74.1 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.579 2.186 . . . . 75.230000000000004 109.291 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.96 148.8 45.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.609 0.966 . . . . 53.109999999999999 113.609 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -83.98 133.9 28.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.917 1.287 . . . . 62.200000000000003 109.251 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -84.29 147.84 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.932 0.893 . . . . 61.409999999999997 110.601 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -126.57 145.56 50.49 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 125.331 1.452 . . . . 60.340000000000003 109.373 171.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -119.27 98.58 6.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.938 -1.875 . . . . 72.230000000000004 105.938 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.484 HD13 ' CZ3' ' A' ' 26' ' ' TRP . 17.4 mt -113.17 133.14 59.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.456 -2.053 . . . . 74.040000000000006 105.456 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 149.86 47.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.85 -1.167 . . . . 53.130000000000003 107.85 167.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.03 28.49 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.113 -1.439 . . . . 74.439999999999998 107.113 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG2' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.87 99.96 3.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.003 -2.221 . . . . 75.409999999999997 105.003 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -121.92 163.7 18.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.067 1.347 . . . . 53.409999999999997 110.335 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.66 -21.15 62.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.707 -1.133 . . . . 72.230000000000004 112.436 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.78 -16.85 44.92 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.36 1.064 . . . . 75.140000000000001 112.888 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.58 36.77 4.72 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 118.55 0.614 . . . . 75.329999999999998 111.756 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER 64.29 24.83 13.4 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.458 1.903 . . . . 75.219999999999999 111.865 165.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.87 -77.98 0.31 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.137 1.351 . . . . 73.0 112.098 -157.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.46 134.69 24.97 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.457 1.438 . . . . 75.329999999999998 109.403 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.99 164.07 26.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.074 1.75 . . . . 64.219999999999999 107.46 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 m -114.63 135.26 54.34 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.593 -1.632 . . . . 74.200000000000003 106.593 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.92 114.9 27.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.371 -2.085 . . . . 72.109999999999999 105.371 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 m -113.17 162.67 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 119.16 0.891 . . . . 75.129999999999995 108.913 167.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 135.85 52.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.364 -1.347 . . . . 75.319999999999993 107.364 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -120.89 102.08 8.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.274 1.035 . . . . 72.030000000000001 111.396 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.832 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.58 -10.95 28.18 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.741 2.417 . . . . 75.319999999999993 111.885 -169.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 2.21 2.92 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.076 1.75 . . . . 75.129999999999995 111.652 170.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.651 0 CA-C-N 120.654 1.57 . . . . 75.120000000000005 114.408 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.657 0 N-CA-C 107.57 -1.271 . . . . 72.319999999999993 107.57 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.78 136.51 58.06 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.136 1.224 . . . . 74.329999999999998 109.546 164.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.01 112.97 3.66 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 125.13 1.348 . . . . 32.520000000000003 114.356 165.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.96 31.01 Favored Pre-proline 0 C--N 1.314 -0.967 0 C-N-CA 127.025 2.13 . . . . 72.120000000000005 105.272 158.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HG3' HG22 ' A' ' 99' ' ' ILE . 37.9 Cg_endo -63.41 159.59 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.065 2.51 . . . . 73.530000000000001 111.268 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.1 m -134.41 176.52 8.54 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.662 1.185 . . . . 74.540000000000006 109.882 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 18.4 5.9 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.593 2.757 . . . . 23.219999999999999 113.758 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.58 120.98 7.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.369 0.668 . . . . 62.130000000000003 109.728 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.67 146.38 27.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.247 -1.39 . . . . 74.140000000000001 107.247 167.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.416 HG12 HD13 ' A' ' 24' ' ' LEU . 9.8 mt -135.71 133.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.383 -2.08 . . . . 74.129999999999995 105.383 161.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 t -146.82 144.51 29.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.434 1.494 . . . . 74.230000000000004 109.312 -173.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -80.45 158.26 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.124 0.57 . . . . 64.420000000000002 110.261 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.45 165.34 18.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.038 1.335 . . . . 61.0 107.935 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 -15.64 35.46 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.105 2.536 . . . . 70.310000000000002 113.464 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -107.74 -26.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.399 1.08 . . . . 70.230000000000004 111.66 -168.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.14 -165.61 37.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.582 -1.807 . . . . 51.520000000000003 108.582 -167.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.31 133.92 42.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.046 -1.465 . . . . 74.099999999999994 107.046 165.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -60.31 115.36 3.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.012 -1.477 . . . . 74.200000000000003 107.012 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD13 HG12 ' A' ' 15' ' ' ILE . 3.9 mm? -105.42 140.35 38.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.4 -1.704 . . . . 71.540000000000006 106.4 168.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 p -150.23 156.56 41.8 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.886 1.221 . . . . 71.439999999999998 109.953 164.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -139.91 158.37 44.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.487 1.515 . . . . 70.319999999999993 108.921 166.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -87.89 161.67 43.57 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.052 0.541 . . . . 61.340000000000003 110.523 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.8 168.08 19.56 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.904 . . . . 74.510000000000005 111.341 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.55 156.5 21.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.005 1.803 . . . . 74.510000000000005 112.973 -166.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.5 52.86 1.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.028 -1.471 . . . . 74.200000000000003 107.028 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG12 HG22 ' A' ' 32' ' ' THR . 33.2 t -137.57 -87.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.149 -1.056 . . . . 71.219999999999999 108.149 160.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.473 HG22 HG12 ' A' ' 31' ' ' VAL . 12.1 t -168.68 40.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.968 -1.083 . . . . 53.32 110.037 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.4 p -68.23 -6.82 25.74 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.103 -1.623 . . . . 71.299999999999997 113.787 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.09 -124.99 6.71 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 120.248 -1.533 . . . . 72.420000000000002 111.49 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -109.11 88.43 2.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.351 1.86 . . . . 62.530000000000001 110.612 -167.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.04 125.58 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.867 1.667 . . . . 63.530000000000001 107.177 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.46 -27.93 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.398 1.079 . . . . 74.239999999999995 111.406 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -151.3 -171.44 3.93 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.692 1.597 . . . . 72.299999999999997 107.434 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 169.49 17.51 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.472 -1.393 . . . . 74.5 108.749 172.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.9 173.24 16.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.587 0.63 . . . . 72.219999999999999 112.6 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.65 99.28 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 128.733 2.813 . . . . 73.310000000000002 105.282 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 42.7 m-85 -82.99 153.34 25.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.957 -1.127 . . . . 73.340000000000003 107.957 163.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.3 tp -143.26 128.19 18.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.956 2.102 . . . . 74.239999999999995 106.105 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 112.78 13.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.829 0.852 . . . . 63.520000000000003 109.143 169.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 pt -86.75 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.155 -1.054 . . . . 63.240000000000002 108.155 160.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 124.231 1.012 . . . . 62.140000000000001 111.139 174.009 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--O 1.241 0.649 0 N-CA-C 109.586 -0.524 . . . . 45.020000000000003 109.586 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.36 120.93 25.06 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.448 0.536 . . . . 70.510000000000005 112.448 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.435 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 37.9 m-85 -148.97 170.91 17.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.268 1.827 . . . . 65.120000000000005 110.33 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 ttp -106.45 5.89 29.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.438 1.495 . . . . 73.340000000000003 113.225 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 44.44 44.35 6.91 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.772 1.629 . . . . 71.329999999999998 115.34 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.6 m -56.4 -9.75 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.446 1.647 . . . . 64.129999999999995 115.446 -171.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -53.67 98.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.292 1.044 . . . . 65.230000000000004 110.783 165.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.6 t -147.32 24.66 1.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.713 . . . . 64.099999999999994 109.145 162.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.79 159.0 53.34 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.123 -0.791 . . . . 52.539999999999999 111.123 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -83.49 -7.05 10.82 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.947 3.098 . . . . 71.200000000000003 112.372 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -131.86 156.61 79.9 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.431 1.892 . . . . 71.219999999999999 109.842 -166.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -4.01 11.96 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.389 3.393 . . . . 70.219999999999999 113.551 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 p -120.46 22.47 11.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.666 2.387 . . . . 65.239999999999995 110.212 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.25 -174.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.654 2.782 . . . . 64.340000000000003 115.34 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.32 102.4 3.06 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 104.881 -2.266 . . . . 71.010000000000005 104.881 167.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.55 108.3 20.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.222 -1.029 . . . . 63.409999999999997 108.222 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -77.0 165.48 24.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.629 0.728 . . . . 73.109999999999999 111.554 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.75 82.08 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.47 1.108 . . . . 72.120000000000005 111.956 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -64.42 -20.29 66.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.924 -1.036 . . . . 54.210000000000001 112.754 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -75.02 -35.84 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.877 1.217 . . . . 50.530000000000001 109.862 172.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.0 -30.58 63.88 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.098 1.359 . . . . 51.200000000000003 110.53 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.4 m -47.09 -44.13 20.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.927 1.291 . . . . 74.209999999999994 113.033 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -84.55 1.73 44.55 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.167 0.802 . . . . 73.219999999999999 113.167 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.0 143.58 55.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.823 0.82 . . . . 72.140000000000001 110.376 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -68.74 140.69 55.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.529 -1.214 . . . . 73.319999999999993 107.808 162.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.6 mm -101.5 123.51 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.91 -1.515 . . . . 73.409999999999997 106.91 172.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.74 145.45 52.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.693 0.621 . . . . 54.409999999999997 110.056 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.7 18.66 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.658 0.783 . . . . 75.150000000000006 111.307 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 t -110.11 -13.58 14.35 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.658 -0.651 . . . . 72.450000000000003 110.908 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -129.02 -63.17 0.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.407 1.483 . . . . 60.420000000000002 111.982 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -154.74 155.55 30.57 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 127.062 2.145 . . . . 73.230000000000004 108.352 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -60.57 101.82 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.433 2.756 . . . . 70.129999999999995 109.516 171.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.515 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -149.94 156.58 41.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 70.120000000000005 110.078 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.44 140.71 16.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.824 -1.917 . . . . 73.450000000000003 105.824 161.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.8 mm -109.26 115.12 48.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.366 1.466 . . . . 63.25 107.555 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -100.72 148.49 24.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.957 0.903 . . . . 64.230000000000004 109.338 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -132.06 94.09 3.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.542 -1.651 . . . . 74.340000000000003 106.542 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 10' ' ' PRO . 31.1 mt -108.55 136.66 43.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.014 -2.217 . . . . 63.229999999999997 105.014 -172.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.52 41.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.909 0.777 . . . . 72.400000000000006 110.115 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 114.56 7.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.473 1.509 . . . . 73.329999999999998 108.066 172.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 81.55 4.72 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 105.475 -2.046 . . . . 73.129999999999995 105.475 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.06 166.02 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.9 1.68 . . . . 70.439999999999998 108.347 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mt-10 -74.48 -36.41 63.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.685 -1.143 . . . . 63.340000000000003 108.836 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -17.04 64.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 115.718 1.748 . . . . 53.399999999999999 115.718 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.82 -97.89 0.13 Allowed Glycine 0 CA--C 1.512 -0.134 0 CA-C-N 120.643 1.565 . . . . 43.219999999999999 112.882 -161.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 3.6 t80 55.52 21.86 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.833 2.853 . . . . 71.099999999999994 111.561 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.8 1.28 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.532 2.015 . . . . 41.210000000000001 108.35 -163.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.0 143.91 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.447 2.098 . . . . 70.209999999999994 109.904 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.18 117.65 16.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.386 -2.079 . . . . 64.299999999999997 105.386 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 m -53.14 120.99 6.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.924 -1.139 . . . . 71.409999999999997 107.924 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -82.64 88.9 6.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.041 -1.837 . . . . 74.519999999999996 106.041 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.21 156.58 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.462 -1.681 . . . . 63.240000000000002 106.462 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 164.13 28.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.87 -1.159 . . . . 64.120000000000005 107.87 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.515 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 19.3 t90 -137.6 114.31 10.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.62 0.724 . . . . 65.299999999999997 111.3 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 25.05 5.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.801 1.64 . . . . 64.200000000000003 112.19 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -108.97 7.75 26.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.507 1.523 . . . . 74.409999999999997 111.508 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 122.101 0.953 . . . . 63.539999999999999 109.021 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 112.772 0.656 . . . . 74.409999999999997 112.772 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.31 4.64 3.22 Favored 'Trans proline' 0 CA--C 1.536 0.611 1 C-N-CA 125.596 4.197 . . . . 62.399999999999999 114.304 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 140.84 8.3 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 108.089 -2.004 . . . . 61.210000000000001 108.089 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.98 161.97 28.27 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.547 2.339 . . . . 64.420000000000002 108.321 171.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' CG ' HG22 ' A' ' 99' ' ' ILE . 11.7 Cg_endo -63.76 142.15 81.75 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.169 1.913 . . . . 73.439999999999998 109.258 160.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.2 m -127.23 170.9 11.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.223 1.409 . . . . 52.119999999999997 110.185 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.75 31.78 0.7 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.801 2.441 . . . . 75.420000000000002 114.951 169.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.486 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.6 mp -54.96 143.61 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 126.597 1.959 . . . . 74.140000000000001 109.004 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -119.15 147.25 44.4 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.573 0.749 . . . . 75.310000000000002 109.362 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.4 mt -146.36 126.72 6.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.979 -1.489 . . . . 71.319999999999993 106.979 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -141.69 173.83 11.14 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 126.924 2.09 . . . . 75.430000000000007 107.752 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -130.64 159.86 35.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.197 0.999 . . . . 60.149999999999999 108.946 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 m -152.91 165.54 17.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 125.855 1.662 . . . . 51.310000000000002 107.987 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.54 -29.22 84.23 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.093 1.862 . . . . 72.430000000000007 112.761 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 -38.22 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.205 0.602 . . . . 73.25 110.702 -169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.34 -165.2 26.34 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.181 1.372 . . . . 71.040000000000006 112.965 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.48 140.1 50.05 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.968 1.884 . . . . 73.219999999999999 110.258 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -85.5 96.07 9.49 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.645 1.578 . . . . 72.420000000000002 109.546 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -98.25 125.26 43.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.26 1.024 . . . . 72.430000000000007 108.745 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -137.48 160.81 38.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.765 0.711 . . . . 63.109999999999999 109.262 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.11 166.97 31.9 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.896 . . . . 74.040000000000006 109.703 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -101.43 159.91 28.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.884 -0.579 . . . . 73.239999999999995 111.395 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.35 175.49 9.28 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.697 3.598 . . . . 55.539999999999999 113.138 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.57 117.02 4.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.044 1.829 . . . . 74.109999999999999 108.707 167.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 m -151.32 19.31 0.75 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.033 1.333 . . . . 75.340000000000003 112.816 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -104.5 -62.16 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.44 -1.319 . . . . 64.400000000000006 107.44 168.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -116.81 161.57 19.07 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.996 -1.113 . . . . 51.299999999999997 107.996 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 m -68.69 -66.66 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.408 0.683 . . . . 72.209999999999994 110.367 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 171.86 2.47 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 122.159 0.866 . . . . 43.509999999999998 111.793 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -110.85 76.56 0.98 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.671 -1.974 . . . . 74.340000000000003 105.671 163.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -64.83 147.42 12.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.117 -1.068 . . . . 75.319999999999993 108.117 170.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.5 pt -130.9 -26.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.656 1.982 . . . . 75.120000000000005 110.106 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -168.07 -175.33 2.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.871 1.669 . . . . 73.299999999999997 107.451 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -127.14 167.89 15.4 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.118 -1.614 . . . . 73.239999999999995 109.128 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t -143.67 168.69 19.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.999 -1.063 . . . . 64.120000000000005 111.507 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.413 HG13 HG12 ' A' ' 99' ' ' ILE . 21.7 t -149.45 128.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.282 -1.377 . . . . 40.329999999999998 107.282 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.62 144.58 43.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.253 1.021 . . . . 74.010000000000005 108.594 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.418 HD22 HG11 ' A' ' 67' ' ' VAL . 14.3 tp -120.73 136.15 54.95 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.342 2.657 . . . . 75.209999999999994 107.662 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.13 130.59 41.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.52 1.963 . . . . 73.329999999999998 109.249 172.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.7 171.59 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.826 1.25 . . . . 75.010000000000005 109.217 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.11 0.964 . . . . 74.450000000000003 108.822 161.047 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.41 HD13 ' CE2' ' A' ' 64' ' ' PHE . 1.4 mt . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 103.726 -2.694 . . . . 75.420000000000002 103.726 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.23 114.06 24.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.859 -0.793 . . . . 63.32 108.859 171.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CE2' HD13 ' A' ' 62' ' ' LEU . 17.4 m-85 -133.82 161.15 35.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.339 1.455 . . . . 74.430000000000007 108.812 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.4 ttp -105.5 130.39 53.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.957 1.303 . . . . 64.040000000000006 107.629 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -71.95 85.95 0.99 Allowed 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.987 -1.116 . . . . 74.109999999999999 107.987 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG11 HD22 ' A' ' 43' ' ' LEU . 3.5 m -65.39 -48.5 82.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.377 0.608 . . . . 63.409999999999997 109.857 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.84 104.77 4.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.846 1.258 . . . . 71.019999999999996 109.882 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.5 t -160.2 75.93 0.6 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.656 -0.868 . . . . 74.140000000000001 108.656 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.24 46.8 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.001 -1.095 . . . . 45.240000000000002 114.445 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.66 -7.09 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.935 3.757 . . . . 73.099999999999994 112.449 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 m -48.32 144.34 6.37 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.356 1.862 . . . . 62.119999999999997 112.362 -169.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.89 109.79 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.339 2.026 . . . . 73.239999999999995 109.121 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.57 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.818 1.647 . . . . 71.409999999999997 108.943 -170.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.2 t -171.49 159.89 5.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.608 2.004 . . . . 74.209999999999994 109.248 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -130.82 97.74 4.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.045 1.738 . . . . 74.019999999999996 106.351 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.83 117.03 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 106.855 -1.535 . . . . 73.430000000000007 106.855 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -60.66 148.07 39.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.492 0.587 . . . . 73.239999999999995 109.951 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -55.23 -32.15 62.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.186 0.994 . . . . 64.409999999999997 112.833 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -61.41 -28.32 69.17 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.643 1.111 . . . . 72.140000000000001 113.216 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -70.31 -38.16 74.9 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.593 -1.317 . . . . 74.030000000000001 109.708 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.04 -40.63 96.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.872 0.869 . . . . 73.349999999999994 108.912 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -59.46 -14.24 11.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.584 1.554 . . . . 60.030000000000001 115.072 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.82 -3.92 12.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.335 0.97 . . . . 54.219999999999999 111.401 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.12 153.12 22.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.016 0.926 . . . . 74.439999999999998 110.189 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -137.51 158.14 45.02 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.883 1.273 . . . . 75.25 109.654 -167.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.77 137.35 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 110.92 -149.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.5 48.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.848 1.659 . . . . 74.420000000000002 110.8 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -57.85 -12.74 3.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.575 1.15 . . . . 73.530000000000001 113.364 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -17.91 60.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.646 1.178 . . . . 64.129999999999995 112.107 170.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -130.07 -58.19 1.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.813 1.645 . . . . 72.230000000000004 110.134 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -150.79 162.08 28.18 Favored Pre-proline 0 C--N 1.341 0.23 0 C-N-CA 124.753 1.221 . . . . 75.129999999999995 110.268 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.71 87.85 0.43 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.477 1.451 . . . . 54.119999999999997 108.805 155.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -151.61 155.45 38.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.74 2.016 . . . . 54.439999999999998 110.428 166.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mt -80.67 -25.22 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 116.295 1.961 . . . . 73.040000000000006 116.295 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mm 61.19 151.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 130.754 3.622 . . . . 71.409999999999997 111.625 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -127.77 145.23 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.65 -1.241 . . . . 75.319999999999993 107.65 166.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.53 99.76 8.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.555 -1.646 . . . . 72.019999999999996 106.555 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 26' ' ' TRP . 44.0 mt -109.29 127.46 66.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.811 -2.292 . . . . 61.399999999999999 104.811 -170.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . . . -150.25 163.76 37.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.382 1.087 . . . . 72.200000000000003 113.334 171.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.75 123.63 30.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.777 1.631 . . . . 51.210000000000001 107.516 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -76.33 104.97 7.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.489 -1.671 . . . . 72.200000000000003 106.489 164.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -123.82 -179.47 4.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.912 1.285 . . . . 74.310000000000002 110.155 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.74 -28.62 60.85 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.011 0.745 . . . . 75.120000000000005 113.011 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.71 -13.41 59.22 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.933 0.893 . . . . 64.430000000000007 111.997 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.38 169.19 45.67 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 124.847 1.213 . . . . 60.409999999999997 111.018 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -67.83 73.9 0.18 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.727 2.011 . . . . 75.040000000000006 111.159 178.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 -64.77 2.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.039 1.78 . . . . 55.399999999999999 110.044 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.28 163.64 35.49 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 120.04 1.92 . . . . 73.0 111.493 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.68 100.67 1.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.231 -1.766 . . . . 61.100000000000001 106.231 168.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -79.18 93.87 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.104 -1.443 . . . . 72.340000000000003 107.104 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.76 84.55 3.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.642 1.577 . . . . 42.149999999999999 108.177 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -82.78 167.63 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.942 -1.133 . . . . 72.200000000000003 107.942 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 152.01 51.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.702 -0.851 . . . . 73.349999999999994 108.702 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.546 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 1.7 t90 -120.7 102.42 8.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.981 1.372 . . . . 73.25 113.297 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -91.93 14.06 16.78 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.435 -0.802 . . . . 53.030000000000001 111.201 -169.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -72.13 -2.0 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.195 -0.907 . . . . 75.239999999999995 110.913 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 120.84 1.655 . . . . 75.439999999999998 112.193 -177.343 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.251 -0.277 . . . . 74.219999999999999 110.251 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.88 172.03 17.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.287 2.658 . . . . 72.329999999999998 111.781 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.01 -113.7 3.72 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.808 -1.717 . . . . 74.200000000000003 108.808 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.14 155.18 0.15 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 129.936 3.294 . . . . 73.540000000000006 111.0 -162.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.84 141.63 59.85 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.43 1.42 . . . . 65.129999999999995 108.924 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -137.5 -169.54 2.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.057 2.143 . . . . 74.239999999999995 107.938 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.3 34.8 3.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.108 1.763 . . . . 52.200000000000003 112.194 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.06 131.12 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.436 -0.95 . . . . 70.230000000000004 108.436 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -133.06 151.31 52.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.848 1.659 . . . . 74.519999999999996 108.393 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 24' ' ' LEU . 30.8 mt -142.73 91.79 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 105.041 -2.207 . . . . 72.439999999999998 105.041 -172.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -88.19 108.32 19.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.251 -1.018 . . . . 64.129999999999995 108.251 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 139.71 45.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.315 0.646 . . . . 73.030000000000001 109.9 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -148.67 166.52 15.25 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 123.564 0.746 . . . . 65.430000000000007 111.056 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -51.42 -46.67 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.9 1.733 . . . . 73.400000000000006 111.281 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -28.61 65.11 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.297 1.039 . . . . 72.400000000000006 111.424 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -104.31 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.569 -1.413 . . . . 74.299999999999997 109.569 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.76 120.97 6.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.793 -1.188 . . . . 45.32 107.793 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.53 134.47 51.34 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.597 1.159 . . . . 71.019999999999996 108.903 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' CD2' HG23 ' A' ' 15' ' ' ILE . 13.9 mt -116.35 144.23 44.53 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.555 -0.535 . . . . 73.329999999999998 109.555 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 p -140.21 160.66 39.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 117.83 -1.081 . . . . 71.010000000000005 108.174 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -159.97 173.75 15.41 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.842 1.657 . . . . 71.439999999999998 108.875 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.47 162.8 20.06 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.419 1.088 . . . . 72.230000000000004 110.263 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.78 155.73 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.748 2.298 . . . . 45.43 111.154 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.62 149.39 23.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.067 2.512 . . . . 74.329999999999998 111.573 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 t 76.48 135.6 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.885 2.474 . . . . 72.319999999999993 109.466 -160.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.96 -27.53 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 113.821 -1.536 . . . . 65.219999999999999 108.48 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.2 p -87.65 175.27 7.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.756 -1.215 . . . . 74.129999999999995 110.233 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 p -45.79 -48.98 15.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.692 1.597 . . . . 65.5 114.094 -169.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.94 -169.99 41.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.426 -1.469 . . . . 61.130000000000003 109.426 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -142.19 52.31 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.307 1.443 . . . . 74.340000000000003 109.493 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.39 142.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.74 -0.837 . . . . 71.239999999999995 108.74 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 pt -136.09 -15.59 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.684 1.993 . . . . 71.340000000000003 111.651 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -169.42 -168.06 0.77 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.048 2.139 . . . . 74.010000000000005 107.602 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.23 -178.6 5.93 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.331 -1.481 . . . . 74.200000000000003 110.077 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -145.78 155.33 42.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.258 1.023 . . . . 54.100000000000001 111.24 167.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -146.75 93.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.408 2.683 . . . . 74.239999999999995 105.15 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -95.98 130.11 43.06 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.825 -1.176 . . . . 65.200000000000003 107.825 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.69 124.07 34.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.663 1.119 . . . . 73.040000000000006 107.993 -168.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.46 129.49 40.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.733 0.697 . . . . 73.030000000000001 110.99 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.2 pt -132.31 171.09 18.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.15 -1.796 . . . . 73.019999999999996 106.15 166.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 73.219999999999999 108.599 172.336 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.293 0 N-CA-C 106.668 -1.605 . . . . 74.310000000000002 106.668 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.68 113.37 7.07 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.143 -0.688 . . . . 62.210000000000001 109.143 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -134.0 -179.51 5.6 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.861 1.665 . . . . 72.349999999999994 110.506 -165.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.9 ptm -80.94 165.92 21.33 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.895 -1.15 . . . . 72.349999999999994 107.895 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -125.42 83.02 2.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.109 -1.441 . . . . 74.329999999999998 107.109 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.75 -38.44 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.966 -0.459 . . . . 73.129999999999995 110.282 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -54.59 110.57 0.65 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.361 . . . . 70.400000000000006 112.533 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.9 p -147.81 24.55 1.07 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.379 0.672 . . . . 74.319999999999993 111.883 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.83 163.78 29.72 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.298 -0.723 . . . . 31.010000000000002 112.456 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.06 -54.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.376 2.717 . . . . 54.310000000000002 110.524 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.18 143.86 96.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.06 -1.089 . . . . 64.400000000000006 108.06 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.9 -46.42 1.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.514 2.143 . . . . 65.209999999999994 109.935 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -66.04 77.0 0.09 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.399 2.68 . . . . 74.019999999999996 108.778 168.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.6 t -96.17 -173.17 2.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.39 2.276 . . . . 51.539999999999999 109.54 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.09 159.97 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.786 -1.196 . . . . 74.219999999999999 109.656 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.48 115.03 47.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.557 -2.016 . . . . 61.219999999999999 105.557 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 151.11 45.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.587 1.155 . . . . 71.200000000000003 111.159 -168.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 p -51.82 -43.58 63.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.757 1.623 . . . . 71.340000000000003 111.96 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.5 t -51.43 -63.43 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.495 1.518 . . . . 51.25 110.235 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -60.77 -33.93 73.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.051 0.54 . . . . 73.230000000000004 110.932 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.2 mt -66.85 -23.11 65.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 117.974 -1.012 . . . . 74.109999999999999 111.778 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -56.42 -24.4 44.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.495 1.043 . . . . 72.25 111.884 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -102.83 1.41 34.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.944 0.898 . . . . 73.040000000000006 111.687 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.7 120.87 13.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.627 0.649 . . . . 75.409999999999997 109.621 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -83.26 148.05 27.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.485 -0.931 . . . . 72.230000000000004 108.485 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -110.69 147.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.108 -0.701 . . . . 75.420000000000002 109.108 -163.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.65 71.0 0.7 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.854 1.662 . . . . 72.430000000000007 111.769 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -76.26 53.0 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.154 1.782 . . . . 74.209999999999994 108.238 170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -55.23 0.34 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.067 -1.02 . . . . 63.219999999999999 108.734 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -94.08 -68.63 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.808 -0.558 . . . . 75.329999999999998 110.121 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -148.14 144.31 18.69 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 125.587 1.555 . . . . 55.32 106.975 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -67.42 108.01 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.959 1.773 . . . . 73.439999999999998 111.238 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 116' ' ' LEU 0.264 . . -147.57 165.54 30.05 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 131.318 3.847 . . . . 75.109999999999999 107.369 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.23 137.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.606 -1.627 . . . . 74.040000000000006 106.606 160.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.9 mm -100.93 152.51 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.373 1.469 . . . . 63.240000000000002 109.29 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.73 129.2 34.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.032 1.333 . . . . 73.010000000000005 109.162 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -96.14 89.89 5.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.791 -1.559 . . . . 73.129999999999995 106.791 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.2 mt -94.33 134.88 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.705 -1.591 . . . . 74.030000000000001 106.705 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.7 144.09 25.88 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.528 0.731 . . . . 74.030000000000001 109.748 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.61 152.21 37.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.298 0.639 . . . . 73.129999999999995 110.448 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.1 98.33 8.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.482 -2.044 . . . . 71.099999999999994 105.482 171.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -129.6 -171.02 2.41 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.272 1.429 . . . . 73.439999999999998 108.519 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -61.05 -35.36 76.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.485 0.55 . . . . 73.310000000000002 112.485 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -60.98 -26.06 67.3 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.882 1.673 . . . . 74.209999999999994 112.843 -166.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.37 36.64 3.77 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 117.076 1.59 . . . . 72.319999999999993 117.076 156.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 55.47 92.39 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 129.832 3.253 . . . . 74.129999999999995 113.187 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.484 ' H ' ' HD2' ' A' ' 109' ' ' PRO . . . -126.36 -70.45 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 126.728 2.108 . . . . 62.140000000000001 108.958 172.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 108' ' ' GLY . 85.9 Cg_endo -72.6 143.05 37.3 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 119.31 1.555 . . . . 73.340000000000003 109.479 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.72 142.92 20.34 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.583 -1.266 . . . . 61.399999999999999 107.583 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 m -108.05 109.73 21.25 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.861 -0.792 . . . . 75.040000000000006 108.861 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -72.4 95.18 1.72 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.226 -1.027 . . . . 73.400000000000006 108.226 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.95 151.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.107 -1.072 . . . . 75.329999999999998 108.107 166.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.74 139.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.418 1.887 . . . . 74.310000000000002 106.751 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -124.18 100.14 6.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.503 0.721 . . . . 75.409999999999997 109.943 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 6.2 mp -90.18 42.64 1.11 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 122.611 1.196 . . . . 74.209999999999994 110.285 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.01 7.83 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.007 2.123 . . . . 71.329999999999998 109.38 176.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 118.719 0.691 . . . . 73.129999999999995 112.649 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 109.585 -0.524 . . . . 71.409999999999997 109.585 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.44 -20.61 13.96 Favored 'Trans proline' 0 C--N 1.347 0.472 1 C-N-CA 125.827 4.352 . . . . 72.150000000000006 113.048 -166.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.53 156.86 48.29 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.022 -1.231 . . . . 64.120000000000005 110.022 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.79 165.57 9.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 126.728 2.011 . . . . 52.229999999999997 107.176 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -61.47 146.17 97.32 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.466 1.444 . . . . 72.030000000000001 109.723 161.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.7 176.5 7.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.337 1.455 . . . . 71.329999999999998 109.422 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 44.29 31.75 0.61 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 128.815 2.846 . . . . 73.299999999999997 113.82 174.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.97 133.28 27.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.158 -1.053 . . . . 72.010000000000005 108.158 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -129.49 142.44 50.78 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 123.546 0.738 . . . . 73.340000000000003 109.244 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.53 128.98 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 103.251 -2.87 . . . . 71.430000000000007 103.251 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -147.14 137.08 23.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.562 1.145 . . . . 65.209999999999994 108.257 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -64.18 144.89 56.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.379 -0.971 . . . . 63.409999999999997 108.379 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.0 162.16 53.71 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 126.888 2.075 . . . . 72.420000000000002 106.424 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 -10.89 27.65 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.028 1.152 . . . . 65.299999999999997 112.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.141 0.882 . . . . 64.430000000000007 111.702 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -118.37 0.83 Allowed Glycine 0 C--N 1.342 0.886 0 O-C-N 120.494 -1.379 . . . . 62.140000000000001 110.763 -172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.47 132.45 26.08 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.537 1.169 . . . . 32.049999999999997 110.963 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.24 149.59 50.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.128 1.371 . . . . 41.340000000000003 109.44 162.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 2.9 mp -142.22 123.26 14.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.646 1.578 . . . . 72.230000000000004 108.702 166.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -133.35 156.96 46.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.092 -0.707 . . . . 53.420000000000002 109.092 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -148.68 178.57 8.53 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.816 0.446 . . . . 73.299999999999997 110.577 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 9.2 mm-40 -139.39 159.52 65.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.114 1.766 . . . . 71.140000000000001 110.363 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.22 167.35 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.156 2.57 . . . . 73.030000000000001 111.05 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.45 -55.58 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.649 2.233 . . . . 73.239999999999995 110.71 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.46 39.92 8.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.474 -1.306 . . . . 64.239999999999995 107.474 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.07 -49.96 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.99 1.316 . . . . 73.340000000000003 113.75 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -64.68 154.66 35.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.099 1.318 . . . . 70.420000000000002 109.864 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -95.41 55.43 1.72 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.681 0.792 . . . . 70.140000000000001 109.572 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.53 134.18 11.64 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 108.561 -1.815 . . . . 70.230000000000004 108.561 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -81.66 82.12 7.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.162 -1.051 . . . . 65.340000000000003 108.162 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.72 131.85 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.739 -1.578 . . . . 74.349999999999994 106.739 168.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -126.86 -24.24 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.869 1.267 . . . . 65.239999999999995 111.36 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -163.3 -170.53 2.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.209 1.404 . . . . 74.409999999999997 107.606 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.37 177.54 8.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.665 1.186 . . . . 73.040000000000006 110.302 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.48 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -135.43 154.56 51.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.15 1.38 . . . . 70.150000000000006 108.601 163.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -143.72 112.24 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.432 -2.062 . . . . 70.120000000000005 105.432 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 40' ' ' SER . 87.3 m-85 -110.93 150.95 28.48 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.337 1.055 . . . . 64.25 109.742 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.78 121.31 25.15 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.342 1.857 . . . . 74.409999999999997 106.045 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.33 121.81 15.2 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.227 1.011 . . . . 71.019999999999996 110.771 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 pt -136.79 -177.11 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.325 1.45 . . . . 61.009999999999998 109.084 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . 0.277 3.5 pp0? . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 123.292 1.52 . . . . 74.310000000000002 112.767 171.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.402 HD22 ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.164 0.507 . . . . 72.109999999999999 110.589 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.78 102.85 4.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.856 1.262 . . . . 72.329999999999998 109.655 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 62' ' ' LEU . 22.6 m-85 -132.37 152.36 51.48 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.881 1.272 . . . . 52.439999999999998 109.58 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.1 ttp -78.34 5.0 11.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.457 1.28 . . . . 74.340000000000003 114.457 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.39 58.65 3.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.403 1.481 . . . . 65.030000000000001 112.155 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.79 -13.34 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.542 0.737 . . . . 62.200000000000003 112.9 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.21 -177.05 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.009 1.323 . . . . 64.109999999999999 112.063 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 44.7 m 62.57 42.69 8.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.455 1.902 . . . . 63.439999999999998 109.7 -168.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 155.88 42.04 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.111 -1.196 . . . . 72.0 110.111 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.74 -20.41 52.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.546 2.831 . . . . 74.439999999999998 112.692 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -135.05 149.37 70.11 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.95 1.3 . . . . 72.040000000000006 110.573 167.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.7 176.82 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 124.484 3.456 . . . . 42.109999999999999 111.86 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.6 p 46.63 40.71 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.45 1.5 . . . . 54.310000000000002 110.707 -170.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.66 123.88 23.5 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.22 1.808 . . . . 52.399999999999999 112.139 -167.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.39 147.37 26.29 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.933 1.293 . . . . 71.099999999999994 108.403 159.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.45 115.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.08 2.152 . . . . 71.340000000000003 105.711 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -65.53 154.38 38.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.801 0.84 . . . . 71.129999999999995 110.776 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -63.63 -19.25 64.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.633 1.173 . . . . 54.310000000000002 112.145 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -37.67 69.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.108 1.763 . . . . 73.400000000000006 111.204 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 m -71.64 -41.9 68.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.775 0.83 . . . . 73.120000000000005 111.267 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -26.19 67.23 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.4 1.08 . . . . 74.439999999999998 111.931 -175.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.49 -33.33 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.233 1.413 . . . . 52.530000000000001 110.602 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.31 -18.82 23.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.113 1.365 . . . . 71.319999999999993 112.267 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.71 9.94 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.16 1.384 . . . . 74.010000000000005 109.665 -170.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 147.49 23.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.675 0.79 . . . . 73.0 109.207 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -103.13 140.73 20.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.443 0.64 . . . . 74.209999999999994 109.305 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -59.2 110.45 1.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.576 1.95 . . . . 74.340000000000003 109.643 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -112.93 14.29 19.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.205 1.002 . . . . 70.129999999999995 110.512 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 82.6 p -102.53 -18.85 15.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.947 1.299 . . . . 51.229999999999997 112.696 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.91 -81.03 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 70.310000000000002 108.67 172.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -142.86 149.13 48.58 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 117.044 -1.455 . . . . 70.420000000000002 109.352 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.67 98.56 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 64.140000000000001 110.869 -171.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -150.97 164.74 35.67 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.475 1.91 . . . . 65.040000000000006 108.969 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.418 HD12 ' CE3' ' A' ' 115' ' ' TRP . 88.1 mt -83.83 128.21 39.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.381 -1.711 . . . . 64.299999999999997 106.381 167.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.8 mm -76.88 132.07 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.683 -1.228 . . . . 73.430000000000007 107.683 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -118.2 143.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.5 -1.296 . . . . 74.340000000000003 107.5 168.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.16 119.83 35.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 106.365 -1.717 . . . . 71.439999999999998 106.365 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.44 137.06 58.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.302 -1.74 . . . . 64.030000000000001 106.302 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 144.89 27.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.415 0.686 . . . . 71.25 110.493 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.42 121.38 20.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.626 1.17 . . . . 63.32 109.915 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.64 81.3 6.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 104.946 -2.242 . . . . 71.109999999999999 104.946 166.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.12 165.62 11.81 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.273 -0.639 . . . . 74.120000000000005 109.273 164.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.9 -18.82 5.42 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.527 1.677 . . . . 74.450000000000003 115.527 -167.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -86.88 -13.05 45.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.778 -1.106 . . . . 74.049999999999997 113.316 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.26 172.91 16.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.566 1.075 . . . . 71.140000000000001 112.761 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -73.17 57.3 0.48 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.997 1.319 . . . . 74.030000000000001 109.977 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.05 3.9 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.031 -0.871 . . . . 73.109999999999999 111.116 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.29 158.47 57.44 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.64 1.56 . . . . 71.450000000000003 109.532 171.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.33 122.14 10.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.463 -1.68 . . . . 65.010000000000005 106.463 169.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.6 m -92.86 108.98 20.41 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.556 -1.646 . . . . 72.030000000000001 106.556 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -67.51 128.55 36.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.156 -1.794 . . . . 72.430000000000007 106.156 163.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.2 154.19 31.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.082 -1.821 . . . . 74.329999999999998 106.082 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.11 157.33 39.96 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.225 -1.028 . . . . 72.439999999999998 108.225 163.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.418 ' CE3' HD12 ' A' ' 95' ' ' ILE . 18.1 t90 -108.35 91.28 3.58 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 74.200000000000003 106.669 172.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 94' ' ' ALA . 17.2 mt -75.9 175.15 9.06 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.685 -0.857 . . . . 65.109999999999999 108.685 175.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 76.24 13.16 2.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.177 2.191 . . . . 74.219999999999999 112.637 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--O 1.237 0.405 0 CA-C-O 122.698 1.237 . . . . 61.119999999999997 111.572 165.623 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.87 0 N-CA-C 109.722 -0.473 . . . . 72.109999999999999 109.722 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.84 84.18 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.096 2.531 . . . . 64.5 111.826 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.08 123.92 0.83 Allowed Glycine 0 C--N 1.338 0.668 0 O-C-N 121.005 -1.059 . . . . 75.109999999999999 115.73 171.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.71 157.83 40.54 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.294 1.438 . . . . 74.109999999999999 109.646 166.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.27 164.25 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.702 3.601 . . . . 74.430000000000007 112.419 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.5 m -137.58 -174.48 3.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 61.509999999999998 110.005 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . . . 58.42 14.68 3.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.931 2.492 . . . . 75.549999999999997 116.986 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.491 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.7 mp -56.48 141.28 13.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 126.558 1.943 . . . . 75.530000000000001 112.031 -168.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -139.82 116.52 10.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.331 1.452 . . . . 72.109999999999999 110.609 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -115.96 131.48 68.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.842 -2.651 . . . . 55.329999999999998 103.842 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 m -143.28 149.12 37.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.625 0.726 . . . . 63.530000000000001 110.346 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -74.06 159.24 32.94 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.506 -0.924 . . . . 74.549999999999997 108.506 162.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 m -143.77 166.32 20.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 130.208 3.403 . . . . 55.049999999999997 105.607 170.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -54.42 -44.08 52.81 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.678 1.585 . . . . 63.119999999999997 111.781 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -12.18 59.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.9 1.68 . . . . 72.150000000000006 113.501 -170.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.89 -160.72 29.88 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.123 -1.191 . . . . 53.140000000000001 110.123 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.69 116.15 30.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.228 1.011 . . . . 61.450000000000003 109.216 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -69.25 140.23 54.46 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 129.603 3.161 . . . . 71.439999999999998 111.454 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.27 128.86 42.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.927 -1.138 . . . . 73.510000000000005 107.927 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -133.03 150.25 52.15 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.637 -0.875 . . . . 71.319999999999993 108.637 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.422 ' CD1' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.99 173.89 11.5 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.286 0.366 . . . . 74.329999999999998 110.272 173.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 25.2 pt-20 -66.85 154.62 91.66 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 119.806 -0.758 . . . . 74.329999999999998 112.277 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.36 160.84 44.01 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.752 2.302 . . . . 75.200000000000003 111.586 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HB2' HD13 ' A' ' 36' ' ' ILE . 62.6 Cg_endo -71.27 89.58 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.905 3.07 . . . . 60.240000000000002 112.182 -172.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -152.76 23.7 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.042 0.756 . . . . 55.219999999999999 113.042 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.4 t -126.23 -86.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.011 -0.995 . . . . 74.439999999999998 110.894 -171.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -131.75 -4.11 3.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.344 1.429 . . . . 75.400000000000006 110.978 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 36' ' ' ILE . 12.2 p -55.66 -19.32 10.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.356 3.062 . . . . 73.430000000000007 116.179 -172.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.4 -159.66 31.05 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 121.962 2.165 . . . . 61.109999999999999 111.675 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -79.52 93.64 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.822 1.649 . . . . 63.109999999999999 109.677 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 33' ' ' SER . 2.3 mp -71.4 142.23 15.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.579 -1.267 . . . . 72.230000000000004 107.579 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.9 pt -135.49 -17.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.783 1.633 . . . . 72.439999999999998 111.464 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -159.93 -171.71 3.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.326 1.851 . . . . 72.5 107.434 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 16.9 m-85 -134.38 174.33 10.65 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.354 -1.467 . . . . 75.140000000000001 108.937 162.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 m -144.01 155.4 44.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.334 -0.854 . . . . 74.239999999999995 108.799 159.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -140.06 119.35 12.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 104.747 -2.316 . . . . 73.129999999999995 104.747 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.413 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 13.6 m-85 -116.47 87.4 2.68 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.122 0.963 . . . . 72.409999999999997 109.814 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 tp -62.63 135.31 57.32 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.1 -1.444 . . . . 74.219999999999999 107.1 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.23 148.04 25.3 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.854 -0.795 . . . . 74.209999999999994 108.854 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.74 -165.9 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.223 1.809 . . . . 65.409999999999997 107.306 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 71.540000000000006 112.509 169.837 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 109.768 -0.456 . . . . 64.150000000000006 109.768 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.32 123.39 22.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.112 -0.699 . . . . 65.219999999999999 109.112 172.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 16.7 m-85 -141.11 155.66 46.09 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.188 0.595 . . . . 74.510000000000005 112.22 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ttp -89.25 -39.36 13.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.81 0.844 . . . . 51.240000000000002 112.493 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 58.01 86.19 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.282 1.433 . . . . 73.310000000000002 109.085 -159.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.77 -5.91 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.904 -0.589 . . . . 72.409999999999997 112.067 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.3 103.07 7.74 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.584 0.629 . . . . 63.43 110.798 -163.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -137.17 53.67 1.88 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.03 1.332 . . . . 71.430000000000007 109.026 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.34 160.5 29.55 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.311 -0.868 . . . . 54.140000000000001 111.228 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -4.68 12.0 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.745 3.63 . . . . 72.219999999999999 112.591 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.0 m -43.46 89.31 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 130.047 3.339 . . . . 72.319999999999993 113.263 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -60.62 148.98 89.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.186 1.257 . . . . 73.140000000000001 111.139 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 p 46.21 47.36 13.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.838 1.255 . . . . 74.230000000000004 111.987 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.37 152.37 43.24 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.625 -1.297 . . . . 42.049999999999997 110.462 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.08 170.35 14.91 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.656 0.782 . . . . 63.409999999999997 110.883 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.55 122.57 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.033 1.733 . . . . 73.25 106.539 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.44 145.9 52.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.059 0.944 . . . . 73.129999999999995 109.657 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.428 ' HA ' HD12 ' A' ' 82' ' ' LEU . 9.8 p -54.28 -37.89 65.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.621 1.169 . . . . 32.210000000000001 111.649 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.77 -47.97 41.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.458 1.503 . . . . 74.420000000000002 111.268 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -78.99 -9.71 59.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.509 1.124 . . . . 24.440000000000001 112.899 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 79' ' ' SER . 74.5 mt -82.03 -34.55 29.46 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.579 1.081 . . . . 65.209999999999994 110.658 171.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -66.91 1.53 1.85 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 117.276 2.324 . . . . 73.409999999999997 117.276 -163.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -123.38 12.28 9.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.95 1.25 . . . . 72.140000000000001 111.505 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.01 156.72 37.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 122.478 1.132 . . . . 72.219999999999999 113.53 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 101.72 3.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.808 -1.182 . . . . 71.530000000000001 107.808 162.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.07 120.82 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.254 -1.758 . . . . 75.319999999999993 106.254 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.21 131.8 51.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 112.799 -2.0 . . . . 75.510000000000005 108.987 166.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.61 9.76 13.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.52 1.128 . . . . 75.540000000000006 111.162 171.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -6.5 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.799 -1.188 . . . . 71.140000000000001 113.942 -162.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.045 2.138 . . . . 73.329999999999998 111.026 173.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -151.8 156.18 34.21 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.604 1.561 . . . . 71.420000000000002 108.009 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.41 122.35 9.57 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.7 2.267 . . . . 72.409999999999997 108.748 164.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -160.47 -170.44 2.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.669 2.387 . . . . 61.450000000000003 108.645 161.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.9 mt -129.48 129.2 66.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 75.540000000000006 108.53 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.5 mm -72.49 142.19 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.507 1.523 . . . . 62.210000000000001 110.088 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -128.21 162.25 27.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.26 1.024 . . . . 61.420000000000002 108.934 167.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -134.98 84.72 2.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.327 1.851 . . . . 71.340000000000003 106.472 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.28 133.44 42.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.032 -1.469 . . . . 75.209999999999994 107.032 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.41 156.98 44.09 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.575 0.547 . . . . 54.009999999999998 110.497 161.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . . . -92.35 109.44 20.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.458 1.103 . . . . 62.340000000000003 109.758 -171.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -69.09 97.98 0.94 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.811 0.844 . . . . 74.310000000000002 109.142 -170.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -122.54 177.17 5.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.706 2.002 . . . . 61.219999999999999 110.824 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.63 -30.97 63.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.927 1.691 . . . . 74.120000000000005 113.821 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -8.96 58.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.207 1.188 . . . . 74.209999999999994 114.207 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.42 2.26 87.51 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.834 -1.166 . . . . 70.5 113.263 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' A' ' 102' ' ' ARG . 19.4 p90 45.59 36.16 2.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.064 1.746 . . . . 74.329999999999998 115.448 156.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.75 -66.5 2.8 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.519 2.009 . . . . 62.409999999999997 113.455 -165.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.84 152.07 81.16 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.158 1.906 . . . . 64.439999999999998 110.241 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.35 169.86 14.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.584 1.154 . . . . 55.130000000000003 108.865 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.1 m -97.26 113.99 25.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.303 0.641 . . . . 75.140000000000001 110.045 -176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.49 75.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.505 1.522 . . . . 75.140000000000001 110.04 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.9 155.14 7.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.858 -1.164 . . . . 75.430000000000007 107.858 164.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -121.74 124.59 44.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.705 -1.591 . . . . 62.409999999999997 106.705 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -75.17 82.73 2.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.132 0.424 . . . . 74.329999999999998 109.859 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 94' ' ' ALA . 27.7 mt -71.47 15.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.773 1.027 . . . . 74.129999999999995 113.773 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -95.74 -1.83 49.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.097 1.359 . . . . 72.140000000000001 111.637 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 C--O 1.234 0.274 0 CA-C-N 119.835 1.198 . . . . 72.219999999999999 110.449 -179.627 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.634 -0.135 . . . . 75.349999999999994 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.03 6.53 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.735 3.624 . . . . 64.129999999999995 114.581 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.2 143.77 15.32 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 107.958 -2.057 . . . . 71.239999999999995 107.958 170.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.3 154.7 36.42 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.053 1.341 . . . . 74.340000000000003 108.278 162.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.59 158.85 30.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.296 1.998 . . . . 71.519999999999996 111.934 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -133.09 -178.09 4.81 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.527 1.531 . . . . 75.329999999999998 109.414 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.21 12.98 4.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.54 1.536 . . . . 51.219999999999999 114.823 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.22 132.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.948 1.299 . . . . 61.409999999999997 110.049 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.8 152.76 45.45 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.534 1.133 . . . . 53.0 110.934 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -142.17 115.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.541 -1.651 . . . . 61.240000000000002 106.541 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -111.35 -167.7 1.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.442 2.297 . . . . 71.439999999999998 110.629 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -143.22 146.51 33.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.903 -1.147 . . . . 75.150000000000006 107.903 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -146.45 160.15 42.75 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 126.234 1.814 . . . . 75.329999999999998 106.95 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.99 73.44 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.777 1.652 . . . . 71.409999999999997 111.594 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.79 -59.73 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 128.807 2.843 . . . . 61.43 105.692 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.15 -166.15 38.56 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.683 -1.367 . . . . 62.030000000000001 109.683 -163.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.14 113.72 26.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.731 1.612 . . . . 53.32 110.583 -165.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 78.42 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.772 3.229 . . . . 73.019999999999996 112.187 164.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.87 110.29 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.873 -1.142 . . . . 75.040000000000006 108.41 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -130.27 158.22 40.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.595 0.634 . . . . 44.039999999999999 111.621 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.503 ' CE3' HD13 ' A' ' 99' ' ' ILE . 25.6 p90 -173.64 175.7 2.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.23 2.612 . . . . 55.140000000000001 110.377 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -115.46 165.21 14.9 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.964 0.906 . . . . 71.129999999999995 111.932 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.14 156.97 51.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.685 2.923 . . . . 72.129999999999995 111.226 167.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.64 139.64 70.71 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.9 1.733 . . . . 60.109999999999999 109.596 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 t -127.67 58.95 1.47 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.77 -2.308 . . . . 64.340000000000003 104.77 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.39 -85.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.164 -1.791 . . . . 71.239999999999995 106.164 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.1 p -112.86 166.11 11.69 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.344 0.52 . . . . 74.329999999999998 110.425 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 m -56.67 -72.92 0.07 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.568 1.547 . . . . 64.140000000000001 111.546 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.43 -173.8 11.1 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.474 -1.45 . . . . 61.399999999999999 109.474 -164.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -137.23 68.54 1.41 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.649 1.58 . . . . 74.230000000000004 107.881 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.8 140.52 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.702 -0.851 . . . . 60.530000000000001 108.702 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 pt -135.89 -21.65 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.514 1.526 . . . . 71.129999999999995 111.34 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -158.02 174.8 14.68 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.117 1.767 . . . . 72.400000000000006 106.929 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.75 163.63 32.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.084 0.954 . . . . 74.099999999999994 108.973 174.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -150.61 153.05 34.99 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.119 -0.988 . . . . 54.43 112.496 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.47 142.56 43.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 126.095 1.758 . . . . 63.030000000000001 107.533 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.7 120.22 40.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.562 -2.014 . . . . 62.240000000000002 105.562 170.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.36 132.93 53.67 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.257 1.423 . . . . 64.349999999999994 107.198 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.44 131.19 40.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 118.17 -0.919 . . . . 73.230000000000004 109.178 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.91 179.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.725 1.21 . . . . 74.109999999999999 110.79 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 C-N-CA 126.253 1.821 . . . . 73.25 109.614 167.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 64' ' ' PHE . 10.0 mt . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 118.815 -0.612 . . . . 61.439999999999998 109.842 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 174.64 104.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.098 2.159 . . . . 73.230000000000004 107.039 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CE2' HD13 ' A' ' 62' ' ' LEU . 21.7 m-30 -127.1 146.56 50.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.939 1.296 . . . . 75.230000000000004 110.106 -166.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttp -77.67 130.25 36.58 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.591 -1.263 . . . . 74.010000000000005 107.591 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -79.13 60.17 2.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.57 1.148 . . . . 73.310000000000002 109.551 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -53.19 -27.21 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 126.501 1.92 . . . . 63.109999999999999 113.903 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.0 121.71 27.03 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.45 -2.426 . . . . 73.239999999999995 104.45 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.5 t -152.03 79.59 1.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.733 -1.951 . . . . 74.239999999999995 105.733 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.93 176.56 45.0 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.717 -0.614 . . . . 75.430000000000007 112.358 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.26 -8.98 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.367 3.378 . . . . 73.329999999999998 112.64 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.38 158.14 8.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.59 1.556 . . . . 54.109999999999999 112.358 -172.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.16 -171.18 1.01 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.819 3.013 . . . . 71.040000000000006 110.653 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.83 110.76 0.25 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.806 2.442 . . . . 53.329999999999998 110.486 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.6 m -104.81 135.42 46.22 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.841 0.746 . . . . 51.509999999999998 110.261 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.48 119.96 10.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.335 1.054 . . . . 60.210000000000001 109.515 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.56 114.41 9.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.109 -1.812 . . . . 75.450000000000003 106.109 167.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.42 158.23 27.27 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.804 0.842 . . . . 53.310000000000002 110.744 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -50.06 -49.49 51.03 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.931 0.892 . . . . 44.109999999999999 112.318 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 p -59.99 -25.52 65.33 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.508 1.049 . . . . 61.329999999999998 113.697 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -40.01 32.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.845 1.202 . . . . 71.219999999999999 110.431 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.39 -45.31 94.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.319 1.047 . . . . 75.140000000000001 110.711 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -62.72 -24.18 67.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.513 1.525 . . . . 64.129999999999995 112.75 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -92.38 -9.52 41.44 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.211 1.004 . . . . 55.439999999999998 112.033 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.43 147.27 49.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.547 1.067 . . . . 73.329999999999998 111.232 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -93.62 129.3 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.382 1.073 . . . . 62.43 111.226 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -68.68 133.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 126.216 1.806 . . . . 75.519999999999996 109.331 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.47 111.29 3.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.856 -0.794 . . . . 61.310000000000002 108.856 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -103.62 64.1 0.8 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.144 0.973 . . . . 73.519999999999996 108.761 165.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 -26.77 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.029 -0.987 . . . . 74.439999999999998 113.616 171.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -146.52 -55.36 0.26 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.23 0.923 . . . . 73.150000000000006 111.266 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -149.53 144.53 17.94 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 117.161 -1.399 . . . . 75.120000000000005 108.19 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.63 97.37 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.144 2.563 . . . . 42.009999999999998 109.883 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -145.98 152.43 39.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.312 2.245 . . . . 72.430000000000007 109.2 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.5 mt -72.16 133.76 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.964 -1.495 . . . . 73.109999999999999 106.964 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.7 mm -81.61 136.07 23.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.068 0.947 . . . . 42.020000000000003 108.992 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -122.15 150.4 42.27 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.104 1.761 . . . . 75.120000000000005 107.785 165.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -133.26 132.96 42.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.169 -1.789 . . . . 74.140000000000001 106.169 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.503 HD13 ' CE3' ' A' ' 26' ' ' TRP . 20.8 mt -131.6 140.46 48.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.41 -0.959 . . . . 75.209999999999994 108.41 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.08 153.79 34.66 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.612 1.165 . . . . 73.549999999999997 110.497 170.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.14 141.38 41.93 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.734 0.813 . . . . 53.200000000000003 109.812 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.4 tpt85 -86.04 108.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 105.967 -1.864 . . . . 72.129999999999995 105.967 164.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -114.57 -176.15 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.398 -0.964 . . . . 61.32 108.398 165.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -52.51 -39.38 61.24 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.726 2.01 . . . . 71.540000000000006 112.048 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -47.7 53.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.28 -0.637 . . . . 63.539999999999999 109.28 -166.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.29 174.75 21.05 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.46 -0.656 . . . . 72.519999999999996 111.46 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -75.45 102.88 5.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.646 -1.612 . . . . 72.349999999999994 106.646 163.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.36 -64.71 0.86 Allowed Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.324 -1.265 . . . . 72.450000000000003 112.126 -171.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.73 179.02 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.21 2.607 . . . . 73.540000000000006 110.002 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.74 107.01 1.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.749 0.82 . . . . 60.450000000000003 109.159 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 m -71.53 110.13 5.92 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.386 -0.968 . . . . 64.510000000000005 108.386 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -82.08 103.12 11.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.451 1.5 . . . . 75.549999999999997 109.205 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.3 159.51 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.282 1.433 . . . . 55.140000000000001 107.747 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.43 155.45 45.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.724 -0.61 . . . . 72.209999999999994 110.325 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -138.32 109.56 6.88 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.107 0.963 . . . . 74.129999999999995 112.078 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.774 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.32 -177.93 5.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 128.732 2.813 . . . . 53.439999999999998 109.299 -177.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 73.72 9.84 4.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.14 1.776 . . . . 71.140000000000001 112.193 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.543 0.692 0 C-N-CA 127.185 2.194 . . . . 74.420000000000002 114.417 178.327 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 . . . . . 0 C--O 1.223 -0.325 0 CA-C-O 118.654 -0.688 . . . . 72.430000000000007 110.694 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.55 96.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.376 2.717 . . . . 71.349999999999994 110.927 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.48 113.78 0.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 124.117 0.865 . . . . 65.239999999999995 111.457 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.36 153.46 8.81 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.09 1.756 . . . . 71.430000000000007 109.14 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.33 166.9 19.95 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 124.976 3.784 . . . . 74.219999999999999 114.396 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -136.59 -179.12 5.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.383 2.273 . . . . 51.310000000000002 110.447 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.82 14.93 5.51 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 128.627 2.771 . . . . 74.219999999999999 115.386 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 131.65 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.219 0.608 . . . . 71.530000000000001 111.197 -162.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -125.17 148.5 48.57 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.715 1.206 . . . . 73.430000000000007 108.728 173.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -148.02 141.57 19.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.31 -1.737 . . . . 72.340000000000003 106.31 168.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -150.17 23.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.218 1.407 . . . . 64.140000000000001 112.962 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 4.3 tttm 48.68 -173.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.611 3.164 . . . . 72.030000000000001 112.944 -173.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.87 165.13 19.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.192 1.397 . . . . 71.140000000000001 107.57 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.91 -24.41 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.82 2.347 . . . . 70.019999999999996 112.345 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.06 -9.92 16.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.984 2.114 . . . . 71.430000000000007 111.182 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.03 -123.08 1.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.686 -1.366 . . . . 50.240000000000002 109.686 -174.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . . . -135.36 124.54 24.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.636 -0.697 . . . . 74.209999999999994 110.457 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -67.12 90.69 0.2 Allowed 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.448 0.699 . . . . 74.310000000000002 109.427 168.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.84 164.11 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.0 0.92 . . . . 45.32 108.558 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.96 157.87 16.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.017 1.727 . . . . 61.229999999999997 109.668 168.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -171.65 -179.73 2.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.74 2.016 . . . . 74.219999999999999 109.527 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -127.59 165.21 31.3 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 127.159 2.184 . . . . 73.329999999999998 109.432 169.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -66.21 168.49 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.668 2.912 . . . . 72.530000000000001 110.735 165.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.02 152.86 80.23 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.098 1.198 . . . . 72.150000000000006 109.861 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 p -118.68 17.61 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.542 1.137 . . . . 71.150000000000006 111.821 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.02 -45.25 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.825 1.25 . . . . 70.540000000000006 110.533 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.4 p -148.37 167.09 26.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.633 1.573 . . . . 63.229999999999997 107.926 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -46.23 -61.18 1.89 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.307 1.843 . . . . 71.120000000000005 111.945 -174.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.06 113.12 0.06 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.899 1.238 . . . . 71.510000000000005 112.943 174.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -89.35 66.38 7.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.006 0.922 . . . . 65.140000000000001 109.419 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -71.03 151.64 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.15 -1.426 . . . . 63.149999999999999 107.15 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.3 pt -135.42 -21.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.376 1.87 . . . . 65.25 111.836 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.72 -167.36 1.52 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.813 0.845 . . . . 71.150000000000006 109.486 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -152.04 172.91 15.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.658 1.983 . . . . 71.329999999999998 108.365 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -150.29 175.68 11.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.812 0.733 . . . . 33.030000000000001 111.212 163.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -144.24 129.74 14.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.605 1.962 . . . . 73.109999999999999 107.222 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.496 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -119.71 119.37 33.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.558 -1.645 . . . . 65.230000000000004 106.558 165.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 tp -87.22 126.83 35.06 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.634 -1.987 . . . . 74.310000000000002 105.634 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.11 138.82 50.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.397 0.544 . . . . 74.209999999999994 110.524 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 pt -126.72 -178.84 2.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 125.925 1.69 . . . . 72.040000000000006 109.786 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 125.68 1.592 . . . . 75.140000000000001 109.2 173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 65.129999999999995 112.921 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.19 135.05 15.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.42 -0.809 . . . . 63.25 109.865 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 78.5 m-85 -149.23 -164.16 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.234 2.613 . . . . 75.409999999999997 107.846 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.9 ttp -112.48 -6.69 13.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.592 1.157 . . . . 75.329999999999998 113.153 166.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 44.23 66.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.373 2.269 . . . . 64.319999999999993 111.614 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.34 -13.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 113.554 0.946 . . . . 64.329999999999998 113.554 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -57.13 135.72 56.37 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.087 -1.008 . . . . 73.340000000000003 112.027 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -142.37 97.68 3.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.761 2.024 . . . . 74.150000000000006 107.73 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 166.94 5.9 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.215 0.912 . . . . 72.150000000000006 113.376 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 -57.4 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.791 1.661 . . . . 70.030000000000001 113.716 -166.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.0 m 57.33 167.66 0.06 OUTLIER Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.208 0.913 . . . . 73.420000000000002 112.872 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.99 -24.23 45.77 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.465 1.443 . . . . 73.209999999999994 112.293 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 p -167.35 41.56 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.913 0.885 . . . . 64.140000000000001 109.33 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 16.2 p 45.11 -166.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.44 1.896 . . . . 53.399999999999999 112.432 -161.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.09 115.05 5.71 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.268 -0.895 . . . . 74.310000000000002 109.326 149.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.53 124.28 45.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 126.116 1.766 . . . . 70.230000000000004 107.502 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.19 49.04 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.212 1.805 . . . . 74.329999999999998 110.938 169.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t -70.46 -16.91 62.98 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.019 1.728 . . . . 70.030000000000001 112.311 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t -46.13 -53.83 9.7 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.008 0.822 . . . . 72.019999999999996 109.489 165.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -72.43 -19.96 61.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.192 0.812 . . . . 71.099999999999994 113.192 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.25 -34.02 65.62 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.547 0.612 . . . . 53.130000000000003 110.868 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -54.18 -47.46 72.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.849 0.459 . . . . 71.340000000000003 109.768 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.46 -7.48 38.32 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.771 1.628 . . . . 64.010000000000005 113.216 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.64 164.82 7.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.347 1.07 . . . . 65.129999999999995 110.713 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -128.12 160.23 32.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.842 -0.799 . . . . 72.129999999999995 108.842 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.56 123.38 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 106.964 -1.495 . . . . 62.329999999999998 106.964 -165.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.92 127.81 33.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.894 -1.151 . . . . 71.150000000000006 107.894 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.32 31.98 5.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.804 -1.184 . . . . 73.25 107.804 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.61 -11.87 7.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.967 1.307 . . . . 71.340000000000003 110.344 -171.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 p -142.25 -66.08 0.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.395 1.478 . . . . 74.109999999999999 109.861 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -150.48 152.92 33.71 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 127.802 2.441 . . . . 71.420000000000002 107.576 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.12 104.63 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.689 2.926 . . . . 73.25 109.556 173.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -147.74 153.1 38.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.17 1.388 . . . . 64.140000000000001 109.839 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 130.12 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.105 -1.813 . . . . 74.310000000000002 106.105 158.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.12 136.57 22.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.954 -1.499 . . . . 44.329999999999998 106.954 166.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.32 159.33 20.34 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.025 0.917 . . . . 74.010000000000005 110.25 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -131.19 100.73 5.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.859 1.664 . . . . 74.329999999999998 106.879 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.36 129.59 75.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 104.316 -2.475 . . . . 65.209999999999994 104.316 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . . . -142.67 163.94 31.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 109.863 171.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.99 132.7 34.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.821 -1.081 . . . . 73.409999999999997 108.286 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -84.5 105.49 15.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.334 -1.728 . . . . 72.030000000000001 106.334 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -115.18 -179.19 3.56 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.009 0.924 . . . . 73.140000000000001 110.484 173.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.34 -35.07 71.36 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.031 1.733 . . . . 73.109999999999999 114.526 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.11 -54.95 6.26 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 125.61 1.564 . . . . 63.229999999999997 108.957 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 159.34 164.39 14.59 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.414 -1.074 . . . . 70.519999999999996 110.414 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 100' ' ' ALA . 9.1 t80 -87.49 45.54 1.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.616 1.566 . . . . 74.140000000000001 110.136 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.28 -87.14 0.07 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.295 1.902 . . . . 74.120000000000005 111.671 -156.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.46 163.48 38.89 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.151 1.901 . . . . 54.020000000000003 109.773 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.75 148.66 35.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.415 -0.957 . . . . 70.450000000000003 108.415 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.8 m -75.88 132.84 40.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.261 -1.755 . . . . 61.439999999999998 106.261 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -113.83 86.61 2.44 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 105.799 -1.926 . . . . 53.149999999999999 105.799 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.75 156.73 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 73.420000000000002 108.618 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.79 116.4 28.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.921 -1.511 . . . . 53.240000000000002 106.921 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -72.99 75.66 1.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.76 -1.2 . . . . 71.129999999999995 107.76 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 94' ' ' ALA . 14.4 mt -70.99 150.79 45.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.5 -1.667 . . . . 70.200000000000003 106.5 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 66.29 24.29 10.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 63.509999999999998 111.146 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 O-C-N 121.792 -0.567 . . . . 65.510000000000005 111.76 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 110.124 -0.325 . . . . 64.450000000000003 110.124 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.97 5.66 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 125.149 3.9 . . . . 63.119999999999997 116.55 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.4 173.12 49.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.675 1.131 . . . . 70.310000000000002 112.394 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.3 161.02 24.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.225 1.41 . . . . 51.25 111.25 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.37 153.86 65.81 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.02 2.48 . . . . 74.150000000000006 110.989 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.4 m -137.38 -174.67 3.82 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.272 1.429 . . . . 60.240000000000002 110.605 -171.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.02 25.62 12.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.205 2.202 . . . . 71.230000000000004 114.205 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.25 141.12 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.681 1.192 . . . . 73.120000000000005 110.81 -172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -125.17 149.53 47.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.297 1.439 . . . . 63.32 109.007 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.0 mt -152.01 95.84 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.268 -1.753 . . . . 74.219999999999999 106.268 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 p -74.7 163.01 28.19 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.517 -0.92 . . . . 71.329999999999998 108.517 164.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -91.38 157.75 16.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.28 -1.378 . . . . 70.319999999999993 107.28 156.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 m -146.97 165.2 19.9 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.393 -1.336 . . . . 62.32 107.393 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.31 -37.43 61.28 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.324 1.35 . . . . 51.030000000000001 112.696 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.99 -47.99 14.06 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.331 -0.855 . . . . 74.519999999999996 110.682 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.74 -146.38 4.33 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.585 -0.606 . . . . 61.240000000000002 111.585 -156.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.03 133.8 32.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.321 1.448 . . . . 74.329999999999998 107.743 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -78.11 79.81 4.56 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.318 -0.623 . . . . 62.219999999999999 109.318 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.43 132.17 52.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.357 -1.349 . . . . 72.409999999999997 107.357 164.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -144.64 152.14 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.391 1.451 . . . . 72.349999999999994 109.255 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.416 ' CE3' HD13 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -137.56 167.57 21.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.206 1.403 . . . . 74.129999999999995 110.565 172.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.77 163.28 69.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.04 0.936 . . . . 74.340000000000003 112.328 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.11 164.83 26.2 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.391 2.727 . . . . 73.239999999999995 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.67 77.39 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.432 2.755 . . . . 53.240000000000002 110.359 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 t -133.02 24.73 4.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.293 2.237 . . . . 73.239999999999995 109.422 -171.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.53 -40.93 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.926 1.291 . . . . 53.210000000000001 107.95 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.0 p -149.45 174.08 12.87 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.017 1.727 . . . . 64.140000000000001 110.419 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -64.24 19.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.572 3.149 . . . . 72.420000000000002 114.88 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.59 -168.15 35.84 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 120.597 -1.314 . . . . 65.439999999999998 114.037 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -135.65 113.4 10.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.193 -1.004 . . . . 74.420000000000002 109.505 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.479 HG12 ' HB1' ' A' ' 101' ' ' ALA . 1.9 mp -109.67 133.63 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.084 1.754 . . . . 64.129999999999995 108.144 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -131.62 -11.42 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 72.120000000000005 112.33 -163.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 39' ' ' TYR . 10.8 tt0 -160.45 -169.51 2.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.222 2.209 . . . . 65.219999999999999 106.685 163.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.441 ' H ' ' HG2' ' A' ' 38' ' ' GLU . 1.4 m-85 -128.4 169.27 14.47 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.22 -1.55 . . . . 74.349999999999994 108.879 165.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.0 m -145.03 156.93 44.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.171 -0.956 . . . . 72.409999999999997 110.526 166.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.66 125.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 105.618 -1.993 . . . . 74.109999999999999 105.618 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.23 127.33 55.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.735 -1.58 . . . . 74.109999999999999 106.735 171.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -121.85 130.54 53.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.983 1.713 . . . . 74.420000000000002 107.574 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.21 126.03 28.28 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.907 0.883 . . . . 71.420000000000002 113.068 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.53 -170.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.769 2.428 . . . . 74.530000000000001 109.236 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 126.046 1.738 . . . . 73.510000000000005 110.695 161.586 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 113.512 0.93 . . . . 63.5 113.512 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.27 82.72 1.97 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.333 0.587 . . . . 64.120000000000005 111.17 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -130.74 150.41 51.93 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.308 1.043 . . . . 73.310000000000002 108.911 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ttp -113.99 133.84 55.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.107 1.763 . . . . 51.340000000000003 108.233 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -82.19 56.73 3.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.606 1.562 . . . . 74.25 112.331 -167.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.66 -19.61 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 115.924 1.824 . . . . 72.530000000000001 115.924 -167.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.08 118.63 7.03 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.842 1.201 . . . . 73.510000000000005 110.032 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.6 m -152.13 73.69 1.06 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 127.172 2.189 . . . . 63.210000000000001 107.625 164.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.44 166.06 25.91 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 121.562 -0.711 . . . . 70.25 111.799 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 -55.64 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.614 2.21 . . . . 72.510000000000005 109.836 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -76.57 144.51 73.82 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.247 0.619 . . . . 70.420000000000002 109.785 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 -26.15 16.68 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.235 1.957 . . . . 73.530000000000001 112.882 -168.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p -80.88 68.9 7.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.232 0.924 . . . . 61.109999999999999 110.216 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.2 m -69.3 115.45 8.59 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.391 -0.818 . . . . 54.329999999999998 110.675 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.8 -178.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.977 2.111 . . . . 54.240000000000002 112.528 159.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.74 146.69 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.521 1.528 . . . . 71.209999999999994 108.222 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -96.26 161.81 13.78 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.601 2.36 . . . . 61.219999999999999 112.778 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -45.87 67.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.961 1.304 . . . . 62.310000000000002 111.72 169.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -62.37 -28.16 69.58 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.615 0.643 . . . . 63.130000000000003 111.623 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -80.36 -46.56 15.86 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.327 -0.858 . . . . 54.219999999999999 109.046 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.1 mt -52.83 -26.7 15.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.193 1.797 . . . . 71.549999999999997 112.926 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.4 m -45.36 -33.88 2.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.12 1.368 . . . . 70.120000000000005 113.232 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -95.0 -10.87 29.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.323 0.649 . . . . 65.230000000000004 111.263 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.66 24.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.061 0.846 . . . . 71.450000000000003 110.123 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.68 120.39 27.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.101 0.96 . . . . 73.349999999999994 109.819 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.08 138.24 21.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.992 1.717 . . . . 73.120000000000005 109.287 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.95 111.33 4.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.816 0.846 . . . . 74.329999999999998 111.006 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -100.65 20.09 15.78 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.461 -0.774 . . . . 73.030000000000001 110.993 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -4.01 6.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.456 0.909 . . . . 63.32 113.456 -163.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 -63.31 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.275 1.43 . . . . 75.230000000000004 108.492 161.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -153.68 154.19 29.95 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 106.536 -1.653 . . . . 72.450000000000003 106.536 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.29 110.16 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.389 2.059 . . . . 64.120000000000005 109.544 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.92 168.56 21.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.72 2.008 . . . . 73.319999999999993 109.301 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.7 mt -101.74 140.05 21.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.274 -1.75 . . . . 73.010000000000005 106.274 166.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.42 124.52 73.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.273 1.029 . . . . 72.010000000000005 110.085 -163.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.47 137.55 54.77 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.848 0.859 . . . . 63.520000000000003 112.488 -167.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -112.78 99.29 7.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.773 1.629 . . . . 62.439999999999998 108.057 167.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.416 HD13 ' CE3' ' A' ' 26' ' ' TRP . 9.7 mt -98.34 144.75 10.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.396 -1.705 . . . . 72.540000000000006 106.396 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.23 142.28 29.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.284 1.034 . . . . 74.25 109.65 168.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB1' HG12 ' A' ' 36' ' ' ILE . . . -74.94 122.51 23.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.338 1.055 . . . . 72.439999999999998 108.87 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -72.89 117.83 15.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.856 -1.535 . . . . 72.349999999999994 106.856 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -131.59 -176.92 4.19 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 127.582 2.353 . . . . 73.430000000000007 109.502 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.78 -27.94 69.53 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.503 0.557 . . . . 74.109999999999999 112.503 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -74.48 -32.13 62.45 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.158 -0.964 . . . . 73.409999999999997 113.05 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.73 166.8 38.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.597 -1.001 . . . . 63.310000000000002 110.597 -166.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.08 64.14 3.2 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.563 1.545 . . . . 62.350000000000001 111.689 -170.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.43 -75.44 0.35 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.291 -1.124 . . . . 63.340000000000003 110.291 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.99 167.65 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.06 3.173 . . . . 73.510000000000005 110.21 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 162.86 39.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.025 2.13 . . . . 71.239999999999995 107.192 165.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.2 t -79.95 179.32 7.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.161 -0.681 . . . . 71.230000000000004 109.161 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -150.54 73.01 1.11 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.143 0.577 . . . . 75.230000000000004 110.031 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.3 m -93.24 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.473 -0.767 . . . . 63.450000000000003 110.424 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 112.24 13.46 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.888 1.275 . . . . 75.349999999999994 110.232 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -71.65 82.68 0.85 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.73 0.812 . . . . 73.230000000000004 110.704 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.83 53.9 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.796 1.638 . . . . 61.450000000000003 108.68 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 17.67 2.99 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.874 1.27 . . . . 75.140000000000001 109.609 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.034 0.445 . . . . 72.150000000000006 110.271 164.165 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 28.6 m-85 . . . . . 0 N--CA 1.44 -0.954 0 N-CA-C 108.273 -1.01 . . . . 74.329999999999998 108.273 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -55.48 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.76 2.307 . . . . 54.420000000000002 112.868 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.73 41.58 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.733 -1.747 . . . . 62.240000000000002 108.733 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.27 159.42 32.11 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.755 1.622 . . . . 71.420000000000002 109.353 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.06 154.27 75.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.232 1.288 . . . . 65.439999999999998 111.719 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.3 m -142.41 -174.65 4.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.614 1.566 . . . . 71.200000000000003 109.488 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.84 37.79 10.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.034 2.534 . . . . 74.299999999999997 113.193 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.52 126.45 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.506 -1.294 . . . . 74.340000000000003 107.506 -171.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -137.56 150.76 47.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.669 -0.863 . . . . 43.140000000000001 108.669 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 24' ' ' LEU . 4.0 mp -125.86 149.74 30.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.459 -2.052 . . . . 53.439999999999998 105.459 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.81 135.84 36.65 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.309 -1.367 . . . . 70.310000000000002 107.309 174.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -72.01 143.85 49.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.398 -1.334 . . . . 73.120000000000005 107.398 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -126.34 165.64 26.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 125.877 1.671 . . . . 71.420000000000002 108.023 169.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.65 -15.2 40.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.359 2.04 . . . . 54.32 112.353 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.24 -29.22 13.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.753 1.221 . . . . 74.430000000000007 110.787 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.14 -152.37 16.94 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 116.377 -2.346 . . . . 63.140000000000001 110.539 -164.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.2 127.95 54.23 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 121.147 2.474 . . . . 71.140000000000001 108.731 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.49 126.14 26.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.214 -1.032 . . . . 74.129999999999995 108.214 164.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' CD2' HG23 ' A' ' 15' ' ' ILE . 5.4 mt -113.12 145.33 41.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.031 -1.099 . . . . 64.239999999999995 108.031 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 t -150.28 171.82 16.35 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.415 0.552 . . . . 65.140000000000001 111.234 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CE3' HD13 ' A' ' 99' ' ' ILE . 15.3 p90 -173.45 -171.57 0.7 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.765 2.026 . . . . 74.299999999999997 111.189 -172.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -111.57 165.49 12.72 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 127.948 2.499 . . . . 73.230000000000004 110.639 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -66.64 166.68 21.33 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.956 3.104 . . . . 53.299999999999997 112.598 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.46 -4.64 14.35 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 124.018 3.145 . . . . 64.409999999999997 111.773 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -148.25 138.43 22.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.916 -1.513 . . . . 54.109999999999999 106.916 -174.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.48 -49.53 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.498 0.666 . . . . 61.020000000000003 110.621 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 t -65.22 158.97 24.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.39 1.076 . . . . 42.229999999999997 109.907 163.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.8 m -54.86 -45.0 74.49 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.409 1.263 . . . . 73.310000000000002 114.409 -163.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.5 -171.48 46.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.965 0.802 . . . . 43.439999999999998 111.566 -171.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -116.42 56.19 0.79 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.571 1.549 . . . . 74.439999999999998 109.187 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.47 140.08 20.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 72.299999999999997 106.245 168.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.96 -23.03 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.573 1.149 . . . . 72.329999999999998 110.609 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -161.24 -175.53 4.9 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.285 1.434 . . . . 74.230000000000004 108.515 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -171.0 2.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.784 1.234 . . . . 74.129999999999995 109.469 170.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . 12.4 p -138.15 155.92 48.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.753 1.621 . . . . 53.100000000000001 107.917 157.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.64 112.43 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.197 -2.519 . . . . 64.0 104.197 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.404 ' HB3' ' CB ' ' A' ' 64' ' ' PHE . 67.7 m-85 -111.51 160.24 17.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.758 0.823 . . . . 74.409999999999997 108.983 175.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 tp -149.96 139.47 21.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.79 2.036 . . . . 72.530000000000001 106.004 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.33 137.58 42.93 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.389 1.076 . . . . 73.319999999999993 110.34 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -141.76 -165.59 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.528 1.531 . . . . 72.430000000000007 110.343 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 127.083 2.153 . . . . 73.549999999999997 110.305 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 62' ' ' LEU . 2.4 mp . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 108.524 -0.917 . . . . 65.319999999999993 108.524 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.98 123.93 3.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 45.140000000000001 109.558 170.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 27.7 m-85 -146.06 162.26 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.008 0.923 . . . . 74.530000000000001 111.333 -173.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.6 ttt -69.35 -29.83 67.72 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.042 1.337 . . . . 71.329999999999998 113.899 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 65.79 80.57 0.22 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.639 1.576 . . . . 61.409999999999997 110.516 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.72 -14.62 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.961 0.904 . . . . 52.549999999999997 112.488 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -54.34 116.13 2.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.406 1.482 . . . . 73.120000000000005 110.266 166.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -157.9 23.94 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.36 0.504 . . . . 72.409999999999997 112.36 157.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 154.54 29.69 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.918 -1.273 . . . . 73.299999999999997 109.918 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.06 -26.28 21.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.342 2.028 . . . . 54.299999999999997 111.845 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -122.81 163.53 32.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.472 1.509 . . . . 74.019999999999996 109.307 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.93 173.46 12.75 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.983 1.789 . . . . 74.340000000000003 111.027 170.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 t 50.46 59.91 4.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.03 1.332 . . . . 73.209999999999994 110.624 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.63 171.53 7.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.88 0.872 . . . . 73.109999999999999 110.673 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.594 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.0 pt? -76.29 171.65 14.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.624 1.342 . . . . 54.310000000000002 114.624 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.25 109.43 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 C-N-CA 126.973 2.109 . . . . 70.430000000000007 111.266 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -57.43 146.75 28.4 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.246 2.219 . . . . 73.019999999999996 111.472 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 p -66.47 -23.68 66.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.737 1.014 . . . . 71.510000000000005 113.737 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 5.5 0.91 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.614 1.566 . . . . 73.430000000000007 113.599 167.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -108.64 -36.69 6.11 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.063 -1.023 . . . . 74.209999999999994 110.055 164.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.27 -37.39 77.86 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.421 1.088 . . . . 72.310000000000002 111.232 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -61.79 -0.86 0.51 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.693 1.597 . . . . 73.349999999999994 113.109 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -129.98 2.15 4.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.954 2.102 . . . . 65.430000000000007 110.255 -167.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.21 132.8 55.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.982 2.113 . . . . 44.310000000000002 109.125 -169.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -87.39 158.17 19.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.978 0.418 . . . . 65.530000000000001 110.875 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -84.43 146.94 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.898 1.279 . . . . 63.409999999999997 108.365 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.45 118.49 20.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.875 -1.157 . . . . 73.319999999999993 107.875 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 24.32 11.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.256 1.023 . . . . 70.209999999999994 109.789 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -100.65 -53.95 2.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.719 -1.215 . . . . 71.230000000000004 107.719 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.8 m -111.08 -54.26 2.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.178 1.791 . . . . 71.549999999999997 109.488 -166.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -160.47 150.08 14.32 Favored Pre-proline 0 C--N 1.343 0.298 0 C-N-CA 127.528 2.331 . . . . 63.140000000000001 109.87 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.86 101.56 0.23 Allowed 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 124.494 3.463 . . . . 64.120000000000005 109.89 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.626 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -162.0 172.9 15.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.95 1.7 . . . . 74.510000000000005 111.199 175.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.51 132.35 42.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.759 -1.571 . . . . 72.510000000000005 106.759 167.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.97 118.85 49.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 124.103 0.961 . . . . 73.510000000000005 109.488 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -93.08 178.34 5.78 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.771 1.228 . . . . 72.299999999999997 111.679 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.19 128.5 14.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 126.453 1.901 . . . . 65.200000000000003 106.638 167.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.505 HD13 ' CE3' ' A' ' 26' ' ' TRP . 34.1 mt -132.14 153.93 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 119.528 1.058 . . . . 63.329999999999998 109.512 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -167.78 136.6 2.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.536 2.334 . . . . 71.140000000000001 110.374 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.2 133.3 55.01 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.605 1.562 . . . . 65.329999999999998 112.849 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 92.11 9.02 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.747 -1.946 . . . . 70.120000000000005 105.747 161.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -101.34 -179.23 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.333 -0.988 . . . . 62.020000000000003 108.333 153.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -57.95 -21.77 45.7 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.105 1.15 . . . . 74.239999999999995 114.105 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -37.26 38.88 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.402 -0.811 . . . . 63.409999999999997 110.181 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.17 -171.8 13.97 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.162 1.363 . . . . 74.140000000000001 112.999 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 14.3 m-85 -81.7 66.1 7.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.969 1.708 . . . . 72.219999999999999 111.285 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.28 -74.22 1.08 Allowed Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.002 -1.061 . . . . 23.449999999999999 111.563 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 56.6 Cg_endo -68.81 167.23 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.381 2.72 . . . . 50.340000000000003 110.118 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.46 152.17 44.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.725 0.774 . . . . 73.120000000000005 110.049 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.3 m -142.01 109.44 5.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.159 -1.793 . . . . 61.530000000000001 106.159 167.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -94.38 139.44 31.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.111 -1.44 . . . . 73.319999999999993 107.111 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -125.24 171.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.081 0.952 . . . . 44.340000000000003 110.43 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 113.46 14.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.525 1.53 . . . . 74.230000000000004 108.21 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -79.03 93.4 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.48 -1.304 . . . . 72.129999999999995 107.48 172.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 94' ' ' ALA . 16.2 mt -77.39 165.25 24.65 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.326 -1.361 . . . . 61.439999999999998 107.326 173.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.06 29.51 19.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.667 0.787 . . . . 75.430000000000007 109.892 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 O-C-N 120.246 -1.534 . . . . 74.319999999999993 114.503 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 108.922 -0.77 . . . . 73.329999999999998 108.922 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.75 114.28 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.105 2.537 . . . . 74.239999999999995 109.751 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.01 -161.83 35.12 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.147 -1.181 . . . . 64.109999999999999 110.147 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.06 82.86 0.21 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 127.092 2.157 . . . . 45.140000000000001 111.891 -163.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.31 165.59 24.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.165 2.577 . . . . 73.340000000000003 110.891 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.8 m -135.57 -175.59 4.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.265 1.426 . . . . 35.109999999999999 112.106 -173.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.8 25.95 2.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.673 2.789 . . . . 63.229999999999997 115.202 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.64 132.69 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.417 -0.802 . . . . 61.420000000000002 110.87 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -117.22 149.37 40.53 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.219 1.008 . . . . 73.510000000000005 109.073 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.6 mt -145.65 141.73 22.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 105.673 -1.973 . . . . 72.019999999999996 105.673 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.8 p -152.29 170.98 18.7 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.087 1.755 . . . . 73.319999999999993 108.861 168.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -95.37 160.02 14.73 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.804 0.729 . . . . 71.140000000000001 109.441 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.4 m -145.56 165.75 20.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.472 2.309 . . . . 73.230000000000004 109.391 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -70.66 -4.37 14.5 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.1 2.533 . . . . 73.430000000000007 112.349 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -131.85 29.13 4.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.45 1.5 . . . . 71.439999999999998 110.655 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.48 -158.36 21.18 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.377 -0.827 . . . . 23.539999999999999 112.739 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 153.03 23.77 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.484 1.142 . . . . 51.039999999999999 108.294 162.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.19 96.9 7.51 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.747 2.419 . . . . 70.450000000000003 109.167 -169.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.96 125.47 53.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.226 2.211 . . . . 73.510000000000005 110.061 -159.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -157.97 152.42 24.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.662 1.574 . . . . 33.119999999999997 114.427 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CE3' HD13 ' A' ' 99' ' ' ILE . 4.2 p90 -149.28 -179.62 7.2 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 127.226 2.21 . . . . 72.209999999999994 113.151 -171.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 1.6 pp20? -115.56 160.36 34.96 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 126.703 2.001 . . . . 70.25 112.756 -170.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 92.1 Cg_endo -69.52 176.24 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 126.647 4.898 . . . . 74.209999999999994 112.171 -176.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.75 113.52 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 108.083 -1.545 . . . . 65.120000000000005 108.083 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -103.47 13.95 32.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.952 0.901 . . . . 55.219999999999999 110.387 168.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 32' ' ' THR . 2.4 m -100.44 -84.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 127.536 2.334 . . . . 60.219999999999999 109.702 -174.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.402 ' H ' HG23 ' A' ' 31' ' ' VAL . 50.8 p -122.25 166.3 14.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.893 0.769 . . . . 54.32 109.364 170.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -60.0 -56.79 17.35 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.493 1.117 . . . . 73.099999999999994 110.205 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.13 -171.54 23.38 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.109 -0.796 . . . . 61.32 111.109 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -133.06 80.31 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.388 -0.967 . . . . 72.310000000000002 108.388 166.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -76.95 145.42 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.46 -1.311 . . . . 73.209999999999994 107.46 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -133.04 -24.49 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.342 1.457 . . . . 72.099999999999994 111.434 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 1.5 tp10 -168.1 -175.09 2.52 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 105.762 -1.94 . . . . 71.5 105.762 -174.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.465 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 75.2 m-85 -136.97 -166.15 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.546 -1.346 . . . . 65.209999999999994 109.913 175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.96 159.71 41.73 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.35 2.26 . . . . 70.219999999999999 109.549 165.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.47 119.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 103.84 -2.652 . . . . 62.409999999999997 103.84 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -114.41 151.9 32.39 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.709 -0.849 . . . . 73.430000000000007 108.709 173.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 tp -136.25 117.86 14.93 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.627 1.971 . . . . 74.329999999999998 107.338 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.6 151.4 28.99 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.229 0.611 . . . . 44.32 111.623 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.38 172.49 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.571 1.148 . . . . 74.450000000000003 111.953 -169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.757 1.223 . . . . 64.329999999999998 109.955 156.831 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 1.7 mt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 119.676 -0.202 . . . . 73.219999999999999 110.549 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 87.93 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.479 0.581 . . . . 63.140000000000001 110.788 172.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 13.5 m-30 -117.87 155.13 30.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.337 1.055 . . . . 74.129999999999995 110.052 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.7 ttp -87.03 146.9 25.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.632 0.773 . . . . 74.409999999999997 109.405 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.59 93.39 8.36 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.636 1.208 . . . . 61.520000000000003 110.961 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -71.61 1.16 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 124.599 1.16 . . . . 73.310000000000002 112.74 168.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -91.22 -163.92 1.1 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.992 1.717 . . . . 74.329999999999998 110.38 174.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.3 m 57.91 35.31 25.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.729 1.612 . . . . 63.549999999999997 110.829 -158.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.29 -177.48 9.89 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 110.167 -1.173 . . . . 53.049999999999997 110.167 163.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -26.08 28.71 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.432 1.421 . . . . 74.510000000000005 111.182 173.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.74 17.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.094 1.358 . . . . 65.420000000000002 109.541 -170.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.25 165.45 28.61 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.414 2.076 . . . . 74.439999999999998 109.745 160.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m 49.35 36.35 9.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.992 1.317 . . . . 61.539999999999999 113.034 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -88.9 162.28 16.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.653 1.216 . . . . 71.540000000000006 111.224 170.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.576 ' H ' HD23 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.25 175.04 1.8 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.06 2.944 . . . . 61.119999999999997 113.705 172.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -135.8 119.68 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.236 1.014 . . . . 53.049999999999997 111.953 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -54.82 140.33 36.87 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.735 0.814 . . . . 73.319999999999993 111.599 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 p -56.14 -34.09 65.79 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.104 0.962 . . . . 72.549999999999997 112.799 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -55.17 -39.24 69.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.072 0.949 . . . . 72.549999999999997 111.583 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 t -74.55 -34.65 62.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.165 -0.959 . . . . 73.340000000000003 110.641 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.3 -33.77 76.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.633 0.651 . . . . 71.310000000000002 110.0 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -58.51 -37.21 75.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.633 1.573 . . . . 53.32 111.406 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.57 -5.58 59.26 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.068 -1.02 . . . . 65.140000000000001 112.711 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 149.82 21.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.607 -0.683 . . . . 53.439999999999998 111.166 -159.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 108.84 20.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.528 1.531 . . . . 74.430000000000007 109.693 -175.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -69.78 157.71 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.466 -0.938 . . . . 70.310000000000002 108.466 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -132.54 82.85 2.03 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.989 1.316 . . . . 63.130000000000003 108.656 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.96 121.61 5.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.438 1.273 . . . . 75.310000000000002 114.438 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 -22.62 43.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.63 -2.077 . . . . 73.319999999999993 112.894 159.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 p -143.67 -62.37 0.4 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.314 1.416 . . . . 74.120000000000005 112.797 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -104.49 141.86 23.41 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 116.811 -1.566 . . . . 72.209999999999994 109.218 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.48 120.58 7.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.229 1.953 . . . . 55.119999999999997 109.311 -176.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -128.95 147.71 50.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.604 -0.887 . . . . 64.230000000000004 108.604 160.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.3 mt -91.76 130.43 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 126.945 2.098 . . . . 74.329999999999998 105.768 168.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.4 mm -82.81 138.13 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.768 -1.197 . . . . 72.530000000000001 107.768 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.5 133.56 55.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.634 -1.247 . . . . 74.519999999999996 107.634 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -98.64 133.01 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 106.56 -1.645 . . . . 61.520000000000003 106.56 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.47 HD13 ' CE3' ' A' ' 26' ' ' TRP . 53.6 mt -135.87 140.27 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 105.686 -1.968 . . . . 62.240000000000002 105.686 175.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.27 164.48 35.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.511 0.724 . . . . 64.099999999999994 110.243 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.48 125.19 40.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.472 1.509 . . . . 65.519999999999996 111.15 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.48 ' HD3' ' CZ ' ' A' ' 107' ' ' TYR . 6.1 tpt180 -76.56 112.77 13.45 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.062 -1.459 . . . . 74.200000000000003 107.062 171.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 167.45 16.93 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.037 0.535 . . . . 71.409999999999997 111.346 162.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.66 -27.3 66.26 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.075 -0.391 . . . . 74.420000000000002 111.895 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -53.99 -40.02 66.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.336 1.454 . . . . 70.219999999999999 111.925 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.72 -173.37 27.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.632 2.063 . . . . 65.5 108.189 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -76.14 -5.05 44.91 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.126 1.528 . . . . 74.430000000000007 115.126 178.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.22 178.52 8.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.952 0.786 . . . . 42.439999999999998 111.958 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.95 148.13 63.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.584 1.523 . . . . 70.120000000000005 108.911 162.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 150.46 20.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.699 0.799 . . . . 71.319999999999993 109.485 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -68.27 166.26 16.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.071 0.948 . . . . 32.32 110.5 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -120.55 86.45 2.57 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.712 -1.958 . . . . 73.409999999999997 105.712 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.7 t -89.44 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 106.945 -1.502 . . . . 64.430000000000007 106.945 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.534 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -128.66 160.97 30.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.734 1.214 . . . . 74.040000000000006 107.945 165.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -119.27 80.13 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.637 1.575 . . . . 75.230000000000004 107.985 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 94' ' ' ALA . 36.9 mt -64.73 -21.74 66.82 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.896 0.702 . . . . 64.150000000000006 112.896 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.27 28.19 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.103 1.361 . . . . 73.040000000000006 111.622 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.496 -1.298 . . . . 60.030000000000001 107.496 164.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.457 0 CA-C-O 118.595 -1.114 . . . . 44.119999999999997 110.827 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 71.4 m -116.97 -41.79 2.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.018 1.409 . . . . 53.25 111.27 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 149.49 94.57 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 120.089 -0.645 . . . . 53.32 110.366 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.68 -18.12 29.04 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.691 2.928 . . . . 71.209999999999994 113.498 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.84 -165.01 10.91 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.158 -1.177 . . . . 75.450000000000003 110.158 -167.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -88.43 165.3 28.96 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.05 -1.463 . . . . 75.25 107.05 169.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.18 6.15 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.095 2.53 . . . . 64.420000000000002 114.528 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.62 -171.77 16.78 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.595 -1.802 . . . . 53.310000000000002 108.595 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.33 163.34 34.68 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 125.871 1.668 . . . . 44.310000000000002 109.609 -175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.15 152.12 81.3 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.651 1.568 . . . . 73.239999999999995 111.287 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 98.9 m -133.61 -173.93 3.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.854 2.462 . . . . 72.319999999999993 108.627 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 45.91 27.32 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.898 2.879 . . . . 54.409999999999997 114.868 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.73 137.71 23.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.036 -0.727 . . . . 63.240000000000002 109.036 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -134.04 159.23 41.42 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.797 0.839 . . . . 73.140000000000001 111.227 163.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -144.18 138.95 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 105.864 -1.902 . . . . 72.310000000000002 105.864 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -135.47 159.99 39.85 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.675 1.99 . . . . 74.420000000000002 108.404 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -83.69 170.92 13.73 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.987 -1.071 . . . . 61.509999999999998 108.4 171.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 161.6 29.15 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 123.888 0.875 . . . . 42.509999999999998 110.26 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.72 -27.77 52.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 121.57 1.513 . . . . 72.430000000000007 110.968 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -113.55 23.37 13.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.114 1.366 . . . . 75.420000000000002 110.854 -171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.24 -149.1 21.03 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 120.652 -1.28 . . . . 73.140000000000001 111.791 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 144.32 40.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.507 2.153 . . . . 61.520000000000003 107.5 152.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -80.13 141.67 35.52 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.947 1.299 . . . . 62.520000000000003 108.084 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mp -132.97 174.65 10.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.003 0.819 . . . . 71.409999999999997 110.015 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.9 t -175.31 155.91 1.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 128.013 2.525 . . . . 74.230000000000004 108.059 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -158.57 167.08 30.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.323 1.449 . . . . 72.519999999999996 109.316 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 7.0 mt-10 -138.65 162.99 49.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 125.866 1.666 . . . . 64.439999999999998 111.682 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.91 174.79 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.186 3.258 . . . . 52.119999999999997 113.808 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.92 179.01 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.88 3.054 . . . . 60.450000000000003 113.646 168.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.0 t -138.36 73.27 1.43 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 105.069 -2.197 . . . . 65.140000000000001 105.069 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 m -141.48 -66.34 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 107.736 -1.209 . . . . 65.319999999999993 107.736 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.3 t -112.28 173.64 6.27 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.814 2.045 . . . . 31.309999999999999 109.441 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 m -49.35 -57.77 6.29 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.267 1.427 . . . . 63.240000000000002 110.289 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.84 118.0 0.12 Allowed Glycine 0 C--N 1.34 0.758 0 C-N-CA 123.777 0.703 . . . . 65.150000000000006 111.379 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -102.4 73.81 1.36 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.617 -0.883 . . . . 75.129999999999995 108.617 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.26 149.91 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.384 -1.71 . . . . 62.119999999999997 106.384 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -141.81 -23.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.279 1.431 . . . . 45.43 112.639 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.43 -170.91 3.5 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 105.41 -2.07 . . . . 52.009999999999998 105.41 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.33 -178.56 5.54 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.211 -2.181 . . . . 72.230000000000004 111.599 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -155.98 162.47 40.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.648 0.779 . . . . 63.210000000000001 111.558 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 68' ' ' TYR . 2.2 p -148.35 115.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 126.728 2.011 . . . . 62.119999999999997 112.154 172.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -99.69 88.37 3.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 74.439999999999998 108.664 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.1 tp -66.58 135.52 54.27 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.496 -1.298 . . . . 64.209999999999994 107.496 171.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.55 150.81 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.121 1.368 . . . . 63.509999999999998 111.002 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 pt -152.03 168.22 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.997 1.719 . . . . 74.129999999999995 110.394 -171.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 92.23 7.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.016 -1.475 . . . . 75.510000000000005 107.016 160.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 t -162.97 172.77 14.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.781 -0.822 . . . . 54.149999999999999 108.781 149.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.3 m -73.0 150.22 42.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.9 -0.5 . . . . 74.540000000000006 109.796 159.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.81 178.47 9.86 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.309 -0.997 . . . . 72.340000000000003 108.309 169.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.91 166.41 11.35 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.843 0.857 . . . . 60.240000000000002 110.913 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.3 p -159.92 116.24 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.274 1.83 . . . . 72.230000000000004 106.202 -169.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.82 110.44 0.36 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.654 -0.978 . . . . 62.509999999999998 110.654 -169.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.31 152.88 68.54 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 117.666 0.733 . . . . 72.150000000000006 111.293 -163.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.33 122.9 11.52 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.474 2.116 . . . . 61.450000000000003 110.298 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 tptt 70.99 -3.43 2.03 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.437 2.295 . . . . 74.319999999999993 114.892 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m 52.19 86.35 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 123.001 1.382 . . . . 71.120000000000005 107.606 -150.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.3 p -133.13 36.87 3.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.374 -0.83 . . . . 72.450000000000003 109.593 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.96 68.9 0.98 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.027 1.331 . . . . 73.540000000000006 108.466 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.49 91.78 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.702 2.268 . . . . 63.210000000000001 110.373 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 177.79 115.48 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 125.227 1.411 . . . . 71.209999999999994 107.393 172.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -47.04 105.61 0.07 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.882 0.873 . . . . 63.119999999999997 110.453 166.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.469 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 18.6 mt -77.14 177.36 7.9 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.357 1.063 . . . . 75.349999999999994 108.305 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.32 5.92 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.43 -0.581 . . . . 72.319999999999993 109.43 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 17.5 m-85 -127.92 176.58 7.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.159 0.984 . . . . 72.450000000000003 110.473 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.5 ptm -126.74 -7.5 6.17 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 124.533 1.133 . . . . 72.409999999999997 112.655 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 53.63 78.13 0.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.883 0.873 . . . . 74.409999999999997 111.324 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 41' ' ' VAL . 13.5 m -77.69 -38.65 25.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-O 117.831 -1.08 . . . . 72.120000000000005 111.777 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.879 ' HB2' HG12 ' A' ' 41' ' ' VAL . 24.9 t80 -65.39 131.19 45.83 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 116.722 -1.991 . . . . 64.549999999999997 112.165 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.43 51.03 0.35 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.966 2.506 . . . . 64.140000000000001 108.262 178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.82 166.06 13.46 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.77 -1.206 . . . . 74.109999999999999 110.29 166.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.52 -50.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.906 2.404 . . . . 75.319999999999993 109.783 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -90.71 154.94 45.92 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 125.845 1.658 . . . . 65.310000000000002 108.665 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.79 -173.22 1.57 Allowed 'Trans proline' 0 N--CA 1.44 -1.624 0 C-N-CA 122.471 2.114 . . . . 65.129999999999995 110.798 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p 57.34 60.57 2.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.454 1.502 . . . . 44.149999999999999 112.56 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.09 176.35 5.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.224 1.41 . . . . 61.509999999999998 110.014 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.61 -172.88 3.74 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.251 1.021 . . . . 51.130000000000003 110.906 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.19 139.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 125.612 1.565 . . . . 73.140000000000001 109.308 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.79 139.51 58.78 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.23 0.923 . . . . 75.340000000000003 110.088 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.1 t -63.15 -26.8 68.98 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.523 -0.736 . . . . 62.32 112.379 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -66.32 -21.26 66.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.855 0.862 . . . . 71.239999999999995 111.227 173.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -82.81 -33.04 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.626 -1.296 . . . . 64.420000000000002 110.533 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.98 -37.32 47.62 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.764 0.826 . . . . 72.329999999999998 112.206 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -60.93 -37.89 83.9 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.59 -0.522 . . . . 43.25 109.59 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -86.46 11.19 13.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.811 2.044 . . . . 73.310000000000002 111.645 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.53 155.69 16.66 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.008 1.323 . . . . 65.209999999999994 111.192 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 140.76 29.8 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.733 0.813 . . . . 52.030000000000001 110.064 173.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.57 155.01 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.89 0.852 . . . . 73.109999999999999 110.273 168.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.453 ' OD2' HD11 ' A' ' 96' ' ' ILE . 9.2 t70 -79.64 130.4 35.33 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 126.377 1.871 . . . . 72.319999999999993 108.534 173.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.59 3.59 4.58 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.473 1.109 . . . . 65.219999999999999 110.79 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 p -90.27 -19.11 24.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.705 2.002 . . . . 73.439999999999998 111.633 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.5 p -135.78 -62.03 0.7 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.59 1.086 . . . . 72.409999999999997 112.739 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -153.24 155.35 31.75 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 119.567 1.076 . . . . 71.239999999999995 109.902 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.58 112.94 3.19 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 121.96 1.773 . . . . 71.329999999999998 108.313 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.651 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -164.02 165.98 21.94 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 128.257 2.623 . . . . 62.109999999999999 109.886 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -90.11 135.19 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 107.955 -1.128 . . . . 62.420000000000002 107.955 167.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.453 HD11 ' OD2' ' A' ' 88' ' ' ASP . 45.6 mm -83.49 147.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.261 0.937 . . . . 62.409999999999997 110.637 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -137.25 115.76 11.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 61.450000000000003 110.122 174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.77 87.38 6.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.646 1.578 . . . . 72.140000000000001 108.654 170.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.485 HG13 HG23 ' A' ' 41' ' ' VAL . 4.7 mt -86.08 151.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.321 -1.363 . . . . 71.209999999999994 107.321 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.63 146.24 24.17 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.835 0.743 . . . . 35.109999999999999 110.337 164.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.69 129.55 34.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.123 0.969 . . . . 63.130000000000003 110.011 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 92.13 8.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 105.909 -1.886 . . . . 75.340000000000003 105.909 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -117.95 173.14 6.94 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.412 1.485 . . . . 75.540000000000006 109.636 175.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.57 -16.53 10.42 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.858 1.429 . . . . 74.439999999999998 114.858 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.84 -18.72 34.02 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.576 -1.328 . . . . 62.350000000000001 112.126 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.25 -178.62 50.69 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.807 1.67 . . . . 35.100000000000001 111.047 -166.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -68.41 133.67 49.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.71 -1.589 . . . . 73.430000000000007 106.71 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -148.23 -86.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.303 0.954 . . . . 64.319999999999993 111.151 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.67 82.66 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.954 2.436 . . . . 51.039999999999999 107.596 166.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.09 160.82 9.47 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.381 -0.825 . . . . 62.109999999999999 109.539 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -115.34 140.5 49.07 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.424 1.09 . . . . 74.209999999999994 108.321 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.77 103.75 14.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 105.604 -1.999 . . . . 73.519999999999996 105.604 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -111.98 152.3 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 75.540000000000006 107.098 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.34 121.19 17.56 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.704 -0.68 . . . . 73.25 109.57 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -76.28 84.49 3.07 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.756 -1.201 . . . . 65.519999999999996 107.756 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 94' ' ' ALA . 19.9 mt -65.92 150.72 48.18 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.5 -1.296 . . . . 75.109999999999999 107.5 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 69.6 27.84 4.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.789 1.235 . . . . 60.219999999999999 111.288 173.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 177.71 0.82 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.174 2.99 . . . . 64.409999999999997 113.648 163.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 p -150.5 143.91 25.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.367 1.867 . . . . 71.129999999999995 109.989 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 m -58.78 -48.17 82.19 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.193 1.183 . . . . 32.130000000000003 114.193 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 69.43 -62.34 0.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.048 2.139 . . . . 75.219999999999999 113.621 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 50.93 83.28 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 128.479 2.712 . . . . 64.540000000000006 110.112 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 p -152.63 104.26 2.87 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.331 -0.856 . . . . 62.43 113.128 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 p -135.58 177.96 7.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.447 1.022 . . . . 14.41 111.218 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -121.81 -61.27 0.22 Allowed Glycine 0 N--CA 1.466 0.699 0 O-C-N 120.764 -1.21 . . . . 64.530000000000001 111.28 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.252 1.234 0 C-N-CA 126.154 1.781 . . . . 71.319999999999993 107.777 178.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.98 0 N-CA-C 109.662 -1.375 . . . . 75.400000000000006 109.662 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 79.2 m 50.73 71.33 0.43 Allowed 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.697 1.999 . . . . 75.239999999999995 111.282 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.98 61.34 7.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 118.552 -0.737 . . . . 71.120000000000005 109.788 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -84.45 64.02 6.72 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.231 2.62 . . . . 75.329999999999998 110.483 -171.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.21 167.18 14.91 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.717 -1.353 . . . . 75.400000000000006 109.717 -172.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -106.71 147.78 35.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.763 0.825 . . . . 72.439999999999998 110.017 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' HG21 ' A' ' 32' ' ' THR . 85.0 Cg_endo -73.2 134.49 21.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.963 2.442 . . . . 74.099999999999994 108.653 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.12 168.07 28.08 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.872 1.701 . . . . 64.420000000000002 109.328 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.05 165.76 2.11 Favored Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 125.861 1.664 . . . . 42.140000000000001 109.257 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -70.82 142.01 42.28 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.379 2.052 . . . . 74.200000000000003 109.541 149.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.1 m -141.82 175.48 9.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.123 1.369 . . . . 40.340000000000003 109.774 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.61 25.69 0.27 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.124 2.969 . . . . 75.439999999999998 114.966 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -55.44 143.41 8.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.829 1.652 . . . . 73.219999999999999 109.691 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -139.48 147.95 42.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.539 1.536 . . . . 75.430000000000007 108.132 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.87 144.21 27.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.874 -1.899 . . . . 74.230000000000004 105.874 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.1 m -144.79 155.79 43.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.635 1.574 . . . . 72.540000000000006 109.083 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.89 168.07 20.19 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.376 -0.827 . . . . 64.519999999999996 110.376 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 75.0 m -150.69 165.2 17.92 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.629 1.972 . . . . 54.229999999999997 106.915 170.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 -26.05 24.13 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.578 2.186 . . . . 54.399999999999999 110.702 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.73 -64.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.552 1.141 . . . . 62.039999999999999 109.183 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.73 -145.82 4.24 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.559 2.028 . . . . 51.439999999999998 108.669 -167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.04 133.9 55.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.155 0.977 . . . . 40.200000000000003 108.723 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.82 135.57 48.19 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.709 -1.219 . . . . 72.209999999999994 107.709 166.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 mp -142.01 138.01 31.54 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 119.037 0.835 . . . . 75.200000000000003 110.503 172.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -144.0 153.45 42.25 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.297 -1.001 . . . . 73.400000000000006 108.297 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.32 21.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.679 1.592 . . . . 74.040000000000006 108.357 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -150.11 165.8 16.65 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.124 0.97 . . . . 73.099999999999994 110.631 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.25 168.42 17.73 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.715 3.61 . . . . 75.430000000000007 113.625 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.27 175.25 11.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.382 2.721 . . . . 75.109999999999999 111.629 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.6 24.53 4.74 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.866 1.266 . . . . 75.409999999999997 111.731 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.17 -22.12 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.167 -0.958 . . . . 72.430000000000007 111.528 -158.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.47 HG21 ' HB2' ' A' ' 7' ' ' PRO . 13.3 t -166.16 162.39 17.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.162 2.185 . . . . 72.329999999999998 106.239 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -71.35 -68.93 0.41 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.373 1.069 . . . . 71.329999999999998 109.375 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.06 -173.05 10.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.623 -1.391 . . . . 71.040000000000006 109.623 -157.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -132.16 83.94 2.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.378 -1.341 . . . . 72.099999999999994 107.378 163.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.03 150.72 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 108.123 -1.066 . . . . 62.310000000000002 108.123 176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.4 pt -134.95 -25.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.788 1.635 . . . . 72.409999999999997 111.192 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.67 -175.86 3.66 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.35 1.46 . . . . 75.230000000000004 108.403 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -140.81 169.6 17.32 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.96 1.704 . . . . 72.040000000000006 108.878 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.4 m -152.68 161.16 42.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.439 0.696 . . . . 61.100000000000001 111.337 167.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -123.59 142.61 39.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.82 1.248 . . . . 63.43 108.672 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -127.0 115.83 19.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.929 2.092 . . . . 75.0 105.833 -171.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -101.03 122.18 43.09 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.673 -1.602 . . . . 75.439999999999998 106.673 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 98' ' ' ARG . . . -77.62 76.81 4.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.088 0.955 . . . . 53.009999999999998 109.801 -177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.25 175.77 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.135 0.974 . . . . 52.520000000000003 111.462 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.18 110.15 7.24 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.061 -1.829 . . . . 71.150000000000006 106.061 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.2 t -168.41 170.06 10.11 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.784 0.834 . . . . 72.209999999999994 110.145 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 p -152.01 96.47 2.21 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.879 -1.897 . . . . 63.310000000000002 105.879 160.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -160.73 161.68 32.26 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.069 1.348 . . . . 70.329999999999998 108.124 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.32 -179.43 0.22 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.102 2.161 . . . . 65.040000000000006 111.791 -174.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -176.49 135.08 0.24 Allowed 'General case' 0 C--O 1.238 0.482 0 N-CA-C 103.428 -2.804 . . . . 74.420000000000002 103.428 -166.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.14 99.32 0.16 Allowed Glycine 0 C--N 1.331 0.281 0 CA-C-N 119.106 0.867 . . . . 32.210000000000001 111.556 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -122.59 163.91 29.78 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 106.475 -1.676 . . . . 71.230000000000004 106.475 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.89 172.65 11.42 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 124.781 3.654 . . . . 72.430000000000007 114.286 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -56.75 -8.1 0.54 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.962 1.705 . . . . 71.340000000000003 114.68 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 m -58.41 -9.22 1.47 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.734 1.214 . . . . 72.030000000000001 113.296 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m 47.68 64.19 1.71 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.342 1.857 . . . . 54.109999999999999 111.937 163.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.66 144.51 53.24 Favored Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 124.832 1.253 . . . . 73.099999999999994 108.497 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.29 99.7 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.206 2.604 . . . . 75.400000000000006 110.508 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.29 83.21 0.28 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.45 1.1 . . . . 60.509999999999998 109.898 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -89.26 143.34 26.91 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.35 0.66 . . . . 64.120000000000005 110.546 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.98 175.66 6.2 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.296 1.838 . . . . 75.510000000000005 109.883 -174.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.11 119.52 5.99 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.265 1.426 . . . . 61.420000000000002 108.847 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 6.7 m-85 -137.69 169.93 16.93 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.751 0.82 . . . . 73.209999999999994 109.307 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -12.46 25.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 74.0 113.453 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 43.97 75.36 0.1 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.523 1.929 . . . . 73.209999999999994 111.531 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.9 m -65.19 -16.01 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 124.405 1.082 . . . . 55.409999999999997 113.343 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -121.24 117.43 27.04 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.538 0.735 . . . . 75.109999999999999 109.975 -169.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.3 m -130.82 137.89 49.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.764 -2.31 . . . . 64.230000000000004 104.764 154.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.59 156.26 7.94 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.645 1.111 . . . . 72.120000000000005 112.496 170.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.97 -14.86 10.8 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.977 3.118 . . . . 75.0 113.385 -170.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.1 m -111.29 85.83 5.91 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.525 1.13 . . . . 74.420000000000002 109.489 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.6 67.78 3.7 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.541 2.827 . . . . 75.340000000000003 110.646 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 p -157.13 11.8 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.785 1.234 . . . . 71.129999999999995 111.618 164.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -89.9 161.76 15.77 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.321 1.049 . . . . 74.030000000000001 113.27 -165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.05 164.46 17.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.538 1.935 . . . . 72.329999999999998 110.393 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.41 125.52 69.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.694 1.598 . . . . 64.430000000000007 107.15 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -66.98 160.79 25.69 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.322 1.049 . . . . 71.340000000000003 111.561 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -55.05 -33.66 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 42.130000000000003 110.391 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -61.06 -12.23 11.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.541 1.536 . . . . 43.140000000000001 113.768 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -118.58 7.85 11.86 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.121 1.368 . . . . 72.0 112.053 171.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -116.51 -12.91 10.94 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.366 1.466 . . . . 73.540000000000006 111.733 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -62.48 -60.95 2.82 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.873 1.269 . . . . 72.319999999999993 111.5 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -73.29 13.26 0.46 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 118.161 -0.923 . . . . 74.340000000000003 112.085 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.76 165.95 2.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 120.243 1.383 . . . . 60.119999999999997 110.122 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.5 108.38 12.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.972 -1.492 . . . . 74.129999999999995 106.972 166.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 mm -68.82 140.78 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.075 -1.454 . . . . 75.140000000000001 107.075 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -56.85 118.13 4.62 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.19 0.996 . . . . 75.409999999999997 109.085 169.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -115.41 31.37 6.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.98 1.312 . . . . 61.32 109.076 170.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -6.36 5.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.667 1.187 . . . . 71.349999999999994 110.363 -164.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.9 m -159.06 -66.25 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.762 2.825 . . . . 72.430000000000007 107.681 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -149.58 151.86 33.97 Favored Pre-proline 0 N--CA 1.463 0.2 0 C-N-CA 125.857 1.663 . . . . 74.340000000000003 109.413 176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.21 100.78 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.967 2.445 . . . . 75.140000000000001 109.89 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -145.34 152.32 39.7 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.349 1.459 . . . . 63.32 110.453 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.3 mt -79.98 124.19 37.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 106.388 -1.708 . . . . 72.519999999999996 106.388 165.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.0 mm -101.52 101.39 12.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.759 -1.2 . . . . 63.520000000000003 107.759 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -79.21 152.62 30.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.156 0.982 . . . . 75.120000000000005 109.292 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HE ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -136.17 124.76 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 104.739 -2.319 . . . . 75.099999999999994 104.739 176.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.69 141.98 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 120.674 1.579 . . . . 75.5 108.149 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.42 155.52 45.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.745 0.702 . . . . 62.130000000000003 111.231 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 125.0 28.75 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.46 1.504 . . . . 51.200000000000003 109.883 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -74.49 101.33 4.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 104.729 -2.323 . . . . 75.430000000000007 104.729 162.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -115.84 174.62 5.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.431 0.634 . . . . 73.409999999999997 110.751 168.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -65.08 -23.94 67.31 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.274 0.842 . . . . 72.0 113.274 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -57.91 6.4 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.205 1.002 . . . . 74.420000000000002 110.653 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.08 165.5 12.33 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.333 1.921 . . . . 62.409999999999997 109.05 -171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -64.75 137.78 58.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.168 -1.419 . . . . 61.32 107.168 166.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.61 -64.15 0.01 OUTLIER Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.377 0.989 . . . . 52.100000000000001 111.907 -176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.07 71.65 6.18 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.554 2.836 . . . . 73.209999999999994 110.774 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.22 112.17 6.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.139 0.576 . . . . 60.32 109.857 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.5 m -81.04 113.12 19.02 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.527 -1.657 . . . . 64.299999999999997 106.527 166.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -81.8 151.02 27.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.987 -1.116 . . . . 75.540000000000006 107.987 169.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 76.2 t -143.72 143.58 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.018 -1.475 . . . . 31.350000000000001 107.018 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.84 154.19 39.98 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.827 0.739 . . . . 71.200000000000003 112.31 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -142.71 112.12 6.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.469 1.108 . . . . 61.119999999999997 109.774 -173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -88.53 3.05 51.7 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 128.702 2.801 . . . . 71.140000000000001 112.286 -172.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -98.27 18.4 16.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.954 1.702 . . . . 71.340000000000003 110.293 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.99 1.71 8.35 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.19 0.996 . . . . 64.329999999999998 113.493 176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 122.65 10.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.299 1.839 . . . . 74.129999999999995 108.749 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.2 t -143.65 -49.87 0.31 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.708 -0.187 . . . . 73.150000000000006 111.107 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -83.97 71.43 10.51 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.517 -0.549 . . . . 71.519999999999996 109.517 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -139.13 143.8 38.37 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.709 -1.589 . . . . 75.450000000000003 106.709 167.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.6 m 48.03 36.23 6.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.311 1.044 . . . . 72.450000000000003 112.0 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -7.25 47.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.715 -1.24 . . . . 54.210000000000001 112.573 -168.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.55 -63.37 1.12 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 106.985 -2.446 . . . . 43.439999999999998 106.985 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.257 1.447 0 C-N-CA 128.807 2.843 . . . . 51.310000000000002 104.189 157.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 109.04 -1.624 . . . . 51.43 109.04 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 98.7 m -112.93 -25.51 8.96 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.196 1.399 . . . . 65.219999999999999 110.574 154.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 mt 45.23 67.99 3.7 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 127.392 2.277 . . . . 73.209999999999994 111.012 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.16 100.08 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.927 2.418 . . . . 72.129999999999995 108.784 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.51 151.93 26.7 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 125.344 1.45 . . . . 44.240000000000002 110.684 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -124.92 165.5 25.29 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.355 2.262 . . . . 75.310000000000002 108.995 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.18 134.95 32.98 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.221 1.947 . . . . 40.310000000000002 113.373 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.39 -179.81 53.33 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.367 1.461 . . . . 61.43 112.301 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 174.49 165.12 0.34 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 129.272 3.029 . . . . 71.409999999999997 110.138 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.34 150.81 81.2 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.624 2.216 . . . . 55.420000000000002 109.666 163.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -137.31 174.89 10.12 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.431 1.092 . . . . 72.439999999999998 110.606 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.99 10.14 4.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.942 2.497 . . . . 71.209999999999994 115.515 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -51.49 111.66 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 125.259 1.424 . . . . 72.319999999999993 113.051 -158.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -86.3 136.46 33.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.534 -1.284 . . . . 62.450000000000003 107.534 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.23 126.33 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 105.4 -2.074 . . . . 63.030000000000001 105.4 160.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -150.33 173.02 14.46 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 128.924 2.889 . . . . 62.130000000000003 106.227 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -90.05 159.68 16.71 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.985 -1.117 . . . . 72.430000000000007 107.985 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -129.56 160.61 63.66 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.559 -1.645 . . . . 71.439999999999998 106.559 157.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -52.65 -45.0 43.29 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 120.91 1.073 . . . . 63.25 109.37 150.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -79.33 26.31 0.28 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.59 2.356 . . . . 71.109999999999999 113.604 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.74 -113.32 2.35 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 124.283 0.944 . . . . 44.310000000000002 111.119 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.59 -160.95 1.09 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.233 1.813 . . . . 35.409999999999997 108.757 172.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -130.34 33.62 4.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.212 1.405 . . . . 74.030000000000001 112.766 -169.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.69 103.42 1.09 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 127.029 2.132 . . . . 63.039999999999999 113.038 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -138.97 150.59 46.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.431 1.469 . . . . 72.040000000000006 110.424 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.401 ' CE3' HD13 ' A' ' 99' ' ' ILE . 1.1 p90 -139.27 162.62 34.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.382 1.073 . . . . 73.319999999999993 110.426 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -74.75 154.81 87.23 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 116.377 -0.374 . . . . 73.420000000000002 111.347 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.49 168.16 25.46 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.067 3.178 . . . . 53.240000000000002 110.9 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.59 116.13 4.57 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.141 2.561 . . . . 73.150000000000006 110.341 175.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.36 60.31 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.685 2.394 . . . . 73.349999999999994 106.266 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.48 -62.31 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 124.267 1.027 . . . . 73.239999999999995 111.329 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 p -133.38 167.02 21.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.304 -0.872 . . . . 74.209999999999994 110.583 -170.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.7 10.35 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.316 2.246 . . . . 64.239999999999995 114.022 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.25 149.01 50.26 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.568 -1.413 . . . . 74.040000000000006 109.568 172.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -121.39 92.11 3.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.473 1.909 . . . . 73.349999999999994 106.517 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -73.73 144.49 12.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.383 -1.735 . . . . 62.240000000000002 106.589 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 pt -131.08 -13.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.924 1.69 . . . . 63.130000000000003 112.243 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -168.38 -175.4 2.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.724 2.41 . . . . 74.409999999999997 107.345 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.22 170.36 15.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.061 -1.025 . . . . 73.120000000000005 109.294 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 92.4 p -146.62 155.18 42.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.852 0.861 . . . . 64.519999999999996 112.898 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.8 t -141.68 137.98 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 126.466 1.906 . . . . 71.540000000000006 106.706 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -128.49 126.75 41.08 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.907 1.683 . . . . 73.430000000000007 107.052 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.4 tp -119.79 131.58 55.37 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.821 1.648 . . . . 75.409999999999997 109.911 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.55 135.85 54.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.914 1.234 . . . . 62.240000000000002 110.834 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.1 pt -141.11 -173.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.987 1.315 . . . . 73.099999999999994 111.003 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -106.96 43.4 1.16 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.557 1.543 . . . . 65.140000000000001 112.503 -168.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.9 m -135.91 -171.25 2.82 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 129.46 3.104 . . . . 73.329999999999998 108.601 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 m -135.59 159.01 42.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.024 -1.047 . . . . 74.129999999999995 110.702 159.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.29 168.76 20.29 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.157 2.583 . . . . 72.299999999999997 105.793 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.37 165.85 11.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.827 0.451 . . . . 45.109999999999999 110.981 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.66 110.69 9.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.2 -2.148 . . . . 63.520000000000003 105.2 -176.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.29 110.53 0.47 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 108.21 -1.956 . . . . 73.420000000000002 108.21 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.24 156.5 81.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.1 0.56 . . . . 73.319999999999993 110.395 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -90.0 61.51 1.89 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.279 2.653 . . . . 53.420000000000002 111.167 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 45.79 48.02 11.88 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.969 1.308 . . . . 73.409999999999997 109.476 -176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 t -79.47 -69.7 0.56 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 125.698 1.599 . . . . 72.109999999999999 107.077 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -173.41 -43.13 0.01 OUTLIER 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.166 0.894 . . . . 65.340000000000003 111.571 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.2 t -135.98 144.4 48.23 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.258 -1.015 . . . . 71.010000000000005 108.258 -158.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.75 161.25 46.71 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.278 1.986 . . . . 74.140000000000001 110.94 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -161.64 104.52 1.22 Allowed 'General case' 0 C--O 1.231 0.089 0 C-N-CA 125.369 1.468 . . . . 63.109999999999999 108.661 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -77.93 116.4 18.4 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 122.1 0.953 . . . . 71.430000000000007 109.668 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.86 153.55 33.31 Favored 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 129.585 3.154 . . . . 64.239999999999995 106.741 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.14 108.4 7.76 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.703 -1.221 . . . . 61.140000000000001 107.703 169.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -118.2 -174.69 2.71 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.826 1.65 . . . . 64.230000000000004 108.849 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.4 ttp -121.82 121.72 37.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.892 2.477 . . . . 75.200000000000003 107.275 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 107.177 -1.416 . . . . 74.099999999999994 107.177 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.2 -28.96 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.804 -0.56 . . . . 73.310000000000002 110.67 168.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 73' ' ' PRO . 4.6 t80 -99.93 93.86 5.99 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 121.562 -0.711 . . . . 75.310000000000002 109.117 -159.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.3 71.92 0.85 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.991 1.317 . . . . 75.209999999999994 107.657 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.55 168.95 41.58 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.849 -0.9 . . . . 64.540000000000006 110.849 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.41 -55.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.565 2.844 . . . . 64.439999999999998 112.451 -174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 m -151.29 73.24 8.39 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.368 1.467 . . . . 72.120000000000005 109.763 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 19.4 Cg_endo -65.72 -47.87 3.55 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 CA-C-O 116.237 -1.651 . . . . 75.430000000000007 110.129 155.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.83 76.6 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.395 1.452 . . . . 71.340000000000003 109.451 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.5 t 77.52 83.16 0.08 Allowed 'General case' 0 C--O 1.233 0.213 0 C-N-CA 130.051 3.341 . . . . 75.150000000000006 111.586 -166.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 97.1 2.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.777 -1.564 . . . . 51.439999999999998 106.777 145.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' A' ' 82' ' ' LEU . 29.2 t -133.35 106.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 O-C-N 120.739 -1.226 . . . . 71.549999999999997 108.349 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -61.77 142.3 57.36 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.885 1.674 . . . . 51.140000000000001 109.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.4 p -57.78 -26.31 61.74 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.46 0.704 . . . . 72.349999999999994 110.815 171.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -53.6 -15.83 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.484 1.914 . . . . 61.109999999999999 114.115 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -99.23 -49.75 4.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.532 1.06 . . . . 73.230000000000004 109.824 171.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' CD2' HG12 ' A' ' 77' ' ' VAL . 2.4 mm? -63.6 -39.46 94.45 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.563 1.074 . . . . 63.420000000000002 112.261 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.8 t -56.25 -44.59 79.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.985 1.314 . . . . 75.519999999999996 109.521 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -84.19 1.43 44.52 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 75.120000000000005 112.376 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.19 145.96 47.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.779 0.799 . . . . 54.200000000000003 109.534 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -69.47 107.4 3.34 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.096 -1.816 . . . . 74.409999999999997 106.096 158.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.01 130.03 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 106.439 -1.689 . . . . 74.409999999999997 106.439 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.49 132.22 53.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.898 1.332 . . . . 71.209999999999994 109.246 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.81 32.2 5.8 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.675 -1.148 . . . . 73.310000000000002 108.263 178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.66 -84.35 0.64 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.638 -1.986 . . . . 71.329999999999998 105.638 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -62.47 -64.34 0.95 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.75 0.82 . . . . 64.129999999999995 110.421 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -155.86 155.65 29.64 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 117.747 -1.121 . . . . 74.030000000000001 110.766 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.44 97.38 0.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.315 2.01 . . . . 54.5 107.949 169.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.492 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -155.71 169.99 23.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.704 2.002 . . . . 73.310000000000002 108.594 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.92 115.45 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.197 -1.779 . . . . 64.430000000000007 106.197 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.14 139.61 19.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.597 -1.26 . . . . 75.310000000000002 107.597 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -127.08 131.31 50.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.055 1.742 . . . . 53.32 107.811 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -103.32 137.72 41.06 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 106.193 -1.78 . . . . 74.420000000000002 106.193 155.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.401 HD13 ' CE3' ' A' ' 26' ' ' TRP . 67.0 mt -130.74 137.75 55.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 104.557 -2.386 . . . . 73.030000000000001 104.557 173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.4 142.77 23.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.87 0.692 . . . . 75.430000000000007 112.87 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.59 128.35 36.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.433 1.893 . . . . 73.450000000000003 109.573 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.49 95.71 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.343 -1.725 . . . . 62.140000000000001 106.343 173.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.41 ' C ' HD22 ' A' ' 103' ' ' ASN . 0.4 OUTLIER -120.84 166.06 14.29 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.079 1.352 . . . . 75.150000000000006 108.297 169.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -55.24 -35.54 65.08 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.852 0.861 . . . . 53.130000000000003 112.438 -171.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -55.37 -21.08 13.9 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.204 1.187 . . . . 71.019999999999996 114.204 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.49 176.26 32.72 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.498 -1.441 . . . . 62.530000000000001 109.498 -168.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -79.73 55.87 2.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.548 1.166 . . . . 75.349999999999994 109.584 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.32 -64.73 3.65 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.632 1.587 . . . . 75.010000000000005 109.289 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.58 142.1 25.76 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 CA-C-N 118.942 1.371 . . . . 51.43 109.255 172.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -151.83 147.79 27.06 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.075 -1.083 . . . . 62.340000000000003 108.075 165.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.8 t -78.01 169.73 17.79 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.343 -0.614 . . . . 71.129999999999995 109.343 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.06 90.58 2.91 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.409 -1.7 . . . . 64.019999999999996 106.409 169.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.87 161.08 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.008 -1.479 . . . . 52.149999999999999 107.008 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 131.16 22.82 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.034 -1.839 . . . . 73.409999999999997 106.034 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -82.76 82.41 8.1 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.195 -1.039 . . . . 74.030000000000001 108.195 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 ' HB2' ' A' ' 94' ' ' ALA . 12.4 mt -68.67 -16.69 63.91 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.763 0.71 . . . . 74.239999999999995 112.519 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -66.2 -17.66 64.86 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.284 -0.885 . . . . 72.420000000000002 111.269 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -107.15 151.6 25.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.012 1.725 . . . . 74.450000000000003 106.547 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.6 m -162.17 141.39 9.5 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.011 1.324 . . . . 75.349999999999994 107.509 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 t -64.08 152.21 41.01 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.923 -0.399 . . . . 73.120000000000005 109.923 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -149.61 162.22 40.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 127.144 2.178 . . . . 75.450000000000003 106.087 165.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 53.58 33.07 15.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.65 1.58 . . . . 73.129999999999995 113.576 158.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 t -56.44 156.63 5.81 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.494 1.918 . . . . 52.140000000000001 112.517 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.61 -154.72 0.27 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.172 1.389 . . . . 54.240000000000002 109.512 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.84 -120.63 0.63 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.067 -1.213 . . . . 34.549999999999997 110.067 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.243 0.713 0 C-N-CA 127.853 2.461 . . . . 65.329999999999998 106.68 174.064 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.446 0 N-CA-C 110.64 -0.984 . . . . 61.420000000000002 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 t -62.18 164.54 6.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.256 1.422 . . . . 52.299999999999997 111.217 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.74 161.2 32.21 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 127.164 2.186 . . . . 71.430000000000007 106.633 170.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.11 173.8 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.291 1.994 . . . . 72.030000000000001 113.158 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.57 147.1 0.98 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.975 1.75 . . . . 61.439999999999998 111.008 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.72 85.77 49.53 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 107.3 -1.37 . . . . 74.019999999999996 107.3 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -69.39 6.92 1.01 Allowed 'Trans proline' 0 CA--C 1.545 1.035 1 C-N-CA 126.734 4.956 . . . . 50.25 114.464 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.87 -114.82 0.09 OUTLIER Glycine 0 C--N 1.335 0.525 0 O-C-N 120.802 -1.186 . . . . 30.030000000000001 111.694 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 109' ' ' PRO . . . 75.27 164.79 0.14 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 129.121 2.968 . . . . 72.310000000000002 111.404 -163.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.36 159.75 11.12 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 124.06 3.173 . . . . 70.340000000000003 110.804 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.4 m -136.45 -173.93 3.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.378 1.071 . . . . 70.239999999999995 110.233 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 33.43 3.49 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.929 2.492 . . . . 62.039999999999999 115.151 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.03 139.36 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.385 0.674 . . . . 65.129999999999995 109.924 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -124.04 140.13 53.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 125.545 1.538 . . . . 73.329999999999998 107.79 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.6 mt -147.3 134.26 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 105.83 -1.915 . . . . 74.409999999999997 105.83 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.04 163.29 40.5 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.645 1.578 . . . . 74.310000000000002 108.237 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -81.97 164.1 21.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.144 0.884 . . . . 72.409999999999997 109.074 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.8 m -138.92 165.54 31.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.774 2.029 . . . . 44.32 106.897 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -64.25 -28.57 64.06 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.695 1.597 . . . . 72.310000000000002 111.631 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.52 17.92 11.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.64 1.576 . . . . 73.109999999999999 111.268 -163.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.38 -141.94 9.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.47 -1.452 . . . . 53.450000000000003 109.47 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.75 163.07 30.62 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.801 1.301 . . . . 42.350000000000001 111.416 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.02 134.76 34.24 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.253 1.821 . . . . 73.109999999999999 108.219 168.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 114.86 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.435 1.494 . . . . 54.539999999999999 110.152 -172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.1 p -135.33 168.81 18.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.654 0.661 . . . . 74.329999999999998 110.953 166.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -148.21 169.47 20.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 130.171 3.388 . . . . 74.209999999999994 107.048 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -110.04 151.72 42.65 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 123.999 0.92 . . . . 71.409999999999997 109.097 172.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.74 164.61 33.28 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.802 2.335 . . . . 64.209999999999994 111.245 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.88 139.83 90.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.888 3.059 . . . . 62.420000000000002 112.679 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.6 t -135.26 16.14 3.46 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.925 . . . . 61.32 113.173 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.91 -45.04 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.236 1.014 . . . . 54.420000000000002 110.345 -171.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 p -144.89 174.16 11.25 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.963 0.905 . . . . 63.350000000000001 109.689 168.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.5 p -50.4 -56.24 12.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.396 1.878 . . . . 42.520000000000003 114.019 -172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.97 176.76 5.53 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.298 1.904 . . . . 63.229999999999997 112.828 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -139.05 93.43 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.606 0.762 . . . . 51.340000000000003 109.222 158.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -86.46 150.95 3.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.264 -1.013 . . . . 74.150000000000006 108.264 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.7 -34.64 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.75 1.22 . . . . 64.219999999999999 111.644 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -160.43 -179.27 7.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.725 -1.213 . . . . 64.420000000000002 107.725 -169.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -136.32 165.48 25.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.306 0.957 . . . . 65.349999999999994 110.413 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 t -145.75 153.57 41.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.041 0.936 . . . . 71.420000000000002 109.368 173.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -132.54 147.9 31.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 125.767 1.627 . . . . 71.129999999999995 107.305 174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -133.0 145.53 50.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.275 -1.379 . . . . 72.319999999999993 107.275 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD21 ' CG2' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -126.28 134.58 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.713 -1.218 . . . . 62.119999999999997 107.713 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.09 131.24 49.91 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 117.75 -1.119 . . . . 63.240000000000002 109.71 176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.3 pt -144.31 -174.09 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.751 -1.203 . . . . 45.030000000000001 107.751 168.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -69.74 13.92 0.12 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.256 1.823 . . . . 71.209999999999994 115.535 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.2 111.46 9.07 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 125.475 1.51 . . . . 73.319999999999993 111.559 -165.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -103.24 114.61 29.03 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.973 1.309 . . . . 74.510000000000005 111.396 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -144.89 158.07 43.93 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.491 1.117 . . . . 73.239999999999995 108.243 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.9 175.18 10.03 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.136 2.174 . . . . 74.230000000000004 109.161 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 t -120.96 -10.55 9.06 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.247 1.819 . . . . 44.200000000000003 111.785 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.49 104.01 1.37 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 108.699 -1.761 . . . . 53.200000000000003 108.699 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 4.5 mm-40 -54.53 162.37 1.73 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.997 1.719 . . . . 71.010000000000005 114.921 -168.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 53' ' ' GLU . 94.6 Cg_endo -70.75 77.8 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.525 1 C-N-CA 127.042 5.161 . . . . 52.5 111.627 177.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? 50.15 38.76 17.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.843 1.257 . . . . 72.319999999999993 110.924 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -90.71 -3.71 57.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.098 0.863 . . . . 64.430000000000007 111.815 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.42 51.0 6.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.967 2.107 . . . . 72.200000000000003 112.145 -170.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 p 43.65 53.89 10.49 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.842 1.657 . . . . 70.409999999999997 112.776 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.28 87.84 1.48 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.5 2.133 . . . . 63.009999999999998 110.347 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 73.72 115.22 0.06 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.268 2.227 . . . . 64.219999999999999 110.029 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.74 162.94 7.92 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.978 -0.749 . . . . 73.140000000000001 108.978 163.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -145.66 168.77 19.89 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.021 -1.049 . . . . 70.030000000000001 112.399 -162.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' SER . . . -129.34 77.53 1.79 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.61 0.764 . . . . 70.310000000000002 111.488 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 62' ' ' LEU . 6.5 m-85 -139.59 129.97 25.48 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.998 0.919 . . . . 74.310000000000002 109.134 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.8 ttp -76.76 151.08 36.14 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.844 1.258 . . . . 54.030000000000001 109.523 169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -79.62 71.39 6.23 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.39 1.876 . . . . 71.340000000000003 112.784 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.56 -32.03 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 118.763 -0.636 . . . . 71.519999999999996 112.63 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -58.92 122.64 14.16 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.34 0.973 . . . . 74.540000000000006 110.545 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.9 t -157.18 40.7 0.31 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.676 0.79 . . . . 73.420000000000002 110.142 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.33 168.6 32.61 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 119.268 0.94 . . . . 54.140000000000001 112.029 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.75 -21.39 6.02 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.734 2.956 . . . . 71.329999999999998 115.438 -165.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.1 m -82.9 143.47 46.29 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 108.315 -0.994 . . . . 73.430000000000007 108.315 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.55 -41.52 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.431 1.42 . . . . 72.319999999999993 109.563 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.9 m -74.7 79.65 2.04 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.564 -1.272 . . . . 51.039999999999999 107.564 161.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.08 171.76 11.33 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.671 -0.643 . . . . 73.120000000000005 110.011 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.13 178.45 6.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.767 0.827 . . . . 74.409999999999997 110.583 167.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.5 t -138.83 146.7 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.952 1.701 . . . . 70.219999999999999 108.247 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -88.41 165.41 14.95 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 129.088 2.955 . . . . 73.439999999999998 112.93 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.4 t -44.98 -47.38 11.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.093 1.357 . . . . 70.129999999999995 111.966 162.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.1 m -56.5 -50.67 71.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.144 0.884 . . . . 72.219999999999999 112.255 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -71.89 -33.88 68.71 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.539 0.736 . . . . 25.140000000000001 110.561 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.68 -39.8 92.7 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.02 0.928 . . . . 64.219999999999999 111.743 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 m -71.66 3.69 3.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 0.817 . . . . 70.340000000000003 113.114 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -117.76 -1.93 11.47 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.975 1.31 . . . . 73.25 111.288 166.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.63 118.57 13.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.205 0.911 . . . . 70.450000000000003 108.735 -172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.12 140.65 56.2 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.542 -0.54 . . . . 74.099999999999994 109.542 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.05 138.78 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.859 -0.793 . . . . 70.049999999999997 108.859 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.0 133.11 49.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.588 0.755 . . . . 65.230000000000004 109.185 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.51 3.48 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.282 1.033 . . . . 72.239999999999995 112.0 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.2 m -65.46 -31.44 72.53 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.496 1.043 . . . . 71.230000000000004 109.589 167.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.86 -69.31 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.825 -0.547 . . . . 65.239999999999995 111.38 -162.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.59 ' HE3' HD22 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -141.95 145.89 38.21 Favored Pre-proline 0 CA--C 1.514 -0.441 0 CA-C-O 118.054 -0.974 . . . . 53.32 109.109 -173.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.49 97.47 0.88 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.343 2.029 . . . . 73.129999999999995 108.437 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.491 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -148.22 162.87 38.6 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.24 2.616 . . . . 74.140000000000001 107.766 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CG2' HD21 ' A' ' 43' ' ' LEU . 64.7 mt -105.02 136.11 40.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.861 -1.163 . . . . 74.010000000000005 107.861 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.13 125.75 53.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.147 0.979 . . . . 74.019999999999996 110.665 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.423 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 95.9 m-85 -109.42 159.95 16.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.672 1.189 . . . . 72.450000000000003 109.775 170.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -127.0 126.95 44.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.188 -2.152 . . . . 64.209999999999994 105.188 164.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.9 mt -120.54 142.53 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.69 -1.596 . . . . 63.25 106.69 171.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 153.31 38.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.435 0.561 . . . . 74.030000000000001 111.56 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.47 131.8 40.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.898 1.279 . . . . 53.43 108.869 163.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -77.83 111.53 13.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.995 -1.854 . . . . 71.439999999999998 105.995 157.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -119.48 175.43 5.84 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.427 0.691 . . . . 73.319999999999993 111.027 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -61.27 -45.99 92.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.428 0.691 . . . . 74.409999999999997 112.295 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -61.84 -27.64 68.92 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.362 0.983 . . . . 74.420000000000002 110.627 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.63 -167.9 29.22 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.375 -1.49 . . . . 65.120000000000005 109.375 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.51 12.03 0.11 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.194 1.924 . . . . 52.130000000000003 116.194 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.4 -160.82 0.57 Allowed Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.817 2.151 . . . . 44.310000000000002 112.11 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.521 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 24.2 Cg_endo -75.2 178.55 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.542 2.161 . . . . 73.439999999999998 109.074 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.42 128.63 48.4 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.334 -0.987 . . . . 62.25 108.334 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.402 ' OG1' ' HB1' ' A' ' 9' ' ' ALA . 97.2 m -76.08 105.47 7.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.773 -1.195 . . . . 74.340000000000003 107.773 169.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -66.56 118.21 9.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.344 -1.724 . . . . 72.010000000000005 106.344 161.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 97' ' ' PHE . 34.9 m -116.54 160.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 O-C-N 121.167 -0.958 . . . . 53.130000000000003 109.165 166.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.77 129.81 52.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.961 0.905 . . . . 71.450000000000003 109.215 168.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -85.37 85.45 7.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.396 -0.964 . . . . 63.140000000000001 108.396 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.59 HD22 ' HE3' ' A' ' 92' ' ' LYS . 66.1 mt -66.06 165.66 13.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.036 -0.727 . . . . 73.049999999999997 109.036 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 75.81 10.92 3.21 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.278 2.231 . . . . 50.539999999999999 113.497 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -57.72 166.79 1.27 Allowed 'General case' 0 C--O 1.246 0.877 0 N-CA-C 113.431 0.9 . . . . 52.549999999999997 113.431 161.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.365 2.8 t -150.25 143.81 25.19 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.273 1.029 . . . . 71.450000000000003 110.928 173.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.8 t -53.37 -61.67 2.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.262 1.825 . . . . 71.230000000000004 107.81 168.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 51.5 42.32 29.3 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.369 1.068 . . . . 63.25 111.07 173.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.04 112.53 1.72 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.388 2.275 . . . . 64.349999999999994 108.027 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.8 p -164.57 174.05 11.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.161 0.984 . . . . 64.120000000000005 109.813 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -126.58 -67.81 0.84 Allowed 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 107.548 -1.278 . . . . 71.420000000000002 107.548 169.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.36 -155.45 16.32 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.834 -1.306 . . . . 23.23 109.834 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--O 1.25 1.114 0 N-CA-C 104.656 -2.35 . . . . 74.239999999999995 104.656 -178.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 CA-C-O 118.333 -1.26 . . . . 53.219999999999999 110.476 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 82.9 m 56.5 89.37 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 75.239999999999995 111.524 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -59.51 165.16 4.36 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 124.069 0.948 . . . . 75.340000000000003 111.675 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.62 87.71 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.324 2.682 . . . . 73.400000000000006 110.873 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.18 154.24 7.41 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 126.059 1.79 . . . . 74.209999999999994 110.006 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.05 146.58 33.92 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 123.395 0.678 . . . . 72.329999999999998 109.212 171.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.13 168.12 22.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.84 2.36 . . . . 62.340000000000003 110.313 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.52 -132.64 11.27 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.703 -1.759 . . . . 71.0 108.703 -170.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 70.11 156.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.321 2.648 . . . . 74.109999999999999 111.841 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -68.97 159.23 54.77 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.894 1.729 . . . . 64.319999999999993 108.955 167.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -136.98 174.21 10.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.57 0.7 . . . . 53.140000000000001 109.853 170.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 50.3 27.28 2.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.094 2.157 . . . . 71.109999999999999 114.899 168.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -56.96 137.97 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.28 . . . . 72.400000000000006 108.699 -171.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -135.85 141.4 44.64 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.492 -1.299 . . . . 53.520000000000003 107.492 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mt -142.92 110.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.111 -1.07 . . . . 63.030000000000001 108.111 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.7 m -106.93 145.3 32.39 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.812 0.845 . . . . 74.219999999999999 109.831 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -82.53 158.86 22.97 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.38 0.672 . . . . 74.319999999999993 109.925 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -143.45 163.42 36.89 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.449 2.299 . . . . 74.400000000000006 109.545 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.97 -13.9 42.26 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.763 2.975 . . . . 63.140000000000001 113.684 172.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 2.47 10.45 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.411 2.284 . . . . 75.319999999999993 111.36 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.86 -127.29 2.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.223 0.92 . . . . 64.030000000000001 112.889 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.09 127.67 17.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.721 1.208 . . . . 62.439999999999998 108.418 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -70.17 98.62 1.37 Allowed 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.52 1.528 . . . . 75.0 108.643 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.99 116.47 23.4 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.457 -1.312 . . . . 71.400000000000006 107.457 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.4 p -136.95 160.24 39.48 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 121.716 -0.615 . . . . 73.439999999999998 109.813 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.87 -178.41 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.192 0.597 . . . . 75.329999999999998 110.137 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 51.8 mt-10 -133.69 158.65 75.02 Favored Pre-proline 0 C--O 1.242 0.706 0 N-CA-C 108.917 -0.771 . . . . 75.209999999999994 108.917 165.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.59 160.64 42.22 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.508 1.472 . . . . 71.430000000000007 109.525 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.58 170.93 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.308 1.339 . . . . 74.129999999999995 111.427 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 t -141.67 70.57 1.34 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 105.091 -2.189 . . . . 71.040000000000006 105.091 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -139.84 -65.39 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.124 0.97 . . . . 73.140000000000001 110.251 172.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -135.09 -173.11 3.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.564 1.074 . . . . 53.439999999999998 110.302 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -26.06 67.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 115.833 1.79 . . . . 63.009999999999998 115.833 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.36 94.67 0.01 OUTLIER Glycine 0 N--CA 1.469 0.839 0 C-N-CA 126.721 2.105 . . . . 43.329999999999998 115.991 167.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -82.23 64.93 7.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.685 1.194 . . . . 71.099999999999994 111.621 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -68.57 147.43 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.58 -0.896 . . . . 73.040000000000006 108.58 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.33 -15.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.312 2.245 . . . . 22.039999999999999 112.1 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -159.19 178.06 10.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.764 1.626 . . . . 72.400000000000006 107.019 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -136.05 168.12 19.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.63 -1.248 . . . . 74.219999999999999 107.63 165.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 42' ' ' TYR . 56.0 m -134.43 141.45 46.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.568 -0.901 . . . . 73.0 108.568 164.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.5 t -136.61 116.98 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.363 -2.458 . . . . 75.200000000000003 104.363 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.479 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 11.2 m-85 -120.63 127.38 52.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.267 -1.012 . . . . 60.329999999999998 108.267 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -115.28 129.37 56.6 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 105.555 -2.017 . . . . 74.340000000000003 105.555 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.32 145.63 33.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 124.021 0.825 . . . . 74.219999999999999 109.367 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -145.23 -179.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 126.169 1.788 . . . . 64.409999999999997 107.903 -177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -71.8 76.3 0.87 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.063 0.545 . . . . 73.109999999999999 111.958 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 82.5 p -158.72 -157.94 0.66 Allowed 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.17 -0.956 . . . . 71.439999999999998 110.252 164.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . 58.5 m -140.99 5.34 1.92 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.58 1.952 . . . . 52.409999999999997 113.509 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -62.89 152.1 37.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.935 0.894 . . . . 75.319999999999993 110.071 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 49.52 32.08 4.55 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.878 2.071 . . . . 74.310000000000002 114.219 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.5 t -73.89 85.61 1.74 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.104 1.761 . . . . 72.319999999999993 108.666 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.88 115.26 0.32 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.432 -0.667 . . . . 74.219999999999999 111.432 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 12.8 pt-20 -138.86 164.15 41.5 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.028 1.331 . . . . 71.310000000000002 108.732 173.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 53' ' ' GLU . 93.2 Cg_endo -73.96 -164.49 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.272 3.315 . . . . 75.129999999999995 112.346 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 tttm 66.68 12.59 8.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.68 1.592 . . . . 61.039999999999999 111.455 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 m 44.92 44.99 8.39 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.18 1.392 . . . . 55.43 111.415 -165.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -110.98 37.74 2.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.849 0.859 . . . . 73.420000000000002 112.631 -170.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.1 p -100.69 85.12 0.52 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.745 1.618 . . . . 72.409999999999997 109.802 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.31 122.87 9.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.001 2.467 . . . . 55.43 110.06 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.44 43.05 5.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.54 1.936 . . . . 54.439999999999998 113.405 161.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.301 10.6 pt20 43.85 74.57 0.12 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.826 2.05 . . . . 72.219999999999999 112.19 -169.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -44.52 162.59 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.785 -1.552 . . . . 74.409999999999997 111.336 153.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 48' ' ' SER . . . -147.63 148.3 30.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.759 -1.941 . . . . 62.140000000000001 105.759 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 23.0 m-85 -143.32 151.14 40.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.691 0.678 . . . . 72.430000000000007 110.67 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -112.22 4.95 18.14 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.6 1.16 . . . . 74.319999999999993 113.506 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 49.93 78.2 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.842 1.657 . . . . 73.0 111.317 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.0 m -77.28 -5.82 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 73.400000000000006 112.751 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -56.24 112.69 1.3 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.974 1.31 . . . . 74.420000000000002 110.103 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.3 p -158.78 31.41 0.22 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.345 1.458 . . . . 75.420000000000002 110.164 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -125.75 75.01 0.41 Allowed Glycine 0 CA--C 1.521 0.469 0 C-N-CA 124.765 1.174 . . . . 74.209999999999994 111.29 -170.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -67.33 -17.5 49.6 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.144 1.896 . . . . 61.340000000000003 111.721 165.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -56.58 144.35 64.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.87 1.268 . . . . 61.310000000000002 109.515 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.79 -21.02 38.92 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.976 1.784 . . . . 43.210000000000001 111.85 -174.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.63 145.85 33.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 128.461 2.704 . . . . 63.32 104.183 163.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -137.7 154.07 49.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.626 1.103 . . . . 72.200000000000003 110.242 175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.07 163.91 27.28 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.513 1.149 . . . . 74.439999999999998 109.585 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.6 t -139.33 128.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 104.383 -2.451 . . . . 73.430000000000007 104.383 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -65.77 139.2 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.944 0.778 . . . . 62.310000000000002 109.502 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -30.27 63.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.843 1.657 . . . . 75.340000000000003 111.779 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.4 p -59.18 -14.61 11.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 55.399999999999999 113.595 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 t -88.07 -48.14 7.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.026 0.83 . . . . 64.140000000000001 108.947 168.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.38 -31.71 72.97 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.009 0.822 . . . . 63.119999999999997 112.151 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 t -44.89 -59.96 2.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.117 2.167 . . . . 62.020000000000003 108.386 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -81.35 0.29 37.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.934 1.294 . . . . 62.439999999999998 111.929 -165.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 153.07 44.48 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.768 0.827 . . . . 72.430000000000007 110.884 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 132.5 36.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.093 -1.077 . . . . 75.0 108.093 165.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -84.06 145.44 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 124.431 1.092 . . . . 75.120000000000005 108.055 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -70.54 132.28 45.27 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.829 0.852 . . . . 73.340000000000003 109.181 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.55 23.72 11.03 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.918 1.287 . . . . 75.340000000000003 109.995 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.53 -38.06 2.82 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.553 1.541 . . . . 53.100000000000001 111.892 -162.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.2 p -136.82 -52.89 0.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.447 1.099 . . . . 72.340000000000003 112.462 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -148.02 150.51 35.67 Favored Pre-proline 0 N--CA 1.468 0.456 0 CA-C-N 120.452 1.478 . . . . 71.239999999999995 110.84 158.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.51 95.93 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.816 3.01 . . . . 73.109999999999999 109.795 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -155.48 166.39 33.68 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 126.054 1.742 . . . . 61.039999999999999 110.6 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 43.1 mt -86.25 118.98 33.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.841 1.257 . . . . 63.329999999999998 107.735 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.56 145.76 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.52 -0.918 . . . . 73.040000000000006 108.52 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -131.92 125.45 31.7 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.682 -1.599 . . . . 63.329999999999998 106.682 162.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.85 126.36 32.88 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.901 -1.888 . . . . 73.200000000000003 105.901 164.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.6 mt -133.22 136.02 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.557 -1.646 . . . . 64.299999999999997 106.557 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 158.58 44.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.681 1.192 . . . . 75.319999999999993 108.709 165.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.82 101.38 9.23 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.814 1.246 . . . . 74.109999999999999 107.818 -171.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.23 111.03 1.81 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.958 1.703 . . . . 64.299999999999997 107.925 -170.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -136.19 179.11 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.809 1.643 . . . . 44.140000000000001 111.378 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -48.89 -33.11 10.08 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.833 1.653 . . . . 63.119999999999997 114.002 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -60.75 -55.31 34.69 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.379 0.991 . . . . 73.319999999999993 111.247 175.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.68 174.55 19.32 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.131 -0.788 . . . . 64.400000000000006 111.131 -162.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -73.26 81.84 1.35 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.882 1.273 . . . . 75.239999999999995 109.639 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.08 -63.94 0.87 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.263 -1.299 . . . . 41.520000000000003 111.522 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.39 155.96 28.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.158 2.572 . . . . 32.240000000000002 109.131 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.58 103.19 1.21 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.96 -0.756 . . . . 63.109999999999999 108.96 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.6 m -71.82 146.81 47.77 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.459 -0.571 . . . . 73.040000000000006 109.459 -173.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.86 83.67 1.8 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.234 1.013 . . . . 74.239999999999995 108.351 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.14 152.52 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 107.004 -1.48 . . . . 51.539999999999999 107.004 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 148.74 50.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.44 1.496 . . . . 75.319999999999993 108.284 174.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -136.61 111.58 8.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.1 1.36 . . . . 75.040000000000006 110.113 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.642 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -86.29 -177.55 6.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.711 2.004 . . . . 72.129999999999995 110.687 -166.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 76.46 -2.67 2.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.025 2.53 . . . . 64.019999999999996 113.572 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.58 90.59 1.78 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.111 0.964 . . . . 75.420000000000002 110.063 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.3 p -140.77 94.08 2.68 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.907 1.283 . . . . 54.420000000000002 108.787 167.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.5 m -75.12 77.89 2.27 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.246 -0.909 . . . . 60.140000000000001 109.3 164.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -144.91 69.79 1.26 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.065 -0.717 . . . . 63.130000000000003 109.065 166.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t0 61.2 177.93 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.858 1.263 . . . . 71.340000000000003 111.401 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 t 65.24 122.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.38 1.872 . . . . 72.409999999999997 108.748 -155.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 80.9 p -147.89 162.51 39.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.227 -1.027 . . . . 44.439999999999998 108.227 153.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.84 165.14 52.23 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.001 -0.439 . . . . 35.149999999999999 112.001 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.312 -1.328 . . . . 62.020000000000003 110.813 161.78 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.692 0 N-CA-C 110.673 -0.971 . . . . 73.040000000000006 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 t -142.89 169.15 18.11 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.774 1.23 . . . . 70.140000000000001 108.63 -175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 50.26 73.22 1.02 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 127.249 2.22 . . . . 63.240000000000002 112.197 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.75 135.33 27.84 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.041 1.827 . . . . 62.020000000000003 109.709 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.88 -112.48 3.19 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.622 1.106 . . . . 41.130000000000003 111.171 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.07 165.34 18.61 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 127.223 2.209 . . . . 73.340000000000003 108.408 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -62.68 7.39 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.073 1 C-N-CA 126.309 4.673 . . . . 72.430000000000007 115.463 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.37 -147.06 13.15 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.241 -1.537 . . . . 53.5 111.294 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.54 80.85 0.27 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.697 1.999 . . . . 61.439999999999998 112.881 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -59.88 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.165 . . . . 63.020000000000003 110.181 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.0 m -132.25 -177.45 4.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.189 1.396 . . . . 73.319999999999993 109.678 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.34 11.74 2.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.716 2.006 . . . . 72.010000000000005 114.688 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -56.95 131.98 20.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.665 1.586 . . . . 53.310000000000002 110.846 -166.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -126.73 163.74 22.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.352 1.061 . . . . 51.409999999999997 110.408 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.45 HG23 ' CD2' ' A' ' 24' ' ' LEU . 4.2 mp -140.13 158.1 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 126.851 2.06 . . . . 54.539999999999999 106.459 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -144.44 133.91 23.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.236 2.214 . . . . 74.329999999999998 107.353 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -64.81 151.65 44.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.622 -0.881 . . . . 62.140000000000001 108.622 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.56 157.51 44.6 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 126.518 1.927 . . . . 52.439999999999998 106.001 176.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.24 -20.12 32.97 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.422 2.081 . . . . 70.310000000000002 111.639 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -114.93 13.47 17.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 129.0 2.92 . . . . 74.219999999999999 111.317 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.66 -163.54 30.02 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 118.878 0.763 . . . . 51.329999999999998 112.164 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -116.91 121.18 40.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 120.017 1.909 . . . . 71.329999999999998 106.562 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -58.62 124.47 19.77 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 107.385 -1.339 . . . . 72.329999999999998 107.385 165.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 15' ' ' ILE . 11.8 mt -120.56 160.79 22.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.321 0.964 . . . . 74.230000000000004 109.08 172.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.2 t -155.47 165.2 37.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.85 0.75 . . . . 73.340000000000003 110.078 166.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.516 ' CE3' HD13 ' A' ' 99' ' ' ILE . 0.5 OUTLIER -151.43 172.35 16.1 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 129.138 2.975 . . . . 72.420000000000002 108.236 177.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -129.3 161.74 56.77 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 124.454 1.102 . . . . 73.319999999999993 111.347 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.19 161.91 38.18 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.605 2.87 . . . . 70.420000000000002 113.392 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.39 143.11 51.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.35 2.033 . . . . 72.430000000000007 110.225 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -133.5 61.81 1.67 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.252 -1.758 . . . . 61.200000000000003 106.252 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -133.29 -68.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.678 -1.23 . . . . 73.439999999999998 107.678 174.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.4 ' H ' HG23 ' A' ' 31' ' ' VAL . 64.6 p -130.22 170.92 13.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.605 1.562 . . . . 62.200000000000003 107.622 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -65.01 -84.9 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.433 1.093 . . . . 71.420000000000002 110.414 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 144.48 2.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 120.665 -1.272 . . . . 71.400000000000006 112.18 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -100.47 83.17 2.57 Favored 'General case' 0 CA--C 1.508 -0.65 0 O-C-N 121.776 -0.838 . . . . 74.319999999999993 108.747 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.85 143.25 14.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.635 -1.246 . . . . 62.030000000000001 107.635 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.87 -23.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 125.331 1.452 . . . . 74.230000000000004 111.367 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -156.66 -170.16 3.23 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.547 1.067 . . . . 65.030000000000001 109.95 171.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.23 175.28 9.25 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.051 1.34 . . . . 74.209999999999994 109.383 163.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -152.36 156.61 39.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.11 1.364 . . . . 64.230000000000004 109.434 170.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.4 t -148.0 121.61 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.949 -1.871 . . . . 44.509999999999998 105.949 -167.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -131.03 140.6 50.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.003 1.321 . . . . 74.400000000000006 109.273 -171.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 125.98 46.75 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.424 -1.324 . . . . 65.010000000000005 107.424 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.32 116.82 15.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.581 1.552 . . . . 44.109999999999999 110.175 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.05 -176.61 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.819 2.048 . . . . 63.119999999999997 108.88 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -60.55 153.12 24.31 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.87 -0.519 . . . . 54.229999999999997 112.145 171.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.9 m 54.59 74.19 0.36 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.314 1.446 . . . . 73.129999999999995 112.617 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -143.03 148.7 37.17 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.773 1.629 . . . . 53.299999999999997 107.138 162.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.73 6.93 13.34 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.098 0.959 . . . . 72.299999999999997 113.203 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.82 160.51 35.41 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.553 1.141 . . . . 43.299999999999997 110.361 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m 177.78 100.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.893 2.077 . . . . 62.109999999999999 109.975 172.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.95 -120.95 0.54 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.24 -1.544 . . . . 71.010000000000005 109.24 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 35.1 mt-10 -140.81 162.02 50.98 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.976 1.388 . . . . 71.310000000000002 110.843 172.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 53' ' ' GLU . 54.0 Cg_endo -65.02 127.23 18.02 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.839 3.693 . . . . 71.239999999999995 110.313 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 mttp 59.95 19.72 8.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.377 . . . . 65.420000000000002 113.261 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -97.28 -86.62 0.33 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.732 1.151 . . . . 50.439999999999998 109.158 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.9 m -135.67 15.89 3.37 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 120.719 1.599 . . . . 73.310000000000002 112.639 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -127.83 59.84 41.71 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.201 -0.937 . . . . 74.019999999999996 109.52 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.2 87.15 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.842 1.695 . . . . 65.329999999999998 109.488 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -157.71 14.77 0.23 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.91 1.078 . . . . 62.409999999999997 113.91 162.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 57.9 179.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.717 2.007 . . . . 74.409999999999997 111.862 -155.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 165.77 20.56 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 125.388 1.475 . . . . 52.32 107.48 -169.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.1 112.63 13.61 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.52 -0.919 . . . . 72.140000000000001 108.52 175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -142.19 150.08 40.56 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.595 1.158 . . . . 70.209999999999994 108.391 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.51 4.9 6.64 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.109 1.522 . . . . 73.030000000000001 115.109 -167.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 43.96 55.39 5.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.464 1.906 . . . . 64.239999999999995 113.172 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.76 -20.9 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.862 1.265 . . . . 74.430000000000007 112.671 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -58.76 120.17 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.022 0.828 . . . . 73.129999999999995 110.596 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -152.24 83.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.385 1.874 . . . . 63.0 105.969 161.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -149.91 159.85 28.26 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.252 -0.749 . . . . 73.010000000000005 111.474 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.11 -55.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.278 2.652 . . . . 73.099999999999994 111.227 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.54 166.59 14.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.159 2.184 . . . . 70.230000000000004 110.509 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.46 169.05 23.23 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.807 1.671 . . . . 70.439999999999998 110.848 168.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 39.11 9.23 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.633 1.573 . . . . 72.430000000000007 112.145 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.2 m -85.5 175.71 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.337 1.065 . . . . 62.340000000000003 110.95 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 168.09 16.91 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.625 1.57 . . . . 74.310000000000002 109.333 165.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.1 p -130.64 144.2 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.236 1.414 . . . . 62.310000000000002 107.628 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -66.42 147.79 52.8 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.165 0.586 . . . . 50.140000000000001 112.285 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -48.47 81.09 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.962 1.705 . . . . 64.120000000000005 110.06 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.0 p -44.91 -48.58 11.25 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.573 1.949 . . . . 52.140000000000001 111.573 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.4 m -67.62 -42.16 82.81 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.343 -0.844 . . . . 73.010000000000005 111.214 -177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.49 -31.46 72.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.168 0.987 . . . . 73.310000000000002 111.407 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -64.39 -0.73 1.39 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.597 1.559 . . . . 70.329999999999998 114.283 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -120.62 -6.23 9.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.274 1.397 . . . . 70.420000000000002 111.679 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.47 137.75 57.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.788 1.235 . . . . 71.340000000000003 111.59 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 161.1 30.39 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.647 -0.872 . . . . 70.439999999999998 108.647 168.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.56 143.52 35.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 124.238 1.015 . . . . 70.120000000000005 108.447 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.98 82.45 0.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.768 1.627 . . . . 73.209999999999994 111.365 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -72.68 -18.35 61.56 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.637 -1.29 . . . . 51.149999999999999 111.21 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -17.81 64.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.224 1.41 . . . . 64.420000000000002 113.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.68 -75.02 0.17 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.433 1.015 . . . . 73.5 110.56 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.25 144.3 27.84 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 117.81 -1.091 . . . . 65.420000000000002 108.395 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.92 100.35 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.907 1.738 . . . . 74.209999999999994 109.8 -170.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.3 157.71 44.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.349 1.86 . . . . 32.350000000000001 109.085 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.1 mt -88.38 132.07 34.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.5 1.12 . . . . 73.0 109.168 169.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.6 136.8 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.777 1.275 . . . . 62.229999999999997 110.388 165.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -119.28 116.71 26.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 112.715 -2.039 . . . . 71.200000000000003 107.568 165.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -81.21 128.79 34.17 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 106.368 -1.716 . . . . 74.219999999999999 106.368 162.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.516 HD13 ' CE3' ' A' ' 26' ' ' TRP . 16.4 mt -133.62 151.7 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.684 -1.969 . . . . 65.310000000000002 105.684 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.49 151.91 25.0 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.522 0.729 . . . . 62.310000000000002 109.721 165.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.44 117.26 13.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.602 1.161 . . . . 62.210000000000001 109.97 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -75.95 99.8 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.643 -1.614 . . . . 73.310000000000002 106.643 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.99 172.98 6.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.688 1.595 . . . . 73.420000000000002 109.595 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -25.99 63.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 114.474 1.287 . . . . 62.439999999999998 114.474 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.55 25.45 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.541 -0.911 . . . . 70.010000000000005 108.541 174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.36 167.04 12.89 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.913 -0.875 . . . . 45.310000000000002 110.913 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -61.6 117.94 6.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 74.019999999999996 106.477 160.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.21 -95.88 2.4 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.455 -1.858 . . . . 22.140000000000001 108.455 173.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.91 147.75 56.13 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.271 1.981 . . . . 64.040000000000006 110.673 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.05 110.48 10.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.601 1.56 . . . . 53.340000000000003 108.635 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.1 m -65.03 123.79 20.39 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.358 -0.978 . . . . 74.140000000000001 108.358 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -97.45 89.44 4.7 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.985 -1.487 . . . . 65.340000000000003 106.985 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.87 171.44 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 120.633 -0.427 . . . . 71.109999999999999 110.168 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.39 123.86 19.52 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.504 1.121 . . . . 71.319999999999993 108.161 172.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -82.48 87.91 6.63 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.847 1.259 . . . . 72.120000000000005 109.106 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.2 mt -73.93 0.87 12.1 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.319 1.229 . . . . 72.439999999999998 114.319 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -115.12 38.4 3.2 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.423 1.01 . . . . 71.219999999999999 108.765 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.48 107.31 0.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 106.612 -1.625 . . . . 50.539999999999999 106.612 164.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.5 p -131.68 145.63 51.75 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.715 -0.846 . . . . 63.240000000000002 108.715 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 t 56.38 -177.43 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.477 1.111 . . . . 74.5 111.763 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -148.87 8.04 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 120.974 -1.078 . . . . 74.019999999999996 111.171 153.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -63.88 156.17 28.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.867 1.267 . . . . 71.040000000000006 108.788 172.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 t -144.23 -36.91 0.32 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.516 1.526 . . . . 74.230000000000004 111.391 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m 56.0 -7.05 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 115.334 1.605 . . . . 62.299999999999997 115.334 -165.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.28 163.12 51.72 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 120.827 1.649 . . . . 72.109999999999999 110.803 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.245 0.847 0 CA-C-O 116.357 -1.782 . . . . 31.02 108.029 151.34 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.48 0 N-CA-C 111.305 -0.718 . . . . 62.0 111.305 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.74 49.27 19.1 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.036 1.734 . . . . 55.409999999999997 112.712 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mp -68.38 145.8 97.52 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.97 -1.493 . . . . 60.210000000000001 106.97 161.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.53 165.74 30.99 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.167 2.578 . . . . 72.310000000000002 113.705 -163.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.97 153.94 3.88 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.973 1.749 . . . . 24.420000000000002 111.434 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -108.35 86.95 3.71 Favored Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 126.968 2.107 . . . . 74.340000000000003 106.998 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.66 67.34 3.79 Favored 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 126.079 4.519 . . . . 75.310000000000002 111.865 -168.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.4 166.35 35.86 Favored Glycine 0 C--N 1.332 0.36 0 O-C-N 121.097 -1.002 . . . . 55.240000000000002 111.96 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.29 161.45 7.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.977 2.511 . . . . 35.130000000000003 106.873 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.79 159.49 52.48 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.702 2.268 . . . . 62.25 112.139 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.5 m -127.27 -178.5 4.47 Favored 'General case' 0 C--N 1.343 0.321 0 O-C-N 121.45 -0.781 . . . . 54.310000000000002 110.664 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 55.11 23.16 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.916 2.487 . . . . 64.439999999999998 114.652 171.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.79 126.83 21.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 118.721 0.691 . . . . 75.540000000000006 110.734 -167.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -120.3 143.88 48.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 125.01 1.324 . . . . 63.140000000000001 107.81 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.2 mt -144.26 126.31 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.49 -2.041 . . . . 75.409999999999997 105.49 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.7 m -143.61 149.77 37.81 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.023 1.329 . . . . 61.219999999999999 110.291 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -84.52 153.71 23.13 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.045 0.938 . . . . 72.530000000000001 110.602 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 166.07 15.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 128.745 2.818 . . . . 54.420000000000002 107.119 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.59 -27.73 15.09 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.404 2.069 . . . . 60.530000000000001 113.693 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.66 -11.52 51.06 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.373 1.069 . . . . 72.430000000000007 112.164 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.67 -163.31 29.02 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.952 -1.259 . . . . 73.409999999999997 109.952 -161.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.62 30.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.061 0.945 . . . . 73.129999999999995 111.092 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -78.84 134.6 36.94 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.846 -1.168 . . . . 75.329999999999998 107.846 157.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.72 137.49 45.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.159 1.384 . . . . 53.350000000000001 107.761 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.7 p -142.92 167.25 22.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.445 1.02 . . . . 73.120000000000005 109.856 167.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.441 ' CE3' HD13 ' A' ' 99' ' ' ILE . 4.0 p90 -160.51 178.4 9.57 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.822 2.049 . . . . 63.450000000000003 109.825 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.6 158.25 66.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 117.925 -1.036 . . . . 74.030000000000001 111.998 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.42 170.82 18.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.04 3.16 . . . . 73.209999999999994 113.85 -168.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.68 166.49 17.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.754 2.303 . . . . 75.200000000000003 111.82 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 t -140.46 21.49 2.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.469 1.508 . . . . 74.400000000000006 110.128 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.72 -55.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.638 1.175 . . . . 73.319999999999993 108.461 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.2 p -124.46 103.46 8.19 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.511 1.124 . . . . 75.230000000000004 109.368 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -64.22 -73.41 0.12 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.995 0.918 . . . . 43.409999999999997 110.899 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.03 1.84 75.57 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 117.587 -1.674 . . . . 43.539999999999999 115.14 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt 65.26 83.58 0.17 Allowed 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 132.479 4.311 . . . . 74.010000000000005 111.113 -172.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.62 136.5 22.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 107.205 -1.406 . . . . 53.200000000000003 107.205 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.7 -17.66 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 126.071 1.748 . . . . 72.409999999999997 111.142 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 3.2 tp10 -164.58 -164.91 0.87 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.048 1.339 . . . . 75.230000000000004 109.237 172.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.418 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 1.1 m-85 -142.25 172.84 12.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.975 1.71 . . . . 73.310000000000002 110.527 171.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.3 p -138.41 167.49 21.77 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.526 1.131 . . . . 75.230000000000004 110.744 168.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 t -146.62 124.74 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 103.537 -2.764 . . . . 73.439999999999998 103.537 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.03 136.12 50.81 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.501 -1.296 . . . . 75.040000000000006 107.501 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.2 tp -123.74 120.84 33.85 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.278 1.831 . . . . 74.129999999999995 107.278 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.55 145.94 55.46 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.886 -0.783 . . . . 72.109999999999999 108.886 170.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 45' ' ' ILE . 0.1 OUTLIER -137.97 -178.33 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.647 1.979 . . . . 74.310000000000002 107.845 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -58.96 136.09 57.8 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.427 -0.796 . . . . 65.439999999999998 109.709 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m 70.58 166.69 0.29 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.921 2.089 . . . . 50.25 113.484 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 p -134.06 116.22 15.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.426 1.49 . . . . 72.439999999999998 108.853 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.1 70.21 0.92 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.998 1.319 . . . . 70.230000000000004 108.84 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.41 156.48 32.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.686 1.194 . . . . 64.450000000000003 110.211 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.61 124.1 11.71 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 104.791 -2.3 . . . . 54.340000000000003 104.791 165.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.45 121.48 0.67 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 107.291 -2.324 . . . . 43.149999999999999 107.291 -174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -143.53 164.5 30.33 Favored Pre-proline 0 C--O 1.241 0.638 0 C-N-CA 125.14 1.376 . . . . 74.239999999999995 111.102 -167.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -51.1 164.76 0.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.613 2.876 . . . . 54.32 112.965 165.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -83.91 25.97 0.76 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.239 1.016 . . . . 54.329999999999998 110.928 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.1 m -93.29 -31.36 14.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 117.702 -1.142 . . . . 73.040000000000006 112.558 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.67 85.83 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.235 1.414 . . . . 41.409999999999997 109.245 -170.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -130.72 144.39 53.23 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.47 0.708 . . . . 74.040000000000006 109.376 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 84.92 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.678 2.919 . . . . 63.420000000000002 111.182 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.15 83.98 1.38 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.106 1.763 . . . . 71.329999999999998 108.124 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.24 102.17 14.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.216 -1.402 . . . . 74.140000000000001 107.216 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.67 155.57 38.98 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.317 -1.734 . . . . 65.420000000000002 106.317 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.3 109.06 5.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.341 -1.355 . . . . 73.120000000000005 107.341 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -133.49 154.43 50.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.186 1.395 . . . . 74.109999999999999 107.286 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.6 ttp -72.44 117.31 13.95 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.282 -1.377 . . . . 71.230000000000004 107.282 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -70.26 80.2 0.53 Allowed 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 107.407 -1.331 . . . . 70.140000000000001 107.407 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.6 -18.83 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.816 0.847 . . . . 43.539999999999999 111.717 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -57.47 105.03 0.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.471 1.108 . . . . 64.319999999999993 110.65 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.3 m -140.24 99.21 3.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.776 -1.935 . . . . 75.25 105.776 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.11 162.12 28.79 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.404 -1.078 . . . . 63.340000000000003 110.404 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 -15.3 17.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.388 2.725 . . . . 61.210000000000001 113.09 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 m -136.46 165.98 31.26 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.702 1.601 . . . . 75.450000000000003 110.439 -169.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -58.48 175.35 0.56 Allowed 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.603 2.869 . . . . 75.420000000000002 112.932 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.8 m 56.3 43.21 26.78 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.995 1.718 . . . . 72.219999999999999 112.303 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 99.5 m -65.89 123.3 19.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 74.329999999999998 109.522 170.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.58 171.73 1.88 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.99 0.916 . . . . 64.230000000000004 111.465 167.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.7 141.17 39.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.467 -1.309 . . . . 75.25 107.467 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -78.02 162.66 26.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.482 1.113 . . . . 75.420000000000002 112.483 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -31.71 71.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.738 1.615 . . . . 71.530000000000001 113.489 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -64.99 -45.16 86.79 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 120.902 -1.123 . . . . 64.510000000000005 112.307 177.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -63.69 -38.19 90.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.859 -0.591 . . . . 64.530000000000001 109.536 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.383 0.673 . . . . 60.140000000000001 112.086 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -67.42 -44.97 77.46 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.104 1.32 . . . . 55.020000000000003 109.666 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -73.87 -18.76 60.88 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 118.601 -0.714 . . . . 52.049999999999997 112.863 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.83 133.98 31.37 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.7 1.6 . . . . 53.329999999999998 112.165 -172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -70.81 127.14 31.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.156 -1.424 . . . . 64.319999999999993 107.156 174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.61 125.33 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.546 -2.02 . . . . 75.439999999999998 105.546 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -58.63 127.17 30.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.84 -0.8 . . . . 75.150000000000006 108.84 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -114.83 9.84 16.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.918 0.487 . . . . 75.530000000000001 110.842 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.0 m -89.79 -24.04 21.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 74.209999999999994 111.114 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -142.6 -74.75 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.328 1.051 . . . . 74.349999999999994 109.828 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.01 146.29 60.81 Favored Pre-proline 0 CA--C 1.513 -0.45 0 C-N-CA 126.541 1.937 . . . . 75.409999999999997 109.134 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.23 84.01 1.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 123.166 2.577 . . . . 73.510000000000005 106.581 169.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -138.86 162.3 35.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.254 2.621 . . . . 63.109999999999999 110.678 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG13 ' HG3' ' A' ' 118' ' ' GLU . 50.4 mt -81.03 148.42 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 108.471 -0.937 . . . . 73.319999999999993 108.471 168.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.5 mm -109.07 139.61 31.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 C-N-CA 124.785 1.234 . . . . 71.209999999999994 108.919 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.02 138.28 54.49 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.671 -1.233 . . . . 75.549999999999997 107.671 168.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -94.83 134.47 37.42 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.22 -1.4 . . . . 75.150000000000006 107.22 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.441 HD13 ' CE3' ' A' ' 26' ' ' TRP . 13.8 mt -127.3 134.95 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.458 -2.053 . . . . 75.010000000000005 105.458 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.46 153.45 46.27 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.961 0.904 . . . . 60.210000000000001 109.098 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.04 135.22 44.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.348 0.659 . . . . 72.140000000000001 109.687 173.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.4 HH11 ' CB ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -85.89 79.92 9.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 104.607 -2.368 . . . . 62.219999999999999 104.607 167.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.04 161.88 13.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.114 0.966 . . . . 73.409999999999997 109.387 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.31 -22.46 66.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.814 1.245 . . . . 75.129999999999995 112.133 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -65.38 -14.42 60.82 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.338 1.236 . . . . 53.310000000000002 114.338 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.75 177.34 28.27 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.696 1.617 . . . . 54.43 110.81 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.93 30.58 1.05 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.56 1.544 . . . . 63.119999999999997 114.421 -165.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.97 -77.05 0.16 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.497 1.046 . . . . 71.120000000000005 114.27 -159.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -89.17 156.1 5.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.578 2.185 . . . . 71.209999999999994 110.629 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.87 156.72 46.68 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.2 1.0 . . . . 62.32 109.188 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.404 HG22 HG13 ' A' ' 113' ' ' VAL . 87.4 m -82.11 123.64 29.14 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.738 -1.949 . . . . 73.140000000000001 105.738 157.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -83.98 119.34 24.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.359 -2.089 . . . . 72.319999999999993 105.359 154.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 111' ' ' THR . 22.1 m -110.51 173.98 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 123.674 0.79 . . . . 71.319999999999993 109.413 165.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.4 156.41 45.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.85 1.66 . . . . 74.549999999999997 109.3 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -139.44 109.64 6.48 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 125.77 1.628 . . . . 75.209999999999994 111.366 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.906 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -96.54 160.57 14.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.328 2.251 . . . . 63.439999999999998 107.872 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 63.06 14.78 7.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.97 1.308 . . . . 73.150000000000006 111.493 -168.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HG3' HG13 ' A' ' 95' ' ' ILE . 2.2 pm0 -62.2 -25.05 67.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.893 2.077 . . . . 73.549999999999997 112.391 162.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.7 119.78 7.23 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.499 1.92 . . . . 53.009999999999998 109.963 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.3 t -159.76 178.84 9.39 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.669 1.987 . . . . 63.450000000000003 106.742 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.02 173.89 11.22 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.091 1.356 . . . . 72.239999999999995 110.379 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 t70 58.09 78.69 0.23 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.469 1.908 . . . . 54.310000000000002 109.667 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.75 106.78 19.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.726 -1.125 . . . . 75.420000000000002 111.59 -161.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t -62.01 173.09 1.16 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.278 0.631 . . . . 74.519999999999996 110.016 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 131.35 -156.39 21.8 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 121.387 -0.82 . . . . 75.540000000000006 111.893 171.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.45 ' H ' ' HB3' ' A' ' 80' ' ' SER . 54.9 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.092 2.557 . . . . 53.409999999999997 109.705 -168.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 108.247 -1.941 . . . . 75.409999999999997 108.247 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.7 t -143.32 144.48 32.12 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.25 -2.129 . . . . 72.239999999999995 105.25 169.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.24 63.75 44.12 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.969 -1.122 . . . . 75.510000000000005 107.969 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -81.13 5.45 6.23 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.93 3.086 . . . . 55.439999999999998 112.94 -170.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.66 167.45 17.2 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 127.208 2.337 . . . . 75.209999999999994 107.863 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.99 89.8 0.15 Allowed Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 127.036 2.134 . . . . 64.209999999999994 112.541 -176.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -60.3 165.33 11.11 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 CA-C-N 121.333 1.512 . . . . 71.109999999999999 111.411 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.45 -126.59 7.0 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.698 1.618 . . . . 52.350000000000001 109.657 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.463 ' HB2' ' HG2' ' A' ' 109' ' ' PRO . . . 63.81 151.81 0.11 Allowed Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 129.215 3.006 . . . . 53.32 114.376 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HG3' HG22 ' A' ' 99' ' ' ILE . 59.3 Cg_endo -68.66 155.28 69.38 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 123.652 2.902 . . . . 71.140000000000001 111.036 -177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -134.69 -179.47 5.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.699 1.6 . . . . 70.540000000000006 110.208 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 51.4 36.9 17.7 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.087 1.355 . . . . 73.510000000000005 112.07 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -75.63 134.17 29.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.286 -1.005 . . . . 44.030000000000001 108.286 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -131.05 155.53 46.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.452 1.101 . . . . 74.400000000000006 109.553 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 mt -149.06 139.3 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 105.499 -2.038 . . . . 61.100000000000001 105.499 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -139.74 147.6 41.09 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.723 1.609 . . . . 71.530000000000001 109.559 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -79.24 143.31 35.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.37 -1.345 . . . . 73.409999999999997 107.37 170.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 p -139.03 166.75 22.59 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 126.701 2.0 . . . . 72.019999999999996 108.022 173.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -56.53 -25.1 56.88 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.619 2.213 . . . . 72.010000000000005 113.355 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -87.58 -20.76 25.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.574 1.079 . . . . 65.310000000000002 111.558 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.11 -163.78 24.25 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.477 -1.049 . . . . 12.550000000000001 110.477 -159.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.65 135.54 36.0 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.884 0.874 . . . . 73.140000000000001 112.093 -166.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -84.58 86.58 7.29 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.941 2.096 . . . . 71.329999999999998 110.047 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.85 131.78 35.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.611 0.764 . . . . 72.140000000000001 110.247 176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -145.85 152.75 39.99 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.871 1.269 . . . . 63.420000000000002 109.294 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -151.25 179.41 8.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.581 1.553 . . . . 74.439999999999998 110.885 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -65.35 160.8 55.83 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 112.618 0.599 . . . . 73.099999999999994 112.618 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.61 156.21 66.31 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.211 1.941 . . . . 63.399999999999999 109.13 156.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.95 95.58 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.024 2.483 . . . . 73.099999999999994 110.53 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.8 m -140.24 22.28 2.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.63 0.604 . . . . 71.140000000000001 112.63 -165.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.9 t -99.2 -50.96 10.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 O-C-N 121.742 -0.599 . . . . 71.540000000000006 110.158 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.5 p -131.24 164.31 25.86 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.44 1.096 . . . . 74.219999999999999 110.118 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -77.64 40.4 0.3 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.237 1.415 . . . . 71.400000000000006 111.996 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.12 132.63 15.37 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.516 -2.234 . . . . 74.109999999999999 107.516 169.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -76.86 79.85 3.44 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.681 -1.229 . . . . 74.510000000000005 107.681 171.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.65 146.18 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.485 -1.302 . . . . 64.510000000000005 107.485 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 pt -141.72 -17.49 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.119 2.168 . . . . 74.209999999999994 111.088 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -160.47 -168.79 2.24 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.59 1.086 . . . . 73.299999999999997 111.325 174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -133.14 162.73 30.98 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.511 1.524 . . . . 75.430000000000007 109.805 164.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m -142.33 160.17 40.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.784 1.634 . . . . 75.109999999999999 108.923 159.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.7 117.39 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.477 -1.675 . . . . 62.310000000000002 106.477 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -93.22 144.17 25.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.906 -1.146 . . . . 74.319999999999993 107.906 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.2 tp -129.75 132.08 46.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.768 2.027 . . . . 74.549999999999997 107.342 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.69 134.12 44.92 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.147 1.34 . . . . 61.140000000000001 109.127 171.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.34 172.5 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.833 1.253 . . . . 72.530000000000001 108.741 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.76 77.14 2.08 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.27 0.486 . . . . 75.340000000000003 110.522 166.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -163.83 -163.82 0.83 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.707 1.203 . . . . 54.450000000000003 108.992 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.407 ' HA ' ' HB1' ' A' ' 63' ' ' ALA . 1.4 m -147.69 134.52 20.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.233 2.213 . . . . 64.150000000000006 107.34 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -160.36 152.84 20.81 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.239 1.382 . . . . 72.209999999999994 112.697 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.53 106.0 0.14 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.553 2.341 . . . . 71.510000000000005 111.336 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 m -156.8 134.13 10.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 127.127 2.171 . . . . 72.349999999999994 105.414 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.93 106.26 0.22 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.711 1.148 . . . . 71.409999999999997 112.289 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 47.7 mm-40 -66.27 160.93 61.72 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.161 -0.611 . . . . 74.540000000000006 110.89 168.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 53' ' ' GLU . 49.4 Cg_endo -75.44 74.08 4.34 Favored 'Trans proline' 0 CA--C 1.536 0.578 1 C-N-CA 126.672 4.914 . . . . 60.420000000000002 110.138 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? 60.72 1.25 0.41 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.155 2.182 . . . . 63.119999999999997 114.433 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 t -61.03 -71.66 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.737 1.153 . . . . 62.530000000000001 109.191 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 m -148.63 87.99 1.6 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.314 0.961 . . . . 75.439999999999998 110.471 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -138.41 57.2 11.61 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 124.936 1.294 . . . . 64.340000000000003 110.548 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -60.99 121.28 9.44 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.008 2.472 . . . . 73.450000000000003 110.244 174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.75 48.67 8.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 127.475 2.31 . . . . 62.43 112.915 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 54.71 81.23 0.11 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.578 1.551 . . . . 63.530000000000001 110.941 165.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.06 145.83 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.548 1.539 . . . . 75.340000000000003 113.197 178.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 48' ' ' SER . . . -122.38 94.95 4.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.746 -1.946 . . . . 54.43 105.746 167.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -123.43 145.94 48.41 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.564 -1.643 . . . . 75.239999999999995 106.564 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 32.5 ttp -96.42 138.15 34.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.405 1.082 . . . . 73.439999999999998 109.731 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -79.49 65.51 4.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.774 1.23 . . . . 64.540000000000006 110.682 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.59 -32.87 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.882 1.273 . . . . 71.420000000000002 112.332 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -80.38 97.08 6.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.095 0.558 . . . . 74.510000000000005 112.238 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.31 117.77 25.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.183 -1.414 . . . . 52.219999999999999 107.183 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.53 160.98 12.05 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.651 -1.38 . . . . 41.039999999999999 109.651 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.29 -55.03 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.955 2.437 . . . . 65.530000000000001 112.011 -169.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -84.32 164.85 41.48 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 121.188 -0.945 . . . . 62.340000000000003 111.257 -171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.97 179.22 3.41 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.814 3.009 . . . . 72.140000000000001 111.297 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 m 58.47 28.13 16.51 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.627 1.343 . . . . 74.319999999999993 114.627 165.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.91 158.36 34.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.334 1.053 . . . . 71.319999999999993 111.936 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.28 169.41 18.28 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.116 0.966 . . . . 63.539999999999999 111.821 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.14 111.86 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 125.194 1.398 . . . . 75.430000000000007 109.041 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -53.5 144.53 16.85 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.27 1.428 . . . . 74.109999999999999 113.459 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.83 -26.71 68.88 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.281 1.432 . . . . 74.209999999999994 113.187 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.7 t -54.34 -54.49 39.66 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.38 -0.825 . . . . 71.019999999999996 109.847 172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -63.19 -37.55 87.68 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.796 0.438 . . . . 55.219999999999999 111.075 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.16 -27.81 67.41 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 118.247 0.476 . . . . 75.340000000000003 111.278 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.8 m -74.0 -34.78 64.3 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.479 0.581 . . . . 55.310000000000002 111.506 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -76.7 -11.29 59.82 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.622 0.601 . . . . 54.350000000000001 112.622 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 134.74 48.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.837 0.827 . . . . 43.32 109.456 -174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -72.79 112.34 8.75 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.942 -1.026 . . . . 60.240000000000002 109.054 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.4 125.17 19.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.844 -1.539 . . . . 64.420000000000002 106.844 162.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.02 135.06 50.28 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 123.999 0.812 . . . . 53.119999999999997 109.94 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -130.84 56.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.823 1.249 . . . . 64.430000000000007 108.143 171.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 p -123.41 -21.47 5.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.328 -0.851 . . . . 55.450000000000003 112.964 163.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.5 p -131.86 -69.88 0.59 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.642 0.777 . . . . 73.140000000000001 112.245 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -144.27 158.42 54.78 Favored Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 120.421 -1.424 . . . . 74.239999999999995 109.073 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.77 96.99 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.685 2.257 . . . . 75.310000000000002 108.46 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.31 37.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.738 1.615 . . . . 73.109999999999999 107.753 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 73.1 mt -98.52 120.63 48.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 106.381 -1.711 . . . . 71.219999999999999 106.381 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.93 152.7 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 108.239 -1.022 . . . . 61.420000000000002 108.239 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -131.74 152.73 50.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.989 0.915 . . . . 73.510000000000005 108.74 164.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -127.36 87.56 2.65 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.035 -1.468 . . . . 74.25 107.035 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.446 HG22 ' HG3' ' A' ' 10' ' ' PRO . 70.7 mt -90.64 133.37 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.27 -2.122 . . . . 63.119999999999997 105.27 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.64 131.63 19.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.283 0.563 . . . . 60.409999999999997 111.868 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.17 122.45 22.79 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.459 -0.941 . . . . 72.310000000000002 108.459 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -77.8 109.8 12.12 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 106.931 -1.507 . . . . 61.530000000000001 106.931 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.63 -178.63 5.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.175 0.99 . . . . 64.450000000000003 109.55 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.94 1.93 56.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.401 -0.818 . . . . 73.530000000000001 112.724 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -66.68 -68.39 0.38 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.384 -1.339 . . . . 73.140000000000001 107.384 154.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.34 37.59 0.27 Allowed Glycine 0 C--N 1.342 0.913 0 C-N-CA 119.34 -1.41 . . . . 72.349999999999994 115.725 -169.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 59.59 -163.65 0.23 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.609 1.963 . . . . 75.230000000000004 109.792 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 161.97 -90.64 0.11 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 105.336 -3.106 . . . . 74.319999999999993 105.336 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 9' ' ' ALA . 79.2 Cg_endo -62.37 150.79 85.96 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.499 2.133 . . . . 72.519999999999996 110.296 172.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.95 112.25 5.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.499 -2.038 . . . . 60.219999999999999 105.499 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.8 m -58.83 124.54 20.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.84 0.856 . . . . 64.150000000000006 108.992 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -79.42 79.28 5.89 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 122.607 1.194 . . . . 75.530000000000001 108.379 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.0 t -86.78 146.77 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.243 -1.762 . . . . 62.450000000000003 106.243 174.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.66 128.44 39.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.094 -1.076 . . . . 55.039999999999999 108.094 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -92.64 104.82 17.07 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.211 0.604 . . . . 75.140000000000001 110.337 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 31.7 mt -80.15 175.36 10.71 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.377 1.471 . . . . 72.329999999999998 109.427 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.22 14.69 3.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.117 2.167 . . . . 54.039999999999999 112.543 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.67 79.45 0.29 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.62 0.768 . . . . 64.340000000000003 110.832 164.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -144.89 103.19 3.87 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 106.882 -1.525 . . . . 73.219999999999999 106.882 158.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.4 m -160.42 157.09 27.13 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.819 1.647 . . . . 75.329999999999998 107.83 166.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -142.81 39.09 1.49 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.582 -0.896 . . . . 75.109999999999999 108.582 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.16 -17.92 41.24 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.393 -0.817 . . . . 64.439999999999998 112.828 -163.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 71.3 m -58.35 150.98 20.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.92 1.288 . . . . 74.329999999999998 112.221 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.2 t -152.44 76.61 1.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 105.943 -1.873 . . . . 64.450000000000003 105.943 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.19 39.73 0.11 Allowed Glycine 0 CA--C 1.522 0.471 0 O-C-N 121.316 -0.865 . . . . 54.219999999999999 111.039 -167.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.832 1.653 . . . . 64.030000000000001 106.734 176.058 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 110.826 -0.91 . . . . 70.409999999999997 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 81.3 m -71.71 -41.97 67.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.273 1.036 . . . . 74.049999999999997 111.989 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.3 mt 43.79 55.72 12.33 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.21 1.804 . . . . 70.209999999999994 113.105 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.61 -54.03 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.746 1.631 . . . . 50.130000000000003 111.886 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.69 145.7 14.6 Favored Glycine 0 C--O 1.241 0.56 0 N-CA-C 111.6 -0.6 . . . . 74.140000000000001 111.6 -173.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -62.21 158.69 44.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.321 1.048 . . . . 71.019999999999996 109.987 166.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 163.16 36.82 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.014 2.476 . . . . 70.340000000000003 110.547 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.31 -117.97 5.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.305 -1.118 . . . . 44.32 110.305 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.33 160.57 0.15 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 128.464 2.706 . . . . 63.109999999999999 112.361 -168.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.1 152.36 56.56 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.696 2.264 . . . . 72.349999999999994 109.217 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -142.17 177.0 8.53 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.861 1.664 . . . . 73.540000000000006 108.535 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.71 42.09 5.56 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.44 2.296 . . . . 70.439999999999998 111.633 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.446 HG23 ' CD1' ' A' ' 26' ' ' TRP . 2.4 mp -67.95 120.73 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 124.168 0.987 . . . . 61.140000000000001 109.021 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -112.55 133.98 54.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.365 -0.976 . . . . 63.399999999999999 108.365 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' A' ' 97' ' ' PHE . 22.7 mt -144.4 124.84 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.728 1.211 . . . . 73.219999999999999 108.076 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.0 m -145.41 161.79 38.85 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.611 1.164 . . . . 64.329999999999998 112.281 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 tptt -83.89 146.01 28.3 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.325 1.05 . . . . 75.430000000000007 109.206 176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 m -152.08 165.3 17.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.917 1.687 . . . . 73.340000000000003 108.204 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.86 -11.18 25.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.209 1.94 . . . . 75.340000000000003 113.544 -167.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.72 7.5 8.8 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.011 0.924 . . . . 75.329999999999998 111.523 -164.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 174.0 13.6 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.82 2.153 . . . . 75.099999999999994 107.93 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.4 129.46 36.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.566 -1.272 . . . . 62.219999999999999 107.566 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -65.89 109.39 2.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.634 -1.247 . . . . 72.400000000000006 107.634 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 5.3 mp -126.06 126.82 44.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.317 1.047 . . . . 62.119999999999997 108.693 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.0 p -139.43 154.18 47.73 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 123.331 0.652 . . . . 75.109999999999999 109.63 167.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CD1' HG23 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -142.94 -178.91 6.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.132 1.373 . . . . 75.310000000000002 107.675 175.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.19 160.37 52.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.199 0.909 . . . . 74.319999999999993 111.22 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.57 156.05 64.89 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.734 3.623 . . . . 74.439999999999998 113.101 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.57 -176.67 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.113 3.209 . . . . 75.349999999999994 111.488 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 14.03 3.57 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.647 1.721 . . . . 63.049999999999997 115.647 -163.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.8 -54.55 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.774 -0.579 . . . . 72.450000000000003 111.468 -160.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -132.9 172.65 12.31 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.967 1.307 . . . . 60.030000000000001 107.908 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.5 m -51.74 -41.86 61.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.606 1.094 . . . . 72.340000000000003 112.394 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.71 163.87 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.087 0.851 . . . . 60.25 111.198 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -131.31 74.26 1.58 Allowed 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.512 -0.993 . . . . 73.010000000000005 108.641 164.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.22 152.44 9.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 75.219999999999999 106.439 167.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.3 pt -136.24 -28.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 125.121 1.368 . . . . 61.119999999999997 110.403 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -157.39 -169.94 3.07 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.353 -1.351 . . . . 73.439999999999998 107.353 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 102' ' ' ARG . 34.8 m-85 -128.11 166.27 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.629 -1.248 . . . . 71.319999999999993 107.629 159.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -130.72 153.42 49.02 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.284 -1.376 . . . . 62.329999999999998 107.284 164.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.932 HG12 ' HB2' ' A' ' 68' ' ' TYR . 3.6 p -153.02 124.64 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.021 0 O-C-N 121.942 -0.474 . . . . 51.310000000000002 110.475 -171.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -99.15 133.98 42.65 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.943 -1.132 . . . . 75.019999999999996 107.943 -171.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 85' ' ' ALA . 10.5 tp -117.63 130.23 56.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.639 2.375 . . . . 72.209999999999994 107.564 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 64' ' ' PHE . . . -63.0 136.25 57.73 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 121.417 1.917 . . . . 64.219999999999999 112.992 169.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.447 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.3 pt -145.11 175.5 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.194 1.398 . . . . 52.420000000000002 110.289 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -63.75 67.01 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.317 1.847 . . . . 74.409999999999997 112.754 164.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -151.8 -33.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.59 1.556 . . . . 52.210000000000001 111.782 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 m 62.05 13.08 5.41 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.807 1.41 . . . . 52.439999999999998 114.807 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.48 132.6 2.88 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.69 1.996 . . . . 64.510000000000005 108.152 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.92 -175.42 4.94 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.547 1.539 . . . . 63.240000000000002 111.017 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.2 m -145.24 131.82 19.85 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 128.406 2.683 . . . . 75.329999999999998 105.699 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.75 -85.19 0.05 OUTLIER Glycine 0 C--O 1.235 0.205 0 C-N-CA 124.733 1.158 . . . . 55.420000000000002 110.883 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -63.14 153.19 82.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.107 0.963 . . . . 72.430000000000007 110.482 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -69.14 148.73 69.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.623 2.215 . . . . 73.340000000000003 109.892 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -102.2 5.34 40.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.069 0.948 . . . . 70.340000000000003 113.047 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.7 m -48.51 -35.01 12.27 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.305 0.957 . . . . 61.229999999999997 113.464 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.7 t -136.31 -62.71 0.66 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.104 0.962 . . . . 74.129999999999995 110.034 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 t -65.2 144.33 99.0 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.841 -1.17 . . . . 74.439999999999998 107.841 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.88 76.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.911 3.074 . . . . 54.219999999999999 110.149 -174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.49 38.85 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.679 2.391 . . . . 45.140000000000001 111.999 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -132.64 72.54 1.49 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.541 1.937 . . . . 65.329999999999998 107.136 -166.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mt -126.12 -170.95 2.28 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.724 -1.213 . . . . 74.519999999999996 107.724 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.19 -154.24 0.06 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.724 -0.671 . . . . 74.120000000000005 111.92 162.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 0.4 OUTLIER 76.69 160.54 0.22 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 131.23 3.812 . . . . 61.329999999999998 113.77 173.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.447 ' SD ' HD13 ' A' ' 45' ' ' ILE . 9.8 ptt? -126.95 147.65 50.09 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.655 1.182 . . . . 55.219999999999999 110.068 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.62 93.72 0.94 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.203 2.201 . . . . 75.409999999999997 112.529 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -94.86 -26.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 116.456 -1.735 . . . . 75.099999999999994 110.162 -165.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.932 ' HB2' HG12 ' A' ' 41' ' ' VAL . 26.3 t80 -58.0 132.68 54.17 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 120.332 1.424 . . . . 72.129999999999995 109.409 -175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.0 p -155.01 27.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.548 1.139 . . . . 73.239999999999995 112.227 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -102.27 152.67 18.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.978 -0.901 . . . . 61.210000000000001 111.195 -168.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.33 -55.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.046 1.831 . . . . 72.140000000000001 109.053 171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.87 144.95 97.99 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 109.29 -0.633 . . . . 64.209999999999994 109.29 169.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.56 -3.54 13.26 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.613 2.875 . . . . 55.340000000000003 112.604 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 p -98.58 44.99 1.02 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.461 1.482 . . . . 73.530000000000001 110.419 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.6 t -51.3 111.82 0.64 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.953 1.301 . . . . 62.100000000000001 110.706 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.3 130.24 37.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.288 -0.634 . . . . 63.140000000000001 109.288 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -76.35 95.38 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 106.846 -1.539 . . . . 72.340000000000003 106.846 162.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -75.75 163.71 26.99 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.294 -0.866 . . . . 54.299999999999997 109.694 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -53.09 -38.35 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.072 1.349 . . . . 73.420000000000002 112.115 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -40.09 63.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.784 2.034 . . . . 63.210000000000001 111.592 -177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.3 m -79.21 -36.09 40.65 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.105 -0.372 . . . . 75.230000000000004 111.873 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.77 -25.53 68.23 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.85 0.46 . . . . 72.230000000000004 111.25 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.1 m -60.84 -10.86 6.18 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.345 1.239 . . . . 55.0 114.345 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -115.51 -6.66 12.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.644 1.111 . . . . 74.140000000000001 111.139 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 43' ' ' LEU . . . -70.1 151.28 45.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.212 1.005 . . . . 72.430000000000007 109.997 -171.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -137.24 153.09 50.45 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.721 0.808 . . . . 74.200000000000003 112.117 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 ' CG2' ' HA ' ' A' ' 93' ' ' PRO . 1.9 mp -88.28 144.54 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.554 1.542 . . . . 64.230000000000004 109.593 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.16 71.42 5.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.417 1.887 . . . . 54.32 109.656 -172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -62.33 4.45 0.14 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.258 1.023 . . . . 74.239999999999995 111.876 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.57 -20.51 31.38 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 119.367 0.985 . . . . 41.299999999999997 110.258 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.8 p -141.66 -85.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.765 1.226 . . . . 65.400000000000006 111.286 161.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HE3' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -117.17 153.93 49.91 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 126.421 1.889 . . . . 73.140000000000001 112.093 -162.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 87' ' ' ILE . 83.2 Cg_endo -77.64 78.76 3.41 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.511 1.474 . . . . 72.319999999999993 112.765 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.653 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -143.69 157.24 44.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.54 2.736 . . . . 53.020000000000003 107.912 175.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.3 mt -73.32 -21.3 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.572 0.582 . . . . 72.140000000000001 112.572 175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.4 mm 60.68 142.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 130.187 3.395 . . . . 65.540000000000006 110.04 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CD2' HD13 ' A' ' 15' ' ' ILE . 10.5 m-85 -135.98 135.75 39.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.235 -1.394 . . . . 71.439999999999998 107.235 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mtp85 -133.95 90.7 2.73 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.084 0.865 . . . . 74.530000000000001 109.627 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.544 ' HA ' HG23 ' A' ' 41' ' ' VAL . 1.1 mt -87.41 153.47 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.249 -1.389 . . . . 74.219999999999999 107.249 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.76 154.74 37.9 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.967 0.803 . . . . 61.020000000000003 111.769 159.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.47 116.22 13.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.217 1.807 . . . . 63.039999999999999 108.57 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.419 ' H ' ' HA ' ' A' ' 39' ' ' TYR . 1.4 tmm_? -79.34 89.26 4.96 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 105.074 -2.195 . . . . 74.219999999999999 105.074 170.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -115.74 178.92 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.298 1.439 . . . . 64.25 109.972 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.94 -3.12 20.75 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.629 0.974 . . . . 75.349999999999994 113.629 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -91.19 -27.96 18.16 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 120.256 -1.527 . . . . 61.450000000000003 109.675 173.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 109.16 -179.25 20.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.631 1.11 . . . . 51.119999999999997 110.98 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -70.7 69.52 0.44 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 126.068 1.747 . . . . 75.219999999999999 109.271 175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 -81.99 1.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.114 -1.594 . . . . 70.439999999999998 109.114 -169.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.61 160.33 25.16 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.091 1.861 . . . . 64.450000000000003 109.05 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.03 160.71 36.92 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.973 0.909 . . . . 71.109999999999999 109.321 172.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 t -95.76 154.0 17.45 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.504 -1.295 . . . . 73.129999999999995 107.504 156.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -129.72 101.58 5.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.791 -2.3 . . . . 73.230000000000004 104.791 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 79.2 t -107.98 164.31 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.542 -1.281 . . . . 63.299999999999997 107.542 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 121.1 24.1 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.452 1.101 . . . . 74.540000000000006 108.095 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -91.74 79.7 5.36 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.316 -1.735 . . . . 74.299999999999997 106.316 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.759 HD21 ' HE3' ' A' ' 92' ' ' LYS . 44.5 mt -76.4 170.73 15.82 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.608 -0.886 . . . . 71.129999999999995 108.608 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 75.58 -6.14 2.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.895 2.478 . . . . 63.5 113.003 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -59.91 165.75 3.05 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.428 1.491 . . . . 74.400000000000006 113.391 171.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.07 144.22 50.52 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.13 1.772 . . . . 72.5 109.857 -171.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 155.12 40.62 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.484 -0.932 . . . . 44.130000000000003 108.484 161.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -149.56 175.68 11.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.283 -1.377 . . . . 73.319999999999993 107.283 152.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -147.88 163.56 36.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.474 0.71 . . . . 71.430000000000007 110.226 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.3 t -164.9 179.93 6.17 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.056 1.742 . . . . 62.229999999999997 109.255 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -141.41 168.43 19.8 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.549 1.54 . . . . 63.130000000000003 108.873 161.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.13 -64.1 0.08 OUTLIER Glycine 0 C--N 1.341 0.848 0 C-N-CA 123.496 0.569 . . . . 75.340000000000003 112.923 -168.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.248 1.005 0 N-CA-C 105.05 -2.204 . . . . 75.329999999999998 105.05 176.722 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.509 0 N-CA-C 111.006 -0.838 . . . . 71.439999999999998 111.006 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.4 p -144.08 17.34 1.75 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.704 1.602 . . . . 40.219999999999999 111.733 -173.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 mp 63.84 161.43 0.12 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.848 2.059 . . . . 72.040000000000006 110.62 -161.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -71.15 -178.74 3.03 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 121.976 1.784 . . . . 61.200000000000003 111.557 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.98 -161.05 0.85 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.555 1.074 . . . . 22.309999999999999 111.203 164.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -102.76 87.2 1.13 Allowed Pre-proline 0 N--CA 1.462 0.16 0 C-N-CA 125.265 1.426 . . . . 72.409999999999997 108.276 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.4 145.81 83.95 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.084 1.856 . . . . 61.310000000000002 109.061 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.9 -133.66 5.07 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.631 -1.387 . . . . 64.340000000000003 109.631 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 74.02 165.06 0.14 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 128.624 2.77 . . . . 75.200000000000003 111.249 -167.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.51 156.33 64.17 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.458 2.105 . . . . 44.240000000000002 110.201 170.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 p -135.06 -178.97 5.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.837 0.827 . . . . 74.319999999999993 112.05 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.28 1.14 0.34 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.838 2.855 . . . . 60.329999999999998 115.744 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.4 mp -44.47 129.67 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.87 2.468 . . . . 61.020000000000003 112.626 -154.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 14' ' ' LYS . 8.0 mmpt? -115.01 131.03 57.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 124.439 1.095 . . . . 71.319999999999993 108.913 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.57 93.45 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.964 -1.495 . . . . 71.209999999999994 106.964 -175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.3 m -96.12 140.35 30.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.581 -1.19 . . . . 34.009999999999998 108.991 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -60.68 154.03 22.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.99 -0.744 . . . . 75.129999999999995 108.99 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.6 m -144.38 165.28 24.12 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 127.612 2.365 . . . . 73.209999999999994 107.963 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.98 -39.31 41.18 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.098 1.865 . . . . 75.510000000000005 112.06 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -106.48 9.79 31.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.732 0.813 . . . . 75.209999999999994 111.574 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.02 -137.37 4.76 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 120.414 -1.429 . . . . 62.140000000000001 112.185 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.12 144.85 32.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.797 0.839 . . . . 51.520000000000003 109.655 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -75.69 155.1 36.04 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 109.24 -0.652 . . . . 73.519999999999996 109.24 163.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.43 107.82 3.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.914 1.686 . . . . 55.329999999999998 108.711 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.3 p -123.41 158.6 30.78 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.034 0.833 . . . . 75.120000000000005 110.251 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.484 ' CZ3' HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -146.78 141.86 27.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.964 0.905 . . . . 72.209999999999994 111.556 176.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -76.36 150.9 83.01 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.348 1.059 . . . . 74.120000000000005 109.206 165.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.23 168.01 25.3 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.625 3.55 . . . . 73.150000000000006 111.126 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.59 153.11 77.22 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.198 1.265 . . . . 55.350000000000001 110.721 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 t -151.86 73.0 1.04 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.738 -1.949 . . . . 74.239999999999995 105.738 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -57.46 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 C-N-CA 124.066 0.946 . . . . 60.340000000000003 110.201 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.7 p -134.86 167.53 20.72 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.448 -0.945 . . . . 73.230000000000004 108.448 162.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 t -47.01 -57.07 5.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.203 1.801 . . . . 73.349999999999994 113.132 -168.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.31 176.72 5.96 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.228 1.394 . . . . 64.299999999999997 111.103 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -141.27 92.06 2.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.379 -1.711 . . . . 71.209999999999994 106.379 157.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.76 145.28 10.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.632 -1.618 . . . . 75.329999999999998 106.632 170.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.45 -28.26 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.471 1.109 . . . . 71.530000000000001 110.932 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.36 -176.26 5.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.663 1.119 . . . . 74.209999999999994 110.283 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -139.64 166.11 25.46 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.355 1.062 . . . . 51.130000000000003 110.273 171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.48 171.93 19.42 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.287 -0.634 . . . . 73.219999999999999 109.287 163.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -138.02 124.48 26.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.19 -1.781 . . . . 71.120000000000005 106.19 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -118.22 119.07 33.57 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 105.794 -1.928 . . . . 75.430000000000007 105.794 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.21 116.03 30.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.285 -1.746 . . . . 71.099999999999994 106.285 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.34 136.4 51.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.003 -1.11 . . . . 61.409999999999997 108.003 173.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 pt -130.37 -177.2 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.288 -1.745 . . . . 64.540000000000006 106.288 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -44.51 101.17 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.491 1.916 . . . . 71.5 110.858 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.8 m -174.52 173.3 2.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.11 2.564 . . . . 62.399999999999999 109.596 -171.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.43 177.92 0.8 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.682 1.193 . . . . 72.099999999999994 112.353 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -76.81 165.42 24.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.975 1.31 . . . . 71.0 111.845 170.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -101.85 -178.77 3.81 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.818 1.647 . . . . 61.240000000000002 110.052 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -174.68 135.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.693 1.997 . . . . 75.230000000000004 109.369 169.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.03 125.11 1.13 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.958 1.266 . . . . 75.439999999999998 112.332 165.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' O ' HG21 ' A' ' 58' ' ' THR . 10.2 mt-10 -69.37 159.02 85.22 Favored Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 118.349 1.075 . . . . 71.230000000000004 110.381 167.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -58.45 135.35 67.16 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.747 2.298 . . . . 74.239999999999995 110.062 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -146.98 37.51 0.96 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.463 1.105 . . . . 75.140000000000001 109.721 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m 58.31 1.21 0.15 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 73.219999999999999 114.856 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.2 m -161.53 -73.42 0.06 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.918 2.087 . . . . 73.310000000000002 107.696 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER 57.64 166.26 0.07 OUTLIER Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.127 0.971 . . . . 75.310000000000002 110.653 -169.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.441 ' HD2' HG22 ' A' ' 58' ' ' THR . 43.2 Cg_endo -79.32 175.05 11.19 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.962 1.775 . . . . 64.230000000000004 110.536 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.48 81.58 4.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.189 -1.782 . . . . 60.530000000000001 106.189 162.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -121.45 63.51 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.226 1.41 . . . . 55.409999999999997 108.156 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.1 168.77 15.62 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.296 -1.372 . . . . 55.420000000000002 107.296 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.13 84.06 1.7 Allowed 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.417 -0.811 . . . . 54.240000000000002 110.287 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.29 158.64 43.72 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.555 1.142 . . . . 71.209999999999994 109.81 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -102.83 7.03 39.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.501 0.926 . . . . 75.129999999999995 113.501 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 45.91 61.12 2.81 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.707 2.003 . . . . 74.5 114.398 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.65 -37.72 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.666 1.186 . . . . 71.5 113.545 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -64.68 118.81 9.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 118.969 0.804 . . . . 73.120000000000005 109.807 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.7 m -135.58 27.58 3.36 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.537 1.535 . . . . 75.209999999999994 109.656 164.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.19 161.05 37.25 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.973 -0.851 . . . . 75.200000000000003 110.973 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.83 -55.17 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.578 2.186 . . . . 74.239999999999995 110.013 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.86 158.75 31.15 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 124.864 1.266 . . . . 72.319999999999993 110.389 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.82 173.63 10.73 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.883 2.388 . . . . 75.420000000000002 110.863 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p 47.87 63.68 1.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.93 1.292 . . . . 64.430000000000007 109.782 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.3 p -70.98 -164.82 0.1 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.856 2.062 . . . . 74.5 110.21 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 77' ' ' VAL . 3.2 pp -130.09 -176.49 3.96 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.227 -1.546 . . . . 72.549999999999997 108.799 164.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.437 ' N ' HD12 ' A' ' 76' ' ' LEU . 31.0 t -135.98 148.23 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.632 1.105 . . . . 74.230000000000004 109.051 174.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -89.41 145.12 25.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.004 2.122 . . . . 73.530000000000001 111.084 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 t -62.48 -27.4 69.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.982 2.113 . . . . 73.540000000000006 112.83 -173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.5 p -57.53 -30.03 64.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.116 0.966 . . . . 74.319999999999993 111.28 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -78.44 -45.43 22.21 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.015 1.326 . . . . 52.420000000000002 109.298 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.35 -37.3 74.91 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.995 1.318 . . . . 75.219999999999999 111.87 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.6 t -50.08 -48.86 52.95 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.144 0.497 . . . . 62.530000000000001 110.531 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -84.32 -5.35 59.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.168 0.987 . . . . 62.409999999999997 112.076 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.81 138.07 55.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.083 0.944 . . . . 72.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -71.85 153.5 41.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.074 -1.421 . . . . 73.120000000000005 110.446 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.2 mm -123.25 136.8 58.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.914 1.286 . . . . 71.430000000000007 109.261 -166.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -74.76 68.14 1.68 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 128.128 2.571 . . . . 74.329999999999998 112.197 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.71 73.07 0.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.827 1.299 . . . . 61.340000000000003 108.443 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 70.5 p -133.92 -28.5 1.37 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.234 2.213 . . . . 72.109999999999999 108.357 165.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.74 -50.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.084 0.954 . . . . 62.399999999999999 111.887 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.41 160.1 69.75 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 120.893 1.679 . . . . 73.129999999999995 112.541 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.53 74.1 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.579 2.186 . . . . 75.230000000000004 109.291 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.96 148.8 45.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.609 0.966 . . . . 53.109999999999999 113.609 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -83.98 133.9 28.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.917 1.287 . . . . 62.200000000000003 109.251 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -84.29 147.84 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.932 0.893 . . . . 61.409999999999997 110.601 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -126.57 145.56 50.49 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 125.331 1.452 . . . . 60.340000000000003 109.373 171.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -119.27 98.58 6.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.938 -1.875 . . . . 72.230000000000004 105.938 169.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.484 HD13 ' CZ3' ' A' ' 26' ' ' TRP . 17.4 mt -113.17 133.14 59.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.456 -2.053 . . . . 74.040000000000006 105.456 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 149.86 47.9 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.85 -1.167 . . . . 53.130000000000003 107.85 167.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.03 28.49 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.113 -1.439 . . . . 74.439999999999998 107.113 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG2' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -73.87 99.96 3.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.003 -2.221 . . . . 75.409999999999997 105.003 174.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -121.92 163.7 18.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.067 1.347 . . . . 53.409999999999997 110.335 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -60.66 -21.15 62.48 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.707 -1.133 . . . . 72.230000000000004 112.436 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.78 -16.85 44.92 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.36 1.064 . . . . 75.140000000000001 112.888 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.58 36.77 4.72 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 118.55 0.614 . . . . 75.329999999999998 111.756 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 102' ' ' ARG . 0.1 OUTLIER 64.29 24.83 13.4 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.458 1.903 . . . . 75.219999999999999 111.865 165.365 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.87 -77.98 0.31 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.137 1.351 . . . . 73.0 112.098 -157.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -71.46 134.69 24.97 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 121.457 1.438 . . . . 75.329999999999998 109.403 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.99 164.07 26.16 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.074 1.75 . . . . 64.219999999999999 107.46 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 m -114.63 135.26 54.34 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.593 -1.632 . . . . 74.200000000000003 106.593 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.92 114.9 27.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.371 -2.085 . . . . 72.109999999999999 105.371 168.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 m -113.17 162.67 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 119.16 0.891 . . . . 75.129999999999995 108.913 167.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 135.85 52.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.364 -1.347 . . . . 75.319999999999993 107.364 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -120.89 102.08 8.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 122.274 1.035 . . . . 72.030000000000001 111.396 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.832 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.58 -10.95 28.18 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.741 2.417 . . . . 75.319999999999993 111.885 -169.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 2.21 2.92 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.076 1.75 . . . . 75.129999999999995 111.652 170.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -4.24 12.62 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.654 1.57 . . . . 75.120000000000005 114.408 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.92 145.93 1.36 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.069 2.548 . . . . 63.420000000000002 112.433 -170.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 p -126.39 94.77 4.16 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.291 1.436 . . . . 74.120000000000005 108.495 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.0 tptt 71.44 -168.59 0.15 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.707 1.603 . . . . 75.120000000000005 109.561 -165.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 55.96 78.49 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.759 2.024 . . . . 74.209999999999994 112.96 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m 55.75 -154.97 0.29 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.878 1.271 . . . . 60.119999999999997 111.308 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.3 m 46.74 47.07 15.15 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.844 1.258 . . . . 71.109999999999999 113.723 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -143.42 68.3 0.43 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.185 -1.166 . . . . 35.439999999999998 110.185 171.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.258 1.55 0 N-CA-C 102.782 -3.044 . . . . 75.450000000000003 102.782 167.58 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 CA-C-O 119.82 -0.433 . . . . 62.140000000000001 112.174 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . 0.273 1.8 p 57.23 -169.11 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.322 1.049 . . . . 65.319999999999993 108.854 -121.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -129.47 165.57 31.87 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.193 1.397 . . . . 64.129999999999995 109.322 -174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.43 146.3 89.37 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.2 1.933 . . . . 70.099999999999994 110.196 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.01 -173.28 53.85 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 122.397 0.998 . . . . 43.100000000000001 111.877 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.4 165.2 34.74 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 127.908 2.483 . . . . 72.319999999999993 107.57 -177.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.78 136.51 58.06 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.136 1.224 . . . . 74.329999999999998 109.546 164.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 102.01 112.97 3.66 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 125.13 1.348 . . . . 32.520000000000003 114.356 165.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.69 155.96 31.01 Favored Pre-proline 0 C--N 1.314 -0.967 0 C-N-CA 127.025 2.13 . . . . 72.120000000000005 105.272 158.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HG3' HG22 ' A' ' 99' ' ' ILE . 37.9 Cg_endo -63.41 159.59 39.42 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.065 2.51 . . . . 73.530000000000001 111.268 -176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.1 m -134.41 176.52 8.54 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.662 1.185 . . . . 74.540000000000006 109.882 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 18.4 5.9 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.593 2.757 . . . . 23.219999999999999 113.758 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.58 120.98 7.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.369 0.668 . . . . 62.130000000000003 109.728 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.67 146.38 27.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.247 -1.39 . . . . 74.140000000000001 107.247 167.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.416 HG12 HD13 ' A' ' 24' ' ' LEU . 9.8 mt -135.71 133.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.383 -2.08 . . . . 74.129999999999995 105.383 161.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 t -146.82 144.51 29.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.434 1.494 . . . . 74.230000000000004 109.312 -173.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -80.45 158.26 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.124 0.57 . . . . 64.420000000000002 110.261 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.45 165.34 18.36 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.038 1.335 . . . . 61.0 107.935 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.21 -15.64 35.46 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.105 2.536 . . . . 70.310000000000002 113.464 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -107.74 -26.97 10.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.399 1.08 . . . . 70.230000000000004 111.66 -168.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.14 -165.61 37.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.582 -1.807 . . . . 51.520000000000003 108.582 -167.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.31 133.92 42.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.046 -1.465 . . . . 74.099999999999994 107.046 165.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -60.31 115.36 3.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.012 -1.477 . . . . 74.200000000000003 107.012 158.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD13 HG12 ' A' ' 15' ' ' ILE . 3.9 mm? -105.42 140.35 38.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.4 -1.704 . . . . 71.540000000000006 106.4 168.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 p -150.23 156.56 41.8 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 119.886 1.221 . . . . 71.439999999999998 109.953 164.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -139.91 158.37 44.19 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.487 1.515 . . . . 70.319999999999993 108.921 166.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -87.89 161.67 43.57 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.052 0.541 . . . . 61.340000000000003 110.523 171.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.8 168.08 19.56 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.904 . . . . 74.510000000000005 111.341 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -80.55 156.5 21.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.005 1.803 . . . . 74.510000000000005 112.973 -166.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.5 52.86 1.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.028 -1.471 . . . . 74.200000000000003 107.028 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG12 HG22 ' A' ' 32' ' ' THR . 33.2 t -137.57 -87.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.149 -1.056 . . . . 71.219999999999999 108.149 160.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.473 HG22 HG12 ' A' ' 31' ' ' VAL . 12.1 t -168.68 40.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.968 -1.083 . . . . 53.32 110.037 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.4 p -68.23 -6.82 25.74 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.103 -1.623 . . . . 71.299999999999997 113.787 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.09 -124.99 6.71 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 120.248 -1.533 . . . . 72.420000000000002 111.49 166.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -109.11 88.43 2.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.351 1.86 . . . . 62.530000000000001 110.612 -167.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -78.04 125.58 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 125.867 1.667 . . . . 63.530000000000001 107.177 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.7 pt -116.46 -27.93 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.398 1.079 . . . . 74.239999999999995 111.406 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -151.3 -171.44 3.93 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.692 1.597 . . . . 72.299999999999997 107.434 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.14 169.49 17.51 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.472 -1.393 . . . . 74.5 108.749 172.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.9 173.24 16.79 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.587 0.63 . . . . 72.219999999999999 112.6 175.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.65 99.28 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 128.733 2.813 . . . . 73.310000000000002 105.282 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 42.7 m-85 -82.99 153.34 25.02 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.957 -1.127 . . . . 73.340000000000003 107.957 163.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.3 tp -143.26 128.19 18.42 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.956 2.102 . . . . 74.239999999999995 106.105 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 112.78 13.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.829 0.852 . . . . 63.520000000000003 109.143 169.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 pt -86.75 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.155 -1.054 . . . . 63.240000000000002 108.155 160.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -48.75 108.61 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.231 1.012 . . . . 62.140000000000001 111.139 174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.8 p -162.61 109.98 1.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.81 1.244 . . . . 54.340000000000003 111.019 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -87.81 4.51 44.17 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.801 0.84 . . . . 64.549999999999997 112.615 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -127.21 168.86 14.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.21 1.404 . . . . 70.219999999999999 110.514 -162.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.78 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.169 2.188 . . . . 72.310000000000002 112.002 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -144.38 129.49 18.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 104.78 -2.304 . . . . 74.209999999999994 104.78 169.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.69 -135.2 1.96 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 108.36 -1.896 . . . . 72.319999999999993 108.36 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.11 156.27 60.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 C-N-CA 125.277 1.431 . . . . 70.430000000000007 109.195 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.92 -176.81 1.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.953 2.435 . . . . 70.540000000000006 110.92 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt 70.08 3.92 4.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.974 1.309 . . . . 70.329999999999998 112.601 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.0 m 44.96 45.75 8.83 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.158 1.783 . . . . 51.329999999999998 111.485 -169.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -66.73 -51.16 59.14 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.87 -0.586 . . . . 34.530000000000001 109.881 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.6 p -125.44 156.94 69.59 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.084 0.856 . . . . 64.129999999999995 109.631 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.38 88.06 1.45 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.187 2.591 . . . . 73.420000000000002 112.85 -170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -176.86 116.52 0.11 Allowed 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 126.621 1.968 . . . . 65.129999999999995 107.386 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -85.56 -168.43 2.22 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.087 0.955 . . . . 64.239999999999995 108.731 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -112.43 171.83 7.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.686 1.194 . . . . 45.020000000000003 109.586 -172.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.36 120.93 25.06 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.448 0.536 . . . . 70.510000000000005 112.448 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.435 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 37.9 m-85 -148.97 170.91 17.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.268 1.827 . . . . 65.120000000000005 110.33 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.0 ttp -106.45 5.89 29.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.438 1.495 . . . . 73.340000000000003 113.225 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 44.44 44.35 6.91 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.772 1.629 . . . . 71.329999999999998 115.34 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.6 m -56.4 -9.75 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 115.446 1.647 . . . . 64.129999999999995 115.446 -171.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -53.67 98.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.292 1.044 . . . . 65.230000000000004 110.783 165.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 39.6 t -147.32 24.66 1.13 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.981 1.713 . . . . 64.099999999999994 109.145 162.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.79 159.0 53.34 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.123 -0.791 . . . . 52.539999999999999 111.123 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -83.49 -7.05 10.82 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.947 3.098 . . . . 71.200000000000003 112.372 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 p -131.86 156.61 79.9 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.431 1.892 . . . . 71.219999999999999 109.842 -166.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -4.01 11.96 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.389 3.393 . . . . 70.219999999999999 113.551 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.0 p -120.46 22.47 11.26 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.666 2.387 . . . . 65.239999999999995 110.212 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.25 -174.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.654 2.782 . . . . 64.340000000000003 115.34 -177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.32 102.4 3.06 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 104.881 -2.266 . . . . 71.010000000000005 104.881 167.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.55 108.3 20.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.222 -1.029 . . . . 63.409999999999997 108.222 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -77.0 165.48 24.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.629 0.728 . . . . 73.109999999999999 111.554 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -42.75 82.08 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.47 1.108 . . . . 72.120000000000005 111.956 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -64.42 -20.29 66.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.924 -1.036 . . . . 54.210000000000001 112.754 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.2 m -75.02 -35.84 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.877 1.217 . . . . 50.530000000000001 109.862 172.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.0 -30.58 63.88 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.098 1.359 . . . . 51.200000000000003 110.53 -177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.4 m -47.09 -44.13 20.91 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.927 1.291 . . . . 74.209999999999994 113.033 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -84.55 1.73 44.55 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.167 0.802 . . . . 73.219999999999999 113.167 -171.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.0 143.58 55.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.823 0.82 . . . . 72.140000000000001 110.376 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -68.74 140.69 55.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.529 -1.214 . . . . 73.319999999999993 107.808 162.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.6 mm -101.5 123.51 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.91 -1.515 . . . . 73.409999999999997 106.91 172.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.74 145.45 52.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.693 0.621 . . . . 54.409999999999997 110.056 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.7 18.66 3.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.658 0.783 . . . . 75.150000000000006 111.307 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 t -110.11 -13.58 14.35 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.658 -0.651 . . . . 72.450000000000003 110.908 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.0 p -129.02 -63.17 0.97 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.407 1.483 . . . . 60.420000000000002 111.982 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -154.74 155.55 30.57 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 127.062 2.145 . . . . 73.230000000000004 108.352 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -60.57 101.82 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.433 2.756 . . . . 70.129999999999995 109.516 171.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.515 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -149.94 156.58 41.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 70.120000000000005 110.078 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.44 140.71 16.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.824 -1.917 . . . . 73.450000000000003 105.824 161.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.8 mm -109.26 115.12 48.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.366 1.466 . . . . 63.25 107.555 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -100.72 148.49 24.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.957 0.903 . . . . 64.230000000000004 109.338 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -132.06 94.09 3.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.542 -1.651 . . . . 74.340000000000003 106.542 -175.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 10' ' ' PRO . 31.1 mt -108.55 136.66 43.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.014 -2.217 . . . . 63.229999999999997 105.014 -172.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.52 41.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.909 0.777 . . . . 72.400000000000006 110.115 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.8 114.56 7.25 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.473 1.509 . . . . 73.329999999999998 108.066 172.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 81.55 4.72 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 105.475 -2.046 . . . . 73.129999999999995 105.475 174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 39.8 p30 -106.06 166.02 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.9 1.68 . . . . 70.439999999999998 108.347 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mt-10 -74.48 -36.41 63.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.685 -1.143 . . . . 63.340000000000003 108.836 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -17.04 64.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 115.718 1.748 . . . . 53.399999999999999 115.718 -174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.82 -97.89 0.13 Allowed Glycine 0 CA--C 1.512 -0.134 0 CA-C-N 120.643 1.565 . . . . 43.219999999999999 112.882 -161.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 3.6 t80 55.52 21.86 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.833 2.853 . . . . 71.099999999999994 111.561 -171.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.27 -78.8 1.28 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.532 2.015 . . . . 41.210000000000001 108.35 -163.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.0 143.91 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.447 2.098 . . . . 70.209999999999994 109.904 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -134.18 117.65 16.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.386 -2.079 . . . . 64.299999999999997 105.386 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.1 m -53.14 120.99 6.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.924 -1.139 . . . . 71.409999999999997 107.924 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -82.64 88.9 6.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.041 -1.837 . . . . 74.519999999999996 106.041 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.21 156.58 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.462 -1.681 . . . . 63.240000000000002 106.462 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.71 164.13 28.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.87 -1.159 . . . . 64.120000000000005 107.87 176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.515 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 19.3 t90 -137.6 114.31 10.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.62 0.724 . . . . 65.299999999999997 111.3 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.79 25.05 5.52 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.801 1.64 . . . . 64.200000000000003 112.19 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -108.97 7.75 26.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.507 1.523 . . . . 74.409999999999997 111.508 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -68.6 118.7 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 122.101 0.953 . . . . 63.539999999999999 109.021 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.52 159.02 0.17 Allowed 'General case' 0 C--O 1.242 0.663 1 C-N-CA 133.227 4.611 . . . . 65.450000000000003 103.368 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 m -71.3 169.45 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.691 1.132 . . . . 70.140000000000001 109.321 165.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -148.6 144.5 27.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.437 -2.061 . . . . 73.319999999999993 105.437 160.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.43 169.98 16.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.291 -0.633 . . . . 70.140000000000001 109.291 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.27 163.93 23.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.205 1.002 . . . . 62.43 110.176 173.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.98 -58.89 0.11 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.721 0.808 . . . . 33.240000000000002 109.315 168.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 162.36 -172.75 38.53 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 118.275 0.489 . . . . 32.049999999999997 112.393 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.245 0.852 0 C-N-CA 127.547 2.339 . . . . 52.310000000000002 105.545 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 109.542 -1.423 . . . . 61.420000000000002 109.542 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.5 p -66.68 160.19 26.12 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.487 1.144 . . . . 73.040000000000006 111.78 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.67 150.28 54.88 Favored Pre-proline 0 C--O 1.234 0.259 0 N-CA-C 106.171 -1.788 . . . . 73.209999999999994 106.171 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.53 162.8 35.26 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.894 1.73 . . . . 43.100000000000001 112.73 -170.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 157.86 32.34 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.266 -0.879 . . . . 60.210000000000001 111.101 172.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-30 -61.39 159.59 30.19 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.025 1.33 . . . . 74.409999999999997 112.772 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.31 4.64 3.22 Favored 'Trans proline' 0 CA--C 1.536 0.611 1 C-N-CA 125.596 4.197 . . . . 62.399999999999999 114.304 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.07 140.84 8.3 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 108.089 -2.004 . . . . 61.210000000000001 108.089 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.98 161.97 28.27 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 127.547 2.339 . . . . 64.420000000000002 108.321 171.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' CG ' HG22 ' A' ' 99' ' ' ILE . 11.7 Cg_endo -63.76 142.15 81.75 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.169 1.913 . . . . 73.439999999999998 109.258 160.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.2 m -127.23 170.9 11.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.223 1.409 . . . . 52.119999999999997 110.185 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 44.75 31.78 0.7 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 127.801 2.441 . . . . 75.420000000000002 114.951 169.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.486 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.6 mp -54.96 143.61 7.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 126.597 1.959 . . . . 74.140000000000001 109.004 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -119.15 147.25 44.4 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.573 0.749 . . . . 75.310000000000002 109.362 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.4 mt -146.36 126.72 6.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.979 -1.489 . . . . 71.319999999999993 106.979 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -141.69 173.83 11.14 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 126.924 2.09 . . . . 75.430000000000007 107.752 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -130.64 159.86 35.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.197 0.999 . . . . 60.149999999999999 108.946 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 m -152.91 165.54 17.37 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 125.855 1.662 . . . . 51.310000000000002 107.987 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.54 -29.22 84.23 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.093 1.862 . . . . 72.430000000000007 112.761 169.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -90.27 -38.22 13.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.205 0.602 . . . . 73.25 110.702 -169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.34 -165.2 26.34 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.181 1.372 . . . . 71.040000000000006 112.965 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.48 140.1 50.05 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.968 1.884 . . . . 73.219999999999999 110.258 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -85.5 96.07 9.49 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.645 1.578 . . . . 72.420000000000002 109.546 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 4.0 mm? -98.25 125.26 43.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.26 1.024 . . . . 72.430000000000007 108.745 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 p -137.48 160.81 38.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.765 0.711 . . . . 63.109999999999999 109.262 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.444 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.11 166.97 31.9 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.939 0.896 . . . . 74.040000000000006 109.703 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -101.43 159.91 28.08 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.884 -0.579 . . . . 73.239999999999995 111.395 -175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.35 175.49 9.28 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 124.697 3.598 . . . . 55.539999999999999 113.138 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.57 117.02 4.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.044 1.829 . . . . 74.109999999999999 108.707 167.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 m -151.32 19.31 0.75 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.033 1.333 . . . . 75.340000000000003 112.816 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -104.5 -62.16 2.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.44 -1.319 . . . . 64.400000000000006 107.44 168.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 t -116.81 161.57 19.07 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.996 -1.113 . . . . 51.299999999999997 107.996 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 m -68.69 -66.66 0.55 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.408 0.683 . . . . 72.209999999999994 110.367 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 171.86 2.47 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 122.159 0.866 . . . . 43.509999999999998 111.793 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -110.85 76.56 0.98 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.671 -1.974 . . . . 74.340000000000003 105.671 163.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -64.83 147.42 12.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.117 -1.068 . . . . 75.319999999999993 108.117 170.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.5 pt -130.9 -26.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.656 1.982 . . . . 75.120000000000005 110.106 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -168.07 -175.33 2.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.871 1.669 . . . . 73.299999999999997 107.451 175.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -127.14 167.89 15.4 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.118 -1.614 . . . . 73.239999999999995 109.128 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 t -143.67 168.69 19.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.999 -1.063 . . . . 64.120000000000005 111.507 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG13 HG12 ' A' ' 99' ' ' ILE . 21.7 t -149.45 128.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.282 -1.377 . . . . 40.329999999999998 107.282 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.62 144.58 43.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.253 1.021 . . . . 74.010000000000005 108.594 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.418 HD22 HG11 ' A' ' 67' ' ' VAL . 14.3 tp -120.73 136.15 54.95 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.342 2.657 . . . . 75.209999999999994 107.662 -175.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.13 130.59 41.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.52 1.963 . . . . 73.329999999999998 109.249 172.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.7 171.59 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.826 1.25 . . . . 75.010000000000005 109.217 177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -82.02 100.01 9.48 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.11 0.964 . . . . 74.450000000000003 108.822 161.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.37 -176.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 131.08 3.752 . . . . 64.010000000000005 106.481 167.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 t -141.43 -174.81 4.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.356 1.462 . . . . 70.150000000000006 109.268 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 64.53 100.18 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.704 2.401 . . . . 71.319999999999993 112.624 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.74 173.12 11.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.566 1.946 . . . . 65.349999999999994 110.198 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 p 174.9 135.84 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.058 1.743 . . . . 70.329999999999998 110.595 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.89 -3.44 0.03 OUTLIER Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.736 1.454 . . . . 63.039999999999999 116.736 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.1 156.9 63.38 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.607 1.704 . . . . 72.310000000000002 112.968 -172.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.42 174.92 10.12 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.092 3.195 . . . . 64.439999999999998 112.174 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? 62.29 5.49 1.57 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.028 1.731 . . . . 54.439999999999998 112.241 -174.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.06 -72.5 0.07 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.746 -1.221 . . . . 65.099999999999994 108.164 -155.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.6 t 65.32 -74.17 0.06 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.721 2.408 . . . . 42.130000000000003 108.191 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 t -165.96 144.43 4.87 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 127.058 2.143 . . . . 73.219999999999999 105.565 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -85.52 82.87 1.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.893 2.395 . . . . 63.210000000000001 109.771 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.34 98.09 0.01 OUTLIER 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.779 2.432 . . . . 74.140000000000001 114.748 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -80.46 34.84 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.54 1.136 . . . . 74.010000000000005 111.739 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.41 HD13 ' CE2' ' A' ' 64' ' ' PHE . 1.4 mt -152.15 148.02 27.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.27 3.028 . . . . 75.420000000000002 103.726 -166.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.23 114.06 24.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.859 -0.793 . . . . 63.32 108.859 171.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CE2' HD13 ' A' ' 62' ' ' LEU . 17.4 m-85 -133.82 161.15 35.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.339 1.455 . . . . 74.430000000000007 108.812 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.4 ttp -105.5 130.39 53.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.957 1.303 . . . . 64.040000000000006 107.629 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm-85 -71.95 85.95 0.99 Allowed 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.987 -1.116 . . . . 74.109999999999999 107.987 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG11 HD22 ' A' ' 43' ' ' LEU . 3.5 m -65.39 -48.5 82.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.377 0.608 . . . . 63.409999999999997 109.857 178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -73.84 104.77 4.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.846 1.258 . . . . 71.019999999999996 109.882 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.5 t -160.2 75.93 0.6 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.656 -0.868 . . . . 74.140000000000001 108.656 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.24 46.8 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.001 -1.095 . . . . 45.240000000000002 114.445 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.66 -7.09 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.935 3.757 . . . . 73.099999999999994 112.449 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.4 m -48.32 144.34 6.37 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.356 1.862 . . . . 62.119999999999997 112.362 -169.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.89 109.79 2.0 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.339 2.026 . . . . 73.239999999999995 109.121 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.57 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.818 1.647 . . . . 71.409999999999997 108.943 -170.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.2 t -171.49 159.89 5.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 121.608 2.004 . . . . 74.209999999999994 109.248 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -130.82 97.74 4.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.045 1.738 . . . . 74.019999999999996 106.351 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.83 117.03 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 106.855 -1.535 . . . . 73.430000000000007 106.855 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -60.66 148.07 39.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.492 0.587 . . . . 73.239999999999995 109.951 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.4 p -55.23 -32.15 62.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.186 0.994 . . . . 64.409999999999997 112.833 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -61.41 -28.32 69.17 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.643 1.111 . . . . 72.140000000000001 113.216 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -70.31 -38.16 74.9 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.593 -1.317 . . . . 74.030000000000001 109.708 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.7 mt -62.04 -40.63 96.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.872 0.869 . . . . 73.349999999999994 108.912 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.5 m -59.46 -14.24 11.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.584 1.554 . . . . 60.030000000000001 115.072 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -115.82 -3.92 12.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.335 0.97 . . . . 54.219999999999999 111.401 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.12 153.12 22.63 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.016 0.926 . . . . 74.439999999999998 110.189 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -137.51 158.14 45.02 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.883 1.273 . . . . 75.25 109.654 -167.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.8 mm -119.77 137.35 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 110.92 -149.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.5 48.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.848 1.659 . . . . 74.420000000000002 110.8 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -57.85 -12.74 3.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.575 1.15 . . . . 73.530000000000001 113.364 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -17.91 60.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.646 1.178 . . . . 64.129999999999995 112.107 170.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -130.07 -58.19 1.08 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.813 1.645 . . . . 72.230000000000004 110.134 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.8 mtpp -150.79 162.08 28.18 Favored Pre-proline 0 C--N 1.341 0.23 0 C-N-CA 124.753 1.221 . . . . 75.129999999999995 110.268 -174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.71 87.85 0.43 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.477 1.451 . . . . 54.119999999999997 108.805 155.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HB1' ' H ' ' A' ' 115' ' ' TRP . . . -151.61 155.45 38.43 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.74 2.016 . . . . 54.439999999999998 110.428 166.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mt -80.67 -25.22 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 116.295 1.961 . . . . 73.040000000000006 116.295 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mm 61.19 151.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 130.754 3.622 . . . . 71.409999999999997 111.625 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -127.77 145.23 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.65 -1.241 . . . . 75.319999999999993 107.65 166.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.53 99.76 8.22 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.555 -1.646 . . . . 72.019999999999996 106.555 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 26' ' ' TRP . 44.0 mt -109.29 127.46 66.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 104.811 -2.292 . . . . 61.399999999999999 104.811 -170.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . . . -150.25 163.76 37.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.382 1.087 . . . . 72.200000000000003 113.334 171.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.75 123.63 30.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.777 1.631 . . . . 51.210000000000001 107.516 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -76.33 104.97 7.12 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.489 -1.671 . . . . 72.200000000000003 106.489 164.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -123.82 -179.47 4.4 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.912 1.285 . . . . 74.310000000000002 110.155 171.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.74 -28.62 60.85 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.011 0.745 . . . . 75.120000000000005 113.011 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -65.71 -13.41 59.22 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.933 0.893 . . . . 64.430000000000007 111.997 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.38 169.19 45.67 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 124.847 1.213 . . . . 60.409999999999997 111.018 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -67.83 73.9 0.18 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.727 2.011 . . . . 75.040000000000006 111.159 178.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 -64.77 2.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.039 1.78 . . . . 55.399999999999999 110.044 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.28 163.64 35.49 Favored 'Trans proline' 0 C--N 1.352 0.743 0 CA-C-N 120.04 1.92 . . . . 73.0 111.493 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.68 100.67 1.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.231 -1.766 . . . . 61.100000000000001 106.231 168.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -79.18 93.87 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.104 -1.443 . . . . 72.340000000000003 107.104 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -76.76 84.55 3.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.642 1.577 . . . . 42.149999999999999 108.177 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -82.78 167.63 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.942 -1.133 . . . . 72.200000000000003 107.942 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 152.01 51.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.702 -0.851 . . . . 73.349999999999994 108.702 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.546 ' H ' ' HB1' ' A' ' 94' ' ' ALA . 1.7 t90 -120.7 102.42 8.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-O 122.981 1.372 . . . . 73.25 113.297 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -91.93 14.06 16.78 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.435 -0.802 . . . . 53.030000000000001 111.201 -169.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -72.13 -2.0 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.195 -0.907 . . . . 75.239999999999995 110.913 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -82.54 52.11 2.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 120.84 1.655 . . . . 75.439999999999998 112.193 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.87 160.68 42.0 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.719 1.208 . . . . 72.209999999999994 109.444 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.3 m -60.52 104.51 0.34 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.26 1.024 . . . . 74.510000000000005 109.977 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -146.82 161.93 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.981 1.712 . . . . 72.549999999999997 107.292 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -157.55 173.6 16.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.984 1.714 . . . . 64.230000000000004 106.424 175.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.8 m 55.94 38.99 30.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.441 1.497 . . . . 53.140000000000001 112.028 164.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.7 m -90.16 -44.51 9.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.425 1.49 . . . . 64.409999999999997 111.491 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -103.75 -168.24 25.34 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 124.794 1.188 . . . . 72.450000000000003 111.856 -165.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.246 0.872 0 C-N-CA 126.006 1.722 . . . . 74.319999999999993 106.654 178.189 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.36 -1.496 . . . . 72.299999999999997 109.36 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.8 m 71.89 44.82 0.45 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.102 2.161 . . . . 73.530000000000001 112.898 174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mp 65.55 160.49 0.13 Allowed Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 127.434 2.293 . . . . 60.329999999999998 112.525 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.14 -55.23 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.644 1.562 . . . . 71.140000000000001 110.601 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.92 167.32 38.07 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.066 -1.213 . . . . 55.420000000000002 110.066 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.45 154.98 70.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 124.116 0.967 . . . . 74.219999999999999 110.251 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -74.88 172.03 17.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.287 2.658 . . . . 72.329999999999998 111.781 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.01 -113.7 3.72 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.808 -1.717 . . . . 74.200000000000003 108.808 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.14 155.18 0.15 Allowed Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 129.936 3.294 . . . . 73.540000000000006 111.0 -162.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.84 141.63 59.85 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.43 1.42 . . . . 65.129999999999995 108.924 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -137.5 -169.54 2.54 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.057 2.143 . . . . 74.239999999999995 107.938 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.3 34.8 3.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.108 1.763 . . . . 52.200000000000003 112.194 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -71.06 131.12 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.436 -0.95 . . . . 70.230000000000004 108.436 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -133.06 151.31 52.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.848 1.659 . . . . 74.519999999999996 108.393 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 24' ' ' LEU . 30.8 mt -142.73 91.79 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 105.041 -2.207 . . . . 72.439999999999998 105.041 -172.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -88.19 108.32 19.22 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.251 -1.018 . . . . 64.129999999999995 108.251 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.98 139.71 45.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.315 0.646 . . . . 73.030000000000001 109.9 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -148.67 166.52 15.25 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 123.564 0.746 . . . . 65.430000000000007 111.056 -173.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -51.42 -46.67 30.1 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.9 1.733 . . . . 73.400000000000006 111.281 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -28.61 65.11 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.297 1.039 . . . . 72.400000000000006 111.424 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -104.31 0.26 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.569 -1.413 . . . . 74.299999999999997 109.569 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.76 120.97 6.24 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.793 -1.188 . . . . 45.32 107.793 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.53 134.47 51.34 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.597 1.159 . . . . 71.019999999999996 108.903 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' CD2' HG23 ' A' ' 15' ' ' ILE . 13.9 mt -116.35 144.23 44.53 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.555 -0.535 . . . . 73.329999999999998 109.555 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.2 p -140.21 160.66 39.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 117.83 -1.081 . . . . 71.010000000000005 108.174 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -159.97 173.75 15.41 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.842 1.657 . . . . 71.439999999999998 108.875 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.47 162.8 20.06 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.419 1.088 . . . . 72.230000000000004 110.263 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.78 155.73 43.98 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.748 2.298 . . . . 45.43 111.154 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.62 149.39 23.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.067 2.512 . . . . 74.329999999999998 111.573 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 t 76.48 135.6 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.885 2.474 . . . . 72.319999999999993 109.466 -160.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.96 -27.53 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 113.821 -1.536 . . . . 65.219999999999999 108.48 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.2 p -87.65 175.27 7.97 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.756 -1.215 . . . . 74.129999999999995 110.233 172.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 p -45.79 -48.98 15.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.692 1.597 . . . . 65.5 114.094 -169.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.94 -169.99 41.52 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.426 -1.469 . . . . 61.130000000000003 109.426 -168.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -142.19 52.31 1.47 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.307 1.443 . . . . 74.340000000000003 109.493 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.39 142.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.74 -0.837 . . . . 71.239999999999995 108.74 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.4 pt -136.09 -15.59 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.684 1.993 . . . . 71.340000000000003 111.651 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -169.42 -168.06 0.77 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.048 2.139 . . . . 74.010000000000005 107.602 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.23 -178.6 5.93 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.331 -1.481 . . . . 74.200000000000003 110.077 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -145.78 155.33 42.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.258 1.023 . . . . 54.100000000000001 111.24 167.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -146.75 93.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.408 2.683 . . . . 74.239999999999995 105.15 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -95.98 130.11 43.06 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.825 -1.176 . . . . 65.200000000000003 107.825 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.69 124.07 34.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.663 1.119 . . . . 73.040000000000006 107.993 -168.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.46 129.49 40.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.733 0.697 . . . . 73.030000000000001 110.99 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.2 pt -132.31 171.09 18.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 106.15 -1.796 . . . . 73.019999999999996 106.15 166.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -81.49 88.89 6.14 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 73.219999999999999 108.599 172.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.1 t -165.07 -178.63 5.24 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.669 1.987 . . . . 65.040000000000006 107.212 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 t -143.49 165.78 26.61 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.376 -0.972 . . . . 71.409999999999997 108.376 153.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -147.09 160.91 41.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.521 1.129 . . . . 54.109999999999999 109.914 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.08 81.77 1.75 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.293 1.037 . . . . 54.210000000000001 110.903 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.82 123.88 4.23 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 104.925 -2.25 . . . . 73.120000000000005 104.925 171.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.64 -128.44 3.49 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 107.385 -2.286 . . . . 54.32 107.385 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 5.3 mt-10 -130.93 167.04 23.19 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.249 1.419 . . . . 54.509999999999998 109.205 168.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 53' ' ' GLU . 87.6 Cg_endo -62.34 -164.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 125.123 3.882 . . . . 64.0 111.113 169.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.1 tttt 66.68 47.57 1.56 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.056 -1.028 . . . . 73.5 111.571 165.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.7 m 58.87 43.86 17.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.613 1.165 . . . . 73.439999999999998 110.099 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.1 -36.7 0.37 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.319 3.047 . . . . 64.409999999999997 113.609 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.276 13.5 t 48.08 159.11 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.071 1 C-N-CA 132.209 4.203 . . . . 64.140000000000001 111.994 -170.634 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.19 171.55 17.62 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.322 2.015 . . . . 61.310000000000002 111.291 165.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 56.06 37.76 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.656 1.982 . . . . 75.439999999999998 112.854 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -67.55 165.07 17.62 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.501 1.521 . . . . 75.319999999999993 108.571 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.83 165.9 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.668 -1.605 . . . . 74.310000000000002 106.668 173.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -143.68 113.37 7.07 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.143 -0.688 . . . . 62.210000000000001 109.143 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -134.0 -179.51 5.6 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.861 1.665 . . . . 72.349999999999994 110.506 -165.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.9 ptm -80.94 165.92 21.33 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.895 -1.15 . . . . 72.349999999999994 107.895 167.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -125.42 83.02 2.12 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.109 -1.441 . . . . 74.329999999999998 107.109 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.9 m -60.75 -38.44 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.966 -0.459 . . . . 73.129999999999995 110.282 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -54.59 110.57 0.65 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.361 . . . . 70.400000000000006 112.533 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.9 p -147.81 24.55 1.07 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.379 0.672 . . . . 74.319999999999993 111.883 165.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.83 163.78 29.72 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.298 -0.723 . . . . 31.010000000000002 112.456 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.06 -54.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.376 2.717 . . . . 54.310000000000002 110.524 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.18 143.86 96.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.06 -1.089 . . . . 64.400000000000006 108.06 171.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.9 -46.42 1.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.514 2.143 . . . . 65.209999999999994 109.935 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 p -66.04 77.0 0.09 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.399 2.68 . . . . 74.019999999999996 108.778 168.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.6 t -96.17 -173.17 2.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.39 2.276 . . . . 51.539999999999999 109.54 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.09 159.97 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.786 -1.196 . . . . 74.219999999999999 109.656 171.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -117.48 115.03 47.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 105.557 -2.016 . . . . 61.219999999999999 105.557 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 151.11 45.43 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.587 1.155 . . . . 71.200000000000003 111.159 -168.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 p -51.82 -43.58 63.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.757 1.623 . . . . 71.340000000000003 111.96 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.5 t -51.43 -63.43 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.495 1.518 . . . . 51.25 110.235 175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -60.77 -33.93 73.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.051 0.54 . . . . 73.230000000000004 110.932 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.2 mt -66.85 -23.11 65.98 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 117.974 -1.012 . . . . 74.109999999999999 111.778 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.3 t -56.42 -24.4 44.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.495 1.043 . . . . 72.25 111.884 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -102.83 1.41 34.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.944 0.898 . . . . 73.040000000000006 111.687 -175.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.7 120.87 13.76 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.627 0.649 . . . . 75.409999999999997 109.621 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -83.26 148.05 27.62 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.485 -0.931 . . . . 72.230000000000004 108.485 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -110.69 147.28 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.108 -0.701 . . . . 75.420000000000002 109.108 -163.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.65 71.0 0.7 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.854 1.662 . . . . 72.430000000000007 111.769 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -76.26 53.0 0.79 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.154 1.782 . . . . 74.209999999999994 108.238 170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.52 -55.23 0.34 Allowed 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.067 -1.02 . . . . 63.219999999999999 108.734 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.7 m -94.08 -68.63 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.808 -0.558 . . . . 75.329999999999998 110.121 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -148.14 144.31 18.69 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 125.587 1.555 . . . . 55.32 106.975 167.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -67.42 108.01 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.959 1.773 . . . . 73.439999999999998 111.238 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 116' ' ' LEU 0.264 . . -147.57 165.54 30.05 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 131.318 3.847 . . . . 75.109999999999999 107.369 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.23 137.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.606 -1.627 . . . . 74.040000000000006 106.606 160.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.9 mm -100.93 152.51 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.373 1.469 . . . . 63.240000000000002 109.29 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -134.73 129.2 34.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.032 1.333 . . . . 73.010000000000005 109.162 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -96.14 89.89 5.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.791 -1.559 . . . . 73.129999999999995 106.791 165.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.2 mt -94.33 134.88 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.705 -1.591 . . . . 74.030000000000001 106.705 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.7 144.09 25.88 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.528 0.731 . . . . 74.030000000000001 109.748 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.61 152.21 37.69 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.298 0.639 . . . . 73.129999999999995 110.448 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.1 98.33 8.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.482 -2.044 . . . . 71.099999999999994 105.482 171.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -129.6 -171.02 2.41 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.272 1.429 . . . . 73.439999999999998 108.519 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -61.05 -35.36 76.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.485 0.55 . . . . 73.310000000000002 112.485 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -60.98 -26.06 67.3 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.882 1.673 . . . . 74.209999999999994 112.843 -166.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.37 36.64 3.77 Favored Glycine 0 N--CA 1.462 0.423 0 N-CA-C 117.076 1.59 . . . . 72.319999999999993 117.076 156.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 55.47 92.39 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 129.832 3.253 . . . . 74.129999999999995 113.187 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' H ' ' HD2' ' A' ' 109' ' ' PRO . . . -126.36 -70.45 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 126.728 2.108 . . . . 62.140000000000001 108.958 172.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 108' ' ' GLY . 85.9 Cg_endo -72.6 143.05 37.3 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 119.31 1.555 . . . . 73.340000000000003 109.479 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -154.72 142.92 20.34 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.583 -1.266 . . . . 61.399999999999999 107.583 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 m -108.05 109.73 21.25 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.861 -0.792 . . . . 75.040000000000006 108.861 -171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -72.4 95.18 1.72 Allowed 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.226 -1.027 . . . . 73.400000000000006 108.226 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.95 151.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 108.107 -1.072 . . . . 75.329999999999998 108.107 166.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.74 139.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.418 1.887 . . . . 74.310000000000002 106.751 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -124.18 100.14 6.57 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.503 0.721 . . . . 75.409999999999997 109.943 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 6.2 mp -90.18 42.64 1.11 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 122.611 1.196 . . . . 74.209999999999994 110.285 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.01 7.83 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.007 2.123 . . . . 71.329999999999998 109.38 176.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -27.86 66.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.719 0.691 . . . . 73.129999999999995 112.649 176.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.8 m -65.61 152.38 44.26 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.168 1.787 . . . . 62.25 110.517 -172.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.7 p -78.92 126.14 30.3 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.495 -0.753 . . . . 72.340000000000003 110.847 -165.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -139.69 -79.05 0.31 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 118.504 -0.76 . . . . 63.420000000000002 110.421 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -164.38 -84.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.582 0.753 . . . . 74.140000000000001 109.996 -166.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.6 t 61.77 83.26 0.15 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.015 1.726 . . . . 74.0 110.509 -164.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 t -130.65 158.65 39.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.992 -1.114 . . . . 72.299999999999997 107.992 158.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 154.93 -170.12 33.13 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.209 -1.957 . . . . 61.0 108.209 -169.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.027 0 N-CA-C 108.616 -0.883 . . . . 71.409999999999997 108.616 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.816 0 N-CA-C 109.663 -1.375 . . . . 43.350000000000001 109.663 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 90.7 m -93.23 6.08 49.28 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.216 1.008 . . . . 63.450000000000003 113.473 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.1 mt 75.91 149.82 0.13 Allowed Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 128.685 2.794 . . . . 74.109999999999999 110.141 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.18 -14.72 35.08 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.097 2.531 . . . . 70.040000000000006 114.176 -166.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.69 -178.65 47.42 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 106.863 -2.495 . . . . 72.329999999999998 106.863 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -116.54 86.1 17.78 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 123.955 0.902 . . . . 71.409999999999997 109.585 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.44 -20.61 13.96 Favored 'Trans proline' 0 C--N 1.347 0.472 1 C-N-CA 125.827 4.352 . . . . 72.150000000000006 113.048 -166.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.53 156.86 48.29 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.022 -1.231 . . . . 64.120000000000005 110.022 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.79 165.57 9.46 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 126.728 2.011 . . . . 52.229999999999997 107.176 -175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -61.47 146.17 97.32 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.466 1.444 . . . . 72.030000000000001 109.723 161.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.7 176.5 7.48 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.337 1.455 . . . . 71.329999999999998 109.422 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . . . 44.29 31.75 0.61 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 128.815 2.846 . . . . 73.299999999999997 113.82 174.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.97 133.28 27.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.158 -1.053 . . . . 72.010000000000005 108.158 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -129.49 142.44 50.78 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 123.546 0.738 . . . . 73.340000000000003 109.244 173.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.53 128.98 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 103.251 -2.87 . . . . 71.430000000000007 103.251 174.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.1 m -147.14 137.08 23.18 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.562 1.145 . . . . 65.209999999999994 108.257 -174.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -64.18 144.89 56.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.379 -0.971 . . . . 63.409999999999997 108.379 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.0 162.16 53.71 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 126.888 2.075 . . . . 72.420000000000002 106.424 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.47 -10.89 27.65 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.028 1.152 . . . . 65.299999999999997 112.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.141 0.882 . . . . 64.430000000000007 111.702 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -118.37 0.83 Allowed Glycine 0 C--N 1.342 0.886 0 O-C-N 120.494 -1.379 . . . . 62.140000000000001 110.763 -172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.47 132.45 26.08 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 118.537 1.169 . . . . 32.049999999999997 110.963 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.24 149.59 50.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.128 1.371 . . . . 41.340000000000003 109.44 162.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 26' ' ' TRP . 2.9 mp -142.22 123.26 14.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.646 1.578 . . . . 72.230000000000004 108.702 166.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.8 p -133.35 156.96 46.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.092 -0.707 . . . . 53.420000000000002 109.092 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -148.68 178.57 8.53 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.816 0.446 . . . . 73.299999999999997 110.577 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 9.2 mm-40 -139.39 159.52 65.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.114 1.766 . . . . 71.140000000000001 110.363 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.22 167.35 26.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.156 2.57 . . . . 73.030000000000001 111.05 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.45 -55.58 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.649 2.233 . . . . 73.239999999999995 110.71 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.46 39.92 8.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.474 -1.306 . . . . 64.239999999999995 107.474 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.07 -49.96 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.99 1.316 . . . . 73.340000000000003 113.75 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -64.68 154.66 35.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.099 1.318 . . . . 70.420000000000002 109.864 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -95.41 55.43 1.72 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.681 0.792 . . . . 70.140000000000001 109.572 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.53 134.18 11.64 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 108.561 -1.815 . . . . 70.230000000000004 108.561 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -81.66 82.12 7.5 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.162 -1.051 . . . . 65.340000000000003 108.162 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.72 131.85 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.739 -1.578 . . . . 74.349999999999994 106.739 168.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.0 pt -126.86 -24.24 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.869 1.267 . . . . 65.239999999999995 111.36 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -163.3 -170.53 2.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.209 1.404 . . . . 74.409999999999997 107.606 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.37 177.54 8.95 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.665 1.186 . . . . 73.040000000000006 110.302 178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.48 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -135.43 154.56 51.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.15 1.38 . . . . 70.150000000000006 108.601 163.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -143.72 112.24 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.432 -2.062 . . . . 70.120000000000005 105.432 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CE2' ' HB3' ' A' ' 40' ' ' SER . 87.3 m-85 -110.93 150.95 28.48 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.337 1.055 . . . . 64.25 109.742 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.78 121.31 25.15 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.342 1.857 . . . . 74.409999999999997 106.045 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.33 121.81 15.2 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.227 1.011 . . . . 71.019999999999996 110.771 175.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 pt -136.79 -177.11 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.325 1.45 . . . . 61.009999999999998 109.084 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . 0.277 3.5 pp0? -130.97 64.36 1.58 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 123.292 1.52 . . . . 74.310000000000002 112.767 171.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.0 m -149.94 162.88 39.47 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.269 1.828 . . . . 73.200000000000003 108.591 162.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.9 m 50.7 -154.55 0.14 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 75.040000000000006 112.83 159.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -149.91 167.84 25.49 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.44 1.096 . . . . 71.040000000000006 109.365 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.67 -174.39 2.89 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.212 0.605 . . . . 73.430000000000007 110.708 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.85 115.86 5.29 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 105.224 -2.139 . . . . 71.319999999999993 105.224 173.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 145.22 114.68 0.92 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 119.793 1.179 . . . . 64.439999999999998 110.363 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.19 164.77 20.32 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 127.058 2.143 . . . . 70.409999999999997 108.356 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.75 -170.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.02 2.48 . . . . 74.319999999999993 110.49 164.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -83.19 48.55 1.4 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.72 2.008 . . . . 73.120000000000005 107.795 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.0 t 70.8 84.9 0.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.719 2.407 . . . . 54.43 108.556 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -144.48 16.1 1.65 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 71.230000000000004 111.799 169.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.2 m -121.66 80.56 39.87 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-N 119.614 1.097 . . . . 54.509999999999998 109.087 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.47 64.22 7.98 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.933 2.422 . . . . 74.019999999999996 109.96 169.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.45 93.7 0.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 127.818 2.447 . . . . 74.329999999999998 105.46 170.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -64.17 138.41 58.43 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.643 -0.503 . . . . 72.230000000000004 109.643 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.402 HD22 ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -144.01 160.94 39.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.766 0.826 . . . . 72.109999999999999 110.589 -175.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.78 102.85 4.84 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.856 1.262 . . . . 72.329999999999998 109.655 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 62' ' ' LEU . 22.6 m-85 -132.37 152.36 51.48 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.881 1.272 . . . . 52.439999999999998 109.58 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.1 ttp -78.34 5.0 11.45 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.457 1.28 . . . . 74.340000000000003 114.457 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.39 58.65 3.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.403 1.481 . . . . 65.030000000000001 112.155 175.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.79 -13.34 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.542 0.737 . . . . 62.200000000000003 112.9 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -63.21 -177.05 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.009 1.323 . . . . 64.109999999999999 112.063 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 44.7 m 62.57 42.69 8.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.455 1.902 . . . . 63.439999999999998 109.7 -168.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -78.57 155.88 42.04 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.111 -1.196 . . . . 72.0 110.111 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.74 -20.41 52.52 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.546 2.831 . . . . 74.439999999999998 112.692 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -135.05 149.37 70.11 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.95 1.3 . . . . 72.040000000000006 110.573 167.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.7 176.82 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 124.484 3.456 . . . . 42.109999999999999 111.86 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.6 p 46.63 40.71 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.45 1.5 . . . . 54.310000000000002 110.707 -170.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.66 123.88 23.5 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.22 1.808 . . . . 52.399999999999999 112.139 -167.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.39 147.37 26.29 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.933 1.293 . . . . 71.099999999999994 108.403 159.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.45 115.53 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.08 2.152 . . . . 71.340000000000003 105.711 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -65.53 154.38 38.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 123.801 0.84 . . . . 71.129999999999995 110.776 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -63.63 -19.25 64.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.633 1.173 . . . . 54.310000000000002 112.145 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -37.67 69.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.108 1.763 . . . . 73.400000000000006 111.204 173.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.8 m -71.64 -41.9 68.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.775 0.83 . . . . 73.120000000000005 111.267 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.26 -26.19 67.23 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.4 1.08 . . . . 74.439999999999998 111.931 -175.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.49 -33.33 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.233 1.413 . . . . 52.530000000000001 110.602 169.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.31 -18.82 23.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.113 1.365 . . . . 71.319999999999993 112.267 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.71 9.94 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.16 1.384 . . . . 74.010000000000005 109.665 -170.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.47 147.49 23.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.675 0.79 . . . . 73.0 109.207 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -103.13 140.73 20.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.443 0.64 . . . . 74.209999999999994 109.305 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -59.2 110.45 1.07 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.576 1.95 . . . . 74.340000000000003 109.643 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -112.93 14.29 19.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.205 1.002 . . . . 70.129999999999995 110.512 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 82.6 p -102.53 -18.85 15.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.947 1.299 . . . . 51.229999999999997 112.696 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.91 -81.03 0.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 70.310000000000002 108.67 172.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -142.86 149.13 48.58 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 117.044 -1.455 . . . . 70.420000000000002 109.352 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.67 98.56 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 64.140000000000001 110.869 -171.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -150.97 164.74 35.67 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.475 1.91 . . . . 65.040000000000006 108.969 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.418 HD12 ' CE3' ' A' ' 115' ' ' TRP . 88.1 mt -83.83 128.21 39.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.381 -1.711 . . . . 64.299999999999997 106.381 167.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.8 mm -76.88 132.07 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.683 -1.228 . . . . 73.430000000000007 107.683 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -118.2 143.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.5 -1.296 . . . . 74.340000000000003 107.5 168.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.16 119.83 35.9 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 106.365 -1.717 . . . . 71.439999999999998 106.365 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.44 137.06 58.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.302 -1.74 . . . . 64.030000000000001 106.302 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 144.89 27.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.415 0.686 . . . . 71.25 110.493 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.42 121.38 20.41 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.626 1.17 . . . . 63.32 109.915 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.64 81.3 6.93 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 104.946 -2.242 . . . . 71.109999999999999 104.946 166.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.12 165.62 11.81 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.273 -0.639 . . . . 74.120000000000005 109.273 164.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.9 -18.82 5.42 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.527 1.677 . . . . 74.450000000000003 115.527 -167.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -86.88 -13.05 45.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 117.778 -1.106 . . . . 74.049999999999997 113.316 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.26 172.91 16.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 119.566 1.075 . . . . 71.140000000000001 112.761 -174.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -73.17 57.3 0.48 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.997 1.319 . . . . 74.030000000000001 109.977 166.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.05 3.9 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 119.031 -0.871 . . . . 73.109999999999999 111.116 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.29 158.47 57.44 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.64 1.56 . . . . 71.450000000000003 109.532 171.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -146.33 122.14 10.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.463 -1.68 . . . . 65.010000000000005 106.463 169.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.6 m -92.86 108.98 20.41 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.556 -1.646 . . . . 72.030000000000001 106.556 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -67.51 128.55 36.86 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.156 -1.794 . . . . 72.430000000000007 106.156 163.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.2 154.19 31.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.082 -1.821 . . . . 74.329999999999998 106.082 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.11 157.33 39.96 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.225 -1.028 . . . . 72.439999999999998 108.225 163.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.418 ' CE3' HD12 ' A' ' 95' ' ' ILE . 18.1 t90 -108.35 91.28 3.58 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.669 -1.604 . . . . 74.200000000000003 106.669 172.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 94' ' ' ALA . 17.2 mt -75.9 175.15 9.06 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.685 -0.857 . . . . 65.109999999999999 108.685 175.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 76.24 13.16 2.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.177 2.191 . . . . 74.219999999999999 112.637 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.11 162.31 17.62 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.698 1.237 . . . . 61.119999999999997 111.572 165.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.7 p -145.64 172.23 13.57 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 129.191 2.997 . . . . 72.200000000000003 106.833 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 m -51.87 -61.85 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.607 1.163 . . . . 73.019999999999996 111.653 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.546 ' HG2' ' H ' ' A' ' 122' ' ' ASP . 20.4 tttt 50.37 -179.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.691 2.396 . . . . 65.420000000000002 113.023 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.546 ' H ' ' HG2' ' A' ' 121' ' ' LYS . 8.8 p-10 -161.69 111.46 1.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.56 2.344 . . . . 70.420000000000002 106.332 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.1 t -172.69 157.23 3.74 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.447 2.299 . . . . 70.340000000000003 107.177 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.4 t -124.79 -170.53 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.576 1.15 . . . . 72.0 110.207 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -127.26 -126.79 2.95 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.903 1.239 . . . . 74.340000000000003 110.696 -175.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.878 1.671 . . . . 50.509999999999998 106.646 -179.31 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.591 0 N-CA-C 110.502 -1.039 . . . . 73.129999999999995 110.502 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 87.5 m -78.09 177.28 8.45 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.045 0.938 . . . . 75.329999999999998 112.135 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.589 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.7 pt? -98.57 155.54 36.67 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.203 1.801 . . . . 64.5 109.08 166.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.05 64.78 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.253 2.635 . . . . 64.230000000000004 111.72 -175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.18 156.65 25.87 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.665 -1.374 . . . . 73.299999999999997 109.665 171.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.36 163.5 39.25 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.722 -0.473 . . . . 72.109999999999999 109.722 168.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.84 84.18 2.08 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.096 2.531 . . . . 64.5 111.826 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.08 123.92 0.83 Allowed Glycine 0 C--N 1.338 0.668 0 O-C-N 121.005 -1.059 . . . . 75.109999999999999 115.73 171.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.71 157.83 40.54 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.294 1.438 . . . . 74.109999999999999 109.646 166.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.27 164.25 24.44 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.702 3.601 . . . . 74.430000000000007 112.419 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.5 m -137.58 -174.48 3.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.951 1.3 . . . . 61.509999999999998 110.005 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . . . 58.42 14.68 3.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.931 2.492 . . . . 75.549999999999997 116.986 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.491 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.7 mp -56.48 141.28 13.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 126.558 1.943 . . . . 75.530000000000001 112.031 -168.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -139.82 116.52 10.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.331 1.452 . . . . 72.109999999999999 110.609 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 mt -115.96 131.48 68.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 103.842 -2.651 . . . . 55.329999999999998 103.842 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 m -143.28 149.12 37.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.625 0.726 . . . . 63.530000000000001 110.346 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -74.06 159.24 32.94 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.506 -0.924 . . . . 74.549999999999997 108.506 162.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 m -143.77 166.32 20.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 130.208 3.403 . . . . 55.049999999999997 105.607 170.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -54.42 -44.08 52.81 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.678 1.585 . . . . 63.119999999999997 111.781 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -12.18 59.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.9 1.68 . . . . 72.150000000000006 113.501 -170.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.89 -160.72 29.88 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.123 -1.191 . . . . 53.140000000000001 110.123 -172.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.69 116.15 30.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.228 1.011 . . . . 61.450000000000003 109.216 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -69.25 140.23 54.46 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 129.603 3.161 . . . . 71.439999999999998 111.454 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 mp -130.27 128.86 42.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.927 -1.138 . . . . 73.510000000000005 107.927 173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.1 p -133.03 150.25 52.15 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.637 -0.875 . . . . 71.319999999999993 108.637 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.422 ' CD1' HG23 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.99 173.89 11.5 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.286 0.366 . . . . 74.329999999999998 110.272 173.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 25.2 pt-20 -66.85 154.62 91.66 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 119.806 -0.758 . . . . 74.329999999999998 112.277 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.36 160.84 44.01 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.752 2.302 . . . . 75.200000000000003 111.586 173.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HB2' HD13 ' A' ' 36' ' ' ILE . 62.6 Cg_endo -71.27 89.58 0.69 Allowed 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.905 3.07 . . . . 60.240000000000002 112.182 -172.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -152.76 23.7 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.042 0.756 . . . . 55.219999999999999 113.042 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.4 t -126.23 -86.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.011 -0.995 . . . . 74.439999999999998 110.894 -171.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.6 p -131.75 -4.11 3.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.344 1.429 . . . . 75.400000000000006 110.978 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 36' ' ' ILE . 12.2 p -55.66 -19.32 10.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.356 3.062 . . . . 73.430000000000007 116.179 -172.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.4 -159.66 31.05 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 121.962 2.165 . . . . 61.109999999999999 111.675 173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -79.52 93.64 5.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.822 1.649 . . . . 63.109999999999999 109.677 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 33' ' ' SER . 2.3 mp -71.4 142.23 15.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.579 -1.267 . . . . 72.230000000000004 107.579 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.9 pt -135.49 -17.2 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.783 1.633 . . . . 72.439999999999998 111.464 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -159.93 -171.71 3.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.326 1.851 . . . . 72.5 107.434 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 16.9 m-85 -134.38 174.33 10.65 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.354 -1.467 . . . . 75.140000000000001 108.937 162.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 m -144.01 155.4 44.0 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.334 -0.854 . . . . 74.239999999999995 108.799 159.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -140.06 119.35 12.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 104.747 -2.316 . . . . 73.129999999999995 104.747 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.413 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 13.6 m-85 -116.47 87.4 2.68 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.122 0.963 . . . . 72.409999999999997 109.814 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 tp -62.63 135.31 57.32 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.1 -1.444 . . . . 74.219999999999999 107.1 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.23 148.04 25.3 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.854 -0.795 . . . . 74.209999999999994 108.854 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.4 pt -147.74 -165.9 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.223 1.809 . . . . 65.409999999999997 107.306 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -58.08 179.36 0.07 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.727 1.611 . . . . 71.540000000000006 112.509 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 m 64.7 -158.2 0.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.118 1.767 . . . . 73.150000000000006 111.357 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -158.41 23.02 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.848 -1.158 . . . . 73.409999999999997 112.747 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -131.12 177.58 7.35 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.179 -0.951 . . . . 64.239999999999995 110.376 -166.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 50.88 61.67 3.12 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.866 2.066 . . . . 70.349999999999994 112.583 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 77.5 p -158.91 121.05 3.52 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.655 1.582 . . . . 53.009999999999998 107.846 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.27 96.75 0.1 Allowed Glycine 0 C--O 1.235 0.191 0 N-CA-C 109.021 -1.632 . . . . 62.130000000000003 109.021 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.02 154.44 92.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.79 0.836 . . . . 72.519999999999996 111.308 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.17 67.13 8.68 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.924 3.083 . . . . 65.540000000000006 110.353 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -110.18 6.17 22.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.191 0.997 . . . . 70.510000000000005 111.197 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.2 t 64.22 -1.77 0.67 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.754 2.022 . . . . 54.240000000000002 113.151 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -157.89 110.61 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.529 3.131 . . . . 73.540000000000006 104.265 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -127.78 68.83 75.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.971 0.908 . . . . 71.219999999999999 109.46 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.15 65.52 8.39 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 124.225 3.284 . . . . 70.439999999999998 112.073 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.419 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -157.78 105.0 1.98 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.875 2.07 . . . . 33.5 108.335 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -89.1 79.69 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.356 -1.35 . . . . 73.150000000000006 107.356 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.419 HD21 ' HB1' ' A' ' 60' ' ' ALA . 11.1 mt -69.84 -171.35 0.4 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.059 1.744 . . . . 64.150000000000006 109.768 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.32 123.39 22.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.112 -0.699 . . . . 65.219999999999999 109.112 172.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 16.7 m-85 -141.11 155.66 46.09 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.188 0.595 . . . . 74.510000000000005 112.22 -176.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ttp -89.25 -39.36 13.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.81 0.844 . . . . 51.240000000000002 112.493 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 58.01 86.19 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.282 1.433 . . . . 73.310000000000002 109.085 -159.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.77 -5.91 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.904 -0.589 . . . . 72.409999999999997 112.067 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.3 103.07 7.74 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.584 0.629 . . . . 63.43 110.798 -163.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.9 m -137.17 53.67 1.88 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.03 1.332 . . . . 71.430000000000007 109.026 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.34 160.5 29.55 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.311 -0.868 . . . . 54.140000000000001 111.228 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -82.03 -4.68 12.0 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.745 3.63 . . . . 72.219999999999999 112.591 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.0 m -43.46 89.31 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 130.047 3.339 . . . . 72.319999999999993 113.263 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -60.62 148.98 89.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.186 1.257 . . . . 73.140000000000001 111.139 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 p 46.21 47.36 13.34 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.838 1.255 . . . . 74.230000000000004 111.987 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.37 152.37 43.24 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.625 -1.297 . . . . 42.049999999999997 110.462 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.08 170.35 14.91 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.656 0.782 . . . . 63.409999999999997 110.883 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.55 122.57 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.033 1.733 . . . . 73.25 106.539 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.44 145.9 52.89 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.059 0.944 . . . . 73.129999999999995 109.657 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.428 ' HA ' HD12 ' A' ' 82' ' ' LEU . 9.8 p -54.28 -37.89 65.26 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.621 1.169 . . . . 32.210000000000001 111.649 -178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -48.77 -47.97 41.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.458 1.503 . . . . 74.420000000000002 111.268 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -78.99 -9.71 59.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.509 1.124 . . . . 24.440000000000001 112.899 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 79' ' ' SER . 74.5 mt -82.03 -34.55 29.46 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.579 1.081 . . . . 65.209999999999994 110.658 171.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -66.91 1.53 1.85 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 117.276 2.324 . . . . 73.409999999999997 117.276 -163.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -123.38 12.28 9.41 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.95 1.25 . . . . 72.140000000000001 111.505 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.01 156.72 37.24 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 122.478 1.132 . . . . 72.219999999999999 113.53 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.66 101.72 3.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.808 -1.182 . . . . 71.530000000000001 107.808 162.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.07 120.82 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 106.254 -1.758 . . . . 75.319999999999993 106.254 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.21 131.8 51.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 112.799 -2.0 . . . . 75.510000000000005 108.987 166.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.61 9.76 13.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.52 1.128 . . . . 75.540000000000006 111.162 171.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -6.5 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.799 -1.188 . . . . 71.140000000000001 113.942 -162.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.36 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.045 2.138 . . . . 73.329999999999998 111.026 173.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -151.8 156.18 34.21 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.604 1.561 . . . . 71.420000000000002 108.009 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.41 122.35 9.57 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.7 2.267 . . . . 72.409999999999997 108.748 164.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.558 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -160.47 -170.44 2.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.669 2.387 . . . . 61.450000000000003 108.645 161.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.9 mt -129.48 129.2 66.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.873 1.269 . . . . 75.540000000000006 108.53 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.5 mm -72.49 142.19 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 125.507 1.523 . . . . 62.210000000000001 110.088 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -128.21 162.25 27.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.26 1.024 . . . . 61.420000000000002 108.934 167.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -134.98 84.72 2.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.327 1.851 . . . . 71.340000000000003 106.472 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.28 133.44 42.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.032 -1.469 . . . . 75.209999999999994 107.032 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.41 156.98 44.09 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 123.575 0.547 . . . . 54.009999999999998 110.497 161.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . . . -92.35 109.44 20.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.458 1.103 . . . . 62.340000000000003 109.758 -171.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -69.09 97.98 0.94 Allowed 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.811 0.844 . . . . 74.310000000000002 109.142 -170.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -122.54 177.17 5.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.706 2.002 . . . . 61.219999999999999 110.824 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -56.63 -30.97 63.88 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.927 1.691 . . . . 74.120000000000005 113.821 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -8.96 58.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.207 1.188 . . . . 74.209999999999994 114.207 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.42 2.26 87.51 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.834 -1.166 . . . . 70.5 113.263 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' A' ' 102' ' ' ARG . 19.4 p90 45.59 36.16 2.44 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.064 1.746 . . . . 74.329999999999998 115.448 156.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.75 -66.5 2.8 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.519 2.009 . . . . 62.409999999999997 113.455 -165.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.84 152.07 81.16 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.158 1.906 . . . . 64.439999999999998 110.241 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.35 169.86 14.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.584 1.154 . . . . 55.130000000000003 108.865 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.1 m -97.26 113.99 25.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.303 0.641 . . . . 75.140000000000001 110.045 -176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.49 75.36 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.505 1.522 . . . . 75.140000000000001 110.04 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.9 155.14 7.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 107.858 -1.164 . . . . 75.430000000000007 107.858 164.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -121.74 124.59 44.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.705 -1.591 . . . . 62.409999999999997 106.705 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -75.17 82.73 2.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.132 0.424 . . . . 74.329999999999998 109.859 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 94' ' ' ALA . 27.7 mt -71.47 15.13 0.14 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.773 1.027 . . . . 74.129999999999995 113.773 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -95.74 -1.83 49.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.097 1.359 . . . . 72.140000000000001 111.637 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -109.22 161.78 14.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.835 1.198 . . . . 72.219999999999999 110.449 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.53 158.65 15.95 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.659 1.584 . . . . 64.510000000000005 106.875 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 54.2 p -87.48 11.42 14.77 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.974 1.31 . . . . 55.119999999999997 112.333 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -68.95 -59.96 2.69 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.622 -1.299 . . . . 71.150000000000006 111.684 -165.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -163.73 164.28 23.85 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 126.492 1.917 . . . . 73.349999999999994 108.154 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.6 m -146.45 131.58 18.35 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 120.051 1.296 . . . . 74.310000000000002 111.142 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.7 m -151.4 -65.42 0.18 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.257 1.023 . . . . 72.340000000000003 109.614 162.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 139.22 3.83 1.59 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.791 -1.56 . . . . 54.310000000000002 115.568 173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.201 1 C-N-CA 133.071 4.549 . . . . 74.540000000000006 107.185 -170.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.513 0 N-CA-C 109.919 -1.273 . . . . 42.32 109.919 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 65.3 m -67.86 146.76 53.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.681 0.792 . . . . 72.530000000000001 109.606 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.7 tp -149.03 72.45 10.26 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.199 0.6 . . . . 74.209999999999994 109.675 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.69 157.67 60.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.258 1.306 . . . . 61.439999999999998 109.139 163.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.16 66.28 1.71 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.616 -0.993 . . . . 73.510000000000005 110.616 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.24 161.96 75.95 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.336 0.654 . . . . 75.349999999999994 110.634 172.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.03 6.53 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.735 3.624 . . . . 64.129999999999995 114.581 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.2 143.77 15.32 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 107.958 -2.057 . . . . 71.239999999999995 107.958 170.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.3 154.7 36.42 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.053 1.341 . . . . 74.340000000000003 108.278 162.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.59 158.85 30.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.296 1.998 . . . . 71.519999999999996 111.934 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.3 p -133.09 -178.09 4.81 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.527 1.531 . . . . 75.329999999999998 109.414 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 61.21 12.98 4.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.54 1.536 . . . . 51.219999999999999 114.823 168.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.22 132.35 26.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.948 1.299 . . . . 61.409999999999997 110.049 -168.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.8 152.76 45.45 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.534 1.133 . . . . 53.0 110.934 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 mt -142.17 115.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 106.541 -1.651 . . . . 61.240000000000002 106.541 -177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -111.35 -167.7 1.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.442 2.297 . . . . 71.439999999999998 110.629 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 tttm -143.22 146.51 33.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.903 -1.147 . . . . 75.150000000000006 107.903 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -146.45 160.15 42.75 Favored Pre-proline 0 C--O 1.234 0.244 0 C-N-CA 126.234 1.814 . . . . 75.329999999999998 106.95 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.99 73.44 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.777 1.652 . . . . 71.409999999999997 111.594 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.79 -59.73 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 128.807 2.843 . . . . 61.43 105.692 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.15 -166.15 38.56 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.683 -1.367 . . . . 62.030000000000001 109.683 -163.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.14 113.72 26.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.731 1.612 . . . . 53.32 110.583 -165.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 78.42 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 129.772 3.229 . . . . 73.019999999999996 112.187 164.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.87 110.29 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.873 -1.142 . . . . 75.040000000000006 108.41 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 t -130.27 158.22 40.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.595 0.634 . . . . 44.039999999999999 111.621 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.503 ' CE3' HD13 ' A' ' 99' ' ' ILE . 25.6 p90 -173.64 175.7 2.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.23 2.612 . . . . 55.140000000000001 110.377 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -115.46 165.21 14.9 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.964 0.906 . . . . 71.129999999999995 111.932 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -63.14 156.97 51.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.685 2.923 . . . . 72.129999999999995 111.226 167.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.64 139.64 70.71 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.9 1.733 . . . . 60.109999999999999 109.596 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 t -127.67 58.95 1.47 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.77 -2.308 . . . . 64.340000000000003 104.77 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.39 -85.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.164 -1.791 . . . . 71.239999999999995 106.164 172.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.1 p -112.86 166.11 11.69 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.344 0.52 . . . . 74.329999999999998 110.425 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.7 m -56.67 -72.92 0.07 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.568 1.547 . . . . 64.140000000000001 111.546 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.43 -173.8 11.1 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.474 -1.45 . . . . 61.399999999999999 109.474 -164.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -137.23 68.54 1.41 Allowed 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.649 1.58 . . . . 74.230000000000004 107.881 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.8 140.52 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.702 -0.851 . . . . 60.530000000000001 108.702 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 pt -135.89 -21.65 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.514 1.526 . . . . 71.129999999999995 111.34 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -158.02 174.8 14.68 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.117 1.767 . . . . 72.400000000000006 106.929 -170.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.75 163.63 32.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.084 0.954 . . . . 74.099999999999994 108.973 174.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -150.61 153.05 34.99 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.119 -0.988 . . . . 54.43 112.496 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.47 142.56 43.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 126.095 1.758 . . . . 63.030000000000001 107.533 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -113.7 120.22 40.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.562 -2.014 . . . . 62.240000000000002 105.562 170.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.36 132.93 53.67 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.257 1.423 . . . . 64.349999999999994 107.198 177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.44 131.19 40.85 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 118.17 -0.919 . . . . 73.230000000000004 109.178 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.91 179.8 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.725 1.21 . . . . 74.109999999999999 110.79 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 79.85 1.26 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.253 1.821 . . . . 73.25 109.614 167.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.7 p -159.06 163.21 36.5 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.445 -0.576 . . . . 62.25 109.445 166.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.5 m -75.53 -175.48 2.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.005 0.522 . . . . 60.130000000000003 110.079 170.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 66.14 87.2 0.12 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.029 1.731 . . . . 73.420000000000002 111.633 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 138.35 43.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.109 1.364 . . . . 75.329999999999998 108.286 164.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 173.95 135.58 0.04 OUTLIER 'General case' 0 C--O 1.237 0.401 0 C-N-CA 129.558 3.143 . . . . 73.420000000000002 107.572 161.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.02 21.05 0.07 OUTLIER Glycine 0 C--N 1.336 0.541 0 CA-C-O 118.662 -1.077 . . . . 72.430000000000007 115.013 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.34 161.78 45.83 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.194 1.398 . . . . 62.32 112.132 -163.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.55 179.3 5.27 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.849 2.366 . . . . 75.109999999999999 111.346 167.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? 53.14 62.21 2.78 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.201 1.801 . . . . 74.150000000000006 111.748 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.6 m -71.94 45.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.054 1.741 . . . . 52.450000000000003 113.796 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.68 6.59 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.313 2.245 . . . . 72.519999999999996 109.945 168.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -68.91 153.54 95.93 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 108.795 -0.817 . . . . 73.349999999999994 108.795 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.16 155.33 35.03 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.538 2.158 . . . . 75.230000000000004 111.152 174.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.46 60.21 4.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.497 1.519 . . . . 24.43 110.878 -171.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -84.86 149.65 25.54 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.464 0.706 . . . . 75.510000000000005 109.47 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 64' ' ' PHE . 10.0 mt 50.04 -157.11 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.876 2.47 . . . . 61.439999999999998 109.842 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 174.64 104.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.098 2.159 . . . . 73.230000000000004 107.039 162.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CE2' HD13 ' A' ' 62' ' ' LEU . 21.7 m-30 -127.1 146.56 50.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.939 1.296 . . . . 75.230000000000004 110.106 -166.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttp -77.67 130.25 36.58 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.591 -1.263 . . . . 74.010000000000005 107.591 173.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -79.13 60.17 2.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.57 1.148 . . . . 73.310000000000002 109.551 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -53.19 -27.21 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 126.501 1.92 . . . . 63.109999999999999 113.903 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -130.0 121.71 27.03 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.45 -2.426 . . . . 73.239999999999995 104.45 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.5 t -152.03 79.59 1.25 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.733 -1.951 . . . . 74.239999999999995 105.733 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.93 176.56 45.0 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.717 -0.614 . . . . 75.430000000000007 112.358 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.26 -8.98 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 124.367 3.378 . . . . 73.329999999999998 112.64 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.38 158.14 8.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.59 1.556 . . . . 54.109999999999999 112.358 -172.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.16 -171.18 1.01 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.819 3.013 . . . . 71.040000000000006 110.653 169.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -44.83 110.76 0.25 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.806 2.442 . . . . 53.329999999999998 110.486 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.6 m -104.81 135.42 46.22 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.841 0.746 . . . . 51.509999999999998 110.261 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 tt -63.48 119.96 10.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.335 1.054 . . . . 60.210000000000001 109.515 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.56 114.41 9.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.109 -1.812 . . . . 75.450000000000003 106.109 167.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.42 158.23 27.27 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.804 0.842 . . . . 53.310000000000002 110.744 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -50.06 -49.49 51.03 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.931 0.892 . . . . 44.109999999999999 112.318 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 p -59.99 -25.52 65.33 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.508 1.049 . . . . 61.329999999999998 113.697 -174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -40.01 32.09 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.845 1.202 . . . . 71.219999999999999 110.431 173.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.39 -45.31 94.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.319 1.047 . . . . 75.140000000000001 110.711 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -62.72 -24.18 67.54 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.513 1.525 . . . . 64.129999999999995 112.75 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -92.38 -9.52 41.44 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.211 1.004 . . . . 55.439999999999998 112.033 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.43 147.27 49.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.547 1.067 . . . . 73.329999999999998 111.232 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -93.62 129.3 39.94 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.382 1.073 . . . . 62.43 111.226 -171.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.3 mm -68.68 133.12 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 126.216 1.806 . . . . 75.519999999999996 109.331 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.47 111.29 3.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.856 -0.794 . . . . 61.310000000000002 108.856 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -103.62 64.1 0.8 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.144 0.973 . . . . 73.519999999999996 108.761 165.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 -26.77 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.029 -0.987 . . . . 74.439999999999998 113.616 171.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.5 p -146.52 -55.36 0.26 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.23 0.923 . . . . 73.150000000000006 111.266 -174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -149.53 144.53 17.94 Favored Pre-proline 0 CA--C 1.519 -0.212 0 CA-C-O 117.161 -1.399 . . . . 75.120000000000005 108.19 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.63 97.37 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.144 2.563 . . . . 42.009999999999998 109.883 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB2' HD13 ' A' ' 116' ' ' LEU . . . -145.98 152.43 39.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.312 2.245 . . . . 72.430000000000007 109.2 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.5 mt -72.16 133.76 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 106.964 -1.495 . . . . 73.109999999999999 106.964 171.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.7 mm -81.61 136.07 23.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.068 0.947 . . . . 42.020000000000003 108.992 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -122.15 150.4 42.27 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.104 1.761 . . . . 75.120000000000005 107.785 165.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -133.26 132.96 42.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.169 -1.789 . . . . 74.140000000000001 106.169 167.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.503 HD13 ' CE3' ' A' ' 26' ' ' TRP . 20.8 mt -131.6 140.46 48.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.41 -0.959 . . . . 75.209999999999994 108.41 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.08 153.79 34.66 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.612 1.165 . . . . 73.549999999999997 110.497 170.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.14 141.38 41.93 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.734 0.813 . . . . 53.200000000000003 109.812 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.4 tpt85 -86.04 108.88 18.45 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 105.967 -1.864 . . . . 72.129999999999995 105.967 164.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -114.57 -176.15 2.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.398 -0.964 . . . . 61.32 108.398 165.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -52.51 -39.38 61.24 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.726 2.01 . . . . 71.540000000000006 112.048 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -47.7 53.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.28 -0.637 . . . . 63.539999999999999 109.28 -166.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 149.29 174.75 21.05 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.46 -0.656 . . . . 72.519999999999996 111.46 -165.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -75.45 102.88 5.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.646 -1.612 . . . . 72.349999999999994 106.646 163.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.36 -64.71 0.86 Allowed Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.324 -1.265 . . . . 72.450000000000003 112.126 -171.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.73 179.02 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.21 2.607 . . . . 73.540000000000006 110.002 176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.74 107.01 1.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.749 0.82 . . . . 60.450000000000003 109.159 156.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 m -71.53 110.13 5.92 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.386 -0.968 . . . . 64.510000000000005 108.386 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -82.08 103.12 11.48 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.451 1.5 . . . . 75.549999999999997 109.205 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.1 t -111.3 159.51 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.282 1.433 . . . . 55.140000000000001 107.747 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.43 155.45 45.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.724 -0.61 . . . . 72.209999999999994 110.325 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -138.32 109.56 6.88 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.107 0.963 . . . . 74.129999999999995 112.078 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.774 ' H ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.32 -177.93 5.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 128.732 2.813 . . . . 53.439999999999998 109.299 -177.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 73.72 9.84 4.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.14 1.776 . . . . 71.140000000000001 112.193 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -81.88 15.71 2.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.185 2.194 . . . . 74.420000000000002 114.417 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.1 m -104.25 78.88 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 119.002 -2.311 . . . . 55.25 109.636 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 t -166.67 84.44 0.27 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.83 1.252 . . . . 60.439999999999998 109.536 159.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -173.16 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.747 1.219 . . . . 73.040000000000006 111.691 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 51.52 55.22 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.66 1.584 . . . . 74.209999999999994 111.263 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.5 t 45.63 68.98 0.5 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.119 1.768 . . . . 35.020000000000003 113.307 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.0 p -64.77 -80.09 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.61 1.564 . . . . 72.140000000000001 110.799 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.39 156.87 7.08 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 127.135 2.302 . . . . 60.340000000000003 109.893 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.25 1.124 0 N-CA-C 106.156 -1.794 . . . . 54.119999999999997 106.156 167.67 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.034 -1.226 . . . . 72.439999999999998 110.034 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 99.5 m -63.4 -54.08 42.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.57 1.548 . . . . 62.450000000000003 113.61 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 45.11 75.1 0.69 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.106 1.363 . . . . 61.229999999999997 110.861 -161.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.72 -35.66 7.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.177 1.251 . . . . 61.25 112.535 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.63 84.96 0.97 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 124.749 1.166 . . . . 54.25 110.851 -172.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -111.07 87.41 7.11 Favored Pre-proline 0 C--O 1.223 -0.325 0 C-N-CA 127.77 2.428 . . . . 72.430000000000007 110.694 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -58.55 96.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.376 2.717 . . . . 71.349999999999994 110.927 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.48 113.78 0.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 124.117 0.865 . . . . 65.239999999999995 111.457 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -166.36 153.46 8.81 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.09 1.756 . . . . 71.430000000000007 109.14 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.33 166.9 19.95 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 124.976 3.784 . . . . 74.219999999999999 114.396 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.6 m -136.59 -179.12 5.49 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.383 2.273 . . . . 51.310000000000002 110.447 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 60.82 14.93 5.51 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 128.627 2.771 . . . . 74.219999999999999 115.386 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 131.65 25.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 123.219 0.608 . . . . 71.530000000000001 111.197 -162.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -125.17 148.5 48.57 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.715 1.206 . . . . 73.430000000000007 108.728 173.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -148.02 141.57 19.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.31 -1.737 . . . . 72.340000000000003 106.31 168.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 m -150.17 23.51 0.84 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.218 1.407 . . . . 64.140000000000001 112.962 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 4.3 tttm 48.68 -173.46 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.611 3.164 . . . . 72.030000000000001 112.944 -173.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.87 165.13 19.14 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.192 1.397 . . . . 71.140000000000001 107.57 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.91 -24.41 29.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.82 2.347 . . . . 70.019999999999996 112.345 169.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -106.06 -9.92 16.78 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.984 2.114 . . . . 71.430000000000007 111.182 -170.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.03 -123.08 1.13 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.686 -1.366 . . . . 50.240000000000002 109.686 -174.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . . . -135.36 124.54 24.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.636 -0.697 . . . . 74.209999999999994 110.457 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -67.12 90.69 0.2 Allowed 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.448 0.699 . . . . 74.310000000000002 109.427 168.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.84 164.11 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.0 0.92 . . . . 45.32 108.558 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.96 157.87 16.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.017 1.727 . . . . 61.229999999999997 109.668 168.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -171.65 -179.73 2.6 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.74 2.016 . . . . 74.219999999999999 109.527 173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -127.59 165.21 31.3 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 127.159 2.184 . . . . 73.329999999999998 109.432 169.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -66.21 168.49 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.668 2.912 . . . . 72.530000000000001 110.735 165.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.02 152.86 80.23 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 121.098 1.198 . . . . 72.150000000000006 109.861 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 p -118.68 17.61 13.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.542 1.137 . . . . 71.150000000000006 111.821 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.02 -45.25 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.825 1.25 . . . . 70.540000000000006 110.533 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 38.4 p -148.37 167.09 26.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.633 1.573 . . . . 63.229999999999997 107.926 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -46.23 -61.18 1.89 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.307 1.843 . . . . 71.120000000000005 111.945 -174.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.06 113.12 0.06 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.899 1.238 . . . . 71.510000000000005 112.943 174.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -89.35 66.38 7.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.006 0.922 . . . . 65.140000000000001 109.419 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -71.03 151.64 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.15 -1.426 . . . . 63.149999999999999 107.15 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 28.3 pt -135.42 -21.97 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.376 1.87 . . . . 65.25 111.836 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.72 -167.36 1.52 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.813 0.845 . . . . 71.150000000000006 109.486 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -152.04 172.91 15.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.658 1.983 . . . . 71.329999999999998 108.365 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -150.29 175.68 11.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.812 0.733 . . . . 33.030000000000001 111.212 163.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -144.24 129.74 14.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.605 1.962 . . . . 73.109999999999999 107.222 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.496 ' HB3' ' CG ' ' A' ' 64' ' ' PHE . 1.7 m-85 -119.71 119.37 33.47 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.558 -1.645 . . . . 65.230000000000004 106.558 165.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 tp -87.22 126.83 35.06 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.634 -1.987 . . . . 74.310000000000002 105.634 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.11 138.82 50.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.397 0.544 . . . . 74.209999999999994 110.524 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 pt -126.72 -178.84 2.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 125.925 1.69 . . . . 72.040000000000006 109.786 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 93.77 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.68 1.592 . . . . 75.140000000000001 109.2 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 p -163.39 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.54 1.936 . . . . 70.109999999999999 109.1 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.2 m 45.07 67.89 0.64 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.509 1.924 . . . . 73.450000000000003 112.508 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -149.72 112.45 4.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.36 1.464 . . . . 74.25 109.658 -170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -163.1 120.06 1.87 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.701 1.2 . . . . 70.109999999999999 109.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.8 m -157.16 40.98 0.32 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.554 1.141 . . . . 63.420000000000002 112.421 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.82 113.13 0.56 Allowed Glycine 0 C--N 1.343 0.956 0 O-C-N 120.139 -1.601 . . . . 51.210000000000001 113.037 -169.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 1.6 mt-10 -64.15 165.57 13.16 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.647 1.579 . . . . 64.530000000000001 111.785 170.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 53' ' ' GLU . 71.9 Cg_endo -67.58 -164.56 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.825 1 C-N-CA 126.271 4.647 . . . . 61.439999999999998 111.598 167.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.96 19.18 11.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.33 1.852 . . . . 61.340000000000003 113.875 174.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m 51.09 76.21 0.17 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.649 1.58 . . . . 62.109999999999999 111.533 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 m -118.24 -40.39 2.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.091 -1.413 . . . . 63.43 109.419 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 t -150.46 144.4 17.37 Favored Pre-proline 0 C--O 1.241 0.648 0 O-C-N 120.903 -1.123 . . . . 53.420000000000002 110.565 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.65 79.96 2.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.534 2.823 . . . . 74.040000000000006 109.468 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.87 37.76 0.81 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.675 1.59 . . . . 61.43 109.576 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -79.47 62.41 3.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.213 1.805 . . . . 75.040000000000006 110.64 -165.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 mp 44.58 -170.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 C-N-CA 132.968 4.507 . . . . 65.129999999999995 112.921 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.19 135.05 15.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.42 -0.809 . . . . 63.25 109.865 170.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 42' ' ' TYR . 78.5 m-85 -149.23 -164.16 1.96 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.234 2.613 . . . . 75.409999999999997 107.846 -175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.9 ttp -112.48 -6.69 13.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.592 1.157 . . . . 75.329999999999998 113.153 166.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 44.23 66.54 0.83 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.373 2.269 . . . . 64.319999999999993 111.614 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.34 -13.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 113.554 0.946 . . . . 64.329999999999998 113.554 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -57.13 135.72 56.37 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.087 -1.008 . . . . 73.340000000000003 112.027 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.6 m -142.37 97.68 3.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.761 2.024 . . . . 74.150000000000006 107.73 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.98 166.94 5.9 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.215 0.912 . . . . 72.150000000000006 113.376 172.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 -57.4 0.24 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.791 1.661 . . . . 70.030000000000001 113.716 -166.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.0 m 57.33 167.66 0.06 OUTLIER Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.208 0.913 . . . . 73.420000000000002 112.872 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.99 -24.23 45.77 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 121.465 1.443 . . . . 73.209999999999994 112.293 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 p -167.35 41.56 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.913 0.885 . . . . 64.140000000000001 109.33 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 16.2 p 45.11 -166.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.44 1.896 . . . . 53.399999999999999 112.432 -161.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -149.09 115.05 5.71 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.268 -0.895 . . . . 74.310000000000002 109.326 149.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.53 124.28 45.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 126.116 1.766 . . . . 70.230000000000004 107.502 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.19 49.04 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.212 1.805 . . . . 74.329999999999998 110.938 169.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t -70.46 -16.91 62.98 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.019 1.728 . . . . 70.030000000000001 112.311 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t -46.13 -53.83 9.7 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.008 0.822 . . . . 72.019999999999996 109.489 165.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 m -72.43 -19.96 61.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.192 0.812 . . . . 71.099999999999994 113.192 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.25 -34.02 65.62 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.547 0.612 . . . . 53.130000000000003 110.868 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 t -54.18 -47.46 72.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.849 0.459 . . . . 71.340000000000003 109.768 172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.46 -7.48 38.32 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.771 1.628 . . . . 64.010000000000005 113.216 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.64 164.82 7.13 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.347 1.07 . . . . 65.129999999999995 110.713 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -128.12 160.23 32.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.842 -0.799 . . . . 72.129999999999995 108.842 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.56 123.38 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 106.964 -1.495 . . . . 62.329999999999998 106.964 -165.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.92 127.81 33.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.894 -1.151 . . . . 71.150000000000006 107.894 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.32 31.98 5.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.804 -1.184 . . . . 73.25 107.804 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.61 -11.87 7.74 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.967 1.307 . . . . 71.340000000000003 110.344 -171.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.3 p -142.25 -66.08 0.4 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.395 1.478 . . . . 74.109999999999999 109.861 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -150.48 152.92 33.71 Favored Pre-proline 0 C--O 1.234 0.286 0 C-N-CA 127.802 2.441 . . . . 71.420000000000002 107.576 169.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.12 104.63 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.689 2.926 . . . . 73.25 109.556 173.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -147.74 153.1 38.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.17 1.388 . . . . 64.140000000000001 109.839 171.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.6 mt -72.96 130.12 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.105 -1.813 . . . . 74.310000000000002 106.105 158.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.12 136.57 22.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 106.954 -1.499 . . . . 44.329999999999998 106.954 166.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.32 159.33 20.34 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.025 0.917 . . . . 74.010000000000005 110.25 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -131.19 100.73 5.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.859 1.664 . . . . 74.329999999999998 106.879 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.2 mt -122.36 129.59 75.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 104.316 -2.475 . . . . 65.209999999999994 104.316 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . . . -142.67 163.94 31.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.625 0.726 . . . . 74.209999999999994 109.863 171.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.99 132.7 34.16 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.821 -1.081 . . . . 73.409999999999997 108.286 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpp180 -84.5 105.49 15.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.334 -1.728 . . . . 72.030000000000001 106.334 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -115.18 -179.19 3.56 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.009 0.924 . . . . 73.140000000000001 110.484 173.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -58.34 -35.07 71.36 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.031 1.733 . . . . 73.109999999999999 114.526 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -75.11 -54.95 6.26 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 125.61 1.564 . . . . 63.229999999999997 108.957 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 159.34 164.39 14.59 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.414 -1.074 . . . . 70.519999999999996 110.414 -172.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 100' ' ' ALA . 9.1 t80 -87.49 45.54 1.28 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.616 1.566 . . . . 74.140000000000001 110.136 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.28 -87.14 0.07 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.295 1.902 . . . . 74.120000000000005 111.671 -156.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.46 163.48 38.89 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.151 1.901 . . . . 54.020000000000003 109.773 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -143.75 148.66 35.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.415 -0.957 . . . . 70.450000000000003 108.415 171.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.8 m -75.88 132.84 40.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.261 -1.755 . . . . 61.439999999999998 106.261 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -113.83 86.61 2.44 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 105.799 -1.926 . . . . 53.149999999999999 105.799 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.75 156.73 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.618 -0.882 . . . . 73.420000000000002 108.618 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.79 116.4 28.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.921 -1.511 . . . . 53.240000000000002 106.921 169.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -72.99 75.66 1.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.76 -1.2 . . . . 71.129999999999995 107.76 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 94' ' ' ALA . 14.4 mt -70.99 150.79 45.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.5 -1.667 . . . . 70.200000000000003 106.5 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 66.29 24.29 10.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.41 1.484 . . . . 63.509999999999998 111.146 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.4 173.92 8.09 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.792 -0.567 . . . . 65.510000000000005 111.76 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.9 m -144.78 125.95 14.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.439 1.496 . . . . 64.310000000000002 107.847 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.08 163.58 26.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.813 1.245 . . . . 54.5 113.527 -166.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.04 60.71 2.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.997 2.119 . . . . 71.0 109.814 -166.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -107.71 145.91 32.8 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.755 0.822 . . . . 61.229999999999997 111.746 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.7 m 59.79 174.39 0.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.015 2.526 . . . . 71.109999999999999 113.45 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.8 t -80.0 -30.23 39.58 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 63.030000000000001 109.824 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 79.22 -52.69 4.09 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.407 -1.218 . . . . 74.299999999999997 111.071 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.259 1.567 0 C-N-CA 125.28 1.432 . . . . 74.239999999999995 108.352 176.454 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 108.359 -1.896 . . . . 71.530000000000001 108.359 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.2 t -145.64 22.5 1.45 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.697 1.199 . . . . 74.200000000000003 110.588 -175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.72 82.38 34.34 Favored Pre-proline 0 C--O 1.237 0.431 0 N-CA-C 107.296 -1.372 . . . . 61.229999999999997 107.296 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -82.58 64.84 8.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.378 2.052 . . . . 62.210000000000001 111.56 -171.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.43 159.12 24.24 Favored Glycine 0 C--O 1.242 0.595 0 N-CA-C 111.001 -0.84 . . . . 33.520000000000003 111.001 169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -76.14 159.51 80.2 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 117.255 0.528 . . . . 64.450000000000003 110.124 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.97 5.66 0.6 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 125.149 3.9 . . . . 63.119999999999997 116.55 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.4 173.12 49.48 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.675 1.131 . . . . 70.310000000000002 112.394 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.3 161.02 24.34 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.225 1.41 . . . . 51.25 111.25 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.37 153.86 65.81 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.02 2.48 . . . . 74.150000000000006 110.989 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.4 m -137.38 -174.67 3.82 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.272 1.429 . . . . 60.240000000000002 110.605 -171.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.02 25.62 12.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.205 2.202 . . . . 71.230000000000004 114.205 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.25 141.12 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.681 1.192 . . . . 73.120000000000005 110.81 -172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -125.17 149.53 47.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.297 1.439 . . . . 63.32 109.007 174.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.0 mt -152.01 95.84 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.268 -1.753 . . . . 74.219999999999999 106.268 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 p -74.7 163.01 28.19 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.517 -0.92 . . . . 71.329999999999998 108.517 164.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -91.38 157.75 16.92 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.28 -1.378 . . . . 70.319999999999993 107.28 156.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.1 m -146.97 165.2 19.9 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.393 -1.336 . . . . 62.32 107.393 176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -62.31 -37.43 61.28 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.324 1.35 . . . . 51.030000000000001 112.696 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.99 -47.99 14.06 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.331 -0.855 . . . . 74.519999999999996 110.682 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.74 -146.38 4.33 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.585 -0.606 . . . . 61.240000000000002 111.585 -156.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.03 133.8 32.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.321 1.448 . . . . 74.329999999999998 107.743 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -78.11 79.81 4.56 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.318 -0.623 . . . . 62.219999999999999 109.318 173.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.43 132.17 52.59 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.357 -1.349 . . . . 72.409999999999997 107.357 164.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.1 p -144.64 152.14 40.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.391 1.451 . . . . 72.349999999999994 109.255 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.416 ' CE3' HD13 ' A' ' 99' ' ' ILE . 0.4 OUTLIER -137.56 167.57 21.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.206 1.403 . . . . 74.129999999999995 110.565 172.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -72.77 163.28 69.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.04 0.936 . . . . 74.340000000000003 112.328 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.11 164.83 26.2 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.391 2.727 . . . . 73.239999999999995 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.67 77.39 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.432 2.755 . . . . 53.240000000000002 110.359 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 t -133.02 24.73 4.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.293 2.237 . . . . 73.239999999999995 109.422 -171.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.53 -40.93 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.926 1.291 . . . . 53.210000000000001 107.95 173.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.0 p -149.45 174.08 12.87 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.017 1.727 . . . . 64.140000000000001 110.419 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -64.24 19.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.572 3.149 . . . . 72.420000000000002 114.88 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.59 -168.15 35.84 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 120.597 -1.314 . . . . 65.439999999999998 114.037 -170.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -135.65 113.4 10.98 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.193 -1.004 . . . . 74.420000000000002 109.505 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.479 HG12 ' HB1' ' A' ' 101' ' ' ALA . 1.9 mp -109.67 133.63 54.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.084 1.754 . . . . 64.129999999999995 108.144 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.6 pt -131.62 -11.42 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 125.786 1.634 . . . . 72.120000000000005 112.33 -163.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 39' ' ' TYR . 10.8 tt0 -160.45 -169.51 2.47 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.222 2.209 . . . . 65.219999999999999 106.685 163.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.441 ' H ' ' HG2' ' A' ' 38' ' ' GLU . 1.4 m-85 -128.4 169.27 14.47 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 120.22 -1.55 . . . . 74.349999999999994 108.879 165.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.0 m -145.03 156.93 44.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.171 -0.956 . . . . 72.409999999999997 110.526 166.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.66 125.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 105.618 -1.993 . . . . 74.109999999999999 105.618 -171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.23 127.33 55.93 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.735 -1.58 . . . . 74.109999999999999 106.735 171.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 tp -121.85 130.54 53.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.983 1.713 . . . . 74.420000000000002 107.574 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.21 126.03 28.28 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.907 0.883 . . . . 71.420000000000002 113.068 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.53 -170.66 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.769 2.428 . . . . 74.530000000000001 109.236 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -87.88 95.06 9.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.046 1.738 . . . . 73.510000000000005 110.695 161.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 t 174.65 162.31 0.21 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 129.742 3.217 . . . . 44.32 108.121 160.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.1 t -146.78 141.36 26.62 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.815 1.246 . . . . 71.109999999999999 108.503 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -157.35 164.14 37.89 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 118.612 0.642 . . . . 74.510000000000005 111.05 170.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.38 168.36 18.66 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.115 2.566 . . . . 72.299999999999997 108.138 155.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 m -151.42 123.1 7.98 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.07 1.348 . . . . 65.540000000000006 107.572 166.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.97 83.26 0.03 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.943 1.735 . . . . 62.399999999999999 113.846 165.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.41 163.83 47.7 Favored Pre-proline 0 N--CA 1.467 0.377 0 C-N-CA 124.204 1.002 . . . . 74.409999999999997 111.807 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.5 172.32 11.57 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.167 2.578 . . . . 74.329999999999998 111.803 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 67.49 85.4 0.14 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 127.394 2.278 . . . . 54.219999999999999 107.926 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.1 m -63.69 74.18 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.203 1.801 . . . . 72.310000000000002 110.833 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -165.15 -62.67 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.804 1.242 . . . . 32.350000000000001 108.557 -163.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 59' ' ' PRO 0.262 73.0 p 50.74 163.2 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.865 2.466 . . . . 41.100000000000001 114.011 -161.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 74.3 Cg_endo -68.38 -175.75 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.631 2.221 . . . . 74.109999999999999 110.24 165.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.07 67.05 1.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.497 1.119 . . . . 61.200000000000003 108.674 166.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 43.7 76.87 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.287 3.035 . . . . 74.510000000000005 111.935 168.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.07 163.9 0.33 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.396 1.878 . . . . 63.5 113.512 178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.27 82.72 1.97 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.333 0.587 . . . . 64.120000000000005 111.17 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -130.74 150.41 51.93 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.308 1.043 . . . . 73.310000000000002 108.911 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ttp -113.99 133.84 55.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.107 1.763 . . . . 51.340000000000003 108.233 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -82.19 56.73 3.3 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.606 1.562 . . . . 74.25 112.331 -167.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.6 m -57.66 -19.61 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 115.924 1.824 . . . . 72.530000000000001 115.924 -167.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -61.08 118.63 7.03 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.842 1.201 . . . . 73.510000000000005 110.032 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.6 m -152.13 73.69 1.06 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 127.172 2.189 . . . . 63.210000000000001 107.625 164.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.44 166.06 25.91 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 121.562 -0.711 . . . . 70.25 111.799 167.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 -55.64 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.614 2.21 . . . . 72.510000000000005 109.836 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -76.57 144.51 73.82 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.247 0.619 . . . . 70.420000000000002 109.785 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 -26.15 16.68 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.235 1.957 . . . . 73.530000000000001 112.882 -168.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p -80.88 68.9 7.31 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.232 0.924 . . . . 61.109999999999999 110.216 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.2 m -69.3 115.45 8.59 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.391 -0.818 . . . . 54.329999999999998 110.675 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.8 -178.52 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.977 2.111 . . . . 54.240000000000002 112.528 159.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -140.74 146.69 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.521 1.528 . . . . 71.209999999999994 108.222 172.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -96.26 161.81 13.78 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.601 2.36 . . . . 61.219999999999999 112.778 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -45.87 67.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.961 1.304 . . . . 62.310000000000002 111.72 169.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.1 t -62.37 -28.16 69.58 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.615 0.643 . . . . 63.130000000000003 111.623 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -80.36 -46.56 15.86 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.327 -0.858 . . . . 54.219999999999999 109.046 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.1 mt -52.83 -26.7 15.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.193 1.797 . . . . 71.549999999999997 112.926 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.4 m -45.36 -33.88 2.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.12 1.368 . . . . 70.120000000000005 113.232 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -95.0 -10.87 29.63 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.323 0.649 . . . . 65.230000000000004 111.263 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.66 24.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.061 0.846 . . . . 71.450000000000003 110.123 -172.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -86.68 120.39 27.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.101 0.96 . . . . 73.349999999999994 109.819 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.08 138.24 21.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.992 1.717 . . . . 73.120000000000005 109.287 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.95 111.33 4.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.816 0.846 . . . . 74.329999999999998 111.006 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -100.65 20.09 15.78 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.461 -0.774 . . . . 73.030000000000001 110.993 173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -4.01 6.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.456 0.909 . . . . 63.32 113.456 -163.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.8 -63.31 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.275 1.43 . . . . 75.230000000000004 108.492 161.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt -153.68 154.19 29.95 Favored Pre-proline 0 N--CA 1.455 -0.183 0 N-CA-C 106.536 -1.653 . . . . 72.450000000000003 106.536 172.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -59.29 110.16 0.66 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.389 2.059 . . . . 64.120000000000005 109.544 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.92 168.56 21.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.72 2.008 . . . . 73.319999999999993 109.301 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.7 mt -101.74 140.05 21.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.274 -1.75 . . . . 73.010000000000005 106.274 166.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.7 mm -119.42 124.52 73.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 124.273 1.029 . . . . 72.010000000000005 110.085 -163.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.47 137.55 54.77 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.848 0.859 . . . . 63.520000000000003 112.488 -167.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -112.78 99.29 7.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.773 1.629 . . . . 62.439999999999998 108.057 167.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.416 HD13 ' CE3' ' A' ' 26' ' ' TRP . 9.7 mt -98.34 144.75 10.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.396 -1.705 . . . . 72.540000000000006 106.396 174.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.23 142.28 29.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.284 1.034 . . . . 74.25 109.65 168.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB1' HG12 ' A' ' 36' ' ' ILE . . . -74.94 122.51 23.55 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.338 1.055 . . . . 72.439999999999998 108.87 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -72.89 117.83 15.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.856 -1.535 . . . . 72.349999999999994 106.856 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -131.59 -176.92 4.19 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 127.582 2.353 . . . . 73.430000000000007 109.502 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.78 -27.94 69.53 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.503 0.557 . . . . 74.109999999999999 112.503 173.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -74.48 -32.13 62.45 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.158 -0.964 . . . . 73.409999999999997 113.05 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.73 166.8 38.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.597 -1.001 . . . . 63.310000000000002 110.597 -166.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.08 64.14 3.2 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.563 1.545 . . . . 62.350000000000001 111.689 -170.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.43 -75.44 0.35 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.291 -1.124 . . . . 63.340000000000003 110.291 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.99 167.65 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 124.06 3.173 . . . . 73.510000000000005 110.21 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 162.86 39.88 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 127.025 2.13 . . . . 71.239999999999995 107.192 165.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.2 t -79.95 179.32 7.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.161 -0.681 . . . . 71.230000000000004 109.161 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -150.54 73.01 1.11 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.143 0.577 . . . . 75.230000000000004 110.031 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.3 m -93.24 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.473 -0.767 . . . . 63.450000000000003 110.424 -173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.69 112.24 13.46 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.888 1.275 . . . . 75.349999999999994 110.232 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -71.65 82.68 0.85 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.73 0.812 . . . . 73.230000000000004 110.704 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.2 mt -80.83 53.9 2.04 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.796 1.638 . . . . 61.450000000000003 108.68 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 17.67 2.99 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 124.874 1.27 . . . . 75.140000000000001 109.609 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.17 168.94 18.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.034 0.445 . . . . 72.150000000000006 110.271 164.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -155.3 129.2 8.68 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.624 -1.991 . . . . 61.340000000000003 105.624 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 m 53.93 30.44 11.62 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.359 1.064 . . . . 53.340000000000003 113.788 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -53.37 -57.73 9.57 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 117.723 -1.132 . . . . 73.450000000000003 112.181 -163.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.3 158.28 26.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.192 0.906 . . . . 42.409999999999997 110.59 160.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.2 p -78.63 -21.77 47.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.374 1.25 . . . . 53.539999999999999 114.374 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.0 m 48.76 82.86 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.242 1.417 . . . . 65.239999999999995 111.995 -175.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -46.62 -38.55 9.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.808 1.194 . . . . 45.039999999999999 114.043 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.51 1.524 . . . . 74.230000000000004 109.885 177.396 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.683 0 N-CA-C 110.259 -1.136 . . . . 44.420000000000002 110.259 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.3 t -150.65 15.86 0.78 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.278 1.831 . . . . 50.340000000000003 110.466 163.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.18 151.36 46.58 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 105.812 -1.922 . . . . 74.329999999999998 105.812 156.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.96 106.77 1.57 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.601 2.868 . . . . 71.5 110.533 -174.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.59 -9.01 87.41 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.28 -0.888 . . . . 50.310000000000002 112.747 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 28.6 m-85 -123.3 163.36 34.54 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 127.379 2.272 . . . . 74.329999999999998 108.273 -177.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -55.48 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.76 2.307 . . . . 54.420000000000002 112.868 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.09 169.73 41.58 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.733 -1.747 . . . . 62.240000000000002 108.733 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.27 159.42 32.11 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.755 1.622 . . . . 71.420000000000002 109.353 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.06 154.27 75.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.232 1.288 . . . . 65.439999999999998 111.719 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.3 m -142.41 -174.65 4.19 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.614 1.566 . . . . 71.200000000000003 109.488 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.84 37.79 10.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.034 2.534 . . . . 74.299999999999997 113.193 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.7 mt -77.52 126.45 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.506 -1.294 . . . . 74.340000000000003 107.506 -171.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -137.56 150.76 47.73 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.669 -0.863 . . . . 43.140000000000001 108.669 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 24' ' ' LEU . 4.0 mp -125.86 149.74 30.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 105.459 -2.052 . . . . 53.439999999999998 105.459 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.81 135.84 36.65 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.309 -1.367 . . . . 70.310000000000002 107.309 174.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 120' ' ' SER . 13.0 tppt? -72.01 143.85 49.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.398 -1.334 . . . . 73.120000000000005 107.398 175.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.6 m -126.34 165.64 26.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 125.877 1.671 . . . . 71.420000000000002 108.023 169.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.65 -15.2 40.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.359 2.04 . . . . 54.32 112.353 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -98.24 -29.22 13.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.753 1.221 . . . . 74.430000000000007 110.787 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.14 -152.37 16.94 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 116.377 -2.346 . . . . 63.140000000000001 110.539 -164.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.2 127.95 54.23 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 121.147 2.474 . . . . 71.140000000000001 108.731 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.49 126.14 26.43 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.214 -1.032 . . . . 74.129999999999995 108.214 164.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' CD2' HG23 ' A' ' 15' ' ' ILE . 5.4 mt -113.12 145.33 41.11 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.031 -1.099 . . . . 64.239999999999995 108.031 170.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 t -150.28 171.82 16.35 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 118.415 0.552 . . . . 65.140000000000001 111.234 170.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CE3' HD13 ' A' ' 99' ' ' ILE . 15.3 p90 -173.45 -171.57 0.7 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.765 2.026 . . . . 74.299999999999997 111.189 -172.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -111.57 165.49 12.72 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 127.948 2.499 . . . . 73.230000000000004 110.639 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -66.64 166.68 21.33 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.956 3.104 . . . . 53.299999999999997 112.598 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.46 -4.64 14.35 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 124.018 3.145 . . . . 64.409999999999997 111.773 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.5 m -148.25 138.43 22.61 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.916 -1.513 . . . . 54.109999999999999 106.916 -174.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.48 -49.53 46.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.498 0.666 . . . . 61.020000000000003 110.621 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 t -65.22 158.97 24.72 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.39 1.076 . . . . 42.229999999999997 109.907 163.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.8 m -54.86 -45.0 74.49 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.409 1.263 . . . . 73.310000000000002 114.409 -163.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.5 -171.48 46.8 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.965 0.802 . . . . 43.439999999999998 111.566 -171.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -116.42 56.19 0.79 Allowed 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.571 1.549 . . . . 74.439999999999998 109.187 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.47 140.08 20.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 72.299999999999997 106.245 168.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.8 pt -129.96 -23.03 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.573 1.149 . . . . 72.329999999999998 110.609 174.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -161.24 -175.53 4.9 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.285 1.434 . . . . 74.230000000000004 108.515 -171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -134.65 -171.0 2.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.784 1.234 . . . . 74.129999999999995 109.469 170.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 107' ' ' TYR . 12.4 p -138.15 155.92 48.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.753 1.621 . . . . 53.100000000000001 107.917 157.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.64 112.43 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.197 -2.519 . . . . 64.0 104.197 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' HB3' ' CB ' ' A' ' 64' ' ' PHE . 67.7 m-85 -111.51 160.24 17.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 123.758 0.823 . . . . 74.409999999999997 108.983 175.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 tp -149.96 139.47 21.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.79 2.036 . . . . 72.530000000000001 106.004 -176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.33 137.58 42.93 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.389 1.076 . . . . 73.319999999999993 110.34 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -141.76 -165.59 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.528 1.531 . . . . 72.430000000000007 110.343 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 81.16 1.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.083 2.153 . . . . 73.549999999999997 110.305 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -146.79 -70.48 0.24 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.757 1.223 . . . . 41.539999999999999 109.547 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.8 m -157.49 -15.79 0.08 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.636 1.347 . . . . 73.239999999999995 114.636 159.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -66.66 130.64 43.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 111.11 -147.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -117.49 140.68 49.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.232 -1.025 . . . . 63.420000000000002 108.232 168.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p 174.56 135.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.373 3.069 . . . . 72.340000000000003 104.663 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.94 4.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.636 -1.091 . . . . 54.200000000000003 115.75 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.24 151.95 79.73 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 120.56 2.18 . . . . 74.030000000000001 113.743 -152.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.21 166.82 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.07 2.513 . . . . 65.129999999999995 112.769 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -66.95 6.11 0.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.242 2.617 . . . . 74.099999999999994 113.324 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.6 m -62.94 -42.24 99.75 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.498 1.119 . . . . 73.420000000000002 111.2 -173.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -177.43 11.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.736 1.214 . . . . 72.030000000000001 112.403 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.0 m 45.02 72.96 1.06 Allowed Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.627 1.571 . . . . 70.319999999999993 112.589 -171.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.12 159.84 48.88 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.484 2.123 . . . . 74.400000000000006 112.888 166.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.81 52.57 0.54 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.457 1.903 . . . . 31.34 111.959 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.454 ' C ' HD12 ' A' ' 62' ' ' LEU . 11.9 mm100 -76.2 102.59 5.86 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.269 -1.011 . . . . 71.439999999999998 108.269 174.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 61' ' ' GLN . 2.4 mp 58.29 -159.79 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.955 2.902 . . . . 65.319999999999993 108.524 177.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.98 123.93 3.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 45.140000000000001 109.558 170.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.404 ' CB ' ' HB3' ' A' ' 42' ' ' TYR . 27.7 m-85 -146.06 162.26 38.31 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.008 0.923 . . . . 74.530000000000001 111.333 -173.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.6 ttt -69.35 -29.83 67.72 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.042 1.337 . . . . 71.329999999999998 113.899 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 65.79 80.57 0.22 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.639 1.576 . . . . 61.409999999999997 110.516 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -70.72 -14.62 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.961 0.904 . . . . 52.549999999999997 112.488 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -54.34 116.13 2.46 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.406 1.482 . . . . 73.120000000000005 110.266 166.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -157.9 23.94 0.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.36 0.504 . . . . 72.409999999999997 112.36 157.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.67 154.54 29.69 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.918 -1.273 . . . . 73.299999999999997 109.918 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.06 -26.28 21.72 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.342 2.028 . . . . 54.299999999999997 111.845 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 m -122.81 163.53 32.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.472 1.509 . . . . 74.019999999999996 109.307 -174.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.93 173.46 12.75 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.983 1.789 . . . . 74.340000000000003 111.027 170.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.5 t 50.46 59.91 4.23 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.03 1.332 . . . . 73.209999999999994 110.624 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.1 m -113.63 171.53 7.52 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.88 0.872 . . . . 73.109999999999999 110.673 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.594 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.0 pt? -76.29 171.65 14.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.624 1.342 . . . . 54.310000000000002 114.624 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.25 109.43 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 C-N-CA 126.973 2.109 . . . . 70.430000000000007 111.266 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -57.43 146.75 28.4 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.246 2.219 . . . . 73.019999999999996 111.472 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 p -66.47 -23.68 66.31 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.737 1.014 . . . . 71.510000000000005 113.737 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 5.5 0.91 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.614 1.566 . . . . 73.430000000000007 113.599 167.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -108.64 -36.69 6.11 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.063 -1.023 . . . . 74.209999999999994 110.055 164.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.27 -37.39 77.86 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.421 1.088 . . . . 72.310000000000002 111.232 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -61.79 -0.86 0.51 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.693 1.597 . . . . 73.349999999999994 113.109 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -129.98 2.15 4.81 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.954 2.102 . . . . 65.430000000000007 110.255 -167.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.21 132.8 55.99 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.982 2.113 . . . . 44.310000000000002 109.125 -169.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -87.39 158.17 19.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.978 0.418 . . . . 65.530000000000001 110.875 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.1 mm -84.43 146.94 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.898 1.279 . . . . 63.409999999999997 108.365 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -78.45 118.49 20.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.875 -1.157 . . . . 73.319999999999993 107.875 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 24.32 11.25 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.256 1.023 . . . . 70.209999999999994 109.789 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -100.65 -53.95 2.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.719 -1.215 . . . . 71.230000000000004 107.719 -176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.8 m -111.08 -54.26 2.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.178 1.791 . . . . 71.549999999999997 109.488 -166.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -160.47 150.08 14.32 Favored Pre-proline 0 C--N 1.343 0.298 0 C-N-CA 127.528 2.331 . . . . 63.140000000000001 109.87 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.86 101.56 0.23 Allowed 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 124.494 3.463 . . . . 64.120000000000005 109.89 173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.626 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -162.0 172.9 15.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.95 1.7 . . . . 74.510000000000005 111.199 175.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.51 132.35 42.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.759 -1.571 . . . . 72.510000000000005 106.759 167.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.97 118.85 49.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 124.103 0.961 . . . . 73.510000000000005 109.488 -175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -93.08 178.34 5.78 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.771 1.228 . . . . 72.299999999999997 111.679 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.19 128.5 14.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 126.453 1.901 . . . . 65.200000000000003 106.638 167.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.505 HD13 ' CE3' ' A' ' 26' ' ' TRP . 34.1 mt -132.14 153.93 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 119.528 1.058 . . . . 63.329999999999998 109.512 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -167.78 136.6 2.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.536 2.334 . . . . 71.140000000000001 110.374 171.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.2 133.3 55.01 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.605 1.562 . . . . 65.329999999999998 112.849 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 92.11 9.02 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 105.747 -1.946 . . . . 70.120000000000005 105.747 161.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -101.34 -179.23 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.333 -0.988 . . . . 62.020000000000003 108.333 153.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -57.95 -21.77 45.7 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.105 1.15 . . . . 74.239999999999995 114.105 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -37.26 38.88 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.402 -0.811 . . . . 63.409999999999997 110.181 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.17 -171.8 13.97 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.162 1.363 . . . . 74.140000000000001 112.999 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 14.3 m-85 -81.7 66.1 7.11 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.969 1.708 . . . . 72.219999999999999 111.285 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.28 -74.22 1.08 Allowed Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.002 -1.061 . . . . 23.449999999999999 111.563 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 6' ' ' PHE . 56.6 Cg_endo -68.81 167.23 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.381 2.72 . . . . 50.340000000000003 110.118 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.46 152.17 44.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.725 0.774 . . . . 73.120000000000005 110.049 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.3 m -142.01 109.44 5.63 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.159 -1.793 . . . . 61.530000000000001 106.159 167.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -94.38 139.44 31.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.111 -1.44 . . . . 73.319999999999993 107.111 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.3 m -125.24 171.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.081 0.952 . . . . 44.340000000000003 110.43 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 113.46 14.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.525 1.53 . . . . 74.230000000000004 108.21 -177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -79.03 93.4 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.48 -1.304 . . . . 72.129999999999995 107.48 172.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 94' ' ' ALA . 16.2 mt -77.39 165.25 24.65 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.326 -1.361 . . . . 61.439999999999998 107.326 173.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.06 29.51 19.09 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.667 0.787 . . . . 75.430000000000007 109.892 176.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -9.88 59.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.246 -1.534 . . . . 74.319999999999993 114.503 -172.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 m -77.14 80.74 3.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.859 1.264 . . . . 72.129999999999995 110.786 -160.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB3' ' HE3' ' A' ' 17' ' ' LYS . 47.4 t -144.14 98.68 3.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.789 -1.189 . . . . 74.530000000000001 107.789 -171.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 tptm 65.6 -165.53 0.23 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.895 0.878 . . . . 71.239999999999995 109.848 -174.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 63.19 36.82 11.74 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.28 2.232 . . . . 72.319999999999993 110.73 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.5 p -84.01 12.22 6.65 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.267 1.58 . . . . 50.350000000000001 115.267 -165.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t 65.71 -178.34 0.19 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.143 0.977 . . . . 52.229999999999997 110.108 -158.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 150.7 -14.21 0.91 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.016 0.817 . . . . 73.340000000000003 114.589 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.254 1.301 0 CA-C-N 119.69 1.745 . . . . 74.409999999999997 108.775 168.391 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 CA-C-O 119.274 -0.737 . . . . 52.530000000000001 111.276 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 t 75.22 90.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.793 2.437 . . . . 74.439999999999998 107.701 -160.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.02 159.79 39.21 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.932 1.693 . . . . 73.200000000000003 108.996 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.02 176.81 8.58 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.497 2.131 . . . . 60.439999999999998 112.478 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.01 84.15 0.23 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.364 -1.094 . . . . 74.540000000000006 110.364 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.56 160.28 32.31 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.464 1.106 . . . . 73.329999999999998 108.922 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.75 114.28 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.105 2.537 . . . . 74.239999999999995 109.751 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.01 -161.83 35.12 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.147 -1.181 . . . . 64.109999999999999 110.147 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.06 82.86 0.21 Allowed Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 127.092 2.157 . . . . 45.140000000000001 111.891 -163.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.31 165.59 24.15 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.165 2.577 . . . . 73.340000000000003 110.891 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.8 m -135.57 -175.59 4.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.265 1.426 . . . . 35.109999999999999 112.106 -173.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 50.8 25.95 2.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.673 2.789 . . . . 63.229999999999997 115.202 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.64 132.69 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 121.417 -0.802 . . . . 61.420000000000002 110.87 -169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -117.22 149.37 40.53 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.219 1.008 . . . . 73.510000000000005 109.073 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.6 mt -145.65 141.73 22.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 105.673 -1.973 . . . . 72.019999999999996 105.673 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.8 p -152.29 170.98 18.7 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.087 1.755 . . . . 73.319999999999993 108.861 168.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -95.37 160.02 14.73 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.804 0.729 . . . . 71.140000000000001 109.441 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.4 m -145.56 165.75 20.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.472 2.309 . . . . 73.230000000000004 109.391 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -70.66 -4.37 14.5 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.1 2.533 . . . . 73.430000000000007 112.349 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -131.85 29.13 4.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.45 1.5 . . . . 71.439999999999998 110.655 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 127.48 -158.36 21.18 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.377 -0.827 . . . . 23.539999999999999 112.739 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.18 153.03 23.77 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.484 1.142 . . . . 51.039999999999999 108.294 162.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.19 96.9 7.51 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.747 2.419 . . . . 70.450000000000003 109.167 -169.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.96 125.47 53.73 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.226 2.211 . . . . 73.510000000000005 110.061 -159.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -157.97 152.42 24.71 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 120.662 1.574 . . . . 33.119999999999997 114.427 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CE3' HD13 ' A' ' 99' ' ' ILE . 4.2 p90 -149.28 -179.62 7.2 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 127.226 2.21 . . . . 72.209999999999994 113.151 -171.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . 1.6 pp20? -115.56 160.36 34.96 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 126.703 2.001 . . . . 70.25 112.756 -170.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 27' ' ' GLU . 92.1 Cg_endo -69.52 176.24 6.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 126.647 4.898 . . . . 74.209999999999994 112.171 -176.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.75 113.52 3.01 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 108.083 -1.545 . . . . 65.120000000000005 108.083 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -103.47 13.95 32.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.952 0.901 . . . . 55.219999999999999 110.387 168.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 32' ' ' THR . 2.4 m -100.44 -84.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 127.536 2.334 . . . . 60.219999999999999 109.702 -174.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.402 ' H ' HG23 ' A' ' 31' ' ' VAL . 50.8 p -122.25 166.3 14.85 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.893 0.769 . . . . 54.32 109.364 170.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -60.0 -56.79 17.35 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.493 1.117 . . . . 73.099999999999994 110.205 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.13 -171.54 23.38 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.109 -0.796 . . . . 61.32 111.109 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -133.06 80.31 1.88 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.388 -0.967 . . . . 72.310000000000002 108.388 166.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -76.95 145.42 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.46 -1.311 . . . . 73.209999999999994 107.46 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.8 pt -133.04 -24.49 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.342 1.457 . . . . 72.099999999999994 111.434 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 39' ' ' TYR . 1.5 tp10 -168.1 -175.09 2.52 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 105.762 -1.94 . . . . 71.5 105.762 -174.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.465 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 75.2 m-85 -136.97 -166.15 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.546 -1.346 . . . . 65.209999999999994 109.913 175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.9 m -142.96 159.71 41.73 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.35 2.26 . . . . 70.219999999999999 109.549 165.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.47 119.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 103.84 -2.652 . . . . 62.409999999999997 103.84 169.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -114.41 151.9 32.39 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.709 -0.849 . . . . 73.430000000000007 108.709 173.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 tp -136.25 117.86 14.93 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.627 1.971 . . . . 74.329999999999998 107.338 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . . . -60.6 151.4 28.99 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.229 0.611 . . . . 44.32 111.623 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.38 172.49 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.571 1.148 . . . . 74.450000000000003 111.953 -169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -66.62 154.72 39.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.757 1.223 . . . . 64.329999999999998 109.955 156.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 t 70.11 -175.41 0.19 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.594 2.358 . . . . 45.420000000000002 112.498 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 p -114.96 166.07 12.18 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.455 1.902 . . . . 65.239999999999995 110.463 -174.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -164.42 -179.99 6.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.458 1.503 . . . . 73.349999999999994 109.311 -176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.32 163.29 13.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.329 1.451 . . . . 52.039999999999999 111.82 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.85 136.05 1.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.913 2.485 . . . . 54.020000000000003 107.701 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.85 93.7 0.1 OUTLIER Glycine 0 CA--C 1.52 0.363 0 N-CA-C 110.343 -1.103 . . . . 53.43 110.343 168.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -64.04 165.17 14.03 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 126.184 1.794 . . . . 73.239999999999995 112.27 -179.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 53' ' ' GLU . 55.3 Cg_endo -62.71 99.34 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 125.14 3.893 . . . . 70.540000000000006 111.7 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp 58.62 34.67 24.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.546 1.539 . . . . 62.109999999999999 112.541 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.4 t -45.1 -68.64 0.18 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.15 2.18 . . . . 41.039999999999999 110.636 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 65.25 15.88 10.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 73.109999999999999 112.764 176.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 t -135.81 152.3 75.65 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.432 1.093 . . . . 65.209999999999994 108.628 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.11 -169.23 0.75 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.399 2.733 . . . . 70.140000000000001 111.597 -176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 61.87 33.83 17.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.641 1.576 . . . . 73.140000000000001 112.91 173.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -72.14 169.04 16.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.377 1.071 . . . . 42.009999999999998 108.988 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 1.7 mt -104.58 -171.09 1.86 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.339 1.056 . . . . 73.219999999999999 110.549 -161.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 87.93 1.44 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.479 0.581 . . . . 63.140000000000001 110.788 172.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CZ ' HD13 ' A' ' 62' ' ' LEU . 13.5 m-30 -117.87 155.13 30.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.337 1.055 . . . . 74.129999999999995 110.052 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.7 ttp -87.03 146.9 25.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.632 0.773 . . . . 74.409999999999997 109.405 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.59 93.39 8.36 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 122.636 1.208 . . . . 61.520000000000003 110.961 175.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 m -71.61 1.16 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 124.599 1.16 . . . . 73.310000000000002 112.74 168.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -91.22 -163.92 1.1 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.992 1.717 . . . . 74.329999999999998 110.38 174.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 75.3 m 57.91 35.31 25.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.729 1.612 . . . . 63.549999999999997 110.829 -158.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.29 -177.48 9.89 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 110.167 -1.173 . . . . 53.049999999999997 110.167 163.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -26.08 28.71 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 121.432 1.421 . . . . 74.510000000000005 111.182 173.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.59 165.74 17.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.094 1.358 . . . . 65.420000000000002 109.541 -170.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.25 165.45 28.61 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.414 2.076 . . . . 74.439999999999998 109.745 160.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.2 m 49.35 36.35 9.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.992 1.317 . . . . 61.539999999999999 113.034 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 61.0 m -88.9 162.28 16.21 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.653 1.216 . . . . 71.540000000000006 111.224 170.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.576 ' H ' HD23 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.25 175.04 1.8 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.06 2.944 . . . . 61.119999999999997 113.705 172.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -135.8 119.68 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.236 1.014 . . . . 53.049999999999997 111.953 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -54.82 140.33 36.87 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.735 0.814 . . . . 73.319999999999993 111.599 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 p -56.14 -34.09 65.79 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.104 0.962 . . . . 72.549999999999997 112.799 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -55.17 -39.24 69.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.072 0.949 . . . . 72.549999999999997 111.583 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 t -74.55 -34.65 62.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.165 -0.959 . . . . 73.340000000000003 110.641 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.3 -33.77 76.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.633 0.651 . . . . 71.310000000000002 110.0 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -58.51 -37.21 75.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.633 1.573 . . . . 53.32 111.406 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -85.57 -5.58 59.26 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.068 -1.02 . . . . 65.140000000000001 112.711 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 149.82 21.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.607 -0.683 . . . . 53.439999999999998 111.166 -159.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 108.84 20.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.528 1.531 . . . . 74.430000000000007 109.693 -175.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -69.78 157.71 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.466 -0.938 . . . . 70.310000000000002 108.466 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -132.54 82.85 2.03 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.989 1.316 . . . . 63.130000000000003 108.656 -164.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.96 121.61 5.9 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 114.438 1.273 . . . . 75.310000000000002 114.438 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -79.44 -22.62 43.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.63 -2.077 . . . . 73.319999999999993 112.894 159.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 p -143.67 -62.37 0.4 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.314 1.416 . . . . 74.120000000000005 112.797 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -104.49 141.86 23.41 Favored Pre-proline 0 C--N 1.351 0.672 0 CA-C-O 116.811 -1.566 . . . . 72.209999999999994 109.218 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.48 120.58 7.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.229 1.953 . . . . 55.119999999999997 109.311 -176.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 116' ' ' LEU . . . -128.95 147.71 50.87 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.604 -0.887 . . . . 64.230000000000004 108.604 160.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.3 mt -91.76 130.43 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 126.945 2.098 . . . . 74.329999999999998 105.768 168.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.4 mm -82.81 138.13 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.768 -1.197 . . . . 72.530000000000001 107.768 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -121.5 133.56 55.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.634 -1.247 . . . . 74.519999999999996 107.634 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.0 mmt-85 -98.64 133.01 43.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 106.56 -1.645 . . . . 61.520000000000003 106.56 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.47 HD13 ' CE3' ' A' ' 26' ' ' TRP . 53.6 mt -135.87 140.27 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 105.686 -1.968 . . . . 62.240000000000002 105.686 175.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.27 164.48 35.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.511 0.724 . . . . 64.099999999999994 110.243 173.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.48 125.19 40.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.472 1.509 . . . . 65.519999999999996 111.15 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.48 ' HD3' ' CZ ' ' A' ' 107' ' ' TYR . 6.1 tpt180 -76.56 112.77 13.45 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.062 -1.459 . . . . 74.200000000000003 107.062 171.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.32 167.45 16.93 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 123.037 0.535 . . . . 71.409999999999997 111.346 162.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.66 -27.3 66.26 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.075 -0.391 . . . . 74.420000000000002 111.895 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -53.99 -40.02 66.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.336 1.454 . . . . 70.219999999999999 111.925 172.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.72 -173.37 27.82 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.632 2.063 . . . . 65.5 108.189 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -76.14 -5.05 44.91 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.126 1.528 . . . . 74.430000000000007 115.126 178.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.22 178.52 8.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.952 0.786 . . . . 42.439999999999998 111.958 -170.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.95 148.13 63.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.584 1.523 . . . . 70.120000000000005 108.911 162.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 150.46 20.65 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.699 0.799 . . . . 71.319999999999993 109.485 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -68.27 166.26 16.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.071 0.948 . . . . 32.32 110.5 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -120.55 86.45 2.57 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.712 -1.958 . . . . 73.409999999999997 105.712 170.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.7 t -89.44 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 106.945 -1.502 . . . . 64.430000000000007 106.945 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.534 ' H ' ' HD3' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -128.66 160.97 30.77 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.734 1.214 . . . . 74.040000000000006 107.945 165.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -119.27 80.13 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.637 1.575 . . . . 75.230000000000004 107.985 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 94' ' ' ALA . 36.9 mt -64.73 -21.74 66.82 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.896 0.702 . . . . 64.150000000000006 112.896 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.27 28.19 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.103 1.361 . . . . 73.040000000000006 111.622 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -58.56 106.09 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.496 -1.298 . . . . 60.030000000000001 107.496 164.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.9 172.51 5.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 128.508 2.723 . . . . 71.109999999999999 105.069 172.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.6 t 69.76 165.06 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.12 1.368 . . . . 52.109999999999999 111.017 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -149.57 22.95 0.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 130.11 3.364 . . . . 72.420000000000002 108.429 161.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 t70 60.43 19.6 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.183 2.193 . . . . 73.439999999999998 115.587 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 -176.47 0.15 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.878 -1.139 . . . . 74.140000000000001 111.756 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.9 m 55.2 -168.86 0.08 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.904 1.282 . . . . 71.25 113.136 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.85 171.15 32.55 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.074 1.797 . . . . 62.149999999999999 109.707 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.26 1.624 0 C-N-CA 125.102 1.361 . . . . 65.239999999999995 108.496 -172.508 . . . . . . . . 1 1 . 1 stop_ save_